"study_id","study_class","treatment_focus_study_level","total_n_randomized","intervention_group","treatment_focus_arm_level","treatment_focus_subclass_arm_level","n_completed_outcome_measure","n_completed_outcome_measure_detail","publication_treatment_name","ncptsd_treatment_name","psychotherapy","psychotherapy_subclass","pharmacotherapy","pharmacotherapy_subclass","cih","cih_subclass","nonpharm_biologic","nonpharm_cognitive_therapy","control","other","collaborative_care","format","delivery_method","arm_n_randomized","outcome_assessment_type","ptsd_outcome_measure_simple","ptsd_outcome_measure_detail","analysis_type","method_for_handling_missing","statistical_analysis_method","assessment_point_category","assessment_point","measure_score_detail","measure_score_mean","measure_score_sd","measure_score_type_of_variance_measure","measure_score_variance_value_or_lower_bound","measure_score_variance_upper_bound","score_difference_from_baseline_detail","score_difference_baseline","score_difference_baseline_sd","score_difference_from_baseline_95_ci_lower_bound","score_difference_from_baseline_95_ci_upper_bound","effect_size_1_detail","effect_size_1_type","effect_size_1_value","effect_size_1_type_of_variance_measure","effect_size_1_variance_value_or_lower_bound","effect_size_1_variance_upper_bound","effect_size_1_p_value","effect_size_2_detail","effect_size_2_type","effect_size_2_value","effect_size_2_type_of_variance_measure","effect_size_2_variance_value_or_lower_bound","effect_size_2_variance_upper_bound","effect_size_2_p_value","def_dc_1","per_dc_change_1","additional_definitions_diag_change","def_cm_1","per_cm_response_1","additional_definitions_clinic_resp","military_status","percent_active_duty_military","percent_veteran","percent_community","female_percent","female_percent_qual","male_percent","trauma_type","trauma_detail","risk_of_bias_rating_study_level","citation","ptsdpubs_id","year_added_to_ptsd_repository"
"acarturk2016_HTQ_A_0_NA","Psychotherapy","PTSD","98","A","PTSD",,,,"EMDR Recent Traumatic Episode Protocol","Eye Movement Desensitization and Reprocessing (EMDR)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","49","Self report","HTQ","HTQ (Arabic version)",,,"Linear mixed models, omega-squared for PTSD measure score, chi-square for diagnostic change","End of Treatment","0",,"1.42",,"SE","0.07",,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.7449",,"0.2551","Terrorism/political violence/forced displacement",,"Medium","Acarturk C, Konuk E, Cetinkaya M, et al. The efficacy of eye movement desensitization and reprocessing for post-traumatic stress disorder and depression among Syrian refugees: results of a randomized controlled trial. Psychol Med. 2016 Sep;46(12):2583-93. doi: 10.1017/S0033291716001070. PMID: 27353367.","45262","2019"
"acarturk2016_HTQ_A_4_NA","Psychotherapy","PTSD","98","A","PTSD",,,,"EMDR Recent Traumatic Episode Protocol","Eye Movement Desensitization and Reprocessing (EMDR)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","49","Self report","HTQ","HTQ (Arabic version)",,,"Linear mixed models, omega-squared for PTSD measure score, chi-square for diagnostic change","Assessment at <3 Months","4",,"1.57",,"SE","0.08",,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.7449",,"0.2551","Terrorism/political violence/forced displacement",,"Medium","Acarturk C, Konuk E, Cetinkaya M, et al. The efficacy of eye movement desensitization and reprocessing for post-traumatic stress disorder and depression among Syrian refugees: results of a randomized controlled trial. Psychol Med. 2016 Sep;46(12):2583-93. doi: 10.1017/S0033291716001070. PMID: 27353367.","45262","2019"
"acarturk2016_HTQ_A_Baseline_NA","Psychotherapy","PTSD","98","A","PTSD",,,,"EMDR Recent Traumatic Episode Protocol","Eye Movement Desensitization and Reprocessing (EMDR)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","49","Self report","HTQ","HTQ (Arabic version)",,,"Linear mixed models, omega-squared for PTSD measure score, chi-square for diagnostic change","Baseline",,,"2.63","0.42",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.7449",,"0.2551","Terrorism/political violence/forced displacement",,"Medium","Acarturk C, Konuk E, Cetinkaya M, et al. The efficacy of eye movement desensitization and reprocessing for post-traumatic stress disorder and depression among Syrian refugees: results of a randomized controlled trial. Psychol Med. 2016 Sep;46(12):2583-93. doi: 10.1017/S0033291716001070. PMID: 27353367.","45262","2019"
"acarturk2016_HTQ_B_0_NA","Psychotherapy","PTSD","98","B","Control",,,,"Waitlist","Waitlist","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,"49","Self report","HTQ","HTQ (Arabic version)",,,"Linear mixed models, omega-squared for PTSD measure score, chi-square for diagnostic change","End of Treatment","0",,"2.38",,"SE","0.08",,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.7449",,"0.2551","Terrorism/political violence/forced displacement",,"Medium","Acarturk C, Konuk E, Cetinkaya M, et al. The efficacy of eye movement desensitization and reprocessing for post-traumatic stress disorder and depression among Syrian refugees: results of a randomized controlled trial. Psychol Med. 2016 Sep;46(12):2583-93. doi: 10.1017/S0033291716001070. PMID: 27353367.","45262","2019"
"acarturk2016_HTQ_B_4_NA","Psychotherapy","PTSD","98","B","Control",,,,"Waitlist","Waitlist","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,"49","Self report","HTQ","HTQ (Arabic version)",,,"Linear mixed models, omega-squared for PTSD measure score, chi-square for diagnostic change","Assessment at <3 Months","4",,"2.38",,"SE","0.08",,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.7449",,"0.2551","Terrorism/political violence/forced displacement",,"Medium","Acarturk C, Konuk E, Cetinkaya M, et al. The efficacy of eye movement desensitization and reprocessing for post-traumatic stress disorder and depression among Syrian refugees: results of a randomized controlled trial. Psychol Med. 2016 Sep;46(12):2583-93. doi: 10.1017/S0033291716001070. PMID: 27353367.","45262","2019"
"acarturk2016_HTQ_B_Baseline_NA","Psychotherapy","PTSD","98","B","Control",,,,"Waitlist","Waitlist","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,"49","Self report","HTQ","HTQ (Arabic version)",,,"Linear mixed models, omega-squared for PTSD measure score, chi-square for diagnostic change","Baseline",,,"2.47","0.43",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.7449",,"0.2551","Terrorism/political violence/forced displacement",,"Medium","Acarturk C, Konuk E, Cetinkaya M, et al. The efficacy of eye movement desensitization and reprocessing for post-traumatic stress disorder and depression among Syrian refugees: results of a randomized controlled trial. Psychol Med. 2016 Sep;46(12):2583-93. doi: 10.1017/S0033291716001070. PMID: 27353367.","45262","2019"
"acarturk2016_IES_A_0_ITT","Psychotherapy","PTSD","98","A","PTSD",,"37",,"EMDR Recent Traumatic Episode Protocol","Eye Movement Desensitization and Reprocessing (EMDR)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","49","Self report","IES","IES-R (Arabic version)","ITT","Imputed","Linear mixed models, omega-squared for PTSD measure score, chi-square for diagnostic change","End of Treatment","0",,"21.36",,"SEM","2.76",,,"-38.33",,,,,,,,,,,,,,,,,,"Not meeting criteria for PTSD according to MINI","0.6122",,,,,"Community",,,"1","0.7449",,"0.2551","Terrorism/political violence/forced displacement",,"Medium","Acarturk C, Konuk E, Cetinkaya M, et al. The efficacy of eye movement desensitization and reprocessing for post-traumatic stress disorder and depression among Syrian refugees: results of a randomized controlled trial. Psychol Med. 2016 Sep;46(12):2583-93. doi: 10.1017/S0033291716001070. PMID: 27353367.","45262","2019"
"acarturk2016_IES_A_4_ITT","Psychotherapy","PTSD","98","A","PTSD",,"31",,"EMDR Recent Traumatic Episode Protocol","Eye Movement Desensitization and Reprocessing (EMDR)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","49","Self report","IES","IES-R (Arabic version)","ITT","Imputed","Linear mixed models, omega-squared for PTSD measure score, chi-square for diagnostic change","Assessment at <3 Months","4",,"25.87",,"SEM","3.01",,,"-33.82",,,,,,,,,,,,,,,,,,"Not meeting criteria for PTSD according to MINI","0.4898",,,,,"Community",,,"1","0.7449",,"0.2551","Terrorism/political violence/forced displacement",,"Medium","Acarturk C, Konuk E, Cetinkaya M, et al. The efficacy of eye movement desensitization and reprocessing for post-traumatic stress disorder and depression among Syrian refugees: results of a randomized controlled trial. Psychol Med. 2016 Sep;46(12):2583-93. doi: 10.1017/S0033291716001070. PMID: 27353367.","45262","2019"
"acarturk2016_IES_A_Baseline_ITT","Psychotherapy","PTSD","98","A","PTSD",,"49",,"EMDR Recent Traumatic Episode Protocol","Eye Movement Desensitization and Reprocessing (EMDR)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","49","Self report","IES","IES-R (Arabic version)","ITT","Imputed","Linear mixed models, omega-squared for PTSD measure score, chi-square for diagnostic change","Baseline",,,"59.69","13.65",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.7449",,"0.2551","Terrorism/political violence/forced displacement",,"Medium","Acarturk C, Konuk E, Cetinkaya M, et al. The efficacy of eye movement desensitization and reprocessing for post-traumatic stress disorder and depression among Syrian refugees: results of a randomized controlled trial. Psychol Med. 2016 Sep;46(12):2583-93. doi: 10.1017/S0033291716001070. PMID: 27353367.","45262","2019"
"acarturk2016_IES_B_0_ITT","Psychotherapy","PTSD","98","B","Control",,"33",,"Waitlist","Waitlist","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,"49","Self report","IES","IES-R (Arabic version)","ITT","Imputed","Linear mixed models, omega-squared for PTSD measure score, chi-square for diagnostic change","End of Treatment","0",,"59.01",,"SEM","2.92",,,"-3.54",,,,,,,,,,,,,,,,,,"Not meeting criteria for PTSD according to MINI","0.0612",,,,,"Community",,,"1","0.7449",,"0.2551","Terrorism/political violence/forced displacement",,"Medium","Acarturk C, Konuk E, Cetinkaya M, et al. The efficacy of eye movement desensitization and reprocessing for post-traumatic stress disorder and depression among Syrian refugees: results of a randomized controlled trial. Psychol Med. 2016 Sep;46(12):2583-93. doi: 10.1017/S0033291716001070. PMID: 27353367.","45262","2019"
"acarturk2016_IES_B_4_ITT","Psychotherapy","PTSD","98","B","Control",,"33",,"Waitlist","Waitlist","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,"49","Self report","IES","IES-R (Arabic version)","ITT","Imputed","Linear mixed models, omega-squared for PTSD measure score, chi-square for diagnostic change","Assessment at <3 Months","4",,"60.37",,"SEM","3.01",,,"-2.18",,,,,,,,,,,,,,,,,,"Not meeting criteria for PTSD according to MINI","0.0409",,,,,"Community",,,"1","0.7449",,"0.2551","Terrorism/political violence/forced displacement",,"Medium","Acarturk C, Konuk E, Cetinkaya M, et al. The efficacy of eye movement desensitization and reprocessing for post-traumatic stress disorder and depression among Syrian refugees: results of a randomized controlled trial. Psychol Med. 2016 Sep;46(12):2583-93. doi: 10.1017/S0033291716001070. PMID: 27353367.","45262","2019"
"acarturk2016_IES_B_Baseline_ITT","Psychotherapy","PTSD","98","B","Control",,"49",,"Waitlist","Waitlist","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,"49","Self report","IES","IES-R (Arabic version)","ITT","Imputed","Linear mixed models, omega-squared for PTSD measure score, chi-square for diagnostic change","Baseline",,,"62.55","12.46",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.7449",,"0.2551","Terrorism/political violence/forced displacement",,"Medium","Acarturk C, Konuk E, Cetinkaya M, et al. The efficacy of eye movement desensitization and reprocessing for post-traumatic stress disorder and depression among Syrian refugees: results of a randomized controlled trial. Psychol Med. 2016 Sep;46(12):2583-93. doi: 10.1017/S0033291716001070. PMID: 27353367.","45262","2019"
"acierno2017_PCL_A_0_Comp","Psychotherapy","PTSD","150","A","PTSD",,"55",,"PE delivered in-person","Prolonged Exposure (PE)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","76","Self report","PCL","PCL-M","Completer","Multiple imputation","Mixed effects model; non-inferiority margin (delta) set at 8.8 for PCL and 5 for BDI-II and analyses conducted with per-protocol sample.","End of Treatment","0",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran",,"1",,"0.0379",,"0.9621","Combat-related",,"Medium","Acierno RE, Knapp RG, Tuerk PW, et al. A non-inferiority trial of prolonged exposure for posttraumatic stress disorder: in person versus home-based telehealth. Behav Res Ther. 2017;89:57-65. doi: 10.1016/j.brat.2016.11.009. PMID: 27894058.","45948","2019"
"acierno2017_PCL_A_0_ITT","Psychotherapy","PTSD","150","A","PTSD",,"68",,"PE delivered in-person","Prolonged Exposure (PE)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","76","Self report","PCL","PCL-M","ITT","Multiple imputation","Mixed effects model; non-inferiority margin (delta) set at 8.8 for PCL and 5 for BDI-II and analyses conducted with per-protocol sample.","End of Treatment","0",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran",,"1",,"0.0379",,"0.9621","Combat-related",,"Medium","Acierno RE, Knapp RG, Tuerk PW, et al. A non-inferiority trial of prolonged exposure for posttraumatic stress disorder: in person versus home-based telehealth. Behav Res Ther. 2017;89:57-65. doi: 10.1016/j.brat.2016.11.009. PMID: 27894058.","45948","2019"
"acierno2017_PCL_A_12_Comp","Psychotherapy","PTSD","150","A","PTSD",,"55",,"PE delivered in-person","Prolonged Exposure (PE)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","76","Self report","PCL","PCL-M","Completer","Multiple imputation","Mixed effects model; non-inferiority margin (delta) set at 8.8 for PCL and 5 for BDI-II and analyses conducted with per-protocol sample.","Assessment at 3 to <6 Months","12",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran",,"1",,"0.0379",,"0.9621","Combat-related",,"Medium","Acierno RE, Knapp RG, Tuerk PW, et al. A non-inferiority trial of prolonged exposure for posttraumatic stress disorder: in person versus home-based telehealth. Behav Res Ther. 2017;89:57-65. doi: 10.1016/j.brat.2016.11.009. PMID: 27894058.","45948","2019"
"acierno2017_PCL_A_12_ITT","Psychotherapy","PTSD","150","A","PTSD",,"68",,"PE delivered in-person","Prolonged Exposure (PE)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","76","Self report","PCL","PCL-M","ITT","Multiple imputation","Mixed effects model; non-inferiority margin (delta) set at 8.8 for PCL and 5 for BDI-II and analyses conducted with per-protocol sample.","Assessment at 3 to <6 Months","12",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran",,"1",,"0.0379",,"0.9621","Combat-related",,"Medium","Acierno RE, Knapp RG, Tuerk PW, et al. A non-inferiority trial of prolonged exposure for posttraumatic stress disorder: in person versus home-based telehealth. Behav Res Ther. 2017;89:57-65. doi: 10.1016/j.brat.2016.11.009. PMID: 27894058.","45948","2019"
"acierno2017_PCL_A_26_Comp","Psychotherapy","PTSD","150","A","PTSD",,"55",,"PE delivered in-person","Prolonged Exposure (PE)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","76","Self report","PCL","PCL-M","Completer","Multiple imputation","Mixed effects model; non-inferiority margin (delta) set at 8.8 for PCL and 5 for BDI-II and analyses conducted with per-protocol sample.","Assessment at 6 to <12 Months","26",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran",,"1",,"0.0379",,"0.9621","Combat-related",,"Medium","Acierno RE, Knapp RG, Tuerk PW, et al. A non-inferiority trial of prolonged exposure for posttraumatic stress disorder: in person versus home-based telehealth. Behav Res Ther. 2017;89:57-65. doi: 10.1016/j.brat.2016.11.009. PMID: 27894058.","45948","2019"
"acierno2017_PCL_A_26_ITT","Psychotherapy","PTSD","150","A","PTSD",,"68",,"PE delivered in-person","Prolonged Exposure (PE)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","76","Self report","PCL","PCL-M","ITT","Multiple imputation","Mixed effects model; non-inferiority margin (delta) set at 8.8 for PCL and 5 for BDI-II and analyses conducted with per-protocol sample.","Assessment at 6 to <12 Months","26",,,,,,,,,,,,,"Slope","-1.9",,,,"p<0.0001",,,,,,,,,,,,,,"Veteran",,"1",,"0.0379",,"0.9621","Combat-related",,"Medium","Acierno RE, Knapp RG, Tuerk PW, et al. A non-inferiority trial of prolonged exposure for posttraumatic stress disorder: in person versus home-based telehealth. Behav Res Ther. 2017;89:57-65. doi: 10.1016/j.brat.2016.11.009. PMID: 27894058.","45948","2019"
"acierno2017_PCL_A_Baseline_Comp","Psychotherapy","PTSD","150","A","PTSD",,"55",,"PE delivered in-person","Prolonged Exposure (PE)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","76","Self report","PCL","PCL-M","Completer","Multiple imputation","Mixed effects model; non-inferiority margin (delta) set at 8.8 for PCL and 5 for BDI-II and analyses conducted with per-protocol sample.","Baseline",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran",,"1",,"0.0379",,"0.9621","Combat-related",,"Medium","Acierno RE, Knapp RG, Tuerk PW, et al. A non-inferiority trial of prolonged exposure for posttraumatic stress disorder: in person versus home-based telehealth. Behav Res Ther. 2017;89:57-65. doi: 10.1016/j.brat.2016.11.009. PMID: 27894058.","45948","2019"
"acierno2017_PCL_A_Baseline_ITT","Psychotherapy","PTSD","150","A","PTSD",,"68",,"PE delivered in-person","Prolonged Exposure (PE)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","76","Self report","PCL","PCL-M","ITT","Multiple imputation","Mixed effects model; non-inferiority margin (delta) set at 8.8 for PCL and 5 for BDI-II and analyses conducted with per-protocol sample.","Baseline",,,"58.3","11.1",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran",,"1",,"0.0379",,"0.9621","Combat-related",,"Medium","Acierno RE, Knapp RG, Tuerk PW, et al. A non-inferiority trial of prolonged exposure for posttraumatic stress disorder: in person versus home-based telehealth. Behav Res Ther. 2017;89:57-65. doi: 10.1016/j.brat.2016.11.009. PMID: 27894058.","45948","2019"
"acierno2017_PCL_B_0_Comp","Psychotherapy","PTSD","150","B","PTSD",,"43",,"PE delivered via home-based telehealth","Prolonged Exposure (PE)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","Video","74","Self report","PCL","PCL-M","Completer","Multiple imputation","Mixed effects model; non-inferiority margin (delta) set at 8.8 for PCL and 5 for BDI-II and analyses conducted with per-protocol sample.","End of Treatment","0",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran",,"1",,"0.0379",,"0.9621","Combat-related",,"Medium","Acierno RE, Knapp RG, Tuerk PW, et al. A non-inferiority trial of prolonged exposure for posttraumatic stress disorder: in person versus home-based telehealth. Behav Res Ther. 2017;89:57-65. doi: 10.1016/j.brat.2016.11.009. PMID: 27894058.","45948","2019"
"acierno2017_PCL_B_0_ITT","Psychotherapy","PTSD","150","B","PTSD",,"64",,"PE delivered via home-based telehealth","Prolonged Exposure (PE)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","Video","74","Self report","PCL","PCL-M","ITT","Multiple imputation","Mixed effects model; non-inferiority margin (delta) set at 8.8 for PCL and 5 for BDI-II and analyses conducted with per-protocol sample.","End of Treatment","0",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran",,"1",,"0.0379",,"0.9621","Combat-related",,"Medium","Acierno RE, Knapp RG, Tuerk PW, et al. A non-inferiority trial of prolonged exposure for posttraumatic stress disorder: in person versus home-based telehealth. Behav Res Ther. 2017;89:57-65. doi: 10.1016/j.brat.2016.11.009. PMID: 27894058.","45948","2019"
"acierno2017_PCL_B_12_Comp","Psychotherapy","PTSD","150","B","PTSD",,"43",,"PE delivered via home-based telehealth","Prolonged Exposure (PE)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","Video","74","Self report","PCL","PCL-M","Completer","Multiple imputation","Mixed effects model; non-inferiority margin (delta) set at 8.8 for PCL and 5 for BDI-II and analyses conducted with per-protocol sample.","Assessment at 3 to <6 Months","12",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran",,"1",,"0.0379",,"0.9621","Combat-related",,"Medium","Acierno RE, Knapp RG, Tuerk PW, et al. A non-inferiority trial of prolonged exposure for posttraumatic stress disorder: in person versus home-based telehealth. Behav Res Ther. 2017;89:57-65. doi: 10.1016/j.brat.2016.11.009. PMID: 27894058.","45948","2019"
"acierno2017_PCL_B_12_ITT","Psychotherapy","PTSD","150","B","PTSD",,"64",,"PE delivered via home-based telehealth","Prolonged Exposure (PE)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","Video","74","Self report","PCL","PCL-M","ITT","Multiple imputation","Mixed effects model; non-inferiority margin (delta) set at 8.8 for PCL and 5 for BDI-II and analyses conducted with per-protocol sample.","Assessment at 3 to <6 Months","12",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran",,"1",,"0.0379",,"0.9621","Combat-related",,"Medium","Acierno RE, Knapp RG, Tuerk PW, et al. A non-inferiority trial of prolonged exposure for posttraumatic stress disorder: in person versus home-based telehealth. Behav Res Ther. 2017;89:57-65. doi: 10.1016/j.brat.2016.11.009. PMID: 27894058.","45948","2019"
"acierno2017_PCL_B_26_Comp","Psychotherapy","PTSD","150","B","PTSD",,"43",,"PE delivered via home-based telehealth","Prolonged Exposure (PE)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","Video","74","Self report","PCL","PCL-M","Completer","Multiple imputation","Mixed effects model; non-inferiority margin (delta) set at 8.8 for PCL and 5 for BDI-II and analyses conducted with per-protocol sample.","Assessment at 6 to <12 Months","26",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran",,"1",,"0.0379",,"0.9621","Combat-related",,"Medium","Acierno RE, Knapp RG, Tuerk PW, et al. A non-inferiority trial of prolonged exposure for posttraumatic stress disorder: in person versus home-based telehealth. Behav Res Ther. 2017;89:57-65. doi: 10.1016/j.brat.2016.11.009. PMID: 27894058.","45948","2019"
"acierno2017_PCL_B_26_ITT","Psychotherapy","PTSD","150","B","PTSD",,"64",,"PE delivered via home-based telehealth","Prolonged Exposure (PE)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","Video","74","Self report","PCL","PCL-M","ITT","Multiple imputation","Mixed effects model; non-inferiority margin (delta) set at 8.8 for PCL and 5 for BDI-II and analyses conducted with per-protocol sample.","Assessment at 6 to <12 Months","26",,,,,,,,,,,,,"Slope","-1.8",,,,"p<0.0001",,,,,,,,,,,,,,"Veteran",,"1",,"0.0379",,"0.9621","Combat-related",,"Medium","Acierno RE, Knapp RG, Tuerk PW, et al. A non-inferiority trial of prolonged exposure for posttraumatic stress disorder: in person versus home-based telehealth. Behav Res Ther. 2017;89:57-65. doi: 10.1016/j.brat.2016.11.009. PMID: 27894058.","45948","2019"
"acierno2017_PCL_B_Baseline_Comp","Psychotherapy","PTSD","150","B","PTSD",,"43",,"PE delivered via home-based telehealth","Prolonged Exposure (PE)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","Video","74","Self report","PCL","PCL-M","Completer","Multiple imputation","Mixed effects model; non-inferiority margin (delta) set at 8.8 for PCL and 5 for BDI-II and analyses conducted with per-protocol sample.","Baseline",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran",,"1",,"0.0379",,"0.9621","Combat-related",,"Medium","Acierno RE, Knapp RG, Tuerk PW, et al. A non-inferiority trial of prolonged exposure for posttraumatic stress disorder: in person versus home-based telehealth. Behav Res Ther. 2017;89:57-65. doi: 10.1016/j.brat.2016.11.009. PMID: 27894058.","45948","2019"
"acierno2017_PCL_B_Baseline_ITT","Psychotherapy","PTSD","150","B","PTSD",,"64",,"PE delivered via home-based telehealth","Prolonged Exposure (PE)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","Video","74","Self report","PCL","PCL-M","ITT","Multiple imputation","Mixed effects model; non-inferiority margin (delta) set at 8.8 for PCL and 5 for BDI-II and analyses conducted with per-protocol sample.","Baseline",,,"60.1","11.3",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran",,"1",,"0.0379",,"0.9621","Combat-related",,"Medium","Acierno RE, Knapp RG, Tuerk PW, et al. A non-inferiority trial of prolonged exposure for posttraumatic stress disorder: in person versus home-based telehealth. Behav Res Ther. 2017;89:57-65. doi: 10.1016/j.brat.2016.11.009. PMID: 27894058.","45948","2019"
"adenauer2011_CAPS_A_16_Comp","Psychotherapy","PTSD","34","A","PTSD",,"11",,"NET","Narrative Exposure Therapy (NET)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","16","Structured Clinical Interview","CAPS","CAPS","Completer",,"Repeated-measures ANOVA with Greenhouse-Geisser's correction of the degrees of freedom as needed; post-hoc Tukey's honest significant difference test; Cohen's d effect sizes","Assessment at 3 to <6 Months","16",,"52.8","18.8",,,,,"-35.2",,,,,"Cohen's d","2.21",,,,"p<0.001",,,,,,,,"Not meeting criteria for PTSD according to CAPS","0.4545",,,,,"Community",,,"1","0.4412",,"0.5588","Terrorism/political violence/forced displacement",,"High","Adenauer H, Catani C, Gola H, et al. Narrative exposure therapy for PTSD increases top-down processing of aversive stimuli -- evidence from a randomized controlled treatment trial. BMC Neurosci. 2011 Dec 19;12:127. doi: 10.1186/1471-2202-12-127. PMID: 22182346.","37889","2019"
"adenauer2011_CAPS_A_Baseline_Comp","Psychotherapy","PTSD","34","A","PTSD",,"11",,"NET","Narrative Exposure Therapy (NET)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","16","Structured Clinical Interview","CAPS","CAPS","Completer",,"Repeated-measures ANOVA with Greenhouse-Geisser's correction of the degrees of freedom as needed; post-hoc Tukey's honest significant difference test; Cohen's d effect sizes","Baseline",,,"88","12.5",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.4412",,"0.5588","Terrorism/political violence/forced displacement",,"High","Adenauer H, Catani C, Gola H, et al. Narrative exposure therapy for PTSD increases top-down processing of aversive stimuli -- evidence from a randomized controlled treatment trial. BMC Neurosci. 2011 Dec 19;12:127. doi: 10.1186/1471-2202-12-127. PMID: 22182346.","37889","2019"
"adenauer2011_CAPS_B_16_Comp","Psychotherapy","PTSD","34","B","Control",,"8",,"Waitlist","Waitlist","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,"18","Structured Clinical Interview","CAPS","CAPS","Completer",,"Repeated-measures ANOVA with Greenhouse-Geisser's correction of the degrees of freedom as needed; post-hoc Tukey's honest significant difference test; Cohen's d effect sizes","Assessment at 3 to <6 Months","16",,"87.9","18.5",,,,,"15.9",,,,,"Cohen's d","-0.97",,,,"p=0.11",,,,,,,,"Not meeting criteria for PTSD according to CAPS","0",,,,,"Community",,,"1","0.4412",,"0.5588","Terrorism/political violence/forced displacement",,"High","Adenauer H, Catani C, Gola H, et al. Narrative exposure therapy for PTSD increases top-down processing of aversive stimuli -- evidence from a randomized controlled treatment trial. BMC Neurosci. 2011 Dec 19;12:127. doi: 10.1186/1471-2202-12-127. PMID: 22182346.","37889","2019"
"adenauer2011_CAPS_B_Baseline_Comp","Psychotherapy","PTSD","34","B","Control",,"8",,"Waitlist","Waitlist","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,"18","Structured Clinical Interview","CAPS","CAPS","Completer",,"Repeated-measures ANOVA with Greenhouse-Geisser's correction of the degrees of freedom as needed; post-hoc Tukey's honest significant difference test; Cohen's d effect sizes","Baseline",,,"72","13.8",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.4412",,"0.5588","Terrorism/political violence/forced displacement",,"High","Adenauer H, Catani C, Gola H, et al. Narrative exposure therapy for PTSD increases top-down processing of aversive stimuli -- evidence from a randomized controlled treatment trial. BMC Neurosci. 2011 Dec 19;12:127. doi: 10.1186/1471-2202-12-127. PMID: 22182346.","37889","2019"
"ahmadi2015_M-PTSD_A_0_Comp","Mixed: Psychotherapy & CIH","PTSD","48","A","PTSD",,"11",,"EMDR","Eye Movement Desensitization and Reprocessing (EMDR)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","16","Self report","M-PTSD","M-PTSD (Persian version)","Completer",,"ANOVA for continuous variables; Tukey's test for multiple comparisons","End of Treatment","0",,,,,,,,"-19.4","10.3",,,,,,,,,,,,,,,,,,,,,,,"Active Duty Military","1","0","0","0",,"1","Combat-related",,"High","Ahmadi K, Hazrati M, Ahmadizadeh MJ, et al. REM desensitization as a new therapeutic method for post-traumatic stress disorder: a randomized controlled trial. Acta Med Indones. 2015 Apr;47(2):111-9.  PMID: 26260553.","46896","2019"
"ahmadi2015_M-PTSD_A_Baseline_Comp","Mixed: Psychotherapy & CIH","PTSD","48","A","PTSD",,"11",,"EMDR","Eye Movement Desensitization and Reprocessing (EMDR)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","16","Self report","M-PTSD","M-PTSD (Persian version)","Completer",,"ANOVA for continuous variables; Tukey's test for multiple comparisons","Baseline",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Active Duty Military","1","0","0","0",,"1","Combat-related",,"High","Ahmadi K, Hazrati M, Ahmadizadeh MJ, et al. REM desensitization as a new therapeutic method for post-traumatic stress disorder: a randomized controlled trial. Acta Med Indones. 2015 Apr;47(2):111-9.  PMID: 26260553.","46896","2019"
"ahmadi2015_M-PTSD_B_0_Comp","Mixed: Psychotherapy & CIH","PTSD","48","B","PTSD",,"10",,"REM Desensitization","Rapid Eye Movement (REM) Desentization","No","Not Applicable","No","Not Applicable","No","Not Applicable","Yes","No","No","No","No","Individual","In Person","16","Self report","M-PTSD","M-PTSD (Persian version)","Completer",,"ANOVA for continuous variables; Tukey's test for multiple comparisons","End of Treatment","0",,,,,,,,"-20","9.5",,,,,,,,,,,,,,,,,,,,,,,"Active Duty Military","1","0","0","0",,"1","Combat-related",,"High","Ahmadi K, Hazrati M, Ahmadizadeh MJ, et al. REM desensitization as a new therapeutic method for post-traumatic stress disorder: a randomized controlled trial. Acta Med Indones. 2015 Apr;47(2):111-9.  PMID: 26260553.","46896","2019"
"ahmadi2015_M-PTSD_B_Baseline_Comp","Mixed: Psychotherapy & CIH","PTSD","48","B","PTSD",,"10",,"REM Desensitization","Rapid Eye Movement (REM) Desentization","No","Not Applicable","No","Not Applicable","No","Not Applicable","Yes","No","No","No","No","Individual","In Person","16","Self report","M-PTSD","M-PTSD (Persian version)","Completer",,"ANOVA for continuous variables; Tukey's test for multiple comparisons","Baseline",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Active Duty Military","1","0","0","0",,"1","Combat-related",,"High","Ahmadi K, Hazrati M, Ahmadizadeh MJ, et al. REM desensitization as a new therapeutic method for post-traumatic stress disorder: a randomized controlled trial. Acta Med Indones. 2015 Apr;47(2):111-9.  PMID: 26260553.","46896","2019"
"ahmadi2015_M-PTSD_C_0_Comp","Mixed: Psychotherapy & CIH","PTSD","48","C","Control",,"12",,"Control","Waitlist","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,"16","Self report","M-PTSD","M-PTSD (Persian version)","Completer",,"ANOVA for continuous variables; Tukey's test for multiple comparisons","End of Treatment","0",,,,,,,,"0.6","5.9",,,,,,,,,,,,,,,,,,,,,,,"Active Duty Military","1","0","0","0",,"1","Combat-related",,"High","Ahmadi K, Hazrati M, Ahmadizadeh MJ, et al. REM desensitization as a new therapeutic method for post-traumatic stress disorder: a randomized controlled trial. Acta Med Indones. 2015 Apr;47(2):111-9.  PMID: 26260553.","46896","2019"
"ahmadi2015_M-PTSD_C_Baseline_Comp","Mixed: Psychotherapy & CIH","PTSD","48","C","Control",,"12",,"Control","Waitlist","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,"16","Self report","M-PTSD","M-PTSD (Persian version)","Completer",,"ANOVA for continuous variables; Tukey's test for multiple comparisons","Baseline",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Active Duty Military","1","0","0","0",,"1","Combat-related",,"High","Ahmadi K, Hazrati M, Ahmadizadeh MJ, et al. REM desensitization as a new therapeutic method for post-traumatic stress disorder: a randomized controlled trial. Acta Med Indones. 2015 Apr;47(2):111-9.  PMID: 26260553.","46896","2019"
"ahmadizadeh2018_PCL_A_0_ITT","Nonpharmacologic biological","PTSD","65","A","PTSD",,"16",,"Bilateral rTMS","Transcranial magnetic stimualtion (TMS)","No","Not Applicable","No","Not Applicable","No","Not Applicable","Yes","No","No","No","No","Individual","In Person","22","Self report","PCL","PCL-M","ITT","LOCF","Repeated measures ANOVA; mixed model analysis; Bonferroni correction for pairwise comparisons; chi-squared for clinically meaningful change","End of Treatment","0",,"45.81","4.67",,,,"SE 2.31","-26.25",,,,,,,,,,"p=0.0001",,,,,,,,,,,"Change in PCL-M ≥2 standard deviation relative to sample's baseline PCL-M score","0.625",,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Ahmadizadeh MJ, Rezaei M. Unilateral right and bilateral dorsolateral prefrontal cortex transcranial magnetic stimulation in treatment post-traumatic stress disorder: a randomized controlled study. Brain Res Bull. 2018;140:334-40. doi: 10.1016/j.brainresbull.2018.06.001. PMID: 29883597.","50480","2019"
"ahmadizadeh2018_PCL_A_Baseline_ITT","Nonpharmacologic biological","PTSD","65","A","PTSD",,"22",,"Bilateral rTMS","Transcranial magnetic stimualtion (TMS)","No","Not Applicable","No","Not Applicable","No","Not Applicable","Yes","No","No","No","No","Individual","In Person","22","Self report","PCL","PCL-M","ITT","LOCF","Repeated measures ANOVA; mixed model analysis; Bonferroni correction for pairwise comparisons; chi-squared for clinically meaningful change","Baseline",,,"71.26","7.65",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Ahmadizadeh MJ, Rezaei M. Unilateral right and bilateral dorsolateral prefrontal cortex transcranial magnetic stimulation in treatment post-traumatic stress disorder: a randomized controlled study. Brain Res Bull. 2018;140:334-40. doi: 10.1016/j.brainresbull.2018.06.001. PMID: 29883597.","50480","2019"
"ahmadizadeh2018_PCL_B_0_ITT","Nonpharmacologic biological","PTSD","65","B","PTSD",,"17",,"Unilateral rTMS","Transcranial magnetic stimualtion (TMS)","No","Not Applicable","No","Not Applicable","No","Not Applicable","Yes","No","No","No","No","Individual","In Person","21","Self report","PCL","PCL-M","ITT","LOCF","Repeated measures ANOVA; mixed model analysis; Bonferroni correction for pairwise comparisons; chi-squared for clinically meaningful change","End of Treatment","0",,"49.41","6.53",,,,"SE 2.55","-21.12",,,,,,,,,,"p=0.0001",,,,,,,,,,,"Change in PCL-M ≥2 standard deviation relative to sample's baseline PCL-M score","0.4118",,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Ahmadizadeh MJ, Rezaei M. Unilateral right and bilateral dorsolateral prefrontal cortex transcranial magnetic stimulation in treatment post-traumatic stress disorder: a randomized controlled study. Brain Res Bull. 2018;140:334-40. doi: 10.1016/j.brainresbull.2018.06.001. PMID: 29883597.","50480","2019"
"ahmadizadeh2018_PCL_B_Baseline_ITT","Nonpharmacologic biological","PTSD","65","B","PTSD",,"21",,"Unilateral rTMS","Transcranial magnetic stimualtion (TMS)","No","Not Applicable","No","Not Applicable","No","Not Applicable","Yes","No","No","No","No","Individual","In Person","21","Self report","PCL","PCL-M","ITT","LOCF","Repeated measures ANOVA; mixed model analysis; Bonferroni correction for pairwise comparisons; chi-squared for clinically meaningful change","Baseline",,,"70.57","9",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Ahmadizadeh MJ, Rezaei M. Unilateral right and bilateral dorsolateral prefrontal cortex transcranial magnetic stimulation in treatment post-traumatic stress disorder: a randomized controlled study. Brain Res Bull. 2018;140:334-40. doi: 10.1016/j.brainresbull.2018.06.001. PMID: 29883597.","50480","2019"
"ahmadizadeh2018_PCL_C_0_ITT","Nonpharmacologic biological","PTSD","65","C","Control",,"16",,"Sham rTMS","Sham","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","22","Self report","PCL","PCL-M","ITT","LOCF","Repeated measures ANOVA; mixed model analysis; Bonferroni correction for pairwise comparisons; chi-squared for clinically meaningful change","End of Treatment","0",,"66.93","10.34",,,,,"-3.62",,,,,,,,,,,,,,,,,,,,,"Change in PCL-M ≥2 standard deviation relative to sample's baseline PCL-M score","0",,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Ahmadizadeh MJ, Rezaei M. Unilateral right and bilateral dorsolateral prefrontal cortex transcranial magnetic stimulation in treatment post-traumatic stress disorder: a randomized controlled study. Brain Res Bull. 2018;140:334-40. doi: 10.1016/j.brainresbull.2018.06.001. PMID: 29883597.","50480","2019"
"ahmadizadeh2018_PCL_C_Baseline_ITT","Nonpharmacologic biological","PTSD","65","C","Control",,"22",,"Sham rTMS","Sham","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","22","Self report","PCL","PCL-M","ITT","LOCF","Repeated measures ANOVA; mixed model analysis; Bonferroni correction for pairwise comparisons; chi-squared for clinically meaningful change","Baseline",,,"70.55","9.04",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Ahmadizadeh MJ, Rezaei M. Unilateral right and bilateral dorsolateral prefrontal cortex transcranial magnetic stimulation in treatment post-traumatic stress disorder: a randomized controlled study. Brain Res Bull. 2018;140:334-40. doi: 10.1016/j.brainresbull.2018.06.001. PMID: 29883597.","50480","2019"
"ahmadizadeh2019_PCL_A_0_Comp","Nonpharmacologic biological","PTSD","40","A","PTSD",,"18",,"Transcranial direct current stimulation (tDCS)","Transcranial direct current stimulation (tDCS)","No","Not Applicable","No","Not Applicable","No","Not Applicable","Yes","No","No","No","No","Individual","In person","20","Self report","PCL","PCL-5","Completer",,"Group x time (2×3) mixed model analysis
Multiple ANOVA for pre-treatment group differences","End of Treatment","0",,"37.44","10.77",,,,,"-16.95",,,,,,,,,,,,,,,,,,"PCL-5 < 33","0.444",,"PCL-5 ≤ 24 on the PCL-5, if reliable change index also exceeds 1.96","0.278",,"Community",,,"1","0.65",,"0.35",,,"Medium","Ahmadizadeh MJ, Rezaei M, Fitzgerald PB. Transcranial direct current stimulation (tDCS) for post-traumatic stress disorder (PTSD): a randomized, double-blinded, controlled trial. Brain research bulletin. 2019;153:273-8. PMID: 31560945.","1545324","2020"
"ahmadizadeh2019_PCL_A_4_Comp","Nonpharmacologic biological","PTSD","40","A","PTSD",,"16",,"Transcranial direct current stimulation (tDCS)","Transcranial direct current stimulation (tDCS)","No","Not Applicable","No","Not Applicable","No","Not Applicable","Yes","No","No","No","No","Individual","In person","20","Self report","PCL","PCL-5","Completer",,"Group x time (2×3) mixed model analysis
Multiple ANOVA for pre-treatment group differences","Assessment at <3 Months","4",,"41.28","8.86",,,,,"-13.11",,,,,,,,,,,,,,,,,,"PCL-5 < 33",,,"PCL-5 ≤ 24 on the PCL-5, if reliable change index also exceeds 1.96",,,"Community",,,"1","0.65",,"0.35",,,"Medium","Ahmadizadeh MJ, Rezaei M, Fitzgerald PB. Transcranial direct current stimulation (tDCS) for post-traumatic stress disorder (PTSD): a randomized, double-blinded, controlled trial. Brain research bulletin. 2019;153:273-8. PMID: 31560945.","1545324","2020"
"ahmadizadeh2019_PCL_A_Baseline_Comp","Nonpharmacologic biological","PTSD","40","A","PTSD",,"20",,"Transcranial direct current stimulation (tDCS)","Transcranial direct current stimulation (tDCS)","No","Not Applicable","No","Not Applicable","No","Not Applicable","Yes","No","No","No","No","Individual","In person","20","Self report","PCL","PCL-5","Completer",,"Group x time (2×3) mixed model analysis
Multiple ANOVA for pre-treatment group differences","Baseline",,,"54.39","2.93",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.65",,"0.35",,,"Medium","Ahmadizadeh MJ, Rezaei M, Fitzgerald PB. Transcranial direct current stimulation (tDCS) for post-traumatic stress disorder (PTSD): a randomized, double-blinded, controlled trial. Brain research bulletin. 2019;153:273-8. PMID: 31560945.","1545324","2020"
"ahmadizadeh2019_PCL_B_0_Comp","Nonpharmacologic biological","PTSD","40","B","Control",,"16",,"Sham transcranial direct current stimulation","Sham","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In person","20","Self report","PCL","PCL-5","Completer",,"Group x time (2×3) mixed model analysis
Multiple ANOVA for pre-treatment group differences","End of Treatment","0",,"52.00","11.19",,,,,"-2.81",,,,,,,,,,,,,,,,,,"PCL-5 < 33","0.125",,"PCL-5 ≤ 24 on the PCL-5, if reliable change index also exceeds 1.96","0.062",,"Community",,,"1","0.65",,"0.35",,,"Medium","Ahmadizadeh MJ, Rezaei M, Fitzgerald PB. Transcranial direct current stimulation (tDCS) for post-traumatic stress disorder (PTSD): a randomized, double-blinded, controlled trial. Brain research bulletin. 2019;153:273-8. PMID: 31560945.","1545324","2020"
"ahmadizadeh2019_PCL_B_4_Comp","Nonpharmacologic biological","PTSD","40","B","Control",,"16",,"Sham transcranial direct current stimulation","Sham","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In person","20","Self report","PCL","PCL-5","Completer",,"Group x time (2×3) mixed model analysis
Multiple ANOVA for pre-treatment group differences","Assessment at <3 Months","4",,"52.81","5.07",,,,,"-2.00",,,,,,,,,,,,,,,,,,"PCL-5 < 33",,,"PCL-5 ≤ 24 on the PCL-5, if reliable change index also exceeds 1.96",,,"Community",,,"1","0.65",,"0.35",,,"Medium","Ahmadizadeh MJ, Rezaei M, Fitzgerald PB. Transcranial direct current stimulation (tDCS) for post-traumatic stress disorder (PTSD): a randomized, double-blinded, controlled trial. Brain research bulletin. 2019;153:273-8. PMID: 31560945.","1545324","2020"
"ahmadizadeh2019_PCL_B_Baseline_Comp","Nonpharmacologic biological","PTSD","40","B","Control",,"20",,"Sham transcranial direct current stimulation","Sham","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In person","20","Self report","PCL","PCL-5","Completer",,"Group x time (2×3) mixed model analysis
Multiple ANOVA for pre-treatment group differences","Baseline",,,"54.81","2.79",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.65",,"0.35",,,"Medium","Ahmadizadeh MJ, Rezaei M, Fitzgerald PB. Transcranial direct current stimulation (tDCS) for post-traumatic stress disorder (PTSD): a randomized, double-blinded, controlled trial. Brain research bulletin. 2019;153:273-8. PMID: 31560945.","1545324","2020"
"ahmadpanah2014_MINI_A_0_ITT","Pharmacotherapy","PTSD","100","A","PTSD",,"33",,"Prazosin","Prazosin","No","Not Applicable","Yes","Antiadrenergic","No","Not Applicable","No","No","No","No","No","Individual","In Person","33","Structured Clinical Interview","MINI","MINI","ITT",,"Group x time (2×3) mixed model analysis
Multiple ANOVA for pre-treatment group differences","End of Treatment","0",,"3.36","0.78",,,,,"-3.64",,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.28",,"0.72","Mixed","combat-related, accidents, natural or manmade disasters, other (not specified)","Medium","Ahmadpanah M, Sabzeiee P, Hosseini SM, et al. Comparing the effect of prazosin and hydroxyzine on sleep quality in patients suffering from posttraumatic stress disorder. Neuropsychobiology. 2014 2016-09-15;69(4):235-42. doi: http://dx.doi.org/10.1159/000362243. PMID: 24993832.","43996","2019"
"ahmadpanah2014_MINI_A_Baseline_ITT","Pharmacotherapy","PTSD","100","A","PTSD",,"33",,"Prazosin","Prazosin","No","Not Applicable","Yes","Antiadrenergic","No","Not Applicable","No","No","No","No","No","Individual","In Person","33","Structured Clinical Interview","MINI","MINI","ITT",,"Group x time (2×3) mixed model analysis
Multiple ANOVA for pre-treatment group differences","Baseline",,,"7","0.04",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.28",,"0.72","Mixed","combat-related, accidents, natural or manmade disasters, other (not specified)","Medium","Ahmadpanah M, Sabzeiee P, Hosseini SM, et al. Comparing the effect of prazosin and hydroxyzine on sleep quality in patients suffering from posttraumatic stress disorder. Neuropsychobiology. 2014 2016-09-15;69(4):235-42. doi: http://dx.doi.org/10.1159/000362243. PMID: 24993832.","43996","2019"
"ahmadpanah2014_MINI_B_0_ITT","Pharmacotherapy","PTSD","100","B","PTSD",,"34",,"Hydroxyzine","Hydroxyzine","No","Not Applicable","Yes","Antianxiety: nonbenzodiazepine","No","Not Applicable","No","No","No","No","No","Individual","In Person","34","Structured Clinical Interview","MINI","MINI","ITT",,"Group x time (2×3) mixed model analysis
Multiple ANOVA for pre-treatment group differences","End of Treatment","0",,"3.58","0.98",,,,,"-3.42",,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.28",,"0.72","Mixed","combat-related, accidents, natural or manmade disasters, other (not specified)","Medium","Ahmadpanah M, Sabzeiee P, Hosseini SM, et al. Comparing the effect of prazosin and hydroxyzine on sleep quality in patients suffering from posttraumatic stress disorder. Neuropsychobiology. 2014 2016-09-15;69(4):235-42. doi: http://dx.doi.org/10.1159/000362243. PMID: 24993832.","43996","2019"
"ahmadpanah2014_MINI_B_Baseline_ITT","Pharmacotherapy","PTSD","100","B","PTSD",,"34",,"Hydroxyzine","Hydroxyzine","No","Not Applicable","Yes","Antianxiety: nonbenzodiazepine","No","Not Applicable","No","No","No","No","No","Individual","In Person","34","Structured Clinical Interview","MINI","MINI","ITT",,"Group x time (2×3) mixed model analysis
Multiple ANOVA for pre-treatment group differences","Baseline",,,"7","0.5",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.28",,"0.72","Mixed","combat-related, accidents, natural or manmade disasters, other (not specified)","Medium","Ahmadpanah M, Sabzeiee P, Hosseini SM, et al. Comparing the effect of prazosin and hydroxyzine on sleep quality in patients suffering from posttraumatic stress disorder. Neuropsychobiology. 2014 2016-09-15;69(4):235-42. doi: http://dx.doi.org/10.1159/000362243. PMID: 24993832.","43996","2019"
"ahmadpanah2014_MINI_C_0_ITT","Pharmacotherapy","PTSD","100","C","Control",,"33",,"Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","33","Structured Clinical Interview","MINI","MINI","ITT",,"Group x time (2×3) mixed model analysis
Multiple ANOVA for pre-treatment group differences","End of Treatment","0",,"5.39","1.29",,,,,"-1.61",,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.28",,"0.72","Mixed","combat-related, accidents, natural or manmade disasters, other (not specified)","Medium","Ahmadpanah M, Sabzeiee P, Hosseini SM, et al. Comparing the effect of prazosin and hydroxyzine on sleep quality in patients suffering from posttraumatic stress disorder. Neuropsychobiology. 2014 2016-09-15;69(4):235-42. doi: http://dx.doi.org/10.1159/000362243. PMID: 24993832.","43996","2019"
"ahmadpanah2014_MINI_C_Baseline_ITT","Pharmacotherapy","PTSD","100","C","Control",,"33",,"Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","33","Structured Clinical Interview","MINI","MINI","ITT",,"Group x time (2×3) mixed model analysis
Multiple ANOVA for pre-treatment group differences","Baseline",,,"7","0.4",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.28",,"0.72","Mixed","combat-related, accidents, natural or manmade disasters, other (not specified)","Medium","Ahmadpanah M, Sabzeiee P, Hosseini SM, et al. Comparing the effect of prazosin and hydroxyzine on sleep quality in patients suffering from posttraumatic stress disorder. Neuropsychobiology. 2014 2016-09-15;69(4):235-42. doi: http://dx.doi.org/10.1159/000362243. PMID: 24993832.","43996","2019"
"akbarian2015_IES_A_0_ITT","Mixed: Psychotherapy & pharmacotherapy","PTSD","40","A","PTSD",,"20",,"CBT","Trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","Yes","Other pharmacotherapy","No","Not Applicable","No","No","No","No","No","Group","In Person","20","Self report","IES","IES-R","ITT","LOCF","Group x time (2×3) mixed model analysis
Multiple ANOVA for pre-treatment group differences","End of Treatment","0",,"55.57","4.77",,,,,"-10.79",,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.7857",,"0.2143","Mixed","intimate partner violence, accidents, illness/medical procedure","Medium","Akbarian F, Bajoghli H, Haghighi M, et al. The effectiveness of cognitive behavioral therapy with respect to psychological symptoms and recovering autobiographical memory in patients suffering from post-traumatic stress disorder. Neuropsychiatr Dis Treat. 2015;11:395-404. doi: 10.2147/NDT.S79581. PMID: 25737635.","43629","2019"
"akbarian2015_IES_A_Baseline_ITT","Mixed: Psychotherapy & pharmacotherapy","PTSD","40","A","PTSD",,"20",,"CBT","Trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","Yes","Other pharmacotherapy","No","Not Applicable","No","No","No","No","No","Group","In Person","20","Self report","IES","IES-R","ITT","LOCF","Group x time (2×3) mixed model analysis
Multiple ANOVA for pre-treatment group differences","Baseline",,,"66.36","4.81",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.7857",,"0.2143","Mixed","intimate partner violence, accidents, illness/medical procedure","Medium","Akbarian F, Bajoghli H, Haghighi M, et al. The effectiveness of cognitive behavioral therapy with respect to psychological symptoms and recovering autobiographical memory in patients suffering from post-traumatic stress disorder. Neuropsychiatr Dis Treat. 2015;11:395-404. doi: 10.2147/NDT.S79581. PMID: 25737635.","43629","2019"
"akbarian2015_IES_B_0_ITT","Mixed: Psychotherapy & pharmacotherapy","PTSD","40","B","Control",,"20",,"Control condition (psychopharmacologic treatment only)","Medication as usual","No","Not Applicable","Yes","Other pharmacotherapy","No","Not Applicable","No","No","No","No","No","Individual","In Person","20","Self report","IES","IES-R","ITT","LOCF","Group x time (2×3) mixed model analysis
Multiple ANOVA for pre-treatment group differences","End of Treatment","0",,"63.5","5.68",,,,,"-0.5",,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.7857",,"0.2143","Mixed","intimate partner violence, accidents, illness/medical procedure","Medium","Akbarian F, Bajoghli H, Haghighi M, et al. The effectiveness of cognitive behavioral therapy with respect to psychological symptoms and recovering autobiographical memory in patients suffering from post-traumatic stress disorder. Neuropsychiatr Dis Treat. 2015;11:395-404. doi: 10.2147/NDT.S79581. PMID: 25737635.","43629","2019"
"akbarian2015_IES_B_Baseline_ITT","Mixed: Psychotherapy & pharmacotherapy","PTSD","40","B","Control",,"20",,"Control condition (psychopharmacologic treatment only)","Medication as usual","No","Not Applicable","Yes","Other pharmacotherapy","No","Not Applicable","No","No","No","No","No","Individual","In Person","20","Self report","IES","IES-R","ITT","LOCF","Group x time (2×3) mixed model analysis
Multiple ANOVA for pre-treatment group differences","Baseline",,,"64","5.11",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.7857",,"0.2143","Mixed","intimate partner violence, accidents, illness/medical procedure","Medium","Akbarian F, Bajoghli H, Haghighi M, et al. The effectiveness of cognitive behavioral therapy with respect to psychological symptoms and recovering autobiographical memory in patients suffering from post-traumatic stress disorder. Neuropsychiatr Dis Treat. 2015;11:395-404. doi: 10.2147/NDT.S79581. PMID: 25737635.","43629","2019"
"akuchekian2004_CAPS_A_0_ITT","Pharmacotherapy","PTSD","67","A","PTSD",,"32",,"Topiramate augmentation","Topiramate augmentation","No","Not Applicable","Yes","Mood Stabilizer","No","Not Applicable","No","No","No","No","No","Individual","In Person","34","Structured Clinical Interview","CAPS","CAPS (11-item severity score)","ITT","LOCF","Group x time (2×3) mixed model analysis
Multiple ANOVA for pre-treatment group differences","End of Treatment","0",,"32.75","8.2",,,,,"-17.95",,,,,,,,,,,,,,,,,,,,,,,,"Veteran",,"1","0","0",,"1","Combat-related",,"Medium","Akuchekian S, Amanat S. The Comparison of Topiramate and Placebo in the Treatment of Posttraumatic Stress Disorder: A Randomized, Double- Blind Study. J Res Med Sci. 2004;9(5):240-4.","50403","2019"
"akuchekian2004_CAPS_A_Baseline_ITT","Pharmacotherapy","PTSD","67","A","PTSD",,"34",,"Topiramate augmentation","Topiramate augmentation","No","Not Applicable","Yes","Mood Stabilizer","No","Not Applicable","No","No","No","No","No","Individual","In Person","34","Structured Clinical Interview","CAPS","CAPS (11-item severity score)","ITT","LOCF","Group x time (2×3) mixed model analysis
Multiple ANOVA for pre-treatment group differences","Baseline",,,"50.70","7.7",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran",,"1","0","0",,"1","Combat-related",,"Medium","Akuchekian S, Amanat S. The Comparison of Topiramate and Placebo in the Treatment of Posttraumatic Stress Disorder: A Randomized, Double- Blind Study. J Res Med Sci. 2004;9(5):240-4.","50403","2019"
"akuchekian2004_CAPS_B_0_ITT","Pharmacotherapy","PTSD","67","B","Control",,"30",,"Placebo augmentation","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","33","Structured Clinical Interview","CAPS","CAPS (11-item severity score)","ITT","LOCF","Group x time (2×3) mixed model analysis
Multiple ANOVA for pre-treatment group differences","End of Treatment","0",,"46.62","8.8",,,,,"-2.28",,,,,,,,,,,,,,,,,,,,,,,,"Veteran",,"1","0","0",,"1","Combat-related",,"Medium","Akuchekian S, Amanat S. The Comparison of Topiramate and Placebo in the Treatment of Posttraumatic Stress Disorder: A Randomized, Double- Blind Study. J Res Med Sci. 2004;9(5):240-4.","50403","2019"
"akuchekian2004_CAPS_B_Baseline_ITT","Pharmacotherapy","PTSD","67","B","Control",,"33",,"Placebo augmentation","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","33","Structured Clinical Interview","CAPS","CAPS (11-item severity score)","ITT","LOCF","Group x time (2×3) mixed model analysis
Multiple ANOVA for pre-treatment group differences","Baseline",,,"48.9","9.13",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran",,"1","0","0",,"1","Combat-related",,"Medium","Akuchekian S, Amanat S. The Comparison of Topiramate and Placebo in the Treatment of Posttraumatic Stress Disorder: A Randomized, Double- Blind Study. J Res Med Sci. 2004;9(5):240-4.","50403","2019"
"aldahadha2012_TSI_A_0_Comp","Psychotherapy","PTSD","51","A","PTSD",,"25",,"EMDR","Eye Movement Desensitization and Reprocessing (EMDR)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","25","Self report","TSI","TSI","Completer",,"Group x time (2×3) mixed model analysis
Multiple ANOVA for pre-treatment group differences","End of Treatment","0",,"43.76","5.11",,,,,"-14.72",,,,,,,,,,"p<0.0001",,,,,,,,,,,,,,"Community",,,"1","0.5294",,"0.4706","Accidents",,"High","Aldahadha B, Al-Harthy H, Sulaiman S. The Efficacy of Eye Movement Desensitization Reprocessing in Resolving the Trauma Caused by the Road Accidents in the Sultanate of Oman. Journal of Instructional Psychology. 2012;39(3/4):146-58.","1548482","2019"
"aldahadha2012_TSI_A_4_Comp","Psychotherapy","PTSD","51","A","PTSD",,"22",,"EMDR","Eye Movement Desensitization and Reprocessing (EMDR)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","25","Self report","TSI","TSI","Completer",,"Group x time (2×3) mixed model analysis
Multiple ANOVA for pre-treatment group differences","Assessment at <3 Months","4",,"42.18","5.84",,,,,"-16.3",,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.5294",,"0.4706","Accidents",,"High","Aldahadha B, Al-Harthy H, Sulaiman S. The Efficacy of Eye Movement Desensitization Reprocessing in Resolving the Trauma Caused by the Road Accidents in the Sultanate of Oman. Journal of Instructional Psychology. 2012;39(3/4):146-58.","1548482","2019"
"aldahadha2012_TSI_A_Baseline_Comp","Psychotherapy","PTSD","51","A","PTSD",,"25",,"EMDR","Eye Movement Desensitization and Reprocessing (EMDR)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","25","Self report","TSI","TSI","Completer",,"Group x time (2×3) mixed model analysis
Multiple ANOVA for pre-treatment group differences","Baseline",,,"58.48","6.66",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.5294",,"0.4706","Accidents",,"High","Aldahadha B, Al-Harthy H, Sulaiman S. The Efficacy of Eye Movement Desensitization Reprocessing in Resolving the Trauma Caused by the Road Accidents in the Sultanate of Oman. Journal of Instructional Psychology. 2012;39(3/4):146-58.","1548482","2019"
"aldahadha2012_TSI_B_0_Comp","Psychotherapy","PTSD","51","B","Control",,"22",,"Waitlist","Waitlist","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,"26","Self report","TSI","TSI","Completer",,"Group x time (2×3) mixed model analysis
Multiple ANOVA for pre-treatment group differences","End of Treatment","0",,"58.08","6.62",,,,,"-1.23",,,,,,,,,,"p=0.5397",,,,,,,,,,,,,,"Community",,,"1","0.5294",,"0.4706","Accidents",,"High","Aldahadha B, Al-Harthy H, Sulaiman S. The Efficacy of Eye Movement Desensitization Reprocessing in Resolving the Trauma Caused by the Road Accidents in the Sultanate of Oman. Journal of Instructional Psychology. 2012;39(3/4):146-58.","1548482","2019"
"aldahadha2012_TSI_B_Baseline_Comp","Psychotherapy","PTSD","51","B","Control",,"26",,"Waitlist","Waitlist","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,"26","Self report","TSI","TSI","Completer",,"Group x time (2×3) mixed model analysis
Multiple ANOVA for pre-treatment group differences","Baseline",,,"59.31","6.9",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.5294",,"0.4706","Accidents",,"High","Aldahadha B, Al-Harthy H, Sulaiman S. The Efficacy of Eye Movement Desensitization Reprocessing in Resolving the Trauma Caused by the Road Accidents in the Sultanate of Oman. Journal of Instructional Psychology. 2012;39(3/4):146-58.","1548482","2019"
"alghamdi2015_SPTSS_A_0_ITT","Psychotherapy","PTSD","34","A","PTSD",,"17",,"NET","Narrative Exposure Therapy (NET)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","17","Self report","SPTSS","SPTSS","ITT","None","ANCOVA and Hedges' g for change in mean score between groups, paired t-test for within-group","End of Treatment","0",,,,,,,,"-6.65",,"-8.05","-5.23",,"Hedges' g","0.75",,,,"p<0.001",,,,,,,,,,,,,,"Community","0","0","1","0",,"1",,,"Medium","Alghamdi M, Hunt NC, Thomas SA. The effectiveness of narrative exposure therapy with traumatised firefighters in Saudi Arabia: a randomized controlled study. Behav Res Ther. 2015 Mar;66:64-71. doi: 10.1016/j.brat.2015.01.008. PMID: 25701801.","46524","2020"
"alghamdi2015_SPTSS_A_12_ITT","Psychotherapy","PTSD","34","A","PTSD",,"14",,"NET","Narrative Exposure Therapy (NET)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","17","Self report","SPTSS","SPTSS","ITT","None","ANCOVA and Hedges' g for change in mean score between groups, paired t-test for within-group","Assessment at 3 to <6 Months","12",,,,,,,,,,,,"reported combined results with waitlist group",,,,,,,,,,,,,,,,,,,,"Community","0","0","1","0",,"1",,,"Medium","Alghamdi M, Hunt NC, Thomas SA. The effectiveness of narrative exposure therapy with traumatised firefighters in Saudi Arabia: a randomized controlled study. Behav Res Ther. 2015 Mar;66:64-71. doi: 10.1016/j.brat.2015.01.008. PMID: 25701801.","46524","2020"
"alghamdi2015_SPTSS_A_26_ITT","Psychotherapy","PTSD","34","A","PTSD",,"14",,"NET","Narrative Exposure Therapy (NET)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","17","Self report","SPTSS","SPTSS","ITT","None","ANCOVA and Hedges' g for change in mean score between groups, paired t-test for within-group","Assessment at 6 to <12 Months","26",,,,,,,,,,,,"reported combined results with waitlist group",,,,,,,,,,,,,,,,,,,,"Community","0","0","1","0",,"1",,,"Medium","Alghamdi M, Hunt NC, Thomas SA. The effectiveness of narrative exposure therapy with traumatised firefighters in Saudi Arabia: a randomized controlled study. Behav Res Ther. 2015 Mar;66:64-71. doi: 10.1016/j.brat.2015.01.008. PMID: 25701801.","46524","2020"
"alghamdi2015_SPTSS_A_3_ITT","Psychotherapy","PTSD","34","A","PTSD",,"17",,"NET","Narrative Exposure Therapy (NET)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","17","Self report","SPTSS","SPTSS","ITT","None","ANCOVA and Hedges' g for change in mean score between groups, paired t-test for within-group","Assessment at <3 Months","3",,,,,,,,,,,,"reported combined results with waitlist group",,,,,,,,,,,,,,,,,,,,"Community","0","0","1","0",,"1",,,"Medium","Alghamdi M, Hunt NC, Thomas SA. The effectiveness of narrative exposure therapy with traumatised firefighters in Saudi Arabia: a randomized controlled study. Behav Res Ther. 2015 Mar;66:64-71. doi: 10.1016/j.brat.2015.01.008. PMID: 25701801.","46524","2020"
"alghamdi2015_SPTSS_A_Baseline_ITT","Psychotherapy","PTSD","34","A","PTSD",,"17",,"NET","Narrative Exposure Therapy (NET)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","17","Self report","SPTSS","SPTSS","ITT","None","ANCOVA and Hedges' g for change in mean score between groups, paired t-test for within-group","Baseline",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community","0","0","1","0",,"1",,,"Medium","Alghamdi M, Hunt NC, Thomas SA. The effectiveness of narrative exposure therapy with traumatised firefighters in Saudi Arabia: a randomized controlled study. Behav Res Ther. 2015 Mar;66:64-71. doi: 10.1016/j.brat.2015.01.008. PMID: 25701801.","46524","2020"
"alghamdi2015_SPTSS_B_0_ITT","Psychotherapy","PTSD","34","B","Control",,"17",,"Waitlist","Waitlist","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,"17","Self report","SPTSS","SPTSS","ITT","None","ANCOVA and Hedges' g for change in mean score between groups, paired t-test for within-group","End of Treatment","0",,,,,,,,"-0.58",,"-2.1","0.96",,"Hedges' g","0.04",,,,,,,,,,,,,,,,,,"Community","0","0","1","0",,"1",,,"Medium","Alghamdi M, Hunt NC, Thomas SA. The effectiveness of narrative exposure therapy with traumatised firefighters in Saudi Arabia: a randomized controlled study. Behav Res Ther. 2015 Mar;66:64-71. doi: 10.1016/j.brat.2015.01.008. PMID: 25701801.","46524","2020"
"alghamdi2015_SPTSS_B_Baseline_ITT","Psychotherapy","PTSD","34","B","Control",,"17",,"Waitlist","Waitlist","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,"17","Self report","SPTSS","SPTSS","ITT","None","ANCOVA and Hedges' g for change in mean score between groups, paired t-test for within-group","Baseline",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community","0","0","1","0",,"1",,,"Medium","Alghamdi M, Hunt NC, Thomas SA. The effectiveness of narrative exposure therapy with traumatised firefighters in Saudi Arabia: a randomized controlled study. Behav Res Ther. 2015 Mar;66:64-71. doi: 10.1016/j.brat.2015.01.008. PMID: 25701801.","46524","2020"
"ardani2017_PCL-M_A_0_NA","Pharmacotherapy","PTSD","36","A","PTSD",,,,"Rivastigmine augmentation","Rivastigmine augmentation","No","Not Applicable","Yes","Other pharmacotherapy","No","Not Applicable","No","No","No","No","No","Individual","In Person","12","Self report","PCL-M","PCL-M",,,"ANCOVA and Hedges' g for change in mean score between groups, paired t-test for within-group","End of Treatment","0",,"44.63","7.67",,,,,"-3.37",,,,,,,,,,"p=0.0001",,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Ardani AR, Hosseini G, Bordbar MRF, et al. Effect of rivastigmine augmentation in treatment of male patients with combat-related chronic posttraumatic stress disorder: a randomized controlled trial. J Clin Psychopharmacol. 2017 Feb;37(1):54-60. doi: 10.1097/jcp.0000000000000624. PMID: 27930500.","47465","2019"
"ardani2017_PCL-M_A_Baseline_NA","Pharmacotherapy","PTSD","36","A","PTSD",,"12",,"Rivastigmine augmentation","Rivastigmine augmentation","No","Not Applicable","Yes","Other pharmacotherapy","No","Not Applicable","No","No","No","No","No","Individual","In Person","12","Self report","PCL-M","PCL-M",,,"ANCOVA and Hedges' g for change in mean score between groups, paired t-test for within-group","Baseline",,,"48.00","7.03",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Ardani AR, Hosseini G, Bordbar MRF, et al. Effect of rivastigmine augmentation in treatment of male patients with combat-related chronic posttraumatic stress disorder: a randomized controlled trial. J Clin Psychopharmacol. 2017 Feb;37(1):54-60. doi: 10.1097/jcp.0000000000000624. PMID: 27930500.","47465","2019"
"ardani2017_PCL-M_B_0_NA","Pharmacotherapy","PTSD","36","B","Control",,,,"Placebo augmentation","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","12","Self report","PCL-M","PCL-M",,,"ANCOVA and Hedges' g for change in mean score between groups, paired t-test for within-group","End of Treatment","0",,"47.25","6.35",,,,,"-3.75",,,,,,,,,,"p=0.0001",,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Ardani AR, Hosseini G, Bordbar MRF, et al. Effect of rivastigmine augmentation in treatment of male patients with combat-related chronic posttraumatic stress disorder: a randomized controlled trial. J Clin Psychopharmacol. 2017 Feb;37(1):54-60. doi: 10.1097/jcp.0000000000000624. PMID: 27930500.","47465","2019"
"ardani2017_PCL-M_B_Baseline_NA","Pharmacotherapy","PTSD","36","B","Control",,"12",,"Placebo augmentation","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","12","Self report","PCL-M","PCL-M",,,"ANCOVA and Hedges' g for change in mean score between groups, paired t-test for within-group","Baseline",,,"51.00","4.15",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Ardani AR, Hosseini G, Bordbar MRF, et al. Effect of rivastigmine augmentation in treatment of male patients with combat-related chronic posttraumatic stress disorder: a randomized controlled trial. J Clin Psychopharmacol. 2017 Feb;37(1):54-60. doi: 10.1097/jcp.0000000000000624. PMID: 27930500.","47465","2019"
"ardani2017_PCL-M_C_0_NA","Pharmacotherapy","PTSD","36","C","Control",,,,"TAU","Treatment as usual (TAU)","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","12","Self report","PCL-M","PCL-M",,,"ANCOVA and Hedges' g for change in mean score between groups, paired t-test for within-group","End of Treatment","0",,"48.83","6.04",,,,,"-3.67",,,,,,,,,,"p=0.0001",,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Ardani AR, Hosseini G, Bordbar MRF, et al. Effect of rivastigmine augmentation in treatment of male patients with combat-related chronic posttraumatic stress disorder: a randomized controlled trial. J Clin Psychopharmacol. 2017 Feb;37(1):54-60. doi: 10.1097/jcp.0000000000000624. PMID: 27930500.","47465","2019"
"ardani2017_PCL-M_C_Baseline_NA","Pharmacotherapy","PTSD","36","C","Control",,"12",,"TAU","Treatment as usual (TAU)","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","12","Self report","PCL-M","PCL-M",,,"ANCOVA and Hedges' g for change in mean score between groups, paired t-test for within-group","Baseline",,,"52.50","2.46",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Ardani AR, Hosseini G, Bordbar MRF, et al. Effect of rivastigmine augmentation in treatment of male patients with combat-related chronic posttraumatic stress disorder: a randomized controlled trial. J Clin Psychopharmacol. 2017 Feb;37(1):54-60. doi: 10.1097/jcp.0000000000000624. PMID: 27930500.","47465","2019"
"arntz2007_PSS-SR_A_0_Comp","Psychotherapy","PTSD","67","A","PTSD",,"21",,"Imaginal Exposure + Imagery Rescripting","Imaginal exposure plus imagery rescripting","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","28","Self report","PSS-SR","PSS-SR (Dutch version)","Completer",,"ANCOVA and Hedges' g for change in mean score between groups, paired t-test for within-group","End of Treatment","0",,"18.52","14.5",,,,,"-11.1",,,,,"Cohen's d","0.89",,,,,,,,,,,,,,,"PSS-SR (Dutch version) score ≤20","0.619",,"Community",,,"1","0.6567",,"0.3433","Mixed","rape/sexual assault, accidents, community/school violence, other (witnessing trauma of others, unspecified childhood trauma)","High","Arntz A, Tiesema M, Kindt M. Treatment of PTSD: a comparison of imaginal exposure with and without imagery rescripting. Journal of Behavior Therapy and Experimental Psychiatry. 2007 2016-09-15;38(4):345-70. doi: http://dx.doi.org/10.1016/j.jbtep.2007.10.006. PMID: 18005935.","30284","2019"
"arntz2007_PSS-SR_A_0_ITT","Psychotherapy","PTSD","67","A","PTSD",,"22",,"Imaginal Exposure + Imagery Rescripting","Imaginal exposure plus imagery rescripting","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","28","Self report","PSS-SR","PSS-SR (Dutch version)","ITT","LOCF","ANCOVA and Hedges' g for change in mean score between groups, paired t-test for within-group","End of Treatment","0",,"20.54","13.62",,,,,"-8.85",,,,,"Cohen's d","0.73",,,,,,,,,,,,,,,"PSS-SR (Dutch version) score ≤20","0.5357",,"Community",,,"1","0.6567",,"0.3433","Mixed","rape/sexual assault, accidents, community/school violence, other (witnessing trauma of others, unspecified childhood trauma)","High","Arntz A, Tiesema M, Kindt M. Treatment of PTSD: a comparison of imaginal exposure with and without imagery rescripting. Journal of Behavior Therapy and Experimental Psychiatry. 2007 2016-09-15;38(4):345-70. doi: http://dx.doi.org/10.1016/j.jbtep.2007.10.006. PMID: 18005935.","30284","2019"
"arntz2007_PSS-SR_A_4_Comp","Psychotherapy","PTSD","67","A","PTSD",,"21",,"Imaginal Exposure + Imagery Rescripting","Imaginal exposure plus imagery rescripting","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","28","Self report","PSS-SR","PSS-SR (Dutch version)","Completer",,"ANCOVA and Hedges' g for change in mean score between groups, paired t-test for within-group","Assessment at <3 Months","4",,"20.43","12.7",,,,,"-9.19",,,,,"Cohen's d","0.75",,,,,,,,,,,,,,,"PSS-SR (Dutch version) score ≤20","0.4762",,"Community",,,"1","0.6567",,"0.3433","Mixed","rape/sexual assault, accidents, community/school violence, other (witnessing trauma of others, unspecified childhood trauma)","High","Arntz A, Tiesema M, Kindt M. Treatment of PTSD: a comparison of imaginal exposure with and without imagery rescripting. Journal of Behavior Therapy and Experimental Psychiatry. 2007 2016-09-15;38(4):345-70. doi: http://dx.doi.org/10.1016/j.jbtep.2007.10.006. PMID: 18005935.","30284","2019"
"arntz2007_PSS-SR_A_4_ITT","Psychotherapy","PTSD","67","A","PTSD",,"20",,"Imaginal Exposure + Imagery Rescripting","Imaginal exposure plus imagery rescripting","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","28","Self report","PSS-SR","PSS-SR (Dutch version)","ITT","LOCF","ANCOVA and Hedges' g for change in mean score between groups, paired t-test for within-group","Assessment at <3 Months","4",,"21.93","12.02",,,,,"-7.46",,,,,"Cohen's d","0.63",,,,,,,,,,,,,,,"PSS-SR (Dutch version) score ≤20","0.4286",,"Community",,,"1","0.6567",,"0.3433","Mixed","rape/sexual assault, accidents, community/school violence, other (witnessing trauma of others, unspecified childhood trauma)","High","Arntz A, Tiesema M, Kindt M. Treatment of PTSD: a comparison of imaginal exposure with and without imagery rescripting. Journal of Behavior Therapy and Experimental Psychiatry. 2007 2016-09-15;38(4):345-70. doi: http://dx.doi.org/10.1016/j.jbtep.2007.10.006. PMID: 18005935.","30284","2019"
"arntz2007_PSS-SR_A_Baseline_Comp","Psychotherapy","PTSD","67","A","PTSD",,"21",,"Imaginal Exposure + Imagery Rescripting","Imaginal exposure plus imagery rescripting","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","28","Self report","PSS-SR","PSS-SR (Dutch version)","Completer",,"ANCOVA and Hedges' g for change in mean score between groups, paired t-test for within-group","Baseline",,,"29.62","10.86",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.6567",,"0.3433","Mixed","rape/sexual assault, accidents, community/school violence, other (witnessing trauma of others, unspecified childhood trauma)","High","Arntz A, Tiesema M, Kindt M. Treatment of PTSD: a comparison of imaginal exposure with and without imagery rescripting. Journal of Behavior Therapy and Experimental Psychiatry. 2007 2016-09-15;38(4):345-70. doi: http://dx.doi.org/10.1016/j.jbtep.2007.10.006. PMID: 18005935.","30284","2019"
"arntz2007_PSS-SR_A_Baseline_ITT","Psychotherapy","PTSD","67","A","PTSD",,"28",,"Imaginal Exposure + Imagery Rescripting","Imaginal exposure plus imagery rescripting","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","28","Self report","PSS-SR","PSS-SR (Dutch version)","ITT","LOCF","ANCOVA and Hedges' g for change in mean score between groups, paired t-test for within-group","Baseline",,,"29.39","10.17",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.6567",,"0.3433","Mixed","rape/sexual assault, accidents, community/school violence, other (witnessing trauma of others, unspecified childhood trauma)","High","Arntz A, Tiesema M, Kindt M. Treatment of PTSD: a comparison of imaginal exposure with and without imagery rescripting. Journal of Behavior Therapy and Experimental Psychiatry. 2007 2016-09-15;38(4):345-70. doi: http://dx.doi.org/10.1016/j.jbtep.2007.10.006. PMID: 18005935.","30284","2019"
"arntz2007_PSS-SR_B_0_Comp","Psychotherapy","PTSD","67","B","PTSD",,"19",,"IE","Imaginal exposure","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","39","Self report","PSS-SR","PSS-SR (Dutch version)","Completer",,"ANCOVA and Hedges' g for change in mean score between groups, paired t-test for within-group","End of Treatment","0",,"17.63","13.76",,,,,"-9.9",,,,,"Cohen's d","0.8",,,,,,,,,,,,,,,"PSS-SR (Dutch version) score ≤20","0.6316",,"Community",,,"1","0.6567",,"0.3433","Mixed","rape/sexual assault, accidents, community/school violence, other (witnessing trauma of others, unspecified childhood trauma)","High","Arntz A, Tiesema M, Kindt M. Treatment of PTSD: a comparison of imaginal exposure with and without imagery rescripting. Journal of Behavior Therapy and Experimental Psychiatry. 2007 2016-09-15;38(4):345-70. doi: http://dx.doi.org/10.1016/j.jbtep.2007.10.006. PMID: 18005935.","30284","2019"
"arntz2007_PSS-SR_B_0_ITT","Psychotherapy","PTSD","67","B","PTSD",,"22",,"IE","Imaginal exposure","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","39","Self report","PSS-SR","PSS-SR (Dutch version)","ITT","LOCF","ANCOVA and Hedges' g for change in mean score between groups, paired t-test for within-group","End of Treatment","0",,"18.28","13.25",,,,,"-6.75",,,,,"Cohen's d","0.56",,,,,,,,,,,,,,,"PSS-SR (Dutch version) score ≤20","0.5897",,"Community",,,"1","0.6567",,"0.3433","Mixed","rape/sexual assault, accidents, community/school violence, other (witnessing trauma of others, unspecified childhood trauma)","High","Arntz A, Tiesema M, Kindt M. Treatment of PTSD: a comparison of imaginal exposure with and without imagery rescripting. Journal of Behavior Therapy and Experimental Psychiatry. 2007 2016-09-15;38(4):345-70. doi: http://dx.doi.org/10.1016/j.jbtep.2007.10.006. PMID: 18005935.","30284","2019"
"arntz2007_PSS-SR_B_4_Comp","Psychotherapy","PTSD","67","B","PTSD",,"19",,"IE","Imaginal exposure","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","39","Self report","PSS-SR","PSS-SR (Dutch version)","Completer",,"ANCOVA and Hedges' g for change in mean score between groups, paired t-test for within-group","Assessment at <3 Months","4",,"18.16","14.97",,,,,"-9.37",,,,,"Cohen's d","0.76",,,,,,,,,,,,,,,"PSS-SR (Dutch version) score ≤20","0.5789",,"Community",,,"1","0.6567",,"0.3433","Mixed","rape/sexual assault, accidents, community/school violence, other (witnessing trauma of others, unspecified childhood trauma)","High","Arntz A, Tiesema M, Kindt M. Treatment of PTSD: a comparison of imaginal exposure with and without imagery rescripting. Journal of Behavior Therapy and Experimental Psychiatry. 2007 2016-09-15;38(4):345-70. doi: http://dx.doi.org/10.1016/j.jbtep.2007.10.006. PMID: 18005935.","30284","2019"
"arntz2007_PSS-SR_B_4_ITT","Psychotherapy","PTSD","67","B","PTSD",,"23",,"IE","Imaginal exposure","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","39","Self report","PSS-SR","PSS-SR (Dutch version)","ITT","LOCF","ANCOVA and Hedges' g for change in mean score between groups, paired t-test for within-group","Assessment at <3 Months","4",,"18.97","13.93",,,,,"-6.06",,,,,"Cohen's d","0.51",,,,,,,,,,,,,,,"PSS-SR (Dutch version) score ≤20","0.5385",,"Community",,,"1","0.6567",,"0.3433","Mixed","rape/sexual assault, accidents, community/school violence, other (witnessing trauma of others, unspecified childhood trauma)","High","Arntz A, Tiesema M, Kindt M. Treatment of PTSD: a comparison of imaginal exposure with and without imagery rescripting. Journal of Behavior Therapy and Experimental Psychiatry. 2007 2016-09-15;38(4):345-70. doi: http://dx.doi.org/10.1016/j.jbtep.2007.10.006. PMID: 18005935.","30284","2019"
"arntz2007_PSS-SR_B_Baseline_Comp","Psychotherapy","PTSD","67","B","PTSD",,"19",,"IE","Imaginal exposure","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","39","Self report","PSS-SR","PSS-SR (Dutch version)","Completer",,"ANCOVA and Hedges' g for change in mean score between groups, paired t-test for within-group","Baseline",,,"27.53","10.04",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.6567",,"0.3433","Mixed","rape/sexual assault, accidents, community/school violence, other (witnessing trauma of others, unspecified childhood trauma)","High","Arntz A, Tiesema M, Kindt M. Treatment of PTSD: a comparison of imaginal exposure with and without imagery rescripting. Journal of Behavior Therapy and Experimental Psychiatry. 2007 2016-09-15;38(4):345-70. doi: http://dx.doi.org/10.1016/j.jbtep.2007.10.006. PMID: 18005935.","30284","2019"
"arntz2007_PSS-SR_B_Baseline_ITT","Psychotherapy","PTSD","67","B","PTSD",,"39",,"IE","Imaginal exposure","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","39","Self report","PSS-SR","PSS-SR (Dutch version)","ITT","LOCF","ANCOVA and Hedges' g for change in mean score between groups, paired t-test for within-group","Baseline",,,"25.03","10.88",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.6567",,"0.3433","Mixed","rape/sexual assault, accidents, community/school violence, other (witnessing trauma of others, unspecified childhood trauma)","High","Arntz A, Tiesema M, Kindt M. Treatment of PTSD: a comparison of imaginal exposure with and without imagery rescripting. Journal of Behavior Therapy and Experimental Psychiatry. 2007 2016-09-15;38(4):345-70. doi: http://dx.doi.org/10.1016/j.jbtep.2007.10.006. PMID: 18005935.","30284","2019"
"arntz2007_PSS-SR_C_0_Comp","Psychotherapy","PTSD","67","C","Control",,"17",,"Waitlist","Waitlist","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,"21","Self report","PSS-SR","PSS-SR (Dutch version)","Completer",,"ANCOVA and Hedges' g for change in mean score between groups, paired t-test for within-group","End of Treatment","0",,"27.47","12.16",,,,,"0.53",,,,,"Cohen's d","-0.04",,,,"p=NS",,,,,,,,,,,"PSS-SR (Dutch version) score ≤20",,,"Community",,,"1","0.6567",,"0.3433","Mixed","rape/sexual assault, accidents, community/school violence, other (witnessing trauma of others, unspecified childhood trauma)","High","Arntz A, Tiesema M, Kindt M. Treatment of PTSD: a comparison of imaginal exposure with and without imagery rescripting. Journal of Behavior Therapy and Experimental Psychiatry. 2007 2016-09-15;38(4):345-70. doi: http://dx.doi.org/10.1016/j.jbtep.2007.10.006. PMID: 18005935.","30284","2019"
"arntz2007_PSS-SR_C_Baseline_Comp","Psychotherapy","PTSD","67","C","Control",,"17",,"Waitlist","Waitlist","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,"21","Self report","PSS-SR","PSS-SR (Dutch version)","Completer",,"ANCOVA and Hedges' g for change in mean score between groups, paired t-test for within-group","Baseline",,,"26.94","12.83",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.6567",,"0.3433","Mixed","rape/sexual assault, accidents, community/school violence, other (witnessing trauma of others, unspecified childhood trauma)","High","Arntz A, Tiesema M, Kindt M. Treatment of PTSD: a comparison of imaginal exposure with and without imagery rescripting. Journal of Behavior Therapy and Experimental Psychiatry. 2007 2016-09-15;38(4):345-70. doi: http://dx.doi.org/10.1016/j.jbtep.2007.10.006. PMID: 18005935.","30284","2019"
"asukai2010_CAPS_A_0_ITT","Psychotherapy","PTSD","24","A","PTSD",,"12",,"PE + TAU","Prolonged Exposure (PE)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","12","Structured Clinical Interview","CAPS","CAPS","ITT",,"ANCOVA and Hedges' g for change in mean score between groups, paired t-test for within-group","End of Treatment","0",,"43.76",,"SE","8.43",,,"-40.82",,,,,"Hedges' g","0.95",,,,"p<0.001",,,,,,,,"Not meeting criteria for PTSD according to CAPS",,,"15-point decrease from CAPS baseline",,"Additional definitions of Clinically Meaningful Response reported in the study","Community",,,"1","0.875",,"0.125","Mixed","rape/sexual assault, accidents, community/school violence","Medium","Asukai N, Saito A, Tsuruta N, et al. Efficacy of exposure therapy for Japanese patients with posttraumatic stress disorder due to mixed traumatic events: A randomized controlled study. J Trauma Stress. 2010 Dec;23(6):744-50. doi: 10.1002/jts.20589. PMID: 21171135.","84311","2019"
"asukai2010_CAPS_A_Baseline_ITT","Psychotherapy","PTSD","24","A","PTSD",,"12",,"PE + TAU","Prolonged Exposure (PE)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","12","Structured Clinical Interview","CAPS","CAPS","ITT",,"ANCOVA and Hedges' g for change in mean score between groups, paired t-test for within-group","Baseline",,,"84.58",,"SE","7.78",,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.875",,"0.125","Mixed","rape/sexual assault, accidents, community/school violence","Medium","Asukai N, Saito A, Tsuruta N, et al. Efficacy of exposure therapy for Japanese patients with posttraumatic stress disorder due to mixed traumatic events: A randomized controlled study. J Trauma Stress. 2010 Dec;23(6):744-50. doi: 10.1002/jts.20589. PMID: 21171135.","84311","2019"
"asukai2010_CAPS_B_0_ITT","Psychotherapy","PTSD","24","B","Control",,"12",,"TAU","Treatment as usual (TAU)","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,"12","Structured Clinical Interview","CAPS","CAPS","ITT",,"ANCOVA and Hedges' g for change in mean score between groups, paired t-test for within-group","End of Treatment","0",,"84.81",,"SE","7.96",,,"0.48",,,,,"Hedges' g","0.71",,,,,,,,,,,,"Not meeting criteria for PTSD according to CAPS",,,"15-point decrease from CAPS baseline",,"Additional definitions of Clinically Meaningful Response reported in the study","Community",,,"1","0.875",,"0.125","Mixed","rape/sexual assault, accidents, community/school violence","Medium","Asukai N, Saito A, Tsuruta N, et al. Efficacy of exposure therapy for Japanese patients with posttraumatic stress disorder due to mixed traumatic events: A randomized controlled study. J Trauma Stress. 2010 Dec;23(6):744-50. doi: 10.1002/jts.20589. PMID: 21171135.","84311","2019"
"asukai2010_CAPS_B_Baseline_ITT","Psychotherapy","PTSD","24","B","Control",,"12",,"TAU","Treatment as usual (TAU)","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,"12","Structured Clinical Interview","CAPS","CAPS","ITT",,"ANCOVA and Hedges' g for change in mean score between groups, paired t-test for within-group","Baseline",,,"84.33",,"SE","7.78",,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.875",,"0.125","Mixed","rape/sexual assault, accidents, community/school violence","Medium","Asukai N, Saito A, Tsuruta N, et al. Efficacy of exposure therapy for Japanese patients with posttraumatic stress disorder due to mixed traumatic events: A randomized controlled study. J Trauma Stress. 2010 Dec;23(6):744-50. doi: 10.1002/jts.20589. PMID: 21171135.","84311","2019"
"asukai2010_IES_A_0_NA","Psychotherapy","PTSD","24","A","PTSD",,,,"PE + TAU","Prolonged Exposure (PE)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","12","Self report","IES","IES-R (Japanese version)",,,"ANCOVA and Hedges' g for change in mean score between groups, paired t-test for within-group","End of Treatment","0",,"21.15",,"SE","5.53",,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.875",,"0.125","Mixed","rape/sexual assault, accidents, community/school violence","Medium","Asukai N, Saito A, Tsuruta N, et al. Efficacy of exposure therapy for Japanese patients with posttraumatic stress disorder due to mixed traumatic events: A randomized controlled study. J Trauma Stress. 2010 Dec;23(6):744-50. doi: 10.1002/jts.20589. PMID: 21171135.","84311","2019"
"asukai2010_IES_A_Baseline_NA","Psychotherapy","PTSD","24","A","PTSD",,,,"PE + TAU","Prolonged Exposure (PE)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","12","Self report","IES","IES-R (Japanese version)",,,"ANCOVA and Hedges' g for change in mean score between groups, paired t-test for within-group","Baseline",,,"59.67",,"SE","5.06",,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.875",,"0.125","Mixed","rape/sexual assault, accidents, community/school violence","Medium","Asukai N, Saito A, Tsuruta N, et al. Efficacy of exposure therapy for Japanese patients with posttraumatic stress disorder due to mixed traumatic events: A randomized controlled study. J Trauma Stress. 2010 Dec;23(6):744-50. doi: 10.1002/jts.20589. PMID: 21171135.","84311","2019"
"asukai2010_IES_B_0_NA","Psychotherapy","PTSD","24","B","Control",,,,"TAU","Treatment as usual (TAU)","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,"12","Self report","IES","IES-R (Japanese version)",,,"ANCOVA and Hedges' g for change in mean score between groups, paired t-test for within-group","End of Treatment","0",,"53.75",,"SE","5.20",,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.875",,"0.125","Mixed","rape/sexual assault, accidents, community/school violence","Medium","Asukai N, Saito A, Tsuruta N, et al. Efficacy of exposure therapy for Japanese patients with posttraumatic stress disorder due to mixed traumatic events: A randomized controlled study. J Trauma Stress. 2010 Dec;23(6):744-50. doi: 10.1002/jts.20589. PMID: 21171135.","84311","2019"
"asukai2010_IES_B_Baseline_NA","Psychotherapy","PTSD","24","B","Control",,,,"TAU","Treatment as usual (TAU)","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,"12","Self report","IES","IES-R (Japanese version)",,,"ANCOVA and Hedges' g for change in mean score between groups, paired t-test for within-group","Baseline",,,"59.75",,"SE","5.06",,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.875",,"0.125","Mixed","rape/sexual assault, accidents, community/school violence","Medium","Asukai N, Saito A, Tsuruta N, et al. Efficacy of exposure therapy for Japanese patients with posttraumatic stress disorder due to mixed traumatic events: A randomized controlled study. J Trauma Stress. 2010 Dec;23(6):744-50. doi: 10.1002/jts.20589. PMID: 21171135.","84311","2019"
"back2019_CAPS_A_0_Comp","Psychotherapy","PTSD+SUD","81","A","PTSD+SUD","Integrated","29",,"COPE","Concurrent Treatment for PTSD and Substance Use Disorder Using Prolonged Exposure (COPE)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","54","Structured Clinical Interview","CAPS","CAPS-IV","Completer","multilevel model utilizing robust maximum likelihood, uses all available data","PTSD scores: Random intercept and slope mutilevel models utilizing robust maximum likelihood. Effect sizes as regression coefficients standardized to baseline SD of each outcome in total sample.
Diagnostic change: binary logistic regression","End of Treatment","0",,,,,,,,,,,,,,,,,,,,,,,,,,"CAPS-IV score <50","0.828",,,,,"Veteran","0","1","0","0.091",,"0.909","Mixed","Combat-related, Rape/sexual assault, Accidents, Community/school violence, Natural or manmade disasters, Terrorism/policital violence/forced displacement; Other (physical assault, assault with a weapon, unwanted or uncomfortable sexual experience, captivity, severe human suffering, sudden violent death of someone close, sudden unexpected death of someone close, other very stressful event or experience)","Medium","Back SE, Killeen T, Badour CL, et al. Concurrent treatment of substance use disorders and PTSD using prolonged exposure: a randomized clinical trial in military veterans. Addict Behav. 2019 Mar;90:369-77. doi: 10.1016/j.addbeh.2018.11.032. PMID: 30529244.","51384","2020"
"back2019_CAPS_A_0_ITT","Psychotherapy","PTSD+SUD","81","A","PTSD+SUD","Integrated","30",,"COPE","Concurrent Treatment for PTSD and Substance Use Disorder Using Prolonged Exposure (COPE)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","54","Structured Clinical Interview","CAPS","CAPS-IV","ITT","multilevel model utilizing robust maximum likelihood, uses all available data","PTSD scores: Random intercept and slope mutilevel models utilizing robust maximum likelihood. Effect sizes as regression coefficients standardized to baseline SD of each outcome in total sample.
Diagnostic change: binary logistic regression","End of Treatment","0",,"27.2","19.4",,,,,"-51.2",,"-59.7","-42.8",,,,,,,,,,,,,,,"CAPS-IV score <50","0.593",,,,,"Veteran","0","1","0","0.091",,"0.909","Mixed","Combat-related, Rape/sexual assault, Accidents, Community/school violence, Natural or manmade disasters, Terrorism/policital violence/forced displacement; Other (physical assault, assault with a weapon, unwanted or uncomfortable sexual experience, captivity, severe human suffering, sudden violent death of someone close, sudden unexpected death of someone close, other very stressful event or experience)","Medium","Back SE, Killeen T, Badour CL, et al. Concurrent treatment of substance use disorders and PTSD using prolonged exposure: a randomized clinical trial in military veterans. Addict Behav. 2019 Mar;90:369-77. doi: 10.1016/j.addbeh.2018.11.032. PMID: 30529244.","51384","2020"
"back2019_CAPS_A_12_ITT","Psychotherapy","PTSD+SUD","81","A","PTSD+SUD","Integrated","28",,"COPE","Concurrent Treatment for PTSD and Substance Use Disorder Using Prolonged Exposure (COPE)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","54","Structured Clinical Interview","CAPS","CAPS-IV","ITT","multilevel model utilizing robust maximum likelihood, uses all available data","PTSD scores: Random intercept and slope mutilevel models utilizing robust maximum likelihood. Effect sizes as regression coefficients standardized to baseline SD of each outcome in total sample.
Diagnostic change: binary logistic regression","Assessment at 3 to <6 Months","12",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0.091",,"0.909","Mixed","Combat-related, Rape/sexual assault, Accidents, Community/school violence, Natural or manmade disasters, Terrorism/policital violence/forced displacement; Other (physical assault, assault with a weapon, unwanted or uncomfortable sexual experience, captivity, severe human suffering, sudden violent death of someone close, sudden unexpected death of someone close, other very stressful event or experience)","Medium","Back SE, Killeen T, Badour CL, et al. Concurrent treatment of substance use disorders and PTSD using prolonged exposure: a randomized clinical trial in military veterans. Addict Behav. 2019 Mar;90:369-77. doi: 10.1016/j.addbeh.2018.11.032. PMID: 30529244.","51384","2020"
"back2019_CAPS_A_26_ITT","Psychotherapy","PTSD+SUD","81","A","PTSD+SUD","Integrated","18",,"COPE","Concurrent Treatment for PTSD and Substance Use Disorder Using Prolonged Exposure (COPE)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","54","Structured Clinical Interview","CAPS","CAPS-IV","ITT","multilevel model utilizing robust maximum likelihood, uses all available data","PTSD scores: Random intercept and slope mutilevel models utilizing robust maximum likelihood. Effect sizes as regression coefficients standardized to baseline SD of each outcome in total sample.
Diagnostic change: binary logistic regression","Assessment at 6 to <12 Months","26",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0.091",,"0.909","Mixed","Combat-related, Rape/sexual assault, Accidents, Community/school violence, Natural or manmade disasters, Terrorism/policital violence/forced displacement; Other (physical assault, assault with a weapon, unwanted or uncomfortable sexual experience, captivity, severe human suffering, sudden violent death of someone close, sudden unexpected death of someone close, other very stressful event or experience)","Medium","Back SE, Killeen T, Badour CL, et al. Concurrent treatment of substance use disorders and PTSD using prolonged exposure: a randomized clinical trial in military veterans. Addict Behav. 2019 Mar;90:369-77. doi: 10.1016/j.addbeh.2018.11.032. PMID: 30529244.","51384","2020"
"back2019_CAPS_A_Baseline_Comp","Psychotherapy","PTSD+SUD","81","A","PTSD+SUD","Integrated","29",,"COPE","Concurrent Treatment for PTSD and Substance Use Disorder Using Prolonged Exposure (COPE)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","54","Structured Clinical Interview","CAPS","CAPS-IV","Completer","multilevel model utilizing robust maximum likelihood, uses all available data","PTSD scores: Random intercept and slope mutilevel models utilizing robust maximum likelihood. Effect sizes as regression coefficients standardized to baseline SD of each outcome in total sample.
Diagnostic change: binary logistic regression","Baseline",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0.091",,"0.909","Mixed","Combat-related, Rape/sexual assault, Accidents, Community/school violence, Natural or manmade disasters, Terrorism/policital violence/forced displacement; Other (physical assault, assault with a weapon, unwanted or uncomfortable sexual experience, captivity, severe human suffering, sudden violent death of someone close, sudden unexpected death of someone close, other very stressful event or experience)","Medium","Back SE, Killeen T, Badour CL, et al. Concurrent treatment of substance use disorders and PTSD using prolonged exposure: a randomized clinical trial in military veterans. Addict Behav. 2019 Mar;90:369-77. doi: 10.1016/j.addbeh.2018.11.032. PMID: 30529244.","51384","2020"
"back2019_CAPS_A_Baseline_ITT","Psychotherapy","PTSD+SUD","81","A","PTSD+SUD","Integrated","54",,"COPE","Concurrent Treatment for PTSD and Substance Use Disorder Using Prolonged Exposure (COPE)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","54","Structured Clinical Interview","CAPS","CAPS-IV","ITT","multilevel model utilizing robust maximum likelihood, uses all available data","PTSD scores: Random intercept and slope mutilevel models utilizing robust maximum likelihood. Effect sizes as regression coefficients standardized to baseline SD of each outcome in total sample.
Diagnostic change: binary logistic regression","Baseline",,,"77.4","18.1",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0.091",,"0.909","Mixed","Combat-related, Rape/sexual assault, Accidents, Community/school violence, Natural or manmade disasters, Terrorism/policital violence/forced displacement; Other (physical assault, assault with a weapon, unwanted or uncomfortable sexual experience, captivity, severe human suffering, sudden violent death of someone close, sudden unexpected death of someone close, other very stressful event or experience)","Medium","Back SE, Killeen T, Badour CL, et al. Concurrent treatment of substance use disorders and PTSD using prolonged exposure: a randomized clinical trial in military veterans. Addict Behav. 2019 Mar;90:369-77. doi: 10.1016/j.addbeh.2018.11.032. PMID: 30529244.","51384","2020"
"back2019_CAPS_B_0_Comp","Psychotherapy","PTSD+SUD","81","B","SUD","Not integrated","13",,"Relapse Prevention","Relapse Prevention","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","27","Structured Clinical Interview","CAPS","CAPS-IV","Completer","multilevel model utilizing robust maximum likelihood, uses all available data","PTSD scores: Random intercept and slope mutilevel models utilizing robust maximum likelihood. Effect sizes as regression coefficients standardized to baseline SD of each outcome in total sample.
Diagnostic change: binary logistic regression","End of Treatment","0",,,,,,,,,,,,,,,,,,,,,,,,,,"CAPS-IV score <50","0.385",,,,,"Veteran","0","1","0","0.091",,"0.909","Mixed","Combat-related, Rape/sexual assault, Accidents, Community/school violence, Natural or manmade disasters, Terrorism/policital violence/forced displacement; Other (physical assault, assault with a weapon, unwanted or uncomfortable sexual experience, captivity, severe human suffering, sudden violent death of someone close, sudden unexpected death of someone close, other very stressful event or experience)","Medium","Back SE, Killeen T, Badour CL, et al. Concurrent treatment of substance use disorders and PTSD using prolonged exposure: a randomized clinical trial in military veterans. Addict Behav. 2019 Mar;90:369-77. doi: 10.1016/j.addbeh.2018.11.032. PMID: 30529244.","51384","2020"
"back2019_CAPS_B_0_ITT","Psychotherapy","PTSD+SUD","81","B","SUD","Not integrated","14",,"Relapse Prevention","Relapse Prevention","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","27","Structured Clinical Interview","CAPS","CAPS-IV","ITT","multilevel model utilizing robust maximum likelihood, uses all available data","PTSD scores: Random intercept and slope mutilevel models utilizing robust maximum likelihood. Effect sizes as regression coefficients standardized to baseline SD of each outcome in total sample.
Diagnostic change: binary logistic regression","End of Treatment","0",,"49.7","25.3",,,,,"-35.9",,"-48.8","-23.0",,,,,,,,,,,,,,,"CAPS-IV score <50","0.222",,,,,"Veteran","0","1","0","0.091",,"0.909","Mixed","Combat-related, Rape/sexual assault, Accidents, Community/school violence, Natural or manmade disasters, Terrorism/policital violence/forced displacement; Other (physical assault, assault with a weapon, unwanted or uncomfortable sexual experience, captivity, severe human suffering, sudden violent death of someone close, sudden unexpected death of someone close, other very stressful event or experience)","Medium","Back SE, Killeen T, Badour CL, et al. Concurrent treatment of substance use disorders and PTSD using prolonged exposure: a randomized clinical trial in military veterans. Addict Behav. 2019 Mar;90:369-77. doi: 10.1016/j.addbeh.2018.11.032. PMID: 30529244.","51384","2020"
"back2019_CAPS_B_12_ITT","Psychotherapy","PTSD+SUD","81","B","SUD","Not integrated","11",,"Relapse Prevention","Relapse Prevention","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","27","Structured Clinical Interview","CAPS","CAPS-IV","ITT","multilevel model utilizing robust maximum likelihood, uses all available data","PTSD scores: Random intercept and slope mutilevel models utilizing robust maximum likelihood. Effect sizes as regression coefficients standardized to baseline SD of each outcome in total sample.
Diagnostic change: binary logistic regression","Assessment at 3 to <6 Months","12",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0.091",,"0.909","Mixed","Combat-related, Rape/sexual assault, Accidents, Community/school violence, Natural or manmade disasters, Terrorism/policital violence/forced displacement; Other (physical assault, assault with a weapon, unwanted or uncomfortable sexual experience, captivity, severe human suffering, sudden violent death of someone close, sudden unexpected death of someone close, other very stressful event or experience)","Medium","Back SE, Killeen T, Badour CL, et al. Concurrent treatment of substance use disorders and PTSD using prolonged exposure: a randomized clinical trial in military veterans. Addict Behav. 2019 Mar;90:369-77. doi: 10.1016/j.addbeh.2018.11.032. PMID: 30529244.","51384","2020"
"back2019_CAPS_B_26_ITT","Psychotherapy","PTSD+SUD","81","B","SUD","Not integrated","12",,"Relapse Prevention","Relapse Prevention","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","27","Structured Clinical Interview","CAPS","CAPS-IV","ITT","multilevel model utilizing robust maximum likelihood, uses all available data","PTSD scores: Random intercept and slope mutilevel models utilizing robust maximum likelihood. Effect sizes as regression coefficients standardized to baseline SD of each outcome in total sample.
Diagnostic change: binary logistic regression","Assessment at 6 to <12 Months","26",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0.091",,"0.909","Mixed","Combat-related, Rape/sexual assault, Accidents, Community/school violence, Natural or manmade disasters, Terrorism/policital violence/forced displacement; Other (physical assault, assault with a weapon, unwanted or uncomfortable sexual experience, captivity, severe human suffering, sudden violent death of someone close, sudden unexpected death of someone close, other very stressful event or experience)","Medium","Back SE, Killeen T, Badour CL, et al. Concurrent treatment of substance use disorders and PTSD using prolonged exposure: a randomized clinical trial in military veterans. Addict Behav. 2019 Mar;90:369-77. doi: 10.1016/j.addbeh.2018.11.032. PMID: 30529244.","51384","2020"
"back2019_CAPS_B_Baseline_Comp","Psychotherapy","PTSD+SUD","81","B","SUD","Not integrated","13",,"Relapse Prevention","Relapse Prevention","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","27","Structured Clinical Interview","CAPS","CAPS-IV","Completer","multilevel model utilizing robust maximum likelihood, uses all available data","PTSD scores: Random intercept and slope mutilevel models utilizing robust maximum likelihood. Effect sizes as regression coefficients standardized to baseline SD of each outcome in total sample.
Diagnostic change: binary logistic regression","Baseline",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0.091",,"0.909","Mixed","Combat-related, Rape/sexual assault, Accidents, Community/school violence, Natural or manmade disasters, Terrorism/policital violence/forced displacement; Other (physical assault, assault with a weapon, unwanted or uncomfortable sexual experience, captivity, severe human suffering, sudden violent death of someone close, sudden unexpected death of someone close, other very stressful event or experience)","Medium","Back SE, Killeen T, Badour CL, et al. Concurrent treatment of substance use disorders and PTSD using prolonged exposure: a randomized clinical trial in military veterans. Addict Behav. 2019 Mar;90:369-77. doi: 10.1016/j.addbeh.2018.11.032. PMID: 30529244.","51384","2020"
"back2019_CAPS_B_Baseline_ITT","Psychotherapy","PTSD+SUD","81","B","SUD","Not integrated","27",,"Relapse Prevention","Relapse Prevention","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","27","Structured Clinical Interview","CAPS","CAPS-IV","ITT","multilevel model utilizing robust maximum likelihood, uses all available data","PTSD scores: Random intercept and slope mutilevel models utilizing robust maximum likelihood. Effect sizes as regression coefficients standardized to baseline SD of each outcome in total sample.
Diagnostic change: binary logistic regression","Baseline",,,"84.7","17.8",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0.091",,"0.909","Mixed","Combat-related, Rape/sexual assault, Accidents, Community/school violence, Natural or manmade disasters, Terrorism/policital violence/forced displacement; Other (physical assault, assault with a weapon, unwanted or uncomfortable sexual experience, captivity, severe human suffering, sudden violent death of someone close, sudden unexpected death of someone close, other very stressful event or experience)","Medium","Back SE, Killeen T, Badour CL, et al. Concurrent treatment of substance use disorders and PTSD using prolonged exposure: a randomized clinical trial in military veterans. Addict Behav. 2019 Mar;90:369-77. doi: 10.1016/j.addbeh.2018.11.032. PMID: 30529244.","51384","2020"
"back2019_PCL_A_0_ITT","Psychotherapy","PTSD+SUD","81","A","PTSD+SUD","Integrated",,,"COPE","Concurrent Treatment for PTSD and Substance Use Disorder Using Prolonged Exposure (COPE)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","54","Self report","PCL","PCL-M","ITT","multilevel model utilizing robust maximum likelihood, uses all available data","PTSD scores: Random intercept and slope mutilevel models utilizing robust maximum likelihood. Effect sizes as regression coefficients standardized to baseline SD of each outcome in total sample.
Diagnostic change: binary logistic regression","End of Treatment","0",,"37.6","17.2",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0.091",,"0.909","Mixed","Combat-related, Rape/sexual assault, Accidents, Community/school violence, Natural or manmade disasters, Terrorism/policital violence/forced displacement; Other (physical assault, assault with a weapon, unwanted or uncomfortable sexual experience, captivity, severe human suffering, sudden violent death of someone close, sudden unexpected death of someone close, other very stressful event or experience)","Medium","Back SE, Killeen T, Badour CL, et al. Concurrent treatment of substance use disorders and PTSD using prolonged exposure: a randomized clinical trial in military veterans. Addict Behav. 2019 Mar;90:369-77. doi: 10.1016/j.addbeh.2018.11.032. PMID: 30529244.","51384","2020"
"back2019_PCL_A_Baseline_ITT","Psychotherapy","PTSD+SUD","81","A","PTSD+SUD","Integrated",,,"COPE","Concurrent Treatment for PTSD and Substance Use Disorder Using Prolonged Exposure (COPE)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","54","Self report","PCL","PCL-M","ITT","multilevel model utilizing robust maximum likelihood, uses all available data","PTSD scores: Random intercept and slope mutilevel models utilizing robust maximum likelihood. Effect sizes as regression coefficients standardized to baseline SD of each outcome in total sample.
Diagnostic change: binary logistic regression","Baseline",,,"62.2","11.0",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0.091",,"0.909","Mixed","Combat-related, Rape/sexual assault, Accidents, Community/school violence, Natural or manmade disasters, Terrorism/policital violence/forced displacement; Other (physical assault, assault with a weapon, unwanted or uncomfortable sexual experience, captivity, severe human suffering, sudden violent death of someone close, sudden unexpected death of someone close, other very stressful event or experience)","Medium","Back SE, Killeen T, Badour CL, et al. Concurrent treatment of substance use disorders and PTSD using prolonged exposure: a randomized clinical trial in military veterans. Addict Behav. 2019 Mar;90:369-77. doi: 10.1016/j.addbeh.2018.11.032. PMID: 30529244.","51384","2020"
"back2019_PCL_B_0_ITT","Psychotherapy","PTSD+SUD","81","B","SUD","Not integrated",,,"Relapse Prevention","Relapse Prevention","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","27","Self report","PCL","PCL-M","ITT","multilevel model utilizing robust maximum likelihood, uses all available data","PTSD scores: Random intercept and slope mutilevel models utilizing robust maximum likelihood. Effect sizes as regression coefficients standardized to baseline SD of each outcome in total sample.
Diagnostic change: binary logistic regression","End of Treatment","0",,"53.1","14.5",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0.091",,"0.909","Mixed","Combat-related, Rape/sexual assault, Accidents, Community/school violence, Natural or manmade disasters, Terrorism/policital violence/forced displacement; Other (physical assault, assault with a weapon, unwanted or uncomfortable sexual experience, captivity, severe human suffering, sudden violent death of someone close, sudden unexpected death of someone close, other very stressful event or experience)","Medium","Back SE, Killeen T, Badour CL, et al. Concurrent treatment of substance use disorders and PTSD using prolonged exposure: a randomized clinical trial in military veterans. Addict Behav. 2019 Mar;90:369-77. doi: 10.1016/j.addbeh.2018.11.032. PMID: 30529244.","51384","2020"
"back2019_PCL_B_Baseline_ITT","Psychotherapy","PTSD+SUD","81","B","SUD","Not integrated",,,"Relapse Prevention","Relapse Prevention","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","27","Self report","PCL","PCL-M","ITT","multilevel model utilizing robust maximum likelihood, uses all available data","PTSD scores: Random intercept and slope mutilevel models utilizing robust maximum likelihood. Effect sizes as regression coefficients standardized to baseline SD of each outcome in total sample.
Diagnostic change: binary logistic regression","Baseline",,,"64.3","8.9",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0.091",,"0.909","Mixed","Combat-related, Rape/sexual assault, Accidents, Community/school violence, Natural or manmade disasters, Terrorism/policital violence/forced displacement; Other (physical assault, assault with a weapon, unwanted or uncomfortable sexual experience, captivity, severe human suffering, sudden violent death of someone close, sudden unexpected death of someone close, other very stressful event or experience)","Medium","Back SE, Killeen T, Badour CL, et al. Concurrent treatment of substance use disorders and PTSD using prolonged exposure: a randomized clinical trial in military veterans. Addict Behav. 2019 Mar;90:369-77. doi: 10.1016/j.addbeh.2018.11.032. PMID: 30529244.","51384","2020"
"badurabrack2015astudy1_PCL_A_0_ITT","Nonpharmacologic cognitive","PTSD","52","A","PTSD",,"14",,"Attention Bias Modification","Attention bias modification (ABM)","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","Yes","No","No","No","Individual","In Person","27","Self report","PCL","PCL","ITT","Imputed using generalized estimating equations","PTSD scores: Random intercept and slope mutilevel models utilizing robust maximum likelihood. Effect sizes as regression coefficients standardized to baseline SD of each outcome in total sample.
Diagnostic change: binary logistic regression","End of Treatment","0",,"56.57","2.74",,,,,"-3.82",,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Badura-Brack AS, Naim R, Ryan TJ, et al. Effect of attention training on attention bias variability and PTSD symptoms: randomized controlled trials in Israeli and U.S. combat veterans. Am J Psychiatry. 2015 Dec;172(12):1233-41. doi: 10.1176/appi.ajp.2015.14121578. PMID: 26206075.","44617","2019"
"badurabrack2015astudy1_PCL_A_Baseline_ITT","Nonpharmacologic cognitive","PTSD","52","A","PTSD",,"27",,"Attention Bias Modification","Attention bias modification (ABM)","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","Yes","No","No","No","Individual","In Person","27","Self report","PCL","PCL","ITT","Imputed using generalized estimating equations","PTSD scores: Random intercept and slope mutilevel models utilizing robust maximum likelihood. Effect sizes as regression coefficients standardized to baseline SD of each outcome in total sample.
Diagnostic change: binary logistic regression","Baseline",,,"60.39","1.77",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Badura-Brack AS, Naim R, Ryan TJ, et al. Effect of attention training on attention bias variability and PTSD symptoms: randomized controlled trials in Israeli and U.S. combat veterans. Am J Psychiatry. 2015 Dec;172(12):1233-41. doi: 10.1176/appi.ajp.2015.14121578. PMID: 26206075.","44617","2019"
"badurabrack2015astudy1_PCL_B_0_ITT","Nonpharmacologic cognitive","PTSD","52","B","PTSD",,"15",,"Attention Control Training","Attention bias modification (ABM)","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","Yes","No","No","No","Individual","In Person","25","Self report","PCL","PCL","ITT","Imputed using generalized estimating equations","PTSD scores: Random intercept and slope mutilevel models utilizing robust maximum likelihood. Effect sizes as regression coefficients standardized to baseline SD of each outcome in total sample.
Diagnostic change: binary logistic regression","End of Treatment","0",,"45.34","3.58",,,,,"-12.95",,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Badura-Brack AS, Naim R, Ryan TJ, et al. Effect of attention training on attention bias variability and PTSD symptoms: randomized controlled trials in Israeli and U.S. combat veterans. Am J Psychiatry. 2015 Dec;172(12):1233-41. doi: 10.1176/appi.ajp.2015.14121578. PMID: 26206075.","44617","2019"
"badurabrack2015astudy1_PCL_B_Baseline_ITT","Nonpharmacologic cognitive","PTSD","52","B","PTSD",,"27",,"Attention Control Training","Attention bias modification (ABM)","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","Yes","No","No","No","Individual","In Person","25","Self report","PCL","PCL","ITT","Imputed using generalized estimating equations","PTSD scores: Random intercept and slope mutilevel models utilizing robust maximum likelihood. Effect sizes as regression coefficients standardized to baseline SD of each outcome in total sample.
Diagnostic change: binary logistic regression","Baseline",,,"58.29","1.84",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Badura-Brack AS, Naim R, Ryan TJ, et al. Effect of attention training on attention bias variability and PTSD symptoms: randomized controlled trials in Israeli and U.S. combat veterans. Am J Psychiatry. 2015 Dec;172(12):1233-41. doi: 10.1176/appi.ajp.2015.14121578. PMID: 26206075.","44617","2019"
"badurabrack2015bstudy2_CAPS_A_0_ITT","Nonpharmacologic cognitive","PTSD","46","A","PTSD",,"17",,"Attention Bias Modification","Attention bias modification (ABM)","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","Yes","No","No","No","Individual","In Person","22","Structured Clinical Interview","CAPS","CAPS","ITT","Imputed using generalized estimating equations","PTSD scores: Random intercept and slope mutilevel models utilizing robust maximum likelihood. Effect sizes as regression coefficients standardized to baseline SD of each outcome in total sample.
Diagnostic change: binary logistic regression","End of Treatment","0",,"56.19","4.9",,,,,"-15.99",,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Badura-Brack AS, Naim R, Ryan TJ, et al. Effect of attention training on attention bias variability and PTSD symptoms: randomized controlled trials in Israeli and U.S. combat veterans. Am J Psychiatry. 2015 Dec;172(12):1233-41. doi: 10.1176/appi.ajp.2015.14121578. PMID: 26206075.","44617","2019"
"badurabrack2015bstudy2_CAPS_A_Baseline_ITT","Nonpharmacologic cognitive","PTSD","46","A","PTSD",,"22",,"Attention Bias Modification","Attention bias modification (ABM)","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","Yes","No","No","No","Individual","In Person","22","Structured Clinical Interview","CAPS","CAPS","ITT","Imputed using generalized estimating equations","PTSD scores: Random intercept and slope mutilevel models utilizing robust maximum likelihood. Effect sizes as regression coefficients standardized to baseline SD of each outcome in total sample.
Diagnostic change: binary logistic regression","Baseline",,,"72.18","3.53",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Badura-Brack AS, Naim R, Ryan TJ, et al. Effect of attention training on attention bias variability and PTSD symptoms: randomized controlled trials in Israeli and U.S. combat veterans. Am J Psychiatry. 2015 Dec;172(12):1233-41. doi: 10.1176/appi.ajp.2015.14121578. PMID: 26206075.","44617","2019"
"badurabrack2015bstudy2_CAPS_B_0_ITT","Nonpharmacologic cognitive","PTSD","46","B","PTSD",,"15",,"Attention Control Training","Attention bias modification (ABM)","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","Yes","No","No","No","Individual","In Person","24","Structured Clinical Interview","CAPS","CAPS","ITT","Imputed using generalized estimating equations","PTSD scores: Random intercept and slope mutilevel models utilizing robust maximum likelihood. Effect sizes as regression coefficients standardized to baseline SD of each outcome in total sample.
Diagnostic change: binary logistic regression","End of Treatment","0",,"44.13","4.92",,,,,"-28.2",,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Badura-Brack AS, Naim R, Ryan TJ, et al. Effect of attention training on attention bias variability and PTSD symptoms: randomized controlled trials in Israeli and U.S. combat veterans. Am J Psychiatry. 2015 Dec;172(12):1233-41. doi: 10.1176/appi.ajp.2015.14121578. PMID: 26206075.","44617","2019"
"badurabrack2015bstudy2_CAPS_B_Baseline_ITT","Nonpharmacologic cognitive","PTSD","46","B","PTSD",,"17",,"Attention Control Training","Attention bias modification (ABM)","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","Yes","No","No","No","Individual","In Person","24","Structured Clinical Interview","CAPS","CAPS","ITT","Imputed using generalized estimating equations","PTSD scores: Random intercept and slope mutilevel models utilizing robust maximum likelihood. Effect sizes as regression coefficients standardized to baseline SD of each outcome in total sample.
Diagnostic change: binary logistic regression","Baseline",,,"72.33","3.00",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Badura-Brack AS, Naim R, Ryan TJ, et al. Effect of attention training on attention bias variability and PTSD symptoms: randomized controlled trials in Israeli and U.S. combat veterans. Am J Psychiatry. 2015 Dec;172(12):1233-41. doi: 10.1176/appi.ajp.2015.14121578. PMID: 26206075.","44617","2019"
"badurabrack2015bstudy2_PCL_A_0_ITT","Nonpharmacologic cognitive","PTSD","46","A","PTSD",,,,"Attention Bias Modification","Attention bias modification (ABM)","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","Yes","No","No","No","Individual","In Person","22","Self report","PCL","PCL-M","ITT",,"PTSD scores: Random intercept and slope mutilevel models utilizing robust maximum likelihood. Effect sizes as regression coefficients standardized to baseline SD of each outcome in total sample.
Diagnostic change: binary logistic regression","End of Treatment","0",,"50.17","2.96",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Badura-Brack AS, Naim R, Ryan TJ, et al. Effect of attention training on attention bias variability and PTSD symptoms: randomized controlled trials in Israeli and U.S. combat veterans. Am J Psychiatry. 2015 Dec;172(12):1233-41. doi: 10.1176/appi.ajp.2015.14121578. PMID: 26206075.","44617","2019"
"badurabrack2015bstudy2_PCL_A_Baseline_ITT","Nonpharmacologic cognitive","PTSD","46","A","PTSD",,,,"Attention Bias Modification","Attention bias modification (ABM)","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","Yes","No","No","No","Individual","In Person","22","Self report","PCL","PCL-M","ITT",,"PTSD scores: Random intercept and slope mutilevel models utilizing robust maximum likelihood. Effect sizes as regression coefficients standardized to baseline SD of each outcome in total sample.
Diagnostic change: binary logistic regression","Baseline",,,"51.68","2.66",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Badura-Brack AS, Naim R, Ryan TJ, et al. Effect of attention training on attention bias variability and PTSD symptoms: randomized controlled trials in Israeli and U.S. combat veterans. Am J Psychiatry. 2015 Dec;172(12):1233-41. doi: 10.1176/appi.ajp.2015.14121578. PMID: 26206075.","44617","2019"
"badurabrack2015bstudy2_PCL_B_0_ITT","Nonpharmacologic cognitive","PTSD","46","B","PTSD",,,,"Attention Control Training","Attention bias modification (ABM)","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","Yes","No","No","No","Individual","In Person","24","Self report","PCL","PCL-M","ITT",,"PTSD scores: Random intercept and slope mutilevel models utilizing robust maximum likelihood. Effect sizes as regression coefficients standardized to baseline SD of each outcome in total sample.
Diagnostic change: binary logistic regression","End of Treatment","0",,"45.40","3.22",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Badura-Brack AS, Naim R, Ryan TJ, et al. Effect of attention training on attention bias variability and PTSD symptoms: randomized controlled trials in Israeli and U.S. combat veterans. Am J Psychiatry. 2015 Dec;172(12):1233-41. doi: 10.1176/appi.ajp.2015.14121578. PMID: 26206075.","44617","2019"
"badurabrack2015bstudy2_PCL_B_Baseline_ITT","Nonpharmacologic cognitive","PTSD","46","B","PTSD",,,,"Attention Control Training","Attention bias modification (ABM)","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","Yes","No","No","No","Individual","In Person","24","Self report","PCL","PCL-M","ITT",,"PTSD scores: Random intercept and slope mutilevel models utilizing robust maximum likelihood. Effect sizes as regression coefficients standardized to baseline SD of each outcome in total sample.
Diagnostic change: binary logistic regression","Baseline",,,"54.16","1.82",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Badura-Brack AS, Naim R, Ryan TJ, et al. Effect of attention training on attention bias variability and PTSD symptoms: randomized controlled trials in Israeli and U.S. combat veterans. Am J Psychiatry. 2015 Dec;172(12):1233-41. doi: 10.1176/appi.ajp.2015.14121578. PMID: 26206075.","44617","2019"
"baker1995_CAPS_A_0_ITT","Pharmacotherapy","PTSD","118","A","PTSD",,"56",,"Brofaromine","Brofaromine","No","Not Applicable","Yes","Antidepressant: MAOI","No","Not Applicable","No","No","No","No","No","Individual","In Person","56","Structured Clinical Interview","CAPS","CAPS","ITT",,"PTSD scores: Random intercept and slope mutilevel models utilizing robust maximum likelihood. Effect sizes as regression coefficients standardized to baseline SD of each outcome in total sample.
Diagnostic change: binary logistic regression","End of Treatment","0",,"54.86",,,,,,"-27.30",,,,,,,,,,"p=0.001",,,,,,,,,,,,,,"Mixed","0","0.602","0.398","0.193",,"0.807","Mixed","combat-related, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (not specified)","Medium","Baker DG, Diamond BI, Gillette GM, et al. A double-blind, randomized, placebo-controlled, multi-center study of brofaromine in the treatment of post-traumatic stress disorder. Psychopharmacology (Berl). 1995 Dec;122(4):386-9. doi: 10.1007/BF02246271. PMID: 8657838.","06773","2019"
"baker1995_CAPS_A_Baseline_ITT","Pharmacotherapy","PTSD","118","A","PTSD",,"56",,"Brofaromine","Brofaromine","No","Not Applicable","Yes","Antidepressant: MAOI","No","Not Applicable","No","No","No","No","No","Individual","In Person","56","Structured Clinical Interview","CAPS","CAPS","ITT",,"PTSD scores: Random intercept and slope mutilevel models utilizing robust maximum likelihood. Effect sizes as regression coefficients standardized to baseline SD of each outcome in total sample.
Diagnostic change: binary logistic regression","Baseline",,,"83.6","17.2",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Mixed","0","0.602","0.398","0.193",,"0.807","Mixed","combat-related, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (not specified)","Medium","Baker DG, Diamond BI, Gillette GM, et al. A double-blind, randomized, placebo-controlled, multi-center study of brofaromine in the treatment of post-traumatic stress disorder. Psychopharmacology (Berl). 1995 Dec;122(4):386-9. doi: 10.1007/BF02246271. PMID: 8657838.","06773","2019"
"baker1995_CAPS_B_0_ITT","Pharmacotherapy","PTSD","118","B","Control",,"58",,"Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","58","Structured Clinical Interview","CAPS","CAPS","ITT",,"PTSD scores: Random intercept and slope mutilevel models utilizing robust maximum likelihood. Effect sizes as regression coefficients standardized to baseline SD of each outcome in total sample.
Diagnostic change: binary logistic regression","End of Treatment","0",,"54.98",,,,,,"-24.68",,,,,,,,,,"p=0.001",,,,,,,,,,,,,,"Mixed","0","0.602","0.398","0.193",,"0.807","Mixed","combat-related, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (not specified)","Medium","Baker DG, Diamond BI, Gillette GM, et al. A double-blind, randomized, placebo-controlled, multi-center study of brofaromine in the treatment of post-traumatic stress disorder. Psychopharmacology (Berl). 1995 Dec;122(4):386-9. doi: 10.1007/BF02246271. PMID: 8657838.","06773","2019"
"baker1995_CAPS_B_Baseline_ITT","Pharmacotherapy","PTSD","118","B","Control",,"58",,"Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","58","Structured Clinical Interview","CAPS","CAPS","ITT",,"PTSD scores: Random intercept and slope mutilevel models utilizing robust maximum likelihood. Effect sizes as regression coefficients standardized to baseline SD of each outcome in total sample.
Diagnostic change: binary logistic regression","Baseline",,,"83.2","18.8",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Mixed","0","0.602","0.398","0.193",,"0.807","Mixed","combat-related, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (not specified)","Medium","Baker DG, Diamond BI, Gillette GM, et al. A double-blind, randomized, placebo-controlled, multi-center study of brofaromine in the treatment of post-traumatic stress disorder. Psychopharmacology (Berl). 1995 Dec;122(4):386-9. doi: 10.1007/BF02246271. PMID: 8657838.","06773","2019"
"baker1995_IES_A_0_NA","Pharmacotherapy","PTSD","118","A","PTSD",,,,"Brofaromine","Brofaromine","No","Not Applicable","Yes","Antidepressant: MAOI","No","Not Applicable","No","No","No","No","No","Individual","In Person","56","Self report","IES","IES",,,"PTSD scores: Random intercept and slope mutilevel models utilizing robust maximum likelihood. Effect sizes as regression coefficients standardized to baseline SD of each outcome in total sample.
Diagnostic change: binary logistic regression","End of Treatment","0",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Mixed","0","0.602","0.398","0.193",,"0.807","Mixed","combat-related, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (not specified)","Medium","Baker DG, Diamond BI, Gillette GM, et al. A double-blind, randomized, placebo-controlled, multi-center study of brofaromine in the treatment of post-traumatic stress disorder. Psychopharmacology (Berl). 1995 Dec;122(4):386-9. doi: 10.1007/BF02246271. PMID: 8657838.","06773","2019"
"baker1995_IES_A_Baseline_NA","Pharmacotherapy","PTSD","118","A","PTSD",,,,"Brofaromine","Brofaromine","No","Not Applicable","Yes","Antidepressant: MAOI","No","Not Applicable","No","No","No","No","No","Individual","In Person","56","Self report","IES","IES",,,"PTSD scores: Random intercept and slope mutilevel models utilizing robust maximum likelihood. Effect sizes as regression coefficients standardized to baseline SD of each outcome in total sample.
Diagnostic change: binary logistic regression","Baseline",,,"31.9","7.9",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Mixed","0","0.602","0.398","0.193",,"0.807","Mixed","combat-related, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (not specified)","Medium","Baker DG, Diamond BI, Gillette GM, et al. A double-blind, randomized, placebo-controlled, multi-center study of brofaromine in the treatment of post-traumatic stress disorder. Psychopharmacology (Berl). 1995 Dec;122(4):386-9. doi: 10.1007/BF02246271. PMID: 8657838.","06773","2019"
"baker1995_IES_B_0_NA","Pharmacotherapy","PTSD","118","B","Control",,,,"Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","58","Self report","IES","IES",,,"PTSD scores: Random intercept and slope mutilevel models utilizing robust maximum likelihood. Effect sizes as regression coefficients standardized to baseline SD of each outcome in total sample.
Diagnostic change: binary logistic regression","End of Treatment","0",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Mixed","0","0.602","0.398","0.193",,"0.807","Mixed","combat-related, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (not specified)","Medium","Baker DG, Diamond BI, Gillette GM, et al. A double-blind, randomized, placebo-controlled, multi-center study of brofaromine in the treatment of post-traumatic stress disorder. Psychopharmacology (Berl). 1995 Dec;122(4):386-9. doi: 10.1007/BF02246271. PMID: 8657838.","06773","2019"
"baker1995_IES_B_Baseline_NA","Pharmacotherapy","PTSD","118","B","Control",,,,"Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","58","Self report","IES","IES",,,"PTSD scores: Random intercept and slope mutilevel models utilizing robust maximum likelihood. Effect sizes as regression coefficients standardized to baseline SD of each outcome in total sample.
Diagnostic change: binary logistic regression","Baseline",,,"32.1","6.9",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Mixed","0","0.602","0.398","0.193",,"0.807","Mixed","combat-related, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (not specified)","Medium","Baker DG, Diamond BI, Gillette GM, et al. A double-blind, randomized, placebo-controlled, multi-center study of brofaromine in the treatment of post-traumatic stress disorder. Psychopharmacology (Berl). 1995 Dec;122(4):386-9. doi: 10.1007/BF02246271. PMID: 8657838.","06773","2019"
"baniasadi2014_PCL-M_A_0_ITT","Pharmacotherapy","PTSD","37","A","PTSD",,"18",,"Pregabalin augmentation","Pregabalin","No","Not Applicable","Yes","Other pharmacotherapy","No","Not Applicable","No","No","No","No","No","Individual","In Person","18","Self report","PCL-M","PCL-M","ITT",,"PTSD scores: Random intercept and slope mutilevel models utilizing robust maximum likelihood. Effect sizes as regression coefficients standardized to baseline SD of each outcome in total sample.
Diagnostic change: binary logistic regression","End of Treatment","0",,"48.77","7.01",,,,,"-8.06",,,,,,,,,,"p=0.0001",,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Baniasadi M, Hosseini G, Fayyazi Bordbar MR, et al. Effect of pregabalin augmentation in treatment of patients with combat-related chronic posttraumatic stress disorder: a randomized controlled trial. J Psychiatr Pract. 2014 Nov;20(6):419-27. doi: 10.1097/01.pra.0000456590.12998.41. PMID: 25406046.","44618","2019"
"baniasadi2014_PCL-M_A_Baseline_ITT","Pharmacotherapy","PTSD","37","A","PTSD",,"18",,"Pregabalin augmentation","Pregabalin","No","Not Applicable","Yes","Other pharmacotherapy","No","Not Applicable","No","No","No","No","No","Individual","In Person","18","Self report","PCL-M","PCL-M","ITT",,"PTSD scores: Random intercept and slope mutilevel models utilizing robust maximum likelihood. Effect sizes as regression coefficients standardized to baseline SD of each outcome in total sample.
Diagnostic change: binary logistic regression","Baseline",,,"56.83","7.66",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Baniasadi M, Hosseini G, Fayyazi Bordbar MR, et al. Effect of pregabalin augmentation in treatment of patients with combat-related chronic posttraumatic stress disorder: a randomized controlled trial. J Psychiatr Pract. 2014 Nov;20(6):419-27. doi: 10.1097/01.pra.0000456590.12998.41. PMID: 25406046.","44618","2019"
"baniasadi2014_PCL-M_B_0_ITT","Pharmacotherapy","PTSD","37","B","Control",,"19",,"Placebo augmentation","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","19","Self report","PCL-M","PCL-M","ITT",,"PTSD scores: Random intercept and slope mutilevel models utilizing robust maximum likelihood. Effect sizes as regression coefficients standardized to baseline SD of each outcome in total sample.
Diagnostic change: binary logistic regression","End of Treatment","0",,"50.79","6.01",,,,,"-4.31",,,,,,,,,,"p=0.0001",,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Baniasadi M, Hosseini G, Fayyazi Bordbar MR, et al. Effect of pregabalin augmentation in treatment of patients with combat-related chronic posttraumatic stress disorder: a randomized controlled trial. J Psychiatr Pract. 2014 Nov;20(6):419-27. doi: 10.1097/01.pra.0000456590.12998.41. PMID: 25406046.","44618","2019"
"baniasadi2014_PCL-M_B_Baseline_ITT","Pharmacotherapy","PTSD","37","B","Control",,"19",,"Placebo augmentation","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","19","Self report","PCL-M","PCL-M","ITT",,"PTSD scores: Random intercept and slope mutilevel models utilizing robust maximum likelihood. Effect sizes as regression coefficients standardized to baseline SD of each outcome in total sample.
Diagnostic change: binary logistic regression","Baseline",,,"55.10","7.75",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Baniasadi M, Hosseini G, Fayyazi Bordbar MR, et al. Effect of pregabalin augmentation in treatment of patients with combat-related chronic posttraumatic stress disorder: a randomized controlled trial. J Psychiatr Pract. 2014 Nov;20(6):419-27. doi: 10.1097/01.pra.0000456590.12998.41. PMID: 25406046.","44618","2019"
"basoglu2005_CAPS_A_0_Comp","Psychotherapy","PTSD","59","A","PTSD",,"31",,"Modified behavioral treatment","Trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","31","Structured Clinical Interview","CAPS","CAPS (Turkish version)","Completer","Excluded","PTSD scores: Random intercept and slope mutilevel models utilizing robust maximum likelihood. Effect sizes as regression coefficients standardized to baseline SD of each outcome in total sample.
Diagnostic change: binary logistic regression","End of Treatment","0",,"44.4","25",,,,,"-23.4",,,,,"Cohen's d","1.3",,,,"p<0.001",,,,,,,,,,,,,,"Community",,,"1","0.8475",,"0.1525","Natural or manmade disasters",,"Medium","Basoglu M, Salcioglu E, Livanou M, et al. Single-session behavioral treatment of earthquake-related posttraumatic stress disorder: a randomized waiting list controlled trial. J Trauma Stress. 2005;18(1):1-11. doi: 10.1002/jts.20011. PMID: 16281190.","18886","2019"
"basoglu2005_CAPS_A_Baseline_Comp","Psychotherapy","PTSD","59","A","PTSD",,"31",,"Modified behavioral treatment","Trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","31","Structured Clinical Interview","CAPS","CAPS (Turkish version)","Completer","Excluded","PTSD scores: Random intercept and slope mutilevel models utilizing robust maximum likelihood. Effect sizes as regression coefficients standardized to baseline SD of each outcome in total sample.
Diagnostic change: binary logistic regression","Baseline",,,"67.8","16.5",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.8475",,"0.1525","Natural or manmade disasters",,"Medium","Basoglu M, Salcioglu E, Livanou M, et al. Single-session behavioral treatment of earthquake-related posttraumatic stress disorder: a randomized waiting list controlled trial. J Trauma Stress. 2005;18(1):1-11. doi: 10.1002/jts.20011. PMID: 16281190.","18886","2019"
"basoglu2005_CAPS_B_0_Comp","Psychotherapy","PTSD","59","B","Control",,"28",,"Waitlist","Waitlist","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,"28","Structured Clinical Interview","CAPS","CAPS (Turkish version)","Completer","Excluded","PTSD scores: Random intercept and slope mutilevel models utilizing robust maximum likelihood. Effect sizes as regression coefficients standardized to baseline SD of each outcome in total sample.
Diagnostic change: binary logistic regression","End of Treatment","0",,"54.7","21.4",,,,,"-5.8",,,,,"Cohen's d","0.3",,,,"p≥0.05",,,,,,,,,,,,,,"Community",,,"1","0.8475",,"0.1525","Natural or manmade disasters",,"Medium","Basoglu M, Salcioglu E, Livanou M, et al. Single-session behavioral treatment of earthquake-related posttraumatic stress disorder: a randomized waiting list controlled trial. J Trauma Stress. 2005;18(1):1-11. doi: 10.1002/jts.20011. PMID: 16281190.","18886","2019"
"basoglu2005_CAPS_B_Baseline_Comp","Psychotherapy","PTSD","59","B","Control",,"28",,"Waitlist","Waitlist","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,"28","Structured Clinical Interview","CAPS","CAPS (Turkish version)","Completer","Excluded","PTSD scores: Random intercept and slope mutilevel models utilizing robust maximum likelihood. Effect sizes as regression coefficients standardized to baseline SD of each outcome in total sample.
Diagnostic change: binary logistic regression","Baseline",,,"60.5","14.1",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.8475",,"0.1525","Natural or manmade disasters",,"Medium","Basoglu M, Salcioglu E, Livanou M, et al. Single-session behavioral treatment of earthquake-related posttraumatic stress disorder: a randomized waiting list controlled trial. J Trauma Stress. 2005;18(1):1-11. doi: 10.1002/jts.20011. PMID: 16281190.","18886","2019"
"basoglu2005_Trau_A_0_NA","Psychotherapy","PTSD","59","A","PTSD",,,,"Modified behavioral treatment","Trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","31","Self report","Traumatic Stress Symptom Checklist","Traumatic Stress Symptom Checklist",,,"PTSD scores: Random intercept and slope mutilevel models utilizing robust maximum likelihood. Effect sizes as regression coefficients standardized to baseline SD of each outcome in total sample.
Diagnostic change: binary logistic regression","End of Treatment","0",,"25.3","15.0",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.8475",,"0.1525","Natural or manmade disasters",,"Medium","Basoglu M, Salcioglu E, Livanou M, et al. Single-session behavioral treatment of earthquake-related posttraumatic stress disorder: a randomized waiting list controlled trial. J Trauma Stress. 2005;18(1):1-11. doi: 10.1002/jts.20011. PMID: 16281190.","18886","2019"
"basoglu2005_Trau_A_Baseline_NA","Psychotherapy","PTSD","59","A","PTSD",,,,"Modified behavioral treatment","Trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","31","Self report","Traumatic Stress Symptom Checklist","Traumatic Stress Symptom Checklist",,,"PTSD scores: Random intercept and slope mutilevel models utilizing robust maximum likelihood. Effect sizes as regression coefficients standardized to baseline SD of each outcome in total sample.
Diagnostic change: binary logistic regression","Baseline",,,"42.0","12.0",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.8475",,"0.1525","Natural or manmade disasters",,"Medium","Basoglu M, Salcioglu E, Livanou M, et al. Single-session behavioral treatment of earthquake-related posttraumatic stress disorder: a randomized waiting list controlled trial. J Trauma Stress. 2005;18(1):1-11. doi: 10.1002/jts.20011. PMID: 16281190.","18886","2019"
"basoglu2005_Trau_B_0_NA","Psychotherapy","PTSD","59","B","Control",,,,"Waitlist","Waitlist","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,"28","Self report","Traumatic Stress Symptom Checklist","Traumatic Stress Symptom Checklist",,,"PTSD scores: Random intercept and slope mutilevel models utilizing robust maximum likelihood. Effect sizes as regression coefficients standardized to baseline SD of each outcome in total sample.
Diagnostic change: binary logistic regression","End of Treatment","0",,"32.6","13.5",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.8475",,"0.1525","Natural or manmade disasters",,"Medium","Basoglu M, Salcioglu E, Livanou M, et al. Single-session behavioral treatment of earthquake-related posttraumatic stress disorder: a randomized waiting list controlled trial. J Trauma Stress. 2005;18(1):1-11. doi: 10.1002/jts.20011. PMID: 16281190.","18886","2019"
"basoglu2005_Trau_B_Baseline_NA","Psychotherapy","PTSD","59","B","Control",,,,"Waitlist","Waitlist","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,"28","Self report","Traumatic Stress Symptom Checklist","Traumatic Stress Symptom Checklist",,,"PTSD scores: Random intercept and slope mutilevel models utilizing robust maximum likelihood. Effect sizes as regression coefficients standardized to baseline SD of each outcome in total sample.
Diagnostic change: binary logistic regression","Baseline",,,"39.9","11.0",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.8475",,"0.1525","Natural or manmade disasters",,"Medium","Basoglu M, Salcioglu E, Livanou M, et al. Single-session behavioral treatment of earthquake-related posttraumatic stress disorder: a randomized waiting list controlled trial. J Trauma Stress. 2005;18(1):1-11. doi: 10.1002/jts.20011. PMID: 16281190.","18886","2019"
"basoglu2007_CAPS_A_0_ITT","Psychotherapy","PTSD","31","A","PTSD",,"15",,"Behavioral treatment","Exposure therapy","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","16","Structured Clinical Interview","CAPS","CAPS","ITT",,"Repeated measures ANOVA and Cohen's d for change in mean score","End of Treatment","0",,"38.7","18.7",,,,,"-24.4",,,,,,,,,,,,,,,,,,,,,"Very/much improved on CGI-I",,,"Community","0","0","1","0.871",,"0.129","Natural or manmade disasters",,"Medium","Basoglu M, Salcioglu E, Livanou M. A randomized controlled study of single-session behavioural treatment of earthquake-related post-traumatic stress disorder using an earthquake simulator. Psychological Medicine. 2007;37(2):203-13. doi: 10.1017/S0033291706009123. PMID: 17254365.","29446","2020"
"basoglu2007_CAPS_A_4_ITT","Psychotherapy","PTSD","31","A","PTSD",,"16",,"Behavioral treatment","Exposure therapy","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","16","Structured Clinical Interview","CAPS","CAPS","ITT",,"Repeated measures ANOVA and Cohen's d for change in mean score","Assessment at <3 Months","4",,"30.2","20.3",,,,,"-32.9",,,,,,,,,,,,,,,,,,,,,,,,"Community","0","0","1","0.871",,"0.129","Natural or manmade disasters",,"Medium","Basoglu M, Salcioglu E, Livanou M. A randomized controlled study of single-session behavioural treatment of earthquake-related post-traumatic stress disorder using an earthquake simulator. Psychological Medicine. 2007;37(2):203-13. doi: 10.1017/S0033291706009123. PMID: 17254365.","29446","2020"
"basoglu2007_CAPS_A_Baseline_ITT","Psychotherapy","PTSD","31","A","PTSD",,"16",,"Behavioral treatment","Exposure therapy","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","16","Structured Clinical Interview","CAPS","CAPS","ITT",,"Repeated measures ANOVA and Cohen's d for change in mean score","Baseline",,,"63.1","10.1",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community","0","0","1","0.871",,"0.129","Natural or manmade disasters",,"Medium","Basoglu M, Salcioglu E, Livanou M. A randomized controlled study of single-session behavioural treatment of earthquake-related post-traumatic stress disorder using an earthquake simulator. Psychological Medicine. 2007;37(2):203-13. doi: 10.1017/S0033291706009123. PMID: 17254365.","29446","2020"
"basoglu2007_CAPS_B_0_ITT","Psychotherapy","PTSD","31","B","Control",,"15",,"Repeated assessment","Waitlist","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","15","Structured Clinical Interview","CAPS","CAPS","ITT",,"Repeated measures ANOVA and Cohen's d for change in mean score","End of Treatment","0",,"54.5","16.9",,,,,"-7.8",,,,,,,,,,,,,,,,,,,,,,,,"Community","0","0","1","0.871",,"0.129","Natural or manmade disasters",,"Medium","Basoglu M, Salcioglu E, Livanou M. A randomized controlled study of single-session behavioural treatment of earthquake-related post-traumatic stress disorder using an earthquake simulator. Psychological Medicine. 2007;37(2):203-13. doi: 10.1017/S0033291706009123. PMID: 17254365.","29446","2020"
"basoglu2007_CAPS_B_4_ITT","Psychotherapy","PTSD","31","B","Control",,"15",,"Repeated assessment","Waitlist","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","15","Structured Clinical Interview","CAPS","CAPS","ITT",,"Repeated measures ANOVA and Cohen's d for change in mean score","Assessment at <3 Months","4",,"49.1","20.3",,,,,"-13.2",,,,,,,,,,,,,,,,,,,,,,,,"Community","0","0","1","0.871",,"0.129","Natural or manmade disasters",,"Medium","Basoglu M, Salcioglu E, Livanou M. A randomized controlled study of single-session behavioural treatment of earthquake-related post-traumatic stress disorder using an earthquake simulator. Psychological Medicine. 2007;37(2):203-13. doi: 10.1017/S0033291706009123. PMID: 17254365.","29446","2020"
"basoglu2007_CAPS_B_Baseline_ITT","Psychotherapy","PTSD","31","B","Control",,"15",,"Repeated assessment","Waitlist","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","15","Structured Clinical Interview","CAPS","CAPS","ITT",,"Repeated measures ANOVA and Cohen's d for change in mean score","Baseline",,,"62.3","14.5",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community","0","0","1","0.871",,"0.129","Natural or manmade disasters",,"Medium","Basoglu M, Salcioglu E, Livanou M. A randomized controlled study of single-session behavioural treatment of earthquake-related post-traumatic stress disorder using an earthquake simulator. Psychological Medicine. 2007;37(2):203-13. doi: 10.1017/S0033291706009123. PMID: 17254365.","29446","2020"
"batki2014_PCL_A_0_ITT","Pharmacotherapy","PTSD+SUD","30","A","PTSD+SUD","Not integrated",,,"Topiramate","Topiramate","No","Not Applicable","Yes","Mood stabilizer","No","Not Applicable","No","No","No","No","No","Individual","In person","14","Self report","PCL","PCL","ITT","Linear mixed models","Random-intercept linear mixed models","End of Treatment","0","average weeks 1 through 12","42.3","16",,,,"difference between baseline and average of weeks 1 through 12","-14.8",,,,"average relative change in outcome per week from baseline through week 12","Incidence rate ratio","-1.22","95% CI","-1.84","0.62","p=0.001",,,,,,,,,,,,,,"Veteran","0","1","0","0.0667",,"0.9333","Mixed","combat-related, other (""civilian related trauma"")","Medium","Batki SL, Pennington DL, Lasher B, et al. Topiramate treatment of alcohol use disorder in veterans with posttraumatic stress disorder: a randomized controlled pilot trial. Alcohol Clin Exp Res. 2014 Aug;38(8):2169-77. doi: 10.1111/acer.12496. PMID: 25092377.","42646","2020"
"batki2014_PCL_A_Baseline_ITT","Pharmacotherapy","PTSD+SUD","30","A","PTSD+SUD","Not integrated","14",,"Topiramate","Topiramate","No","Not Applicable","Yes","Mood stabilizer","No","Not Applicable","No","No","No","No","No","Individual","In person","14","Self report","PCL","PCL","ITT","Linear mixed models","Random-intercept linear mixed models","Baseline",,,"57.1","13.4",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0.0667",,"0.9333","Mixed","combat-related, other (""civilian related trauma"")","Medium","Batki SL, Pennington DL, Lasher B, et al. Topiramate treatment of alcohol use disorder in veterans with posttraumatic stress disorder: a randomized controlled pilot trial. Alcohol Clin Exp Res. 2014 Aug;38(8):2169-77. doi: 10.1111/acer.12496. PMID: 25092377.","42646","2020"
"batki2014_PCL_B_0_ITT","Pharmacotherapy","PTSD+SUD","30","B","Control","Not integrated",,,"Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In person","16","Self report","PCL","PCL","ITT","Linear mixed models","Random-intercept linear mixed models","End of Treatment","0","average weeks 1 through 12","49.0","16.5",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0.0667",,"0.9333","Mixed","combat-related, other (""civilian related trauma"")","Medium","Batki SL, Pennington DL, Lasher B, et al. Topiramate treatment of alcohol use disorder in veterans with posttraumatic stress disorder: a randomized controlled pilot trial. Alcohol Clin Exp Res. 2014 Aug;38(8):2169-77. doi: 10.1111/acer.12496. PMID: 25092377.","42646","2020"
"batki2014_PCL_B_Baseline_ITT","Pharmacotherapy","PTSD+SUD","30","B","Control","Not integrated","16",,"Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In person","16","Self report","PCL","PCL","ITT","Linear mixed models","Random-intercept linear mixed models","Baseline",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0.0667",,"0.9333","Mixed","combat-related, other (""civilian related trauma"")","Medium","Batki SL, Pennington DL, Lasher B, et al. Topiramate treatment of alcohol use disorder in veterans with posttraumatic stress disorder: a randomized controlled pilot trial. Alcohol Clin Exp Res. 2014 Aug;38(8):2169-77. doi: 10.1111/acer.12496. PMID: 25092377.","42646","2020"
"battaglia2016_PCL_A_0_ITT","Other mixed","PTSD+SUD","175","A","PTSD+SUD","Not integrated","62",,"MI for smoking cessation + PTSD home telehealth care management program","Motivational Interviewing (MI) for smoking cessation + PTSD home telehealth care management program","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","Yes","Individual","Mixed","89","Self report","PCL","PCL","ITT",,"Mean score differences between groups using t-test (nonparametric tests if skewed) and linear regression models","End of Treatment","0",,"54.5","13.2",,,,,"-2.8",,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0.1371",,"0.8629",,,"Medium","Battaglia C, Peterson J, Whitfield E, et al. Integrating motivational interviewing into a home telehealth program for veterans with posttraumatic stress disorder who smoke: a randomized controlled trial. J Clin Psychol. 2016 Mar;72(3):194-206. doi: 10.1002/jclp.22252. PMID: 26783736.","49060","2020"
"battaglia2016_PCL_A_26_ITT","Other mixed","PTSD+SUD","175","A","PTSD+SUD","Not integrated","61",,"MI for smoking cessation + PTSD home telehealth care management program","Motivational Interviewing (MI) for smoking cessation + PTSD home telehealth care management program","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","Yes","Individual","Mixed","89","Self report","PCL","PCL","ITT",,"Mean score differences between groups using t-test (nonparametric tests if skewed) and linear regression models","Assessment at 6 to <12 Months","26",,"58.4","11.4",,,,,"1.1",,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0.1371",,"0.8629",,,"Medium","Battaglia C, Peterson J, Whitfield E, et al. Integrating motivational interviewing into a home telehealth program for veterans with posttraumatic stress disorder who smoke: a randomized controlled trial. J Clin Psychol. 2016 Mar;72(3):194-206. doi: 10.1002/jclp.22252. PMID: 26783736.","49060","2020"
"battaglia2016_PCL_A_Baseline_ITT","Other mixed","PTSD+SUD","175","A","PTSD+SUD","Not integrated","84",,"MI for smoking cessation + PTSD home telehealth care management program","Motivational Interviewing (MI) for smoking cessation + PTSD home telehealth care management program","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","Yes","Individual","Mixed","89","Self report","PCL","PCL","ITT",,"Mean score differences between groups using t-test (nonparametric tests if skewed) and linear regression models","Baseline",,,"57.3","11.9",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0.1371",,"0.8629",,,"Medium","Battaglia C, Peterson J, Whitfield E, et al. Integrating motivational interviewing into a home telehealth program for veterans with posttraumatic stress disorder who smoke: a randomized controlled trial. J Clin Psychol. 2016 Mar;72(3):194-206. doi: 10.1002/jclp.22252. PMID: 26783736.","49060","2020"
"battaglia2016_PCL_B_0_ITT","Other mixed","PTSD+SUD","175","B","PTSD","Not integrated","59",,"PTSD home telehealth care management program","PTSD home telehealth care management program","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","Technology alone","86","Self report","PCL","PCL","ITT",,"Mean score differences between groups using t-test (nonparametric tests if skewed) and linear regression models","End of Treatment","0",,"55.9","13.5",,,,,"-4.5",,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0.1371",,"0.8629",,,"Medium","Battaglia C, Peterson J, Whitfield E, et al. Integrating motivational interviewing into a home telehealth program for veterans with posttraumatic stress disorder who smoke: a randomized controlled trial. J Clin Psychol. 2016 Mar;72(3):194-206. doi: 10.1002/jclp.22252. PMID: 26783736.","49060","2020"
"battaglia2016_PCL_B_26_ITT","Other mixed","PTSD+SUD","175","B","PTSD","Not integrated","59",,"PTSD home telehealth care management program","PTSD home telehealth care management program","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","Technology alone","86","Self report","PCL","PCL","ITT",,"Mean score differences between groups using t-test (nonparametric tests if skewed) and linear regression models","Assessment at 6 to <12 Months","26",,"62.4","10.9",,,,,"2",,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0.1371",,"0.8629",,,"Medium","Battaglia C, Peterson J, Whitfield E, et al. Integrating motivational interviewing into a home telehealth program for veterans with posttraumatic stress disorder who smoke: a randomized controlled trial. J Clin Psychol. 2016 Mar;72(3):194-206. doi: 10.1002/jclp.22252. PMID: 26783736.","49060","2020"
"battaglia2016_PCL_B_Baseline_ITT","Other mixed","PTSD+SUD","175","B","PTSD","Not integrated","81",,"PTSD home telehealth care management program","PTSD home telehealth care management program","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","Technology alone","86","Self report","PCL","PCL","ITT",,"Mean score differences between groups using t-test (nonparametric tests if skewed) and linear regression models","Baseline",,,"60.4","11",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0.1371",,"0.8629",,,"Medium","Battaglia C, Peterson J, Whitfield E, et al. Integrating motivational interviewing into a home telehealth program for veterans with posttraumatic stress disorder who smoke: a randomized controlled trial. J Clin Psychol. 2016 Mar;72(3):194-206. doi: 10.1002/jclp.22252. PMID: 26783736.","49060","2020"
"battersby2013_PCL_A_0_ITT","Collaborative care","PTSD","82","A","PTSD",,"44",,"Flinders Program + Usual Care","Flinders Program","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","No","No","Yes","Individual","Mixed","46","Self report","PCL","PCL-M","ITT","Used available data (not imputed)","ANCOVA, effect sizes with Cohen's d and paired sample t-tests","End of Treatment","0",,"48.95","10.39",,,,,"-4.46",,,,,"Cohen's d","-0.42",,,,"p<0.01",,,,,,,,,,,,,,"Veteran","0","1","0",,,,,,"Medium","Battersby MW, Beattie J, Pols RG, et al. A randomised controlled trial of the Flinders Program™ of chronic condition management in Vietnam veterans with co-morbid alcohol misuse, and psychiatric and medical conditions. Aust N Z J Psychiatry. 2013 May;47(5):451-62. doi: 10.1177/0004867412471977. PMID: 23307806.",,"2020"
"battersby2013_PCL_A_39_ITT","Collaborative care","PTSD","82","A","PTSD",,"25",,"Flinders Program + Usual Care","Flinders Program","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","No","No","Yes","Individual","Mixed","46","Self report","PCL","PCL-M","ITT","Used available data (not imputed)","ANCOVA, effect sizes with Cohen's d and paired sample t-tests","Assessment at 6 to <12 Months","39",,"44.04","13.21",,,,,"-9.37",,,,,"Cohen's d","-0.71",,,,"p<0.001",,,,,,,,,,,,,,"Veteran","0","1","0",,,,,,"Medium","Battersby MW, Beattie J, Pols RG, et al. A randomised controlled trial of the Flinders Program™ of chronic condition management in Vietnam veterans with co-morbid alcohol misuse, and psychiatric and medical conditions. Aust N Z J Psychiatry. 2013 May;47(5):451-62. doi: 10.1177/0004867412471977. PMID: 23307806.",,"2020"
"battersby2013_PCL_A_Baseline_ITT","Collaborative care","PTSD","82","A","PTSD",,"44",,"Flinders Program + Usual Care","Flinders Program","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","No","No","Yes","Individual","Mixed","46","Self report","PCL","PCL-M","ITT","Used available data (not imputed)","ANCOVA, effect sizes with Cohen's d and paired sample t-tests","Baseline",,,"53.41","10.95",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0",,,,,,"Medium","Battersby MW, Beattie J, Pols RG, et al. A randomised controlled trial of the Flinders Program™ of chronic condition management in Vietnam veterans with co-morbid alcohol misuse, and psychiatric and medical conditions. Aust N Z J Psychiatry. 2013 May;47(5):451-62. doi: 10.1177/0004867412471977. PMID: 23307806.",,"2020"
"battersby2013_PCL_B_0_ITT","Collaborative care","PTSD","82","B","Control",,"28",,"Usual care","Treatment as usual (TAU)","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In person","31","Self report","PCL","PCL-M","ITT","Used available data (not imputed)","ANCOVA, effect sizes with Cohen's d and paired sample t-tests","End of Treatment","0",,"47.00","13.75",,,,,"-5.57",,,,,"Cohen's d","-0.41",,,,"p<0.01",,,,,,,,,,,,,,"Veteran","0","1","0",,,,,,"Medium","Battersby MW, Beattie J, Pols RG, et al. A randomised controlled trial of the Flinders Program™ of chronic condition management in Vietnam veterans with co-morbid alcohol misuse, and psychiatric and medical conditions. Aust N Z J Psychiatry. 2013 May;47(5):451-62. doi: 10.1177/0004867412471977. PMID: 23307806.",,"2020"
"battersby2013_PCL_B_Baseline_ITT","Collaborative care","PTSD","82","B","Control",,"28",,"Usual care","Treatment as usual (TAU)","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In person","31","Self report","PCL","PCL-M","ITT","Used available data (not imputed)","ANCOVA, effect sizes with Cohen's d and paired sample t-tests","Baseline",,,"52.57","13.03",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0",,,,,,"Medium","Battersby MW, Beattie J, Pols RG, et al. A randomised controlled trial of the Flinders Program™ of chronic condition management in Vietnam veterans with co-morbid alcohol misuse, and psychiatric and medical conditions. Aust N Z J Psychiatry. 2013 May;47(5):451-62. doi: 10.1177/0004867412471977. PMID: 23307806.",,"2020"
"beck2009_CAPS_A_0_Comp","Psychotherapy","PTSD","44","A","PTSD",,"17",,"Group CBT","Trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Group","In Person","26","Structured Clinical Interview","CAPS","CAPS","Completer",,"ANCOVA, effect sizes with Cohen's d and paired sample t-tests","End of Treatment","0",,"28.9","19.9",,,,,"-28.4",,,,,,,,,,"p<0.05",,,,,,,,"Not meeting criteria for PTSD according to CAPS","0.8824",,"RCI for CAPS","0.8235","Additional definitions of Clinically Meaningful Response reported in the study","Community",,,"1","0.8182",,"0.1818","Accidents",,"High","Beck JG, Coffey SF, Foy DW, et al. Group cognitive behavior therapy for chronic posttraumatic stress disorder: an initial randomized pilot study. Behav Ther. 2009 Mar;40(1):82-92. doi: 10.1016/j.beth.2008.01.003. PMID: 19187819.","32054","2019"
"beck2009_CAPS_A_12_Comp","Psychotherapy","PTSD","44","A","PTSD",,"15",,"Group CBT","Trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Group","In Person","26","Structured Clinical Interview","CAPS","CAPS","Completer",,"ANCOVA, effect sizes with Cohen's d and paired sample t-tests","Assessment at 3 to <6 Months","12",,"19.7","18.8",,,,,"-37.6",,,,,,,,,,,,,,,,,,"Not meeting criteria for PTSD according to CAPS","0.9333",,"RCI for CAPS","0.9333","Additional definitions of Clinically Meaningful Response reported in the study","Community",,,"1","0.8182",,"0.1818","Accidents",,"High","Beck JG, Coffey SF, Foy DW, et al. Group cognitive behavior therapy for chronic posttraumatic stress disorder: an initial randomized pilot study. Behav Ther. 2009 Mar;40(1):82-92. doi: 10.1016/j.beth.2008.01.003. PMID: 19187819.","32054","2019"
"beck2009_CAPS_A_Baseline_Comp","Psychotherapy","PTSD","44","A","PTSD",,"17",,"Group CBT","Trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Group","In Person","26","Structured Clinical Interview","CAPS","CAPS","Completer",,"ANCOVA, effect sizes with Cohen's d and paired sample t-tests","Baseline",,,"57.3","15.5",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.8182",,"0.1818","Accidents",,"High","Beck JG, Coffey SF, Foy DW, et al. Group cognitive behavior therapy for chronic posttraumatic stress disorder: an initial randomized pilot study. Behav Ther. 2009 Mar;40(1):82-92. doi: 10.1016/j.beth.2008.01.003. PMID: 19187819.","32054","2019"
"beck2009_CAPS_B_0_Comp","Psychotherapy","PTSD","44","B","Control",,"16",,"Minimum contact","Minimal attention","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","Phone","18","Structured Clinical Interview","CAPS","CAPS","Completer",,"ANCOVA, effect sizes with Cohen's d and paired sample t-tests","End of Treatment","0",,"49.4","27",,,,,"-8.4",,,,,,,,,,"p<0.05",,,,,,,,"Not meeting criteria for PTSD according to CAPS","0.3125",,"RCI for CAPS","0.3125","Additional definitions of Clinically Meaningful Response reported in the study","Community",,,"1","0.8182",,"0.1818","Accidents",,"High","Beck JG, Coffey SF, Foy DW, et al. Group cognitive behavior therapy for chronic posttraumatic stress disorder: an initial randomized pilot study. Behav Ther. 2009 Mar;40(1):82-92. doi: 10.1016/j.beth.2008.01.003. PMID: 19187819.","32054","2019"
"beck2009_CAPS_B_Baseline_Comp","Psychotherapy","PTSD","44","B","Control",,"16",,"Minimum contact","Minimal attention","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","Phone","18","Structured Clinical Interview","CAPS","CAPS","Completer",,"ANCOVA, effect sizes with Cohen's d and paired sample t-tests","Baseline",,,"57.8","14.9",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.8182",,"0.1818","Accidents",,"High","Beck JG, Coffey SF, Foy DW, et al. Group cognitive behavior therapy for chronic posttraumatic stress disorder: an initial randomized pilot study. Behav Ther. 2009 Mar;40(1):82-92. doi: 10.1016/j.beth.2008.01.003. PMID: 19187819.","32054","2019"
"beck2009_IES_A_0_NA","Psychotherapy","PTSD","44","A","PTSD",,,,"Group CBT","Trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Group","In Person","26","Self report","IES","IES-R",,,"ANCOVA, effect sizes with Cohen's d and paired sample t-tests","End of Treatment","0",,"0.95","0.9",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.8182",,"0.1818","Accidents",,"High","Beck JG, Coffey SF, Foy DW, et al. Group cognitive behavior therapy for chronic posttraumatic stress disorder: an initial randomized pilot study. Behav Ther. 2009 Mar;40(1):82-92. doi: 10.1016/j.beth.2008.01.003. PMID: 19187819.","32054","2019"
"beck2009_IES_A_Baseline_NA","Psychotherapy","PTSD","44","A","PTSD",,,,"Group CBT","Trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Group","In Person","26","Self report","IES","IES-R",,,"ANCOVA, effect sizes with Cohen's d and paired sample t-tests","Baseline",,,"1.75","0.7",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.8182",,"0.1818","Accidents",,"High","Beck JG, Coffey SF, Foy DW, et al. Group cognitive behavior therapy for chronic posttraumatic stress disorder: an initial randomized pilot study. Behav Ther. 2009 Mar;40(1):82-92. doi: 10.1016/j.beth.2008.01.003. PMID: 19187819.","32054","2019"
"beck2009_IES_B_0_NA","Psychotherapy","PTSD","44","B","Control",,,,"Minimum contact","Minimal attention","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","Phone","18","Self report","IES","IES-R",,,"ANCOVA, effect sizes with Cohen's d and paired sample t-tests","End of Treatment","0",,"1.91","1.0",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.8182",,"0.1818","Accidents",,"High","Beck JG, Coffey SF, Foy DW, et al. Group cognitive behavior therapy for chronic posttraumatic stress disorder: an initial randomized pilot study. Behav Ther. 2009 Mar;40(1):82-92. doi: 10.1016/j.beth.2008.01.003. PMID: 19187819.","32054","2019"
"beck2009_IES_B_Baseline_NA","Psychotherapy","PTSD","44","B","Control",,,,"Minimum contact","Minimal attention","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","Phone","18","Self report","IES","IES-R",,,"ANCOVA, effect sizes with Cohen's d and paired sample t-tests","Baseline",,,"2.10","0.9",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.8182",,"0.1818","Accidents",,"High","Beck JG, Coffey SF, Foy DW, et al. Group cognitive behavior therapy for chronic posttraumatic stress disorder: an initial randomized pilot study. Behav Ther. 2009 Mar;40(1):82-92. doi: 10.1016/j.beth.2008.01.003. PMID: 19187819.","32054","2019"
"becker2007_CAPS_A_0_ITT","Pharmacotherapy","PTSD","30","A","PTSD",,"15",,"Bupropion sustained release","Bupropion","No","Not Applicable","Yes","Antidepressant: Other","No","Not Applicable","No","No","No","No","No","Individual","In Person","18","Structured Clinical Interview","CAPS","CAPS","ITT","LOCF","ANCOVA, effect sizes with Cohen's d and paired sample t-tests","End of Treatment","0",,,,,,,,"-12.33","24.12",,,,,,,,,,,,,,,,,,,,"CGI rated at least minimally improved","0.5556",,"Mixed","0","0.7857","0.2143","0.2143",,"0.7857","Mixed","combat-related, child sexual abuse, child physical abuse, intimate partner violence, rape/sexual assault, accidents, illness/medical procedure, other (homicide, death/suicide of a loved one)","Medium","Becker ME, Hertzberg MA, Moore SD, et al. A placebo-controlled trial of bupropion SR in the treatment of chronic posttraumatic stress disorder. J Clin Psychopharmacol. 2007 Apr;27(2):193-7. doi: 10.1097/JCP.0b013e318032eaed. PMID: 17414245.","31131","2019"
"becker2007_CAPS_A_Baseline_ITT","Pharmacotherapy","PTSD","30","A","PTSD",,"18",,"Bupropion sustained release","Bupropion","No","Not Applicable","Yes","Antidepressant: Other","No","Not Applicable","No","No","No","No","No","Individual","In Person","18","Structured Clinical Interview","CAPS","CAPS","ITT","LOCF","ANCOVA, effect sizes with Cohen's d and paired sample t-tests","Baseline",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"CGI rated at least minimally improved",,,"Mixed","0","0.7857","0.2143","0.2143",,"0.7857","Mixed","combat-related, child sexual abuse, child physical abuse, intimate partner violence, rape/sexual assault, accidents, illness/medical procedure, other (homicide, death/suicide of a loved one)","Medium","Becker ME, Hertzberg MA, Moore SD, et al. A placebo-controlled trial of bupropion SR in the treatment of chronic posttraumatic stress disorder. J Clin Psychopharmacol. 2007 Apr;27(2):193-7. doi: 10.1097/JCP.0b013e318032eaed. PMID: 17414245.","31131","2019"
"becker2007_CAPS_B_0_ITT","Pharmacotherapy","PTSD","30","B","Control",,"7",,"Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","10","Structured Clinical Interview","CAPS","CAPS","ITT","LOCF","ANCOVA, effect sizes with Cohen's d and paired sample t-tests","End of Treatment","0",,,,,,,,"-16.99","11.26",,,,,,,,,,,,,,,,,,,,"CGI rated at least minimally improved",,,"Mixed","0","0.7857","0.2143","0.2143",,"0.7857","Mixed","combat-related, child sexual abuse, child physical abuse, intimate partner violence, rape/sexual assault, accidents, illness/medical procedure, other (homicide, death/suicide of a loved one)","Medium","Becker ME, Hertzberg MA, Moore SD, et al. A placebo-controlled trial of bupropion SR in the treatment of chronic posttraumatic stress disorder. J Clin Psychopharmacol. 2007 Apr;27(2):193-7. doi: 10.1097/JCP.0b013e318032eaed. PMID: 17414245.","31131","2019"
"becker2007_CAPS_B_Baseline_ITT","Pharmacotherapy","PTSD","30","B","Control",,"10",,"Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","10","Structured Clinical Interview","CAPS","CAPS","ITT","LOCF","ANCOVA, effect sizes with Cohen's d and paired sample t-tests","Baseline",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"CGI rated at least minimally improved",,,"Mixed","0","0.7857","0.2143","0.2143",,"0.7857","Mixed","combat-related, child sexual abuse, child physical abuse, intimate partner violence, rape/sexual assault, accidents, illness/medical procedure, other (homicide, death/suicide of a loved one)","Medium","Becker ME, Hertzberg MA, Moore SD, et al. A placebo-controlled trial of bupropion SR in the treatment of chronic posttraumatic stress disorder. J Clin Psychopharmacol. 2007 Apr;27(2):193-7. doi: 10.1097/JCP.0b013e318032eaed. PMID: 17414245.","31131","2019"
"beidel2011_CAPS_A_0_Comp","Psychotherapy","PTSD","35","A","PTSD",,"13",,"Trauma Management Therapy with Exposure Therapy","Trauma Management Therapy with exposure therapy","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Mixed","In Person","18","Structured Clinical Interview","CAPS","CAPS","Completer","Excluded","ANCOVA, effect sizes with Cohen's d and paired sample t-tests","End of Treatment","0",,"69","24",,,,,"-15.9",,,,,,,,,,,,,,,,,,,,,"CGI-I rated as 1 or 2","0.43",,"Veteran","0","1","0","0",,"1","Combat-related",,"High","Beidel DC, Frueh BC, Uhde TW, et al. Multicomponent behavioral treatment for chronic combat-related posttraumatic stress disorder: a randomized controlled trial. J Anxiety Disord. 2011 Mar;25(2):224-31. doi: 10.1016/j.janxdis.2010.09.006. PMID: 20951543.","35248","2019"
"beidel2011_CAPS_A_Baseline_Comp","Psychotherapy","PTSD","35","A","PTSD",,"16",,"Trauma Management Therapy with Exposure Therapy","Trauma Management Therapy with exposure therapy","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Mixed","In Person","18","Structured Clinical Interview","CAPS","CAPS","Completer","Excluded","ANCOVA, effect sizes with Cohen's d and paired sample t-tests","Baseline",,,"84.9","14.3",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"High","Beidel DC, Frueh BC, Uhde TW, et al. Multicomponent behavioral treatment for chronic combat-related posttraumatic stress disorder: a randomized controlled trial. J Anxiety Disord. 2011 Mar;25(2):224-31. doi: 10.1016/j.janxdis.2010.09.006. PMID: 20951543.","35248","2019"
"beidel2011_CAPS_B_0_Comp","Psychotherapy","PTSD","35","B","PTSD",,"12",,"Exposure Therapy + psychoeducation","Exposure therapy","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Mixed","In Person","17","Structured Clinical Interview","CAPS","CAPS","Completer","Excluded","ANCOVA, effect sizes with Cohen's d and paired sample t-tests","End of Treatment","0",,"65.5","20.2",,,,,"-25.1",,,,,,,,,,,,,,,,,,,,,"CGI-I rated as 1 or 2","0.44",,"Veteran","0","1","0","0",,"1","Combat-related",,"High","Beidel DC, Frueh BC, Uhde TW, et al. Multicomponent behavioral treatment for chronic combat-related posttraumatic stress disorder: a randomized controlled trial. J Anxiety Disord. 2011 Mar;25(2):224-31. doi: 10.1016/j.janxdis.2010.09.006. PMID: 20951543.","35248","2019"
"beidel2011_CAPS_B_Baseline_Comp","Psychotherapy","PTSD","35","B","PTSD",,"14",,"Exposure Therapy + psychoeducation","Exposure therapy","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Mixed","In Person","17","Structured Clinical Interview","CAPS","CAPS","Completer","Excluded","ANCOVA, effect sizes with Cohen's d and paired sample t-tests","Baseline",,,"90.6","14.4",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"High","Beidel DC, Frueh BC, Uhde TW, et al. Multicomponent behavioral treatment for chronic combat-related posttraumatic stress disorder: a randomized controlled trial. J Anxiety Disord. 2011 Mar;25(2):224-31. doi: 10.1016/j.janxdis.2010.09.006. PMID: 20951543.","35248","2019"
"beidel2011_PCL_A_0_NA","Psychotherapy","PTSD","35","A","PTSD",,,,"Trauma Management Therapy with Exposure Therapy","Trauma Management Therapy with exposure therapy","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Mixed","In Person","18","Self report","PCL","PCL-M",,,"ANCOVA, effect sizes with Cohen's d and paired sample t-tests","End of Treatment","0",,"60.9","11.6",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"High","Beidel DC, Frueh BC, Uhde TW, et al. Multicomponent behavioral treatment for chronic combat-related posttraumatic stress disorder: a randomized controlled trial. J Anxiety Disord. 2011 Mar;25(2):224-31. doi: 10.1016/j.janxdis.2010.09.006. PMID: 20951543.","35248","2019"
"beidel2011_PCL_A_Baseline_NA","Psychotherapy","PTSD","35","A","PTSD",,,,"Trauma Management Therapy with Exposure Therapy","Trauma Management Therapy with exposure therapy","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Mixed","In Person","18","Self report","PCL","PCL-M",,,"ANCOVA, effect sizes with Cohen's d and paired sample t-tests","Baseline",,,"67.0","11.1",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"High","Beidel DC, Frueh BC, Uhde TW, et al. Multicomponent behavioral treatment for chronic combat-related posttraumatic stress disorder: a randomized controlled trial. J Anxiety Disord. 2011 Mar;25(2):224-31. doi: 10.1016/j.janxdis.2010.09.006. PMID: 20951543.","35248","2019"
"beidel2011_PCL_B_0_NA","Psychotherapy","PTSD","35","B","PTSD",,,,"Exposure Therapy + psychoeducation","Exposure therapy","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Mixed","In Person","17","Self report","PCL","PCL-M",,,"ANCOVA, effect sizes with Cohen's d and paired sample t-tests","End of Treatment","0",,"63.6","11.9",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"High","Beidel DC, Frueh BC, Uhde TW, et al. Multicomponent behavioral treatment for chronic combat-related posttraumatic stress disorder: a randomized controlled trial. J Anxiety Disord. 2011 Mar;25(2):224-31. doi: 10.1016/j.janxdis.2010.09.006. PMID: 20951543.","35248","2019"
"beidel2011_PCL_B_Baseline_NA","Psychotherapy","PTSD","35","B","PTSD",,,,"Exposure Therapy + psychoeducation","Exposure therapy","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Mixed","In Person","17","Self report","PCL","PCL-M",,,"ANCOVA, effect sizes with Cohen's d and paired sample t-tests","Baseline",,,"68.2","8.3",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"High","Beidel DC, Frueh BC, Uhde TW, et al. Multicomponent behavioral treatment for chronic combat-related posttraumatic stress disorder: a randomized controlled trial. J Anxiety Disord. 2011 Mar;25(2):224-31. doi: 10.1016/j.janxdis.2010.09.006. PMID: 20951543.","35248","2019"
"bell2019_PCL_A_0_Comp","Complementary and integrative health (CIH)","PTSD","24","A","PTSD",,"12",,"LORETA z-score neurofeedback","LORETA z-score neurofeedback","No","Not Applicable","No","Not Applicable","Yes","Relaxation","No","No","No","No","No","Individual","In person","12","Self report","PCL","PCL-5","Completer","Complete case analysis","Nonparametric Mann-Withney U analysis; Cohen's d effect sizes","End of Treatment","0",,"18.08","12.65",,,,,"-28.09",,,,,"Cohen's d","2.09",,,,"p=0.003",,,,,,,,,,,,,,"Community","0",,"1",,,,"Mixed","combat-related, rape/sexual assault, community/school violence, illness/medical procedure, natural or manmade disasters, child other abuse, other (""work-related trauma [e.g. first responders]"")","Medium","Bell AN, Moss D, Kallmeyer RJ. Healing the neurophysiological roots of trauma: a controlled study examining loreta z-score neurofeedback and HRV biofeedback for chronic PTSD. NeuroRegulation. 2019;6(2):54-70. doi: 10.15540/nr.6.2.54.",,"2020"
"bell2019_PCL_A_Baseline_Comp","Complementary and integrative health (CIH)","PTSD","24","A","PTSD",,"12",,"LORETA z-score neurofeedback","LORETA z-score neurofeedback","No","Not Applicable","No","Not Applicable","Yes","Relaxation","No","No","No","No","No","Individual","In person","12","Self report","PCL","PCL-5","Completer","Complete case analysis","Nonparametric Mann-Withney U analysis; Cohen's d effect sizes","Baseline",,,"46.17","14.23",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community","0",,"1",,,,"Mixed","combat-related, rape/sexual assault, community/school violence, illness/medical procedure, natural or manmade disasters, child other abuse, other (""work-related trauma [e.g. first responders]"")","Medium","Bell AN, Moss D, Kallmeyer RJ. Healing the neurophysiological roots of trauma: a controlled study examining loreta z-score neurofeedback and HRV biofeedback for chronic PTSD. NeuroRegulation. 2019;6(2):54-70. doi: 10.15540/nr.6.2.54.",,"2020"
"bell2019_PCL_B_0_Comp","Complementary and integrative health (CIH)","PTSD","24","B","Control",,"11",,"Heart rate variability biofeedback","Heart rate variability biofeedback","No","Not Applicable","No","Not Applicable","Yes","Relaxation","No","No","No","No","No","Individual","In person","12","Self report","PCL","PCL-5","Completer","Complete case analysis","Nonparametric Mann-Withney U analysis; Cohen's d effect sizes","End of Treatment","0",,"31.18","13.53",,,,,"-18.64",,,,,"Cohen's d","1.40",,,,"p=0.006",,,,,,,,,,,,,,"Community","0",,"1",,,,"Mixed","combat-related, rape/sexual assault, community/school violence, illness/medical procedure, natural or manmade disasters, child other abuse, other (""work-related trauma [e.g. first responders]"")","Medium","Bell AN, Moss D, Kallmeyer RJ. Healing the neurophysiological roots of trauma: a controlled study examining loreta z-score neurofeedback and HRV biofeedback for chronic PTSD. NeuroRegulation. 2019;6(2):54-70. doi: 10.15540/nr.6.2.54.",,"2020"
"bell2019_PCL_B_Baseline_Comp","Complementary and integrative health (CIH)","PTSD","24","B","Control",,"11",,"Heart rate variability biofeedback","Heart rate variability biofeedback","No","Not Applicable","No","Not Applicable","Yes","Relaxation","No","No","No","No","No","Individual","In person","12","Self report","PCL","PCL-5","Completer","Complete case analysis","Nonparametric Mann-Withney U analysis; Cohen's d effect sizes","Baseline",,,"49.82","10.16",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community","0",,"1",,,,"Mixed","combat-related, rape/sexual assault, community/school violence, illness/medical procedure, natural or manmade disasters, child other abuse, other (""work-related trauma [e.g. first responders]"")","Medium","Bell AN, Moss D, Kallmeyer RJ. Healing the neurophysiological roots of trauma: a controlled study examining loreta z-score neurofeedback and HRV biofeedback for chronic PTSD. NeuroRegulation. 2019;6(2):54-70. doi: 10.15540/nr.6.2.54.",,"2020"
"belleville2018_Modi_A_0_ITT","Psychotherapy","PTSD","42","A","PTSD",,"16",,"Imagery rehearsal therapy + CBT","Imagery rehearsal training (IRT) + trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","22","Self report","Modified PSS-SR","Modified PSS-SR","ITT","Replaced missing data with average item response for questionnaire; however, data missing because of attrition or questionnaires not completed at all were not replaced.","Mixed-model ANOVA","End of Treatment","0",,"21.53","11.84",,,,,"-43.40",,,,,,,,,,,,,,,,,,"Not fulfilling diagnostic criteria for PTSD according to DSM-IV-TR",,,,,,"Community","0","0","1","0.881",,"0.119","Mixed","child sexual abuse, rape/sexual assault","Medium","Belleville G, Dube-Frenette M, Rousseau A. Efficacy of imagery rehearsal therapy and cognitive behavioral therapy in sexual assault victims with posttraumatic stress disorder: a randomized controlled trial. J Trauma Stress. 2018 Aug;31(4):591-601. doi: 10.1002/jts.22306. PMID: 30070398.","50883","2020"
"belleville2018_Modi_A_Baseline_ITT","Psychotherapy","PTSD","42","A","PTSD",,"22",,"Imagery rehearsal therapy + CBT","Imagery rehearsal training (IRT) + trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","22","Self report","Modified PSS-SR","Modified PSS-SR","ITT","Replaced missing data with average item response for questionnaire; however, data missing because of attrition or questionnaires not completed at all were not replaced.","Mixed-model ANOVA","Baseline",,,"64.83","19.30",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community","0","0","1","0.881",,"0.119","Mixed","child sexual abuse, rape/sexual assault","Medium","Belleville G, Dube-Frenette M, Rousseau A. Efficacy of imagery rehearsal therapy and cognitive behavioral therapy in sexual assault victims with posttraumatic stress disorder: a randomized controlled trial. J Trauma Stress. 2018 Aug;31(4):591-601. doi: 10.1002/jts.22306. PMID: 30070398.","50883","2020"
"belleville2018_Modi_B_0_Comp","Psychotherapy","PTSD","42","B","PTSD",,,,"CBT only","Trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","20","Self report","Modified PSS-SR","Modified PSS-SR","Completer","Replaced missing data with average item response for questionnaire; however, data missing because of attrition or questionnaires not completed at all were not replaced.","Mixed-model ANOVA","End of Treatment","0",,,,,,,,,,,,,,,,,,,,,,,,,,"Not fulfilling diagnostic criteria for PTSD according to DSM-IV-TR","0.733",,,,,"Community","0","0","1","0.881",,"0.119","Mixed","child sexual abuse, rape/sexual assault","Medium","Belleville G, Dube-Frenette M, Rousseau A. Efficacy of imagery rehearsal therapy and cognitive behavioral therapy in sexual assault victims with posttraumatic stress disorder: a randomized controlled trial. J Trauma Stress. 2018 Aug;31(4):591-601. doi: 10.1002/jts.22306. PMID: 30070398.","50883","2020"
"belleville2018_Modi_B_0_ITT","Psychotherapy","PTSD","42","B","PTSD",,"15",,"CBT only","Trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","20","Self report","Modified PSS-SR","Modified PSS-SR","ITT","Replaced missing data with average item response for questionnaire; however, data missing because of attrition or questionnaires not completed at all were not replaced.","Mixed-model ANOVA","End of Treatment","0",,"30.95","16.12",,,,,"-38.20",,,,,,,,,,,,,,,,,,"Not fulfilling diagnostic criteria for PTSD according to DSM-IV-TR",,,,,,"Community","0","0","1","0.881",,"0.119","Mixed","child sexual abuse, rape/sexual assault","Medium","Belleville G, Dube-Frenette M, Rousseau A. Efficacy of imagery rehearsal therapy and cognitive behavioral therapy in sexual assault victims with posttraumatic stress disorder: a randomized controlled trial. J Trauma Stress. 2018 Aug;31(4):591-601. doi: 10.1002/jts.22306. PMID: 30070398.","50883","2020"
"belleville2018_Modi_B_Baseline_Comp","Psychotherapy","PTSD","42","B","PTSD",,,,"CBT only","Trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","20","Self report","Modified PSS-SR","Modified PSS-SR","Completer","Replaced missing data with average item response for questionnaire; however, data missing because of attrition or questionnaires not completed at all were not replaced.","Mixed-model ANOVA","Baseline",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community","0","0","1","0.881",,"0.119","Mixed","child sexual abuse, rape/sexual assault","Medium","Belleville G, Dube-Frenette M, Rousseau A. Efficacy of imagery rehearsal therapy and cognitive behavioral therapy in sexual assault victims with posttraumatic stress disorder: a randomized controlled trial. J Trauma Stress. 2018 Aug;31(4):591-601. doi: 10.1002/jts.22306. PMID: 30070398.","50883","2020"
"belleville2018_Modi_B_Baseline_ITT","Psychotherapy","PTSD","42","B","PTSD",,"20",,"CBT only","Trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","20","Self report","Modified PSS-SR","Modified PSS-SR","ITT","Replaced missing data with average item response for questionnaire; however, data missing because of attrition or questionnaires not completed at all were not replaced.","Mixed-model ANOVA","Baseline",,,"69.15","25.67",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community","0","0","1","0.881",,"0.119","Mixed","child sexual abuse, rape/sexual assault","Medium","Belleville G, Dube-Frenette M, Rousseau A. Efficacy of imagery rehearsal therapy and cognitive behavioral therapy in sexual assault victims with posttraumatic stress disorder: a randomized controlled trial. J Trauma Stress. 2018 Aug;31(4):591-601. doi: 10.1002/jts.22306. PMID: 30070398.","50883","2020"
"bichescu2007_CIDI_A_26_NA","Psychotherapy","PTSD","18","A","PTSD",,"9",,"NET","Narrative Exposure Therapy (NET)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","9","Structured Clinical Interview","CIDI","CIDI",,,"Mixed-model ANOVA","Assessment at 6 to <12 Months","26",,"5.4","1.3",,,,,"-6.4",,,,,"Cohen's d","3.15",,,,,,,,,,,,"Not meeting PTSD criteria according to the CIDI","0.5556",,,,,"Community",,,"1","0.0556",,"0.9444","Terrorism/political violence/forced displacement",,"High","Bichescu D, Neuner F, Schauer M, et al. Narrative exposure therapy for political imprisonment-related chronic posttraumatic stress disorder and depression. Behav Res Ther. 2007 Sep;45(9):2212-20. doi: 10.1016/j.brat.2006.12.006. PMID: 17288990.","29906","2019"
"bichescu2007_CIDI_A_Baseline_NA","Psychotherapy","PTSD","18","A","PTSD",,"9",,"NET","Narrative Exposure Therapy (NET)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","9","Structured Clinical Interview","CIDI","CIDI",,,"Mixed-model ANOVA","Baseline",,,"11.8","1.6",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.0556",,"0.9444","Terrorism/political violence/forced displacement",,"High","Bichescu D, Neuner F, Schauer M, et al. Narrative exposure therapy for political imprisonment-related chronic posttraumatic stress disorder and depression. Behav Res Ther. 2007 Sep;45(9):2212-20. doi: 10.1016/j.brat.2006.12.006. PMID: 17288990.","29906","2019"
"bichescu2007_CIDI_B_26_NA","Psychotherapy","PTSD","18","B","Control",,"9",,"Psychoeducation","Psychoeducation","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","No","Yes","No","Individual","In Person","9","Structured Clinical Interview","CIDI","CIDI",,,"Mixed-model ANOVA","Assessment at 6 to <12 Months","26",,"9.9","4.1",,,,,"-1.5",,,,,"Cohen's d","0.31",,,,,,,,,,,,"Not meeting PTSD criteria according to the CIDI","0.1111",,,,,"Community",,,"1","0.0556",,"0.9444","Terrorism/political violence/forced displacement",,"High","Bichescu D, Neuner F, Schauer M, et al. Narrative exposure therapy for political imprisonment-related chronic posttraumatic stress disorder and depression. Behav Res Ther. 2007 Sep;45(9):2212-20. doi: 10.1016/j.brat.2006.12.006. PMID: 17288990.","29906","2019"
"blanchard2003_CAPS_A_0_C-F","Psychotherapy","PTSD","98","A","PTSD",,"26",,"CBT","Trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","37","Structured Clinical Interview","CAPS","CAPS","Follow-up completer",,"Mixed-model ANOVA","End of Treatment","0",,"23.7","26.2",,,,,"-45.9",,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.7347",,"0.2653","Accidents",,"Medium","Blanchard EB, Hickling EJ, Devineni T, et al. A controlled evaluation of cognitive behavioural therapy for posttraumatic stress in motor vehicle accident survivors. Behav Res Ther. 2003 Jan;41(1):79-96.  PMID: 12488121.","25272","2019"
"blanchard2003_CAPS_A_0_C-P","Psychotherapy","PTSD","98","A","PTSD",,"27",,"CBT","Trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","37","Structured Clinical Interview","CAPS","CAPS","Posttreatment completer",,"Mixed-model ANOVA","End of Treatment","0",,"23.7","26.2",,,,,"-44.5",,,,,,,,,,,,,,,,,,"Not meeting criteria for PTSD according to the CAPS","0.7619",,,,,"Community",,,"1","0.7347",,"0.2653","Accidents",,"Medium","Blanchard EB, Hickling EJ, Devineni T, et al. A controlled evaluation of cognitive behavioural therapy for posttraumatic stress in motor vehicle accident survivors. Behav Res Ther. 2003 Jan;41(1):79-96.  PMID: 12488121.","25272","2019"
"blanchard2003_CAPS_A_12_C-F","Psychotherapy","PTSD","98","A","PTSD",,"26",,"CBT","Trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","37","Structured Clinical Interview","CAPS","CAPS","Follow-up completer",,"Mixed-model ANOVA","Assessment at 3 to <6 Months","12",,"22.1","24.8",,,,,"-47.5",,,,,,,,,,,,,,,,,,"Not meeting criteria for PTSD according to the CAPS","0.8095",,,,,"Community",,,"1","0.7347",,"0.2653","Accidents",,"Medium","Blanchard EB, Hickling EJ, Devineni T, et al. A controlled evaluation of cognitive behavioural therapy for posttraumatic stress in motor vehicle accident survivors. Behav Res Ther. 2003 Jan;41(1):79-96.  PMID: 12488121.","25272","2019"
"blanchard2003_CAPS_A_Baseline_C-F","Psychotherapy","PTSD","98","A","PTSD",,"26",,"CBT","Trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","37","Structured Clinical Interview","CAPS","CAPS","Follow-up completer",,"Mixed-model ANOVA","Baseline",,,"69.6","22.9",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.7347",,"0.2653","Accidents",,"Medium","Blanchard EB, Hickling EJ, Devineni T, et al. A controlled evaluation of cognitive behavioural therapy for posttraumatic stress in motor vehicle accident survivors. Behav Res Ther. 2003 Jan;41(1):79-96.  PMID: 12488121.","25272","2019"
"blanchard2003_CAPS_A_Baseline_C-P","Psychotherapy","PTSD","98","A","PTSD",,"27",,"CBT","Trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","37","Structured Clinical Interview","CAPS","CAPS","Posttreatment completer",,"Mixed-model ANOVA","Baseline",,,"68.2","22.7",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.7347",,"0.2653","Accidents",,"Medium","Blanchard EB, Hickling EJ, Devineni T, et al. A controlled evaluation of cognitive behavioural therapy for posttraumatic stress in motor vehicle accident survivors. Behav Res Ther. 2003 Jan;41(1):79-96.  PMID: 12488121.","25272","2019"
"blanchard2003_CAPS_A_Baseline_ITT","Psychotherapy","PTSD","98","A","PTSD",,"37",,"CBT","Trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","37","Structured Clinical Interview","CAPS","CAPS","ITT",,"Mixed-model ANOVA","Baseline",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.7347",,"0.2653","Accidents",,"Medium","Blanchard EB, Hickling EJ, Devineni T, et al. A controlled evaluation of cognitive behavioural therapy for posttraumatic stress in motor vehicle accident survivors. Behav Res Ther. 2003 Jan;41(1):79-96.  PMID: 12488121.","25272","2019"
"blanchard2003_CAPS_B_0_C-F","Psychotherapy","PTSD","98","B","PTSD",,"26",,"Supportive psychotherapy","PTSD psychotherapy","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","36","Structured Clinical Interview","CAPS","CAPS","Follow-up completer",,"Mixed-model ANOVA","End of Treatment","0",,"41.2","25.5",,,,,"-24.7",,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.7347",,"0.2653","Accidents",,"Medium","Blanchard EB, Hickling EJ, Devineni T, et al. A controlled evaluation of cognitive behavioural therapy for posttraumatic stress in motor vehicle accident survivors. Behav Res Ther. 2003 Jan;41(1):79-96.  PMID: 12488121.","25272","2019"
"blanchard2003_CAPS_B_0_C-P","Psychotherapy","PTSD","98","B","PTSD",,"27",,"Supportive psychotherapy","PTSD psychotherapy","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","36","Structured Clinical Interview","CAPS","CAPS","Posttreatment completer",,"Mixed-model ANOVA","End of Treatment","0",,"40.1","25.7",,,,,"-24.9",,,,,,,,,,,,,,,,,,"Not meeting criteria for PTSD according to the CAPS","0.4762",,,,,"Community",,,"1","0.7347",,"0.2653","Accidents",,"Medium","Blanchard EB, Hickling EJ, Devineni T, et al. A controlled evaluation of cognitive behavioural therapy for posttraumatic stress in motor vehicle accident survivors. Behav Res Ther. 2003 Jan;41(1):79-96.  PMID: 12488121.","25272","2019"
"blanchard2003_CAPS_B_12_C-F","Psychotherapy","PTSD","98","B","PTSD",,"26",,"Supportive psychotherapy","PTSD psychotherapy","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","36","Structured Clinical Interview","CAPS","CAPS","Follow-up completer",,"Mixed-model ANOVA","Assessment at 3 to <6 Months","12",,"40.4","29.8",,,,,"-25.5",,,,,,,,,,,,,,,,,,"Not meeting criteria for PTSD according to the CAPS","0.4286",,,,,"Community",,,"1","0.7347",,"0.2653","Accidents",,"Medium","Blanchard EB, Hickling EJ, Devineni T, et al. A controlled evaluation of cognitive behavioural therapy for posttraumatic stress in motor vehicle accident survivors. Behav Res Ther. 2003 Jan;41(1):79-96.  PMID: 12488121.","25272","2019"
"blanchard2003_CAPS_B_Baseline_C-F","Psychotherapy","PTSD","98","B","PTSD",,"26",,"Supportive psychotherapy","PTSD psychotherapy","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","36","Structured Clinical Interview","CAPS","CAPS","Follow-up completer",,"Mixed-model ANOVA","Baseline",,,"65.9","26.1",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.7347",,"0.2653","Accidents",,"Medium","Blanchard EB, Hickling EJ, Devineni T, et al. A controlled evaluation of cognitive behavioural therapy for posttraumatic stress in motor vehicle accident survivors. Behav Res Ther. 2003 Jan;41(1):79-96.  PMID: 12488121.","25272","2019"
"blanchard2003_CAPS_B_Baseline_C-P","Psychotherapy","PTSD","98","B","PTSD",,"36",,"Supportive psychotherapy","PTSD psychotherapy","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","36","Structured Clinical Interview","CAPS","CAPS","Posttreatment completer",,"Mixed-model ANOVA","Baseline",,,"65.0","25.9",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.7347",,"0.2653","Accidents",,"Medium","Blanchard EB, Hickling EJ, Devineni T, et al. A controlled evaluation of cognitive behavioural therapy for posttraumatic stress in motor vehicle accident survivors. Behav Res Ther. 2003 Jan;41(1):79-96.  PMID: 12488121.","25272","2019"
"blanchard2003_CAPS_C_0_C-P","Psychotherapy","PTSD","98","C","Control",,"24",,"Waitlist","Waitlist","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,"25","Structured Clinical Interview","CAPS","CAPS","Posttreatment completer",,"Mixed-model ANOVA","End of Treatment","0",,"54.0","25.9",,,,,"-11.8",,,,,,,,,,,,,,,,,,"Not meeting criteria for PTSD according to the CAPS","0.2381",,,,,"Community",,,"1","0.7347",,"0.2653","Accidents",,"Medium","Blanchard EB, Hickling EJ, Devineni T, et al. A controlled evaluation of cognitive behavioural therapy for posttraumatic stress in motor vehicle accident survivors. Behav Res Ther. 2003 Jan;41(1):79-96.  PMID: 12488121.","25272","2019"
"blanchard2003_CAPS_C_Baseline_C-P","Psychotherapy","PTSD","98","C","Control",,"24",,"Waitlist","Waitlist","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,"25","Structured Clinical Interview","CAPS","CAPS","Posttreatment completer",,"Mixed-model ANOVA","Baseline",,,"65.8","26.6",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.7347",,"0.2653","Accidents",,"Medium","Blanchard EB, Hickling EJ, Devineni T, et al. A controlled evaluation of cognitive behavioural therapy for posttraumatic stress in motor vehicle accident survivors. Behav Res Ther. 2003 Jan;41(1):79-96.  PMID: 12488121.","25272","2019"
"blanchard2003_CAPS_C_Baseline_ITT","Psychotherapy","PTSD","98","C","Control",,"25",,"Waitlist","Waitlist","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,"25","Structured Clinical Interview","CAPS","CAPS","ITT",,"Mixed-model ANOVA","Baseline",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.7347",,"0.2653","Accidents",,"Medium","Blanchard EB, Hickling EJ, Devineni T, et al. A controlled evaluation of cognitive behavioural therapy for posttraumatic stress in motor vehicle accident survivors. Behav Res Ther. 2003 Jan;41(1):79-96.  PMID: 12488121.","25272","2019"
"blanchard2003_IES_A_0_Comp","Psychotherapy","PTSD","98","A","PTSD",,,,"CBT","Trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","37","Self report","IES","IES","Completer",,"Mixed-model ANOVA","End of Treatment","0",,"12.1","14.9",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.7347",,"0.2653","Accidents",,"Medium","Blanchard EB, Hickling EJ, Devineni T, et al. A controlled evaluation of cognitive behavioural therapy for posttraumatic stress in motor vehicle accident survivors. Behav Res Ther. 2003 Jan;41(1):79-96.  PMID: 12488121.","25272","2019"
"blanchard2003_IES_A_12_Comp","Psychotherapy","PTSD","98","A","PTSD",,,,"CBT","Trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","37","Self report","IES","IES","Completer",,"Mixed-model ANOVA","Assessment at 3 to <6 Months","12",,"12.2","13.6",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.7347",,"0.2653","Accidents",,"Medium","Blanchard EB, Hickling EJ, Devineni T, et al. A controlled evaluation of cognitive behavioural therapy for posttraumatic stress in motor vehicle accident survivors. Behav Res Ther. 2003 Jan;41(1):79-96.  PMID: 12488121.","25272","2019"
"blanchard2003_IES_A_Baseline_Comp","Psychotherapy","PTSD","98","A","PTSD",,,,"CBT","Trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","37","Self report","IES","IES","Completer",,"Mixed-model ANOVA","Baseline",,,"40.4","13.8",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.7347",,"0.2653","Accidents",,"Medium","Blanchard EB, Hickling EJ, Devineni T, et al. A controlled evaluation of cognitive behavioural therapy for posttraumatic stress in motor vehicle accident survivors. Behav Res Ther. 2003 Jan;41(1):79-96.  PMID: 12488121.","25272","2019"
"blanchard2003_IES_B_0_Comp","Psychotherapy","PTSD","98","B","PTSD",,,,"Supportive psychotherapy","PTSD psychotherapy","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","36","Self report","IES","IES","Completer",,"Mixed-model ANOVA","End of Treatment","0",,"27.4","19.1",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.7347",,"0.2653","Accidents",,"Medium","Blanchard EB, Hickling EJ, Devineni T, et al. A controlled evaluation of cognitive behavioural therapy for posttraumatic stress in motor vehicle accident survivors. Behav Res Ther. 2003 Jan;41(1):79-96.  PMID: 12488121.","25272","2019"
"blanchard2003_IES_B_12_Comp","Psychotherapy","PTSD","98","B","PTSD",,,,"Supportive psychotherapy","PTSD psychotherapy","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","36","Self report","IES","IES","Completer",,"Mixed-model ANOVA","Assessment at 3 to <6 Months","12",,"24.0","20.1",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.7347",,"0.2653","Accidents",,"Medium","Blanchard EB, Hickling EJ, Devineni T, et al. A controlled evaluation of cognitive behavioural therapy for posttraumatic stress in motor vehicle accident survivors. Behav Res Ther. 2003 Jan;41(1):79-96.  PMID: 12488121.","25272","2019"
"blanchard2003_IES_B_Baseline_Comp","Psychotherapy","PTSD","98","B","PTSD",,,,"Supportive psychotherapy","PTSD psychotherapy","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","36","Self report","IES","IES","Completer",,"Mixed-model ANOVA","Baseline",,,"38.7","20.9",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.7347",,"0.2653","Accidents",,"Medium","Blanchard EB, Hickling EJ, Devineni T, et al. A controlled evaluation of cognitive behavioural therapy for posttraumatic stress in motor vehicle accident survivors. Behav Res Ther. 2003 Jan;41(1):79-96.  PMID: 12488121.","25272","2019"
"blanchard2003_IES_C_0_Comp","Psychotherapy","PTSD","98","C","Control",,,,"Waitlist","Waitlist","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,"25","Self report","IES","IES","Completer",,"Mixed-model ANOVA","End of Treatment","0",,"36.6","17.2",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.7347",,"0.2653","Accidents",,"Medium","Blanchard EB, Hickling EJ, Devineni T, et al. A controlled evaluation of cognitive behavioural therapy for posttraumatic stress in motor vehicle accident survivors. Behav Res Ther. 2003 Jan;41(1):79-96.  PMID: 12488121.","25272","2019"
"blanchard2003_IES_C_Baseline_Comp","Psychotherapy","PTSD","98","C","Control",,,,"Waitlist","Waitlist","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,"25","Self report","IES","IES","Completer",,"Mixed-model ANOVA","Baseline",,,"40.2","15.9",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.7347",,"0.2653","Accidents",,"Medium","Blanchard EB, Hickling EJ, Devineni T, et al. A controlled evaluation of cognitive behavioural therapy for posttraumatic stress in motor vehicle accident survivors. Behav Res Ther. 2003 Jan;41(1):79-96.  PMID: 12488121.","25272","2019"
"blanchard2003_PCL_A_0_Comp","Psychotherapy","PTSD","98","A","PTSD",,,,"CBT","Trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","37","Self report","PCL","PCL","Completer",,"Mixed-model ANOVA","End of Treatment","0",,"31.3","14.1",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.7347",,"0.2653","Accidents",,"Medium","Blanchard EB, Hickling EJ, Devineni T, et al. A controlled evaluation of cognitive behavioural therapy for posttraumatic stress in motor vehicle accident survivors. Behav Res Ther. 2003 Jan;41(1):79-96.  PMID: 12488121.","25272","2019"
"blanchard2003_PCL_A_12_Comp","Psychotherapy","PTSD","98","A","PTSD",,,,"CBT","Trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","37","Self report","PCL","PCL","Completer",,"Mixed-model ANOVA","Assessment at 3 to <6 Months","12",,"31.1","14.2",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.7347",,"0.2653","Accidents",,"Medium","Blanchard EB, Hickling EJ, Devineni T, et al. A controlled evaluation of cognitive behavioural therapy for posttraumatic stress in motor vehicle accident survivors. Behav Res Ther. 2003 Jan;41(1):79-96.  PMID: 12488121.","25272","2019"
"blanchard2003_PCL_A_Baseline_Comp","Psychotherapy","PTSD","98","A","PTSD",,,,"CBT","Trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","37","Self report","PCL","PCL","Completer",,"Mixed-model ANOVA","Baseline",,,"54.4","12.2",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.7347",,"0.2653","Accidents",,"Medium","Blanchard EB, Hickling EJ, Devineni T, et al. A controlled evaluation of cognitive behavioural therapy for posttraumatic stress in motor vehicle accident survivors. Behav Res Ther. 2003 Jan;41(1):79-96.  PMID: 12488121.","25272","2019"
"blanchard2003_PCL_B_0_Comp","Psychotherapy","PTSD","98","B","PTSD",,,,"Supportive psychotherapy","PTSD psychotherapy","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","36","Self report","PCL","PCL","Completer",,"Mixed-model ANOVA","End of Treatment","0",,"43.8","14.6",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.7347",,"0.2653","Accidents",,"Medium","Blanchard EB, Hickling EJ, Devineni T, et al. A controlled evaluation of cognitive behavioural therapy for posttraumatic stress in motor vehicle accident survivors. Behav Res Ther. 2003 Jan;41(1):79-96.  PMID: 12488121.","25272","2019"
"blanchard2003_PCL_B_12_Comp","Psychotherapy","PTSD","98","B","PTSD",,,,"Supportive psychotherapy","PTSD psychotherapy","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","36","Self report","PCL","PCL","Completer",,"Mixed-model ANOVA","Assessment at 3 to <6 Months","12",,"40.8","14.4",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.7347",,"0.2653","Accidents",,"Medium","Blanchard EB, Hickling EJ, Devineni T, et al. A controlled evaluation of cognitive behavioural therapy for posttraumatic stress in motor vehicle accident survivors. Behav Res Ther. 2003 Jan;41(1):79-96.  PMID: 12488121.","25272","2019"
"blanchard2003_PCL_B_Baseline_Comp","Psychotherapy","PTSD","98","B","PTSD",,,,"Supportive psychotherapy","PTSD psychotherapy","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","36","Self report","PCL","PCL","Completer",,"Mixed-model ANOVA","Baseline",,,"55.0","14.7",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.7347",,"0.2653","Accidents",,"Medium","Blanchard EB, Hickling EJ, Devineni T, et al. A controlled evaluation of cognitive behavioural therapy for posttraumatic stress in motor vehicle accident survivors. Behav Res Ther. 2003 Jan;41(1):79-96.  PMID: 12488121.","25272","2019"
"blanchard2003_PCL_C_0_Comp","Psychotherapy","PTSD","98","C","Control",,,,"Waitlist","Waitlist","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,"25","Self report","PCL","PCL","Completer",,"Mixed-model ANOVA","End of Treatment","0",,"53.9","14.1",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.7347",,"0.2653","Accidents",,"Medium","Blanchard EB, Hickling EJ, Devineni T, et al. A controlled evaluation of cognitive behavioural therapy for posttraumatic stress in motor vehicle accident survivors. Behav Res Ther. 2003 Jan;41(1):79-96.  PMID: 12488121.","25272","2019"
"blanchard2003_PCL_C_Baseline_Comp","Psychotherapy","PTSD","98","C","Control",,,,"Waitlist","Waitlist","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,"25","Self report","PCL","PCL","Completer",,"Mixed-model ANOVA","Baseline",,,"55.9","13.3",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.7347",,"0.2653","Accidents",,"Medium","Blanchard EB, Hickling EJ, Devineni T, et al. A controlled evaluation of cognitive behavioural therapy for posttraumatic stress in motor vehicle accident survivors. Behav Res Ther. 2003 Jan;41(1):79-96.  PMID: 12488121.","25272","2019"
"boals2015_PCL_A_0_Comp","Psychotherapy","PTSD","70","A","PTSD",,"16",,"ACT analog","Acceptance and Commitment Therapy (ACT) + expressive writing","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","Mixed","26","Self report","PCL","PCL-S","Completer",,"Mixed-model ANOVA","End of Treatment","0",,"39.06","14.11",,,,,"-11.53",,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1",,,,,,"High","Boals A, Murrell AR, Berntsen D, et al. Experimentally reducing event centrality using a modified expressive writing intervention. J Contextual Behav Sci. 2015 Oct;4(4):269-76. doi: 10.1016/j.jcbs.2015.10.001.","1548485","2019"
"boals2015_PCL_A_3_Comp","Psychotherapy","PTSD","70","A","PTSD",,"16",,"ACT analog","Acceptance and Commitment Therapy (ACT) + expressive writing","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","Mixed","26","Self report","PCL","PCL-S","Completer",,"Mixed-model ANOVA","Assessment at <3 Months","3",,"38.89","15.84",,,,,"-11.7",,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1",,,,,,"High","Boals A, Murrell AR, Berntsen D, et al. Experimentally reducing event centrality using a modified expressive writing intervention. J Contextual Behav Sci. 2015 Oct;4(4):269-76. doi: 10.1016/j.jcbs.2015.10.001.","1548485","2019"
"boals2015_PCL_A_Baseline_Comp","Psychotherapy","PTSD","70","A","PTSD",,"16",,"ACT analog","Acceptance and Commitment Therapy (ACT) + expressive writing","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","Mixed","26","Self report","PCL","PCL-S","Completer",,"Mixed-model ANOVA","Baseline",,,"50.59","14.29",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1",,,,,,"High","Boals A, Murrell AR, Berntsen D, et al. Experimentally reducing event centrality using a modified expressive writing intervention. J Contextual Behav Sci. 2015 Oct;4(4):269-76. doi: 10.1016/j.jcbs.2015.10.001.","1548485","2019"
"boals2015_PCL_B_0_Comp","Psychotherapy","PTSD","70","B","PTSD",,"10",,"CBT analog","Cognitive behavioral therapy (CBT) + expressive writing","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","Mixed","20","Self report","PCL","PCL-S","Completer",,"Mixed-model ANOVA","End of Treatment","0",,"37.75","12.49",,,,,"-11",,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1",,,,,,"High","Boals A, Murrell AR, Berntsen D, et al. Experimentally reducing event centrality using a modified expressive writing intervention. J Contextual Behav Sci. 2015 Oct;4(4):269-76. doi: 10.1016/j.jcbs.2015.10.001.","1548485","2019"
"boals2015_PCL_B_3_Comp","Psychotherapy","PTSD","70","B","PTSD",,"10",,"CBT analog","Cognitive behavioral therapy (CBT) + expressive writing","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","Mixed","20","Self report","PCL","PCL-S","Completer",,"Mixed-model ANOVA","Assessment at <3 Months","3",,"32","14.22",,,,,"-16.75",,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1",,,,,,"High","Boals A, Murrell AR, Berntsen D, et al. Experimentally reducing event centrality using a modified expressive writing intervention. J Contextual Behav Sci. 2015 Oct;4(4):269-76. doi: 10.1016/j.jcbs.2015.10.001.","1548485","2019"
"boals2015_PCL_B_Baseline_Comp","Psychotherapy","PTSD","70","B","PTSD",,"10",,"CBT analog","Cognitive behavioral therapy (CBT) + expressive writing","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","Mixed","20","Self report","PCL","PCL-S","Completer",,"Mixed-model ANOVA","Baseline",,,"48.75","14.6",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1",,,,,,"High","Boals A, Murrell AR, Berntsen D, et al. Experimentally reducing event centrality using a modified expressive writing intervention. J Contextual Behav Sci. 2015 Oct;4(4):269-76. doi: 10.1016/j.jcbs.2015.10.001.","1548485","2019"
"boals2015_PCL_C_0_Comp","Psychotherapy","PTSD","70","C","Control",,"22",,"Neutral script and writing","Control writing","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","Mixed","23","Self report","PCL","PCL-S","Completer",,"Mixed-model ANOVA","End of Treatment","0",,"38.64","15.75",,,,,"-10.06",,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1",,,,,,"High","Boals A, Murrell AR, Berntsen D, et al. Experimentally reducing event centrality using a modified expressive writing intervention. J Contextual Behav Sci. 2015 Oct;4(4):269-76. doi: 10.1016/j.jcbs.2015.10.001.","1548485","2019"
"boals2015_PCL_C_3_Comp","Psychotherapy","PTSD","70","C","Control",,"22",,"Neutral script and writing","Control writing","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","Mixed","23","Self report","PCL","PCL-S","Completer",,"Mixed-model ANOVA","Assessment at <3 Months","3",,"34.68","14.17",,,,,"-14.02",,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1",,,,,,"High","Boals A, Murrell AR, Berntsen D, et al. Experimentally reducing event centrality using a modified expressive writing intervention. J Contextual Behav Sci. 2015 Oct;4(4):269-76. doi: 10.1016/j.jcbs.2015.10.001.","1548485","2019"
"boals2015_PCL_C_Baseline_Comp","Psychotherapy","PTSD","70","C","Control",,"22",,"Neutral script and writing","Control writing","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","Mixed","23","Self report","PCL","PCL-S","Completer",,"Mixed-model ANOVA","Baseline",,,"48.7","15.47",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1",,,,,,"High","Boals A, Murrell AR, Berntsen D, et al. Experimentally reducing event centrality using a modified expressive writing intervention. J Contextual Behav Sci. 2015 Oct;4(4):269-76. doi: 10.1016/j.jcbs.2015.10.001.","1548485","2019"
"boggio2010_TOP-8_A_0_ITT","Nonpharmacologic biological","PTSD","30","A","PTSD",,"9",,"High-frequency left rTMS","Transcranial magnetic stimualtion (TMS)","No","Not Applicable","No","Not Applicable","No","Not Applicable","Yes","No","No","No","No","Individual","In Person","10","Structured Clinical Interview","TOP-8","TOP-8","ITT","LOCF","Mixed-model ANOVA","End of Treatment","0",,,,,,,,,,,,,,,,,,"p=0.0039 (Bonferroni corrected)",,,,,,,,,,,,,,"Community",,,"1","0.7",,"0.3","Mixed","rape/sexual assault, community/school violence, other (death or severe disease of relative, perceived physical harm/psychological distress)","Medium","Boggio PS, Rocha M, Oliveira MO, et al. Noninvasive brain stimulation with high-frequency and low-intensity repetitive transcranial magnetic stimulation treatment for posttraumatic stress disorder. J Clin Psychiatry. 2010 Aug;71(8):992-9. doi: 10.4088/JCP.08m04638blu. PMID: 20051219.","33726","2019"
"boggio2010_TOP-8_A_12_ITT","Nonpharmacologic biological","PTSD","30","A","PTSD",,,,"High-frequency left rTMS","Transcranial magnetic stimualtion (TMS)","No","Not Applicable","No","Not Applicable","No","Not Applicable","Yes","No","No","No","No","Individual","In Person","10","Structured Clinical Interview","TOP-8","TOP-8","ITT","LOCF","Mixed-model ANOVA","Assessment at 3 to <6 Months","12",,,,,,,,,,,,,,,,,,"p<0.005 (Bonferroni corrected)",,,,,,,,,,,,,,"Community",,,"1","0.7",,"0.3","Mixed","rape/sexual assault, community/school violence, other (death or severe disease of relative, perceived physical harm/psychological distress)","Medium","Boggio PS, Rocha M, Oliveira MO, et al. Noninvasive brain stimulation with high-frequency and low-intensity repetitive transcranial magnetic stimulation treatment for posttraumatic stress disorder. J Clin Psychiatry. 2010 Aug;71(8):992-9. doi: 10.4088/JCP.08m04638blu. PMID: 20051219.","33726","2019"
"boggio2010_TOP-8_A_Baseline_ITT","Nonpharmacologic biological","PTSD","30","A","PTSD",,"10",,"High-frequency left rTMS","Transcranial magnetic stimualtion (TMS)","No","Not Applicable","No","Not Applicable","No","Not Applicable","Yes","No","No","No","No","Individual","In Person","10","Structured Clinical Interview","TOP-8","TOP-8","ITT","LOCF","Mixed-model ANOVA","Baseline",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.7",,"0.3","Mixed","rape/sexual assault, community/school violence, other (death or severe disease of relative, perceived physical harm/psychological distress)","Medium","Boggio PS, Rocha M, Oliveira MO, et al. Noninvasive brain stimulation with high-frequency and low-intensity repetitive transcranial magnetic stimulation treatment for posttraumatic stress disorder. J Clin Psychiatry. 2010 Aug;71(8):992-9. doi: 10.4088/JCP.08m04638blu. PMID: 20051219.","33726","2019"
"boggio2010_TOP-8_B_0_ITT","Nonpharmacologic biological","PTSD","30","B","PTSD",,"9",,"High-frequency Right rTMS","Transcranial magnetic stimualtion (TMS)","No","Not Applicable","No","Not Applicable","No","Not Applicable","Yes","No","No","No","No","Individual","In Person","10","Structured Clinical Interview","TOP-8","TOP-8","ITT","LOCF","Mixed-model ANOVA","End of Treatment","0",,,,,,,,,,,,,,,,,,"p=0.008 (Bonferroni corrected)",,,,,,,,,,,,,,"Community",,,"1","0.7",,"0.3","Mixed","rape/sexual assault, community/school violence, other (death or severe disease of relative, perceived physical harm/psychological distress)","Medium","Boggio PS, Rocha M, Oliveira MO, et al. Noninvasive brain stimulation with high-frequency and low-intensity repetitive transcranial magnetic stimulation treatment for posttraumatic stress disorder. J Clin Psychiatry. 2010 Aug;71(8):992-9. doi: 10.4088/JCP.08m04638blu. PMID: 20051219.","33726","2019"
"boggio2010_TOP-8_B_12_ITT","Nonpharmacologic biological","PTSD","30","B","PTSD",,,,"High-frequency Right rTMS","Transcranial magnetic stimualtion (TMS)","No","Not Applicable","No","Not Applicable","No","Not Applicable","Yes","No","No","No","No","Individual","In Person","10","Structured Clinical Interview","TOP-8","TOP-8","ITT","LOCF","Mixed-model ANOVA","Assessment at 3 to <6 Months","12",,,,,,,,,,,,,,,,,,"p<0.005 (Bonferroni corrected)",,,,,,,,,,,,,,"Community",,,"1","0.7",,"0.3","Mixed","rape/sexual assault, community/school violence, other (death or severe disease of relative, perceived physical harm/psychological distress)","Medium","Boggio PS, Rocha M, Oliveira MO, et al. Noninvasive brain stimulation with high-frequency and low-intensity repetitive transcranial magnetic stimulation treatment for posttraumatic stress disorder. J Clin Psychiatry. 2010 Aug;71(8):992-9. doi: 10.4088/JCP.08m04638blu. PMID: 20051219.","33726","2019"
"boggio2010_TOP-8_B_Baseline_ITT","Nonpharmacologic biological","PTSD","30","B","PTSD",,"10",,"High-frequency Right rTMS","Transcranial magnetic stimualtion (TMS)","No","Not Applicable","No","Not Applicable","No","Not Applicable","Yes","No","No","No","No","Individual","In Person","10","Structured Clinical Interview","TOP-8","TOP-8","ITT","LOCF","Mixed-model ANOVA","Baseline",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.7",,"0.3","Mixed","rape/sexual assault, community/school violence, other (death or severe disease of relative, perceived physical harm/psychological distress)","Medium","Boggio PS, Rocha M, Oliveira MO, et al. Noninvasive brain stimulation with high-frequency and low-intensity repetitive transcranial magnetic stimulation treatment for posttraumatic stress disorder. J Clin Psychiatry. 2010 Aug;71(8):992-9. doi: 10.4088/JCP.08m04638blu. PMID: 20051219.","33726","2019"
"boggio2010_TOP-8_C_0_ITT","Nonpharmacologic biological","PTSD","30","C","Control",,"8",,"Sham rTMS","Sham","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","10","Structured Clinical Interview","TOP-8","TOP-8","ITT","LOCF","Mixed-model ANOVA","End of Treatment","0",,,,,,,,,,,,,,,,,,"p=0.36 (Bonferroni corrected)",,,,,,,,,,,,,,"Community",,,"1","0.7",,"0.3","Mixed","rape/sexual assault, community/school violence, other (death or severe disease of relative, perceived physical harm/psychological distress)","Medium","Boggio PS, Rocha M, Oliveira MO, et al. Noninvasive brain stimulation with high-frequency and low-intensity repetitive transcranial magnetic stimulation treatment for posttraumatic stress disorder. J Clin Psychiatry. 2010 Aug;71(8):992-9. doi: 10.4088/JCP.08m04638blu. PMID: 20051219.","33726","2019"
"boggio2010_TOP-8_C_Baseline_ITT","Nonpharmacologic biological","PTSD","30","C","Control",,"10",,"Sham rTMS","Sham","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","10","Structured Clinical Interview","TOP-8","TOP-8","ITT","LOCF","Mixed-model ANOVA","Baseline",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.7",,"0.3","Mixed","rape/sexual assault, community/school violence, other (death or severe disease of relative, perceived physical harm/psychological distress)","Medium","Boggio PS, Rocha M, Oliveira MO, et al. Noninvasive brain stimulation with high-frequency and low-intensity repetitive transcranial magnetic stimulation treatment for posttraumatic stress disorder. J Clin Psychiatry. 2010 Aug;71(8):992-9. doi: 10.4088/JCP.08m04638blu. PMID: 20051219.","33726","2019"
"bohus2013_CAPS_A_0_Comp","Psychotherapy","PTSD","82","A","PTSD",,"29",,"DBT-PTSD","Dialectical Behavior Therapy (DBT) +  trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Mixed","In Person","43","Structured Clinical Interview","CAPS","CAPS","Completer","imputed","Mixed-model ANOVA","End of Treatment","0",,"57.24","25.49",,,,,"-30.68",,,,,,,,,,,,,,,,,,"Not meeting DSM-IV PTSD criteria according to CAPS",,,"Reduction of >= 30 points on CAPS score",,,"Community",,,"1","1",,"0","Child sexual abuse",,"Medium","Bohus MJ, Dyer AS, Priebe K, et al. Dialectical behaviour therapy for post-traumatic stress disorder after childhood sexual abuse in patients with and without borderline personality disorder: a randomised controlled trial. Psychother Psychosom. 2013 Jun;82(4):221-33. doi: 10.1159/000348451. PMID: 23712109.","41533","2019"
"bohus2013_CAPS_A_0_ITT","Psychotherapy","PTSD","82","A","PTSD",,"34",,"DBT-PTSD","Dialectical Behavior Therapy (DBT) +  trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Mixed","In Person","43","Structured Clinical Interview","CAPS","CAPS","ITT","LOCF","Mixed-model ANOVA","End of Treatment","0",,"60.31","26.79",,,,,"-27.61",,,,,,,,,,,,,,,,,,"Not meeting DSM-IV PTSD criteria according to CAPS",,,"Reduction of >= 30 points on CAPS score",,,"Community",,,"1","1",,"0","Child sexual abuse",,"Medium","Bohus MJ, Dyer AS, Priebe K, et al. Dialectical behaviour therapy for post-traumatic stress disorder after childhood sexual abuse in patients with and without borderline personality disorder: a randomised controlled trial. Psychother Psychosom. 2013 Jun;82(4):221-33. doi: 10.1159/000348451. PMID: 23712109.","41533","2019"
"bohus2013_CAPS_A_12_Comp","Psychotherapy","PTSD","82","A","PTSD",,"29",,"DBT-PTSD","Dialectical Behavior Therapy (DBT) +  trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Mixed","In Person","43","Structured Clinical Interview","CAPS","CAPS","Completer","imputed","Mixed-model ANOVA","Assessment at 3 to <6 Months","12",,"54.76","24.05",,,,,"-33.16",,,,,,,,,,,,,,,,,,"Not meeting DSM-IV PTSD criteria according to CAPS",,,"Reduction of >= 30 points on CAPS score",,,"Community",,,"1","1",,"0","Child sexual abuse",,"Medium","Bohus MJ, Dyer AS, Priebe K, et al. Dialectical behaviour therapy for post-traumatic stress disorder after childhood sexual abuse in patients with and without borderline personality disorder: a randomised controlled trial. Psychother Psychosom. 2013 Jun;82(4):221-33. doi: 10.1159/000348451. PMID: 23712109.","41533","2019"
"bohus2013_CAPS_A_12_ITT","Psychotherapy","PTSD","82","A","PTSD",,"29",,"DBT-PTSD","Dialectical Behavior Therapy (DBT) +  trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Mixed","In Person","43","Structured Clinical Interview","CAPS","CAPS","ITT","LOCF","Mixed-model ANOVA","Assessment at 3 to <6 Months","12",,"58.5","24.2",,,,,,,,,,,,,,,,,,,,,,,"Not meeting DSM-IV PTSD criteria according to CAPS","0.3889",,"Reduction of >= 30 points on CAPS score","0.3889",,"Community",,,"1","1",,"0","Child sexual abuse",,"Medium","Bohus MJ, Dyer AS, Priebe K, et al. Dialectical behaviour therapy for post-traumatic stress disorder after childhood sexual abuse in patients with and without borderline personality disorder: a randomised controlled trial. Psychother Psychosom. 2013 Jun;82(4):221-33. doi: 10.1159/000348451. PMID: 23712109.","41533","2019"
"bohus2013_CAPS_A_6_Comp","Psychotherapy","PTSD","82","A","PTSD",,"29",,"DBT-PTSD","Dialectical Behavior Therapy (DBT) +  trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Mixed","In Person","43","Structured Clinical Interview","CAPS","CAPS","Completer","imputed","Mixed-model ANOVA","Assessment at <3 Months","6",,"53.07","21.44",,,,,,,,,,,,,,,,,,,,,,,"Not meeting DSM-IV PTSD criteria according to CAPS",,,"Reduction of >= 30 points on CAPS score",,,"Community",,,"1","1",,"0","Child sexual abuse",,"Medium","Bohus MJ, Dyer AS, Priebe K, et al. Dialectical behaviour therapy for post-traumatic stress disorder after childhood sexual abuse in patients with and without borderline personality disorder: a randomised controlled trial. Psychother Psychosom. 2013 Jun;82(4):221-33. doi: 10.1159/000348451. PMID: 23712109.","41533","2019"
"bohus2013_CAPS_A_6_ITT","Psychotherapy","PTSD","82","A","PTSD",,"28",,"DBT-PTSD","Dialectical Behavior Therapy (DBT) +  trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Mixed","In Person","43","Structured Clinical Interview","CAPS","CAPS","ITT","LOCF","Mixed-model ANOVA","Assessment at <3 Months","6",,"57.47","25.66",,,,,"-30.45",,,,,,,,,,,,,,,,,,"Not meeting DSM-IV PTSD criteria according to CAPS",,,"Reduction of >= 30 points on CAPS score",,,"Community",,,"1","1",,"0","Child sexual abuse",,"Medium","Bohus MJ, Dyer AS, Priebe K, et al. Dialectical behaviour therapy for post-traumatic stress disorder after childhood sexual abuse in patients with and without borderline personality disorder: a randomised controlled trial. Psychother Psychosom. 2013 Jun;82(4):221-33. doi: 10.1159/000348451. PMID: 23712109.","41533","2019"
"bohus2013_CAPS_A_Baseline_Comp","Psychotherapy","PTSD","82","A","PTSD",,"29",,"DBT-PTSD","Dialectical Behavior Therapy (DBT) +  trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Mixed","In Person","43","Structured Clinical Interview","CAPS","CAPS","Completer","imputed","Mixed-model ANOVA","Baseline",,,"87.92","14.2",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","1",,"0","Child sexual abuse",,"Medium","Bohus MJ, Dyer AS, Priebe K, et al. Dialectical behaviour therapy for post-traumatic stress disorder after childhood sexual abuse in patients with and without borderline personality disorder: a randomised controlled trial. Psychother Psychosom. 2013 Jun;82(4):221-33. doi: 10.1159/000348451. PMID: 23712109.","41533","2019"
"bohus2013_CAPS_A_Baseline_ITT","Psychotherapy","PTSD","82","A","PTSD",,"36",,"DBT-PTSD","Dialectical Behavior Therapy (DBT) +  trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Mixed","In Person","43","Structured Clinical Interview","CAPS","CAPS","ITT","LOCF","Mixed-model ANOVA","Baseline",,,"87.92","14.2",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","1",,"0","Child sexual abuse",,"Medium","Bohus MJ, Dyer AS, Priebe K, et al. Dialectical behaviour therapy for post-traumatic stress disorder after childhood sexual abuse in patients with and without borderline personality disorder: a randomised controlled trial. Psychother Psychosom. 2013 Jun;82(4):221-33. doi: 10.1159/000348451. PMID: 23712109.","41533","2019"
"bohus2013_CAPS_B_0_Comp","Psychotherapy","PTSD","82","B","Control",,"29",,"TAU waitlist","Treatment as usual (TAU)","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,"In Person","39","Structured Clinical Interview","CAPS","CAPS","Completer","imputed","Mixed-model ANOVA","End of Treatment","0",,"82.73","17.19",,,,,"0.1",,,,,,,,,,,,,,,,,,"Not meeting DSM-IV PTSD criteria according to CAPS",,,"Reduction of >= 30 points on CAPS score",,,"Community",,,"1","1",,"0","Child sexual abuse",,"Medium","Bohus MJ, Dyer AS, Priebe K, et al. Dialectical behaviour therapy for post-traumatic stress disorder after childhood sexual abuse in patients with and without borderline personality disorder: a randomised controlled trial. Psychother Psychosom. 2013 Jun;82(4):221-33. doi: 10.1159/000348451. PMID: 23712109.","41533","2019"
"bohus2013_CAPS_B_0_ITT","Psychotherapy","PTSD","82","B","Control",,"34",,"TAU waitlist","Treatment as usual (TAU)","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,"In Person","39","Structured Clinical Interview","CAPS","CAPS","ITT","LOCF","Mixed-model ANOVA","End of Treatment","0",,"83.53","16.5",,,,,"0.9",,,,,,,,,,,,,,,,,,"Not meeting DSM-IV PTSD criteria according to CAPS",,,"Reduction of >= 30 points on CAPS score",,,"Community",,,"1","1",,"0","Child sexual abuse",,"Medium","Bohus MJ, Dyer AS, Priebe K, et al. Dialectical behaviour therapy for post-traumatic stress disorder after childhood sexual abuse in patients with and without borderline personality disorder: a randomised controlled trial. Psychother Psychosom. 2013 Jun;82(4):221-33. doi: 10.1159/000348451. PMID: 23712109.","41533","2019"
"bohus2013_CAPS_B_12_Comp","Psychotherapy","PTSD","82","B","Control",,"29",,"TAU waitlist","Treatment as usual (TAU)","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,"In Person","39","Structured Clinical Interview","CAPS","CAPS","Completer","imputed","Mixed-model ANOVA","Assessment at 3 to <6 Months","12",,"80.55","19.89",,,,,"-2.08",,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","1",,"0","Child sexual abuse",,"Medium","Bohus MJ, Dyer AS, Priebe K, et al. Dialectical behaviour therapy for post-traumatic stress disorder after childhood sexual abuse in patients with and without borderline personality disorder: a randomised controlled trial. Psychother Psychosom. 2013 Jun;82(4):221-33. doi: 10.1159/000348451. PMID: 23712109.","41533","2019"
"bohus2013_CAPS_B_12_ITT","Psychotherapy","PTSD","82","B","Control",,"33",,"TAU waitlist","Treatment as usual (TAU)","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,"In Person","39","Structured Clinical Interview","CAPS","CAPS","ITT","LOCF","Mixed-model ANOVA","Assessment at 3 to <6 Months","12",,"80.21","19.21",,,,,"-2.42",,,,,,,,,,,,,,,,,,"Not meeting DSM-IV PTSD criteria according to CAPS","0.1053",,"Reduction of >= 30 points on CAPS score","0.0263",,"Community",,,"1","1",,"0","Child sexual abuse",,"Medium","Bohus MJ, Dyer AS, Priebe K, et al. Dialectical behaviour therapy for post-traumatic stress disorder after childhood sexual abuse in patients with and without borderline personality disorder: a randomised controlled trial. Psychother Psychosom. 2013 Jun;82(4):221-33. doi: 10.1159/000348451. PMID: 23712109.","41533","2019"
"bohus2013_CAPS_B_6_Comp","Psychotherapy","PTSD","82","B","Control",,"29",,"TAU waitlist","Treatment as usual (TAU)","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,"In Person","39","Structured Clinical Interview","CAPS","CAPS","Completer","imputed","Mixed-model ANOVA","Assessment at <3 Months","6",,"79.03","22.98",,,,,"-3.6",,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","1",,"0","Child sexual abuse",,"Medium","Bohus MJ, Dyer AS, Priebe K, et al. Dialectical behaviour therapy for post-traumatic stress disorder after childhood sexual abuse in patients with and without borderline personality disorder: a randomised controlled trial. Psychother Psychosom. 2013 Jun;82(4):221-33. doi: 10.1159/000348451. PMID: 23712109.","41533","2019"
"bohus2013_CAPS_B_6_ITT","Psychotherapy","PTSD","82","B","Control",,"32",,"TAU waitlist","Treatment as usual (TAU)","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,"In Person","39","Structured Clinical Interview","CAPS","CAPS","ITT","LOCF","Mixed-model ANOVA","Assessment at <3 Months","6",,"79.74","21.67",,,,,"-2.89",,,,,,,,,,,,,,,,,,"Not meeting DSM-IV PTSD criteria according to CAPS",,,"Reduction of >= 30 points on CAPS score",,,"Community",,,"1","1",,"0","Child sexual abuse",,"Medium","Bohus MJ, Dyer AS, Priebe K, et al. Dialectical behaviour therapy for post-traumatic stress disorder after childhood sexual abuse in patients with and without borderline personality disorder: a randomised controlled trial. Psychother Psychosom. 2013 Jun;82(4):221-33. doi: 10.1159/000348451. PMID: 23712109.","41533","2019"
"bohus2013_CAPS_B_Baseline_Comp","Psychotherapy","PTSD","82","B","Control",,"29",,"TAU waitlist","Treatment as usual (TAU)","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,"In Person","39","Structured Clinical Interview","CAPS","CAPS","Completer","imputed","Mixed-model ANOVA","Baseline",,,"82.63","18.2",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","1",,"0","Child sexual abuse",,"Medium","Bohus MJ, Dyer AS, Priebe K, et al. Dialectical behaviour therapy for post-traumatic stress disorder after childhood sexual abuse in patients with and without borderline personality disorder: a randomised controlled trial. Psychother Psychosom. 2013 Jun;82(4):221-33. doi: 10.1159/000348451. PMID: 23712109.","41533","2019"
"bohus2013_CAPS_B_Baseline_ITT","Psychotherapy","PTSD","82","B","Control",,"38",,"TAU waitlist","Treatment as usual (TAU)","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,"In Person","39","Structured Clinical Interview","CAPS","CAPS","ITT","LOCF","Mixed-model ANOVA","Baseline",,,"82.63","18.2",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","1",,"0","Child sexual abuse",,"Medium","Bohus MJ, Dyer AS, Priebe K, et al. Dialectical behaviour therapy for post-traumatic stress disorder after childhood sexual abuse in patients with and without borderline personality disorder: a randomised controlled trial. Psychother Psychosom. 2013 Jun;82(4):221-33. doi: 10.1159/000348451. PMID: 23712109.","41533","2019"
"bohus2013_PDS_A_0_Comp","Psychotherapy","PTSD","82","A","PTSD",,,,"DBT-PTSD","Dialectical Behavior Therapy (DBT) +  trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Mixed","In Person","43","Self report","PDS","PDS","Completer",,"Mixed-model ANOVA","End of Treatment","0",,"1.61","0.67",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","1",,"0","Child sexual abuse",,"Medium","Bohus MJ, Dyer AS, Priebe K, et al. Dialectical behaviour therapy for post-traumatic stress disorder after childhood sexual abuse in patients with and without borderline personality disorder: a randomised controlled trial. Psychother Psychosom. 2013 Jun;82(4):221-33. doi: 10.1159/000348451. PMID: 23712109.","41533","2019"
"bohus2013_PDS_A_0_ITT","Psychotherapy","PTSD","82","A","PTSD",,,,"DBT-PTSD","Dialectical Behavior Therapy (DBT) +  trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Mixed","In Person","43","Self report","PDS","PDS","ITT",,"Mixed-model ANOVA","End of Treatment","0",,"1.61","0.64",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","1",,"0","Child sexual abuse",,"Medium","Bohus MJ, Dyer AS, Priebe K, et al. Dialectical behaviour therapy for post-traumatic stress disorder after childhood sexual abuse in patients with and without borderline personality disorder: a randomised controlled trial. Psychother Psychosom. 2013 Jun;82(4):221-33. doi: 10.1159/000348451. PMID: 23712109.","41533","2019"
"bohus2013_PDS_A_12_Comp","Psychotherapy","PTSD","82","A","PTSD",,,,"DBT-PTSD","Dialectical Behavior Therapy (DBT) +  trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Mixed","In Person","43","Self report","PDS","PDS","Completer",,"Mixed-model ANOVA","Assessment at 3 to <6 Months","12",,"1.57","0.67",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","1",,"0","Child sexual abuse",,"Medium","Bohus MJ, Dyer AS, Priebe K, et al. Dialectical behaviour therapy for post-traumatic stress disorder after childhood sexual abuse in patients with and without borderline personality disorder: a randomised controlled trial. Psychother Psychosom. 2013 Jun;82(4):221-33. doi: 10.1159/000348451. PMID: 23712109.","41533","2019"
"bohus2013_PDS_A_12_ITT","Psychotherapy","PTSD","82","A","PTSD",,,,"DBT-PTSD","Dialectical Behavior Therapy (DBT) +  trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Mixed","In Person","43","Self report","PDS","PDS","ITT",,"Mixed-model ANOVA","Assessment at 3 to <6 Months","12",,"1.54","0.64",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","1",,"0","Child sexual abuse",,"Medium","Bohus MJ, Dyer AS, Priebe K, et al. Dialectical behaviour therapy for post-traumatic stress disorder after childhood sexual abuse in patients with and without borderline personality disorder: a randomised controlled trial. Psychother Psychosom. 2013 Jun;82(4):221-33. doi: 10.1159/000348451. PMID: 23712109.","41533","2019"
"bohus2013_PDS_A_6_Comp","Psychotherapy","PTSD","82","A","PTSD",,,,"DBT-PTSD","Dialectical Behavior Therapy (DBT) +  trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Mixed","In Person","43","Self report","PDS","PDS","Completer",,"Mixed-model ANOVA","Assessment at <3 Months","6",,"1.51","0.35",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","1",,"0","Child sexual abuse",,"Medium","Bohus MJ, Dyer AS, Priebe K, et al. Dialectical behaviour therapy for post-traumatic stress disorder after childhood sexual abuse in patients with and without borderline personality disorder: a randomised controlled trial. Psychother Psychosom. 2013 Jun;82(4):221-33. doi: 10.1159/000348451. PMID: 23712109.","41533","2019"
"bohus2013_PDS_A_6_ITT","Psychotherapy","PTSD","82","A","PTSD",,,,"DBT-PTSD","Dialectical Behavior Therapy (DBT) +  trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Mixed","In Person","43","Self report","PDS","PDS","ITT",,"Mixed-model ANOVA","Assessment at <3 Months","6",,"1.58","0.51",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","1",,"0","Child sexual abuse",,"Medium","Bohus MJ, Dyer AS, Priebe K, et al. Dialectical behaviour therapy for post-traumatic stress disorder after childhood sexual abuse in patients with and without borderline personality disorder: a randomised controlled trial. Psychother Psychosom. 2013 Jun;82(4):221-33. doi: 10.1159/000348451. PMID: 23712109.","41533","2019"
"bohus2013_PDS_A_Baseline_Comp","Psychotherapy","PTSD","82","A","PTSD",,,,"DBT-PTSD","Dialectical Behavior Therapy (DBT) +  trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Mixed","In Person","43","Self report","PDS","PDS","Completer",,"Mixed-model ANOVA","Baseline",,,"2.22","0.44",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","1",,"0","Child sexual abuse",,"Medium","Bohus MJ, Dyer AS, Priebe K, et al. Dialectical behaviour therapy for post-traumatic stress disorder after childhood sexual abuse in patients with and without borderline personality disorder: a randomised controlled trial. Psychother Psychosom. 2013 Jun;82(4):221-33. doi: 10.1159/000348451. PMID: 23712109.","41533","2019"
"bohus2013_PDS_A_Baseline_ITT","Psychotherapy","PTSD","82","A","PTSD",,,,"DBT-PTSD","Dialectical Behavior Therapy (DBT) +  trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Mixed","In Person","43","Self report","PDS","PDS","ITT",,"Mixed-model ANOVA","Baseline",,,"2.22","0.44",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","1",,"0","Child sexual abuse",,"Medium","Bohus MJ, Dyer AS, Priebe K, et al. Dialectical behaviour therapy for post-traumatic stress disorder after childhood sexual abuse in patients with and without borderline personality disorder: a randomised controlled trial. Psychother Psychosom. 2013 Jun;82(4):221-33. doi: 10.1159/000348451. PMID: 23712109.","41533","2019"
"bohus2013_PDS_B_0_Comp","Psychotherapy","PTSD","82","B","Control",,,,"TAU waitlist","Treatment as usual (TAU)","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,"In Person","39","Self report","PDS","PDS","Completer",,"Mixed-model ANOVA","End of Treatment","0",,"2.02","0.47",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","1",,"0","Child sexual abuse",,"Medium","Bohus MJ, Dyer AS, Priebe K, et al. Dialectical behaviour therapy for post-traumatic stress disorder after childhood sexual abuse in patients with and without borderline personality disorder: a randomised controlled trial. Psychother Psychosom. 2013 Jun;82(4):221-33. doi: 10.1159/000348451. PMID: 23712109.","41533","2019"
"bohus2013_PDS_B_0_ITT","Psychotherapy","PTSD","82","B","Control",,,,"TAU waitlist","Treatment as usual (TAU)","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,"In Person","39","Self report","PDS","PDS","ITT",,"Mixed-model ANOVA","End of Treatment","0",,"2.09","0.46",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","1",,"0","Child sexual abuse",,"Medium","Bohus MJ, Dyer AS, Priebe K, et al. Dialectical behaviour therapy for post-traumatic stress disorder after childhood sexual abuse in patients with and without borderline personality disorder: a randomised controlled trial. Psychother Psychosom. 2013 Jun;82(4):221-33. doi: 10.1159/000348451. PMID: 23712109.","41533","2019"
"bohus2013_PDS_B_12_Comp","Psychotherapy","PTSD","82","B","Control",,,,"TAU waitlist","Treatment as usual (TAU)","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,"In Person","39","Self report","PDS","PDS","Completer",,"Mixed-model ANOVA","Assessment at 3 to <6 Months","12",,"1.90","0.44",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","1",,"0","Child sexual abuse",,"Medium","Bohus MJ, Dyer AS, Priebe K, et al. Dialectical behaviour therapy for post-traumatic stress disorder after childhood sexual abuse in patients with and without borderline personality disorder: a randomised controlled trial. Psychother Psychosom. 2013 Jun;82(4):221-33. doi: 10.1159/000348451. PMID: 23712109.","41533","2019"
"bohus2013_PDS_B_12_ITT","Psychotherapy","PTSD","82","B","Control",,,,"TAU waitlist","Treatment as usual (TAU)","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,"In Person","39","Self report","PDS","PDS","ITT",,"Mixed-model ANOVA","Assessment at 3 to <6 Months","12",,"1.97","0.44",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","1",,"0","Child sexual abuse",,"Medium","Bohus MJ, Dyer AS, Priebe K, et al. Dialectical behaviour therapy for post-traumatic stress disorder after childhood sexual abuse in patients with and without borderline personality disorder: a randomised controlled trial. Psychother Psychosom. 2013 Jun;82(4):221-33. doi: 10.1159/000348451. PMID: 23712109.","41533","2019"
"bohus2013_PDS_B_6_Comp","Psychotherapy","PTSD","82","B","Control",,,,"TAU waitlist","Treatment as usual (TAU)","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,"In Person","39","Self report","PDS","PDS","Completer",,"Mixed-model ANOVA","Assessment at <3 Months","6",,"1.97","0.50",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","1",,"0","Child sexual abuse",,"Medium","Bohus MJ, Dyer AS, Priebe K, et al. Dialectical behaviour therapy for post-traumatic stress disorder after childhood sexual abuse in patients with and without borderline personality disorder: a randomised controlled trial. Psychother Psychosom. 2013 Jun;82(4):221-33. doi: 10.1159/000348451. PMID: 23712109.","41533","2019"
"bohus2013_PDS_B_6_ITT","Psychotherapy","PTSD","82","B","Control",,,,"TAU waitlist","Treatment as usual (TAU)","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,"In Person","39","Self report","PDS","PDS","ITT",,"Mixed-model ANOVA","Assessment at <3 Months","6",,"2.00","0.49",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","1",,"0","Child sexual abuse",,"Medium","Bohus MJ, Dyer AS, Priebe K, et al. Dialectical behaviour therapy for post-traumatic stress disorder after childhood sexual abuse in patients with and without borderline personality disorder: a randomised controlled trial. Psychother Psychosom. 2013 Jun;82(4):221-33. doi: 10.1159/000348451. PMID: 23712109.","41533","2019"
"bohus2013_PDS_B_Baseline_Comp","Psychotherapy","PTSD","82","B","Control",,,,"TAU waitlist","Treatment as usual (TAU)","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,"In Person","39","Self report","PDS","PDS","Completer",,"Mixed-model ANOVA","Baseline",,,"2.09","0.45",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","1",,"0","Child sexual abuse",,"Medium","Bohus MJ, Dyer AS, Priebe K, et al. Dialectical behaviour therapy for post-traumatic stress disorder after childhood sexual abuse in patients with and without borderline personality disorder: a randomised controlled trial. Psychother Psychosom. 2013 Jun;82(4):221-33. doi: 10.1159/000348451. PMID: 23712109.","41533","2019"
"bohus2013_PDS_B_Baseline_ITT","Psychotherapy","PTSD","82","B","Control",,,,"TAU waitlist","Treatment as usual (TAU)","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,"In Person","39","Self report","PDS","PDS","ITT",,"Mixed-model ANOVA","Baseline",,,"2.09","0.45",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","1",,"0","Child sexual abuse",,"Medium","Bohus MJ, Dyer AS, Priebe K, et al. Dialectical behaviour therapy for post-traumatic stress disorder after childhood sexual abuse in patients with and without borderline personality disorder: a randomised controlled trial. Psychother Psychosom. 2013 Jun;82(4):221-33. doi: 10.1159/000348451. PMID: 23712109.","41533","2019"
"bomyea2015_CAPS_A_0_Comp","Nonpharmacologic cognitive","PTSD","42","A","PTSD",,"13",,"High Interference Control Training","Interference control training","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","Yes","No","No","No","Individual","In Person","22","Structured Clinical Interview","CAPS","CAPS","Completer",,"Mixed-model ANOVA","End of Treatment","0",,"33.77","15.67",,,,,"-27.23",,,,,"Cohen's d","1.85",,,,"p<0.00",,,,,,,,"Not meeting criteria for PTSD according to CAPS","0.77",,"≥80% reduction in total PTSD symptoms","0.85",,"Community",,,"1","1",,"0","Rape/sexual assault",,"Medium","Bomyea J, Stein MB, Lang AJ. Interference control training for PTSD: A randomized controlled trial of a novel computer-based intervention. J Anxiety Disord. 2015 Aug;34:33-42. doi: 10.1016/j.janxdis.2015.05.010. PMID: 26114901.","44517","2019"
"bomyea2015_CAPS_A_0_ITT","Nonpharmacologic cognitive","PTSD","42","A","PTSD",,"22",,"High Interference Control Training","Interference control training","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","Yes","No","No","No","Individual","In Person","22","Structured Clinical Interview","CAPS","CAPS","ITT","LOCF","Mixed-model ANOVA","End of Treatment","0",,"45.32","19.92",,,,,"-16.09",,,,,"Cohen's d","0.92",,,,"p<0.00",,,,,,,,"Not meeting criteria for PTSD according to CAPS","0.45",,"≥80% reduction in total PTSD symptoms","0.5",,"Community",,,"1","1",,"0","Rape/sexual assault",,"Medium","Bomyea J, Stein MB, Lang AJ. Interference control training for PTSD: A randomized controlled trial of a novel computer-based intervention. J Anxiety Disord. 2015 Aug;34:33-42. doi: 10.1016/j.janxdis.2015.05.010. PMID: 26114901.","44517","2019"
"bomyea2015_CAPS_A_Baseline_Comp","Nonpharmacologic cognitive","PTSD","42","A","PTSD",,"13",,"High Interference Control Training","Interference control training","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","Yes","No","No","No","Individual","In Person","22","Structured Clinical Interview","CAPS","CAPS","Completer",,"Mixed-model ANOVA","Baseline",,,"61","13.4",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","1",,"0","Rape/sexual assault",,"Medium","Bomyea J, Stein MB, Lang AJ. Interference control training for PTSD: A randomized controlled trial of a novel computer-based intervention. J Anxiety Disord. 2015 Aug;34:33-42. doi: 10.1016/j.janxdis.2015.05.010. PMID: 26114901.","44517","2019"
"bomyea2015_CAPS_A_Baseline_ITT","Nonpharmacologic cognitive","PTSD","42","A","PTSD",,"22",,"High Interference Control Training","Interference control training","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","Yes","No","No","No","Individual","In Person","22","Structured Clinical Interview","CAPS","CAPS","ITT","LOCF","Mixed-model ANOVA","Baseline",,,"61.41","12.54",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","1",,"0","Rape/sexual assault",,"Medium","Bomyea J, Stein MB, Lang AJ. Interference control training for PTSD: A randomized controlled trial of a novel computer-based intervention. J Anxiety Disord. 2015 Aug;34:33-42. doi: 10.1016/j.janxdis.2015.05.010. PMID: 26114901.","44517","2019"
"bomyea2015_CAPS_B_0_Comp","Nonpharmacologic cognitive","PTSD","42","B","Control",,"8",,"Low Interference Control Training","Interference control training","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","20","Structured Clinical Interview","CAPS","CAPS","Completer",,"Mixed-model ANOVA","End of Treatment","0",,"45.88","20.55",,,,,"-22.12",,,,,"Cohen's d","1.1",,,,"p<0.01",,,,,,,,"Not meeting criteria for PTSD according to CAPS","0.63",,"≥80% reduction in total PTSD symptoms","0.75",,"Community",,,"1","1",,"0","Rape/sexual assault",,"Medium","Bomyea J, Stein MB, Lang AJ. Interference control training for PTSD: A randomized controlled trial of a novel computer-based intervention. J Anxiety Disord. 2015 Aug;34:33-42. doi: 10.1016/j.janxdis.2015.05.010. PMID: 26114901.","44517","2019"
"bomyea2015_CAPS_B_0_ITT","Nonpharmacologic cognitive","PTSD","42","B","Control",,"20",,"Low Interference Control Training","Interference control training","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","20","Structured Clinical Interview","CAPS","CAPS","ITT","LOCF","Mixed-model ANOVA","End of Treatment","0",,"58.5","18.61",,,,,"-8.85",,,,,"Cohen's d","0.52",,,,"p<0.05",,,,,,,,"Not meeting criteria for PTSD according to CAPS","0.3",,"≥80% reduction in total PTSD symptoms","0.3",,"Community",,,"1","1",,"0","Rape/sexual assault",,"Medium","Bomyea J, Stein MB, Lang AJ. Interference control training for PTSD: A randomized controlled trial of a novel computer-based intervention. J Anxiety Disord. 2015 Aug;34:33-42. doi: 10.1016/j.janxdis.2015.05.010. PMID: 26114901.","44517","2019"
"bomyea2015_CAPS_B_Baseline_Comp","Nonpharmacologic cognitive","PTSD","42","B","Control",,"8",,"Low Interference Control Training","Interference control training","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","20","Structured Clinical Interview","CAPS","CAPS","Completer",,"Mixed-model ANOVA","Baseline",,,"68","19.86",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","1",,"0","Rape/sexual assault",,"Medium","Bomyea J, Stein MB, Lang AJ. Interference control training for PTSD: A randomized controlled trial of a novel computer-based intervention. J Anxiety Disord. 2015 Aug;34:33-42. doi: 10.1016/j.janxdis.2015.05.010. PMID: 26114901.","44517","2019"
"bomyea2015_CAPS_B_Baseline_ITT","Nonpharmacologic cognitive","PTSD","42","B","Control",,"20",,"Low Interference Control Training","Interference control training","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","20","Structured Clinical Interview","CAPS","CAPS","ITT","LOCF","Mixed-model ANOVA","Baseline",,,"67.35","15",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","1",,"0","Rape/sexual assault",,"Medium","Bomyea J, Stein MB, Lang AJ. Interference control training for PTSD: A randomized controlled trial of a novel computer-based intervention. J Anxiety Disord. 2015 Aug;34:33-42. doi: 10.1016/j.janxdis.2015.05.010. PMID: 26114901.","44517","2019"
"bormann2008_CAPS_A_0_ITT","Complementary and integrative health (CIH)","PTSD","29","A","PTSD",,"14",,"Mantram","Mantram Repetition","No","Not Applicable","No","Not Applicable","Yes","Meditation","No","No","No","No","No","Group","In Person","14","Structured Clinical Interview","CAPS","CAPS","ITT",,"Mixed-model ANOVA","End of Treatment","0",,,,,,,,"-4.79","7.45",,,,,,,,,,,,,,,,,,,,,,,"Veteran",,"1",,"0",,"1","Combat-related",,"Medium","Bormann JE, Thorp S, Wetherell JL, et al. A spiritually based group intervention for combat veterans with posttraumatic stress disorder: feasibility study. J Holist Nurs. 2008 Jun;26(2):109-16. doi: 10.1177/0898010107311276. PMID: 18356284.","30929","2019"
"bormann2008_CAPS_A_Baseline_ITT","Complementary and integrative health (CIH)","PTSD","29","A","PTSD",,"14",,"Mantram","Mantram Repetition","No","Not Applicable","No","Not Applicable","Yes","Meditation","No","No","No","No","No","Group","In Person","14","Structured Clinical Interview","CAPS","CAPS","ITT",,"Mixed-model ANOVA","Baseline",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran",,"1",,"0",,"1","Combat-related",,"Medium","Bormann JE, Thorp S, Wetherell JL, et al. A spiritually based group intervention for combat veterans with posttraumatic stress disorder: feasibility study. J Holist Nurs. 2008 Jun;26(2):109-16. doi: 10.1177/0898010107311276. PMID: 18356284.","30929","2019"
"bormann2008_CAPS_B_0_ITT","Complementary and integrative health (CIH)","PTSD","29","B","Control",,"15",,"Usual care delayed-treatment","Treatment as usual (TAU)","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,"In Person","15","Structured Clinical Interview","CAPS","CAPS","ITT",,"Mixed-model ANOVA","End of Treatment","0",,,,,,,,"-2.64","5.44",,,,,,,,,,,,,,,,,,,,,,,"Veteran",,"1",,"0",,"1","Combat-related",,"Medium","Bormann JE, Thorp S, Wetherell JL, et al. A spiritually based group intervention for combat veterans with posttraumatic stress disorder: feasibility study. J Holist Nurs. 2008 Jun;26(2):109-16. doi: 10.1177/0898010107311276. PMID: 18356284.","30929","2019"
"bormann2008_CAPS_B_Baseline_ITT","Complementary and integrative health (CIH)","PTSD","29","B","Control",,"15",,"Usual care delayed-treatment","Treatment as usual (TAU)","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,"In Person","15","Structured Clinical Interview","CAPS","CAPS","ITT",,"Mixed-model ANOVA","Baseline",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran",,"1",,"0",,"1","Combat-related",,"Medium","Bormann JE, Thorp S, Wetherell JL, et al. A spiritually based group intervention for combat veterans with posttraumatic stress disorder: feasibility study. J Holist Nurs. 2008 Jun;26(2):109-16. doi: 10.1177/0898010107311276. PMID: 18356284.","30929","2019"
"bormann2013_CAPS_A_0_ITT","Complementary and integrative health (CIH)","PTSD","146","A","PTSD",,"66",,"Mantram Repetition Program + TAU","Mantram Repetition","No","Not Applicable","No","Not Applicable","Yes","Meditation","No","No","No","No","No","Group","In Person","71","Structured Clinical Interview","CAPS","CAPS","ITT","Imputed","Mixed-model ANOVA","End of Treatment","0",,"66.16","23.58",,,,,"-16.92",,,,,,,,,,,,,,,,,,,,,"≥10-point reduction on CAPS and CAPS score ≤45","0.24",,"Veteran",,"1",,"0.0274",,"0.9726","Combat-related",,"Low","Bormann JE, Thorp SR, Wetherell JL, et al. Meditation-based mantram intervention for veterans with posttraumatic stress disorder: A randomized trial. Psychol Trauma. 2013 May;5(3):259-67. doi: 10.1037/a0027522.","38465","2019"
"bormann2013_CAPS_A_6_ITT","Complementary and integrative health (CIH)","PTSD","146","A","PTSD",,"66",,"Mantram Repetition Program + TAU","Mantram Repetition","No","Not Applicable","No","Not Applicable","Yes","Meditation","No","No","No","No","No","Group","In Person","71","Structured Clinical Interview","CAPS","CAPS","ITT","Imputed","Mixed-model ANOVA","Assessment at <3 Months","6",,"61.82","23.53",,,,,"-21.26",,,,,,,,,,,,,,,,,,,,,"≥10-point reduction on CAPS and CAPS score ≤45",,,"Veteran",,"1",,"0.0274",,"0.9726","Combat-related",,"Low","Bormann JE, Thorp SR, Wetherell JL, et al. Meditation-based mantram intervention for veterans with posttraumatic stress disorder: A randomized trial. Psychol Trauma. 2013 May;5(3):259-67. doi: 10.1037/a0027522.","38465","2019"
"bormann2013_CAPS_A_Baseline_ITT","Complementary and integrative health (CIH)","PTSD","146","A","PTSD",,"69",,"Mantram Repetition Program + TAU","Mantram Repetition","No","Not Applicable","No","Not Applicable","Yes","Meditation","No","No","No","No","No","Group","In Person","71","Structured Clinical Interview","CAPS","CAPS","ITT","Imputed","Mixed-model ANOVA","Baseline",,,"83.08","16.17",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran",,"1",,"0.0274",,"0.9726","Combat-related",,"Low","Bormann JE, Thorp SR, Wetherell JL, et al. Meditation-based mantram intervention for veterans with posttraumatic stress disorder: A randomized trial. Psychol Trauma. 2013 May;5(3):259-67. doi: 10.1037/a0027522.","38465","2019"
"bormann2013_CAPS_B_0_ITT","Complementary and integrative health (CIH)","PTSD","146","B","Control",,"70",,"TAU","Treatment as usual (TAU)","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,"In Person","75","Structured Clinical Interview","CAPS","CAPS","ITT","Imputed","Mixed-model ANOVA","End of Treatment","0",,"72.59","24.97",,,,,"-10.24",,,,,,,,,,,,,,,,,,,,,"≥10-point reduction on CAPS and CAPS score ≤45","0.12",,"Veteran",,"1",,"0.0274",,"0.9726","Combat-related",,"Low","Bormann JE, Thorp SR, Wetherell JL, et al. Meditation-based mantram intervention for veterans with posttraumatic stress disorder: A randomized trial. Psychol Trauma. 2013 May;5(3):259-67. doi: 10.1037/a0027522.","38465","2019"
"bormann2013_CAPS_B_Baseline_ITT","Complementary and integrative health (CIH)","PTSD","146","B","Control",,"73",,"TAU","Treatment as usual (TAU)","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,"In Person","75","Structured Clinical Interview","CAPS","CAPS","ITT","Imputed","Mixed-model ANOVA","Baseline",,,"82.83","19.44",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran",,"1",,"0.0274",,"0.9726","Combat-related",,"Low","Bormann JE, Thorp SR, Wetherell JL, et al. Meditation-based mantram intervention for veterans with posttraumatic stress disorder: A randomized trial. Psychol Trauma. 2013 May;5(3):259-67. doi: 10.1037/a0027522.","38465","2019"
"bormann2013_PCL_A_0_NA","Complementary and integrative health (CIH)","PTSD","146","A","PTSD",,,,"Mantram Repetition Program + TAU","Mantram Repetition","No","Not Applicable","No","Not Applicable","Yes","Meditation","No","No","No","No","No","Group","In Person","71","Self report","PCL","PCL",,,"Mixed-model ANOVA","End of Treatment","0",,"55.77","14.30",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran",,"1",,"0.0274",,"0.9726","Combat-related",,"Low","Bormann JE, Thorp SR, Wetherell JL, et al. Meditation-based mantram intervention for veterans with posttraumatic stress disorder: A randomized trial. Psychol Trauma. 2013 May;5(3):259-67. doi: 10.1037/a0027522.","38465","2019"
"bormann2013_PCL_A_Baseline_NA","Complementary and integrative health (CIH)","PTSD","146","A","PTSD",,,,"Mantram Repetition Program + TAU","Mantram Repetition","No","Not Applicable","No","Not Applicable","Yes","Meditation","No","No","No","No","No","Group","In Person","71","Self report","PCL","PCL",,,"Mixed-model ANOVA","Baseline",,,"61.39","11.62",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran",,"1",,"0.0274",,"0.9726","Combat-related",,"Low","Bormann JE, Thorp SR, Wetherell JL, et al. Meditation-based mantram intervention for veterans with posttraumatic stress disorder: A randomized trial. Psychol Trauma. 2013 May;5(3):259-67. doi: 10.1037/a0027522.","38465","2019"
"bormann2013_PCL_B_0_NA","Complementary and integrative health (CIH)","PTSD","146","B","Control",,,,"TAU","Treatment as usual (TAU)","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,"In Person","75","Self report","PCL","PCL",,,"Mixed-model ANOVA","End of Treatment","0",,"60.23","12.17",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran",,"1",,"0.0274",,"0.9726","Combat-related",,"Low","Bormann JE, Thorp SR, Wetherell JL, et al. Meditation-based mantram intervention for veterans with posttraumatic stress disorder: A randomized trial. Psychol Trauma. 2013 May;5(3):259-67. doi: 10.1037/a0027522.","38465","2019"
"bormann2013_PCL_B_Baseline_NA","Complementary and integrative health (CIH)","PTSD","146","B","Control",,,,"TAU","Treatment as usual (TAU)","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,"In Person","75","Self report","PCL","PCL",,,"Mixed-model ANOVA","Baseline",,,"62.70","10.40",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran",,"1",,"0.0274",,"0.9726","Combat-related",,"Low","Bormann JE, Thorp SR, Wetherell JL, et al. Meditation-based mantram intervention for veterans with posttraumatic stress disorder: A randomized trial. Psychol Trauma. 2013 May;5(3):259-67. doi: 10.1037/a0027522.","38465","2019"
"bradshaw2014_CAPS_A_0_ITT","Psychotherapy","PTSD","10","A","PTSD",,"5",,"Observed and  Experiential Integration - Switching component","Observed and  Experiential Integration - Switching component","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","5","Structured Clinical Interview","CAPS","CAPS","ITT",,"Mixed-model ANOVA","End of Treatment","0",,"21","7.38",,,,,"-50.4",,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.8",,"0.2","Mixed","rape/sexual assault, intimate partner violence, accidents, community/school violence","High","Bradshaw RA, McDonald MJ, Grace R, et al. A randomized clinical trial of Observed and Experiential Integration (OEI): a simple, innovative intervention for affect regulation in clients with PTSD. Traumatology (Tallahass Fla). 2014 Sep;20(3):161-71. doi: 10.1037/h0099401.","45231","2019"
"bradshaw2014_CAPS_A_Baseline_ITT","Psychotherapy","PTSD","10","A","PTSD",,"5",,"Observed and  Experiential Integration - Switching component","Observed and  Experiential Integration - Switching component","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","5","Structured Clinical Interview","CAPS","CAPS","ITT",,"Mixed-model ANOVA","Baseline",,,"71.4","18.24",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.8",,"0.2","Mixed","rape/sexual assault, intimate partner violence, accidents, community/school violence","High","Bradshaw RA, McDonald MJ, Grace R, et al. A randomized clinical trial of Observed and Experiential Integration (OEI): a simple, innovative intervention for affect regulation in clients with PTSD. Traumatology (Tallahass Fla). 2014 Sep;20(3):161-71. doi: 10.1037/h0099401.","45231","2019"
"bradshaw2014_CAPS_B_0_ITT","Psychotherapy","PTSD","10","B","Control",,"5",,"Waitlist","Waitlist","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,"5","Structured Clinical Interview","CAPS","CAPS","ITT",,"Mixed-model ANOVA","End of Treatment","0",,"85.2","27.67",,,,,"-2.2",,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.8",,"0.2","Mixed","rape/sexual assault, intimate partner violence, accidents, community/school violence","High","Bradshaw RA, McDonald MJ, Grace R, et al. A randomized clinical trial of Observed and Experiential Integration (OEI): a simple, innovative intervention for affect regulation in clients with PTSD. Traumatology (Tallahass Fla). 2014 Sep;20(3):161-71. doi: 10.1037/h0099401.","45231","2019"
"bradshaw2014_CAPS_B_Baseline_ITT","Psychotherapy","PTSD","10","B","Control",,"5",,"Waitlist","Waitlist","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,"5","Structured Clinical Interview","CAPS","CAPS","ITT",,"Mixed-model ANOVA","Baseline",,,"87.4","16.21",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.8",,"0.2","Mixed","rape/sexual assault, intimate partner violence, accidents, community/school violence","High","Bradshaw RA, McDonald MJ, Grace R, et al. A randomized clinical trial of Observed and Experiential Integration (OEI): a simple, innovative intervention for affect regulation in clients with PTSD. Traumatology (Tallahass Fla). 2014 Sep;20(3):161-71. doi: 10.1037/h0099401.","45231","2019"
"brady2000_CAPS_A_0_ITT","Pharmacotherapy","PTSD","187","A","PTSD",,"93",,"Sertraline","Sertraline","No","Not Applicable","Yes","Antidepressant: SSRI","No","Not Applicable","No","No","No","No","No","Individual","In Person","94","Structured Clinical Interview","CAPS","CAPS-2","ITT","LOCF","Mixed-model ANOVA","End of Treatment","0",,"43.4","28.1",,,,"SEM 2.8","-33.0",,,,,,,,,,,,,,,,,,,,,"≥30% decrease in CAPS-2 score and CGI-I score of 1 or 2","0.53",,"Community",,,"1","0.733",,"0.267","Mixed","combat-related, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (seeing someone hurt or die, kidnapping)","Medium","Brady K, Pearlstein T, Asnis GM, et al. Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial. JAMA. 2000 Apr;283(14):1837-44. doi: 10.1001/jama.283.14.1837. PMID: 10770145.","22232","2019"
"brady2000_CAPS_A_Baseline_ITT","Pharmacotherapy","PTSD","187","A","PTSD",,"93",,"Sertraline","Sertraline","No","Not Applicable","Yes","Antidepressant: SSRI","No","Not Applicable","No","No","No","No","No","Individual","In Person","94","Structured Clinical Interview","CAPS","CAPS-2","ITT","LOCF","Mixed-model ANOVA","Baseline",,,"76.6","17.5",,,,,,,,,,,,,,,,,,,,,,,,,,"≥30% decrease in CAPS-2 score and CGI-I score of 1 or 2",,,"Community",,,"1","0.733",,"0.267","Mixed","combat-related, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (seeing someone hurt or die, kidnapping)","Medium","Brady K, Pearlstein T, Asnis GM, et al. Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial. JAMA. 2000 Apr;283(14):1837-44. doi: 10.1001/jama.283.14.1837. PMID: 10770145.","22232","2019"
"brady2000_CAPS_B_0_ITT","Pharmacotherapy","PTSD","187","B","Control",,"90",,"Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","93","Structured Clinical Interview","CAPS","CAPS-2","ITT","LOCF","Mixed-model ANOVA","End of Treatment","0",,"51.9","28.7",,,,"SEM 2.9","-23.2",,,,,,,,,,,,,,,,,,,,,"≥30% decrease in CAPS-2 score and CGI-I score of 1 or 2","0.32",,"Community",,,"1","0.733",,"0.267","Mixed","combat-related, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (seeing someone hurt or die, kidnapping)","Medium","Brady K, Pearlstein T, Asnis GM, et al. Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial. JAMA. 2000 Apr;283(14):1837-44. doi: 10.1001/jama.283.14.1837. PMID: 10770145.","22232","2019"
"brady2000_CAPS_B_Baseline_ITT","Pharmacotherapy","PTSD","187","B","Control",,"90",,"Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","93","Structured Clinical Interview","CAPS","CAPS-2","ITT","LOCF","Mixed-model ANOVA","Baseline",,,"75.1","17.7",,,,,,,,,,,,,,,,,,,,,,,,,,"≥30% decrease in CAPS-2 score and CGI-I score of 1 or 2",,,"Community",,,"1","0.733",,"0.267","Mixed","combat-related, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (seeing someone hurt or die, kidnapping)","Medium","Brady K, Pearlstein T, Asnis GM, et al. Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial. JAMA. 2000 Apr;283(14):1837-44. doi: 10.1001/jama.283.14.1837. PMID: 10770145.","22232","2019"
"brady2000_DTS_A_0_NA","Pharmacotherapy","PTSD","187","A","PTSD",,,,"Sertraline","Sertraline","No","Not Applicable","Yes","Antidepressant: SSRI","No","Not Applicable","No","No","No","No","No","Individual","In Person","94","Self report","DTS","DTS",,,"Mixed-model ANOVA","End of Treatment","0",,"43.2","29.9",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.733",,"0.267","Mixed","combat-related, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (seeing someone hurt or die, kidnapping)","Medium","Brady K, Pearlstein T, Asnis GM, et al. Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial. JAMA. 2000 Apr;283(14):1837-44. doi: 10.1001/jama.283.14.1837. PMID: 10770145.","22232","2019"
"brady2000_DTS_A_Baseline_NA","Pharmacotherapy","PTSD","187","A","PTSD",,,,"Sertraline","Sertraline","No","Not Applicable","Yes","Antidepressant: SSRI","No","Not Applicable","No","No","No","No","No","Individual","In Person","94","Self report","DTS","DTS",,,"Mixed-model ANOVA","Baseline",,,"71.9","24.1",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.733",,"0.267","Mixed","combat-related, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (seeing someone hurt or die, kidnapping)","Medium","Brady K, Pearlstein T, Asnis GM, et al. Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial. JAMA. 2000 Apr;283(14):1837-44. doi: 10.1001/jama.283.14.1837. PMID: 10770145.","22232","2019"
"brady2000_DTS_B_0_NA","Pharmacotherapy","PTSD","187","B","Control",,,,"Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","93","Self report","DTS","DTS",,,"Mixed-model ANOVA","End of Treatment","0",,"52.2","31.3",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.733",,"0.267","Mixed","combat-related, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (seeing someone hurt or die, kidnapping)","Medium","Brady K, Pearlstein T, Asnis GM, et al. Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial. JAMA. 2000 Apr;283(14):1837-44. doi: 10.1001/jama.283.14.1837. PMID: 10770145.","22232","2019"
"brady2000_DTS_B_Baseline_NA","Pharmacotherapy","PTSD","187","B","Control",,,,"Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","93","Self report","DTS","DTS",,,"Mixed-model ANOVA","Baseline",,,"68.5","27.8",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.733",,"0.267","Mixed","combat-related, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (seeing someone hurt or die, kidnapping)","Medium","Brady K, Pearlstein T, Asnis GM, et al. Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial. JAMA. 2000 Apr;283(14):1837-44. doi: 10.1001/jama.283.14.1837. PMID: 10770145.","22232","2019"
"brady2000_IES_A_0_NA","Pharmacotherapy","PTSD","187","A","PTSD",,,,"Sertraline","Sertraline","No","Not Applicable","Yes","Antidepressant: SSRI","No","Not Applicable","No","No","No","No","No","Individual","In Person","94","Self report","IES","IES",,,"Mixed-model ANOVA","End of Treatment","0",,"21.0","17.6",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.733",,"0.267","Mixed","combat-related, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (seeing someone hurt or die, kidnapping)","Medium","Brady K, Pearlstein T, Asnis GM, et al. Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial. JAMA. 2000 Apr;283(14):1837-44. doi: 10.1001/jama.283.14.1837. PMID: 10770145.","22232","2019"
"brady2000_IES_A_Baseline_NA","Pharmacotherapy","PTSD","187","A","PTSD",,,,"Sertraline","Sertraline","No","Not Applicable","Yes","Antidepressant: SSRI","No","Not Applicable","No","No","No","No","No","Individual","In Person","94","Self report","IES","IES",,,"Mixed-model ANOVA","Baseline",,,"37.7","15.7",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.733",,"0.267","Mixed","combat-related, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (seeing someone hurt or die, kidnapping)","Medium","Brady K, Pearlstein T, Asnis GM, et al. Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial. JAMA. 2000 Apr;283(14):1837-44. doi: 10.1001/jama.283.14.1837. PMID: 10770145.","22232","2019"
"brady2000_IES_B_0_NA","Pharmacotherapy","PTSD","187","B","Control",,,,"Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","93","Self report","IES","IES",,,"Mixed-model ANOVA","End of Treatment","0",,"24.5","17.5",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.733",,"0.267","Mixed","combat-related, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (seeing someone hurt or die, kidnapping)","Medium","Brady K, Pearlstein T, Asnis GM, et al. Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial. JAMA. 2000 Apr;283(14):1837-44. doi: 10.1001/jama.283.14.1837. PMID: 10770145.","22232","2019"
"brady2000_IES_B_Baseline_NA","Pharmacotherapy","PTSD","187","B","Control",,,,"Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","93","Self report","IES","IES",,,"Mixed-model ANOVA","Baseline",,,"36.7","15.4",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.733",,"0.267","Mixed","combat-related, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (seeing someone hurt or die, kidnapping)","Medium","Brady K, Pearlstein T, Asnis GM, et al. Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial. JAMA. 2000 Apr;283(14):1837-44. doi: 10.1001/jama.283.14.1837. PMID: 10770145.","22232","2019"
"brady2005_CAPS_A_0_ITT","Pharmacotherapy","PTSD+SUD","94","A","PTSD+SUD","Not integrated","49",,"Sertraline + CBT for alcohol dependence","Cognitive behavioral therapy (CBT) for alcohol use + sertraline","Yes","Non-TF","Yes","Antidepressant: SSRI","No","Not Applicable","No","No","No","No","No","Individual","In person","49","Structured Clinical Interview","CAPS","CAPS","ITT","Mixed-model ANOVA and ANCOVA analyses take into account missing data","ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","End of Treatment","0",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"≥30% decrease in CAPS total score (baseline to end of treatment) and score ≤2 on CAPS question 20 (with or without alcohol treatment response)","0.7105",,"Community",,,"1","0.457",,"0.543","Mixed","rape/sexual assault, accidents, community/school violence, other (childhood trauma not specified)","Medium","Brady KT, Sonne SC, Anton RF, et al. Sertraline in the treatment of co-occurring alcohol dependence and posttraumatic stress disorder. Alcohol Clin Exp Res. 2005 Mar;29(3):395-401. doi: 10.1097/01.ALC.0000156129.98265.57. PMID: 15770115.","27416","2020"
"brady2005_CAPS_A_Baseline_ITT","Pharmacotherapy","PTSD+SUD","94","A","PTSD+SUD","Not integrated","49",,"Sertraline + CBT for alcohol dependence","Cognitive behavioral therapy (CBT) for alcohol use + sertraline","Yes","Non-TF","Yes","Antidepressant: SSRI","No","Not Applicable","No","No","No","No","No","Individual","In person","49","Structured Clinical Interview","CAPS","CAPS","ITT","Mixed-model ANOVA and ANCOVA analyses take into account missing data","ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","Baseline",,,"60.1","18.1",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.457",,"0.543","Mixed","rape/sexual assault, accidents, community/school violence, other (childhood trauma not specified)","Medium","Brady KT, Sonne SC, Anton RF, et al. Sertraline in the treatment of co-occurring alcohol dependence and posttraumatic stress disorder. Alcohol Clin Exp Res. 2005 Mar;29(3):395-401. doi: 10.1097/01.ALC.0000156129.98265.57. PMID: 15770115.","27416","2020"
"brady2005_CAPS_B_0_ITT","Pharmacotherapy","PTSD+SUD","94","B","Control","Not integrated","45",,"Placebo + CBT for alcohol dependence","Cognitive behavioral therapy (CBT) for alcohol use","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In person","45","Structured Clinical Interview","CAPS","CAPS","ITT","Mixed-model ANOVA and ANCOVA analyses take into account missing data","ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","End of Treatment","0",,,,,,,,,,,,,,,,,,,,,,,,,,,"0.6316",,,,,"Community",,,"1","0.457",,"0.543","Mixed","rape/sexual assault, accidents, community/school violence, other (childhood trauma not specified)","Medium","Brady KT, Sonne SC, Anton RF, et al. Sertraline in the treatment of co-occurring alcohol dependence and posttraumatic stress disorder. Alcohol Clin Exp Res. 2005 Mar;29(3):395-401. doi: 10.1097/01.ALC.0000156129.98265.57. PMID: 15770115.","27416","2020"
"brady2005_CAPS_B_Baseline_ITT","Pharmacotherapy","PTSD+SUD","94","B","Control","Not integrated","45",,"Placebo + CBT for alcohol dependence","Cognitive behavioral therapy (CBT) for alcohol use","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In person","45","Structured Clinical Interview","CAPS","CAPS","ITT","Mixed-model ANOVA and ANCOVA analyses take into account missing data","ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","Baseline",,,"57.6","20.3",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.457",,"0.543","Mixed","rape/sexual assault, accidents, community/school violence, other (childhood trauma not specified)","Medium","Brady KT, Sonne SC, Anton RF, et al. Sertraline in the treatment of co-occurring alcohol dependence and posttraumatic stress disorder. Alcohol Clin Exp Res. 2005 Mar;29(3):395-401. doi: 10.1097/01.ALC.0000156129.98265.57. PMID: 15770115.","27416","2020"
"braun1990_IES_A_0_NA","Pharmacotherapy","PTSD","16","A","PTSD",,,,"Alprazolam","Alprazolam","No","Not Applicable","Yes","Antianxiety: benzodiazepine","No","Not Applicable","No","No","No","No","No","Individual","In Person","16","Self report","IES","IES",,,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","End of Treatment","0",,"24.8","7.30",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1",,,,"Mixed","combat-related, accidents, terrorism/political violence/forced displacement","High","Braun P, Greenberg D, Dasberg H, et al. Core symptoms of posttraumatic stress disorder unimproved by alprazolam treatment. J. Clin. Psychiatry. 1990 Jun;51(6):236-8.  PMID: 2189869.","02466","2019"
"braun1990_IES_A_Baseline_NA","Pharmacotherapy","PTSD","16","A","PTSD",,,,"Alprazolam","Alprazolam","No","Not Applicable","Yes","Antianxiety: benzodiazepine","No","Not Applicable","No","No","No","No","No","Individual","In Person","16","Self report","IES","IES",,,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","Baseline",,,"28.1","6.07",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1",,,,"Mixed","combat-related, accidents, terrorism/political violence/forced displacement","High","Braun P, Greenberg D, Dasberg H, et al. Core symptoms of posttraumatic stress disorder unimproved by alprazolam treatment. J. Clin. Psychiatry. 1990 Jun;51(6):236-8.  PMID: 2189869.","02466","2019"
"braun1990_IES_B_0_NA","Pharmacotherapy","PTSD","16","B","Control",,,,"Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","16","Self report","IES","IES",,,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","End of Treatment","0",,"26.4","6.99",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1",,,,"Mixed","combat-related, accidents, terrorism/political violence/forced displacement","High","Braun P, Greenberg D, Dasberg H, et al. Core symptoms of posttraumatic stress disorder unimproved by alprazolam treatment. J. Clin. Psychiatry. 1990 Jun;51(6):236-8.  PMID: 2189869.","02466","2019"
"braun1990_IES_B_Baseline_NA","Pharmacotherapy","PTSD","16","B","Control",,,,"Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","16","Self report","IES","IES",,,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","Baseline",,,"26.7","11.26",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1",,,,"Mixed","combat-related, accidents, terrorism/political violence/forced displacement","High","Braun P, Greenberg D, Dasberg H, et al. Core symptoms of posttraumatic stress disorder unimproved by alprazolam treatment. J. Clin. Psychiatry. 1990 Jun;51(6):236-8.  PMID: 2189869.","02466","2019"
"braun1990_PSS_A_0_Comp","Pharmacotherapy","PTSD","16","A","PTSD",,"10",,"Alprazolam","Alprazolam","No","Not Applicable","Yes","Antianxiety: benzodiazepine","No","Not Applicable","No","No","No","No","No","Individual","In Person","16","Self report","PSS","PSS","Completer",,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","End of Treatment","0",,"26.6","7.44",,,,,"-4.3",,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1",,,,"Mixed","combat-related, accidents, terrorism/political violence/forced displacement","High","Braun P, Greenberg D, Dasberg H, et al. Core symptoms of posttraumatic stress disorder unimproved by alprazolam treatment. J. Clin. Psychiatry. 1990 Jun;51(6):236-8.  PMID: 2189869.","02466","2019"
"braun1990_PSS_A_Baseline_Comp","Pharmacotherapy","PTSD","16","A","PTSD",,"10",,"Alprazolam","Alprazolam","No","Not Applicable","Yes","Antianxiety: benzodiazepine","No","Not Applicable","No","No","No","No","No","Individual","In Person","16","Self report","PSS","PSS","Completer",,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","Baseline",,,"30.9","8.50",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1",,,,"Mixed","combat-related, accidents, terrorism/political violence/forced displacement","High","Braun P, Greenberg D, Dasberg H, et al. Core symptoms of posttraumatic stress disorder unimproved by alprazolam treatment. J. Clin. Psychiatry. 1990 Jun;51(6):236-8.  PMID: 2189869.","02466","2019"
"braun1990_PSS_B_0_Comp","Pharmacotherapy","PTSD","16","B","Control",,"10",,"Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","16","Self report","PSS","PSS","Completer",,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","End of Treatment","0",,"28.8","8.16",,,,,"-1.2",,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1",,,,"Mixed","combat-related, accidents, terrorism/political violence/forced displacement","High","Braun P, Greenberg D, Dasberg H, et al. Core symptoms of posttraumatic stress disorder unimproved by alprazolam treatment. J. Clin. Psychiatry. 1990 Jun;51(6):236-8.  PMID: 2189869.","02466","2019"
"braun1990_PSS_B_Baseline_Comp","Pharmacotherapy","PTSD","16","B","Control",,"10",,"Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","16","Self report","PSS","PSS","Completer",,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","Baseline",,,"30","9.34",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1",,,,"Mixed","combat-related, accidents, terrorism/political violence/forced displacement","High","Braun P, Greenberg D, Dasberg H, et al. Core symptoms of posttraumatic stress disorder unimproved by alprazolam treatment. J. Clin. Psychiatry. 1990 Jun;51(6):236-8.  PMID: 2189869.","02466","2019"
"bremner2017_CAPS_A_0_Comp","Mixed: Psychotherapy & CIH","PTSD","26","A","PTSD",,"9",,"MBSR","Mindfulness-based stress reduction (MBSR)","No","Not Applicable","No","Not Applicable","Yes","Meditation","No","No","No","No","No","Group","In Person","17","Structured Clinical Interview","CAPS","CAPS","Completer",,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","End of Treatment","0",,"28","20",,,,,"-28",,,,,,,,,,"p=0.016",,,,,,,,,,,,,,"Veteran",,"1",,"0",,"1","Combat-related",,"Medium","Bremner JD, Mishra S, Campanella C, et al. A pilot study of the effects of mindfulness-based stress reduction on post-traumatic stress disorder symptoms and brain response to traumatic reminders of combat in Operation Enduring Freedom/Operation Iraqi Freedom combat veterans with post-traumatic stress disorder. Front Psychiatry. 2017 Aug 25;8:157. doi: 10.3389/fpsyt.2017.00157. PMID: 28890702.","49077","2019"
"bremner2017_CAPS_A_26_Comp","Mixed: Psychotherapy & CIH","PTSD","26","A","PTSD",,"9",,"MBSR","Mindfulness-based stress reduction (MBSR)","No","Not Applicable","No","Not Applicable","Yes","Meditation","No","No","No","No","No","Group","In Person","17","Structured Clinical Interview","CAPS","CAPS","Completer",,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","Assessment at 6 to <12 Months","26",,,,,,,,,,,,"""these effects [end of treatment] persisted at the 6-month followup period""",,,,,,,,,,,,,,,,,,,,"Veteran",,"1",,"0",,"1","Combat-related",,"Medium","Bremner JD, Mishra S, Campanella C, et al. A pilot study of the effects of mindfulness-based stress reduction on post-traumatic stress disorder symptoms and brain response to traumatic reminders of combat in Operation Enduring Freedom/Operation Iraqi Freedom combat veterans with post-traumatic stress disorder. Front Psychiatry. 2017 Aug 25;8:157. doi: 10.3389/fpsyt.2017.00157. PMID: 28890702.","49077","2019"
"bremner2017_CAPS_A_Baseline_Comp","Mixed: Psychotherapy & CIH","PTSD","26","A","PTSD",,"9",,"MBSR","Mindfulness-based stress reduction (MBSR)","No","Not Applicable","No","Not Applicable","Yes","Meditation","No","No","No","No","No","Group","In Person","17","Structured Clinical Interview","CAPS","CAPS","Completer",,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","Baseline",,,"56","29",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran",,"1",,"0",,"1","Combat-related",,"Medium","Bremner JD, Mishra S, Campanella C, et al. A pilot study of the effects of mindfulness-based stress reduction on post-traumatic stress disorder symptoms and brain response to traumatic reminders of combat in Operation Enduring Freedom/Operation Iraqi Freedom combat veterans with post-traumatic stress disorder. Front Psychiatry. 2017 Aug 25;8:157. doi: 10.3389/fpsyt.2017.00157. PMID: 28890702.","49077","2019"
"bremner2017_CAPS_B_0_Comp","Mixed: Psychotherapy & CIH","PTSD","26","B","PTSD",,"8",,"Group PCT","Present Centered Therapy (PCT)","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Group","In Person","9","Structured Clinical Interview","CAPS","CAPS","Completer",,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","End of Treatment","0",,"43","15",,,,,"-8",,,,,,,,,,"p>0.05",,,,,,,,,,,,,,"Veteran",,"1",,"0",,"1","Combat-related",,"Medium","Bremner JD, Mishra S, Campanella C, et al. A pilot study of the effects of mindfulness-based stress reduction on post-traumatic stress disorder symptoms and brain response to traumatic reminders of combat in Operation Enduring Freedom/Operation Iraqi Freedom combat veterans with post-traumatic stress disorder. Front Psychiatry. 2017 Aug 25;8:157. doi: 10.3389/fpsyt.2017.00157. PMID: 28890702.","49077","2019"
"bremner2017_CAPS_B_26_Comp","Mixed: Psychotherapy & CIH","PTSD","26","B","PTSD",,"8",,"Group PCT","Present Centered Therapy (PCT)","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Group","In Person","9","Structured Clinical Interview","CAPS","CAPS","Completer",,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","Assessment at 6 to <12 Months","26",,,,,,,,,,,,"""these effects [end of treatment] persisted at the 6-month followup period""",,,,,,,,,,,,,,,,,,,,"Veteran",,"1",,"0",,"1","Combat-related",,"Medium","Bremner JD, Mishra S, Campanella C, et al. A pilot study of the effects of mindfulness-based stress reduction on post-traumatic stress disorder symptoms and brain response to traumatic reminders of combat in Operation Enduring Freedom/Operation Iraqi Freedom combat veterans with post-traumatic stress disorder. Front Psychiatry. 2017 Aug 25;8:157. doi: 10.3389/fpsyt.2017.00157. PMID: 28890702.","49077","2019"
"bremner2017_CAPS_B_Baseline_Comp","Mixed: Psychotherapy & CIH","PTSD","26","B","PTSD",,"8",,"Group PCT","Present Centered Therapy (PCT)","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Group","In Person","9","Structured Clinical Interview","CAPS","CAPS","Completer",,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","Baseline",,,"51","14",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran",,"1",,"0",,"1","Combat-related",,"Medium","Bremner JD, Mishra S, Campanella C, et al. A pilot study of the effects of mindfulness-based stress reduction on post-traumatic stress disorder symptoms and brain response to traumatic reminders of combat in Operation Enduring Freedom/Operation Iraqi Freedom combat veterans with post-traumatic stress disorder. Front Psychiatry. 2017 Aug 25;8:157. doi: 10.3389/fpsyt.2017.00157. PMID: 28890702.","49077","2019"
"brom1989_IES_A_0_NA","Mixed: Psychotherapy & CIH","PTSD","112","A","PTSD",,,,"Trauma Desensitization","Exposure therapy","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","31","Self report","IES","IES",,,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","End of Treatment","0",,"28","19.5",,,,,"-19.4",,,,,,,,,,"p<0.05",,,,,,,,,,,,,,"Community",,,"1","0.79",,"0.21","Mixed","accidents, community/school violence, illness/medical procedure, other (loss of loved one, undefined)","High","Brom D, Kleber RJ, Defares PB. Brief psychotherapy for posttraumatic stress disorders. J Consult Clin Psychol. 1989;57(5):607-12.  PMID: 2571625.","03090","2019"
"brom1989_IES_A_12_NA","Mixed: Psychotherapy & CIH","PTSD","112","A","PTSD",,,,"Trauma Desensitization","Exposure therapy","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","31","Self report","IES","IES",,,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","Assessment at 3 to <6 Months","12",,"31.3","21.1",,,,,"-16.1",,,,,,,,,,"p<0.05",,,,,,,,,,,,,,"Community",,,"1","0.79",,"0.21","Mixed","accidents, community/school violence, illness/medical procedure, other (loss of loved one, undefined)","High","Brom D, Kleber RJ, Defares PB. Brief psychotherapy for posttraumatic stress disorders. J Consult Clin Psychol. 1989;57(5):607-12.  PMID: 2571625.","03090","2019"
"brom1989_IES_A_Baseline_NA","Mixed: Psychotherapy & CIH","PTSD","112","A","PTSD",,,,"Trauma Desensitization","Exposure therapy","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","31","Self report","IES","IES",,,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","Baseline",,,"47.4","12",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.79",,"0.21","Mixed","accidents, community/school violence, illness/medical procedure, other (loss of loved one, undefined)","High","Brom D, Kleber RJ, Defares PB. Brief psychotherapy for posttraumatic stress disorders. J Consult Clin Psychol. 1989;57(5):607-12.  PMID: 2571625.","03090","2019"
"brom1989_IES_B_0_NA","Mixed: Psychotherapy & CIH","PTSD","112","B","PTSD",,,,"Hypnotherapy","Hypnotherapy","No","Not Applicable","No","Not Applicable","Yes","Clinical hypnosis","No","No","No","No","No","Individual","In Person","29","Self report","IES","IES",,,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","End of Treatment","0",,"33.7","22.9",,,,,"-17.1",,,,,,,,,,"p<0.05",,,,,,,,,,,,,,"Community",,,"1","0.79",,"0.21","Mixed","accidents, community/school violence, illness/medical procedure, other (loss of loved one, undefined)","High","Brom D, Kleber RJ, Defares PB. Brief psychotherapy for posttraumatic stress disorders. J Consult Clin Psychol. 1989;57(5):607-12.  PMID: 2571625.","03090","2019"
"brom1989_IES_B_12_NA","Mixed: Psychotherapy & CIH","PTSD","112","B","PTSD",,,,"Hypnotherapy","Hypnotherapy","No","Not Applicable","No","Not Applicable","Yes","Clinical hypnosis","No","No","No","No","No","Individual","In Person","29","Self report","IES","IES",,,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","Assessment at 3 to <6 Months","12",,"31.7","22",,,,,"-19.1",,,,,,,,,,"p<0.05",,,,,,,,,,,,,,"Community",,,"1","0.79",,"0.21","Mixed","accidents, community/school violence, illness/medical procedure, other (loss of loved one, undefined)","High","Brom D, Kleber RJ, Defares PB. Brief psychotherapy for posttraumatic stress disorders. J Consult Clin Psychol. 1989;57(5):607-12.  PMID: 2571625.","03090","2019"
"brom1989_IES_B_Baseline_NA","Mixed: Psychotherapy & CIH","PTSD","112","B","PTSD",,,,"Hypnotherapy","Hypnotherapy","No","Not Applicable","No","Not Applicable","Yes","Clinical hypnosis","No","No","No","No","No","Individual","In Person","29","Self report","IES","IES",,,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","Baseline",,,"50.8","11.7",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.79",,"0.21","Mixed","accidents, community/school violence, illness/medical procedure, other (loss of loved one, undefined)","High","Brom D, Kleber RJ, Defares PB. Brief psychotherapy for posttraumatic stress disorders. J Consult Clin Psychol. 1989;57(5):607-12.  PMID: 2571625.","03090","2019"
"brom1989_IES_C_0_NA","Mixed: Psychotherapy & CIH","PTSD","112","C","PTSD",,,,"Psychodynamic therapy","Psychodynamic psychotherapy","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","29","Self report","IES","IES",,,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","End of Treatment","0",,"32.7","16.5",,,,,"-13.6",,,,,,,,,,"p<0.05",,,,,,,,,,,,,,"Community",,,"1","0.79",,"0.21","Mixed","accidents, community/school violence, illness/medical procedure, other (loss of loved one, undefined)","High","Brom D, Kleber RJ, Defares PB. Brief psychotherapy for posttraumatic stress disorders. J Consult Clin Psychol. 1989;57(5):607-12.  PMID: 2571625.","03090","2019"
"brom1989_IES_C_12_NA","Mixed: Psychotherapy & CIH","PTSD","112","C","PTSD",,,,"Psychodynamic therapy","Psychodynamic psychotherapy","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","29","Self report","IES","IES",,,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","Assessment at 3 to <6 Months","12",,"27","17",,,,,"-19.3",,,,,,,,,,"p<0.05",,,,,,,,,,,,,,"Community",,,"1","0.79",,"0.21","Mixed","accidents, community/school violence, illness/medical procedure, other (loss of loved one, undefined)","High","Brom D, Kleber RJ, Defares PB. Brief psychotherapy for posttraumatic stress disorders. J Consult Clin Psychol. 1989;57(5):607-12.  PMID: 2571625.","03090","2019"
"brom1989_IES_C_Baseline_NA","Mixed: Psychotherapy & CIH","PTSD","112","C","PTSD",,,,"Psychodynamic therapy","Psychodynamic psychotherapy","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","29","Self report","IES","IES",,,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","Baseline",,,"46.3","13.5",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.79",,"0.21","Mixed","accidents, community/school violence, illness/medical procedure, other (loss of loved one, undefined)","High","Brom D, Kleber RJ, Defares PB. Brief psychotherapy for posttraumatic stress disorders. J Consult Clin Psychol. 1989;57(5):607-12.  PMID: 2571625.","03090","2019"
"brom1989_IES_D_0_NA","Mixed: Psychotherapy & CIH","PTSD","112","D","Control",,,,"Waitlist","Waitlist","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,"23","Self report","IES","IES",,,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","End of Treatment","0",,"46.5","15.2",,,,,"-4.6",,,,,,,,,,"p>0.05",,,,,,,,,,,,,,"Community",,,"1","0.79",,"0.21","Mixed","accidents, community/school violence, illness/medical procedure, other (loss of loved one, undefined)","High","Brom D, Kleber RJ, Defares PB. Brief psychotherapy for posttraumatic stress disorders. J Consult Clin Psychol. 1989;57(5):607-12.  PMID: 2571625.","03090","2019"
"brom1989_IES_D_Baseline_NA","Mixed: Psychotherapy & CIH","PTSD","112","D","Control",,,,"Waitlist","Waitlist","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,"23","Self report","IES","IES",,,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","Baseline",,,"51.1","14.1",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.79",,"0.21","Mixed","accidents, community/school violence, illness/medical procedure, other (loss of loved one, undefined)","High","Brom D, Kleber RJ, Defares PB. Brief psychotherapy for posttraumatic stress disorders. J Consult Clin Psychol. 1989;57(5):607-12.  PMID: 2571625.","03090","2019"
"brom2017_CAPS_A_0_ITT","Complementary and integrative health (CIH)","PTSD","63","A","PTSD",,"28",,"Somatic Experiencing","Somatic Experiencing","No","Not Applicable","No","Not Applicable","Yes","Meditation","No","No","No","No","No","Individual","In Person","33","Structured Clinical Interview","CAPS","CAPS (Hebrew version)","ITT","Maximum likelihood imputation using unstructured covariance matrix","ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","End of Treatment","0",,"36.31","29.02",,,,,"-32.06",,,,,"Cohen's d","1.26",,,,"p=""significant""",,,,,,,,"Not meeting criteria for PTSD according to CAPS",,,,,,"Community",,,"1","0.507",,"0.493","Mixed","combat-related, accidents, illness/medical procedure, community/school violence terrorism/political violence/forced displacement, other (death or injury of family member, threat)","Medium","Brom D, Stokar Y, Lawi C, et al. Somatic experiencing for posttraumatic stress disorder: a randomized controlled outcome study. J Trauma Stress. 2017 Jun;30(3):304-12. doi: 10.1002/jts.22189. PMID: 28585761.","48274","2019"
"brom2017_CAPS_A_Baseline_ITT","Complementary and integrative health (CIH)","PTSD","63","A","PTSD",,"33",,"Somatic Experiencing","Somatic Experiencing","No","Not Applicable","No","Not Applicable","Yes","Meditation","No","No","No","No","No","Individual","In Person","33","Structured Clinical Interview","CAPS","CAPS (Hebrew version)","ITT","Maximum likelihood imputation using unstructured covariance matrix","ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","Baseline",,,"68.37","20.05",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.507",,"0.493","Mixed","combat-related, accidents, illness/medical procedure, community/school violence terrorism/political violence/forced displacement, other (death or injury of family member, threat)","Medium","Brom D, Stokar Y, Lawi C, et al. Somatic experiencing for posttraumatic stress disorder: a randomized controlled outcome study. J Trauma Stress. 2017 Jun;30(3):304-12. doi: 10.1002/jts.22189. PMID: 28585761.","48274","2019"
"brom2017_CAPS_B_0_ITT","Complementary and integrative health (CIH)","PTSD","63","B","Control",,"30",,"Waitlist","Waitlist","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,"30","Structured Clinical Interview","CAPS","CAPS (Hebrew version)","ITT","Maximum likelihood imputation using unstructured covariance matrix","ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","End of Treatment","0",,"58.62","29.58",,,,,"-9.31",,,,,"Cohen's d","0.38",,,,"p=NS",,,,,,,,"Not meeting criteria for PTSD according to CAPS",,,,,,"Community",,,"1","0.507",,"0.493","Mixed","combat-related, accidents, illness/medical procedure, community/school violence terrorism/political violence/forced displacement, other (death or injury of family member, threat)","Medium","Brom D, Stokar Y, Lawi C, et al. Somatic experiencing for posttraumatic stress disorder: a randomized controlled outcome study. J Trauma Stress. 2017 Jun;30(3):304-12. doi: 10.1002/jts.22189. PMID: 28585761.","48274","2019"
"brom2017_CAPS_B_Baseline_ITT","Complementary and integrative health (CIH)","PTSD","63","B","Control",,"30",,"Waitlist","Waitlist","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,"30","Structured Clinical Interview","CAPS","CAPS (Hebrew version)","ITT","Maximum likelihood imputation using unstructured covariance matrix","ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","Baseline",,,"67.93","20.43",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.507",,"0.493","Mixed","combat-related, accidents, illness/medical procedure, community/school violence terrorism/political violence/forced displacement, other (death or injury of family member, threat)","Medium","Brom D, Stokar Y, Lawi C, et al. Somatic experiencing for posttraumatic stress disorder: a randomized controlled outcome study. J Trauma Stress. 2017 Jun;30(3):304-12. doi: 10.1002/jts.22189. PMID: 28585761.","48274","2019"
"brom2017_PDS_A_0_NA","Complementary and integrative health (CIH)","PTSD","63","A","PTSD",,,,"Somatic Experiencing","Somatic Experiencing","No","Not Applicable","No","Not Applicable","Yes","Meditation","No","No","No","No","No","Individual","In Person","33","Self report","PDS","PDS (Hebrew version)",,,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","End of Treatment","0",,"21.36",,"SE","2.18",,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.507",,"0.493","Mixed","combat-related, accidents, illness/medical procedure, community/school violence terrorism/political violence/forced displacement, other (death or injury of family member, threat)","Medium","Brom D, Stokar Y, Lawi C, et al. Somatic experiencing for posttraumatic stress disorder: a randomized controlled outcome study. J Trauma Stress. 2017 Jun;30(3):304-12. doi: 10.1002/jts.22189. PMID: 28585761.","48274","2019"
"brom2017_PDS_A_Baseline_NA","Complementary and integrative health (CIH)","PTSD","63","A","PTSD",,,,"Somatic Experiencing","Somatic Experiencing","No","Not Applicable","No","Not Applicable","Yes","Meditation","No","No","No","No","No","Individual","In Person","33","Self report","PDS","PDS (Hebrew version)",,,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","Baseline",,,"34.13",,"SE","1.60",,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.507",,"0.493","Mixed","combat-related, accidents, illness/medical procedure, community/school violence terrorism/political violence/forced displacement, other (death or injury of family member, threat)","Medium","Brom D, Stokar Y, Lawi C, et al. Somatic experiencing for posttraumatic stress disorder: a randomized controlled outcome study. J Trauma Stress. 2017 Jun;30(3):304-12. doi: 10.1002/jts.22189. PMID: 28585761.","48274","2019"
"brom2017_PDS_B_0_NA","Complementary and integrative health (CIH)","PTSD","63","B","Control",,,,"Waitlist","Waitlist","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,"30","Self report","PDS","PDS (Hebrew version)",,,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","End of Treatment","0",,"32.50",,"SE","2.19",,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.507",,"0.493","Mixed","combat-related, accidents, illness/medical procedure, community/school violence terrorism/political violence/forced displacement, other (death or injury of family member, threat)","Medium","Brom D, Stokar Y, Lawi C, et al. Somatic experiencing for posttraumatic stress disorder: a randomized controlled outcome study. J Trauma Stress. 2017 Jun;30(3):304-12. doi: 10.1002/jts.22189. PMID: 28585761.","48274","2019"
"brom2017_PDS_B_Baseline_NA","Complementary and integrative health (CIH)","PTSD","63","B","Control",,,,"Waitlist","Waitlist","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,"30","Self report","PDS","PDS (Hebrew version)",,,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","Baseline",,,"34.08",,"SE","1.73",,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.507",,"0.493","Mixed","combat-related, accidents, illness/medical procedure, community/school violence terrorism/political violence/forced displacement, other (death or injury of family member, threat)","Medium","Brom D, Stokar Y, Lawi C, et al. Somatic experiencing for posttraumatic stress disorder: a randomized controlled outcome study. J Trauma Stress. 2017 Jun;30(3):304-12. doi: 10.1002/jts.22189. PMID: 28585761.","48274","2019"
"brunet2018_CAPS_A_0_Comp","Mixed: Psychotherapy & pharmacotherapy","PTSD","61","A","PTSD",,"15",,"Propranolol + traumatic memory reactivation","Propranolol + imaginal exposure (experimental paradigm)","Yes","TF","Yes","Antiadrenergic","No","Not Applicable","No","No","No","No","No","Individual","In Person","30","Structured Clinical Interview","CAPS","CAPS","Completer",,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","End of Treatment","0",,"48.00","26.88",,,,,"-26.87",,,,,"Cohen's d","1.64",,,,,,,,,,,,"Not meeting criteria for PTSD according to CAPS","0.407",,"Decrease of ≥10 on PCL-S",,,"Community",,,"1","0.5833",,"0.4167","Mixed","combat-related. rape/sexual assault, accidents, illness/medical procedure, community/school violence, other (war zone, captivity, life threat, sudden unexpected death, other trauma not specified)","Medium","Brunet A, Saumier D, Liu A, et al. Reduction of PTSD Symptoms with pre-reactivation propranolol therapy: a randomized controlled trial. Am J Psychiatry. 2018 May 1doi: 10.1176/appi.ajp.2017.17050481. PMID: 29325446.","49661","2019"
"brunet2018_CAPS_A_0_ITT","Mixed: Psychotherapy & pharmacotherapy","PTSD","61","A","PTSD",,"30",,"Propranolol + traumatic memory reactivation","Propranolol + imaginal exposure (experimental paradigm)","Yes","TF","Yes","Antiadrenergic","No","Not Applicable","No","No","No","No","No","Individual","In Person","30","Structured Clinical Interview","CAPS","CAPS","ITT","Imputation using Markov Chain Monte Carlo algorithm and LOCF for outcomes with large amounts of missing data (not pre-defined)","ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","End of Treatment","0",,"47.16","25.36",,,,,"-28.91",,,,,"Cohen's d","1.76",,,,,,,,,,,,"Not meeting criteria for PTSD according to CAPS",,,"Decrease of ≥10 on PCL-S","0.6333",,"Community",,,"1","0.5833",,"0.4167","Mixed","combat-related. rape/sexual assault, accidents, illness/medical procedure, community/school violence, other (war zone, captivity, life threat, sudden unexpected death, other trauma not specified)","Medium","Brunet A, Saumier D, Liu A, et al. Reduction of PTSD Symptoms with pre-reactivation propranolol therapy: a randomized controlled trial. Am J Psychiatry. 2018 May 1doi: 10.1176/appi.ajp.2017.17050481. PMID: 29325446.","49661","2019"
"brunet2018_CAPS_A_26_ITT","Mixed: Psychotherapy & pharmacotherapy","PTSD","61","A","PTSD",,"9",,"Propranolol + traumatic memory reactivation","Propranolol + imaginal exposure (experimental paradigm)","Yes","TF","Yes","Antiadrenergic","No","Not Applicable","No","No","No","No","No","Individual","In Person","30","Structured Clinical Interview","CAPS","CAPS","ITT","Imputation using Markov Chain Monte Carlo algorithm and LOCF for outcomes with large amounts of missing data (not pre-defined)","ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","Assessment at 6 to <12 Months","26",,"52.0",,,,,,"-24.07",,,,,,,,,,,,,,,,,,"Not meeting criteria for PTSD according to CAPS",,,"Decrease of ≥10 on PCL-S",,,"Community",,,"1","0.5833",,"0.4167","Mixed","combat-related. rape/sexual assault, accidents, illness/medical procedure, community/school violence, other (war zone, captivity, life threat, sudden unexpected death, other trauma not specified)","Medium","Brunet A, Saumier D, Liu A, et al. Reduction of PTSD Symptoms with pre-reactivation propranolol therapy: a randomized controlled trial. Am J Psychiatry. 2018 May 1doi: 10.1176/appi.ajp.2017.17050481. PMID: 29325446.","49661","2019"
"brunet2018_CAPS_A_Baseline_Comp","Mixed: Psychotherapy & pharmacotherapy","PTSD","61","A","PTSD",,"15",,"Propranolol + traumatic memory reactivation","Propranolol + imaginal exposure (experimental paradigm)","Yes","TF","Yes","Antiadrenergic","No","Not Applicable","No","No","No","No","No","Individual","In Person","30","Structured Clinical Interview","CAPS","CAPS","Completer",,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","Baseline",,,"74.87","16.92",,,,,,,,,,,,,,,,,,,,,,,"Not meeting criteria for PTSD according to CAPS",,,"Decrease of ≥10 on PCL-S",,,"Community",,,"1","0.5833",,"0.4167","Mixed","combat-related. rape/sexual assault, accidents, illness/medical procedure, community/school violence, other (war zone, captivity, life threat, sudden unexpected death, other trauma not specified)","Medium","Brunet A, Saumier D, Liu A, et al. Reduction of PTSD Symptoms with pre-reactivation propranolol therapy: a randomized controlled trial. Am J Psychiatry. 2018 May 1doi: 10.1176/appi.ajp.2017.17050481. PMID: 29325446.","49661","2019"
"brunet2018_CAPS_A_Baseline_ITT","Mixed: Psychotherapy & pharmacotherapy","PTSD","61","A","PTSD",,"30",,"Propranolol + traumatic memory reactivation","Propranolol + imaginal exposure (experimental paradigm)","Yes","TF","Yes","Antiadrenergic","No","Not Applicable","No","No","No","No","No","Individual","In Person","30","Structured Clinical Interview","CAPS","CAPS","ITT","Imputation using Markov Chain Monte Carlo algorithm and LOCF for outcomes with large amounts of missing data (not pre-defined)","ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","Baseline",,,"76.07","16.98",,,,,,,,,,,,,,,,,,,,,,,"Not meeting criteria for PTSD according to CAPS",,,"Decrease of ≥10 on PCL-S",,,"Community",,,"1","0.5833",,"0.4167","Mixed","combat-related. rape/sexual assault, accidents, illness/medical procedure, community/school violence, other (war zone, captivity, life threat, sudden unexpected death, other trauma not specified)","Medium","Brunet A, Saumier D, Liu A, et al. Reduction of PTSD Symptoms with pre-reactivation propranolol therapy: a randomized controlled trial. Am J Psychiatry. 2018 May 1doi: 10.1176/appi.ajp.2017.17050481. PMID: 29325446.","49661","2019"
"brunet2018_CAPS_B_0_Comp","Mixed: Psychotherapy & pharmacotherapy","PTSD","61","B","Control",,"15",,"Placebo + traumatic memory reactivation","Imaginal exposure (experimental paradigm) + placebo","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","31","Structured Clinical Interview","CAPS","CAPS","Completer",,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","End of Treatment","0",,"65.31","19.06",,,,,"-10.82",,,,,"Cohen's d","0.72",,,,,,,,,,,,"Not meeting criteria for PTSD according to CAPS","0.197",,"Decrease of ≥10 on PCL-S",,,"Community",,,"1","0.5833",,"0.4167","Mixed","combat-related. rape/sexual assault, accidents, illness/medical procedure, community/school violence, other (war zone, captivity, life threat, sudden unexpected death, other trauma not specified)","Medium","Brunet A, Saumier D, Liu A, et al. Reduction of PTSD Symptoms with pre-reactivation propranolol therapy: a randomized controlled trial. Am J Psychiatry. 2018 May 1doi: 10.1176/appi.ajp.2017.17050481. PMID: 29325446.","49661","2019"
"brunet2018_CAPS_B_0_ITT","Mixed: Psychotherapy & pharmacotherapy","PTSD","61","B","Control",,"30",,"Placebo + traumatic memory reactivation","Imaginal exposure (experimental paradigm) + placebo","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","31","Structured Clinical Interview","CAPS","CAPS","ITT","Imputation using Markov Chain Monte Carlo algorithm and LOCF for outcomes with large amounts of missing data (not pre-defined)","ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","End of Treatment","0",,"53.69","26.95",,,,,"-17.35",,,,,"Cohen's d","1.25",,,,,,,,,,,,"Not meeting criteria for PTSD according to CAPS",,,"Decrease of ≥10 on PCL-S","0.3333",,"Community",,,"1","0.5833",,"0.4167","Mixed","combat-related. rape/sexual assault, accidents, illness/medical procedure, community/school violence, other (war zone, captivity, life threat, sudden unexpected death, other trauma not specified)","Medium","Brunet A, Saumier D, Liu A, et al. Reduction of PTSD Symptoms with pre-reactivation propranolol therapy: a randomized controlled trial. Am J Psychiatry. 2018 May 1doi: 10.1176/appi.ajp.2017.17050481. PMID: 29325446.","49661","2019"
"brunet2018_CAPS_B_26_ITT","Mixed: Psychotherapy & pharmacotherapy","PTSD","61","B","Control",,"5",,"Placebo + traumatic memory reactivation","Imaginal exposure (experimental paradigm) + placebo","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","31","Structured Clinical Interview","CAPS","CAPS","ITT","Imputation using Markov Chain Monte Carlo algorithm and LOCF for outcomes with large amounts of missing data (not pre-defined)","ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","Assessment at 6 to <12 Months","26",,"69.2",,,,,,"-1.84",,,,,,,,,,,,,,,,,,"Not meeting criteria for PTSD according to CAPS",,,"Decrease of ≥10 on PCL-S",,,"Community",,,"1","0.5833",,"0.4167","Mixed","combat-related. rape/sexual assault, accidents, illness/medical procedure, community/school violence, other (war zone, captivity, life threat, sudden unexpected death, other trauma not specified)","Medium","Brunet A, Saumier D, Liu A, et al. Reduction of PTSD Symptoms with pre-reactivation propranolol therapy: a randomized controlled trial. Am J Psychiatry. 2018 May 1doi: 10.1176/appi.ajp.2017.17050481. PMID: 29325446.","49661","2019"
"brunet2018_CAPS_B_Baseline_Comp","Mixed: Psychotherapy & pharmacotherapy","PTSD","61","B","Control",,"15",,"Placebo + traumatic memory reactivation","Imaginal exposure (experimental paradigm) + placebo","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","31","Structured Clinical Interview","CAPS","CAPS","Completer",,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","Baseline",,,"76.13","12.86",,,,,,,,,,,,,,,,,,,,,,,"Not meeting criteria for PTSD according to CAPS",,,"Decrease of ≥10 on PCL-S",,,"Community",,,"1","0.5833",,"0.4167","Mixed","combat-related. rape/sexual assault, accidents, illness/medical procedure, community/school violence, other (war zone, captivity, life threat, sudden unexpected death, other trauma not specified)","Medium","Brunet A, Saumier D, Liu A, et al. Reduction of PTSD Symptoms with pre-reactivation propranolol therapy: a randomized controlled trial. Am J Psychiatry. 2018 May 1doi: 10.1176/appi.ajp.2017.17050481. PMID: 29325446.","49661","2019"
"brunet2018_CAPS_B_Baseline_ITT","Mixed: Psychotherapy & pharmacotherapy","PTSD","61","B","Control",,"30",,"Placebo + traumatic memory reactivation","Imaginal exposure (experimental paradigm) + placebo","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","31","Structured Clinical Interview","CAPS","CAPS","ITT","Imputation using Markov Chain Monte Carlo algorithm and LOCF for outcomes with large amounts of missing data (not pre-defined)","ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","Baseline",,,"71.04","14.68",,,,,,,,,,,,,,,,,,,,,,,"Not meeting criteria for PTSD according to CAPS",,,"Decrease of ≥10 on PCL-S",,,"Community",,,"1","0.5833",,"0.4167","Mixed","combat-related. rape/sexual assault, accidents, illness/medical procedure, community/school violence, other (war zone, captivity, life threat, sudden unexpected death, other trauma not specified)","Medium","Brunet A, Saumier D, Liu A, et al. Reduction of PTSD Symptoms with pre-reactivation propranolol therapy: a randomized controlled trial. Am J Psychiatry. 2018 May 1doi: 10.1176/appi.ajp.2017.17050481. PMID: 29325446.","49661","2019"
"brunet2018_PCL_A_0_Comp","Mixed: Psychotherapy & pharmacotherapy","PTSD","61","A","PTSD",,,,"Propranolol + traumatic memory reactivation","Propranolol + imaginal exposure (experimental paradigm)","Yes","TF","Yes","Antiadrenergic","No","Not Applicable","No","No","No","No","No","Individual","In Person","30","Self report","PCL","PCL-S","Completer",,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","End of Treatment","0",,"38.07","16.73",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.5833",,"0.4167","Mixed","combat-related. rape/sexual assault, accidents, illness/medical procedure, community/school violence, other (war zone, captivity, life threat, sudden unexpected death, other trauma not specified)","Medium","Brunet A, Saumier D, Liu A, et al. Reduction of PTSD Symptoms with pre-reactivation propranolol therapy: a randomized controlled trial. Am J Psychiatry. 2018 May 1doi: 10.1176/appi.ajp.2017.17050481. PMID: 29325446.","49661","2019"
"brunet2018_PCL_A_0_ITT","Mixed: Psychotherapy & pharmacotherapy","PTSD","61","A","PTSD",,,,"Propranolol + traumatic memory reactivation","Propranolol + imaginal exposure (experimental paradigm)","Yes","TF","Yes","Antiadrenergic","No","Not Applicable","No","No","No","No","No","Individual","In Person","30","Self report","PCL","PCL-S","ITT",,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","End of Treatment","0",,"36.60","18.46",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.5833",,"0.4167","Mixed","combat-related. rape/sexual assault, accidents, illness/medical procedure, community/school violence, other (war zone, captivity, life threat, sudden unexpected death, other trauma not specified)","Medium","Brunet A, Saumier D, Liu A, et al. Reduction of PTSD Symptoms with pre-reactivation propranolol therapy: a randomized controlled trial. Am J Psychiatry. 2018 May 1doi: 10.1176/appi.ajp.2017.17050481. PMID: 29325446.","49661","2019"
"brunet2018_PCL_A_26_ITT","Mixed: Psychotherapy & pharmacotherapy","PTSD","61","A","PTSD",,,,"Propranolol + traumatic memory reactivation","Propranolol + imaginal exposure (experimental paradigm)","Yes","TF","Yes","Antiadrenergic","No","Not Applicable","No","No","No","No","No","Individual","In Person","30","Self report","PCL","PCL-S","ITT",,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","Assessment at 6 to <12 Months","26",,"38.4",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.5833",,"0.4167","Mixed","combat-related. rape/sexual assault, accidents, illness/medical procedure, community/school violence, other (war zone, captivity, life threat, sudden unexpected death, other trauma not specified)","Medium","Brunet A, Saumier D, Liu A, et al. Reduction of PTSD Symptoms with pre-reactivation propranolol therapy: a randomized controlled trial. Am J Psychiatry. 2018 May 1doi: 10.1176/appi.ajp.2017.17050481. PMID: 29325446.","49661","2019"
"brunet2018_PCL_A_Baseline_Comp","Mixed: Psychotherapy & pharmacotherapy","PTSD","61","A","PTSD",,,,"Propranolol + traumatic memory reactivation","Propranolol + imaginal exposure (experimental paradigm)","Yes","TF","Yes","Antiadrenergic","No","Not Applicable","No","No","No","No","No","Individual","In Person","30","Self report","PCL","PCL-S","Completer",,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","Baseline",,,"61.73","7.94",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.5833",,"0.4167","Mixed","combat-related. rape/sexual assault, accidents, illness/medical procedure, community/school violence, other (war zone, captivity, life threat, sudden unexpected death, other trauma not specified)","Medium","Brunet A, Saumier D, Liu A, et al. Reduction of PTSD Symptoms with pre-reactivation propranolol therapy: a randomized controlled trial. Am J Psychiatry. 2018 May 1doi: 10.1176/appi.ajp.2017.17050481. PMID: 29325446.","49661","2019"
"brunet2018_PCL_A_Baseline_ITT","Mixed: Psychotherapy & pharmacotherapy","PTSD","61","A","PTSD",,,,"Propranolol + traumatic memory reactivation","Propranolol + imaginal exposure (experimental paradigm)","Yes","TF","Yes","Antiadrenergic","No","Not Applicable","No","No","No","No","No","Individual","In Person","30","Self report","PCL","PCL-S","ITT",,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","Baseline",,,"61.81","9.31",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.5833",,"0.4167","Mixed","combat-related. rape/sexual assault, accidents, illness/medical procedure, community/school violence, other (war zone, captivity, life threat, sudden unexpected death, other trauma not specified)","Medium","Brunet A, Saumier D, Liu A, et al. Reduction of PTSD Symptoms with pre-reactivation propranolol therapy: a randomized controlled trial. Am J Psychiatry. 2018 May 1doi: 10.1176/appi.ajp.2017.17050481. PMID: 29325446.","49661","2019"
"brunet2018_PCL_B_0_Comp","Mixed: Psychotherapy & pharmacotherapy","PTSD","61","B","Control",,,,"Placebo + traumatic memory reactivation","Imaginal exposure (experimental paradigm) + placebo","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","31","Self report","PCL","PCL-S","Completer",,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","End of Treatment","0",,"55.71","13.79",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.5833",,"0.4167","Mixed","combat-related. rape/sexual assault, accidents, illness/medical procedure, community/school violence, other (war zone, captivity, life threat, sudden unexpected death, other trauma not specified)","Medium","Brunet A, Saumier D, Liu A, et al. Reduction of PTSD Symptoms with pre-reactivation propranolol therapy: a randomized controlled trial. Am J Psychiatry. 2018 May 1doi: 10.1176/appi.ajp.2017.17050481. PMID: 29325446.","49661","2019"
"brunet2018_PCL_B_0_ITT","Mixed: Psychotherapy & pharmacotherapy","PTSD","61","B","Control",,,,"Placebo + traumatic memory reactivation","Imaginal exposure (experimental paradigm) + placebo","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","31","Self report","PCL","PCL-S","ITT",,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","End of Treatment","0",,"51.20","18.62",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.5833",,"0.4167","Mixed","combat-related. rape/sexual assault, accidents, illness/medical procedure, community/school violence, other (war zone, captivity, life threat, sudden unexpected death, other trauma not specified)","Medium","Brunet A, Saumier D, Liu A, et al. Reduction of PTSD Symptoms with pre-reactivation propranolol therapy: a randomized controlled trial. Am J Psychiatry. 2018 May 1doi: 10.1176/appi.ajp.2017.17050481. PMID: 29325446.","49661","2019"
"brunet2018_PCL_B_26_ITT","Mixed: Psychotherapy & pharmacotherapy","PTSD","61","B","Control",,,,"Placebo + traumatic memory reactivation","Imaginal exposure (experimental paradigm) + placebo","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","31","Self report","PCL","PCL-S","ITT",,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","Assessment at 6 to <12 Months","26",,"69.0",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.5833",,"0.4167","Mixed","combat-related. rape/sexual assault, accidents, illness/medical procedure, community/school violence, other (war zone, captivity, life threat, sudden unexpected death, other trauma not specified)","Medium","Brunet A, Saumier D, Liu A, et al. Reduction of PTSD Symptoms with pre-reactivation propranolol therapy: a randomized controlled trial. Am J Psychiatry. 2018 May 1doi: 10.1176/appi.ajp.2017.17050481. PMID: 29325446.","49661","2019"
"brunet2018_PCL_B_Baseline_Comp","Mixed: Psychotherapy & pharmacotherapy","PTSD","61","B","Control",,,,"Placebo + traumatic memory reactivation","Imaginal exposure (experimental paradigm) + placebo","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","31","Self report","PCL","PCL-S","Completer",,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","Baseline",,,"61.27","8.79",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.5833",,"0.4167","Mixed","combat-related. rape/sexual assault, accidents, illness/medical procedure, community/school violence, other (war zone, captivity, life threat, sudden unexpected death, other trauma not specified)","Medium","Brunet A, Saumier D, Liu A, et al. Reduction of PTSD Symptoms with pre-reactivation propranolol therapy: a randomized controlled trial. Am J Psychiatry. 2018 May 1doi: 10.1176/appi.ajp.2017.17050481. PMID: 29325446.","49661","2019"
"brunet2018_PCL_B_Baseline_ITT","Mixed: Psychotherapy & pharmacotherapy","PTSD","61","B","Control",,,,"Placebo + traumatic memory reactivation","Imaginal exposure (experimental paradigm) + placebo","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","31","Self report","PCL","PCL-S","ITT",,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","Baseline",,,"56.96","11.83",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.5833",,"0.4167","Mixed","combat-related. rape/sexual assault, accidents, illness/medical procedure, community/school violence, other (war zone, captivity, life threat, sudden unexpected death, other trauma not specified)","Medium","Brunet A, Saumier D, Liu A, et al. Reduction of PTSD Symptoms with pre-reactivation propranolol therapy: a randomized controlled trial. Am J Psychiatry. 2018 May 1doi: 10.1176/appi.ajp.2017.17050481. PMID: 29325446.","49661","2019"
"bryant2003_CAPS_A_0_Comp","Psychotherapy","PTSD","58","A","PTSD",,"15",,"Prolonged Imaginal Exposure with Cognitive Restructuring","Trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","20","Structured Clinical Interview","CAPS","CAPS intensity","Completer",,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","End of Treatment","0",,"10.33","9.75",,,,,"-22.4",,,,,"Hedges' g","2.47",,,,,,,,,,,,"Not meeting criteria for PTSD according to CAPS-2","0.87",,"CAPS intensity score plus CAPS frequency score <19 and BDI-2 score <10",,,"Community",,,"1","0.52",,"0.48","Mixed","accidents, community/school violence","Medium","Bryant RA, Moulds ML, Guthrie RM, et al. Imaginal exposure alone and imaginal exposure with cognitive restructuring in treatment of posttraumatic stress disorder. J Consult Clin Psychol. 2003 Aug;71(4):706.  PMID: 12924676.","25807","2019"
"bryant2003_CAPS_A_0_ITT","Psychotherapy","PTSD","58","A","PTSD",,"20",,"Prolonged Imaginal Exposure with Cognitive Restructuring","Trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","20","Structured Clinical Interview","CAPS","CAPS intensity","ITT","LOCF","ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","End of Treatment","0",,"15.9","13.36",,,,,"-16.8",,,,,"Hedges' g","1.58",,,,,,,,,,,,"Not meeting criteria for PTSD according to CAPS-2","0.65",,"CAPS intensity score plus CAPS frequency score <19 and BDI-2 score <10",,,"Community",,,"1","0.52",,"0.48","Mixed","accidents, community/school violence","Medium","Bryant RA, Moulds ML, Guthrie RM, et al. Imaginal exposure alone and imaginal exposure with cognitive restructuring in treatment of posttraumatic stress disorder. J Consult Clin Psychol. 2003 Aug;71(4):706.  PMID: 12924676.","25807","2019"
"bryant2003_CAPS_A_26_Comp","Psychotherapy","PTSD","58","A","PTSD",,"15",,"Prolonged Imaginal Exposure with Cognitive Restructuring","Trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","20","Structured Clinical Interview","CAPS","CAPS intensity","Completer",,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","Assessment at 6 to <12 Months","26",,"8.53","10.25",,,,,"-24.2",,,,,"Hedges' g","2.6",,,,,,,,,,,,"Not meeting criteria for PTSD according to CAPS-2","0.8",,"CAPS intensity score plus CAPS frequency score <19 and BDI-2 score <10","0.6",,"Community",,,"1","0.52",,"0.48","Mixed","accidents, community/school violence","Medium","Bryant RA, Moulds ML, Guthrie RM, et al. Imaginal exposure alone and imaginal exposure with cognitive restructuring in treatment of posttraumatic stress disorder. J Consult Clin Psychol. 2003 Aug;71(4):706.  PMID: 12924676.","25807","2019"
"bryant2003_CAPS_A_26_ITT","Psychotherapy","PTSD","58","A","PTSD",,"20",,"Prolonged Imaginal Exposure with Cognitive Restructuring","Trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","20","Structured Clinical Interview","CAPS","CAPS intensity","ITT","LOCF","ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","Assessment at 6 to <12 Months","26",,"15.7","14.79",,,,,"-17",,,,,"Hedges' g","1.49",,,,,,,,,,,,"Not meeting criteria for PTSD according to CAPS-2","0.6",,"CAPS intensity score plus CAPS frequency score <19 and BDI-2 score <10","0.4",,"Community",,,"1","0.52",,"0.48","Mixed","accidents, community/school violence","Medium","Bryant RA, Moulds ML, Guthrie RM, et al. Imaginal exposure alone and imaginal exposure with cognitive restructuring in treatment of posttraumatic stress disorder. J Consult Clin Psychol. 2003 Aug;71(4):706.  PMID: 12924676.","25807","2019"
"bryant2003_CAPS_A_Baseline_Comp","Psychotherapy","PTSD","58","A","PTSD",,"15",,"Prolonged Imaginal Exposure with Cognitive Restructuring","Trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","20","Structured Clinical Interview","CAPS","CAPS intensity","Completer",,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","Baseline",,,"32.73","7.88",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.52",,"0.48","Mixed","accidents, community/school violence","Medium","Bryant RA, Moulds ML, Guthrie RM, et al. Imaginal exposure alone and imaginal exposure with cognitive restructuring in treatment of posttraumatic stress disorder. J Consult Clin Psychol. 2003 Aug;71(4):706.  PMID: 12924676.","25807","2019"
"bryant2003_CAPS_A_Baseline_ITT","Psychotherapy","PTSD","58","A","PTSD",,"20",,"Prolonged Imaginal Exposure with Cognitive Restructuring","Trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","20","Structured Clinical Interview","CAPS","CAPS intensity","ITT","LOCF","ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","Baseline",,,"32.70","7.51",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.52",,"0.48","Mixed","accidents, community/school violence","Medium","Bryant RA, Moulds ML, Guthrie RM, et al. Imaginal exposure alone and imaginal exposure with cognitive restructuring in treatment of posttraumatic stress disorder. J Consult Clin Psychol. 2003 Aug;71(4):706.  PMID: 12924676.","25807","2019"
"bryant2003_CAPS_B_0_Comp","Psychotherapy","PTSD","58","B","PTSD",,"15",,"Imaginal Exposure","Imaginal exposure","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","20","Structured Clinical Interview","CAPS","CAPS intensity","Completer",,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","End of Treatment","0",,"14","7.96",,,,,"-16.07",,,,,"Hedges' g","1.96",,,,,,,,,,,,"Not meeting criteria for PTSD according to CAPS-2","0.67",,"CAPS intensity score plus CAPS frequency score <19 and BDI-2 score <10",,,"Community",,,"1","0.52",,"0.48","Mixed","accidents, community/school violence","Medium","Bryant RA, Moulds ML, Guthrie RM, et al. Imaginal exposure alone and imaginal exposure with cognitive restructuring in treatment of posttraumatic stress disorder. J Consult Clin Psychol. 2003 Aug;71(4):706.  PMID: 12924676.","25807","2019"
"bryant2003_CAPS_B_0_ITT","Psychotherapy","PTSD","58","B","PTSD",,"20",,"Imaginal Exposure","Imaginal exposure","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","20","Structured Clinical Interview","CAPS","CAPS intensity","ITT","LOCF","ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","End of Treatment","0",,"19.15","11.12",,,,,"-13.35",,,,,"Hedges' g","1.25",,,,,,,,,,,,"Not meeting criteria for PTSD according to CAPS-2","0.5",,"CAPS intensity score plus CAPS frequency score <19 and BDI-2 score <10",,,"Community",,,"1","0.52",,"0.48","Mixed","accidents, community/school violence","Medium","Bryant RA, Moulds ML, Guthrie RM, et al. Imaginal exposure alone and imaginal exposure with cognitive restructuring in treatment of posttraumatic stress disorder. J Consult Clin Psychol. 2003 Aug;71(4):706.  PMID: 12924676.","25807","2019"
"bryant2003_CAPS_B_26_Comp","Psychotherapy","PTSD","58","B","PTSD",,"15",,"Imaginal Exposure","Imaginal exposure","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","20","Structured Clinical Interview","CAPS","CAPS intensity","Completer",,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","Assessment at 6 to <12 Months","26",,"16.67","10.49",,,,,"-14",,,,,"Hedges' g","1.5",,,,,,,,,,,,"Not meeting criteria for PTSD according to CAPS-2","0.67",,"CAPS intensity score plus CAPS frequency score <19 and BDI-2 score <10","0.2",,"Community",,,"1","0.52",,"0.48","Mixed","accidents, community/school violence","Medium","Bryant RA, Moulds ML, Guthrie RM, et al. Imaginal exposure alone and imaginal exposure with cognitive restructuring in treatment of posttraumatic stress disorder. J Consult Clin Psychol. 2003 Aug;71(4):706.  PMID: 12924676.","25807","2019"
"bryant2003_CAPS_B_26_ITT","Psychotherapy","PTSD","58","B","PTSD",,"20",,"Imaginal Exposure","Imaginal exposure","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","20","Structured Clinical Interview","CAPS","CAPS intensity","ITT","LOCF","ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","Assessment at 6 to <12 Months","26",,"20.7","12",,,,,"-11.8",,,,,"Hedges' g","1.05",,,,,,,,,,,,"Not meeting criteria for PTSD according to CAPS-2","0.5",,"CAPS intensity score plus CAPS frequency score <19 and BDI-2 score <10","0.15",,"Community",,,"1","0.52",,"0.48","Mixed","accidents, community/school violence","Medium","Bryant RA, Moulds ML, Guthrie RM, et al. Imaginal exposure alone and imaginal exposure with cognitive restructuring in treatment of posttraumatic stress disorder. J Consult Clin Psychol. 2003 Aug;71(4):706.  PMID: 12924676.","25807","2019"
"bryant2003_CAPS_B_Baseline_Comp","Psychotherapy","PTSD","58","B","PTSD",,"15",,"Imaginal Exposure","Imaginal exposure","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","20","Structured Clinical Interview","CAPS","CAPS intensity","Completer",,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","Baseline",,,"30.67","7.94",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.52",,"0.48","Mixed","accidents, community/school violence","Medium","Bryant RA, Moulds ML, Guthrie RM, et al. Imaginal exposure alone and imaginal exposure with cognitive restructuring in treatment of posttraumatic stress disorder. J Consult Clin Psychol. 2003 Aug;71(4):706.  PMID: 12924676.","25807","2019"
"bryant2003_CAPS_B_Baseline_ITT","Psychotherapy","PTSD","58","B","PTSD",,"20",,"Imaginal Exposure","Imaginal exposure","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","20","Structured Clinical Interview","CAPS","CAPS intensity","ITT","LOCF","ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","Baseline",,,"32.5","8.71",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.52",,"0.48","Mixed","accidents, community/school violence","Medium","Bryant RA, Moulds ML, Guthrie RM, et al. Imaginal exposure alone and imaginal exposure with cognitive restructuring in treatment of posttraumatic stress disorder. J Consult Clin Psychol. 2003 Aug;71(4):706.  PMID: 12924676.","25807","2019"
"bryant2003_CAPS_C_0_Comp","Psychotherapy","PTSD","58","C","PTSD",,"15",,"Supportive Counseling","Supportive counseling","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","18","Structured Clinical Interview","CAPS","CAPS intensity","Completer",,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","End of Treatment","0",,"23.73","12.94",,,,,"-8.14",,,,,"Hedges' g","0.77",,,,,,,,,,,,"Not meeting criteria for PTSD according to CAPS-2","0.4",,"CAPS intensity score plus CAPS frequency score <19 and BDI-2 score <10",,,"Community",,,"1","0.52",,"0.48","Mixed","accidents, community/school violence","Medium","Bryant RA, Moulds ML, Guthrie RM, et al. Imaginal exposure alone and imaginal exposure with cognitive restructuring in treatment of posttraumatic stress disorder. J Consult Clin Psychol. 2003 Aug;71(4):706.  PMID: 12924676.","25807","2019"
"bryant2003_CAPS_C_0_ITT","Psychotherapy","PTSD","58","C","PTSD",,"18",,"Supportive Counseling","Supportive counseling","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","18","Structured Clinical Interview","CAPS","CAPS intensity","ITT","LOCF","ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","End of Treatment","0",,"28","15.31",,,,,"-4.83",,,,,"Hedges' g","0.41",,,,,,,,,,,,"Not meeting criteria for PTSD according to CAPS-2","0.33",,"CAPS intensity score plus CAPS frequency score <19 and BDI-2 score <10",,,"Community",,,"1","0.52",,"0.48","Mixed","accidents, community/school violence","Medium","Bryant RA, Moulds ML, Guthrie RM, et al. Imaginal exposure alone and imaginal exposure with cognitive restructuring in treatment of posttraumatic stress disorder. J Consult Clin Psychol. 2003 Aug;71(4):706.  PMID: 12924676.","25807","2019"
"bryant2003_CAPS_C_26_Comp","Psychotherapy","PTSD","58","C","PTSD",,"15",,"Supportive Counseling","Supportive counseling","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","18","Structured Clinical Interview","CAPS","CAPS intensity","Completer",,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","Assessment at 6 to <12 Months","26",,"26.4","10.24",,,,,"-5.47",,,,,"Hedges' g","0.6",,,,,,,,,,,,"Not meeting criteria for PTSD according to CAPS-2","0.27",,"CAPS intensity score plus CAPS frequency score <19 and BDI-2 score <10","0",,"Community",,,"1","0.52",,"0.48","Mixed","accidents, community/school violence","Medium","Bryant RA, Moulds ML, Guthrie RM, et al. Imaginal exposure alone and imaginal exposure with cognitive restructuring in treatment of posttraumatic stress disorder. J Consult Clin Psychol. 2003 Aug;71(4):706.  PMID: 12924676.","25807","2019"
"bryant2003_CAPS_C_26_ITT","Psychotherapy","PTSD","58","C","PTSD",,"18",,"Supportive Counseling","Supportive counseling","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","18","Structured Clinical Interview","CAPS","CAPS intensity","ITT","LOCF","ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","Assessment at 6 to <12 Months","26",,"30.28","12.89",,,,,"-2.55",,,,,"Hedges' g","0.24",,,,,,,,,,,,"Not meeting criteria for PTSD according to CAPS-2","0.22",,"CAPS intensity score plus CAPS frequency score <19 and BDI-2 score <10","0",,"Community",,,"1","0.52",,"0.48","Mixed","accidents, community/school violence","Medium","Bryant RA, Moulds ML, Guthrie RM, et al. Imaginal exposure alone and imaginal exposure with cognitive restructuring in treatment of posttraumatic stress disorder. J Consult Clin Psychol. 2003 Aug;71(4):706.  PMID: 12924676.","25807","2019"
"bryant2003_CAPS_C_Baseline_Comp","Psychotherapy","PTSD","58","C","PTSD",,"15",,"Supportive Counseling","Supportive counseling","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","18","Structured Clinical Interview","CAPS","CAPS intensity","Completer",,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","Baseline",,,"31.87","7.49",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.52",,"0.48","Mixed","accidents, community/school violence","Medium","Bryant RA, Moulds ML, Guthrie RM, et al. Imaginal exposure alone and imaginal exposure with cognitive restructuring in treatment of posttraumatic stress disorder. J Consult Clin Psychol. 2003 Aug;71(4):706.  PMID: 12924676.","25807","2019"
"bryant2003_CAPS_C_Baseline_ITT","Psychotherapy","PTSD","58","C","PTSD",,"18",,"Supportive Counseling","Supportive counseling","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","18","Structured Clinical Interview","CAPS","CAPS intensity","ITT","LOCF","ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","Baseline",,,"32.83","8.01",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.52",,"0.48","Mixed","accidents, community/school violence","Medium","Bryant RA, Moulds ML, Guthrie RM, et al. Imaginal exposure alone and imaginal exposure with cognitive restructuring in treatment of posttraumatic stress disorder. J Consult Clin Psychol. 2003 Aug;71(4):706.  PMID: 12924676.","25807","2019"
"bryant2008_CAPS_A_0_Comp","Psychotherapy","PTSD","118","A","PTSD",,"21",,"Imaginal Exposure","Imaginal exposure","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","31","Structured Clinical Interview","CAPS","CAPS","Completer",,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","End of Treatment","0",,"59.94","32.36",,,,"difference from the ITT Baseline","-27.94",,,,,,,,,,,,,,,,,,"CAPS <19","0.48",,"CAPS <19 and BDI <10",,"Additional definitions of Clinically Meaningful Response reported in the study","Community",,,"1",,,,"Mixed","accidents, community/school violence","Medium","Bryant RA, Moulds ML, Guthrie RM, et al. A randomized controlled trial of exposure therapy and cognitive restructuring for posttraumatic stress disorder. J Consult Clin Psychol. 2008 Aug;76(4):695-703. doi: 10.1037/a0012616. PMID: 18665697.","31196","2019"
"bryant2008_CAPS_A_0_ITT","Psychotherapy","PTSD","118","A","PTSD",,"23",,"Imaginal Exposure","Imaginal exposure","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","31","Structured Clinical Interview","CAPS","CAPS","ITT","LOCF","ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","End of Treatment","0",,"55.5","33.83",,,,,"-17.79",,,,,,,,,,,,,,,,,,"CAPS <19","0.37",,"CAPS <19 and BDI <10",,"Additional definitions of Clinically Meaningful Response reported in the study","Community",,,"1",,,,"Mixed","accidents, community/school violence","Medium","Bryant RA, Moulds ML, Guthrie RM, et al. A randomized controlled trial of exposure therapy and cognitive restructuring for posttraumatic stress disorder. J Consult Clin Psychol. 2008 Aug;76(4):695-703. doi: 10.1037/a0012616. PMID: 18665697.","31196","2019"
"bryant2008_CAPS_A_26_Comp","Psychotherapy","PTSD","118","A","PTSD",,"21",,"Imaginal Exposure","Imaginal exposure","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","31","Structured Clinical Interview","CAPS","CAPS","Completer",,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","Assessment at 6 to <12 Months","26",,"46.81","29.1",,,,"difference from the ITT Baseline","-26.48",,,,,,,,,,,,,,,,,,"CAPS <19","0.57",,"CAPS <19 and BDI <10","0.14","Additional definitions of Clinically Meaningful Response reported in the study","Community",,,"1",,,,"Mixed","accidents, community/school violence","Medium","Bryant RA, Moulds ML, Guthrie RM, et al. A randomized controlled trial of exposure therapy and cognitive restructuring for posttraumatic stress disorder. J Consult Clin Psychol. 2008 Aug;76(4):695-703. doi: 10.1037/a0012616. PMID: 18665697.","31196","2019"
"bryant2008_CAPS_A_26_ITT","Psychotherapy","PTSD","118","A","PTSD",,"21",,"Imaginal Exposure","Imaginal exposure","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","31","Structured Clinical Interview","CAPS","CAPS","ITT","LOCF","ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","Assessment at 6 to <12 Months","26",,"59.95","32.36",,,,,"-13.35",,,,,,,,,,,,,,,,,,"CAPS <19","0.25",,"CAPS <19 and BDI <10","0.1","Additional definitions of Clinically Meaningful Response reported in the study","Community",,,"1",,,,"Mixed","accidents, community/school violence","Medium","Bryant RA, Moulds ML, Guthrie RM, et al. A randomized controlled trial of exposure therapy and cognitive restructuring for posttraumatic stress disorder. J Consult Clin Psychol. 2008 Aug;76(4):695-703. doi: 10.1037/a0012616. PMID: 18665697.","31196","2019"
"bryant2008_CAPS_A_Baseline_Comp","Psychotherapy","PTSD","118","A","PTSD",,"21",,"Imaginal Exposure","Imaginal exposure","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","31","Structured Clinical Interview","CAPS","CAPS","Completer",,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","Baseline",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1",,,,"Mixed","accidents, community/school violence","Medium","Bryant RA, Moulds ML, Guthrie RM, et al. A randomized controlled trial of exposure therapy and cognitive restructuring for posttraumatic stress disorder. J Consult Clin Psychol. 2008 Aug;76(4):695-703. doi: 10.1037/a0012616. PMID: 18665697.","31196","2019"
"bryant2008_CAPS_A_Baseline_ITT","Psychotherapy","PTSD","118","A","PTSD",,"31",,"Imaginal Exposure","Imaginal exposure","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","31","Structured Clinical Interview","CAPS","CAPS","ITT","LOCF","ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","Baseline",,,"73.29","18.82",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1",,,,"Mixed","accidents, community/school violence","Medium","Bryant RA, Moulds ML, Guthrie RM, et al. A randomized controlled trial of exposure therapy and cognitive restructuring for posttraumatic stress disorder. J Consult Clin Psychol. 2008 Aug;76(4):695-703. doi: 10.1037/a0012616. PMID: 18665697.","31196","2019"
"bryant2008_CAPS_B_0_Comp","Psychotherapy","PTSD","118","B","PTSD",,"22",,"In vivo exposure","In vivo exposure","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","28","Structured Clinical Interview","CAPS","CAPS","Completer",,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","End of Treatment","0",,"49.55","23.28",,,,"difference from the ITT Baseline","-27.24",,,,,,,,,,,,,,,,,,"CAPS <19","0.45",,"CAPS <19 and BDI <10",,"Additional definitions of Clinically Meaningful Response reported in the study","Community",,,"1",,,,"Mixed","accidents, community/school violence","Medium","Bryant RA, Moulds ML, Guthrie RM, et al. A randomized controlled trial of exposure therapy and cognitive restructuring for posttraumatic stress disorder. J Consult Clin Psychol. 2008 Aug;76(4):695-703. doi: 10.1037/a0012616. PMID: 18665697.","31196","2019"
"bryant2008_CAPS_B_0_ITT","Psychotherapy","PTSD","118","B","PTSD",,"22",,"In vivo exposure","In vivo exposure","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","28","Structured Clinical Interview","CAPS","CAPS","ITT","LOCF","ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","End of Treatment","0",,"55.96","24.56",,,,,"-20.83",,,,,,,,,,,,,,,,,,"CAPS <19","0.35",,"CAPS <19 and BDI <10",,"Additional definitions of Clinically Meaningful Response reported in the study","Community",,,"1",,,,"Mixed","accidents, community/school violence","Medium","Bryant RA, Moulds ML, Guthrie RM, et al. A randomized controlled trial of exposure therapy and cognitive restructuring for posttraumatic stress disorder. J Consult Clin Psychol. 2008 Aug;76(4):695-703. doi: 10.1037/a0012616. PMID: 18665697.","31196","2019"
"bryant2008_CAPS_B_26_Comp","Psychotherapy","PTSD","118","B","PTSD",,"21",,"In vivo exposure","In vivo exposure","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","28","Structured Clinical Interview","CAPS","CAPS","Completer",,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","Assessment at 6 to <12 Months","26",,"52.53","30.92",,,,"difference from the ITT Baseline","-24.26",,,,,,,,,,,,,,,,,,"CAPS <19","0.38",,"CAPS <19 and BDI <10","0.24","Additional definitions of Clinically Meaningful Response reported in the study","Community",,,"1",,,,"Mixed","accidents, community/school violence","Medium","Bryant RA, Moulds ML, Guthrie RM, et al. A randomized controlled trial of exposure therapy and cognitive restructuring for posttraumatic stress disorder. J Consult Clin Psychol. 2008 Aug;76(4):695-703. doi: 10.1037/a0012616. PMID: 18665697.","31196","2019"
"bryant2008_CAPS_B_26_ITT","Psychotherapy","PTSD","118","B","PTSD",,"21",,"In vivo exposure","In vivo exposure","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","28","Structured Clinical Interview","CAPS","CAPS","ITT","LOCF","ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","Assessment at 6 to <12 Months","26",,"59.32","29.62",,,,,"-17.47",,,,,,,,,,,,,,,,,,"CAPS <19","0.31",,"CAPS <19 and BDI <10","0.18","Additional definitions of Clinically Meaningful Response reported in the study","Community",,,"1",,,,"Mixed","accidents, community/school violence","Medium","Bryant RA, Moulds ML, Guthrie RM, et al. A randomized controlled trial of exposure therapy and cognitive restructuring for posttraumatic stress disorder. J Consult Clin Psychol. 2008 Aug;76(4):695-703. doi: 10.1037/a0012616. PMID: 18665697.","31196","2019"
"bryant2008_CAPS_B_Baseline_Comp","Psychotherapy","PTSD","118","B","PTSD",,"22",,"In vivo exposure","In vivo exposure","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","28","Structured Clinical Interview","CAPS","CAPS","Completer",,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","Baseline",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1",,,,"Mixed","accidents, community/school violence","Medium","Bryant RA, Moulds ML, Guthrie RM, et al. A randomized controlled trial of exposure therapy and cognitive restructuring for posttraumatic stress disorder. J Consult Clin Psychol. 2008 Aug;76(4):695-703. doi: 10.1037/a0012616. PMID: 18665697.","31196","2019"
"bryant2008_CAPS_B_Baseline_ITT","Psychotherapy","PTSD","118","B","PTSD",,"28",,"In vivo exposure","In vivo exposure","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","28","Structured Clinical Interview","CAPS","CAPS","ITT","LOCF","ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","Baseline",,,"76.79","15.53",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1",,,,"Mixed","accidents, community/school violence","Medium","Bryant RA, Moulds ML, Guthrie RM, et al. A randomized controlled trial of exposure therapy and cognitive restructuring for posttraumatic stress disorder. J Consult Clin Psychol. 2008 Aug;76(4):695-703. doi: 10.1037/a0012616. PMID: 18665697.","31196","2019"
"bryant2008_CAPS_C_0_Comp","Psychotherapy","PTSD","118","C","PTSD",,"21",,"Imaginal exposure + In vivo exposure","Trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","31","Structured Clinical Interview","CAPS","CAPS","Completer",,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","End of Treatment","0",,"36.95","30.57",,,,"difference from the ITT Baseline","-39.11",,,,,,,,,,,,,,,,,,"CAPS <19","0.52",,"CAPS <19 and BDI <10",,"Additional definitions of Clinically Meaningful Response reported in the study","Community",,,"1",,,,"Mixed","accidents, community/school violence","Medium","Bryant RA, Moulds ML, Guthrie RM, et al. A randomized controlled trial of exposure therapy and cognitive restructuring for posttraumatic stress disorder. J Consult Clin Psychol. 2008 Aug;76(4):695-703. doi: 10.1037/a0012616. PMID: 18665697.","31196","2019"
"bryant2008_CAPS_C_0_ITT","Psychotherapy","PTSD","118","C","PTSD",,"21",,"Imaginal exposure + In vivo exposure","Trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","31","Structured Clinical Interview","CAPS","CAPS","ITT","LOCF","ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","End of Treatment","0",,"55.39","37.45",,,,,"-20.67",,,,,,,,,,,,,,,,,,"CAPS <19","0.41",,"CAPS <19 and BDI <10",,"Additional definitions of Clinically Meaningful Response reported in the study","Community",,,"1",,,,"Mixed","accidents, community/school violence","Medium","Bryant RA, Moulds ML, Guthrie RM, et al. A randomized controlled trial of exposure therapy and cognitive restructuring for posttraumatic stress disorder. J Consult Clin Psychol. 2008 Aug;76(4):695-703. doi: 10.1037/a0012616. PMID: 18665697.","31196","2019"
"bryant2008_CAPS_C_26_Comp","Psychotherapy","PTSD","118","C","PTSD",,"21",,"Imaginal exposure + In vivo exposure","Trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","31","Structured Clinical Interview","CAPS","CAPS","Completer",,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","Assessment at 6 to <12 Months","26",,"38.43","28.6",,,,"difference from the ITT Baseline","-37.63",,,,,,,,,,,,,,,,,,"CAPS <19","0.57",,"CAPS <19 and BDI <10","0.24","Additional definitions of Clinically Meaningful Response reported in the study","Community",,,"1",,,,"Mixed","accidents, community/school violence","Medium","Bryant RA, Moulds ML, Guthrie RM, et al. A randomized controlled trial of exposure therapy and cognitive restructuring for posttraumatic stress disorder. J Consult Clin Psychol. 2008 Aug;76(4):695-703. doi: 10.1037/a0012616. PMID: 18665697.","31196","2019"
"bryant2008_CAPS_C_26_ITT","Psychotherapy","PTSD","118","C","PTSD",,"21",,"Imaginal exposure + In vivo exposure","Trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","31","Structured Clinical Interview","CAPS","CAPS","ITT","LOCF","ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","Assessment at 6 to <12 Months","26",,"56.39","35.87",,,,,"-19.67",,,,,,,,,,,,,,,,,,"CAPS <19","0.37",,"CAPS <19 and BDI <10","0.16","Additional definitions of Clinically Meaningful Response reported in the study","Community",,,"1",,,,"Mixed","accidents, community/school violence","Medium","Bryant RA, Moulds ML, Guthrie RM, et al. A randomized controlled trial of exposure therapy and cognitive restructuring for posttraumatic stress disorder. J Consult Clin Psychol. 2008 Aug;76(4):695-703. doi: 10.1037/a0012616. PMID: 18665697.","31196","2019"
"bryant2008_CAPS_C_Baseline_Comp","Psychotherapy","PTSD","118","C","PTSD",,"21",,"Imaginal exposure + In vivo exposure","Trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","31","Structured Clinical Interview","CAPS","CAPS","Completer",,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","Baseline",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1",,,,"Mixed","accidents, community/school violence","Medium","Bryant RA, Moulds ML, Guthrie RM, et al. A randomized controlled trial of exposure therapy and cognitive restructuring for posttraumatic stress disorder. J Consult Clin Psychol. 2008 Aug;76(4):695-703. doi: 10.1037/a0012616. PMID: 18665697.","31196","2019"
"bryant2008_CAPS_C_Baseline_ITT","Psychotherapy","PTSD","118","C","PTSD",,"31",,"Imaginal exposure + In vivo exposure","Trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","31","Structured Clinical Interview","CAPS","CAPS","ITT","LOCF","ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","Baseline",,,"76.06","19.19",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1",,,,"Mixed","accidents, community/school violence","Medium","Bryant RA, Moulds ML, Guthrie RM, et al. A randomized controlled trial of exposure therapy and cognitive restructuring for posttraumatic stress disorder. J Consult Clin Psychol. 2008 Aug;76(4):695-703. doi: 10.1037/a0012616. PMID: 18665697.","31196","2019"
"bryant2008_CAPS_D_0_Comp","Psychotherapy","PTSD","118","D","PTSD",,"24",,"Imaginal exposure + In vivo exposure + Cognitive restructuring","Trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","28","Structured Clinical Interview","CAPS","CAPS","Completer",,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","End of Treatment","0",,"21.71","18.42",,,,"difference from the ITT Baseline","-49.64",,,,,,,,,,,,,,,,,,"CAPS <19","0.79",,"CAPS <19 and BDI <10",,"Additional definitions of Clinically Meaningful Response reported in the study","Community",,,"1",,,,"Mixed","accidents, community/school violence","Medium","Bryant RA, Moulds ML, Guthrie RM, et al. A randomized controlled trial of exposure therapy and cognitive restructuring for posttraumatic stress disorder. J Consult Clin Psychol. 2008 Aug;76(4):695-703. doi: 10.1037/a0012616. PMID: 18665697.","31196","2019"
"bryant2008_CAPS_D_0_ITT","Psychotherapy","PTSD","118","D","PTSD",,"24",,"Imaginal exposure + In vivo exposure + Cognitive restructuring","Trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","28","Structured Clinical Interview","CAPS","CAPS","ITT","LOCF","ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","End of Treatment","0",,"29.86","27.11",,,,,"-41.49",,,,,,,,,,,,,,,,,,"CAPS <19","0.65",,"CAPS <19 and BDI <10",,"Additional definitions of Clinically Meaningful Response reported in the study","Community",,,"1",,,,"Mixed","accidents, community/school violence","Medium","Bryant RA, Moulds ML, Guthrie RM, et al. A randomized controlled trial of exposure therapy and cognitive restructuring for posttraumatic stress disorder. J Consult Clin Psychol. 2008 Aug;76(4):695-703. doi: 10.1037/a0012616. PMID: 18665697.","31196","2019"
"bryant2008_CAPS_D_26_Comp","Psychotherapy","PTSD","118","D","PTSD",,"21",,"Imaginal exposure + In vivo exposure + Cognitive restructuring","Trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","28","Structured Clinical Interview","CAPS","CAPS","Completer",,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","Assessment at 6 to <12 Months","26",,"23.71","19.46",,,,"difference from the ITT Baseline","-47.64",,,,,,,,,,,,,,,,,,"CAPS <19","0.86",,"CAPS <19 and BDI <10","0.46","Additional definitions of Clinically Meaningful Response reported in the study","Community",,,"1",,,,"Mixed","accidents, community/school violence","Medium","Bryant RA, Moulds ML, Guthrie RM, et al. A randomized controlled trial of exposure therapy and cognitive restructuring for posttraumatic stress disorder. J Consult Clin Psychol. 2008 Aug;76(4):695-703. doi: 10.1037/a0012616. PMID: 18665697.","31196","2019"
"bryant2008_CAPS_D_26_ITT","Psychotherapy","PTSD","118","D","PTSD",,"21",,"Imaginal exposure + In vivo exposure + Cognitive restructuring","Trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","28","Structured Clinical Interview","CAPS","CAPS","ITT","LOCF","ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","Assessment at 6 to <12 Months","26",,"32.86","27.44",,,,,"-38.49",,,,,,,,,,,,,,,,,,"CAPS <19","0.69",,"CAPS <19 and BDI <10","0.36","Additional definitions of Clinically Meaningful Response reported in the study","Community",,,"1",,,,"Mixed","accidents, community/school violence","Medium","Bryant RA, Moulds ML, Guthrie RM, et al. A randomized controlled trial of exposure therapy and cognitive restructuring for posttraumatic stress disorder. J Consult Clin Psychol. 2008 Aug;76(4):695-703. doi: 10.1037/a0012616. PMID: 18665697.","31196","2019"
"bryant2008_CAPS_D_Baseline_Comp","Psychotherapy","PTSD","118","D","PTSD",,"24",,"Imaginal exposure + In vivo exposure + Cognitive restructuring","Trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","28","Structured Clinical Interview","CAPS","CAPS","Completer",,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","Baseline",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1",,,,"Mixed","accidents, community/school violence","Medium","Bryant RA, Moulds ML, Guthrie RM, et al. A randomized controlled trial of exposure therapy and cognitive restructuring for posttraumatic stress disorder. J Consult Clin Psychol. 2008 Aug;76(4):695-703. doi: 10.1037/a0012616. PMID: 18665697.","31196","2019"
"bryant2008_CAPS_D_Baseline_ITT","Psychotherapy","PTSD","118","D","PTSD",,"28",,"Imaginal exposure + In vivo exposure + Cognitive restructuring","Trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","28","Structured Clinical Interview","CAPS","CAPS","ITT","LOCF","ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","Baseline",,,"71.35","17.28",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1",,,,"Mixed","accidents, community/school violence","Medium","Bryant RA, Moulds ML, Guthrie RM, et al. A randomized controlled trial of exposure therapy and cognitive restructuring for posttraumatic stress disorder. J Consult Clin Psychol. 2008 Aug;76(4):695-703. doi: 10.1037/a0012616. PMID: 18665697.","31196","2019"
"bryant2011_PSS-I_A_0_ITT","Psychotherapy","PTSD","28","A","PTSD",,"16",,"CBT","Trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","16","Structured Clinical Interview","PSS-I","PSS-I","ITT",,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","End of Treatment","0",,"4.1","8",,,,,"-22.7",,,,,,,,,,,,,,,,,,,,,"CAPS score <19 and BDI-II score <10",,,"Community",,,"1","0.9643",,"0.0357","Terrorism/political violence/forced displacement",,"Medium","Bryant RA, Ekassawin S, Chakkraband MLS, et al. A randomized controlled effectiveness trial of cognitive behavior therapy for post-traumatic stress disorder in terrorist-affected people in Thailand. World Psychiatry. 2011 Oct;10(3):205-9.  PMID: 21991280.","37395","2019"
"bryant2011_PSS-I_A_12_ITT","Psychotherapy","PTSD","28","A","PTSD",,"16",,"CBT","Trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","16","Structured Clinical Interview","PSS-I","PSS-I","ITT",,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","Assessment at 3 to <6 Months","12",,"7.5","11.1",,,,,"-19.3",,,,,"Hedges' g","1.78","95% CI","0.96","2.60",,,,,,,,,,,,"CAPS score <19 and BDI-II score <10","0.75",,"Community",,,"1","0.9643",,"0.0357","Terrorism/political violence/forced displacement",,"Medium","Bryant RA, Ekassawin S, Chakkraband MLS, et al. A randomized controlled effectiveness trial of cognitive behavior therapy for post-traumatic stress disorder in terrorist-affected people in Thailand. World Psychiatry. 2011 Oct;10(3):205-9.  PMID: 21991280.","37395","2019"
"bryant2011_PSS-I_A_Baseline_ITT","Psychotherapy","PTSD","28","A","PTSD",,"16",,"CBT","Trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","16","Structured Clinical Interview","PSS-I","PSS-I","ITT",,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","Baseline",,,"26.8","10",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.9643",,"0.0357","Terrorism/political violence/forced displacement",,"Medium","Bryant RA, Ekassawin S, Chakkraband MLS, et al. A randomized controlled effectiveness trial of cognitive behavior therapy for post-traumatic stress disorder in terrorist-affected people in Thailand. World Psychiatry. 2011 Oct;10(3):205-9.  PMID: 21991280.","37395","2019"
"bryant2011_PSS-I_B_0_ITT","Psychotherapy","PTSD","28","B","Control",,"12",,"TAU","Supportive counseling","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","12","Structured Clinical Interview","PSS-I","PSS-I","ITT",,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","End of Treatment","0",,"12.3","8.4",,,,,"-10.4",,,,,,,,,,,,,,,,,,,,,"CAPS score <19 and BDI-II score <10",,,"Community",,,"1","0.9643",,"0.0357","Terrorism/political violence/forced displacement",,"Medium","Bryant RA, Ekassawin S, Chakkraband MLS, et al. A randomized controlled effectiveness trial of cognitive behavior therapy for post-traumatic stress disorder in terrorist-affected people in Thailand. World Psychiatry. 2011 Oct;10(3):205-9.  PMID: 21991280.","37395","2019"
"bryant2011_PSS-I_B_12_ITT","Psychotherapy","PTSD","28","B","Control",,"12",,"TAU","Supportive counseling","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","12","Structured Clinical Interview","PSS-I","PSS-I","ITT",,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","Assessment at 3 to <6 Months","12",,"15.2","13.1",,,,,"-7.5",,,,,"Hedges' g","0.57","95% CI","0.25","1.38",,,,,,,,,,,,"CAPS score <19 and BDI-II score <10","0.33",,"Community",,,"1","0.9643",,"0.0357","Terrorism/political violence/forced displacement",,"Medium","Bryant RA, Ekassawin S, Chakkraband MLS, et al. A randomized controlled effectiveness trial of cognitive behavior therapy for post-traumatic stress disorder in terrorist-affected people in Thailand. World Psychiatry. 2011 Oct;10(3):205-9.  PMID: 21991280.","37395","2019"
"bryant2011_PSS-I_B_Baseline_ITT","Psychotherapy","PTSD","28","B","Control",,"12",,"TAU","Supportive counseling","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","12","Structured Clinical Interview","PSS-I","PSS-I","ITT",,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","Baseline",,,"22.7","12.4",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.9643",,"0.0357","Terrorism/political violence/forced displacement",,"Medium","Bryant RA, Ekassawin S, Chakkraband MLS, et al. A randomized controlled effectiveness trial of cognitive behavior therapy for post-traumatic stress disorder in terrorist-affected people in Thailand. World Psychiatry. 2011 Oct;10(3):205-9.  PMID: 21991280.","37395","2019"
"bryant2013_CAPS_A_0_Comp","Psychotherapy","PTSD","70","A","PTSD",,"30",,"Emotion Regulation Training + CBT","Emotion Regulation Training followed by trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","36","Structured Clinical Interview","CAPS","CAPS-2","Completer",,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","End of Treatment","0",,"34.36","27.95",,,,,"-39.39",,,,,,,,,,,,,,,,,,"CAPS score <19",,,"CAPS score <19 and BDI-II score <10",,,"Community",,,"1","0.5429",,"0.4571","Mixed","accidents, community/school violence","Medium","Bryant RA, Mastrodomenico JA, Hopwood S, et al. Augmenting cognitive behaviour therapy for post-traumatic stress disorder with emotion tolerance training: a randomized controlled trial. Psychol Med. 2013 Oct;43(10):2153-60. doi: 10.1017/S0033291713000068. PMID: 23406821.","40045","2019"
"bryant2013_CAPS_A_0_ITT","Psychotherapy","PTSD","70","A","PTSD",,"21",,"Emotion Regulation Training + CBT","Emotion Regulation Training followed by trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","36","Structured Clinical Interview","CAPS","CAPS-2","ITT","imputed","ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","End of Treatment","0",,"32.43","21.61",,,,,"-41.32",,,,,,,,,,,,,,,,,,"CAPS score <19","0.81",,"CAPS score <19 and BDI-II score <10",,,"Community",,,"1","0.5429",,"0.4571","Mixed","accidents, community/school violence","Medium","Bryant RA, Mastrodomenico JA, Hopwood S, et al. Augmenting cognitive behaviour therapy for post-traumatic stress disorder with emotion tolerance training: a randomized controlled trial. Psychol Med. 2013 Oct;43(10):2153-60. doi: 10.1017/S0033291713000068. PMID: 23406821.","40045","2019"
"bryant2013_CAPS_A_26_Comp","Psychotherapy","PTSD","70","A","PTSD",,"21",,"Emotion Regulation Training + CBT","Emotion Regulation Training followed by trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","36","Structured Clinical Interview","CAPS","CAPS-2","Completer",,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","Assessment at 6 to <12 Months","26",,"27.81","23.49",,,,,"-45.94",,,,,,,,,,,,,,,,,,"CAPS score <19",,,"CAPS score <19 and BDI-II score <10",,,"Community",,,"1","0.5429",,"0.4571","Mixed","accidents, community/school violence","Medium","Bryant RA, Mastrodomenico JA, Hopwood S, et al. Augmenting cognitive behaviour therapy for post-traumatic stress disorder with emotion tolerance training: a randomized controlled trial. Psychol Med. 2013 Oct;43(10):2153-60. doi: 10.1017/S0033291713000068. PMID: 23406821.","40045","2019"
"bryant2013_CAPS_A_26_ITT","Psychotherapy","PTSD","70","A","PTSD",,"36",,"Emotion Regulation Training + CBT","Emotion Regulation Training followed by trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","36","Structured Clinical Interview","CAPS","CAPS-2","ITT","imputed","ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","Assessment at 6 to <12 Months","26",,"37.47","23.49",,,,,"-36.28",,,,,,,,,,,,,,,,,,"CAPS score <19","0.72",,"CAPS score <19 and BDI-II score <10","0.31",,"Community",,,"1","0.5429",,"0.4571","Mixed","accidents, community/school violence","Medium","Bryant RA, Mastrodomenico JA, Hopwood S, et al. Augmenting cognitive behaviour therapy for post-traumatic stress disorder with emotion tolerance training: a randomized controlled trial. Psychol Med. 2013 Oct;43(10):2153-60. doi: 10.1017/S0033291713000068. PMID: 23406821.","40045","2019"
"bryant2013_CAPS_A_Baseline_Comp","Psychotherapy","PTSD","70","A","PTSD",,"30",,"Emotion Regulation Training + CBT","Emotion Regulation Training followed by trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","36","Structured Clinical Interview","CAPS","CAPS-2","Completer",,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","Baseline",,,"73.75","17.79",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.5429",,"0.4571","Mixed","accidents, community/school violence","Medium","Bryant RA, Mastrodomenico JA, Hopwood S, et al. Augmenting cognitive behaviour therapy for post-traumatic stress disorder with emotion tolerance training: a randomized controlled trial. Psychol Med. 2013 Oct;43(10):2153-60. doi: 10.1017/S0033291713000068. PMID: 23406821.","40045","2019"
"bryant2013_CAPS_A_Baseline_ITT","Psychotherapy","PTSD","70","A","PTSD",,"36",,"Emotion Regulation Training + CBT","Emotion Regulation Training followed by trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","36","Structured Clinical Interview","CAPS","CAPS-2","ITT","imputed","ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","Baseline",,,"73.75","17.79",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.5429",,"0.4571","Mixed","accidents, community/school violence","Medium","Bryant RA, Mastrodomenico JA, Hopwood S, et al. Augmenting cognitive behaviour therapy for post-traumatic stress disorder with emotion tolerance training: a randomized controlled trial. Psychol Med. 2013 Oct;43(10):2153-60. doi: 10.1017/S0033291713000068. PMID: 23406821.","40045","2019"
"bryant2013_CAPS_B_0_Comp","Psychotherapy","PTSD","70","B","PTSD",,"21",,"Supportive counseling + CBT","Supportive counseling followed by trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","34","Structured Clinical Interview","CAPS","CAPS-2","Completer",,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","End of Treatment","0",,"31","29.42",,,,,"-36.69",,,,,,,,,,,,,,,,,,"CAPS score <19",,,"CAPS score <19 and BDI-II score <10",,,"Community",,,"1","0.5429",,"0.4571","Mixed","accidents, community/school violence","Medium","Bryant RA, Mastrodomenico JA, Hopwood S, et al. Augmenting cognitive behaviour therapy for post-traumatic stress disorder with emotion tolerance training: a randomized controlled trial. Psychol Med. 2013 Oct;43(10):2153-60. doi: 10.1017/S0033291713000068. PMID: 23406821.","40045","2019"
"bryant2013_CAPS_B_0_ITT","Psychotherapy","PTSD","70","B","PTSD",,"21",,"Supportive counseling + CBT","Supportive counseling followed by trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","34","Structured Clinical Interview","CAPS","CAPS-2","ITT","imputed","ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","End of Treatment","0",,"38.76","20.81",,,,,"-28.93",,,,,,,,,,,,,,,,,,"CAPS score <19","0.74",,"CAPS score <19 and BDI-II score <10",,,"Community",,,"1","0.5429",,"0.4571","Mixed","accidents, community/school violence","Medium","Bryant RA, Mastrodomenico JA, Hopwood S, et al. Augmenting cognitive behaviour therapy for post-traumatic stress disorder with emotion tolerance training: a randomized controlled trial. Psychol Med. 2013 Oct;43(10):2153-60. doi: 10.1017/S0033291713000068. PMID: 23406821.","40045","2019"
"bryant2013_CAPS_B_26_Comp","Psychotherapy","PTSD","70","B","PTSD",,"11",,"Supportive counseling + CBT","Supportive counseling followed by trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","34","Structured Clinical Interview","CAPS","CAPS-2","Completer",,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","Assessment at 6 to <12 Months","26",,"34.63","29.73",,,,,"-33.06",,,,,,,,,,,,,,,,,,"CAPS score <19",,,"CAPS score <19 and BDI-II score <10",,,"Community",,,"1","0.5429",,"0.4571","Mixed","accidents, community/school violence","Medium","Bryant RA, Mastrodomenico JA, Hopwood S, et al. Augmenting cognitive behaviour therapy for post-traumatic stress disorder with emotion tolerance training: a randomized controlled trial. Psychol Med. 2013 Oct;43(10):2153-60. doi: 10.1017/S0033291713000068. PMID: 23406821.","40045","2019"
"bryant2013_CAPS_B_26_ITT","Psychotherapy","PTSD","70","B","PTSD",,"11",,"Supportive counseling + CBT","Supportive counseling followed by trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","34","Structured Clinical Interview","CAPS","CAPS-2","ITT","imputed","ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","Assessment at 6 to <12 Months","26",,"47.54","22.45",,,,,"-20.15",,,,,,,,,,,,,,,,,,"CAPS score <19","0.5",,"CAPS score <19 and BDI-II score <10","0.12",,"Community",,,"1","0.5429",,"0.4571","Mixed","accidents, community/school violence","Medium","Bryant RA, Mastrodomenico JA, Hopwood S, et al. Augmenting cognitive behaviour therapy for post-traumatic stress disorder with emotion tolerance training: a randomized controlled trial. Psychol Med. 2013 Oct;43(10):2153-60. doi: 10.1017/S0033291713000068. PMID: 23406821.","40045","2019"
"bryant2013_CAPS_B_Baseline_Comp","Psychotherapy","PTSD","70","B","PTSD",,"21",,"Supportive counseling + CBT","Supportive counseling followed by trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","34","Structured Clinical Interview","CAPS","CAPS-2","Completer",,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","Baseline",,,"67.69","16.26",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.5429",,"0.4571","Mixed","accidents, community/school violence","Medium","Bryant RA, Mastrodomenico JA, Hopwood S, et al. Augmenting cognitive behaviour therapy for post-traumatic stress disorder with emotion tolerance training: a randomized controlled trial. Psychol Med. 2013 Oct;43(10):2153-60. doi: 10.1017/S0033291713000068. PMID: 23406821.","40045","2019"
"bryant2013_CAPS_B_Baseline_ITT","Psychotherapy","PTSD","70","B","PTSD",,"34",,"Supportive counseling + CBT","Supportive counseling followed by trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","34","Structured Clinical Interview","CAPS","CAPS-2","ITT","imputed","ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables","Baseline",,,"67.69","16.26",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.5429",,"0.4571","Mixed","accidents, community/school violence","Medium","Bryant RA, Mastrodomenico JA, Hopwood S, et al. Augmenting cognitive behaviour therapy for post-traumatic stress disorder with emotion tolerance training: a randomized controlled trial. Psychol Med. 2013 Oct;43(10):2153-60. doi: 10.1017/S0033291713000068. PMID: 23406821.","40045","2019"
"bryant2019_CAPS_A_0_Comp","Psychotherapy","PTSD","100","A","PTSD",,,,"CBT with prolonged exposure","Trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","33","Structured Clinical Interview","CAPS","CAPS","Completer","Models that handle missing data by calculating estimates of trajectories","Hierarchical linear mixed models, time x treatment interactions, 
Wald test and Cohen’s (d)","End of Treatment","0",,,,,,,,,,,,,,,,,,,,,,,,,,"Not fulfilling diagnostic criteria for PTSD","0.5926",,,,,"Community","0","0","1","0.23",,"0.77","Other (emergency service personnel including police, firefighters, and paramedics; exposure to fatality)",,"Medium","Bryant RA, Kenny L, Rawson N, et al. Efficacy of exposure-based cognitive behaviour therapy for post-traumatic stress disorder in emergency service personnel: a randomised clinical trial. Psychol Med. 2019 Jul;49(9):1565-73. doi: 10.1017/S0033291718002234. PMID: 30149825.","51039","2020"
"bryant2019_CAPS_A_0_ITT","Psychotherapy","PTSD","100","A","PTSD",,"27",,"CBT with prolonged exposure","Trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","33","Structured Clinical Interview","CAPS","CAPS","ITT","Models that handle missing data by calculating estimates of trajectories","Hierarchical linear mixed models, time x treatment interactions, 
Wald test and Cohen’s (d)","End of Treatment","0",,,,,,,,"-38.4",,"-46.1","-30.7",,,,,,,,,,,,,,,"Not fulfilling diagnostic criteria for PTSD",,,,,,"Community","0","0","1","0.23",,"0.77","Other (emergency service personnel including police, firefighters, and paramedics; exposure to fatality)",,"Medium","Bryant RA, Kenny L, Rawson N, et al. Efficacy of exposure-based cognitive behaviour therapy for post-traumatic stress disorder in emergency service personnel: a randomised clinical trial. Psychol Med. 2019 Jul;49(9):1565-73. doi: 10.1017/S0033291718002234. PMID: 30149825.","51039","2020"
"bryant2019_CAPS_A_Baseline_Comp","Psychotherapy","PTSD","100","A","PTSD",,,,"CBT with prolonged exposure","Trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","33","Structured Clinical Interview","CAPS","CAPS","Completer","Models that handle missing data by calculating estimates of trajectories","Hierarchical linear mixed models, time x treatment interactions, 
Wald test and Cohen’s (d)","Baseline",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community","0","0","1","0.23",,"0.77","Other (emergency service personnel including police, firefighters, and paramedics; exposure to fatality)",,"Medium","Bryant RA, Kenny L, Rawson N, et al. Efficacy of exposure-based cognitive behaviour therapy for post-traumatic stress disorder in emergency service personnel: a randomised clinical trial. Psychol Med. 2019 Jul;49(9):1565-73. doi: 10.1017/S0033291718002234. PMID: 30149825.","51039","2020"
"bryant2019_CAPS_A_Baseline_ITT","Psychotherapy","PTSD","100","A","PTSD",,"33",,"CBT with prolonged exposure","Trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","33","Structured Clinical Interview","CAPS","CAPS","ITT","Models that handle missing data by calculating estimates of trajectories","Hierarchical linear mixed models, time x treatment interactions, 
Wald test and Cohen’s (d)","Baseline",,,"80.4","14.1",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community","0","0","1","0.23",,"0.77","Other (emergency service personnel including police, firefighters, and paramedics; exposure to fatality)",,"Medium","Bryant RA, Kenny L, Rawson N, et al. Efficacy of exposure-based cognitive behaviour therapy for post-traumatic stress disorder in emergency service personnel: a randomised clinical trial. Psychol Med. 2019 Jul;49(9):1565-73. doi: 10.1017/S0033291718002234. PMID: 30149825.","51039","2020"
"bryant2019_CAPS_B_0_Comp","Psychotherapy","PTSD","100","B","PTSD",,,,"CBT with brief exposure","Trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","33","Structured Clinical Interview","CAPS","CAPS","Completer","Models that handle missing data by calculating estimates of trajectories","Hierarchical linear mixed models, time x treatment interactions, 
Wald test and Cohen’s (d)","End of Treatment","0",,,,,,,,,,,,,,,,,,,,,,,,,,"Not fulfilling diagnostic criteria for PTSD","0.7586",,,,,"Community","0","0","1","0.23",,"0.77","Other (emergency service personnel including police, firefighters, and paramedics; exposure to fatality)",,"Medium","Bryant RA, Kenny L, Rawson N, et al. Efficacy of exposure-based cognitive behaviour therapy for post-traumatic stress disorder in emergency service personnel: a randomised clinical trial. Psychol Med. 2019 Jul;49(9):1565-73. doi: 10.1017/S0033291718002234. PMID: 30149825.","51039","2020"
"bryant2019_CAPS_B_0_ITT","Psychotherapy","PTSD","100","B","PTSD",,"29",,"CBT with brief exposure","Trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","33","Structured Clinical Interview","CAPS","CAPS","ITT","Models that handle missing data by calculating estimates of trajectories","Hierarchical linear mixed models, time x treatment interactions, 
Wald test and Cohen’s (d)","End of Treatment","0",,,,,,,,"-39.7",,"-47.2","-32.1",,,,,,,,,,,,,,,"Not fulfilling diagnostic criteria for PTSD",,,,,,"Community","0","0","1","0.23",,"0.77","Other (emergency service personnel including police, firefighters, and paramedics; exposure to fatality)",,"Medium","Bryant RA, Kenny L, Rawson N, et al. Efficacy of exposure-based cognitive behaviour therapy for post-traumatic stress disorder in emergency service personnel: a randomised clinical trial. Psychol Med. 2019 Jul;49(9):1565-73. doi: 10.1017/S0033291718002234. PMID: 30149825.","51039","2020"
"bryant2019_CAPS_B_Baseline_Comp","Psychotherapy","PTSD","100","B","PTSD",,,,"CBT with brief exposure","Trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","33","Structured Clinical Interview","CAPS","CAPS","Completer","Models that handle missing data by calculating estimates of trajectories","Hierarchical linear mixed models, time x treatment interactions, 
Wald test and Cohen’s (d)","Baseline",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community","0","0","1","0.23",,"0.77","Other (emergency service personnel including police, firefighters, and paramedics; exposure to fatality)",,"Medium","Bryant RA, Kenny L, Rawson N, et al. Efficacy of exposure-based cognitive behaviour therapy for post-traumatic stress disorder in emergency service personnel: a randomised clinical trial. Psychol Med. 2019 Jul;49(9):1565-73. doi: 10.1017/S0033291718002234. PMID: 30149825.","51039","2020"
"bryant2019_CAPS_B_Baseline_ITT","Psychotherapy","PTSD","100","B","PTSD",,"33",,"CBT with brief exposure","Trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","33","Structured Clinical Interview","CAPS","CAPS","ITT","Models that handle missing data by calculating estimates of trajectories","Hierarchical linear mixed models, time x treatment interactions, 
Wald test and Cohen’s (d)","Baseline",,,"70.5","18.6",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community","0","0","1","0.23",,"0.77","Other (emergency service personnel including police, firefighters, and paramedics; exposure to fatality)",,"Medium","Bryant RA, Kenny L, Rawson N, et al. Efficacy of exposure-based cognitive behaviour therapy for post-traumatic stress disorder in emergency service personnel: a randomised clinical trial. Psychol Med. 2019 Jul;49(9):1565-73. doi: 10.1017/S0033291718002234. PMID: 30149825.","51039","2020"
"bryant2019_CAPS_C_0_Comp","Psychotherapy","PTSD","100","C","Control",,,,"Waitlist","Waitlist","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,"34","Structured Clinical Interview","CAPS","CAPS","Completer","Models that handle missing data by calculating estimates of trajectories","Hierarchical linear mixed models, time x treatment interactions, 
Wald test and Cohen’s (d)","End of Treatment","0",,,,,,,,,,,,,,,,,,,,,,,,,,"Not fulfilling diagnostic criteria for PTSD","0.1071",,,,,"Community","0","0","1","0.23",,"0.77","Other (emergency service personnel including police, firefighters, and paramedics; exposure to fatality)",,"Medium","Bryant RA, Kenny L, Rawson N, et al. Efficacy of exposure-based cognitive behaviour therapy for post-traumatic stress disorder in emergency service personnel: a randomised clinical trial. Psychol Med. 2019 Jul;49(9):1565-73. doi: 10.1017/S0033291718002234. PMID: 30149825.","51039","2020"
"bryant2019_CAPS_C_0_ITT","Psychotherapy","PTSD","100","C","Control",,"27",,"Waitlist","Waitlist","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,"34","Structured Clinical Interview","CAPS","CAPS","ITT","Models that handle missing data by calculating estimates of trajectories","Hierarchical linear mixed models, time x treatment interactions, 
Wald test and Cohen’s (d)","End of Treatment","0",,,,,,,,"-11.9",,"-19.5","-4.4",,,,,,,,,,,,,,,"Not fulfilling diagnostic criteria for PTSD",,,,,,"Community","0","0","1","0.23",,"0.77","Other (emergency service personnel including police, firefighters, and paramedics; exposure to fatality)",,"Medium","Bryant RA, Kenny L, Rawson N, et al. Efficacy of exposure-based cognitive behaviour therapy for post-traumatic stress disorder in emergency service personnel: a randomised clinical trial. Psychol Med. 2019 Jul;49(9):1565-73. doi: 10.1017/S0033291718002234. PMID: 30149825.","51039","2020"
"bryant2019_CAPS_C_Baseline_Comp","Psychotherapy","PTSD","100","C","Control",,,,"Waitlist","Waitlist","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,"34","Structured Clinical Interview","CAPS","CAPS","Completer","Models that handle missing data by calculating estimates of trajectories","Hierarchical linear mixed models, time x treatment interactions, 
Wald test and Cohen’s (d)","Baseline",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community","0","0","1","0.23",,"0.77","Other (emergency service personnel including police, firefighters, and paramedics; exposure to fatality)",,"Medium","Bryant RA, Kenny L, Rawson N, et al. Efficacy of exposure-based cognitive behaviour therapy for post-traumatic stress disorder in emergency service personnel: a randomised clinical trial. Psychol Med. 2019 Jul;49(9):1565-73. doi: 10.1017/S0033291718002234. PMID: 30149825.","51039","2020"
"bryant2019_CAPS_C_Baseline_ITT","Psychotherapy","PTSD","100","C","Control",,"34",,"Waitlist","Waitlist","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,"34","Structured Clinical Interview","CAPS","CAPS","ITT","Models that handle missing data by calculating estimates of trajectories","Hierarchical linear mixed models, time x treatment interactions, 
Wald test and Cohen’s (d)","Baseline",,,"75.0","16.2",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community","0","0","1","0.23",,"0.77","Other (emergency service personnel including police, firefighters, and paramedics; exposure to fatality)",,"Medium","Bryant RA, Kenny L, Rawson N, et al. Efficacy of exposure-based cognitive behaviour therapy for post-traumatic stress disorder in emergency service personnel: a randomised clinical trial. Psychol Med. 2019 Jul;49(9):1565-73. doi: 10.1017/S0033291718002234. PMID: 30149825.","51039","2020"
"buhmann2016_HTQ_A_0_ITT","Mixed: Psychotherapy & pharmacotherapy","PTSD","280","A","PTSD",,"55",,"CBT + sertraline and/or mianserin","Trauma-focused cognitive behavioral therapy (TF-CBT) + sertraline and/or mianserin","Yes","TF","Yes","Mixed","No","Not Applicable","No","No","No","No","No","Individual","In Person","71","Self report","HTQ","HTQ","ITT","Imputed using full information maximum likelihood","Hierarchical linear mixed models, time x treatment interactions, 
Wald test and Cohen’s (d)","End of Treatment","0",,"3.2","0.7",,,,,"0",,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.4101",,"0.5899","Terrorism/political violence/forced displacement",,"Medium","Buhmann CB, Nordentoft M, Ekstrom M, et al. The effect of flexible cognitive-behavioural therapy and medical treatment, including antidepressants on post-traumatic stress disorder and depression in traumatised refugees: pragmatic randomised controlled clinical trial. Br J Psychiatry. 2016 Mar;208(3):252-9. doi: 10.1192/bjp.bp.114.150961. PMID: 26541687.","46863","2019"
"buhmann2016_HTQ_A_Baseline_ITT","Mixed: Psychotherapy & pharmacotherapy","PTSD","280","A","PTSD",,"71",,"CBT + sertraline and/or mianserin","Trauma-focused cognitive behavioral therapy (TF-CBT) + sertraline and/or mianserin","Yes","TF","Yes","Mixed","No","Not Applicable","No","No","No","No","No","Individual","In Person","71","Self report","HTQ","HTQ","ITT","Imputed using full information maximum likelihood","Hierarchical linear mixed models, time x treatment interactions, 
Wald test and Cohen’s (d)","Baseline",,,"3.2","0.6",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.4101",,"0.5899","Terrorism/political violence/forced displacement",,"Medium","Buhmann CB, Nordentoft M, Ekstrom M, et al. The effect of flexible cognitive-behavioural therapy and medical treatment, including antidepressants on post-traumatic stress disorder and depression in traumatised refugees: pragmatic randomised controlled clinical trial. Br J Psychiatry. 2016 Mar;208(3):252-9. doi: 10.1192/bjp.bp.114.150961. PMID: 26541687.","46863","2019"
"buhmann2016_HTQ_B_0_ITT","Mixed: Psychotherapy & pharmacotherapy","PTSD","280","B","PTSD",,"52",,"CBT","Trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","70","Self report","HTQ","HTQ","ITT","Imputed using full information maximum likelihood","Hierarchical linear mixed models, time x treatment interactions, 
Wald test and Cohen’s (d)","End of Treatment","0",,"3.3","0.7",,,,,"0",,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.4101",,"0.5899","Terrorism/political violence/forced displacement",,"Medium","Buhmann CB, Nordentoft M, Ekstrom M, et al. The effect of flexible cognitive-behavioural therapy and medical treatment, including antidepressants on post-traumatic stress disorder and depression in traumatised refugees: pragmatic randomised controlled clinical trial. Br J Psychiatry. 2016 Mar;208(3):252-9. doi: 10.1192/bjp.bp.114.150961. PMID: 26541687.","46863","2019"
"buhmann2016_HTQ_B_26_ITT","Mixed: Psychotherapy & pharmacotherapy","PTSD","280","B","PTSD",,,,"CBT","Trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","70","Self report","HTQ","HTQ","ITT","Imputed using full information maximum likelihood","Hierarchical linear mixed models, time x treatment interactions, 
Wald test and Cohen’s (d)","Assessment at 6 to <12 Months","26",,"3.18",,,,,,"-0.12",,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.4101",,"0.5899","Terrorism/political violence/forced displacement",,"Medium","Buhmann CB, Nordentoft M, Ekstrom M, et al. The effect of flexible cognitive-behavioural therapy and medical treatment, including antidepressants on post-traumatic stress disorder and depression in traumatised refugees: pragmatic randomised controlled clinical trial. Br J Psychiatry. 2016 Mar;208(3):252-9. doi: 10.1192/bjp.bp.114.150961. PMID: 26541687.","46863","2019"
"buhmann2016_HTQ_B_68_ITT","Mixed: Psychotherapy & pharmacotherapy","PTSD","280","B","PTSD",,,,"CBT","Trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","70","Self report","HTQ","HTQ","ITT","Imputed using full information maximum likelihood","Hierarchical linear mixed models, time x treatment interactions, 
Wald test and Cohen’s (d)","Assessment at ≥12 Months","68",,"3.30",,,,,,"0.00",,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.4101",,"0.5899","Terrorism/political violence/forced displacement",,"Medium","Buhmann CB, Nordentoft M, Ekstrom M, et al. The effect of flexible cognitive-behavioural therapy and medical treatment, including antidepressants on post-traumatic stress disorder and depression in traumatised refugees: pragmatic randomised controlled clinical trial. Br J Psychiatry. 2016 Mar;208(3):252-9. doi: 10.1192/bjp.bp.114.150961. PMID: 26541687.","46863","2019"
"buhmann2016_HTQ_B_Baseline_ITT","Mixed: Psychotherapy & pharmacotherapy","PTSD","280","B","PTSD",,"70",,"CBT","Trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","70","Self report","HTQ","HTQ","ITT","Imputed using full information maximum likelihood","Hierarchical linear mixed models, time x treatment interactions, 
Wald test and Cohen’s (d)","Baseline",,,"3.3","0.5",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.4101",,"0.5899","Terrorism/political violence/forced displacement",,"Medium","Buhmann CB, Nordentoft M, Ekstrom M, et al. The effect of flexible cognitive-behavioural therapy and medical treatment, including antidepressants on post-traumatic stress disorder and depression in traumatised refugees: pragmatic randomised controlled clinical trial. Br J Psychiatry. 2016 Mar;208(3):252-9. doi: 10.1192/bjp.bp.114.150961. PMID: 26541687.","46863","2019"
"buhmann2016_HTQ_C_0_ITT","Mixed: Psychotherapy & pharmacotherapy","PTSD","280","C","PTSD",,"62",,"Sertraline and/or mianserin","Sertraline and/or mianserin","No","Not Applicable","Yes","Mixed","No","Not Applicable","No","No","No","No","No","Individual","In Person","71","Self report","HTQ","HTQ","ITT","Imputed using full information maximum likelihood","Hierarchical linear mixed models, time x treatment interactions, 
Wald test and Cohen’s (d)","End of Treatment","0",,"3.2","0.6",,,,,"-0.1",,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.4101",,"0.5899","Terrorism/political violence/forced displacement",,"Medium","Buhmann CB, Nordentoft M, Ekstrom M, et al. The effect of flexible cognitive-behavioural therapy and medical treatment, including antidepressants on post-traumatic stress disorder and depression in traumatised refugees: pragmatic randomised controlled clinical trial. Br J Psychiatry. 2016 Mar;208(3):252-9. doi: 10.1192/bjp.bp.114.150961. PMID: 26541687.","46863","2019"
"buhmann2016_HTQ_C_26_ITT","Mixed: Psychotherapy & pharmacotherapy","PTSD","280","C","PTSD",,,,"Sertraline and/or mianserin","Sertraline and/or mianserin","No","Not Applicable","Yes","Mixed","No","Not Applicable","No","No","No","No","No","Individual","In Person","71","Self report","HTQ","HTQ","ITT","Imputed using full information maximum likelihood","Hierarchical linear mixed models, time x treatment interactions, 
Wald test and Cohen’s (d)","Assessment at 6 to <12 Months","26",,"3.09",,,,,,"-0.21",,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.4101",,"0.5899","Terrorism/political violence/forced displacement",,"Medium","Buhmann CB, Nordentoft M, Ekstrom M, et al. The effect of flexible cognitive-behavioural therapy and medical treatment, including antidepressants on post-traumatic stress disorder and depression in traumatised refugees: pragmatic randomised controlled clinical trial. Br J Psychiatry. 2016 Mar;208(3):252-9. doi: 10.1192/bjp.bp.114.150961. PMID: 26541687.","46863","2019"
"buhmann2016_HTQ_C_68_ITT","Mixed: Psychotherapy & pharmacotherapy","PTSD","280","C","PTSD",,,,"Sertraline and/or mianserin","Sertraline and/or mianserin","No","Not Applicable","Yes","Mixed","No","Not Applicable","No","No","No","No","No","Individual","In Person","71","Self report","HTQ","HTQ","ITT","Imputed using full information maximum likelihood","Hierarchical linear mixed models, time x treatment interactions, 
Wald test and Cohen’s (d)","Assessment at ≥12 Months","68",,"2.91",,,,,,"-0.39",,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.4101",,"0.5899","Terrorism/political violence/forced displacement",,"Medium","Buhmann CB, Nordentoft M, Ekstrom M, et al. The effect of flexible cognitive-behavioural therapy and medical treatment, including antidepressants on post-traumatic stress disorder and depression in traumatised refugees: pragmatic randomised controlled clinical trial. Br J Psychiatry. 2016 Mar;208(3):252-9. doi: 10.1192/bjp.bp.114.150961. PMID: 26541687.","46863","2019"
"buhmann2016_HTQ_C_Baseline_ITT","Mixed: Psychotherapy & pharmacotherapy","PTSD","280","C","PTSD",,"71",,"Sertraline and/or mianserin","Sertraline and/or mianserin","No","Not Applicable","Yes","Mixed","No","Not Applicable","No","No","No","No","No","Individual","In Person","71","Self report","HTQ","HTQ","ITT","Imputed using full information maximum likelihood","Hierarchical linear mixed models, time x treatment interactions, 
Wald test and Cohen’s (d)","Baseline",,,"3.3","0.5",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.4101",,"0.5899","Terrorism/political violence/forced displacement",,"Medium","Buhmann CB, Nordentoft M, Ekstrom M, et al. The effect of flexible cognitive-behavioural therapy and medical treatment, including antidepressants on post-traumatic stress disorder and depression in traumatised refugees: pragmatic randomised controlled clinical trial. Br J Psychiatry. 2016 Mar;208(3):252-9. doi: 10.1192/bjp.bp.114.150961. PMID: 26541687.","46863","2019"
"buhmann2016_HTQ_D_0_ITT","Mixed: Psychotherapy & pharmacotherapy","PTSD","280","D","Control",,"48",,"Waitlist","Waitlist","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","68","Self report","HTQ","HTQ","ITT","Imputed using full information maximum likelihood","Hierarchical linear mixed models, time x treatment interactions, 
Wald test and Cohen’s (d)","End of Treatment","0",,"3.2","0.5",,,,,"-0.1",,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.4101",,"0.5899","Terrorism/political violence/forced displacement",,"Medium","Buhmann CB, Nordentoft M, Ekstrom M, et al. The effect of flexible cognitive-behavioural therapy and medical treatment, including antidepressants on post-traumatic stress disorder and depression in traumatised refugees: pragmatic randomised controlled clinical trial. Br J Psychiatry. 2016 Mar;208(3):252-9. doi: 10.1192/bjp.bp.114.150961. PMID: 26541687.","46863","2019"
"buhmann2016_HTQ_D_Baseline_ITT","Mixed: Psychotherapy & pharmacotherapy","PTSD","280","D","Control",,"68",,"Waitlist","Waitlist","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","68","Self report","HTQ","HTQ","ITT","Imputed using full information maximum likelihood","Hierarchical linear mixed models, time x treatment interactions, 
Wald test and Cohen’s (d)","Baseline",,,"3.3","0.5",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.4101",,"0.5899","Terrorism/political violence/forced displacement",,"Medium","Buhmann CB, Nordentoft M, Ekstrom M, et al. The effect of flexible cognitive-behavioural therapy and medical treatment, including antidepressants on post-traumatic stress disorder and depression in traumatised refugees: pragmatic randomised controlled clinical trial. Br J Psychiatry. 2016 Mar;208(3):252-9. doi: 10.1192/bjp.bp.114.150961. PMID: 26541687.","46863","2019"
"butler2018_Inte_A_0_NA","Psychotherapy","PTSD","20","A","PTSD",,,,"EMDR + PMR + group psychoeducation","Eye Movement Desensitization and Reprocessing (EMDR) + progressive muscle relaxation (PMR) + group psychoeducation","Yes","TF","No","Not Applicable","Yes","Relaxation","No","No","No","Yes","No","Individual","In person","11","Self report","Interpretation of PTSD Symptoms Inventory","Interpretation of PTSD Symptoms Inventory",,,"Repeated measures ANOVA","End of Treatment","0",,"3.2","1.1",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Active Duty Military","1","0","0","0",,"1","Combat-related",,"High","Butler O, Willmund G, Gleich T, et al. Hippocampal gray matter increases following multimodal psychological treatment for combat-related post-traumatic stress disorder. Brain Behav. 2018 May;8(5):e00956. doi: 10.1002/brb3.956. PMID: 29761009.",,"2020"
"butler2018_Inte_A_Baseline_NA","Psychotherapy","PTSD","20","A","PTSD",,,,"EMDR + PMR + group psychoeducation","Eye Movement Desensitization and Reprocessing (EMDR) + progressive muscle relaxation (PMR) + group psychoeducation","Yes","TF","No","Not Applicable","Yes","Relaxation","No","No","No","Yes","No","Individual","In person","11","Self report","Interpretation of PTSD Symptoms Inventory","Interpretation of PTSD Symptoms Inventory",,,"Repeated measures ANOVA","Baseline",,,"3.8","1.3",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Active Duty Military","1","0","0","0",,"1","Combat-related",,"High","Butler O, Willmund G, Gleich T, et al. Hippocampal gray matter increases following multimodal psychological treatment for combat-related post-traumatic stress disorder. Brain Behav. 2018 May;8(5):e00956. doi: 10.1002/brb3.956. PMID: 29761009.",,"2020"
"butler2018_Inte_B_0_NA","Psychotherapy","PTSD","20","B","Control",,,,"Waitlist","Waitlist","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,"9","Self report","Interpretation of PTSD Symptoms Inventory","Interpretation of PTSD Symptoms Inventory",,,"Repeated measures ANOVA","End of Treatment","0",,"3.0","1.5",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Active Duty Military","1","0","0","0",,"1","Combat-related",,"High","Butler O, Willmund G, Gleich T, et al. Hippocampal gray matter increases following multimodal psychological treatment for combat-related post-traumatic stress disorder. Brain Behav. 2018 May;8(5):e00956. doi: 10.1002/brb3.956. PMID: 29761009.",,"2020"
"butler2018_Inte_B_Baseline_NA","Psychotherapy","PTSD","20","B","Control",,,,"Waitlist","Waitlist","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,"9","Self report","Interpretation of PTSD Symptoms Inventory","Interpretation of PTSD Symptoms Inventory",,,"Repeated measures ANOVA","Baseline",,,"3.2","1.0",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Active Duty Military","1","0","0","0",,"1","Combat-related",,"High","Butler O, Willmund G, Gleich T, et al. Hippocampal gray matter increases following multimodal psychological treatment for combat-related post-traumatic stress disorder. Brain Behav. 2018 May;8(5):e00956. doi: 10.1002/brb3.956. PMID: 29761009.",,"2020"
"butler2018_PDS_A_0_NA","Psychotherapy","PTSD","20","A","PTSD",,"9",,"EMDR + PMR + group psychoeducation","Eye Movement Desensitization and Reprocessing (EMDR) + progressive muscle relaxation (PMR) + group psychoeducation","Yes","TF","No","Not Applicable","Yes","Relaxation","No","No","No","Yes","No","Individual","In person","11","Self report","PDS","PDS",,"Pairwise deletion","Repeated measures ANOVA","End of Treatment","0",,"28.1","12.0",,,,,"-6.3",,,,,,,,,,"p=0.029",,,,,,,,,,,,,,"Active Duty Military","1","0","0","0",,"1","Combat-related",,"High","Butler O, Willmund G, Gleich T, et al. Hippocampal gray matter increases following multimodal psychological treatment for combat-related post-traumatic stress disorder. Brain Behav. 2018 May;8(5):e00956. doi: 10.1002/brb3.956. PMID: 29761009.",,"2020"
"butler2018_PDS_A_Baseline_NA","Psychotherapy","PTSD","20","A","PTSD",,"9",,"EMDR + PMR + group psychoeducation","Eye Movement Desensitization and Reprocessing (EMDR) + progressive muscle relaxation (PMR) + group psychoeducation","Yes","TF","No","Not Applicable","Yes","Relaxation","No","No","No","Yes","No","Individual","In person","11","Self report","PDS","PDS",,"Pairwise deletion","Repeated measures ANOVA","Baseline",,,"34.4","7.28",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Active Duty Military","1","0","0","0",,"1","Combat-related",,"High","Butler O, Willmund G, Gleich T, et al. Hippocampal gray matter increases following multimodal psychological treatment for combat-related post-traumatic stress disorder. Brain Behav. 2018 May;8(5):e00956. doi: 10.1002/brb3.956. PMID: 29761009.",,"2020"
"butler2018_PDS_B_0_NA","Psychotherapy","PTSD","20","B","Control",,"7",,"Waitlist","Waitlist","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,"9","Self report","PDS","PDS",,"Pairwise deletion","Repeated measures ANOVA","End of Treatment","0",,"24.0","14.5",,,,,"-7.2",,,,,,,,,,"p=0.031",,,,,,,,,,,,,,"Active Duty Military","1","0","0","0",,"1","Combat-related",,"High","Butler O, Willmund G, Gleich T, et al. Hippocampal gray matter increases following multimodal psychological treatment for combat-related post-traumatic stress disorder. Brain Behav. 2018 May;8(5):e00956. doi: 10.1002/brb3.956. PMID: 29761009.",,"2020"
"butler2018_PDS_B_Baseline_NA","Psychotherapy","PTSD","20","B","Control",,"7",,"Waitlist","Waitlist","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,"9","Self report","PDS","PDS",,"Pairwise deletion","Repeated measures ANOVA","Baseline",,,"31.2","14.1",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Active Duty Military","1","0","0","0",,"1","Combat-related",,"High","Butler O, Willmund G, Gleich T, et al. Hippocampal gray matter increases following multimodal psychological treatment for combat-related post-traumatic stress disorder. Brain Behav. 2018 May;8(5):e00956. doi: 10.1002/brb3.956. PMID: 29761009.",,"2020"
"butollo2016_IES_A_0_Comp","Psychotherapy","PTSD","141","A","PTSD",,,,"Dialogical Exposure Therapy","Dialogical Exposure Therapy","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","74","Self report","IES","IES-R","Completer","LOCF","MANOVA, repeated measures ANOVA, and t-test for change in mean score; chi-square for diagnostic change and clinically meaningful response","End of Treatment","0",,"36.35","31.89",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.6596",,"0.4404","Mixed","accidents, illness/medical procedure, other (""interpersonal"", ""loss"", not specified)","High","Butollo WH, Karl R, König J, et al. A randomized controlled clinical trial of dialogical exposure therapy versus cognitive processing therapy for adult outpatients suffering from PTSD after type I trauma in adulthood. Psychother Psychosom. 2016 Jan;85(1):16-26. doi: 10.1159/000440726. PMID: 26610167.","45076","2020"
"butollo2016_IES_A_0_ITT","Psychotherapy","PTSD","141","A","PTSD",,,,"Dialogical Exposure Therapy","Dialogical Exposure Therapy","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","74","Self report","IES","IES-R","ITT","LOCF","MANOVA, repeated measures ANOVA, and t-test for change in mean score; chi-square for diagnostic change and clinically meaningful response","End of Treatment","0",,"40.06","32.31",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.6596",,"0.4404","Mixed","accidents, illness/medical procedure, other (""interpersonal"", ""loss"", not specified)","High","Butollo WH, Karl R, König J, et al. A randomized controlled clinical trial of dialogical exposure therapy versus cognitive processing therapy for adult outpatients suffering from PTSD after type I trauma in adulthood. Psychother Psychosom. 2016 Jan;85(1):16-26. doi: 10.1159/000440726. PMID: 26610167.","45076","2020"
"butollo2016_IES_A_103.9_Comp","Psychotherapy","PTSD","141","A","PTSD",,,,"Dialogical Exposure Therapy","Dialogical Exposure Therapy","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","74","Self report","IES","IES-R","Completer","LOCF","MANOVA, repeated measures ANOVA, and t-test for change in mean score; chi-square for diagnostic change and clinically meaningful response","Assessment at ≥12 Months","103.9",,"30.18","29.26",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.6596",,"0.4404","Mixed","accidents, illness/medical procedure, other (""interpersonal"", ""loss"", not specified)","High","Butollo WH, Karl R, König J, et al. A randomized controlled clinical trial of dialogical exposure therapy versus cognitive processing therapy for adult outpatients suffering from PTSD after type I trauma in adulthood. Psychother Psychosom. 2016 Jan;85(1):16-26. doi: 10.1159/000440726. PMID: 26610167.","45076","2020"
"butollo2016_IES_A_26_Comp","Psychotherapy","PTSD","141","A","PTSD",,,,"Dialogical Exposure Therapy","Dialogical Exposure Therapy","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","74","Self report","IES","IES-R","Completer","LOCF","MANOVA, repeated measures ANOVA, and t-test for change in mean score; chi-square for diagnostic change and clinically meaningful response","Assessment at 6 to <12 Months","26",,"32.31","29.48",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.6596",,"0.4404","Mixed","accidents, illness/medical procedure, other (""interpersonal"", ""loss"", not specified)","High","Butollo WH, Karl R, König J, et al. A randomized controlled clinical trial of dialogical exposure therapy versus cognitive processing therapy for adult outpatients suffering from PTSD after type I trauma in adulthood. Psychother Psychosom. 2016 Jan;85(1):16-26. doi: 10.1159/000440726. PMID: 26610167.","45076","2020"
"butollo2016_IES_A_26_ITT","Psychotherapy","PTSD","141","A","PTSD",,,,"Dialogical Exposure Therapy","Dialogical Exposure Therapy","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","74","Self report","IES","IES-R","ITT","LOCF","MANOVA, repeated measures ANOVA, and t-test for change in mean score; chi-square for diagnostic change and clinically meaningful response","Assessment at 6 to <12 Months","26",,"36.47","30.69",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.6596",,"0.4404","Mixed","accidents, illness/medical procedure, other (""interpersonal"", ""loss"", not specified)","High","Butollo WH, Karl R, König J, et al. A randomized controlled clinical trial of dialogical exposure therapy versus cognitive processing therapy for adult outpatients suffering from PTSD after type I trauma in adulthood. Psychother Psychosom. 2016 Jan;85(1):16-26. doi: 10.1159/000440726. PMID: 26610167.","45076","2020"
"butollo2016_IES_A_Baseline_Comp","Psychotherapy","PTSD","141","A","PTSD",,,,"Dialogical Exposure Therapy","Dialogical Exposure Therapy","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","74","Self report","IES","IES-R","Completer","LOCF","MANOVA, repeated measures ANOVA, and t-test for change in mean score; chi-square for diagnostic change and clinically meaningful response","Baseline",,,"69.16","16.09",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.6596",,"0.4404","Mixed","accidents, illness/medical procedure, other (""interpersonal"", ""loss"", not specified)","High","Butollo WH, Karl R, König J, et al. A randomized controlled clinical trial of dialogical exposure therapy versus cognitive processing therapy for adult outpatients suffering from PTSD after type I trauma in adulthood. Psychother Psychosom. 2016 Jan;85(1):16-26. doi: 10.1159/000440726. PMID: 26610167.","45076","2020"
"butollo2016_IES_A_Baseline_ITT","Psychotherapy","PTSD","141","A","PTSD",,,,"Dialogical Exposure Therapy","Dialogical Exposure Therapy","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","74","Self report","IES","IES-R","ITT","LOCF","MANOVA, repeated measures ANOVA, and t-test for change in mean score; chi-square for diagnostic change and clinically meaningful response","Baseline",,,"69.22","16.07",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.6596",,"0.4404","Mixed","accidents, illness/medical procedure, other (""interpersonal"", ""loss"", not specified)","High","Butollo WH, Karl R, König J, et al. A randomized controlled clinical trial of dialogical exposure therapy versus cognitive processing therapy for adult outpatients suffering from PTSD after type I trauma in adulthood. Psychother Psychosom. 2016 Jan;85(1):16-26. doi: 10.1159/000440726. PMID: 26610167.","45076","2020"
"butollo2016_IES_B_0_Comp","Psychotherapy","PTSD","141","B","PTSD",,,,"CPT","Cognitive Processing Therapy (CPT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","67","Self report","IES","IES-R","Completer","LOCF","MANOVA, repeated measures ANOVA, and t-test for change in mean score; chi-square for diagnostic change and clinically meaningful response","End of Treatment","0",,"20.07","22.42",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.6596",,"0.4404","Mixed","accidents, illness/medical procedure, other (""interpersonal"", ""loss"", not specified)","High","Butollo WH, Karl R, König J, et al. A randomized controlled clinical trial of dialogical exposure therapy versus cognitive processing therapy for adult outpatients suffering from PTSD after type I trauma in adulthood. Psychother Psychosom. 2016 Jan;85(1):16-26. doi: 10.1159/000440726. PMID: 26610167.","45076","2020"
"butollo2016_IES_B_0_ITT","Psychotherapy","PTSD","141","B","PTSD",,,,"CPT","Cognitive Processing Therapy (CPT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","67","Self report","IES","IES-R","ITT","LOCF","MANOVA, repeated measures ANOVA, and t-test for change in mean score; chi-square for diagnostic change and clinically meaningful response","End of Treatment","0",,"27.96","28.98",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.6596",,"0.4404","Mixed","accidents, illness/medical procedure, other (""interpersonal"", ""loss"", not specified)","High","Butollo WH, Karl R, König J, et al. A randomized controlled clinical trial of dialogical exposure therapy versus cognitive processing therapy for adult outpatients suffering from PTSD after type I trauma in adulthood. Psychother Psychosom. 2016 Jan;85(1):16-26. doi: 10.1159/000440726. PMID: 26610167.","45076","2020"
"butollo2016_IES_B_103.9_Comp","Psychotherapy","PTSD","141","B","PTSD",,,,"CPT","Cognitive Processing Therapy (CPT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","67","Self report","IES","IES-R","Completer","LOCF","MANOVA, repeated measures ANOVA, and t-test for change in mean score; chi-square for diagnostic change and clinically meaningful response","Assessment at ≥12 Months","103.9",,"22.13","22.78",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.6596",,"0.4404","Mixed","accidents, illness/medical procedure, other (""interpersonal"", ""loss"", not specified)","High","Butollo WH, Karl R, König J, et al. A randomized controlled clinical trial of dialogical exposure therapy versus cognitive processing therapy for adult outpatients suffering from PTSD after type I trauma in adulthood. Psychother Psychosom. 2016 Jan;85(1):16-26. doi: 10.1159/000440726. PMID: 26610167.","45076","2020"
"butollo2016_IES_B_26_Comp","Psychotherapy","PTSD","141","B","PTSD",,,,"CPT","Cognitive Processing Therapy (CPT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","67","Self report","IES","IES-R","Completer","LOCF","MANOVA, repeated measures ANOVA, and t-test for change in mean score; chi-square for diagnostic change and clinically meaningful response","Assessment at 6 to <12 Months","26",,"22.38","22.91",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.6596",,"0.4404","Mixed","accidents, illness/medical procedure, other (""interpersonal"", ""loss"", not specified)","High","Butollo WH, Karl R, König J, et al. A randomized controlled clinical trial of dialogical exposure therapy versus cognitive processing therapy for adult outpatients suffering from PTSD after type I trauma in adulthood. Psychother Psychosom. 2016 Jan;85(1):16-26. doi: 10.1159/000440726. PMID: 26610167.","45076","2020"
"butollo2016_IES_B_26_ITT","Psychotherapy","PTSD","141","B","PTSD",,,,"CPT","Cognitive Processing Therapy (CPT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","67","Self report","IES","IES-R","ITT","LOCF","MANOVA, repeated measures ANOVA, and t-test for change in mean score; chi-square for diagnostic change and clinically meaningful response","Assessment at 6 to <12 Months","26",,"29.91","28.77",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.6596",,"0.4404","Mixed","accidents, illness/medical procedure, other (""interpersonal"", ""loss"", not specified)","High","Butollo WH, Karl R, König J, et al. A randomized controlled clinical trial of dialogical exposure therapy versus cognitive processing therapy for adult outpatients suffering from PTSD after type I trauma in adulthood. Psychother Psychosom. 2016 Jan;85(1):16-26. doi: 10.1159/000440726. PMID: 26610167.","45076","2020"
"butollo2016_IES_B_Baseline_Comp","Psychotherapy","PTSD","141","B","PTSD",,,,"CPT","Cognitive Processing Therapy (CPT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","67","Self report","IES","IES-R","Completer","LOCF","MANOVA, repeated measures ANOVA, and t-test for change in mean score; chi-square for diagnostic change and clinically meaningful response","Baseline",,,"65.75","19.08",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.6596",,"0.4404","Mixed","accidents, illness/medical procedure, other (""interpersonal"", ""loss"", not specified)","High","Butollo WH, Karl R, König J, et al. A randomized controlled clinical trial of dialogical exposure therapy versus cognitive processing therapy for adult outpatients suffering from PTSD after type I trauma in adulthood. Psychother Psychosom. 2016 Jan;85(1):16-26. doi: 10.1159/000440726. PMID: 26610167.","45076","2020"
"butollo2016_IES_B_Baseline_ITT","Psychotherapy","PTSD","141","B","PTSD",,,,"CPT","Cognitive Processing Therapy (CPT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","67","Self report","IES","IES-R","ITT","LOCF","MANOVA, repeated measures ANOVA, and t-test for change in mean score; chi-square for diagnostic change and clinically meaningful response","Baseline",,,"66.76","19.36",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.6596",,"0.4404","Mixed","accidents, illness/medical procedure, other (""interpersonal"", ""loss"", not specified)","High","Butollo WH, Karl R, König J, et al. A randomized controlled clinical trial of dialogical exposure therapy versus cognitive processing therapy for adult outpatients suffering from PTSD after type I trauma in adulthood. Psychother Psychosom. 2016 Jan;85(1):16-26. doi: 10.1159/000440726. PMID: 26610167.","45076","2020"
"butollo2016_PDS_A_0_Comp","Psychotherapy","PTSD","141","A","PTSD",,,"≤65","Dialogical Exposure Therapy","Dialogical Exposure Therapy","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","74","Self report","PDS","PDS","Completer","LOCF","MANOVA, repeated measures ANOVA, and t-test for change in mean score; chi-square for diagnostic change and clinically meaningful response","End of Treatment","0",,"17.22","13.73",,,,,"-12.70",,,,,"Hedges' g","0.98",,,,,,,,,,,,"PDS <18",,,"RCI for PDS",,"Additional definitions of Clinically Meaningful Response reported in the study","Community",,,"1","0.6596",,"0.4404","Mixed","accidents, illness/medical procedure, other (""interpersonal"", ""loss"", not specified)","High","Butollo WH, Karl R, König J, et al. A randomized controlled clinical trial of dialogical exposure therapy versus cognitive processing therapy for adult outpatients suffering from PTSD after type I trauma in adulthood. Psychother Psychosom. 2016 Jan;85(1):16-26. doi: 10.1159/000440726. PMID: 26610167.","45076","2020"
"butollo2016_PDS_A_0_ITT","Psychotherapy","PTSD","141","A","PTSD",,"72",,"Dialogical Exposure Therapy","Dialogical Exposure Therapy","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","74","Self report","PDS","PDS","ITT","LOCF","MANOVA, repeated measures ANOVA, and t-test for change in mean score; chi-square for diagnostic change and clinically meaningful response","End of Treatment","0",,"18.79","14.02",,,,,"-11.29",,,,,"Hedges' g","0.93",,,,,,,,,,,,"PDS <18","0.527",,"RCI for PDS",,"Additional definitions of Clinically Meaningful Response reported in the study","Community",,,"1","0.6596",,"0.4404","Mixed","accidents, illness/medical procedure, other (""interpersonal"", ""loss"", not specified)","High","Butollo WH, Karl R, König J, et al. A randomized controlled clinical trial of dialogical exposure therapy versus cognitive processing therapy for adult outpatients suffering from PTSD after type I trauma in adulthood. Psychother Psychosom. 2016 Jan;85(1):16-26. doi: 10.1159/000440726. PMID: 26610167.","45076","2020"
"butollo2016_PDS_A_103.9_Comp","Psychotherapy","PTSD","141","A","PTSD",,"17",,"Dialogical Exposure Therapy","Dialogical Exposure Therapy","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","74","Self report","PDS","PDS","Completer","LOCF","MANOVA, repeated measures ANOVA, and t-test for change in mean score; chi-square for diagnostic change and clinically meaningful response","Assessment at ≥12 Months","103.9",,"14.08","13.06",,,,,"-15.84",,,,,"Hedges' g","1.28",,,,,,,,,,,,"PDS <18","0.7231",,"RCI for PDS","0.6667","Additional definitions of Clinically Meaningful Response reported in the study","Community",,,"1","0.6596",,"0.4404","Mixed","accidents, illness/medical procedure, other (""interpersonal"", ""loss"", not specified)","High","Butollo WH, Karl R, König J, et al. A randomized controlled clinical trial of dialogical exposure therapy versus cognitive processing therapy for adult outpatients suffering from PTSD after type I trauma in adulthood. Psychother Psychosom. 2016 Jan;85(1):16-26. doi: 10.1159/000440726. PMID: 26610167.","45076","2020"
"butollo2016_PDS_A_26_Comp","Psychotherapy","PTSD","141","A","PTSD",,,"≤65","Dialogical Exposure Therapy","Dialogical Exposure Therapy","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","74","Self report","PDS","PDS","Completer","LOCF","MANOVA, repeated measures ANOVA, and t-test for change in mean score; chi-square for diagnostic change and clinically meaningful response","Assessment at 6 to <12 Months","26",,"15.06","13.24",,,,,"-14.86",,,,,"Hedges' g","1.19",,,,,,,,,,,,"PDS <18",,,"RCI for PDS",,"Additional definitions of Clinically Meaningful Response reported in the study","Community",,,"1","0.6596",,"0.4404","Mixed","accidents, illness/medical procedure, other (""interpersonal"", ""loss"", not specified)","High","Butollo WH, Karl R, König J, et al. A randomized controlled clinical trial of dialogical exposure therapy versus cognitive processing therapy for adult outpatients suffering from PTSD after type I trauma in adulthood. Psychother Psychosom. 2016 Jan;85(1):16-26. doi: 10.1159/000440726. PMID: 26610167.","45076","2020"
"butollo2016_PDS_A_26_ITT","Psychotherapy","PTSD","141","A","PTSD",,"48",,"Dialogical Exposure Therapy","Dialogical Exposure Therapy","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","74","Self report","PDS","PDS","ITT","LOCF","MANOVA, repeated measures ANOVA, and t-test for change in mean score; chi-square for diagnostic change and clinically meaningful response","Assessment at 6 to <12 Months","26",,"16.88","13.83",,,,,"-13.20",,,,,"Hedges' g","1.10",,,,,,,,,,,,"PDS <18","0.5946",,"RCI for PDS","0.5211","Additional definitions of Clinically Meaningful Response reported in the study","Community",,,"1","0.6596",,"0.4404","Mixed","accidents, illness/medical procedure, other (""interpersonal"", ""loss"", not specified)","High","Butollo WH, Karl R, König J, et al. A randomized controlled clinical trial of dialogical exposure therapy versus cognitive processing therapy for adult outpatients suffering from PTSD after type I trauma in adulthood. Psychother Psychosom. 2016 Jan;85(1):16-26. doi: 10.1159/000440726. PMID: 26610167.","45076","2020"
"butollo2016_PDS_A_Baseline_Comp","Psychotherapy","PTSD","141","A","PTSD",,,"≤65","Dialogical Exposure Therapy","Dialogical Exposure Therapy","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","74","Self report","PDS","PDS","Completer","LOCF","MANOVA, repeated measures ANOVA, and t-test for change in mean score; chi-square for diagnostic change and clinically meaningful response","Baseline",,,"29.92","9.98",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.6596",,"0.4404","Mixed","accidents, illness/medical procedure, other (""interpersonal"", ""loss"", not specified)","High","Butollo WH, Karl R, König J, et al. A randomized controlled clinical trial of dialogical exposure therapy versus cognitive processing therapy for adult outpatients suffering from PTSD after type I trauma in adulthood. Psychother Psychosom. 2016 Jan;85(1):16-26. doi: 10.1159/000440726. PMID: 26610167.","45076","2020"
"butollo2016_PDS_A_Baseline_ITT","Psychotherapy","PTSD","141","A","PTSD",,"71",,"Dialogical Exposure Therapy","Dialogical Exposure Therapy","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","74","Self report","PDS","PDS","ITT","LOCF","MANOVA, repeated measures ANOVA, and t-test for change in mean score; chi-square for diagnostic change and clinically meaningful response","Baseline",,,"30.08","9.89",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.6596",,"0.4404","Mixed","accidents, illness/medical procedure, other (""interpersonal"", ""loss"", not specified)","High","Butollo WH, Karl R, König J, et al. A randomized controlled clinical trial of dialogical exposure therapy versus cognitive processing therapy for adult outpatients suffering from PTSD after type I trauma in adulthood. Psychother Psychosom. 2016 Jan;85(1):16-26. doi: 10.1159/000440726. PMID: 26610167.","45076","2020"
"butollo2016_PDS_B_0_Comp","Psychotherapy","PTSD","141","B","PTSD",,"57",,"CPT","Cognitive Processing Therapy (CPT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","67","Self report","PDS","PDS","Completer","LOCF","MANOVA, repeated measures ANOVA, and t-test for change in mean score; chi-square for diagnostic change and clinically meaningful response","End of Treatment","0",,"14.11","11.83",,,,,"-14.85",,,,,"Hedges' g","1.35",,,,,,,,,,,,"PDS <18",,,"RCI for PDS",,"Additional definitions of Clinically Meaningful Response reported in the study","Community",,,"1","0.6596",,"0.4404","Mixed","accidents, illness/medical procedure, other (""interpersonal"", ""loss"", not specified)","High","Butollo WH, Karl R, König J, et al. A randomized controlled clinical trial of dialogical exposure therapy versus cognitive processing therapy for adult outpatients suffering from PTSD after type I trauma in adulthood. Psychother Psychosom. 2016 Jan;85(1):16-26. doi: 10.1159/000440726. PMID: 26610167.","45076","2020"
"butollo2016_PDS_B_0_ITT","Psychotherapy","PTSD","141","B","PTSD",,"67",,"CPT","Cognitive Processing Therapy (CPT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","67","Self report","PDS","PDS","ITT","LOCF","MANOVA, repeated measures ANOVA, and t-test for change in mean score; chi-square for diagnostic change and clinically meaningful response","End of Treatment","0",,"15.93","12.36",,,,,"-12.63",,,,,"Hedges' g","1.12",,,,,,,,,,,,"PDS <18","0.6119",,"RCI for PDS",,"Additional definitions of Clinically Meaningful Response reported in the study","Community",,,"1","0.6596",,"0.4404","Mixed","accidents, illness/medical procedure, other (""interpersonal"", ""loss"", not specified)","High","Butollo WH, Karl R, König J, et al. A randomized controlled clinical trial of dialogical exposure therapy versus cognitive processing therapy for adult outpatients suffering from PTSD after type I trauma in adulthood. Psychother Psychosom. 2016 Jan;85(1):16-26. doi: 10.1159/000440726. PMID: 26610167.","45076","2020"
"butollo2016_PDS_B_103.9_Comp","Psychotherapy","PTSD","141","B","PTSD",,"19",,"CPT","Cognitive Processing Therapy (CPT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","67","Self report","PDS","PDS","Completer","LOCF","MANOVA, repeated measures ANOVA, and t-test for change in mean score; chi-square for diagnostic change and clinically meaningful response","Assessment at ≥12 Months","103.9",,"14.09","12.61",,,,,"-14.87",,,,,"Hedges' g","1.30",,,,,,,,,,,,"PDS <18","0.7018",,"RCI for PDS","0.6429","Additional definitions of Clinically Meaningful Response reported in the study","Community",,,"1","0.6596",,"0.4404","Mixed","accidents, illness/medical procedure, other (""interpersonal"", ""loss"", not specified)","High","Butollo WH, Karl R, König J, et al. A randomized controlled clinical trial of dialogical exposure therapy versus cognitive processing therapy for adult outpatients suffering from PTSD after type I trauma in adulthood. Psychother Psychosom. 2016 Jan;85(1):16-26. doi: 10.1159/000440726. PMID: 26610167.","45076","2020"
"butollo2016_PDS_B_26_Comp","Psychotherapy","PTSD","141","B","PTSD",,,"≤57","CPT","Cognitive Processing Therapy (CPT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","67","Self report","PDS","PDS","Completer","LOCF","MANOVA, repeated measures ANOVA, and t-test for change in mean score; chi-square for diagnostic change and clinically meaningful response","Assessment at 6 to <12 Months","26",,"14.30","12.4",,,,,"-14.66",,,,,"Hedges' g","1.27",,,,,,,,,,,,"PDS <18",,,"RCI for PDS",,"Additional definitions of Clinically Meaningful Response reported in the study","Community",,,"1","0.6596",,"0.4404","Mixed","accidents, illness/medical procedure, other (""interpersonal"", ""loss"", not specified)","High","Butollo WH, Karl R, König J, et al. A randomized controlled clinical trial of dialogical exposure therapy versus cognitive processing therapy for adult outpatients suffering from PTSD after type I trauma in adulthood. Psychother Psychosom. 2016 Jan;85(1):16-26. doi: 10.1159/000440726. PMID: 26610167.","45076","2020"
"butollo2016_PDS_B_26_ITT","Psychotherapy","PTSD","141","B","PTSD",,"52",,"CPT","Cognitive Processing Therapy (CPT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","67","Self report","PDS","PDS","ITT","LOCF","MANOVA, repeated measures ANOVA, and t-test for change in mean score; chi-square for diagnostic change and clinically meaningful response","Assessment at 6 to <12 Months","26",,"16.03","13.17",,,,,"-12.53",,,,,"Hedges' g","1.07",,,,,,,,,,,,"PDS <18","0.6418",,"RCI for PDS","0.561","Additional definitions of Clinically Meaningful Response reported in the study","Community",,,"1","0.6596",,"0.4404","Mixed","accidents, illness/medical procedure, other (""interpersonal"", ""loss"", not specified)","High","Butollo WH, Karl R, König J, et al. A randomized controlled clinical trial of dialogical exposure therapy versus cognitive processing therapy for adult outpatients suffering from PTSD after type I trauma in adulthood. Psychother Psychosom. 2016 Jan;85(1):16-26. doi: 10.1159/000440726. PMID: 26610167.","45076","2020"
"butollo2016_PDS_B_Baseline_Comp","Psychotherapy","PTSD","141","B","PTSD",,,"≤57","CPT","Cognitive Processing Therapy (CPT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","67","Self report","PDS","PDS","Completer","LOCF","MANOVA, repeated measures ANOVA, and t-test for change in mean score; chi-square for diagnostic change and clinically meaningful response","Baseline",,,"28.96","10.14",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.6596",,"0.4404","Mixed","accidents, illness/medical procedure, other (""interpersonal"", ""loss"", not specified)","High","Butollo WH, Karl R, König J, et al. A randomized controlled clinical trial of dialogical exposure therapy versus cognitive processing therapy for adult outpatients suffering from PTSD after type I trauma in adulthood. Psychother Psychosom. 2016 Jan;85(1):16-26. doi: 10.1159/000440726. PMID: 26610167.","45076","2020"
"butollo2016_PDS_B_Baseline_ITT","Psychotherapy","PTSD","141","B","PTSD",,"66",,"CPT","Cognitive Processing Therapy (CPT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","67","Self report","PDS","PDS","ITT","LOCF","MANOVA, repeated measures ANOVA, and t-test for change in mean score; chi-square for diagnostic change and clinically meaningful response","Baseline",,,"28.56","10.15",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.6596",,"0.4404","Mixed","accidents, illness/medical procedure, other (""interpersonal"", ""loss"", not specified)","High","Butollo WH, Karl R, König J, et al. A randomized controlled clinical trial of dialogical exposure therapy versus cognitive processing therapy for adult outpatients suffering from PTSD after type I trauma in adulthood. Psychother Psychosom. 2016 Jan;85(1):16-26. doi: 10.1159/000440726. PMID: 26610167.","45076","2020"
"butterfield2001_DTS_A_0_NA","Pharmacotherapy","PTSD","15","A","PTSD",,,,"Olanzapine","Olanzapine","No","Not Applicable","Yes","Antipsychotic","No","Not Applicable","No","No","No","No","No","Individual","In Person","10","Self report","DTS","DTS",,,"MANOVA, repeated measures ANOVA, and t-test for change in mean score; chi-square for diagnostic change and clinically meaningful response","End of Treatment","0",,"57.4","35.6",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0.9333",,"0.0667","Mixed","MST, child physical abuse, rape/sexual assault, intimate partner violence, community/school violence, other (military harassment, ""nurse in Vietnam"", ""Persian Gulf"" [non-combat trauma])","Medium","Butterfield M, Becker M, Connor K, et al. Olanzapine in the treatment of post-traumatic stress disorder: a pilot study. Int Clin Psychopharmacol. 2001;16(4):197-203.  PMID: 11459333.","23547","2019"
"butterfield2001_DTS_A_Baseline_NA","Pharmacotherapy","PTSD","15","A","PTSD",,,,"Olanzapine","Olanzapine","No","Not Applicable","Yes","Antipsychotic","No","Not Applicable","No","No","No","No","No","Individual","In Person","10","Self report","DTS","DTS",,,"MANOVA, repeated measures ANOVA, and t-test for change in mean score; chi-square for diagnostic change and clinically meaningful response","Baseline",,,"91.6","25.4",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0.9333",,"0.0667","Mixed","MST, child physical abuse, rape/sexual assault, intimate partner violence, community/school violence, other (military harassment, ""nurse in Vietnam"", ""Persian Gulf"" [non-combat trauma])","Medium","Butterfield M, Becker M, Connor K, et al. Olanzapine in the treatment of post-traumatic stress disorder: a pilot study. Int Clin Psychopharmacol. 2001;16(4):197-203.  PMID: 11459333.","23547","2019"
"butterfield2001_DTS_B_0_NA","Pharmacotherapy","PTSD","15","B","Control",,,,"Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","5","Self report","DTS","DTS",,,"MANOVA, repeated measures ANOVA, and t-test for change in mean score; chi-square for diagnostic change and clinically meaningful response","End of Treatment","0",,"56.0","36.6",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0.9333",,"0.0667","Mixed","MST, child physical abuse, rape/sexual assault, intimate partner violence, community/school violence, other (military harassment, ""nurse in Vietnam"", ""Persian Gulf"" [non-combat trauma])","Medium","Butterfield M, Becker M, Connor K, et al. Olanzapine in the treatment of post-traumatic stress disorder: a pilot study. Int Clin Psychopharmacol. 2001;16(4):197-203.  PMID: 11459333.","23547","2019"
"butterfield2001_DTS_B_Baseline_NA","Pharmacotherapy","PTSD","15","B","Control",,,,"Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","5","Self report","DTS","DTS",,,"MANOVA, repeated measures ANOVA, and t-test for change in mean score; chi-square for diagnostic change and clinically meaningful response","Baseline",,,"95.8","16.7",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0.9333",,"0.0667","Mixed","MST, child physical abuse, rape/sexual assault, intimate partner violence, community/school violence, other (military harassment, ""nurse in Vietnam"", ""Persian Gulf"" [non-combat trauma])","Medium","Butterfield M, Becker M, Connor K, et al. Olanzapine in the treatment of post-traumatic stress disorder: a pilot study. Int Clin Psychopharmacol. 2001;16(4):197-203.  PMID: 11459333.","23547","2019"
"butterfield2001_SI-PTSD_A_0_ITT","Pharmacotherapy","PTSD","15","A","PTSD",,"10",,"Olanzapine","Olanzapine","No","Not Applicable","Yes","Antipsychotic","No","Not Applicable","No","No","No","No","No","Individual","In Person","10","Structured Clinical Interview","SI-PTSD","SI-PTSD","ITT",,"MANOVA, repeated measures ANOVA, and t-test for change in mean score; chi-square for diagnostic change and clinically meaningful response","End of Treatment","0",,"19.2","8.7",,,,,"-20.5",,,,,,,,,,,,,,,,,,,,,"CGI score of 1 or 2","0.60",,"Veteran","0","1","0","0.9333",,"0.0667","Mixed","MST, child physical abuse, rape/sexual assault, intimate partner violence, community/school violence, other (military harassment, ""nurse in Vietnam"", ""Persian Gulf"" [non-combat trauma])","Medium","Butterfield M, Becker M, Connor K, et al. Olanzapine in the treatment of post-traumatic stress disorder: a pilot study. Int Clin Psychopharmacol. 2001;16(4):197-203.  PMID: 11459333.","23547","2019"
"butterfield2001_SI-PTSD_A_Baseline_ITT","Pharmacotherapy","PTSD","15","A","PTSD",,"10",,"Olanzapine","Olanzapine","No","Not Applicable","Yes","Antipsychotic","No","Not Applicable","No","No","No","No","No","Individual","In Person","10","Structured Clinical Interview","SI-PTSD","SI-PTSD","ITT",,"MANOVA, repeated measures ANOVA, and t-test for change in mean score; chi-square for diagnostic change and clinically meaningful response","Baseline",,,"39.7","9.7",,,,,,,,,,,,,,,,,,,,,,,,,,"CGI score of 1 or 2",,,"Veteran","0","1","0","0.9333",,"0.0667","Mixed","MST, child physical abuse, rape/sexual assault, intimate partner violence, community/school violence, other (military harassment, ""nurse in Vietnam"", ""Persian Gulf"" [non-combat trauma])","Medium","Butterfield M, Becker M, Connor K, et al. Olanzapine in the treatment of post-traumatic stress disorder: a pilot study. Int Clin Psychopharmacol. 2001;16(4):197-203.  PMID: 11459333.","23547","2019"
"butterfield2001_SI-PTSD_B_0_ITT","Pharmacotherapy","PTSD","15","B","Control",,"5",,"Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","5","Structured Clinical Interview","SI-PTSD","SI-PTSD","ITT",,"MANOVA, repeated measures ANOVA, and t-test for change in mean score; chi-square for diagnostic change and clinically meaningful response","End of Treatment","0",,"17.0","17.5",,,,,"-28.9",,,,,,,,,,,,,,,,,,,,,"CGI score of 1 or 2","0.60",,"Veteran","0","1","0","0.9333",,"0.0667","Mixed","MST, child physical abuse, rape/sexual assault, intimate partner violence, community/school violence, other (military harassment, ""nurse in Vietnam"", ""Persian Gulf"" [non-combat trauma])","Medium","Butterfield M, Becker M, Connor K, et al. Olanzapine in the treatment of post-traumatic stress disorder: a pilot study. Int Clin Psychopharmacol. 2001;16(4):197-203.  PMID: 11459333.","23547","2019"
"butterfield2001_SI-PTSD_B_Baseline_ITT","Pharmacotherapy","PTSD","15","B","Control",,"5",,"Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","5","Structured Clinical Interview","SI-PTSD","SI-PTSD","ITT",,"MANOVA, repeated measures ANOVA, and t-test for change in mean score; chi-square for diagnostic change and clinically meaningful response","Baseline",,,"45.9","8.2",,,,,,,,,,,,,,,,,,,,,,,,,,"CGI score of 1 or 2",,,"Veteran","0","1","0","0.9333",,"0.0667","Mixed","MST, child physical abuse, rape/sexual assault, intimate partner violence, community/school violence, other (military harassment, ""nurse in Vietnam"", ""Persian Gulf"" [non-combat trauma])","Medium","Butterfield M, Becker M, Connor K, et al. Olanzapine in the treatment of post-traumatic stress disorder: a pilot study. Int Clin Psychopharmacol. 2001;16(4):197-203.  PMID: 11459333.","23547","2019"
"butterfield2001_SPRINT_A_0_NA","Pharmacotherapy","PTSD","15","A","PTSD",,,,"Olanzapine","Olanzapine","No","Not Applicable","Yes","Antipsychotic","No","Not Applicable","No","No","No","No","No","Individual","In Person","10","Self report","SPRINT","SPRINT",,,"MANOVA, repeated measures ANOVA, and t-test for change in mean score; chi-square for diagnostic change and clinically meaningful response","End of Treatment","0",,"17.9","7.8",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0.9333",,"0.0667","Mixed","MST, child physical abuse, rape/sexual assault, intimate partner violence, community/school violence, other (military harassment, ""nurse in Vietnam"", ""Persian Gulf"" [non-combat trauma])","Medium","Butterfield M, Becker M, Connor K, et al. Olanzapine in the treatment of post-traumatic stress disorder: a pilot study. Int Clin Psychopharmacol. 2001;16(4):197-203.  PMID: 11459333.","23547","2019"
"butterfield2001_SPRINT_A_Baseline_NA","Pharmacotherapy","PTSD","15","A","PTSD",,,,"Olanzapine","Olanzapine","No","Not Applicable","Yes","Antipsychotic","No","Not Applicable","No","No","No","No","No","Individual","In Person","10","Self report","SPRINT","SPRINT",,,"MANOVA, repeated measures ANOVA, and t-test for change in mean score; chi-square for diagnostic change and clinically meaningful response","Baseline",,,"31.5","5.7",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0.9333",,"0.0667","Mixed","MST, child physical abuse, rape/sexual assault, intimate partner violence, community/school violence, other (military harassment, ""nurse in Vietnam"", ""Persian Gulf"" [non-combat trauma])","Medium","Butterfield M, Becker M, Connor K, et al. Olanzapine in the treatment of post-traumatic stress disorder: a pilot study. Int Clin Psychopharmacol. 2001;16(4):197-203.  PMID: 11459333.","23547","2019"
"butterfield2001_SPRINT_B_0_NA","Pharmacotherapy","PTSD","15","B","Control",,,,"Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","5","Self report","SPRINT","SPRINT",,,"MANOVA, repeated measures ANOVA, and t-test for change in mean score; chi-square for diagnostic change and clinically meaningful response","End of Treatment","0",,"20.5","11.1",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0.9333",,"0.0667","Mixed","MST, child physical abuse, rape/sexual assault, intimate partner violence, community/school violence, other (military harassment, ""nurse in Vietnam"", ""Persian Gulf"" [non-combat trauma])","Medium","Butterfield M, Becker M, Connor K, et al. Olanzapine in the treatment of post-traumatic stress disorder: a pilot study. Int Clin Psychopharmacol. 2001;16(4):197-203.  PMID: 11459333.","23547","2019"
"butterfield2001_SPRINT_B_Baseline_NA","Pharmacotherapy","PTSD","15","B","Control",,,,"Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","5","Self report","SPRINT","SPRINT",,,"MANOVA, repeated measures ANOVA, and t-test for change in mean score; chi-square for diagnostic change and clinically meaningful response","Baseline",,,"34.8","2.1",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0.9333",,"0.0667","Mixed","MST, child physical abuse, rape/sexual assault, intimate partner violence, community/school violence, other (military harassment, ""nurse in Vietnam"", ""Persian Gulf"" [non-combat trauma])","Medium","Butterfield M, Becker M, Connor K, et al. Olanzapine in the treatment of post-traumatic stress disorder: a pilot study. Int Clin Psychopharmacol. 2001;16(4):197-203.  PMID: 11459333.","23547","2019"
"butterfield2001_TOP-8_A_0_NA","Pharmacotherapy","PTSD","15","A","PTSD",,,,"Olanzapine","Olanzapine","No","Not Applicable","Yes","Antipsychotic","No","Not Applicable","No","No","No","No","No","Individual","In Person","10","Structured Clinical Interview","TOP-8","TOP-8",,,"MANOVA, repeated measures ANOVA, and t-test for change in mean score; chi-square for diagnostic change and clinically meaningful response","End of Treatment","0",,"12.6","6.4",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0.9333",,"0.0667","Mixed","MST, child physical abuse, rape/sexual assault, intimate partner violence, community/school violence, other (military harassment, ""nurse in Vietnam"", ""Persian Gulf"" [non-combat trauma])","Medium","Butterfield M, Becker M, Connor K, et al. Olanzapine in the treatment of post-traumatic stress disorder: a pilot study. Int Clin Psychopharmacol. 2001;16(4):197-203.  PMID: 11459333.","23547","2019"
"butterfield2001_TOP-8_A_Baseline_NA","Pharmacotherapy","PTSD","15","A","PTSD",,,,"Olanzapine","Olanzapine","No","Not Applicable","Yes","Antipsychotic","No","Not Applicable","No","No","No","No","No","Individual","In Person","10","Structured Clinical Interview","TOP-8","TOP-8",,,"MANOVA, repeated measures ANOVA, and t-test for change in mean score; chi-square for diagnostic change and clinically meaningful response","Baseline",,,"19.3","4.2",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0.9333",,"0.0667","Mixed","MST, child physical abuse, rape/sexual assault, intimate partner violence, community/school violence, other (military harassment, ""nurse in Vietnam"", ""Persian Gulf"" [non-combat trauma])","Medium","Butterfield M, Becker M, Connor K, et al. Olanzapine in the treatment of post-traumatic stress disorder: a pilot study. Int Clin Psychopharmacol. 2001;16(4):197-203.  PMID: 11459333.","23547","2019"
"butterfield2001_TOP-8_B_0_NA","Pharmacotherapy","PTSD","15","B","Control",,,,"Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","5","Structured Clinical Interview","TOP-8","TOP-8",,,"MANOVA, repeated measures ANOVA, and t-test for change in mean score; chi-square for diagnostic change and clinically meaningful response","End of Treatment","0",,"10.5","8.7",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0.9333",,"0.0667","Mixed","MST, child physical abuse, rape/sexual assault, intimate partner violence, community/school violence, other (military harassment, ""nurse in Vietnam"", ""Persian Gulf"" [non-combat trauma])","Medium","Butterfield M, Becker M, Connor K, et al. Olanzapine in the treatment of post-traumatic stress disorder: a pilot study. Int Clin Psychopharmacol. 2001;16(4):197-203.  PMID: 11459333.","23547","2019"
"butterfield2001_TOP-8_B_Baseline_NA","Pharmacotherapy","PTSD","15","B","Control",,,,"Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","5","Structured Clinical Interview","TOP-8","TOP-8",,,"MANOVA, repeated measures ANOVA, and t-test for change in mean score; chi-square for diagnostic change and clinically meaningful response","Baseline",,,"21.8","3.3",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0.9333",,"0.0667","Mixed","MST, child physical abuse, rape/sexual assault, intimate partner violence, community/school violence, other (military harassment, ""nurse in Vietnam"", ""Persian Gulf"" [non-combat trauma])","Medium","Butterfield M, Becker M, Connor K, et al. Olanzapine in the treatment of post-traumatic stress disorder: a pilot study. Int Clin Psychopharmacol. 2001;16(4):197-203.  PMID: 11459333.","23547","2019"
"capone2018_CAPS_A_0_ITT","Psychotherapy","PTSD+SUD","44","A","PTSD+SUD","Integrated","19",,"Integrated CBT","Integrated Cognitive Behavioral Therapy (ICBT)","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","21","Structured Clinical Interview","CAPS","CAPS-4","ITT","Maximum likelihood method","Covariance pattern (unstructured) general linear mixed models","End of Treatment","0",,"61.67","18.27",,,,,"-15.16",,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0.0455",,"0.9545","Mixed","MST, combat-related, child sexual abuse, rape/sexual assault","Medium","Capone C, Presseau C, Saunders E, et al. Is integrated CBT effective in reducing PTSD symptoms and substance use in Iraq and Afghanistan veterans? Results from a randomized clinical trial. Cognit Ther Res. 2018;42(6):735-46. doi: 10.1007/s10608-018-9931-8.","50582","2020"
"capone2018_CAPS_A_12_ITT","Psychotherapy","PTSD+SUD","44","A","PTSD+SUD","Integrated","15",,"Integrated CBT","Integrated Cognitive Behavioral Therapy (ICBT)","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","21","Structured Clinical Interview","CAPS","CAPS-4","ITT","Maximum likelihood method","Covariance pattern (unstructured) general linear mixed models","Assessment at 3 to <6 Months","12",,"66.07","17.60",,,,,"-10.26",,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0.0455",,"0.9545","Mixed","MST, combat-related, child sexual abuse, rape/sexual assault","Medium","Capone C, Presseau C, Saunders E, et al. Is integrated CBT effective in reducing PTSD symptoms and substance use in Iraq and Afghanistan veterans? Results from a randomized clinical trial. Cognit Ther Res. 2018;42(6):735-46. doi: 10.1007/s10608-018-9931-8.","50582","2020"
"capone2018_CAPS_A_Baseline_ITT","Psychotherapy","PTSD+SUD","44","A","PTSD+SUD","Integrated","21",,"Integrated CBT","Integrated Cognitive Behavioral Therapy (ICBT)","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","21","Structured Clinical Interview","CAPS","CAPS-4","ITT","Maximum likelihood method","Covariance pattern (unstructured) general linear mixed models","Baseline",,,"76.33","14.71",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0.0455",,"0.9545","Mixed","MST, combat-related, child sexual abuse, rape/sexual assault","Medium","Capone C, Presseau C, Saunders E, et al. Is integrated CBT effective in reducing PTSD symptoms and substance use in Iraq and Afghanistan veterans? Results from a randomized clinical trial. Cognit Ther Res. 2018;42(6):735-46. doi: 10.1007/s10608-018-9931-8.","50582","2020"
"capone2018_CAPS_B_0_ITT","Psychotherapy","PTSD+SUD","44","B","Control","Not integrated","19",,"TAU","Treatment as usual (TAU)","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In person","23","Structured Clinical Interview","CAPS","CAPS-4","ITT","Maximum likelihood method","Covariance pattern (unstructured) general linear mixed models","End of Treatment","0",,"69.42","26.26",,,,,"-9.36",,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0.0455",,"0.9545","Mixed","MST, combat-related, child sexual abuse, rape/sexual assault","Medium","Capone C, Presseau C, Saunders E, et al. Is integrated CBT effective in reducing PTSD symptoms and substance use in Iraq and Afghanistan veterans? Results from a randomized clinical trial. Cognit Ther Res. 2018;42(6):735-46. doi: 10.1007/s10608-018-9931-8.","50582","2020"
"capone2018_CAPS_B_12_ITT","Psychotherapy","PTSD+SUD","44","B","Control","Not integrated","16",,"TAU","Treatment as usual (TAU)","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In person","23","Structured Clinical Interview","CAPS","CAPS-4","ITT","Maximum likelihood method","Covariance pattern (unstructured) general linear mixed models","Assessment at 3 to <6 Months","12",,"62.27","26.26",,,,,"-16.51",,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0.0455",,"0.9545","Mixed","MST, combat-related, child sexual abuse, rape/sexual assault","Medium","Capone C, Presseau C, Saunders E, et al. Is integrated CBT effective in reducing PTSD symptoms and substance use in Iraq and Afghanistan veterans? Results from a randomized clinical trial. Cognit Ther Res. 2018;42(6):735-46. doi: 10.1007/s10608-018-9931-8.","50582","2020"
"capone2018_CAPS_B_Baseline_ITT","Psychotherapy","PTSD+SUD","44","B","Control","Not integrated","23",,"TAU","Treatment as usual (TAU)","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In person","23","Structured Clinical Interview","CAPS","CAPS-4","ITT","Maximum likelihood method","Covariance pattern (unstructured) general linear mixed models","Baseline",,,"78.78","16.62",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0.0455",,"0.9545","Mixed","MST, combat-related, child sexual abuse, rape/sexual assault","Medium","Capone C, Presseau C, Saunders E, et al. Is integrated CBT effective in reducing PTSD symptoms and substance use in Iraq and Afghanistan veterans? Results from a randomized clinical trial. Cognit Ther Res. 2018;42(6):735-46. doi: 10.1007/s10608-018-9931-8.","50582","2020"
"carey2012_CAPS_A_0_Comp","Pharmacotherapy","PTSD","34","A","PTSD",,"14",,"Olanzapine","Olanzapine","No","Not Applicable","Yes","Antipsychotic","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"Structured Clinical Interview","CAPS","CAPS","Completer","LOCF","Covariance pattern (unstructured) general linear mixed models","End of Treatment","0",,"33.6","28.2",,,,,"-45.8",,,,,,,,,,,,,,,,,,"CAPS score <50","0.7143",,">50% reduction from baseline on CAPS","0.7143","Additional definitions of Clinically Meaningful Response reported in the study","Community",,,"1","0.6071",,"0.3929","Mixed","intimate partner violence, community/school violence","Medium","Carey P, Suliman S, Ganesan K, et al. Olanzapine monotherapy in posttraumatic stress disorder: efficacy in a randomized, double-blind, placebo-controlled study. Hum Psychopharmacol. 2012 Jul;27(4):386-91. doi: 10.1002/hup.2238. PMID: 22730105.","38996","2019"
"carey2012_CAPS_A_Baseline_Comp","Pharmacotherapy","PTSD","34","A","PTSD",,,,"Olanzapine","Olanzapine","No","Not Applicable","Yes","Antipsychotic","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"Structured Clinical Interview","CAPS","CAPS","Completer","LOCF","Covariance pattern (unstructured) general linear mixed models","Baseline",,,"79.4","16",,,,,,,,,,,,,,,,,,,,,,,"CAPS score <50",,,">50% reduction from baseline on CAPS",,"Additional definitions of Clinically Meaningful Response reported in the study","Community",,,"1","0.6071",,"0.3929","Mixed","intimate partner violence, community/school violence","Medium","Carey P, Suliman S, Ganesan K, et al. Olanzapine monotherapy in posttraumatic stress disorder: efficacy in a randomized, double-blind, placebo-controlled study. Hum Psychopharmacol. 2012 Jul;27(4):386-91. doi: 10.1002/hup.2238. PMID: 22730105.","38996","2019"
"carey2012_CAPS_B_0_Comp","Pharmacotherapy","PTSD","34","B","Control",,"14",,"Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,"Structured Clinical Interview","CAPS","CAPS","Completer","LOCF","Covariance pattern (unstructured) general linear mixed models","End of Treatment","0",,"62.3","31.9",,,,,"-19.3",,,,,,,,,,,,,,,,,,"CAPS score <50","0.2143",,">50% reduction from baseline on CAPS","0.2143","Additional definitions of Clinically Meaningful Response reported in the study","Community",,,"1","0.6071",,"0.3929","Mixed","intimate partner violence, community/school violence","Medium","Carey P, Suliman S, Ganesan K, et al. Olanzapine monotherapy in posttraumatic stress disorder: efficacy in a randomized, double-blind, placebo-controlled study. Hum Psychopharmacol. 2012 Jul;27(4):386-91. doi: 10.1002/hup.2238. PMID: 22730105.","38996","2019"
"carey2012_CAPS_B_Baseline_Comp","Pharmacotherapy","PTSD","34","B","Control",,,,"Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,"Structured Clinical Interview","CAPS","CAPS","Completer","LOCF","Covariance pattern (unstructured) general linear mixed models","Baseline",,,"81.6","11.3",,,,,,,,,,,,,,,,,,,,,,,"CAPS score <50",,,">50% reduction from baseline on CAPS",,"Additional definitions of Clinically Meaningful Response reported in the study","Community",,,"1","0.6071",,"0.3929","Mixed","intimate partner violence, community/school violence","Medium","Carey P, Suliman S, Ganesan K, et al. Olanzapine monotherapy in posttraumatic stress disorder: efficacy in a randomized, double-blind, placebo-controlled study. Hum Psychopharmacol. 2012 Jul;27(4):386-91. doi: 10.1002/hup.2238. PMID: 22730105.","38996","2019"
"carey2012_DTS_A_0_NA","Pharmacotherapy","PTSD","34","A","PTSD",,,,"Olanzapine","Olanzapine","No","Not Applicable","Yes","Antipsychotic","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"Self report","DTS","DTS",,,"Covariance pattern (unstructured) general linear mixed models","End of Treatment","0",,"37.9","32",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.6071",,"0.3929","Mixed","intimate partner violence, community/school violence","Medium","Carey P, Suliman S, Ganesan K, et al. Olanzapine monotherapy in posttraumatic stress disorder: efficacy in a randomized, double-blind, placebo-controlled study. Hum Psychopharmacol. 2012 Jul;27(4):386-91. doi: 10.1002/hup.2238. PMID: 22730105.","38996","2019"
"carey2012_DTS_A_Baseline_NA","Pharmacotherapy","PTSD","34","A","PTSD",,,,"Olanzapine","Olanzapine","No","Not Applicable","Yes","Antipsychotic","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"Self report","DTS","DTS",,,"Covariance pattern (unstructured) general linear mixed models","Baseline",,,"75","16.3",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.6071",,"0.3929","Mixed","intimate partner violence, community/school violence","Medium","Carey P, Suliman S, Ganesan K, et al. Olanzapine monotherapy in posttraumatic stress disorder: efficacy in a randomized, double-blind, placebo-controlled study. Hum Psychopharmacol. 2012 Jul;27(4):386-91. doi: 10.1002/hup.2238. PMID: 22730105.","38996","2019"
"carey2012_DTS_B_0_NA","Pharmacotherapy","PTSD","34","B","Control",,,,"Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,"Self report","DTS","DTS",,,"Covariance pattern (unstructured) general linear mixed models","End of Treatment","0",,"75.8","34.5",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.6071",,"0.3929","Mixed","intimate partner violence, community/school violence","Medium","Carey P, Suliman S, Ganesan K, et al. Olanzapine monotherapy in posttraumatic stress disorder: efficacy in a randomized, double-blind, placebo-controlled study. Hum Psychopharmacol. 2012 Jul;27(4):386-91. doi: 10.1002/hup.2238. PMID: 22730105.","38996","2019"
"carey2012_DTS_B_Baseline_NA","Pharmacotherapy","PTSD","34","B","Control",,,,"Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,"Self report","DTS","DTS",,,"Covariance pattern (unstructured) general linear mixed models","Baseline",,,"88.1","22.5",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.6071",,"0.3929","Mixed","intimate partner violence, community/school violence","Medium","Carey P, Suliman S, Ganesan K, et al. Olanzapine monotherapy in posttraumatic stress disorder: efficacy in a randomized, double-blind, placebo-controlled study. Hum Psychopharmacol. 2012 Jul;27(4):386-91. doi: 10.1002/hup.2238. PMID: 22730105.","38996","2019"
"carlson1998_CAPS_A_0_Comp","Mixed: Psychotherapy & CIH","PTSD","35","A","PTSD",,,,"EMDR","Eye Movement Desensitization and Reprocessing (EMDR)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","10","Structured Clinical Interview","CAPS","CAPS intensity","Completer",,"Covariance pattern (unstructured) general linear mixed models","End of Treatment","0",,,,,,,,,,,,,,,,,,,,,,,,,,"Not meeting criteria for PTSD according to CAPS","0.7778",,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Carlson JG, Chemtob CM, Rusnak K, et al. Eye Movement Desensitization and Reprocessing (EMDR) treatment for combat-related posttraumatic stress disorder. J Trauma Stress. 1998 Jan;11(1):3-24. doi: 10.1023/A:1024448814268. PMID: 9479673.","13921","2019"
"carlson1998_CAPS_A_12_Comp","Mixed: Psychotherapy & CIH","PTSD","35","A","PTSD",,"9",,"EMDR","Eye Movement Desensitization and Reprocessing (EMDR)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","10","Structured Clinical Interview","CAPS","CAPS intensity","Completer",,"Covariance pattern (unstructured) general linear mixed models","Assessment at 3 to <6 Months","12",,"13.6","11.9",,,,,"-27.2",,,,,,,,,,,,,,,,,,"Not meeting criteria for PTSD according to CAPS",,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Carlson JG, Chemtob CM, Rusnak K, et al. Eye Movement Desensitization and Reprocessing (EMDR) treatment for combat-related posttraumatic stress disorder. J Trauma Stress. 1998 Jan;11(1):3-24. doi: 10.1023/A:1024448814268. PMID: 9479673.","13921","2019"
"carlson1998_CAPS_A_39_Comp","Mixed: Psychotherapy & CIH","PTSD","35","A","PTSD",,"8",,"EMDR","Eye Movement Desensitization and Reprocessing (EMDR)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","10","Structured Clinical Interview","CAPS","CAPS overall","Completer",,"Covariance pattern (unstructured) general linear mixed models","Assessment at 6 to <12 Months","39",,"36.9","28.6",,,,,,,,,,,,,,,,,,,,,,,"Not meeting criteria for PTSD according to CAPS",,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Carlson JG, Chemtob CM, Rusnak K, et al. Eye Movement Desensitization and Reprocessing (EMDR) treatment for combat-related posttraumatic stress disorder. J Trauma Stress. 1998 Jan;11(1):3-24. doi: 10.1023/A:1024448814268. PMID: 9479673.","13921","2019"
"carlson1998_CAPS_A_Baseline_Comp","Mixed: Psychotherapy & CIH","PTSD","35","A","PTSD",,"10",,"EMDR","Eye Movement Desensitization and Reprocessing (EMDR)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","10","Structured Clinical Interview","CAPS","CAPS intensity","Completer",,"Covariance pattern (unstructured) general linear mixed models","Baseline",,,"40.8","10.2",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Carlson JG, Chemtob CM, Rusnak K, et al. Eye Movement Desensitization and Reprocessing (EMDR) treatment for combat-related posttraumatic stress disorder. J Trauma Stress. 1998 Jan;11(1):3-24. doi: 10.1023/A:1024448814268. PMID: 9479673.","13921","2019"
"carlson1998_CAPS_B_0_Comp","Mixed: Psychotherapy & CIH","PTSD","35","B","PTSD",,,,"Biofeedback-assisted relaxation","Biofeedback-assisted relaxation","No","Not Applicable","No","Not Applicable","Yes","Relaxation","No","No","No","No","No","Individual","In Person","13","Structured Clinical Interview","CAPS","CAPS intensity","Completer",,"Covariance pattern (unstructured) general linear mixed models","End of Treatment","0",,,,,,,,,,,,,,,,,,,,,,,,,,"Not meeting criteria for PTSD according to CAPS","0.2222",,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Carlson JG, Chemtob CM, Rusnak K, et al. Eye Movement Desensitization and Reprocessing (EMDR) treatment for combat-related posttraumatic stress disorder. J Trauma Stress. 1998 Jan;11(1):3-24. doi: 10.1023/A:1024448814268. PMID: 9479673.","13921","2019"
"carlson1998_CAPS_B_12_Comp","Mixed: Psychotherapy & CIH","PTSD","35","B","PTSD",,"9",,"Biofeedback-assisted relaxation","Biofeedback-assisted relaxation","No","Not Applicable","No","Not Applicable","Yes","Relaxation","No","No","No","No","No","Individual","In Person","13","Structured Clinical Interview","CAPS","CAPS intensity","Completer",,"Covariance pattern (unstructured) general linear mixed models","Assessment at 3 to <6 Months","12",,"34.0","8.5",,,,,"-6.8",,,,,,,,,,,,,,,,,,"Not meeting criteria for PTSD according to CAPS",,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Carlson JG, Chemtob CM, Rusnak K, et al. Eye Movement Desensitization and Reprocessing (EMDR) treatment for combat-related posttraumatic stress disorder. J Trauma Stress. 1998 Jan;11(1):3-24. doi: 10.1023/A:1024448814268. PMID: 9479673.","13921","2019"
"carlson1998_CAPS_B_39_Comp","Mixed: Psychotherapy & CIH","PTSD","35","B","PTSD",,"4",,"Biofeedback-assisted relaxation","Biofeedback-assisted relaxation","No","Not Applicable","No","Not Applicable","Yes","Relaxation","No","No","No","No","No","Individual","In Person","13","Structured Clinical Interview","CAPS","CAPS overall","Completer",,"Covariance pattern (unstructured) general linear mixed models","Assessment at 6 to <12 Months","39",,"67.8","24.7",,,,,,,,,,,,,,,,,,,,,,,"Not meeting criteria for PTSD according to CAPS",,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Carlson JG, Chemtob CM, Rusnak K, et al. Eye Movement Desensitization and Reprocessing (EMDR) treatment for combat-related posttraumatic stress disorder. J Trauma Stress. 1998 Jan;11(1):3-24. doi: 10.1023/A:1024448814268. PMID: 9479673.","13921","2019"
"carlson1998_CAPS_B_Baseline_Comp","Mixed: Psychotherapy & CIH","PTSD","35","B","PTSD",,"13",,"Biofeedback-assisted relaxation","Biofeedback-assisted relaxation","No","Not Applicable","No","Not Applicable","Yes","Relaxation","No","No","No","No","No","Individual","In Person","13","Structured Clinical Interview","CAPS","CAPS intensity","Completer",,"Covariance pattern (unstructured) general linear mixed models","Baseline",,,"40.8","8.5",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Carlson JG, Chemtob CM, Rusnak K, et al. Eye Movement Desensitization and Reprocessing (EMDR) treatment for combat-related posttraumatic stress disorder. J Trauma Stress. 1998 Jan;11(1):3-24. doi: 10.1023/A:1024448814268. PMID: 9479673.","13921","2019"
"carlson1998_CAPS_C_Baseline_Comp","Mixed: Psychotherapy & CIH","PTSD","35","C","Control",,"12",,"TAU waitlist","Treatment as usual (TAU)","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,"12","Structured Clinical Interview","CAPS","CAPS intensity","Completer",,"Covariance pattern (unstructured) general linear mixed models","Baseline",,,"42.5",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Carlson JG, Chemtob CM, Rusnak K, et al. Eye Movement Desensitization and Reprocessing (EMDR) treatment for combat-related posttraumatic stress disorder. J Trauma Stress. 1998 Jan;11(1):3-24. doi: 10.1023/A:1024448814268. PMID: 9479673.","13921","2019"
"carlson1998_IES_A_0_NA","Mixed: Psychotherapy & CIH","PTSD","35","A","PTSD",,,,"EMDR","Eye Movement Desensitization and Reprocessing (EMDR)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","10","Self report","IES","IES",,,"Covariance pattern (unstructured) general linear mixed models","End of Treatment","0",,"35.2","22.0",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Carlson JG, Chemtob CM, Rusnak K, et al. Eye Movement Desensitization and Reprocessing (EMDR) treatment for combat-related posttraumatic stress disorder. J Trauma Stress. 1998 Jan;11(1):3-24. doi: 10.1023/A:1024448814268. PMID: 9479673.","13921","2019"
"carlson1998_IES_A_12_NA","Mixed: Psychotherapy & CIH","PTSD","35","A","PTSD",,,,"EMDR","Eye Movement Desensitization and Reprocessing (EMDR)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","10","Self report","IES","IES",,,"Covariance pattern (unstructured) general linear mixed models","Assessment at 3 to <6 Months","12",,"29.1","22.0",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Carlson JG, Chemtob CM, Rusnak K, et al. Eye Movement Desensitization and Reprocessing (EMDR) treatment for combat-related posttraumatic stress disorder. J Trauma Stress. 1998 Jan;11(1):3-24. doi: 10.1023/A:1024448814268. PMID: 9479673.","13921","2019"
"carlson1998_IES_A_39_NA","Mixed: Psychotherapy & CIH","PTSD","35","A","PTSD",,,,"EMDR","Eye Movement Desensitization and Reprocessing (EMDR)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","10","Self report","IES","IES",,,"Covariance pattern (unstructured) general linear mixed models","Assessment at 6 to <12 Months","39",,"34.8","28.0",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Carlson JG, Chemtob CM, Rusnak K, et al. Eye Movement Desensitization and Reprocessing (EMDR) treatment for combat-related posttraumatic stress disorder. J Trauma Stress. 1998 Jan;11(1):3-24. doi: 10.1023/A:1024448814268. PMID: 9479673.","13921","2019"
"carlson1998_IES_A_Baseline_NA","Mixed: Psychotherapy & CIH","PTSD","35","A","PTSD",,,,"EMDR","Eye Movement Desensitization and Reprocessing (EMDR)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","10","Self report","IES","IES",,,"Covariance pattern (unstructured) general linear mixed models","Baseline",,,"52.5","9.0",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Carlson JG, Chemtob CM, Rusnak K, et al. Eye Movement Desensitization and Reprocessing (EMDR) treatment for combat-related posttraumatic stress disorder. J Trauma Stress. 1998 Jan;11(1):3-24. doi: 10.1023/A:1024448814268. PMID: 9479673.","13921","2019"
"carlson1998_IES_B_0_NA","Mixed: Psychotherapy & CIH","PTSD","35","B","PTSD",,,,"Biofeedback-assisted relaxation","Biofeedback-assisted relaxation","No","Not Applicable","No","Not Applicable","Yes","Relaxation","No","No","No","No","No","Individual","In Person","13","Self report","IES","IES",,,"Covariance pattern (unstructured) general linear mixed models","End of Treatment","0",,"44.5","17.4",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Carlson JG, Chemtob CM, Rusnak K, et al. Eye Movement Desensitization and Reprocessing (EMDR) treatment for combat-related posttraumatic stress disorder. J Trauma Stress. 1998 Jan;11(1):3-24. doi: 10.1023/A:1024448814268. PMID: 9479673.","13921","2019"
"carlson1998_IES_B_12_NA","Mixed: Psychotherapy & CIH","PTSD","35","B","PTSD",,,,"Biofeedback-assisted relaxation","Biofeedback-assisted relaxation","No","Not Applicable","No","Not Applicable","Yes","Relaxation","No","No","No","No","No","Individual","In Person","13","Self report","IES","IES",,,"Covariance pattern (unstructured) general linear mixed models","Assessment at 3 to <6 Months","12",,"45.7","15.0",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Carlson JG, Chemtob CM, Rusnak K, et al. Eye Movement Desensitization and Reprocessing (EMDR) treatment for combat-related posttraumatic stress disorder. J Trauma Stress. 1998 Jan;11(1):3-24. doi: 10.1023/A:1024448814268. PMID: 9479673.","13921","2019"
"carlson1998_IES_B_39_NA","Mixed: Psychotherapy & CIH","PTSD","35","B","PTSD",,,,"Biofeedback-assisted relaxation","Biofeedback-assisted relaxation","No","Not Applicable","No","Not Applicable","Yes","Relaxation","No","No","No","No","No","Individual","In Person","13","Self report","IES","IES",,,"Covariance pattern (unstructured) general linear mixed models","Assessment at 6 to <12 Months","39",,"47.0","23.0",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Carlson JG, Chemtob CM, Rusnak K, et al. Eye Movement Desensitization and Reprocessing (EMDR) treatment for combat-related posttraumatic stress disorder. J Trauma Stress. 1998 Jan;11(1):3-24. doi: 10.1023/A:1024448814268. PMID: 9479673.","13921","2019"
"carlson1998_IES_B_Baseline_NA","Mixed: Psychotherapy & CIH","PTSD","35","B","PTSD",,,,"Biofeedback-assisted relaxation","Biofeedback-assisted relaxation","No","Not Applicable","No","Not Applicable","Yes","Relaxation","No","No","No","No","No","Individual","In Person","13","Self report","IES","IES",,,"Covariance pattern (unstructured) general linear mixed models","Baseline",,,"52.9","9.3",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Carlson JG, Chemtob CM, Rusnak K, et al. Eye Movement Desensitization and Reprocessing (EMDR) treatment for combat-related posttraumatic stress disorder. J Trauma Stress. 1998 Jan;11(1):3-24. doi: 10.1023/A:1024448814268. PMID: 9479673.","13921","2019"
"carlson1998_IES_C_0_NA","Mixed: Psychotherapy & CIH","PTSD","35","C","Control",,,,"TAU waitlist","Treatment as usual (TAU)","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,"12","Self report","IES","IES",,,"Covariance pattern (unstructured) general linear mixed models","End of Treatment","0",,"38.7","16.2",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Carlson JG, Chemtob CM, Rusnak K, et al. Eye Movement Desensitization and Reprocessing (EMDR) treatment for combat-related posttraumatic stress disorder. J Trauma Stress. 1998 Jan;11(1):3-24. doi: 10.1023/A:1024448814268. PMID: 9479673.","13921","2019"
"carlson1998_IES_C_Baseline_NA","Mixed: Psychotherapy & CIH","PTSD","35","C","Control",,,,"TAU waitlist","Treatment as usual (TAU)","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,"12","Self report","IES","IES",,,"Covariance pattern (unstructured) general linear mixed models","Baseline",,,"52.8","11.5",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Carlson JG, Chemtob CM, Rusnak K, et al. Eye Movement Desensitization and Reprocessing (EMDR) treatment for combat-related posttraumatic stress disorder. J Trauma Stress. 1998 Jan;11(1):3-24. doi: 10.1023/A:1024448814268. PMID: 9479673.","13921","2019"
"carlson1998_M-PTSD_A_0_NA","Mixed: Psychotherapy & CIH","PTSD","35","A","PTSD",,,,"EMDR","Eye Movement Desensitization and Reprocessing (EMDR)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","10","Self report","M-PTSD","M-PTSD",,,"Covariance pattern (unstructured) general linear mixed models","End of Treatment","0",,"92.8","20.8",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Carlson JG, Chemtob CM, Rusnak K, et al. Eye Movement Desensitization and Reprocessing (EMDR) treatment for combat-related posttraumatic stress disorder. J Trauma Stress. 1998 Jan;11(1):3-24. doi: 10.1023/A:1024448814268. PMID: 9479673.","13921","2019"
"carlson1998_M-PTSD_A_12_NA","Mixed: Psychotherapy & CIH","PTSD","35","A","PTSD",,,,"EMDR","Eye Movement Desensitization and Reprocessing (EMDR)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","10","Self report","M-PTSD","M-PTSD",,,"Covariance pattern (unstructured) general linear mixed models","Assessment at 3 to <6 Months","12",,"92.4","17.2",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Carlson JG, Chemtob CM, Rusnak K, et al. Eye Movement Desensitization and Reprocessing (EMDR) treatment for combat-related posttraumatic stress disorder. J Trauma Stress. 1998 Jan;11(1):3-24. doi: 10.1023/A:1024448814268. PMID: 9479673.","13921","2019"
"carlson1998_M-PTSD_A_39_NA","Mixed: Psychotherapy & CIH","PTSD","35","A","PTSD",,,,"EMDR","Eye Movement Desensitization and Reprocessing (EMDR)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","10","Self report","M-PTSD","M-PTSD",,,"Covariance pattern (unstructured) general linear mixed models","Assessment at 6 to <12 Months","39",,"97.8","29.8",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Carlson JG, Chemtob CM, Rusnak K, et al. Eye Movement Desensitization and Reprocessing (EMDR) treatment for combat-related posttraumatic stress disorder. J Trauma Stress. 1998 Jan;11(1):3-24. doi: 10.1023/A:1024448814268. PMID: 9479673.","13921","2019"
"carlson1998_M-PTSD_A_Baseline_NA","Mixed: Psychotherapy & CIH","PTSD","35","A","PTSD",,,,"EMDR","Eye Movement Desensitization and Reprocessing (EMDR)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","10","Self report","M-PTSD","M-PTSD",,,"Covariance pattern (unstructured) general linear mixed models","Baseline",,,"117.5","14.3",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Carlson JG, Chemtob CM, Rusnak K, et al. Eye Movement Desensitization and Reprocessing (EMDR) treatment for combat-related posttraumatic stress disorder. J Trauma Stress. 1998 Jan;11(1):3-24. doi: 10.1023/A:1024448814268. PMID: 9479673.","13921","2019"
"carlson1998_M-PTSD_B_0_NA","Mixed: Psychotherapy & CIH","PTSD","35","B","PTSD",,,,"Biofeedback-assisted relaxation","Biofeedback-assisted relaxation","No","Not Applicable","No","Not Applicable","Yes","Relaxation","No","No","No","No","No","Individual","In Person","13","Self report","M-PTSD","M-PTSD",,,"Covariance pattern (unstructured) general linear mixed models","End of Treatment","0",,"114.2","17.5",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Carlson JG, Chemtob CM, Rusnak K, et al. Eye Movement Desensitization and Reprocessing (EMDR) treatment for combat-related posttraumatic stress disorder. J Trauma Stress. 1998 Jan;11(1):3-24. doi: 10.1023/A:1024448814268. PMID: 9479673.","13921","2019"
"carlson1998_M-PTSD_B_12_NA","Mixed: Psychotherapy & CIH","PTSD","35","B","PTSD",,,,"Biofeedback-assisted relaxation","Biofeedback-assisted relaxation","No","Not Applicable","No","Not Applicable","Yes","Relaxation","No","No","No","No","No","Individual","In Person","13","Self report","M-PTSD","M-PTSD",,,"Covariance pattern (unstructured) general linear mixed models","Assessment at 3 to <6 Months","12",,"110.6","18.6",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Carlson JG, Chemtob CM, Rusnak K, et al. Eye Movement Desensitization and Reprocessing (EMDR) treatment for combat-related posttraumatic stress disorder. J Trauma Stress. 1998 Jan;11(1):3-24. doi: 10.1023/A:1024448814268. PMID: 9479673.","13921","2019"
"carlson1998_M-PTSD_B_39_NA","Mixed: Psychotherapy & CIH","PTSD","35","B","PTSD",,,,"Biofeedback-assisted relaxation","Biofeedback-assisted relaxation","No","Not Applicable","No","Not Applicable","Yes","Relaxation","No","No","No","No","No","Individual","In Person","13","Self report","M-PTSD","M-PTSD",,,"Covariance pattern (unstructured) general linear mixed models","Assessment at 6 to <12 Months","39",,"127.0","12.4",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Carlson JG, Chemtob CM, Rusnak K, et al. Eye Movement Desensitization and Reprocessing (EMDR) treatment for combat-related posttraumatic stress disorder. J Trauma Stress. 1998 Jan;11(1):3-24. doi: 10.1023/A:1024448814268. PMID: 9479673.","13921","2019"
"carlson1998_M-PTSD_B_Baseline_NA","Mixed: Psychotherapy & CIH","PTSD","35","B","PTSD",,,,"Biofeedback-assisted relaxation","Biofeedback-assisted relaxation","No","Not Applicable","No","Not Applicable","Yes","Relaxation","No","No","No","No","No","Individual","In Person","13","Self report","M-PTSD","M-PTSD",,,"Covariance pattern (unstructured) general linear mixed models","Baseline",,,"119.4","18.3",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Carlson JG, Chemtob CM, Rusnak K, et al. Eye Movement Desensitization and Reprocessing (EMDR) treatment for combat-related posttraumatic stress disorder. J Trauma Stress. 1998 Jan;11(1):3-24. doi: 10.1023/A:1024448814268. PMID: 9479673.","13921","2019"
"carlson1998_M-PTSD_C_0_NA","Mixed: Psychotherapy & CIH","PTSD","35","C","Control",,,,"TAU waitlist","Treatment as usual (TAU)","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,"12","Self report","M-PTSD","M-PTSD",,,"Covariance pattern (unstructured) general linear mixed models","End of Treatment","0",,"112.9","21.7",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Carlson JG, Chemtob CM, Rusnak K, et al. Eye Movement Desensitization and Reprocessing (EMDR) treatment for combat-related posttraumatic stress disorder. J Trauma Stress. 1998 Jan;11(1):3-24. doi: 10.1023/A:1024448814268. PMID: 9479673.","13921","2019"
"carlson1998_M-PTSD_C_Baseline_NA","Mixed: Psychotherapy & CIH","PTSD","35","C","Control",,,,"TAU waitlist","Treatment as usual (TAU)","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,"12","Self report","M-PTSD","M-PTSD",,,"Covariance pattern (unstructured) general linear mixed models","Baseline",,,"117.9","17.6",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Carlson JG, Chemtob CM, Rusnak K, et al. Eye Movement Desensitization and Reprocessing (EMDR) treatment for combat-related posttraumatic stress disorder. J Trauma Stress. 1998 Jan;11(1):3-24. doi: 10.1023/A:1024448814268. PMID: 9479673.","13921","2019"
"carlson1998_PSS-SR_A_0_NA","Mixed: Psychotherapy & CIH","PTSD","35","A","PTSD",,,,"EMDR","Eye Movement Desensitization and Reprocessing (EMDR)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","10","Self report","PSS-SR","PSS-SR",,,"Covariance pattern (unstructured) general linear mixed models","End of Treatment","0",,"3.0","2.4",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Carlson JG, Chemtob CM, Rusnak K, et al. Eye Movement Desensitization and Reprocessing (EMDR) treatment for combat-related posttraumatic stress disorder. J Trauma Stress. 1998 Jan;11(1):3-24. doi: 10.1023/A:1024448814268. PMID: 9479673.","13921","2019"
"carlson1998_PSS-SR_A_12_NA","Mixed: Psychotherapy & CIH","PTSD","35","A","PTSD",,,,"EMDR","Eye Movement Desensitization and Reprocessing (EMDR)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","10","Self report","PSS-SR","PSS-SR",,,"Covariance pattern (unstructured) general linear mixed models","Assessment at 3 to <6 Months","12",,"2.1","2.0",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Carlson JG, Chemtob CM, Rusnak K, et al. Eye Movement Desensitization and Reprocessing (EMDR) treatment for combat-related posttraumatic stress disorder. J Trauma Stress. 1998 Jan;11(1):3-24. doi: 10.1023/A:1024448814268. PMID: 9479673.","13921","2019"
"carlson1998_PSS-SR_A_Baseline_NA","Mixed: Psychotherapy & CIH","PTSD","35","A","PTSD",,,,"EMDR","Eye Movement Desensitization and Reprocessing (EMDR)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","10","Self report","PSS-SR","PSS-SR",,,"Covariance pattern (unstructured) general linear mixed models","Baseline",,,"7.3","2.1",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Carlson JG, Chemtob CM, Rusnak K, et al. Eye Movement Desensitization and Reprocessing (EMDR) treatment for combat-related posttraumatic stress disorder. J Trauma Stress. 1998 Jan;11(1):3-24. doi: 10.1023/A:1024448814268. PMID: 9479673.","13921","2019"
"carlson1998_PSS-SR_B_0_NA","Mixed: Psychotherapy & CIH","PTSD","35","B","PTSD",,,,"Biofeedback-assisted relaxation","Biofeedback-assisted relaxation","No","Not Applicable","No","Not Applicable","Yes","Relaxation","No","No","No","No","No","Individual","In Person","13","Self report","PSS-SR","PSS-SR",,,"Covariance pattern (unstructured) general linear mixed models","End of Treatment","0",,"4.7","2.3",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Carlson JG, Chemtob CM, Rusnak K, et al. Eye Movement Desensitization and Reprocessing (EMDR) treatment for combat-related posttraumatic stress disorder. J Trauma Stress. 1998 Jan;11(1):3-24. doi: 10.1023/A:1024448814268. PMID: 9479673.","13921","2019"
"carlson1998_PSS-SR_B_12_NA","Mixed: Psychotherapy & CIH","PTSD","35","B","PTSD",,,,"Biofeedback-assisted relaxation","Biofeedback-assisted relaxation","No","Not Applicable","No","Not Applicable","Yes","Relaxation","No","No","No","No","No","Individual","In Person","13","Self report","PSS-SR","PSS-SR",,,"Covariance pattern (unstructured) general linear mixed models","Assessment at 3 to <6 Months","12",,"5.1","1.9",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Carlson JG, Chemtob CM, Rusnak K, et al. Eye Movement Desensitization and Reprocessing (EMDR) treatment for combat-related posttraumatic stress disorder. J Trauma Stress. 1998 Jan;11(1):3-24. doi: 10.1023/A:1024448814268. PMID: 9479673.","13921","2019"
"carlson1998_PSS-SR_B_Baseline_NA","Mixed: Psychotherapy & CIH","PTSD","35","B","PTSD",,,,"Biofeedback-assisted relaxation","Biofeedback-assisted relaxation","No","Not Applicable","No","Not Applicable","Yes","Relaxation","No","No","No","No","No","Individual","In Person","13","Self report","PSS-SR","PSS-SR",,,"Covariance pattern (unstructured) general linear mixed models","Baseline",,,"6.8","2.3",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Carlson JG, Chemtob CM, Rusnak K, et al. Eye Movement Desensitization and Reprocessing (EMDR) treatment for combat-related posttraumatic stress disorder. J Trauma Stress. 1998 Jan;11(1):3-24. doi: 10.1023/A:1024448814268. PMID: 9479673.","13921","2019"
"carlson1998_PSS-SR_C_0_NA","Mixed: Psychotherapy & CIH","PTSD","35","C","Control",,,,"TAU waitlist","Treatment as usual (TAU)","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,"12","Self report","PSS-SR","PSS-SR",,,"Covariance pattern (unstructured) general linear mixed models","End of Treatment","0",,"6.2","2.4",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Carlson JG, Chemtob CM, Rusnak K, et al. Eye Movement Desensitization and Reprocessing (EMDR) treatment for combat-related posttraumatic stress disorder. J Trauma Stress. 1998 Jan;11(1):3-24. doi: 10.1023/A:1024448814268. PMID: 9479673.","13921","2019"
"carlson1998_PSS-SR_C_Baseline_NA","Mixed: Psychotherapy & CIH","PTSD","35","C","Control",,,,"TAU waitlist","Treatment as usual (TAU)","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,"12","Self report","PSS-SR","PSS-SR",,,"Covariance pattern (unstructured) general linear mixed models","Baseline",,,"7.5","1.7",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Carlson JG, Chemtob CM, Rusnak K, et al. Eye Movement Desensitization and Reprocessing (EMDR) treatment for combat-related posttraumatic stress disorder. J Trauma Stress. 1998 Jan;11(1):3-24. doi: 10.1023/A:1024448814268. PMID: 9479673.","13921","2019"
"carlsson2018_HTQ_A_0_ITT","Psychotherapy","PTSD","140","A","PTSD",,"62",,"SIT","Stress Inoculation Training (SIT)","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","70","Self report","HTQ","HTQ","ITT","Imputed","Covariance pattern (unstructured) general linear mixed models","End of Treatment","0",,"3.1",,"SE","0.08",,"SE 0.06","-0.08",,,,,"Effect size","0.19",,,,"p=0.19",,,,,,,,,,,,,,"Community",,,"1","0.4365",,"0.5635","Terrorism/political violence/forced displacement",,"Medium","Carlsson J, Sonne C, Vindbjerg E, et al. Stress management versus cognitive restructuring in trauma-affected refugees‚Äö√Ñ√Æa pragmatic randomised study. Psychiatry Res. 2018 Aug;266:116-23. doi: 10.1016/j.psychres.2018.05.015. PMID: 29859498","1519484","2019"
"carlsson2018_HTQ_A_Baseline_ITT","Psychotherapy","PTSD","140","A","PTSD",,"62",,"SIT","Stress Inoculation Training (SIT)","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","70","Self report","HTQ","HTQ","ITT","Imputed","Covariance pattern (unstructured) general linear mixed models","Baseline",,,"3.18",,"SE","0.06",,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.4365",,"0.5635","Terrorism/political violence/forced displacement",,"Medium","Carlsson J, Sonne C, Vindbjerg E, et al. Stress management versus cognitive restructuring in trauma-affected refugees‚Äö√Ñ√Æa pragmatic randomised study. Psychiatry Res. 2018 Aug;266:116-23. doi: 10.1016/j.psychres.2018.05.015. PMID: 29859498","1519484","2019"
"carlsson2018_HTQ_B_0_ITT","Psychotherapy","PTSD","140","B","PTSD",,"64",,"CR","Trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","70","Self report","HTQ","HTQ","ITT","Imputed","Covariance pattern (unstructured) general linear mixed models","End of Treatment","0",,"3.06",,"SE","0.07",,"SE 0.07","-0.15",,,,,"Effect size","0.35",,,,"p=0.03",,,,,,,,,,,,,,"Community",,,"1","0.4365",,"0.5635","Terrorism/political violence/forced displacement",,"Medium","Carlsson J, Sonne C, Vindbjerg E, et al. Stress management versus cognitive restructuring in trauma-affected refugees‚Äö√Ñ√Æa pragmatic randomised study. Psychiatry Res. 2018 Aug;266:116-23. doi: 10.1016/j.psychres.2018.05.015. PMID: 29859498","1519484","2019"
"carlsson2018_HTQ_B_Baseline_ITT","Psychotherapy","PTSD","140","B","PTSD",,"64",,"CR","Trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","70","Self report","HTQ","HTQ","ITT","Imputed","Covariance pattern (unstructured) general linear mixed models","Baseline",,,"3.21",,"SE","0.05",,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.4365",,"0.5635","Terrorism/political violence/forced displacement",,"Medium","Carlsson J, Sonne C, Vindbjerg E, et al. Stress management versus cognitive restructuring in trauma-affected refugees‚Äö√Ñ√Æa pragmatic randomised study. Psychiatry Res. 2018 Aug;266:116-23. doi: 10.1016/j.psychres.2018.05.015. PMID: 29859498","1519484","2019"
"carr2012_IES_A_0_ITT","Complementary and integrative health (CIH)","PTSD","17","A","PTSD",,"8",,"Music Therapy","Music therapy","No","Not Applicable","No","Not Applicable","Yes","Creative therapies","No","No","No","No","No","Group","In Person","9","Self report","IES","IES-R","ITT",,"Covariance pattern (unstructured) general linear mixed models","End of Treatment","0",,"30.87","10.6",,,,,"-21.82",,,,,"LSM","-24.5","95% CI","-32.30","16.69","p=0.0001",,,,,,,,,,,,,,"Community",,,"1","0.5625",,"0.4375","Mixed","child sexual abuse, rape/sexual assault, community/school violence, terrorism/political violence/forced displacement, other (torture)","Medium","Carr C, D'Ardenne P, Sloboda A, et al. Group music therapy for patients with persistent post-traumatic stress disorder -- an exploratory randomized controlled trial with mixed methods evaluation. Psychol Psychother. 2012 Jun;85(2):179-202. doi: 10.1111/j.2044-8341.2011.02026.x. PMID: 22903909.","39454","2019"
"carr2012_IES_A_Baseline_ITT","Complementary and integrative health (CIH)","PTSD","17","A","PTSD",,"8",,"Music Therapy","Music therapy","No","Not Applicable","No","Not Applicable","Yes","Creative therapies","No","No","No","No","No","Group","In Person","9","Self report","IES","IES-R","ITT",,"Covariance pattern (unstructured) general linear mixed models","Baseline",,,"52.69","13.82",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.5625",,"0.4375","Mixed","child sexual abuse, rape/sexual assault, community/school violence, terrorism/political violence/forced displacement, other (torture)","Medium","Carr C, D'Ardenne P, Sloboda A, et al. Group music therapy for patients with persistent post-traumatic stress disorder -- an exploratory randomized controlled trial with mixed methods evaluation. Psychol Psychother. 2012 Jun;85(2):179-202. doi: 10.1111/j.2044-8341.2011.02026.x. PMID: 22903909.","39454","2019"
"carr2012_IES_B_0_ITT","Complementary and integrative health (CIH)","PTSD","17","B","Control",,"8",,"Waitlist","Waitlist","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,"8","Self report","IES","IES-R","ITT",,"Covariance pattern (unstructured) general linear mixed models","End of Treatment","0",,"53.12","9.2",,,,,"-5.66",,,,,"LSM","-4.32","95% CI","-12.06","3.42","p=0.2286",,,,,,,,,,,,,,"Community",,,"1","0.5625",,"0.4375","Mixed","child sexual abuse, rape/sexual assault, community/school violence, terrorism/political violence/forced displacement, other (torture)","Medium","Carr C, D'Ardenne P, Sloboda A, et al. Group music therapy for patients with persistent post-traumatic stress disorder -- an exploratory randomized controlled trial with mixed methods evaluation. Psychol Psychother. 2012 Jun;85(2):179-202. doi: 10.1111/j.2044-8341.2011.02026.x. PMID: 22903909.","39454","2019"
"carr2012_IES_B_Baseline_ITT","Complementary and integrative health (CIH)","PTSD","17","B","Control",,"8",,"Waitlist","Waitlist","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,"8","Self report","IES","IES-R","ITT",,"Covariance pattern (unstructured) general linear mixed models","Baseline",,,"58.78","10.98",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.5625",,"0.4375","Mixed","child sexual abuse, rape/sexual assault, community/school violence, terrorism/political violence/forced displacement, other (torture)","Medium","Carr C, D'Ardenne P, Sloboda A, et al. Group music therapy for patients with persistent post-traumatic stress disorder -- an exploratory randomized controlled trial with mixed methods evaluation. Psychol Psychother. 2012 Jun;85(2):179-202. doi: 10.1111/j.2044-8341.2011.02026.x. PMID: 22903909.","39454","2019"
"carter2013_CAPS_A_0_Comp","Complementary and integrative health (CIH)","PTSD","31","A","PTSD",,"14","assessment conducted 6 weeks post intervention","Sudarshan Kriya Yoga","Yoga","No","Not Applicable","No","Not Applicable","Yes","Yoga","No","No","No","No","No","Group","In Person","16","Structured Clinical Interview","CAPS","CAPS","Completer","LOCF","Covariance pattern (unstructured) general linear mixed models","End of Treatment","0",,"42.1","18.2",,,,,"-14.2",,,,,,,,,,"p<0.01",,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1",,,"Medium","Carter JJ, Gerbarg PL, Brown RP, et al. Multi-component yoga breath program for Vietnam veteran post traumatic stress disorder: randomized controlled trial. J Trauma Stress Disord Treat. 2013 Jul 31;2(3)doi: 10.4172/2324-8947.1000108.","46976","2019"
"carter2013_CAPS_A_26_Comp","Complementary and integrative health (CIH)","PTSD","31","A","PTSD",,"14",,"Sudarshan Kriya Yoga","Yoga","No","Not Applicable","No","Not Applicable","Yes","Yoga","No","No","No","No","No","Group","In Person","16","Structured Clinical Interview","CAPS","CAPS","Completer","LOCF","Covariance pattern (unstructured) general linear mixed models","Assessment at 6 to <12 Months","26",,"26.2","14.8",,,,,"-30.1",,,,,"Partial eta-squared","0.89",,,,"p<0.00","compared to end-of-treatment",,,,,,"p<0.01",,,,,,,"Veteran","0","1","0","0",,"1",,,"Medium","Carter JJ, Gerbarg PL, Brown RP, et al. Multi-component yoga breath program for Vietnam veteran post traumatic stress disorder: randomized controlled trial. J Trauma Stress Disord Treat. 2013 Jul 31;2(3)doi: 10.4172/2324-8947.1000108.","46976","2019"
"carter2013_CAPS_A_Baseline_Comp","Complementary and integrative health (CIH)","PTSD","31","A","PTSD",,"14",,"Sudarshan Kriya Yoga","Yoga","No","Not Applicable","No","Not Applicable","Yes","Yoga","No","No","No","No","No","Group","In Person","16","Structured Clinical Interview","CAPS","CAPS","Completer","LOCF","Covariance pattern (unstructured) general linear mixed models","Baseline",,,"56.3","12.3",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1",,,"Medium","Carter JJ, Gerbarg PL, Brown RP, et al. Multi-component yoga breath program for Vietnam veteran post traumatic stress disorder: randomized controlled trial. J Trauma Stress Disord Treat. 2013 Jul 31;2(3)doi: 10.4172/2324-8947.1000108.","46976","2019"
"carter2013_CAPS_B_0_Comp","Complementary and integrative health (CIH)","PTSD","31","B","Control",,"11",,"Waitlist","Waitlist","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,"15","Structured Clinical Interview","CAPS","CAPS","Completer","LOCF","Covariance pattern (unstructured) general linear mixed models","End of Treatment","0",,"56.6","18.9",,,,,"0",,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1",,,"Medium","Carter JJ, Gerbarg PL, Brown RP, et al. Multi-component yoga breath program for Vietnam veteran post traumatic stress disorder: randomized controlled trial. J Trauma Stress Disord Treat. 2013 Jul 31;2(3)doi: 10.4172/2324-8947.1000108.","46976","2019"
"carter2013_CAPS_B_Baseline_Comp","Complementary and integrative health (CIH)","PTSD","31","B","Control",,"11",,"Waitlist","Waitlist","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,"15","Structured Clinical Interview","CAPS","CAPS","Completer","LOCF","Covariance pattern (unstructured) general linear mixed models","Baseline",,,"56.6","18.7",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1",,,"Medium","Carter JJ, Gerbarg PL, Brown RP, et al. Multi-component yoga breath program for Vietnam veteran post traumatic stress disorder: randomized controlled trial. J Trauma Stress Disord Treat. 2013 Jul 31;2(3)doi: 10.4172/2324-8947.1000108.","46976","2019"
"carter2013_PCL_A_0_NA","Complementary and integrative health (CIH)","PTSD","31","A","PTSD",,,,"Sudarshan Kriya Yoga","Yoga","No","Not Applicable","No","Not Applicable","Yes","Yoga","No","No","No","No","No","Group","In Person","16","Self report","PCL","PCL-M",,,"Covariance pattern (unstructured) general linear mixed models","End of Treatment","0",,"35.6","11.4",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1",,,"Medium","Carter JJ, Gerbarg PL, Brown RP, et al. Multi-component yoga breath program for Vietnam veteran post traumatic stress disorder: randomized controlled trial. J Trauma Stress Disord Treat. 2013 Jul 31;2(3)doi: 10.4172/2324-8947.1000108.","46976","2019"
"carter2013_PCL_A_Baseline_NA","Complementary and integrative health (CIH)","PTSD","31","A","PTSD",,,,"Sudarshan Kriya Yoga","Yoga","No","Not Applicable","No","Not Applicable","Yes","Yoga","No","No","No","No","No","Group","In Person","16","Self report","PCL","PCL-M",,,"Covariance pattern (unstructured) general linear mixed models","Baseline",,,"53.0","13.8",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1",,,"Medium","Carter JJ, Gerbarg PL, Brown RP, et al. Multi-component yoga breath program for Vietnam veteran post traumatic stress disorder: randomized controlled trial. J Trauma Stress Disord Treat. 2013 Jul 31;2(3)doi: 10.4172/2324-8947.1000108.","46976","2019"
"carter2013_PCL_B_0_NA","Complementary and integrative health (CIH)","PTSD","31","B","Control",,,,"Waitlist","Waitlist","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,"15","Self report","PCL","PCL-M",,,"Covariance pattern (unstructured) general linear mixed models","End of Treatment","0",,"37.9","12.1",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1",,,"Medium","Carter JJ, Gerbarg PL, Brown RP, et al. Multi-component yoga breath program for Vietnam veteran post traumatic stress disorder: randomized controlled trial. J Trauma Stress Disord Treat. 2013 Jul 31;2(3)doi: 10.4172/2324-8947.1000108.","46976","2019"
"carter2013_PCL_B_Baseline_NA","Complementary and integrative health (CIH)","PTSD","31","B","Control",,,,"Waitlist","Waitlist","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,"15","Self report","PCL","PCL-M",,,"Covariance pattern (unstructured) general linear mixed models","Baseline",,,"51.2","12.2",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1",,,"Medium","Carter JJ, Gerbarg PL, Brown RP, et al. Multi-component yoga breath program for Vietnam veteran post traumatic stress disorder: randomized controlled trial. J Trauma Stress Disord Treat. 2013 Jul 31;2(3)doi: 10.4172/2324-8947.1000108.","46976","2019"
"castillo2016_CAPS_A_0_ITT","Psychotherapy","PTSD","86","A","PTSD",,"31",,"Group-delivered Cognitive/Exposure Therapy","Trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Group","In Person","44","Structured Clinical Interview","CAPS","CAPS","ITT","Imputed using SAS Proc Multiple imputation","Covariance pattern (unstructured) general linear mixed models","End of Treatment","0",,"47.23","16.42",,,,,"-24.37",,,,,"Cohen's d","1.72",,,,"p<0.001",,,,,,,,"CAPS total score ≤45","0.5186",,"≥10-point decrease on total CAPS score","0.7738","Additional definitions of Clinically Meaningful Response reported in the study","Veteran",,"1",,"1",,"0","Mixed","MST, combat-related, other (not specified)","Medium","Castillo DT, Chee CL, Nason E, et al. Group-delivered cognitive/exposure therapy for PTSD in women veterans: a randomized controlled trial. Psychol Trauma. 2016 May;8(3):404-12. doi: 10.1037/tra0000111. PMID: 26854355.","44771","2019"
"castillo2016_CAPS_A_12_ITT","Psychotherapy","PTSD","86","A","PTSD",,"31",,"Group-delivered Cognitive/Exposure Therapy","Trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Group","In Person","44","Structured Clinical Interview","CAPS","CAPS","ITT","Imputed using SAS Proc Multiple imputation","Covariance pattern (unstructured) general linear mixed models","Assessment at 3 to <6 Months","12",,"49.43","19.07",,,,,"-22.17",,,,"compared to post-treatment",,,,,,"p=0.62",,,,,,,,"CAPS total score ≤45","0.4376",,"≥10-point decrease on total CAPS score","0.6771","Additional definitions of Clinically Meaningful Response reported in the study","Veteran",,"1",,"1",,"0","Mixed","MST, combat-related, other (not specified)","Medium","Castillo DT, Chee CL, Nason E, et al. Group-delivered cognitive/exposure therapy for PTSD in women veterans: a randomized controlled trial. Psychol Trauma. 2016 May;8(3):404-12. doi: 10.1037/tra0000111. PMID: 26854355.","44771","2019"
"castillo2016_CAPS_A_26_ITT","Psychotherapy","PTSD","86","A","PTSD",,"31",,"Group-delivered Cognitive/Exposure Therapy","Trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Group","In Person","44","Structured Clinical Interview","CAPS","CAPS","ITT","Imputed using SAS Proc Multiple imputation","Covariance pattern (unstructured) general linear mixed models","Assessment at 6 to <12 Months","26",,"49.04","17.54",,,,,"-22.56",,,,"compared to post-treatment",,,,,,"p=0.54",,,,,,,,"CAPS total score ≤45","0.4629",,"≥10-point decrease on total CAPS score","0.731","Additional definitions of Clinically Meaningful Response reported in the study","Veteran",,"1",,"1",,"0","Mixed","MST, combat-related, other (not specified)","Medium","Castillo DT, Chee CL, Nason E, et al. Group-delivered cognitive/exposure therapy for PTSD in women veterans: a randomized controlled trial. Psychol Trauma. 2016 May;8(3):404-12. doi: 10.1037/tra0000111. PMID: 26854355.","44771","2019"
"castillo2016_CAPS_A_Baseline_ITT","Psychotherapy","PTSD","86","A","PTSD",,"42",,"Group-delivered Cognitive/Exposure Therapy","Trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Group","In Person","44","Structured Clinical Interview","CAPS","CAPS","ITT","Imputed using SAS Proc Multiple imputation","Covariance pattern (unstructured) general linear mixed models","Baseline",,,"71.6","10.32",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran",,"1",,"1",,"0","Mixed","MST, combat-related, other (not specified)","Medium","Castillo DT, Chee CL, Nason E, et al. Group-delivered cognitive/exposure therapy for PTSD in women veterans: a randomized controlled trial. Psychol Trauma. 2016 May;8(3):404-12. doi: 10.1037/tra0000111. PMID: 26854355.","44771","2019"
"castillo2016_CAPS_B_0_ITT","Psychotherapy","PTSD","86","B","Control",,"35",,"Waitlist with minimal intervention","Supportive counseling","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","Mixed","42","Structured Clinical Interview","CAPS","CAPS","ITT","Imputed using SAS Proc Multiple imputation","Covariance pattern (unstructured) general linear mixed models","End of Treatment","0",,"70.61","19.82",,,,,"-3.38",,,,,,,,,,"p=0.37",,,,,,,,"CAPS total score ≤45",,,"≥10-point decrease on total CAPS score",,"Additional definitions of Clinically Meaningful Response reported in the study","Veteran",,"1",,"1",,"0","Mixed","MST, combat-related, other (not specified)","Medium","Castillo DT, Chee CL, Nason E, et al. Group-delivered cognitive/exposure therapy for PTSD in women veterans: a randomized controlled trial. Psychol Trauma. 2016 May;8(3):404-12. doi: 10.1037/tra0000111. PMID: 26854355.","44771","2019"
"castillo2016_CAPS_B_Baseline_ITT","Psychotherapy","PTSD","86","B","Control",,"42",,"Waitlist with minimal intervention","Supportive counseling","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","Mixed","42","Structured Clinical Interview","CAPS","CAPS","ITT","Imputed using SAS Proc Multiple imputation","Covariance pattern (unstructured) general linear mixed models","Baseline",,,"73.99","10.62",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran",,"1",,"1",,"0","Mixed","MST, combat-related, other (not specified)","Medium","Castillo DT, Chee CL, Nason E, et al. Group-delivered cognitive/exposure therapy for PTSD in women veterans: a randomized controlled trial. Psychol Trauma. 2016 May;8(3):404-12. doi: 10.1037/tra0000111. PMID: 26854355.","44771","2019"
"celik2011_CAPS_A_0_Comp","Pharmacotherapy","PTSD","50","A","PTSD",,"22",,"Paroxetine","Paroxetine","No","Not Applicable","Yes","Antidepressant: SSRI","No","Not Applicable","No","No","No","No","No","Individual","In Person","25","Structured Clinical Interview","CAPS","CAPS-2","Completer",,"Covariance pattern (unstructured) general linear mixed models","End of Treatment","0",,"35.6","9.6",,,,,"-10.3","12.8",,,,,,,,,,,,,,,,,,,,"≥30% decrease in CAPS-2 score and CGI-I rating of 1 or 2","0.318",,"Community",,,"1",,,,"Combat-related",,"High","Celik C, Ozdemir B, Ozmenler KN, et al. Efficacy of paroxetine and amitriptyline in posttraumatic stress disorder: an open-label comparative study. Klinik Psikofarmakol B√ºlteni. 2011 Sep;21(3):179-85. doi: 10.5455/bcp.20110627111141.","1519639","2019"
"celik2011_CAPS_A_Baseline_Comp","Pharmacotherapy","PTSD","50","A","PTSD",,"22",,"Paroxetine","Paroxetine","No","Not Applicable","Yes","Antidepressant: SSRI","No","Not Applicable","No","No","No","No","No","Individual","In Person","25","Structured Clinical Interview","CAPS","CAPS-2","Completer",,"Covariance pattern (unstructured) general linear mixed models","Baseline",,,"45.9","10.2",,,,,,,,,,,,,,,,,,,,,,,,,,"≥30% decrease in CAPS-2 score and CGI-I rating of 1 or 2",,,"Community",,,"1",,,,"Combat-related",,"High","Celik C, Ozdemir B, Ozmenler KN, et al. Efficacy of paroxetine and amitriptyline in posttraumatic stress disorder: an open-label comparative study. Klinik Psikofarmakol B√ºlteni. 2011 Sep;21(3):179-85. doi: 10.5455/bcp.20110627111141.","1519639","2019"
"celik2011_CAPS_B_0_Comp","Pharmacotherapy","PTSD","50","B","PTSD",,"20",,"Amitriptyline","Amitriptyline","No","Not Applicable","Yes","Antidepressant: TCA","No","Not Applicable","No","No","No","No","No","Individual","In Person","25","Structured Clinical Interview","CAPS","CAPS-2","Completer",,"Covariance pattern (unstructured) general linear mixed models","End of Treatment","0",,"29.6","11.9",,,,,"-20.2","16.7",,,,,,,,,,,,,,,,,,,,"≥30% decrease in CAPS-2 score and CGI-I rating of 1 or 2","0.55",,"Community",,,"1",,,,"Combat-related",,"High","Celik C, Ozdemir B, Ozmenler KN, et al. Efficacy of paroxetine and amitriptyline in posttraumatic stress disorder: an open-label comparative study. Klinik Psikofarmakol B√ºlteni. 2011 Sep;21(3):179-85. doi: 10.5455/bcp.20110627111141.","1519639","2019"
"celik2011_CAPS_B_Baseline_Comp","Pharmacotherapy","PTSD","50","B","PTSD",,"20",,"Amitriptyline","Amitriptyline","No","Not Applicable","Yes","Antidepressant: TCA","No","Not Applicable","No","No","No","No","No","Individual","In Person","25","Structured Clinical Interview","CAPS","CAPS-2","Completer",,"Covariance pattern (unstructured) general linear mixed models","Baseline",,,"49.7","12.7",,,,,,,,,,,,,,,,,,,,,,,,,,"≥30% decrease in CAPS-2 score and CGI-I rating of 1 or 2",,,"Community",,,"1",,,,"Combat-related",,"High","Celik C, Ozdemir B, Ozmenler KN, et al. Efficacy of paroxetine and amitriptyline in posttraumatic stress disorder: an open-label comparative study. Klinik Psikofarmakol B√ºlteni. 2011 Sep;21(3):179-85. doi: 10.5455/bcp.20110627111141.","1519639","2019"
"chard2005_CAPS_A_0_Comp","Psychotherapy","PTSD","71","A","PTSD",,"28",,"CPT for sexual abuse survivor","Cognitive Processing Therapy (CPT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Mixed","In Person","36","Structured Clinical Interview","CAPS","CAPS one-week","Completer",,"Covariance pattern (unstructured) general linear mixed models","End of Treatment","0",,"9","11.04",,,,,"-56.46",,,,,,,,,,,,,,,,,,"Not meeting criteria for PTSD according to CAPS-SX","0.9286",,"MPSS score ≤20 and BDI-II ≤10","0.7857",,"Community",,,"1","1",,"0","Child sexual abuse",,"Medium","Chard KM. An evaluation of cognitive processing therapy for the treatment of posttraumatic stress disorder related to childhood sexual abuse. J Consult Clin Psychol. 2005 Oct;73(5):965-71. doi: 10.1037/0022-006X.73.5.965. PMID: 16287396.","27944","2019"
"chard2005_CAPS_A_Baseline_Comp","Psychotherapy","PTSD","71","A","PTSD",,"36",,"CPT for sexual abuse survivor","Cognitive Processing Therapy (CPT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Mixed","In Person","36","Structured Clinical Interview","CAPS","CAPS one-week","Completer",,"Covariance pattern (unstructured) general linear mixed models","Baseline",,,"65.46","26.39",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","1",,"0","Child sexual abuse",,"Medium","Chard KM. An evaluation of cognitive processing therapy for the treatment of posttraumatic stress disorder related to childhood sexual abuse. J Consult Clin Psychol. 2005 Oct;73(5):965-71. doi: 10.1037/0022-006X.73.5.965. PMID: 16287396.","27944","2019"
"chard2005_CAPS_B_0_Comp","Psychotherapy","PTSD","71","B","Control",,"27",,"Minimal attention waitlist","Minimal attention","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","Telephone","35","Structured Clinical Interview","CAPS","CAPS one-week","Completer",,"Covariance pattern (unstructured) general linear mixed models","End of Treatment","0",,"62.96","30.68",,,,,"-5.34",,,,,,,,,,"p=NS",,,,,,,,"Not meeting criteria for PTSD according to CAPS-SX","0.2593",,"MPSS score ≤20 and BDI-II ≤10","0.037",,"Community",,,"1","1",,"0","Child sexual abuse",,"Medium","Chard KM. An evaluation of cognitive processing therapy for the treatment of posttraumatic stress disorder related to childhood sexual abuse. J Consult Clin Psychol. 2005 Oct;73(5):965-71. doi: 10.1037/0022-006X.73.5.965. PMID: 16287396.","27944","2019"
"chard2005_CAPS_B_Baseline_Comp","Psychotherapy","PTSD","71","B","Control",,"35",,"Minimal attention waitlist","Minimal attention","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","Telephone","35","Structured Clinical Interview","CAPS","CAPS one-week","Completer",,"Covariance pattern (unstructured) general linear mixed models","Baseline",,,"68.3","23.67",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","1",,"0","Child sexual abuse",,"Medium","Chard KM. An evaluation of cognitive processing therapy for the treatment of posttraumatic stress disorder related to childhood sexual abuse. J Consult Clin Psychol. 2005 Oct;73(5):965-71. doi: 10.1037/0022-006X.73.5.965. PMID: 16287396.","27944","2019"
"chard2005_MPSS_A_0_NA","Psychotherapy","PTSD","71","A","PTSD",,,,"CPT for sexual abuse survivor","Cognitive Processing Therapy (CPT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Mixed","In Person","36","Self report","MPSS","MPSS",,,"Covariance pattern (unstructured) general linear mixed models","End of Treatment","0",,"7.54","9.51",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","1",,"0","Child sexual abuse",,"Medium","Chard KM. An evaluation of cognitive processing therapy for the treatment of posttraumatic stress disorder related to childhood sexual abuse. J Consult Clin Psychol. 2005 Oct;73(5):965-71. doi: 10.1037/0022-006X.73.5.965. PMID: 16287396.","27944","2019"
"chard2005_MPSS_A_Baseline_NA","Psychotherapy","PTSD","71","A","PTSD",,,,"CPT for sexual abuse survivor","Cognitive Processing Therapy (CPT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Mixed","In Person","36","Self report","MPSS","MPSS",,,"Covariance pattern (unstructured) general linear mixed models","Baseline",,,"57.57","22.85",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","1",,"0","Child sexual abuse",,"Medium","Chard KM. An evaluation of cognitive processing therapy for the treatment of posttraumatic stress disorder related to childhood sexual abuse. J Consult Clin Psychol. 2005 Oct;73(5):965-71. doi: 10.1037/0022-006X.73.5.965. PMID: 16287396.","27944","2019"
"chard2005_MPSS_B_0_NA","Psychotherapy","PTSD","71","B","Control",,,,"Minimal attention waitlist","Minimal attention","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","Telephone","35","Self report","MPSS","MPSS",,,"Covariance pattern (unstructured) general linear mixed models","End of Treatment","0",,"57.70","27.47",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","1",,"0","Child sexual abuse",,"Medium","Chard KM. An evaluation of cognitive processing therapy for the treatment of posttraumatic stress disorder related to childhood sexual abuse. J Consult Clin Psychol. 2005 Oct;73(5):965-71. doi: 10.1037/0022-006X.73.5.965. PMID: 16287396.","27944","2019"
"chard2005_MPSS_B_Baseline_NA","Psychotherapy","PTSD","71","B","Control",,,,"Minimal attention waitlist","Minimal attention","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","Telephone","35","Self report","MPSS","MPSS",,,"Covariance pattern (unstructured) general linear mixed models","Baseline",,,"57.52","24.74",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","1",,"0","Child sexual abuse",,"Medium","Chard KM. An evaluation of cognitive processing therapy for the treatment of posttraumatic stress disorder related to childhood sexual abuse. J Consult Clin Psychol. 2005 Oct;73(5):965-71. doi: 10.1037/0022-006X.73.5.965. PMID: 16287396.","27944","2019"
"chung2004_CAPS_A_0_Comp","Pharmacotherapy","PTSD","113","A","PTSD",,"51",,"Mirtazapine","Mirtazapine","No","Not Applicable","Yes","Antidepressant: Other","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"Structured Clinical Interview","CAPS","CAPS-2","Completer",,"Covariance pattern (unstructured) general linear mixed models","End of Treatment","0",,"58.4",,,,,,"-44.8","19.7",,,,,,,,,"p=0.0001",,,,,,,,,,,"≥30% decrease in CAPS-2 score","0.8824","Additional definitions of Clinically Meaningful Response reported in the study","Veteran","0","1","0","0",,"1","Combat-related",,"High","Chung MY, Min KH, Jun YJ, et al. Efficacy and tolerability of mirtazapine and sertraline in Korean veterans with posttraumatic stress disorder: a randomized open label trial. Hum Psychopharmacol. 2004 Oct;19(7):489-94. doi: 10.1002/hup.615. PMID: 15378676.","26712","2019"
"chung2004_CAPS_A_Baseline_Comp","Pharmacotherapy","PTSD","113","A","PTSD",,"51",,"Mirtazapine","Mirtazapine","No","Not Applicable","Yes","Antidepressant: Other","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"Structured Clinical Interview","CAPS","CAPS-2","Completer",,"Covariance pattern (unstructured) general linear mixed models","Baseline",,,"103.2","24.4",,,,,,,,,,,,,,,,,,,,,,,,,,"≥30% decrease in CAPS-2 score",,"Additional definitions of Clinically Meaningful Response reported in the study","Veteran","0","1","0","0",,"1","Combat-related",,"High","Chung MY, Min KH, Jun YJ, et al. Efficacy and tolerability of mirtazapine and sertraline in Korean veterans with posttraumatic stress disorder: a randomized open label trial. Hum Psychopharmacol. 2004 Oct;19(7):489-94. doi: 10.1002/hup.615. PMID: 15378676.","26712","2019"
"chung2004_CAPS_B_0_Comp","Pharmacotherapy","PTSD","113","B","PTSD",,"49",,"Sertraline","Sertraline","No","Not Applicable","Yes","Antidepressant: SSRI","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"Structured Clinical Interview","CAPS","CAPS-2","Completer",,"Covariance pattern (unstructured) general linear mixed models","End of Treatment","0",,"55.6",,,,,,"-33.2","20.4",,,,,,,,,"p=0.0001",,,,,,,,,,,"≥30% decrease in CAPS-2 score","0.6939","Additional definitions of Clinically Meaningful Response reported in the study","Veteran","0","1","0","0",,"1","Combat-related",,"High","Chung MY, Min KH, Jun YJ, et al. Efficacy and tolerability of mirtazapine and sertraline in Korean veterans with posttraumatic stress disorder: a randomized open label trial. Hum Psychopharmacol. 2004 Oct;19(7):489-94. doi: 10.1002/hup.615. PMID: 15378676.","26712","2019"
"chung2004_CAPS_B_Baseline_Comp","Pharmacotherapy","PTSD","113","B","PTSD",,"49",,"Sertraline","Sertraline","No","Not Applicable","Yes","Antidepressant: SSRI","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"Structured Clinical Interview","CAPS","CAPS-2","Completer",,"Covariance pattern (unstructured) general linear mixed models","Baseline",,,"88.8","23.9",,,,,,,,,,,,,,,,,,,,,,,,,,"≥30% decrease in CAPS-2 score",,"Additional definitions of Clinically Meaningful Response reported in the study","Veteran","0","1","0","0",,"1","Combat-related",,"High","Chung MY, Min KH, Jun YJ, et al. Efficacy and tolerability of mirtazapine and sertraline in Korean veterans with posttraumatic stress disorder: a randomized open label trial. Hum Psychopharmacol. 2004 Oct;19(7):489-94. doi: 10.1002/hup.615. PMID: 15378676.","26712","2019"
"church2013_PCL_A_0_Comp","Psychotherapy","PTSD","59","A","PTSD",,"29",,"Emotional Freedom Technique","Emotional Freedom Technique (EFT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","30","Self report","PCL","PCL-M","Completer",,"Covariance pattern (unstructured) general linear mixed models","End of Treatment","0",,"39.41",,"SE","2.7",,,"-22.6",,,,,,,,,,"p<0.003",,,,,,,,"PCL-M <50","0.8967",,,,,"Veteran","0","1","0","0.1017",,"0.8983",,,"Medium","Church D, Hawk C, Brooks AJ, et al. Psychological trauma symptom improvement in veterans using Emotional Freedom Techniques. J Nerv Ment Dis. 2013 Feb;201(2):153-60. doi: 10.1097/NMD.0b013e31827f6351. PMID: 23364126.","40000","2019"
"church2013_PCL_A_Baseline_Comp","Psychotherapy","PTSD","59","A","PTSD",,"29",,"Emotional Freedom Technique","Emotional Freedom Technique (EFT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","30","Self report","PCL","PCL-M","Completer",,"Covariance pattern (unstructured) general linear mixed models","Baseline",,,"62.01",,"SE","2.1",,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0.1017",,"0.8983",,,"Medium","Church D, Hawk C, Brooks AJ, et al. Psychological trauma symptom improvement in veterans using Emotional Freedom Techniques. J Nerv Ment Dis. 2013 Feb;201(2):153-60. doi: 10.1097/NMD.0b013e31827f6351. PMID: 23364126.","40000","2019"
"church2013_PCL_B_0_Comp","Psychotherapy","PTSD","59","B","Control",,"25",,"Standard of care","Treatment as usual (TAU)","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,"29","Self report","PCL","PCL-M","Completer",,"Covariance pattern (unstructured) general linear mixed models","End of Treatment","0",,"63.23",,"SE","2.0",,,"0.52",,,,,,,,,,"p=NS",,,,,,,,"PCL-M <50","0.04",,,,,"Veteran","0","1","0","0.1017",,"0.8983",,,"Medium","Church D, Hawk C, Brooks AJ, et al. Psychological trauma symptom improvement in veterans using Emotional Freedom Techniques. J Nerv Ment Dis. 2013 Feb;201(2):153-60. doi: 10.1097/NMD.0b013e31827f6351. PMID: 23364126.","40000","2019"
"church2013_PCL_B_Baseline_Comp","Psychotherapy","PTSD","59","B","Control",,"25",,"Standard of care","Treatment as usual (TAU)","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,"29","Self report","PCL","PCL-M","Completer",,"Covariance pattern (unstructured) general linear mixed models","Baseline",,,"62.71",,"SE","2.3",,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0.1017",,"0.8983",,,"Medium","Church D, Hawk C, Brooks AJ, et al. Psychological trauma symptom improvement in veterans using Emotional Freedom Techniques. J Nerv Ment Dis. 2013 Feb;201(2):153-60. doi: 10.1097/NMD.0b013e31827f6351. PMID: 23364126.","40000","2019"
"classen2001_TSC-40_A_0_NA","Psychotherapy","PTSD","58","A","PTSD",,,,"Trauma-focused or Present-focused group therapy","Trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Group","In Person",,"Self report","TSC-40","TSC-40",,,"Covariance pattern (unstructured) general linear mixed models","End of Treatment","0",,,,,,,,"-8.1","17",,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","1","Sexual orientation
Heterosexual: 82.69%
Lesbian: 9.62%
Bisexual: 7.69%","0","Child sexual abuse",,"High","Classen CC, Koopman C, Nevill-Manning K, et al. A preliminary report comparing trauma-focused and present-focused group therapy against a wait-listed condition among childhood sexual abuse survivors with PTSD. J Aggress Maltreat Trauma. 2001 Jun;4(2):265-88. doi: 10.1300/J146v04n02_12.","16145","2019"
"classen2001_TSC-40_B_0_NA","Psychotherapy","PTSD","58","B","Control",,"33",,"Waitlist","Present Centered Therapy (PCT)","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Group","In Person",,"Self report","TSC-40","TSC-40",,,"Covariance pattern (unstructured) general linear mixed models","End of Treatment","0",,,,,,,,"-3.8","14.1",,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","1","Sexual orientation
Heterosexual: 82.69%
Lesbian: 9.62%
Bisexual: 7.69%","0","Child sexual abuse",,"High","Classen CC, Koopman C, Nevill-Manning K, et al. A preliminary report comparing trauma-focused and present-focused group therapy against a wait-listed condition among childhood sexual abuse survivors with PTSD. J Aggress Maltreat Trauma. 2001 Jun;4(2):265-88. doi: 10.1300/J146v04n02_12.","16145","2019"
"classen2001_TSC-40_B_Baseline_NA","Psychotherapy","PTSD","58","B","Control",,"33",,"Waitlist","Present Centered Therapy (PCT)","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Group","In Person",,"Self report","TSC-40","TSC-40",,,"Covariance pattern (unstructured) general linear mixed models","Baseline",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","1","Sexual orientation
Heterosexual: 82.69%
Lesbian: 9.62%
Bisexual: 7.69%","0","Child sexual abuse",,"High","Classen CC, Koopman C, Nevill-Manning K, et al. A preliminary report comparing trauma-focused and present-focused group therapy against a wait-listed condition among childhood sexual abuse survivors with PTSD. J Aggress Maltreat Trauma. 2001 Jun;4(2):265-88. doi: 10.1300/J146v04n02_12.","16145","2019"
"cloitre2002_CAPS_A_0_Comp","Psychotherapy","PTSD","58","A","PTSD",,"22",,"STAIR + modified PE","Skills Training in Affect and Interpersonal Regulation (STAIR) plus modified Prolonged Exposure (PE)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","31","Structured Clinical Interview","CAPS","CAPS","Completer",,"Covariance pattern (unstructured) general linear mixed models","End of Treatment","0",,"31","25.2",,,,,"-38",,,,,,,,,,"p=""significant""",,,,,,,,"Not meeting criteria for PTSD according to CAPS","0.7727",,"MPSS score <20, STAI-S score <40, and BDI score <10","0.4545",,"Community",,,"1","1",,"0","Mixed","child physical abuse, child sexual abuse","Medium","Cloitre M, Koenen KC, Cohen LR, et al. Skills training in affective and interpersonal regulation followed by exposure: a phase-based treatment for PTSD related to childhood abuse. J Consult Clin Psychol. 2002 Oct;70(5):1067-74. doi: 10.1037//0022-006X.70.5.1067. PMID: 12362957.","24762","2019"
"cloitre2002_CAPS_A_0_ITT","Psychotherapy","PTSD","58","A","PTSD",,"31",,"STAIR + modified PE","Skills Training in Affect and Interpersonal Regulation (STAIR) plus modified Prolonged Exposure (PE)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","31","Structured Clinical Interview","CAPS","CAPS","ITT","LOCF","Covariance pattern (unstructured) general linear mixed models","End of Treatment","0",,,,,,,,,,,,,,,,,,"p=""significant""",,,,,,,,"Not meeting criteria for PTSD according to CAPS",,,"MPSS score <20, STAI-S score <40, and BDI score <10",,,"Community",,,"1","1",,"0","Mixed","child physical abuse, child sexual abuse","Medium","Cloitre M, Koenen KC, Cohen LR, et al. Skills training in affective and interpersonal regulation followed by exposure: a phase-based treatment for PTSD related to childhood abuse. J Consult Clin Psychol. 2002 Oct;70(5):1067-74. doi: 10.1037//0022-006X.70.5.1067. PMID: 12362957.","24762","2019"
"cloitre2002_CAPS_A_12_Comp","Psychotherapy","PTSD","58","A","PTSD",,"20",,"STAIR + modified PE","Skills Training in Affect and Interpersonal Regulation (STAIR) plus modified Prolonged Exposure (PE)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","31","Structured Clinical Interview","CAPS","CAPS","Completer",,"Covariance pattern (unstructured) general linear mixed models","Assessment at 3 to <6 Months","12",,"26","17.4",,,,,"-43",,,,"compared to posttreatment",,,,,,"p=0.04",,,,,,,,"Not meeting criteria for PTSD according to CAPS",,,"MPSS score <20, STAI-S score <40, and BDI score <10",,,"Community",,,"1","1",,"0","Mixed","child physical abuse, child sexual abuse","Medium","Cloitre M, Koenen KC, Cohen LR, et al. Skills training in affective and interpersonal regulation followed by exposure: a phase-based treatment for PTSD related to childhood abuse. J Consult Clin Psychol. 2002 Oct;70(5):1067-74. doi: 10.1037//0022-006X.70.5.1067. PMID: 12362957.","24762","2019"
"cloitre2002_CAPS_A_39_Comp","Psychotherapy","PTSD","58","A","PTSD",,"17",,"STAIR + modified PE","Skills Training in Affect and Interpersonal Regulation (STAIR) plus modified Prolonged Exposure (PE)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","31","Structured Clinical Interview","CAPS","CAPS","Completer",,"Covariance pattern (unstructured) general linear mixed models","Assessment at 6 to <12 Months","39",,"22","14.5",,,,,"-47",,,,"compared to posttreatment",,,,,,"p=0.01",,,,,,,,"Not meeting criteria for PTSD according to CAPS",,,"MPSS score <20, STAI-S score <40, and BDI score <10",,,"Community",,,"1","1",,"0","Mixed","child physical abuse, child sexual abuse","Medium","Cloitre M, Koenen KC, Cohen LR, et al. Skills training in affective and interpersonal regulation followed by exposure: a phase-based treatment for PTSD related to childhood abuse. J Consult Clin Psychol. 2002 Oct;70(5):1067-74. doi: 10.1037//0022-006X.70.5.1067. PMID: 12362957.","24762","2019"
"cloitre2002_CAPS_A_Baseline_Comp","Psychotherapy","PTSD","58","A","PTSD",,"22",,"STAIR + modified PE","Skills Training in Affect and Interpersonal Regulation (STAIR) plus modified Prolonged Exposure (PE)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","31","Structured Clinical Interview","CAPS","CAPS","Completer",,"Covariance pattern (unstructured) general linear mixed models","Baseline",,,"69","16.3",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","1",,"0","Mixed","child physical abuse, child sexual abuse","Medium","Cloitre M, Koenen KC, Cohen LR, et al. Skills training in affective and interpersonal regulation followed by exposure: a phase-based treatment for PTSD related to childhood abuse. J Consult Clin Psychol. 2002 Oct;70(5):1067-74. doi: 10.1037//0022-006X.70.5.1067. PMID: 12362957.","24762","2019"
"cloitre2002_CAPS_A_Baseline_ITT","Psychotherapy","PTSD","58","A","PTSD",,"31",,"STAIR + modified PE","Skills Training in Affect and Interpersonal Regulation (STAIR) plus modified Prolonged Exposure (PE)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","31","Structured Clinical Interview","CAPS","CAPS","ITT","LOCF","Covariance pattern (unstructured) general linear mixed models","Baseline",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","1",,"0","Mixed","child physical abuse, child sexual abuse","Medium","Cloitre M, Koenen KC, Cohen LR, et al. Skills training in affective and interpersonal regulation followed by exposure: a phase-based treatment for PTSD related to childhood abuse. J Consult Clin Psychol. 2002 Oct;70(5):1067-74. doi: 10.1037//0022-006X.70.5.1067. PMID: 12362957.","24762","2019"
"cloitre2002_CAPS_B_0_Comp","Psychotherapy","PTSD","58","B","Control",,"24",,"Minimal attention","Minimal attention","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","Phone","27","Structured Clinical Interview","CAPS","CAPS","Completer",,"Covariance pattern (unstructured) general linear mixed models","End of Treatment","0",,"62","22.7",,,,,"-7",,,,,,,,,,,,,,,,,,"Not meeting criteria for PTSD according to CAPS","0.25",,"MPSS score <20, STAI-S score <40, and BDI score <10","0.0417",,"Community",,,"1","1",,"0","Mixed","child physical abuse, child sexual abuse","Medium","Cloitre M, Koenen KC, Cohen LR, et al. Skills training in affective and interpersonal regulation followed by exposure: a phase-based treatment for PTSD related to childhood abuse. J Consult Clin Psychol. 2002 Oct;70(5):1067-74. doi: 10.1037//0022-006X.70.5.1067. PMID: 12362957.","24762","2019"
"cloitre2002_CAPS_B_0_ITT","Psychotherapy","PTSD","58","B","Control",,"27",,"Minimal attention","Minimal attention","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","Phone","27","Structured Clinical Interview","CAPS","CAPS","ITT","LOCF","Covariance pattern (unstructured) general linear mixed models","End of Treatment","0",,,,,,,,,,,,,,,,,,,,,,,,,,"Not meeting criteria for PTSD according to CAPS",,,"MPSS score <20, STAI-S score <40, and BDI score <10",,,"Community",,,"1","1",,"0","Mixed","child physical abuse, child sexual abuse","Medium","Cloitre M, Koenen KC, Cohen LR, et al. Skills training in affective and interpersonal regulation followed by exposure: a phase-based treatment for PTSD related to childhood abuse. J Consult Clin Psychol. 2002 Oct;70(5):1067-74. doi: 10.1037//0022-006X.70.5.1067. PMID: 12362957.","24762","2019"
"cloitre2002_CAPS_B_Baseline_Comp","Psychotherapy","PTSD","58","B","Control",,"24",,"Minimal attention","Minimal attention","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","Phone","27","Structured Clinical Interview","CAPS","CAPS","Completer",,"Covariance pattern (unstructured) general linear mixed models","Baseline",,,"69","16.6",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","1",,"0","Mixed","child physical abuse, child sexual abuse","Medium","Cloitre M, Koenen KC, Cohen LR, et al. Skills training in affective and interpersonal regulation followed by exposure: a phase-based treatment for PTSD related to childhood abuse. J Consult Clin Psychol. 2002 Oct;70(5):1067-74. doi: 10.1037//0022-006X.70.5.1067. PMID: 12362957.","24762","2019"
"cloitre2002_CAPS_B_Baseline_ITT","Psychotherapy","PTSD","58","B","Control",,"27",,"Minimal attention","Minimal attention","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","Phone","27","Structured Clinical Interview","CAPS","CAPS","ITT","LOCF","Covariance pattern (unstructured) general linear mixed models","Baseline",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","1",,"0","Mixed","child physical abuse, child sexual abuse","Medium","Cloitre M, Koenen KC, Cohen LR, et al. Skills training in affective and interpersonal regulation followed by exposure: a phase-based treatment for PTSD related to childhood abuse. J Consult Clin Psychol. 2002 Oct;70(5):1067-74. doi: 10.1037//0022-006X.70.5.1067. PMID: 12362957.","24762","2019"
"cloitre2002_MPSS_A_0_Comp","Psychotherapy","PTSD","58","A","PTSD",,,,"STAIR + modified PE","Skills Training in Affect and Interpersonal Regulation (STAIR) plus modified Prolonged Exposure (PE)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","31","Self report","MPSS","MPSS","Completer",,"Covariance pattern (unstructured) general linear mixed models","End of Treatment","0",,"29","27.6",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","1",,"0","Mixed","child physical abuse, child sexual abuse","Medium","Cloitre M, Koenen KC, Cohen LR, et al. Skills training in affective and interpersonal regulation followed by exposure: a phase-based treatment for PTSD related to childhood abuse. J Consult Clin Psychol. 2002 Oct;70(5):1067-74. doi: 10.1037//0022-006X.70.5.1067. PMID: 12362957.","24762","2019"
"cloitre2002_MPSS_A_Baseline_Comp","Psychotherapy","PTSD","58","A","PTSD",,,,"STAIR + modified PE","Skills Training in Affect and Interpersonal Regulation (STAIR) plus modified Prolonged Exposure (PE)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","31","Self report","MPSS","MPSS","Completer",,"Covariance pattern (unstructured) general linear mixed models","Baseline",,,"69","16.6",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","1",,"0","Mixed","child physical abuse, child sexual abuse","Medium","Cloitre M, Koenen KC, Cohen LR, et al. Skills training in affective and interpersonal regulation followed by exposure: a phase-based treatment for PTSD related to childhood abuse. J Consult Clin Psychol. 2002 Oct;70(5):1067-74. doi: 10.1037//0022-006X.70.5.1067. PMID: 12362957.","24762","2019"
"cloitre2002_MPSS_B_0_Comp","Psychotherapy","PTSD","58","B","Control",,,,"Minimal attention","Minimal attention","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","Phone","27","Self report","MPSS","MPSS","Completer",,"Covariance pattern (unstructured) general linear mixed models","End of Treatment","0",,"58","28.6",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","1",,"0","Mixed","child physical abuse, child sexual abuse","Medium","Cloitre M, Koenen KC, Cohen LR, et al. Skills training in affective and interpersonal regulation followed by exposure: a phase-based treatment for PTSD related to childhood abuse. J Consult Clin Psychol. 2002 Oct;70(5):1067-74. doi: 10.1037//0022-006X.70.5.1067. PMID: 12362957.","24762","2019"
"cloitre2002_MPSS_B_Baseline_Comp","Psychotherapy","PTSD","58","B","Control",,,,"Minimal attention","Minimal attention","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","Phone","27","Self report","MPSS","MPSS","Completer",,"Covariance pattern (unstructured) general linear mixed models","Baseline",,,"73","18.6",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","1",,"0","Mixed","child physical abuse, child sexual abuse","Medium","Cloitre M, Koenen KC, Cohen LR, et al. Skills training in affective and interpersonal regulation followed by exposure: a phase-based treatment for PTSD related to childhood abuse. J Consult Clin Psychol. 2002 Oct;70(5):1067-74. doi: 10.1037//0022-006X.70.5.1067. PMID: 12362957.","24762","2019"
"cloitre2010_CAPS_A_0_ITT","Psychotherapy","PTSD","104","A","PTSD",,"28",,"STAIR + Exposure Treatment","Skills Training in Affect and Interpersonal Regulation (STAIR) + exposure therapy","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","33","Structured Clinical Interview","CAPS","CAPS","ITT","Imputed (continuous outcomes), LOCF (categorical outcomes)","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","End of Treatment","0",,"32.70","19.37",,,,,"-30.38",,,,,,,,,,,,,,,,,,"Not meeting criteria for PTSD according to the CAPS","0.61",,"CAPS score <20","0.27",,"Community",,,"1","1",,"0","Mixed","child physical abuse, child sexual abuse, child other abuse, intimate partner violence, rape/sexual assault, community/school violence, other (""other interpersonal victimization"")","Medium","Cloitre M, Stovall-McClough KC, Nooner K, et al. Treatment for PTSD related to childhood abuse: a randomized controlled trial. Am J Psychiatry. 2010 Aug;167(8):915-24. doi: 10.1176/appi.ajp.2010.09081247. PMID: 20595411.","34562","2020"
"cloitre2010_CAPS_A_12_ITT","Psychotherapy","PTSD","104","A","PTSD",,"25",,"STAIR + Exposure Treatment","Skills Training in Affect and Interpersonal Regulation (STAIR) + exposure therapy","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","33","Structured Clinical Interview","CAPS","CAPS","ITT","Imputed (continuous outcomes), LOCF (categorical outcomes)","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Assessment at 3 to <6 Months","12",,"24.66","18.47",,,,,"-38.42",,,,,,,,,,,,,,,,,,"Not meeting criteria for PTSD according to the CAPS",,,"CAPS score <20",,,"Community",,,"1","1",,"0","Mixed","child physical abuse, child sexual abuse, child other abuse, intimate partner violence, rape/sexual assault, community/school violence, other (""other interpersonal victimization"")","Medium","Cloitre M, Stovall-McClough KC, Nooner K, et al. Treatment for PTSD related to childhood abuse: a randomized controlled trial. Am J Psychiatry. 2010 Aug;167(8):915-24. doi: 10.1176/appi.ajp.2010.09081247. PMID: 20595411.","34562","2020"
"cloitre2010_CAPS_A_26_ITT","Psychotherapy","PTSD","104","A","PTSD",,"23",,"STAIR + Exposure Treatment","Skills Training in Affect and Interpersonal Regulation (STAIR) + exposure therapy","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","33","Structured Clinical Interview","CAPS","CAPS","ITT","Imputed (continuous outcomes), LOCF (categorical outcomes)","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Assessment at 6 to <12 Months","26",,"20.44","19.01",,,,,"-42.64",,,,,"Cohen's d","2.29",,,,,,,,,,,,"Not meeting criteria for PTSD according to the CAPS","0.55",,"CAPS score <20","0.24",,"Community",,,"1","1",,"0","Mixed","child physical abuse, child sexual abuse, child other abuse, intimate partner violence, rape/sexual assault, community/school violence, other (""other interpersonal victimization"")","Medium","Cloitre M, Stovall-McClough KC, Nooner K, et al. Treatment for PTSD related to childhood abuse: a randomized controlled trial. Am J Psychiatry. 2010 Aug;167(8):915-24. doi: 10.1176/appi.ajp.2010.09081247. PMID: 20595411.","34562","2020"
"cloitre2010_CAPS_A_Baseline_ITT","Psychotherapy","PTSD","104","A","PTSD",,"33",,"STAIR + Exposure Treatment","Skills Training in Affect and Interpersonal Regulation (STAIR) + exposure therapy","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","33","Structured Clinical Interview","CAPS","CAPS","ITT","Imputed (continuous outcomes), LOCF (categorical outcomes)","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Baseline",,,"63.08","18.29",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","1",,"0","Mixed","child physical abuse, child sexual abuse, child other abuse, intimate partner violence, rape/sexual assault, community/school violence, other (""other interpersonal victimization"")","Medium","Cloitre M, Stovall-McClough KC, Nooner K, et al. Treatment for PTSD related to childhood abuse: a randomized controlled trial. Am J Psychiatry. 2010 Aug;167(8):915-24. doi: 10.1176/appi.ajp.2010.09081247. PMID: 20595411.","34562","2020"
"cloitre2010_CAPS_B_0_ITT","Psychotherapy","PTSD","104","B","PTSD",,"28",,"STAIR + Supportive Counseling","Skills Training in Affect and Interpersonal Regulation (STAIR) + supportive therapy","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","38","Structured Clinical Interview","CAPS","CAPS","ITT","Imputed (continuous outcomes), LOCF (categorical outcomes)","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","End of Treatment","0",,"32.32","23.04",,,,,"-32.02",,,,,,,,,,,,,,,,,,"Not meeting criteria for PTSD according to the CAPS","0.47",,"CAPS score <20","0.24",,"Community",,,"1","1",,"0","Mixed","child physical abuse, child sexual abuse, child other abuse, intimate partner violence, rape/sexual assault, community/school violence, other (""other interpersonal victimization"")","Medium","Cloitre M, Stovall-McClough KC, Nooner K, et al. Treatment for PTSD related to childhood abuse: a randomized controlled trial. Am J Psychiatry. 2010 Aug;167(8):915-24. doi: 10.1176/appi.ajp.2010.09081247. PMID: 20595411.","34562","2020"
"cloitre2010_CAPS_B_12_ITT","Psychotherapy","PTSD","104","B","PTSD",,"26",,"STAIR + Supportive Counseling","Skills Training in Affect and Interpersonal Regulation (STAIR) + supportive therapy","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","38","Structured Clinical Interview","CAPS","CAPS","ITT","Imputed (continuous outcomes), LOCF (categorical outcomes)","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Assessment at 3 to <6 Months","12",,"31.88","22.98",,,,,"-32.46",,,,,,,,,,,,,,,,,,"Not meeting criteria for PTSD according to the CAPS",,,"CAPS score <20",,,"Community",,,"1","1",,"0","Mixed","child physical abuse, child sexual abuse, child other abuse, intimate partner violence, rape/sexual assault, community/school violence, other (""other interpersonal victimization"")","Medium","Cloitre M, Stovall-McClough KC, Nooner K, et al. Treatment for PTSD related to childhood abuse: a randomized controlled trial. Am J Psychiatry. 2010 Aug;167(8):915-24. doi: 10.1176/appi.ajp.2010.09081247. PMID: 20595411.","34562","2020"
"cloitre2010_CAPS_B_26_ITT","Psychotherapy","PTSD","104","B","PTSD",,"23",,"STAIR + Supportive Counseling","Skills Training in Affect and Interpersonal Regulation (STAIR) + supportive therapy","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","38","Structured Clinical Interview","CAPS","CAPS","ITT","Imputed (continuous outcomes), LOCF (categorical outcomes)","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Assessment at 6 to <12 Months","26",,"32.51","22.69",,,,,"-31.83",,,,,"Cohen's d","1.72",,,,,,,,,,,,"Not meeting criteria for PTSD according to the CAPS","0.37",,"CAPS score <20","0.13",,"Community",,,"1","1",,"0","Mixed","child physical abuse, child sexual abuse, child other abuse, intimate partner violence, rape/sexual assault, community/school violence, other (""other interpersonal victimization"")","Medium","Cloitre M, Stovall-McClough KC, Nooner K, et al. Treatment for PTSD related to childhood abuse: a randomized controlled trial. Am J Psychiatry. 2010 Aug;167(8):915-24. doi: 10.1176/appi.ajp.2010.09081247. PMID: 20595411.","34562","2020"
"cloitre2010_CAPS_B_Baseline_ITT","Psychotherapy","PTSD","104","B","PTSD",,"38",,"STAIR + Supportive Counseling","Skills Training in Affect and Interpersonal Regulation (STAIR) + supportive therapy","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","38","Structured Clinical Interview","CAPS","CAPS","ITT","Imputed (continuous outcomes), LOCF (categorical outcomes)","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Baseline",,,"64.34","21.15",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","1",,"0","Mixed","child physical abuse, child sexual abuse, child other abuse, intimate partner violence, rape/sexual assault, community/school violence, other (""other interpersonal victimization"")","Medium","Cloitre M, Stovall-McClough KC, Nooner K, et al. Treatment for PTSD related to childhood abuse: a randomized controlled trial. Am J Psychiatry. 2010 Aug;167(8):915-24. doi: 10.1176/appi.ajp.2010.09081247. PMID: 20595411.","34562","2020"
"cloitre2010_CAPS_C_0_ITT","Psychotherapy","PTSD","104","C","PTSD",,"20",,"Supportive Counseling + Exposure Treatment","Supportive counseling + exposure","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","33","Structured Clinical Interview","CAPS","CAPS","ITT","Imputed (continuous outcomes), LOCF (categorical outcomes)","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","End of Treatment","0",,"39.72","18.34",,,,,"-24.78",,,,,,,,,,,,,,,,,,"Not meeting criteria for PTSD according to the CAPS","0.33",,"CAPS score <20","0.06",,"Community",,,"1","1",,"0","Mixed","child physical abuse, child sexual abuse, child other abuse, intimate partner violence, rape/sexual assault, community/school violence, other (""other interpersonal victimization"")","Medium","Cloitre M, Stovall-McClough KC, Nooner K, et al. Treatment for PTSD related to childhood abuse: a randomized controlled trial. Am J Psychiatry. 2010 Aug;167(8):915-24. doi: 10.1176/appi.ajp.2010.09081247. PMID: 20595411.","34562","2020"
"cloitre2010_CAPS_C_12_ITT","Psychotherapy","PTSD","104","C","PTSD",,"20",,"Supportive Counseling + Exposure Treatment","Supportive counseling + exposure","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","33","Structured Clinical Interview","CAPS","CAPS","ITT","Imputed (continuous outcomes), LOCF (categorical outcomes)","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Assessment at 3 to <6 Months","12",,"39.71","17.59",,,,,"-24.79",,,,,,,,,,,,,,,,,,"Not meeting criteria for PTSD according to the CAPS","0.29",,"CAPS score <20",,,"Community",,,"1","1",,"0","Mixed","child physical abuse, child sexual abuse, child other abuse, intimate partner violence, rape/sexual assault, community/school violence, other (""other interpersonal victimization"")","Medium","Cloitre M, Stovall-McClough KC, Nooner K, et al. Treatment for PTSD related to childhood abuse: a randomized controlled trial. Am J Psychiatry. 2010 Aug;167(8):915-24. doi: 10.1176/appi.ajp.2010.09081247. PMID: 20595411.","34562","2020"
"cloitre2010_CAPS_C_26_ITT","Psychotherapy","PTSD","104","C","PTSD",,"20",,"Supportive Counseling + Exposure Treatment","Supportive counseling + exposure","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","33","Structured Clinical Interview","CAPS","CAPS","ITT","Imputed (continuous outcomes), LOCF (categorical outcomes)","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Assessment at 6 to <12 Months","26",,"28.56","21.00",,,,,"-35.94",,,,,"Cohen's d","1.94",,,,,,,,,,,,"Not meeting criteria for PTSD according to the CAPS","0.21",,"CAPS score <20","0",,"Community",,,"1","1",,"0","Mixed","child physical abuse, child sexual abuse, child other abuse, intimate partner violence, rape/sexual assault, community/school violence, other (""other interpersonal victimization"")","Medium","Cloitre M, Stovall-McClough KC, Nooner K, et al. Treatment for PTSD related to childhood abuse: a randomized controlled trial. Am J Psychiatry. 2010 Aug;167(8):915-24. doi: 10.1176/appi.ajp.2010.09081247. PMID: 20595411.","34562","2020"
"cloitre2010_CAPS_C_Baseline_ITT","Psychotherapy","PTSD","104","C","PTSD",,"33",,"Supportive Counseling + Exposure Treatment","Supportive counseling + exposure","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","33","Structured Clinical Interview","CAPS","CAPS","ITT","Imputed (continuous outcomes), LOCF (categorical outcomes)","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Baseline",,,"64.50","15.86",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","1",,"0","Mixed","child physical abuse, child sexual abuse, child other abuse, intimate partner violence, rape/sexual assault, community/school violence, other (""other interpersonal victimization"")","Medium","Cloitre M, Stovall-McClough KC, Nooner K, et al. Treatment for PTSD related to childhood abuse: a randomized controlled trial. Am J Psychiatry. 2010 Aug;167(8):915-24. doi: 10.1176/appi.ajp.2010.09081247. PMID: 20595411.","34562","2020"
"cloitre2010_Gene_A_0_ITT","Psychotherapy","PTSD","104","A","PTSD",,,,"STAIR + Exposure Treatment","Skills Training in Affect and Interpersonal Regulation (STAIR) + exposure therapy","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","33","Self report","General Expectancy for Negative Mood Regulation Scale","General Expectancy for Negative Mood Regulation Scale","ITT","Imputed (continuous outcomes), LOCF (categorical outcomes)","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","End of Treatment","0",,"110.5","16.17",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","1",,"0","Mixed","child physical abuse, child sexual abuse, child other abuse, intimate partner violence, rape/sexual assault, community/school violence, other (""other interpersonal victimization"")","Medium","Cloitre M, Stovall-McClough KC, Nooner K, et al. Treatment for PTSD related to childhood abuse: a randomized controlled trial. Am J Psychiatry. 2010 Aug;167(8):915-24. doi: 10.1176/appi.ajp.2010.09081247. PMID: 20595411.","34562","2020"
"cloitre2010_Gene_A_12_ITT","Psychotherapy","PTSD","104","A","PTSD",,,,"STAIR + Exposure Treatment","Skills Training in Affect and Interpersonal Regulation (STAIR) + exposure therapy","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","33","Self report","General Expectancy for Negative Mood Regulation Scale","General Expectancy for Negative Mood Regulation Scale","ITT","Imputed (continuous outcomes), LOCF (categorical outcomes)","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Assessment at 3 to <6 Months","12",,"108.5","17.86",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","1",,"0","Mixed","child physical abuse, child sexual abuse, child other abuse, intimate partner violence, rape/sexual assault, community/school violence, other (""other interpersonal victimization"")","Medium","Cloitre M, Stovall-McClough KC, Nooner K, et al. Treatment for PTSD related to childhood abuse: a randomized controlled trial. Am J Psychiatry. 2010 Aug;167(8):915-24. doi: 10.1176/appi.ajp.2010.09081247. PMID: 20595411.","34562","2020"
"cloitre2010_Gene_A_26_ITT","Psychotherapy","PTSD","104","A","PTSD",,,,"STAIR + Exposure Treatment","Skills Training in Affect and Interpersonal Regulation (STAIR) + exposure therapy","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","33","Self report","General Expectancy for Negative Mood Regulation Scale","General Expectancy for Negative Mood Regulation Scale","ITT","Imputed (continuous outcomes), LOCF (categorical outcomes)","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Assessment at 6 to <12 Months","26",,"113.7","15.99",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","1",,"0","Mixed","child physical abuse, child sexual abuse, child other abuse, intimate partner violence, rape/sexual assault, community/school violence, other (""other interpersonal victimization"")","Medium","Cloitre M, Stovall-McClough KC, Nooner K, et al. Treatment for PTSD related to childhood abuse: a randomized controlled trial. Am J Psychiatry. 2010 Aug;167(8):915-24. doi: 10.1176/appi.ajp.2010.09081247. PMID: 20595411.","34562","2020"
"cloitre2010_Gene_A_Baseline_ITT","Psychotherapy","PTSD","104","A","PTSD",,,,"STAIR + Exposure Treatment","Skills Training in Affect and Interpersonal Regulation (STAIR) + exposure therapy","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","33","Self report","General Expectancy for Negative Mood Regulation Scale","General Expectancy for Negative Mood Regulation Scale","ITT","Imputed (continuous outcomes), LOCF (categorical outcomes)","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Baseline",,,"90.6","14.68",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","1",,"0","Mixed","child physical abuse, child sexual abuse, child other abuse, intimate partner violence, rape/sexual assault, community/school violence, other (""other interpersonal victimization"")","Medium","Cloitre M, Stovall-McClough KC, Nooner K, et al. Treatment for PTSD related to childhood abuse: a randomized controlled trial. Am J Psychiatry. 2010 Aug;167(8):915-24. doi: 10.1176/appi.ajp.2010.09081247. PMID: 20595411.","34562","2020"
"cloitre2010_Gene_B_0_ITT","Psychotherapy","PTSD","104","B","PTSD",,,,"STAIR + Supportive Counseling","Skills Training in Affect and Interpersonal Regulation (STAIR) + supportive therapy","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","38","Self report","General Expectancy for Negative Mood Regulation Scale","General Expectancy for Negative Mood Regulation Scale","ITT","Imputed (continuous outcomes), LOCF (categorical outcomes)","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","End of Treatment","0",,"105.7","16.77",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","1",,"0","Mixed","child physical abuse, child sexual abuse, child other abuse, intimate partner violence, rape/sexual assault, community/school violence, other (""other interpersonal victimization"")","Medium","Cloitre M, Stovall-McClough KC, Nooner K, et al. Treatment for PTSD related to childhood abuse: a randomized controlled trial. Am J Psychiatry. 2010 Aug;167(8):915-24. doi: 10.1176/appi.ajp.2010.09081247. PMID: 20595411.","34562","2020"
"cloitre2010_Gene_B_12_ITT","Psychotherapy","PTSD","104","B","PTSD",,,,"STAIR + Supportive Counseling","Skills Training in Affect and Interpersonal Regulation (STAIR) + supportive therapy","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","38","Self report","General Expectancy for Negative Mood Regulation Scale","General Expectancy for Negative Mood Regulation Scale","ITT","Imputed (continuous outcomes), LOCF (categorical outcomes)","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Assessment at 3 to <6 Months","12",,"99.6","19.08",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","1",,"0","Mixed","child physical abuse, child sexual abuse, child other abuse, intimate partner violence, rape/sexual assault, community/school violence, other (""other interpersonal victimization"")","Medium","Cloitre M, Stovall-McClough KC, Nooner K, et al. Treatment for PTSD related to childhood abuse: a randomized controlled trial. Am J Psychiatry. 2010 Aug;167(8):915-24. doi: 10.1176/appi.ajp.2010.09081247. PMID: 20595411.","34562","2020"
"cloitre2010_Gene_B_26_ITT","Psychotherapy","PTSD","104","B","PTSD",,,,"STAIR + Supportive Counseling","Skills Training in Affect and Interpersonal Regulation (STAIR) + supportive therapy","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","38","Self report","General Expectancy for Negative Mood Regulation Scale","General Expectancy for Negative Mood Regulation Scale","ITT","Imputed (continuous outcomes), LOCF (categorical outcomes)","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Assessment at 6 to <12 Months","26",,"105.4","15.95",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","1",,"0","Mixed","child physical abuse, child sexual abuse, child other abuse, intimate partner violence, rape/sexual assault, community/school violence, other (""other interpersonal victimization"")","Medium","Cloitre M, Stovall-McClough KC, Nooner K, et al. Treatment for PTSD related to childhood abuse: a randomized controlled trial. Am J Psychiatry. 2010 Aug;167(8):915-24. doi: 10.1176/appi.ajp.2010.09081247. PMID: 20595411.","34562","2020"
"cloitre2010_Gene_B_Baseline_ITT","Psychotherapy","PTSD","104","B","PTSD",,,,"STAIR + Supportive Counseling","Skills Training in Affect and Interpersonal Regulation (STAIR) + supportive therapy","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","38","Self report","General Expectancy for Negative Mood Regulation Scale","General Expectancy for Negative Mood Regulation Scale","ITT","Imputed (continuous outcomes), LOCF (categorical outcomes)","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Baseline",,,"91.5","16.12",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","1",,"0","Mixed","child physical abuse, child sexual abuse, child other abuse, intimate partner violence, rape/sexual assault, community/school violence, other (""other interpersonal victimization"")","Medium","Cloitre M, Stovall-McClough KC, Nooner K, et al. Treatment for PTSD related to childhood abuse: a randomized controlled trial. Am J Psychiatry. 2010 Aug;167(8):915-24. doi: 10.1176/appi.ajp.2010.09081247. PMID: 20595411.","34562","2020"
"cloitre2010_Gene_C_0_ITT","Psychotherapy","PTSD","104","C","PTSD",,,,"Supportive Counseling + Exposure Treatment","Supportive counseling + exposure","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","33","Self report","General Expectancy for Negative Mood Regulation Scale","General Expectancy for Negative Mood Regulation Scale","ITT","Imputed (continuous outcomes), LOCF (categorical outcomes)","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","End of Treatment","0",,"105.8","17.11",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","1",,"0","Mixed","child physical abuse, child sexual abuse, child other abuse, intimate partner violence, rape/sexual assault, community/school violence, other (""other interpersonal victimization"")","Medium","Cloitre M, Stovall-McClough KC, Nooner K, et al. Treatment for PTSD related to childhood abuse: a randomized controlled trial. Am J Psychiatry. 2010 Aug;167(8):915-24. doi: 10.1176/appi.ajp.2010.09081247. PMID: 20595411.","34562","2020"
"cloitre2010_Gene_C_12_ITT","Psychotherapy","PTSD","104","C","PTSD",,,,"Supportive Counseling + Exposure Treatment","Supportive counseling + exposure","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","33","Self report","General Expectancy for Negative Mood Regulation Scale","General Expectancy for Negative Mood Regulation Scale","ITT","Imputed (continuous outcomes), LOCF (categorical outcomes)","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Assessment at 3 to <6 Months","12",,"101.2","21.82",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","1",,"0","Mixed","child physical abuse, child sexual abuse, child other abuse, intimate partner violence, rape/sexual assault, community/school violence, other (""other interpersonal victimization"")","Medium","Cloitre M, Stovall-McClough KC, Nooner K, et al. Treatment for PTSD related to childhood abuse: a randomized controlled trial. Am J Psychiatry. 2010 Aug;167(8):915-24. doi: 10.1176/appi.ajp.2010.09081247. PMID: 20595411.","34562","2020"
"cloitre2010_Gene_C_26_ITT","Psychotherapy","PTSD","104","C","PTSD",,,,"Supportive Counseling + Exposure Treatment","Supportive counseling + exposure","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","33","Self report","General Expectancy for Negative Mood Regulation Scale","General Expectancy for Negative Mood Regulation Scale","ITT","Imputed (continuous outcomes), LOCF (categorical outcomes)","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Assessment at 6 to <12 Months","26",,"106.8","17.63",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","1",,"0","Mixed","child physical abuse, child sexual abuse, child other abuse, intimate partner violence, rape/sexual assault, community/school violence, other (""other interpersonal victimization"")","Medium","Cloitre M, Stovall-McClough KC, Nooner K, et al. Treatment for PTSD related to childhood abuse: a randomized controlled trial. Am J Psychiatry. 2010 Aug;167(8):915-24. doi: 10.1176/appi.ajp.2010.09081247. PMID: 20595411.","34562","2020"
"cloitre2010_Gene_C_Baseline_ITT","Psychotherapy","PTSD","104","C","PTSD",,,,"Supportive Counseling + Exposure Treatment","Supportive counseling + exposure","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","33","Self report","General Expectancy for Negative Mood Regulation Scale","General Expectancy for Negative Mood Regulation Scale","ITT","Imputed (continuous outcomes), LOCF (categorical outcomes)","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Baseline",,,"90.2","17.18",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","1",,"0","Mixed","child physical abuse, child sexual abuse, child other abuse, intimate partner violence, rape/sexual assault, community/school violence, other (""other interpersonal victimization"")","Medium","Cloitre M, Stovall-McClough KC, Nooner K, et al. Treatment for PTSD related to childhood abuse: a randomized controlled trial. Am J Psychiatry. 2010 Aug;167(8):915-24. doi: 10.1176/appi.ajp.2010.09081247. PMID: 20595411.","34562","2020"
"cloitre2010_PSS-SR_A_0_ITT","Psychotherapy","PTSD","104","A","PTSD",,,,"STAIR + Exposure Treatment","Skills Training in Affect and Interpersonal Regulation (STAIR) + exposure therapy","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","33","Self report","PSS-SR","PSS-SR","ITT","Imputed (continuous outcomes), LOCF (categorical outcomes)","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","End of Treatment","0",,"14.0","11.46",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","1",,"0","Mixed","child physical abuse, child sexual abuse, child other abuse, intimate partner violence, rape/sexual assault, community/school violence, other (""other interpersonal victimization"")","Medium","Cloitre M, Stovall-McClough KC, Nooner K, et al. Treatment for PTSD related to childhood abuse: a randomized controlled trial. Am J Psychiatry. 2010 Aug;167(8):915-24. doi: 10.1176/appi.ajp.2010.09081247. PMID: 20595411.","34562","2020"
"cloitre2010_PSS-SR_A_12_ITT","Psychotherapy","PTSD","104","A","PTSD",,,,"STAIR + Exposure Treatment","Skills Training in Affect and Interpersonal Regulation (STAIR) + exposure therapy","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","33","Self report","PSS-SR","PSS-SR","ITT","Imputed (continuous outcomes), LOCF (categorical outcomes)","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Assessment at 3 to <6 Months","12",,"12.5","11.41",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","1",,"0","Mixed","child physical abuse, child sexual abuse, child other abuse, intimate partner violence, rape/sexual assault, community/school violence, other (""other interpersonal victimization"")","Medium","Cloitre M, Stovall-McClough KC, Nooner K, et al. Treatment for PTSD related to childhood abuse: a randomized controlled trial. Am J Psychiatry. 2010 Aug;167(8):915-24. doi: 10.1176/appi.ajp.2010.09081247. PMID: 20595411.","34562","2020"
"cloitre2010_PSS-SR_A_26_ITT","Psychotherapy","PTSD","104","A","PTSD",,,,"STAIR + Exposure Treatment","Skills Training in Affect and Interpersonal Regulation (STAIR) + exposure therapy","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","33","Self report","PSS-SR","PSS-SR","ITT","Imputed (continuous outcomes), LOCF (categorical outcomes)","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Assessment at 6 to <12 Months","26",,"8.9","9.83",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","1",,"0","Mixed","child physical abuse, child sexual abuse, child other abuse, intimate partner violence, rape/sexual assault, community/school violence, other (""other interpersonal victimization"")","Medium","Cloitre M, Stovall-McClough KC, Nooner K, et al. Treatment for PTSD related to childhood abuse: a randomized controlled trial. Am J Psychiatry. 2010 Aug;167(8):915-24. doi: 10.1176/appi.ajp.2010.09081247. PMID: 20595411.","34562","2020"
"cloitre2010_PSS-SR_A_Baseline_ITT","Psychotherapy","PTSD","104","A","PTSD",,,,"STAIR + Exposure Treatment","Skills Training in Affect and Interpersonal Regulation (STAIR) + exposure therapy","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","33","Self report","PSS-SR","PSS-SR","ITT","Imputed (continuous outcomes), LOCF (categorical outcomes)","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Baseline",,,"36.7","12.87",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","1",,"0","Mixed","child physical abuse, child sexual abuse, child other abuse, intimate partner violence, rape/sexual assault, community/school violence, other (""other interpersonal victimization"")","Medium","Cloitre M, Stovall-McClough KC, Nooner K, et al. Treatment for PTSD related to childhood abuse: a randomized controlled trial. Am J Psychiatry. 2010 Aug;167(8):915-24. doi: 10.1176/appi.ajp.2010.09081247. PMID: 20595411.","34562","2020"
"cloitre2010_PSS-SR_B_0_ITT","Psychotherapy","PTSD","104","B","PTSD",,,,"STAIR + Supportive Counseling","Skills Training in Affect and Interpersonal Regulation (STAIR) + supportive therapy","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","38","Self report","PSS-SR","PSS-SR","ITT","Imputed (continuous outcomes), LOCF (categorical outcomes)","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","End of Treatment","0",,"14.5","12.79",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","1",,"0","Mixed","child physical abuse, child sexual abuse, child other abuse, intimate partner violence, rape/sexual assault, community/school violence, other (""other interpersonal victimization"")","Medium","Cloitre M, Stovall-McClough KC, Nooner K, et al. Treatment for PTSD related to childhood abuse: a randomized controlled trial. Am J Psychiatry. 2010 Aug;167(8):915-24. doi: 10.1176/appi.ajp.2010.09081247. PMID: 20595411.","34562","2020"
"cloitre2010_PSS-SR_B_12_ITT","Psychotherapy","PTSD","104","B","PTSD",,,,"STAIR + Supportive Counseling","Skills Training in Affect and Interpersonal Regulation (STAIR) + supportive therapy","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","38","Self report","PSS-SR","PSS-SR","ITT","Imputed (continuous outcomes), LOCF (categorical outcomes)","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Assessment at 3 to <6 Months","12",,"17.3","10.10",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","1",,"0","Mixed","child physical abuse, child sexual abuse, child other abuse, intimate partner violence, rape/sexual assault, community/school violence, other (""other interpersonal victimization"")","Medium","Cloitre M, Stovall-McClough KC, Nooner K, et al. Treatment for PTSD related to childhood abuse: a randomized controlled trial. Am J Psychiatry. 2010 Aug;167(8):915-24. doi: 10.1176/appi.ajp.2010.09081247. PMID: 20595411.","34562","2020"
"cloitre2010_PSS-SR_B_26_ITT","Psychotherapy","PTSD","104","B","PTSD",,,,"STAIR + Supportive Counseling","Skills Training in Affect and Interpersonal Regulation (STAIR) + supportive therapy","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","38","Self report","PSS-SR","PSS-SR","ITT","Imputed (continuous outcomes), LOCF (categorical outcomes)","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Assessment at 6 to <12 Months","26",,"13.7","13.64",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","1",,"0","Mixed","child physical abuse, child sexual abuse, child other abuse, intimate partner violence, rape/sexual assault, community/school violence, other (""other interpersonal victimization"")","Medium","Cloitre M, Stovall-McClough KC, Nooner K, et al. Treatment for PTSD related to childhood abuse: a randomized controlled trial. Am J Psychiatry. 2010 Aug;167(8):915-24. doi: 10.1176/appi.ajp.2010.09081247. PMID: 20595411.","34562","2020"
"cloitre2010_PSS-SR_B_Baseline_ITT","Psychotherapy","PTSD","104","B","PTSD",,,,"STAIR + Supportive Counseling","Skills Training in Affect and Interpersonal Regulation (STAIR) + supportive therapy","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","38","Self report","PSS-SR","PSS-SR","ITT","Imputed (continuous outcomes), LOCF (categorical outcomes)","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Baseline",,,"39.9","12.65",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","1",,"0","Mixed","child physical abuse, child sexual abuse, child other abuse, intimate partner violence, rape/sexual assault, community/school violence, other (""other interpersonal victimization"")","Medium","Cloitre M, Stovall-McClough KC, Nooner K, et al. Treatment for PTSD related to childhood abuse: a randomized controlled trial. Am J Psychiatry. 2010 Aug;167(8):915-24. doi: 10.1176/appi.ajp.2010.09081247. PMID: 20595411.","34562","2020"
"cloitre2010_PSS-SR_C_0_ITT","Psychotherapy","PTSD","104","C","PTSD",,,,"Supportive Counseling + Exposure Treatment","Supportive counseling + exposure","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","33","Self report","PSS-SR","PSS-SR","ITT","Imputed (continuous outcomes), LOCF (categorical outcomes)","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","End of Treatment","0",,"19.0","9.83",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","1",,"0","Mixed","child physical abuse, child sexual abuse, child other abuse, intimate partner violence, rape/sexual assault, community/school violence, other (""other interpersonal victimization"")","Medium","Cloitre M, Stovall-McClough KC, Nooner K, et al. Treatment for PTSD related to childhood abuse: a randomized controlled trial. Am J Psychiatry. 2010 Aug;167(8):915-24. doi: 10.1176/appi.ajp.2010.09081247. PMID: 20595411.","34562","2020"
"cloitre2010_PSS-SR_C_12_ITT","Psychotherapy","PTSD","104","C","PTSD",,,,"Supportive Counseling + Exposure Treatment","Supportive counseling + exposure","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","33","Self report","PSS-SR","PSS-SR","ITT","Imputed (continuous outcomes), LOCF (categorical outcomes)","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Assessment at 3 to <6 Months","12",,"21.4","11.54",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","1",,"0","Mixed","child physical abuse, child sexual abuse, child other abuse, intimate partner violence, rape/sexual assault, community/school violence, other (""other interpersonal victimization"")","Medium","Cloitre M, Stovall-McClough KC, Nooner K, et al. Treatment for PTSD related to childhood abuse: a randomized controlled trial. Am J Psychiatry. 2010 Aug;167(8):915-24. doi: 10.1176/appi.ajp.2010.09081247. PMID: 20595411.","34562","2020"
"cloitre2010_PSS-SR_C_26_ITT","Psychotherapy","PTSD","104","C","PTSD",,,,"Supportive Counseling + Exposure Treatment","Supportive counseling + exposure","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","33","Self report","PSS-SR","PSS-SR","ITT","Imputed (continuous outcomes), LOCF (categorical outcomes)","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Assessment at 6 to <12 Months","26",,"20.5","13.56",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","1",,"0","Mixed","child physical abuse, child sexual abuse, child other abuse, intimate partner violence, rape/sexual assault, community/school violence, other (""other interpersonal victimization"")","Medium","Cloitre M, Stovall-McClough KC, Nooner K, et al. Treatment for PTSD related to childhood abuse: a randomized controlled trial. Am J Psychiatry. 2010 Aug;167(8):915-24. doi: 10.1176/appi.ajp.2010.09081247. PMID: 20595411.","34562","2020"
"cloitre2010_PSS-SR_C_Baseline_ITT","Psychotherapy","PTSD","104","C","PTSD",,,,"Supportive Counseling + Exposure Treatment","Supportive counseling + exposure","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","33","Self report","PSS-SR","PSS-SR","ITT","Imputed (continuous outcomes), LOCF (categorical outcomes)","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Baseline",,,"38.2","11.14",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","1",,"0","Mixed","child physical abuse, child sexual abuse, child other abuse, intimate partner violence, rape/sexual assault, community/school violence, other (""other interpersonal victimization"")","Medium","Cloitre M, Stovall-McClough KC, Nooner K, et al. Treatment for PTSD related to childhood abuse: a randomized controlled trial. Am J Psychiatry. 2010 Aug;167(8):915-24. doi: 10.1176/appi.ajp.2010.09081247. PMID: 20595411.","34562","2020"
"coffey2006_IES_A_0_Comp","Psychotherapy","PTSD","43","A","PTSD",,"8",,"Imaginal Exposure","Imaginal exposure","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"Self report","IES","IES-R","Completer",,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","End of Treatment","0",,"24.1","13.1",,,,,"-23",,,,,,,,,,"p=0.002",,,,,,,,,,,,,,"Community",,,"1","0.6744",,"0.3256","Mixed","child physical abuse, child sexual abuse","High","Coffey SF, Stasiewicz PR, Hughes PM, et al. Trauma-focused imaginal exposure for individuals with comorbid posttraumatic stress disorder and alcohol dependence: revealing mechanisms of alcohol craving in a cue reactivity paradigm. Psychol Addict Behav. 2006 Dec;20(4):425-35. doi: 10.1037/0893-164X.20.4.425. PMID: 17176177.","34482","2019"
"coffey2006_IES_A_Baseline_Comp","Psychotherapy","PTSD","43","A","PTSD",,,,"Imaginal Exposure","Imaginal exposure","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"Self report","IES","IES-R","Completer",,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Baseline",,,"47.1","15",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.6744",,"0.3256","Mixed","child physical abuse, child sexual abuse","High","Coffey SF, Stasiewicz PR, Hughes PM, et al. Trauma-focused imaginal exposure for individuals with comorbid posttraumatic stress disorder and alcohol dependence: revealing mechanisms of alcohol craving in a cue reactivity paradigm. Psychol Addict Behav. 2006 Dec;20(4):425-35. doi: 10.1037/0893-164X.20.4.425. PMID: 17176177.","34482","2019"
"coffey2006_IES_B_0_Comp","Psychotherapy","PTSD","43","B","Control",,"9",,"Relaxation","Relaxation","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,"Self report","IES","IES-R","Completer",,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","End of Treatment","0",,"45","15.4",,,,,"-1.7",,,,,,,,,,"p=NS",,,,,,,,,,,,,,"Community",,,"1","0.6744",,"0.3256","Mixed","child physical abuse, child sexual abuse","High","Coffey SF, Stasiewicz PR, Hughes PM, et al. Trauma-focused imaginal exposure for individuals with comorbid posttraumatic stress disorder and alcohol dependence: revealing mechanisms of alcohol craving in a cue reactivity paradigm. Psychol Addict Behav. 2006 Dec;20(4):425-35. doi: 10.1037/0893-164X.20.4.425. PMID: 17176177.","34482","2019"
"coffey2006_IES_B_Baseline_Comp","Psychotherapy","PTSD","43","B","Control",,,,"Relaxation","Relaxation","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,"Self report","IES","IES-R","Completer",,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Baseline",,,"46.7","13.9",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.6744",,"0.3256","Mixed","child physical abuse, child sexual abuse","High","Coffey SF, Stasiewicz PR, Hughes PM, et al. Trauma-focused imaginal exposure for individuals with comorbid posttraumatic stress disorder and alcohol dependence: revealing mechanisms of alcohol craving in a cue reactivity paradigm. Psychol Addict Behav. 2006 Dec;20(4):425-35. doi: 10.1037/0893-164X.20.4.425. PMID: 17176177.","34482","2019"
"coffey2016_IES_A_0_ITT","Psychotherapy","PTSD","126","A","PTSD+SUD","Not integrated","35",,"Modified PE with trauma-focused motivational enhancement session, plus standard SUD TAU","Motivational enhancement session followed by modified Prolonged Exposure (PE) + standard substance use treatment as usual","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","40","Self report","IES","IES-R","ITT","Maximum likelihood imputation using multilevel mixed-effects models","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","End of Treatment","0",,"20.49",,"95% CI","14.77","26.20",,"-34.46",,,,,,,,,,,,,,,,,,,,,"≥2 standard deviation decrease from pooled mean on IES-R (20.23)","0.6",,"Community",,,"1","0.4603",,"0.5397","Mixed","child sexual abuse, child physical abuse, rape/sexual assault, accidents, natural or manmade disasters","Medium","Coffey SF, Schumacher JA, Nosen E, et al. Trauma-focused exposure therapy for chronic posttraumatic stress disorder in alcohol and drug dependent patients: a randomized controlled trial. Psychol. Addict Behav. 2016 Nov;30(7):778-90. doi: 10.1037/adb0000201. PMID: 27786516.","48230","2019"
"coffey2016_IES_A_12_ITT","Psychotherapy","PTSD","126","A","PTSD+SUD","Not integrated","29",,"Modified PE with trauma-focused motivational enhancement session, plus standard SUD TAU","Motivational enhancement session followed by modified Prolonged Exposure (PE) + standard substance use treatment as usual","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","40","Self report","IES","IES-R","ITT","Maximum likelihood imputation using multilevel mixed-effects models","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Assessment at 3 to <6 Months","12",,"19.1",,"95% CI","13.01","25.18",,"-35.85",,,,,,,,,,,,,,,,,,,,,"≥2 standard deviation decrease from pooled mean on IES-R (20.23)",,,"Community",,,"1","0.4603",,"0.5397","Mixed","child sexual abuse, child physical abuse, rape/sexual assault, accidents, natural or manmade disasters","Medium","Coffey SF, Schumacher JA, Nosen E, et al. Trauma-focused exposure therapy for chronic posttraumatic stress disorder in alcohol and drug dependent patients: a randomized controlled trial. Psychol. Addict Behav. 2016 Nov;30(7):778-90. doi: 10.1037/adb0000201. PMID: 27786516.","48230","2019"
"coffey2016_IES_A_26_ITT","Psychotherapy","PTSD","126","A","PTSD+SUD","Not integrated","31",,"Modified PE with trauma-focused motivational enhancement session, plus standard SUD TAU","Motivational enhancement session followed by modified Prolonged Exposure (PE) + standard substance use treatment as usual","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","40","Self report","IES","IES-R","ITT","Maximum likelihood imputation using multilevel mixed-effects models","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Assessment at 6 to <12 Months","26",,"20.48",,"95% CI","14.53","26.42",,"-34.47",,,,,,,,,,,,,,,,,,,,,"≥2 standard deviation decrease from pooled mean on IES-R (20.23)",,,"Community",,,"1","0.4603",,"0.5397","Mixed","child sexual abuse, child physical abuse, rape/sexual assault, accidents, natural or manmade disasters","Medium","Coffey SF, Schumacher JA, Nosen E, et al. Trauma-focused exposure therapy for chronic posttraumatic stress disorder in alcohol and drug dependent patients: a randomized controlled trial. Psychol. Addict Behav. 2016 Nov;30(7):778-90. doi: 10.1037/adb0000201. PMID: 27786516.","48230","2019"
"coffey2016_IES_A_Baseline_ITT","Psychotherapy","PTSD","126","A","PTSD+SUD","Not integrated","40",,"Modified PE with trauma-focused motivational enhancement session, plus standard SUD TAU","Motivational enhancement session followed by modified Prolonged Exposure (PE) + standard substance use treatment as usual","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","40","Self report","IES","IES-R","ITT","Maximum likelihood imputation using multilevel mixed-effects models","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Baseline",,,"54.95",,"95% CI","49.51","60.39",,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.4603",,"0.5397","Mixed","child sexual abuse, child physical abuse, rape/sexual assault, accidents, natural or manmade disasters","Medium","Coffey SF, Schumacher JA, Nosen E, et al. Trauma-focused exposure therapy for chronic posttraumatic stress disorder in alcohol and drug dependent patients: a randomized controlled trial. Psychol. Addict Behav. 2016 Nov;30(7):778-90. doi: 10.1037/adb0000201. PMID: 27786516.","48230","2019"
"coffey2016_IES_B_0_ITT","Psychotherapy","PTSD","126","B","PTSD+SUD","Not integrated","33",,"Modified PE plus standard SUD TAU","Prolonged Exposure (PE)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","45","Self report","IES","IES-R","ITT","Maximum likelihood imputation using multilevel mixed-effects models","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","End of Treatment","0",,"16.2",,"95% CI","10.48","21.92",,"-32.36",,,,,,,,,,,,,,,,,,,,,"≥2 standard deviation decrease from pooled mean on IES-R (20.23)","0.7576",,"Community",,,"1","0.4603",,"0.5397","Mixed","child sexual abuse, child physical abuse, rape/sexual assault, accidents, natural or manmade disasters","Medium","Coffey SF, Schumacher JA, Nosen E, et al. Trauma-focused exposure therapy for chronic posttraumatic stress disorder in alcohol and drug dependent patients: a randomized controlled trial. Psychol. Addict Behav. 2016 Nov;30(7):778-90. doi: 10.1037/adb0000201. PMID: 27786516.","48230","2019"
"coffey2016_IES_B_12_ITT","Psychotherapy","PTSD","126","B","PTSD+SUD","Not integrated","32",,"Modified PE plus standard SUD TAU","Prolonged Exposure (PE)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","45","Self report","IES","IES-R","ITT","Maximum likelihood imputation using multilevel mixed-effects models","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Assessment at 3 to <6 Months","12",,"14.11",,"95% CI","8.33","19.90",,"-34.45",,,,,,,,,,,,,,,,,,,,,"≥2 standard deviation decrease from pooled mean on IES-R (20.23)",,,"Community",,,"1","0.4603",,"0.5397","Mixed","child sexual abuse, child physical abuse, rape/sexual assault, accidents, natural or manmade disasters","Medium","Coffey SF, Schumacher JA, Nosen E, et al. Trauma-focused exposure therapy for chronic posttraumatic stress disorder in alcohol and drug dependent patients: a randomized controlled trial. Psychol. Addict Behav. 2016 Nov;30(7):778-90. doi: 10.1037/adb0000201. PMID: 27786516.","48230","2019"
"coffey2016_IES_B_26_ITT","Psychotherapy","PTSD","126","B","PTSD+SUD","Not integrated","35",,"Modified PE plus standard SUD TAU","Prolonged Exposure (PE)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","45","Self report","IES","IES-R","ITT","Maximum likelihood imputation using multilevel mixed-effects models","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Assessment at 6 to <12 Months","26",,"16.45",,"95% CI","10.85","22.06",,"-32.11",,,,,,,,,,,,,,,,,,,,,"≥2 standard deviation decrease from pooled mean on IES-R (20.23)",,,"Community",,,"1","0.4603",,"0.5397","Mixed","child sexual abuse, child physical abuse, rape/sexual assault, accidents, natural or manmade disasters","Medium","Coffey SF, Schumacher JA, Nosen E, et al. Trauma-focused exposure therapy for chronic posttraumatic stress disorder in alcohol and drug dependent patients: a randomized controlled trial. Psychol. Addict Behav. 2016 Nov;30(7):778-90. doi: 10.1037/adb0000201. PMID: 27786516.","48230","2019"
"coffey2016_IES_B_Baseline_ITT","Psychotherapy","PTSD","126","B","PTSD+SUD","Not integrated","43",,"Modified PE plus standard SUD TAU","Prolonged Exposure (PE)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","45","Self report","IES","IES-R","ITT","Maximum likelihood imputation using multilevel mixed-effects models","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Baseline",,,"48.56",,"95% CI","43.43","53.68",,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.4603",,"0.5397","Mixed","child sexual abuse, child physical abuse, rape/sexual assault, accidents, natural or manmade disasters","Medium","Coffey SF, Schumacher JA, Nosen E, et al. Trauma-focused exposure therapy for chronic posttraumatic stress disorder in alcohol and drug dependent patients: a randomized controlled trial. Psychol. Addict Behav. 2016 Nov;30(7):778-90. doi: 10.1037/adb0000201. PMID: 27786516.","48230","2019"
"coffey2016_IES_C_0_ITT","Psychotherapy","PTSD","126","C","SUD",,"36",,"Healthy lifestyle sessions plus standard SUD TAU","Healthy lifetsyle session +  substance use treatment as usual","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","41","Self report","IES","IES-R","ITT","Maximum likelihood imputation using multilevel mixed-effects models","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","End of Treatment","0",,"27.4",,"95% CI","21.80","33.01",,"-23.62",,,,,,,,,,,,,,,,,,,,,"≥2 standard deviation decrease from pooled mean on IES-R (20.23)","0.4444",,"Community",,,"1","0.4603",,"0.5397","Mixed","child sexual abuse, child physical abuse, rape/sexual assault, accidents, natural or manmade disasters","Medium","Coffey SF, Schumacher JA, Nosen E, et al. Trauma-focused exposure therapy for chronic posttraumatic stress disorder in alcohol and drug dependent patients: a randomized controlled trial. Psychol. Addict Behav. 2016 Nov;30(7):778-90. doi: 10.1037/adb0000201. PMID: 27786516.","48230","2019"
"coffey2016_IES_C_12_ITT","Psychotherapy","PTSD","126","C","SUD",,"32",,"Healthy lifestyle sessions plus standard SUD TAU","Healthy lifetsyle session +  substance use treatment as usual","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","41","Self report","IES","IES-R","ITT","Maximum likelihood imputation using multilevel mixed-effects models","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Assessment at 3 to <6 Months","12",,"26",,"95% CI","20.15","31.85",,"-25.02",,,,,,,,,,,,,,,,,,,,,"≥2 standard deviation decrease from pooled mean on IES-R (20.23)",,,"Community",,,"1","0.4603",,"0.5397","Mixed","child sexual abuse, child physical abuse, rape/sexual assault, accidents, natural or manmade disasters","Medium","Coffey SF, Schumacher JA, Nosen E, et al. Trauma-focused exposure therapy for chronic posttraumatic stress disorder in alcohol and drug dependent patients: a randomized controlled trial. Psychol. Addict Behav. 2016 Nov;30(7):778-90. doi: 10.1037/adb0000201. PMID: 27786516.","48230","2019"
"coffey2016_IES_C_26_ITT","Psychotherapy","PTSD","126","C","SUD",,"32",,"Healthy lifestyle sessions plus standard SUD TAU","Healthy lifetsyle session +  substance use treatment as usual","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","41","Self report","IES","IES-R","ITT","Maximum likelihood imputation using multilevel mixed-effects models","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Assessment at 6 to <12 Months","26",,"26.5",,"95% CI","20.52","32.50",,"-24.52",,,,,,,,,,,,,,,,,,,,,"≥2 standard deviation decrease from pooled mean on IES-R (20.23)",,,"Community",,,"1","0.4603",,"0.5397","Mixed","child sexual abuse, child physical abuse, rape/sexual assault, accidents, natural or manmade disasters","Medium","Coffey SF, Schumacher JA, Nosen E, et al. Trauma-focused exposure therapy for chronic posttraumatic stress disorder in alcohol and drug dependent patients: a randomized controlled trial. Psychol. Addict Behav. 2016 Nov;30(7):778-90. doi: 10.1037/adb0000201. PMID: 27786516.","48230","2019"
"coffey2016_IES_C_Baseline_ITT","Psychotherapy","PTSD","126","C","SUD",,"41",,"Healthy lifestyle sessions plus standard SUD TAU","Healthy lifetsyle session +  substance use treatment as usual","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","41","Self report","IES","IES-R","ITT","Maximum likelihood imputation using multilevel mixed-effects models","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Baseline",,,"51.02",,"95% CI","45.65","56.40",,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.4603",,"0.5397","Mixed","child sexual abuse, child physical abuse, rape/sexual assault, accidents, natural or manmade disasters","Medium","Coffey SF, Schumacher JA, Nosen E, et al. Trauma-focused exposure therapy for chronic posttraumatic stress disorder in alcohol and drug dependent patients: a randomized controlled trial. Psychol. Addict Behav. 2016 Nov;30(7):778-90. doi: 10.1037/adb0000201. PMID: 27786516.","48230","2019"
"cohen2004_CAPS_A_0_Comp","Nonpharmacologic biological","PTSD","29","A","PTSD",,"8",,"Low frequency rTMS","Transcranial magnetic stimualtion (TMS)","No","Not Applicable","No","Not Applicable","No","Not Applicable","Yes","No","No","No","No","Individual","In Person","10","Structured Clinical Interview","CAPS","CAPS","Completer",,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","End of Treatment","0",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.29",,"0.71","Mixed","combat-related, accidents, rape/sexual assault, community/school violence, other (occupational, unexpected death of relative)","High","Cohen H, Kaplan Z, Kotler M, et al. Repetitive transcranial magnetic stimulation of the right dorsolateral prefrontal cortex in posttraumatic stress disorder: a double-blind, placebo-controlled study. Am J Psychiatry. 2004 Mar;161(3):515-24. doi: 10.1176/appi.ajp.161.3.515. PMID: 14992978.","26291","2019"
"cohen2004_CAPS_A_2_Comp","Nonpharmacologic biological","PTSD","29","A","PTSD",,"8",,"Low frequency rTMS","Transcranial magnetic stimualtion (TMS)","No","Not Applicable","No","Not Applicable","No","Not Applicable","Yes","No","No","No","No","Individual","In Person","10","Structured Clinical Interview","CAPS","CAPS","Completer",,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Assessment at <3 Months","2","calculated score 84.5","87.9","17.5",,,,,"-2","6.4",,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.29",,"0.71","Mixed","combat-related, accidents, rape/sexual assault, community/school violence, other (occupational, unexpected death of relative)","High","Cohen H, Kaplan Z, Kotler M, et al. Repetitive transcranial magnetic stimulation of the right dorsolateral prefrontal cortex in posttraumatic stress disorder: a double-blind, placebo-controlled study. Am J Psychiatry. 2004 Mar;161(3):515-24. doi: 10.1176/appi.ajp.161.3.515. PMID: 14992978.","26291","2019"
"cohen2004_CAPS_A_Baseline_Comp","Nonpharmacologic biological","PTSD","29","A","PTSD",,"8",,"Low frequency rTMS","Transcranial magnetic stimualtion (TMS)","No","Not Applicable","No","Not Applicable","No","Not Applicable","Yes","No","No","No","No","Individual","In Person","10","Structured Clinical Interview","CAPS","CAPS","Completer",,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Baseline",,,"87.9","17.5",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.29",,"0.71","Mixed","combat-related, accidents, rape/sexual assault, community/school violence, other (occupational, unexpected death of relative)","High","Cohen H, Kaplan Z, Kotler M, et al. Repetitive transcranial magnetic stimulation of the right dorsolateral prefrontal cortex in posttraumatic stress disorder: a double-blind, placebo-controlled study. Am J Psychiatry. 2004 Mar;161(3):515-24. doi: 10.1176/appi.ajp.161.3.515. PMID: 14992978.","26291","2019"
"cohen2004_CAPS_B_0_Comp","Nonpharmacologic biological","PTSD","29","B","PTSD",,"10",,"High frequency rTMS","Transcranial magnetic stimualtion (TMS)","No","Not Applicable","No","Not Applicable","No","Not Applicable","Yes","No","No","No","No","Individual","In Person","11","Structured Clinical Interview","CAPS","CAPS","Completer",,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","End of Treatment","0",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.29",,"0.71","Mixed","combat-related, accidents, rape/sexual assault, community/school violence, other (occupational, unexpected death of relative)","High","Cohen H, Kaplan Z, Kotler M, et al. Repetitive transcranial magnetic stimulation of the right dorsolateral prefrontal cortex in posttraumatic stress disorder: a double-blind, placebo-controlled study. Am J Psychiatry. 2004 Mar;161(3):515-24. doi: 10.1176/appi.ajp.161.3.515. PMID: 14992978.","26291","2019"
"cohen2004_CAPS_B_2_Comp","Nonpharmacologic biological","PTSD","29","B","PTSD",,"10",,"High frequency rTMS","Transcranial magnetic stimualtion (TMS)","No","Not Applicable","No","Not Applicable","No","Not Applicable","Yes","No","No","No","No","Individual","In Person","11","Structured Clinical Interview","CAPS","CAPS","Completer",,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Assessment at <3 Months","2",,"64","16.1",,,,,"-30.5","11.6",,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.29",,"0.71","Mixed","combat-related, accidents, rape/sexual assault, community/school violence, other (occupational, unexpected death of relative)","High","Cohen H, Kaplan Z, Kotler M, et al. Repetitive transcranial magnetic stimulation of the right dorsolateral prefrontal cortex in posttraumatic stress disorder: a double-blind, placebo-controlled study. Am J Psychiatry. 2004 Mar;161(3):515-24. doi: 10.1176/appi.ajp.161.3.515. PMID: 14992978.","26291","2019"
"cohen2004_CAPS_B_Baseline_Comp","Nonpharmacologic biological","PTSD","29","B","PTSD",,"10",,"High frequency rTMS","Transcranial magnetic stimualtion (TMS)","No","Not Applicable","No","Not Applicable","No","Not Applicable","Yes","No","No","No","No","Individual","In Person","11","Structured Clinical Interview","CAPS","CAPS","Completer",,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Baseline",,,"94.5","15.8",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.29",,"0.71","Mixed","combat-related, accidents, rape/sexual assault, community/school violence, other (occupational, unexpected death of relative)","High","Cohen H, Kaplan Z, Kotler M, et al. Repetitive transcranial magnetic stimulation of the right dorsolateral prefrontal cortex in posttraumatic stress disorder: a double-blind, placebo-controlled study. Am J Psychiatry. 2004 Mar;161(3):515-24. doi: 10.1176/appi.ajp.161.3.515. PMID: 14992978.","26291","2019"
"cohen2004_CAPS_C_0_Comp","Nonpharmacologic biological","PTSD","29","C","Control",,"6",,"Sham rTMS","Sham","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","8","Structured Clinical Interview","CAPS","CAPS","Completer",,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","End of Treatment","0",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.29",,"0.71","Mixed","combat-related, accidents, rape/sexual assault, community/school violence, other (occupational, unexpected death of relative)","High","Cohen H, Kaplan Z, Kotler M, et al. Repetitive transcranial magnetic stimulation of the right dorsolateral prefrontal cortex in posttraumatic stress disorder: a double-blind, placebo-controlled study. Am J Psychiatry. 2004 Mar;161(3):515-24. doi: 10.1176/appi.ajp.161.3.515. PMID: 14992978.","26291","2019"
"cohen2004_CAPS_C_2_Comp","Nonpharmacologic biological","PTSD","29","C","Control",,"6",,"Sham rTMS","Sham","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","8","Structured Clinical Interview","CAPS","CAPS","Completer",,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Assessment at <3 Months","2",,"74.9","9.7",,,,,"-9.8","17.3",,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.29",,"0.71","Mixed","combat-related, accidents, rape/sexual assault, community/school violence, other (occupational, unexpected death of relative)","High","Cohen H, Kaplan Z, Kotler M, et al. Repetitive transcranial magnetic stimulation of the right dorsolateral prefrontal cortex in posttraumatic stress disorder: a double-blind, placebo-controlled study. Am J Psychiatry. 2004 Mar;161(3):515-24. doi: 10.1176/appi.ajp.161.3.515. PMID: 14992978.","26291","2019"
"cohen2004_CAPS_C_Baseline_Comp","Nonpharmacologic biological","PTSD","29","C","Control",,"6",,"Sham rTMS","Sham","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","8","Structured Clinical Interview","CAPS","CAPS","Completer",,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Baseline",,,"84.3","19.3",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.29",,"0.71","Mixed","combat-related, accidents, rape/sexual assault, community/school violence, other (occupational, unexpected death of relative)","High","Cohen H, Kaplan Z, Kotler M, et al. Repetitive transcranial magnetic stimulation of the right dorsolateral prefrontal cortex in posttraumatic stress disorder: a double-blind, placebo-controlled study. Am J Psychiatry. 2004 Mar;161(3):515-24. doi: 10.1176/appi.ajp.161.3.515. PMID: 14992978.","26291","2019"
"cohen2004_PCL_A_0_NA","Nonpharmacologic biological","PTSD","29","A","PTSD",,,,"Low frequency rTMS","Transcranial magnetic stimualtion (TMS)","No","Not Applicable","No","Not Applicable","No","Not Applicable","Yes","No","No","No","No","Individual","In Person","10","Self report","PCL","PCL",,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","End of Treatment","0",,"56.0","9.5",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.29",,"0.71","Mixed","combat-related, accidents, rape/sexual assault, community/school violence, other (occupational, unexpected death of relative)","High","Cohen H, Kaplan Z, Kotler M, et al. Repetitive transcranial magnetic stimulation of the right dorsolateral prefrontal cortex in posttraumatic stress disorder: a double-blind, placebo-controlled study. Am J Psychiatry. 2004 Mar;161(3):515-24. doi: 10.1176/appi.ajp.161.3.515. PMID: 14992978.","26291","2019"
"cohen2004_PCL_A_2_NA","Nonpharmacologic biological","PTSD","29","A","PTSD",,,,"Low frequency rTMS","Transcranial magnetic stimualtion (TMS)","No","Not Applicable","No","Not Applicable","No","Not Applicable","Yes","No","No","No","No","Individual","In Person","10","Self report","PCL","PCL",,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Assessment at <3 Months","2",,"58.7","9.3",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.29",,"0.71","Mixed","combat-related, accidents, rape/sexual assault, community/school violence, other (occupational, unexpected death of relative)","High","Cohen H, Kaplan Z, Kotler M, et al. Repetitive transcranial magnetic stimulation of the right dorsolateral prefrontal cortex in posttraumatic stress disorder: a double-blind, placebo-controlled study. Am J Psychiatry. 2004 Mar;161(3):515-24. doi: 10.1176/appi.ajp.161.3.515. PMID: 14992978.","26291","2019"
"cohen2004_PCL_A_Baseline_NA","Nonpharmacologic biological","PTSD","29","A","PTSD",,,,"Low frequency rTMS","Transcranial magnetic stimualtion (TMS)","No","Not Applicable","No","Not Applicable","No","Not Applicable","Yes","No","No","No","No","Individual","In Person","10","Self report","PCL","PCL",,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Baseline",,,"62.5","7.8",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.29",,"0.71","Mixed","combat-related, accidents, rape/sexual assault, community/school violence, other (occupational, unexpected death of relative)","High","Cohen H, Kaplan Z, Kotler M, et al. Repetitive transcranial magnetic stimulation of the right dorsolateral prefrontal cortex in posttraumatic stress disorder: a double-blind, placebo-controlled study. Am J Psychiatry. 2004 Mar;161(3):515-24. doi: 10.1176/appi.ajp.161.3.515. PMID: 14992978.","26291","2019"
"cohen2004_PCL_B_0_NA","Nonpharmacologic biological","PTSD","29","B","PTSD",,,,"High frequency rTMS","Transcranial magnetic stimualtion (TMS)","No","Not Applicable","No","Not Applicable","No","Not Applicable","Yes","No","No","No","No","Individual","In Person","11","Self report","PCL","PCL",,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","End of Treatment","0",,"43.5","8.3",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.29",,"0.71","Mixed","combat-related, accidents, rape/sexual assault, community/school violence, other (occupational, unexpected death of relative)","High","Cohen H, Kaplan Z, Kotler M, et al. Repetitive transcranial magnetic stimulation of the right dorsolateral prefrontal cortex in posttraumatic stress disorder: a double-blind, placebo-controlled study. Am J Psychiatry. 2004 Mar;161(3):515-24. doi: 10.1176/appi.ajp.161.3.515. PMID: 14992978.","26291","2019"
"cohen2004_PCL_B_2_NA","Nonpharmacologic biological","PTSD","29","B","PTSD",,,,"High frequency rTMS","Transcranial magnetic stimualtion (TMS)","No","Not Applicable","No","Not Applicable","No","Not Applicable","Yes","No","No","No","No","Individual","In Person","11","Self report","PCL","PCL",,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Assessment at <3 Months","2",,"46.3","10.8",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.29",,"0.71","Mixed","combat-related, accidents, rape/sexual assault, community/school violence, other (occupational, unexpected death of relative)","High","Cohen H, Kaplan Z, Kotler M, et al. Repetitive transcranial magnetic stimulation of the right dorsolateral prefrontal cortex in posttraumatic stress disorder: a double-blind, placebo-controlled study. Am J Psychiatry. 2004 Mar;161(3):515-24. doi: 10.1176/appi.ajp.161.3.515. PMID: 14992978.","26291","2019"
"cohen2004_PCL_B_Baseline_NA","Nonpharmacologic biological","PTSD","29","B","PTSD",,,,"High frequency rTMS","Transcranial magnetic stimualtion (TMS)","No","Not Applicable","No","Not Applicable","No","Not Applicable","Yes","No","No","No","No","Individual","In Person","11","Self report","PCL","PCL",,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Baseline",,,"63.2","13.1",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.29",,"0.71","Mixed","combat-related, accidents, rape/sexual assault, community/school violence, other (occupational, unexpected death of relative)","High","Cohen H, Kaplan Z, Kotler M, et al. Repetitive transcranial magnetic stimulation of the right dorsolateral prefrontal cortex in posttraumatic stress disorder: a double-blind, placebo-controlled study. Am J Psychiatry. 2004 Mar;161(3):515-24. doi: 10.1176/appi.ajp.161.3.515. PMID: 14992978.","26291","2019"
"cohen2004_PCL_C_0_NA","Nonpharmacologic biological","PTSD","29","C","Control",,,,"Sham rTMS","Sham","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","8","Self report","PCL","PCL",,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","End of Treatment","0",,"55.0","4.9",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.29",,"0.71","Mixed","combat-related, accidents, rape/sexual assault, community/school violence, other (occupational, unexpected death of relative)","High","Cohen H, Kaplan Z, Kotler M, et al. Repetitive transcranial magnetic stimulation of the right dorsolateral prefrontal cortex in posttraumatic stress disorder: a double-blind, placebo-controlled study. Am J Psychiatry. 2004 Mar;161(3):515-24. doi: 10.1176/appi.ajp.161.3.515. PMID: 14992978.","26291","2019"
"cohen2004_PCL_C_2_NA","Nonpharmacologic biological","PTSD","29","C","Control",,,,"Sham rTMS","Sham","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","8","Self report","PCL","PCL",,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Assessment at <3 Months","2",,"53.0","5.5",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.29",,"0.71","Mixed","combat-related, accidents, rape/sexual assault, community/school violence, other (occupational, unexpected death of relative)","High","Cohen H, Kaplan Z, Kotler M, et al. Repetitive transcranial magnetic stimulation of the right dorsolateral prefrontal cortex in posttraumatic stress disorder: a double-blind, placebo-controlled study. Am J Psychiatry. 2004 Mar;161(3):515-24. doi: 10.1176/appi.ajp.161.3.515. PMID: 14992978.","26291","2019"
"cohen2004_PCL_C_Baseline_NA","Nonpharmacologic biological","PTSD","29","C","Control",,,,"Sham rTMS","Sham","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","8","Self report","PCL","PCL",,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Baseline",,,"56.8","3.6",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.29",,"0.71","Mixed","combat-related, accidents, rape/sexual assault, community/school violence, other (occupational, unexpected death of relative)","High","Cohen H, Kaplan Z, Kotler M, et al. Repetitive transcranial magnetic stimulation of the right dorsolateral prefrontal cortex in posttraumatic stress disorder: a double-blind, placebo-controlled study. Am J Psychiatry. 2004 Mar;161(3):515-24. doi: 10.1176/appi.ajp.161.3.515. PMID: 14992978.","26291","2019"
"cohen2004_TOP-8_A_0_NA","Nonpharmacologic biological","PTSD","29","A","PTSD",,,,"Low frequency rTMS","Transcranial magnetic stimualtion (TMS)","No","Not Applicable","No","Not Applicable","No","Not Applicable","Yes","No","No","No","No","Individual","In Person","10","Structured Clinical Interview","TOP-8","TOP-8",,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","End of Treatment","0",,"19.5","4.2",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.29",,"0.71","Mixed","combat-related, accidents, rape/sexual assault, community/school violence, other (occupational, unexpected death of relative)","High","Cohen H, Kaplan Z, Kotler M, et al. Repetitive transcranial magnetic stimulation of the right dorsolateral prefrontal cortex in posttraumatic stress disorder: a double-blind, placebo-controlled study. Am J Psychiatry. 2004 Mar;161(3):515-24. doi: 10.1176/appi.ajp.161.3.515. PMID: 14992978.","26291","2019"
"cohen2004_TOP-8_A_2_NA","Nonpharmacologic biological","PTSD","29","A","PTSD",,,,"Low frequency rTMS","Transcranial magnetic stimualtion (TMS)","No","Not Applicable","No","Not Applicable","No","Not Applicable","Yes","No","No","No","No","Individual","In Person","10","Structured Clinical Interview","TOP-8","TOP-8",,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Assessment at <3 Months","2",,"21.0","3.8",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.29",,"0.71","Mixed","combat-related, accidents, rape/sexual assault, community/school violence, other (occupational, unexpected death of relative)","High","Cohen H, Kaplan Z, Kotler M, et al. Repetitive transcranial magnetic stimulation of the right dorsolateral prefrontal cortex in posttraumatic stress disorder: a double-blind, placebo-controlled study. Am J Psychiatry. 2004 Mar;161(3):515-24. doi: 10.1176/appi.ajp.161.3.515. PMID: 14992978.","26291","2019"
"cohen2004_TOP-8_A_Baseline_NA","Nonpharmacologic biological","PTSD","29","A","PTSD",,,,"Low frequency rTMS","Transcranial magnetic stimualtion (TMS)","No","Not Applicable","No","Not Applicable","No","Not Applicable","Yes","No","No","No","No","Individual","In Person","10","Structured Clinical Interview","TOP-8","TOP-8",,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Baseline",,,"22.9","2.3",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.29",,"0.71","Mixed","combat-related, accidents, rape/sexual assault, community/school violence, other (occupational, unexpected death of relative)","High","Cohen H, Kaplan Z, Kotler M, et al. Repetitive transcranial magnetic stimulation of the right dorsolateral prefrontal cortex in posttraumatic stress disorder: a double-blind, placebo-controlled study. Am J Psychiatry. 2004 Mar;161(3):515-24. doi: 10.1176/appi.ajp.161.3.515. PMID: 14992978.","26291","2019"
"cohen2004_TOP-8_B_0_NA","Nonpharmacologic biological","PTSD","29","B","PTSD",,,,"High frequency rTMS","Transcranial magnetic stimualtion (TMS)","No","Not Applicable","No","Not Applicable","No","Not Applicable","Yes","No","No","No","No","Individual","In Person","11","Structured Clinical Interview","TOP-8","TOP-8",,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","End of Treatment","0",,"12.9","4.5",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.29",,"0.71","Mixed","combat-related, accidents, rape/sexual assault, community/school violence, other (occupational, unexpected death of relative)","High","Cohen H, Kaplan Z, Kotler M, et al. Repetitive transcranial magnetic stimulation of the right dorsolateral prefrontal cortex in posttraumatic stress disorder: a double-blind, placebo-controlled study. Am J Psychiatry. 2004 Mar;161(3):515-24. doi: 10.1176/appi.ajp.161.3.515. PMID: 14992978.","26291","2019"
"cohen2004_TOP-8_B_2_NA","Nonpharmacologic biological","PTSD","29","B","PTSD",,,,"High frequency rTMS","Transcranial magnetic stimualtion (TMS)","No","Not Applicable","No","Not Applicable","No","Not Applicable","Yes","No","No","No","No","Individual","In Person","11","Structured Clinical Interview","TOP-8","TOP-8",,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Assessment at <3 Months","2",,"17.2","6.3",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.29",,"0.71","Mixed","combat-related, accidents, rape/sexual assault, community/school violence, other (occupational, unexpected death of relative)","High","Cohen H, Kaplan Z, Kotler M, et al. Repetitive transcranial magnetic stimulation of the right dorsolateral prefrontal cortex in posttraumatic stress disorder: a double-blind, placebo-controlled study. Am J Psychiatry. 2004 Mar;161(3):515-24. doi: 10.1176/appi.ajp.161.3.515. PMID: 14992978.","26291","2019"
"cohen2004_TOP-8_B_Baseline_NA","Nonpharmacologic biological","PTSD","29","B","PTSD",,,,"High frequency rTMS","Transcranial magnetic stimualtion (TMS)","No","Not Applicable","No","Not Applicable","No","Not Applicable","Yes","No","No","No","No","Individual","In Person","11","Structured Clinical Interview","TOP-8","TOP-8",,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Baseline",,,"22.3","6.6",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.29",,"0.71","Mixed","combat-related, accidents, rape/sexual assault, community/school violence, other (occupational, unexpected death of relative)","High","Cohen H, Kaplan Z, Kotler M, et al. Repetitive transcranial magnetic stimulation of the right dorsolateral prefrontal cortex in posttraumatic stress disorder: a double-blind, placebo-controlled study. Am J Psychiatry. 2004 Mar;161(3):515-24. doi: 10.1176/appi.ajp.161.3.515. PMID: 14992978.","26291","2019"
"cohen2004_TOP-8_C_0_NA","Nonpharmacologic biological","PTSD","29","C","Control",,,,"Sham rTMS","Sham","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","8","Structured Clinical Interview","TOP-8","TOP-8",,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","End of Treatment","0",,"18.0","3.2",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.29",,"0.71","Mixed","combat-related, accidents, rape/sexual assault, community/school violence, other (occupational, unexpected death of relative)","High","Cohen H, Kaplan Z, Kotler M, et al. Repetitive transcranial magnetic stimulation of the right dorsolateral prefrontal cortex in posttraumatic stress disorder: a double-blind, placebo-controlled study. Am J Psychiatry. 2004 Mar;161(3):515-24. doi: 10.1176/appi.ajp.161.3.515. PMID: 14992978.","26291","2019"
"cohen2004_TOP-8_C_2_NA","Nonpharmacologic biological","PTSD","29","C","Control",,,,"Sham rTMS","Sham","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","8","Structured Clinical Interview","TOP-8","TOP-8",,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Assessment at <3 Months","2",,"15.6","3.2",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.29",,"0.71","Mixed","combat-related, accidents, rape/sexual assault, community/school violence, other (occupational, unexpected death of relative)","High","Cohen H, Kaplan Z, Kotler M, et al. Repetitive transcranial magnetic stimulation of the right dorsolateral prefrontal cortex in posttraumatic stress disorder: a double-blind, placebo-controlled study. Am J Psychiatry. 2004 Mar;161(3):515-24. doi: 10.1176/appi.ajp.161.3.515. PMID: 14992978.","26291","2019"
"cohen2004_TOP-8_C_Baseline_NA","Nonpharmacologic biological","PTSD","29","C","Control",,,,"Sham rTMS","Sham","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","8","Structured Clinical Interview","TOP-8","TOP-8",,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Baseline",,,"18.3","6.0",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.29",,"0.71","Mixed","combat-related, accidents, rape/sexual assault, community/school violence, other (occupational, unexpected death of relative)","High","Cohen H, Kaplan Z, Kotler M, et al. Repetitive transcranial magnetic stimulation of the right dorsolateral prefrontal cortex in posttraumatic stress disorder: a double-blind, placebo-controlled study. Am J Psychiatry. 2004 Mar;161(3):515-24. doi: 10.1176/appi.ajp.161.3.515. PMID: 14992978.","26291","2019"
"connor1999_DTS_A_0_NA","Pharmacotherapy","PTSD","54","A","PTSD",,,,"Fluoxetine","Fluoxetine","No","Not Applicable","Yes","Antidepressant: SSRI","No","Not Applicable","No","No","No","No","No","Individual","In Person","27","Self report","DTS","DTS",,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","End of Treatment","0",,"24.8","25.9",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community","0","0","1","0.91",,"0.09","Mixed","rape/sexual assault, accidents, illness/medical procedure, community/school violence, natural or manmade disasters. other (traumatic bereavement, father in intensive care unit, witnessed emotional abuse)","Medium","Connor KM, Sutherland SM, Tupler LA, et al. Fluoxetine in post-traumatic stress disorder: randomised, double-blind study. Br J Psychiatry. 1999 Jul;175:17-22.  PMID: 10621763.","21108","2019"
"connor1999_DTS_A_Baseline_NA","Pharmacotherapy","PTSD","54","A","PTSD",,,,"Fluoxetine","Fluoxetine","No","Not Applicable","Yes","Antidepressant: SSRI","No","Not Applicable","No","No","No","No","No","Individual","In Person","27","Self report","DTS","DTS",,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Baseline",,,"73.7","20.4",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community","0","0","1","0.91",,"0.09","Mixed","rape/sexual assault, accidents, illness/medical procedure, community/school violence, natural or manmade disasters. other (traumatic bereavement, father in intensive care unit, witnessed emotional abuse)","Medium","Connor KM, Sutherland SM, Tupler LA, et al. Fluoxetine in post-traumatic stress disorder: randomised, double-blind study. Br J Psychiatry. 1999 Jul;175:17-22.  PMID: 10621763.","21108","2019"
"connor1999_DTS_B_0_NA","Pharmacotherapy","PTSD","54","B","Control",,,,"Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","27","Self report","DTS","DTS",,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","End of Treatment","0",,"52.1","30.9",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community","0","0","1","0.91",,"0.09","Mixed","rape/sexual assault, accidents, illness/medical procedure, community/school violence, natural or manmade disasters. other (traumatic bereavement, father in intensive care unit, witnessed emotional abuse)","Medium","Connor KM, Sutherland SM, Tupler LA, et al. Fluoxetine in post-traumatic stress disorder: randomised, double-blind study. Br J Psychiatry. 1999 Jul;175:17-22.  PMID: 10621763.","21108","2019"
"connor1999_DTS_B_Baseline_NA","Pharmacotherapy","PTSD","54","B","Control",,,,"Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","27","Self report","DTS","DTS",,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Baseline",,,"79.4","22.8",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community","0","0","1","0.91",,"0.09","Mixed","rape/sexual assault, accidents, illness/medical procedure, community/school violence, natural or manmade disasters. other (traumatic bereavement, father in intensive care unit, witnessed emotional abuse)","Medium","Connor KM, Sutherland SM, Tupler LA, et al. Fluoxetine in post-traumatic stress disorder: randomised, double-blind study. Br J Psychiatry. 1999 Jul;175:17-22.  PMID: 10621763.","21108","2019"
"connor1999_SI-PTSD_A_0_ITT","Pharmacotherapy","PTSD","54","A","PTSD",,"25",,"Fluoxetine","Fluoxetine","No","Not Applicable","Yes","Antidepressant: SSRI","No","Not Applicable","No","No","No","No","No","Individual","In Person","27","Structured Clinical Interview","SI-PTSD","SI-PTSD","ITT","LOCF","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","End of Treatment","0",,"10.1","9.8",,,,,"-23.9",,,,,,,,,,,,,,,,,,,,,"CGI score of 1 or 2","0.8519","Additional definitions of Clinically Meaningful Response reported in the study","Community","0","0","1","0.91",,"0.09","Mixed","rape/sexual assault, accidents, illness/medical procedure, community/school violence, natural or manmade disasters. other (traumatic bereavement, father in intensive care unit, witnessed emotional abuse)","Medium","Connor KM, Sutherland SM, Tupler LA, et al. Fluoxetine in post-traumatic stress disorder: randomised, double-blind study. Br J Psychiatry. 1999 Jul;175:17-22.  PMID: 10621763.","21108","2019"
"connor1999_SI-PTSD_A_Baseline_ITT","Pharmacotherapy","PTSD","54","A","PTSD",,"25",,"Fluoxetine","Fluoxetine","No","Not Applicable","Yes","Antidepressant: SSRI","No","Not Applicable","No","No","No","No","No","Individual","In Person","27","Structured Clinical Interview","SI-PTSD","SI-PTSD","ITT","LOCF","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Baseline",,,"34.0","8.8",,,,,,,,,,,,,,,,,,,,,,,,,,"CGI score of 1 or 2",,"Additional definitions of Clinically Meaningful Response reported in the study","Community","0","0","1","0.91",,"0.09","Mixed","rape/sexual assault, accidents, illness/medical procedure, community/school violence, natural or manmade disasters. other (traumatic bereavement, father in intensive care unit, witnessed emotional abuse)","Medium","Connor KM, Sutherland SM, Tupler LA, et al. Fluoxetine in post-traumatic stress disorder: randomised, double-blind study. Br J Psychiatry. 1999 Jul;175:17-22.  PMID: 10621763.","21108","2019"
"connor1999_SI-PTSD_B_0_ITT","Pharmacotherapy","PTSD","54","B","Control",,"22",,"Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","27","Structured Clinical Interview","SI-PTSD","SI-PTSD","ITT","LOCF","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","End of Treatment","0",,"20.5","12.6",,,,,"-14.0",,,,,,,,,,,,,,,,,,,,,"CGI score of 1 or 2","0.6154","Additional definitions of Clinically Meaningful Response reported in the study","Community","0","0","1","0.91",,"0.09","Mixed","rape/sexual assault, accidents, illness/medical procedure, community/school violence, natural or manmade disasters. other (traumatic bereavement, father in intensive care unit, witnessed emotional abuse)","Medium","Connor KM, Sutherland SM, Tupler LA, et al. Fluoxetine in post-traumatic stress disorder: randomised, double-blind study. Br J Psychiatry. 1999 Jul;175:17-22.  PMID: 10621763.","21108","2019"
"connor1999_SI-PTSD_B_Baseline_ITT","Pharmacotherapy","PTSD","54","B","Control",,"22",,"Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","27","Structured Clinical Interview","SI-PTSD","SI-PTSD","ITT","LOCF","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Baseline",,,"35.4","8.2",,,,,,,,,,,,,,,,,,,,,,,,,,"CGI score of 1 or 2",,"Additional definitions of Clinically Meaningful Response reported in the study","Community","0","0","1","0.91",,"0.09","Mixed","rape/sexual assault, accidents, illness/medical procedure, community/school violence, natural or manmade disasters. other (traumatic bereavement, father in intensive care unit, witnessed emotional abuse)","Medium","Connor KM, Sutherland SM, Tupler LA, et al. Fluoxetine in post-traumatic stress disorder: randomised, double-blind study. Br J Psychiatry. 1999 Jul;175:17-22.  PMID: 10621763.","21108","2019"
"connor2006_DTS_A_0_NA","Pharmacotherapy","PTSD","18","A","PTSD",,,,"Tiagabine","Tiagabine","No","Not Applicable","Yes","Mood Stabilizer","No","Not Applicable","No","No","No","No","No","Individual","In Person","10","Self report","DTS","DTS",,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","End of Treatment","0",,"22.9","25.3",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.7308",,"0.2692","Mixed","combat-related, rape/sexual assault, accidents, community/school violence, other (unexpected death of or threat of harm to a loved one; unwanted therapeutic abortion)","High","Connor KM, Davidson JRT, Weisler RH, et al. Tiagabine for posttraumatic stress disorder: effects of open-label and double-blind discontinuation treatment. Psychopharmacology (Berl). 2006 Jan;184(1):21-5. doi: 10.1007/s00213-005-0265-3. PMID: 16341846.","29324","2019"
"connor2006_DTS_A_Baseline_NA","Pharmacotherapy","PTSD","18","A","PTSD",,,,"Tiagabine","Tiagabine","No","Not Applicable","Yes","Mood Stabilizer","No","Not Applicable","No","No","No","No","No","Individual","In Person","10","Self report","DTS","DTS",,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Baseline",,,"39.6",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.7308",,"0.2692","Mixed","combat-related, rape/sexual assault, accidents, community/school violence, other (unexpected death of or threat of harm to a loved one; unwanted therapeutic abortion)","High","Connor KM, Davidson JRT, Weisler RH, et al. Tiagabine for posttraumatic stress disorder: effects of open-label and double-blind discontinuation treatment. Psychopharmacology (Berl). 2006 Jan;184(1):21-5. doi: 10.1007/s00213-005-0265-3. PMID: 16341846.","29324","2019"
"connor2006_DTS_B_0_NA","Pharmacotherapy","PTSD","18","B","Control",,,,"Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","8","Self report","DTS","DTS",,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","End of Treatment","0",,"23.0","28.5",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.7308",,"0.2692","Mixed","combat-related, rape/sexual assault, accidents, community/school violence, other (unexpected death of or threat of harm to a loved one; unwanted therapeutic abortion)","High","Connor KM, Davidson JRT, Weisler RH, et al. Tiagabine for posttraumatic stress disorder: effects of open-label and double-blind discontinuation treatment. Psychopharmacology (Berl). 2006 Jan;184(1):21-5. doi: 10.1007/s00213-005-0265-3. PMID: 16341846.","29324","2019"
"connor2006_DTS_B_Baseline_NA","Pharmacotherapy","PTSD","18","B","Control",,,,"Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","8","Self report","DTS","DTS",,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Baseline",,,"26.1",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.7308",,"0.2692","Mixed","combat-related, rape/sexual assault, accidents, community/school violence, other (unexpected death of or threat of harm to a loved one; unwanted therapeutic abortion)","High","Connor KM, Davidson JRT, Weisler RH, et al. Tiagabine for posttraumatic stress disorder: effects of open-label and double-blind discontinuation treatment. Psychopharmacology (Berl). 2006 Jan;184(1):21-5. doi: 10.1007/s00213-005-0265-3. PMID: 16341846.","29324","2019"
"connor2006_SI-PTSD_A_0_ITT","Pharmacotherapy","PTSD","18","A","PTSD",,"6",,"Tiagabine","Tiagabine","No","Not Applicable","Yes","Mood Stabilizer","No","Not Applicable","No","No","No","No","No","Individual","In Person","10","Structured Clinical Interview","SI-PTSD","SI-PTSD","ITT","LOCF","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","End of Treatment","0",,"15.7","11.7",,,,,,,,,,,,,,,,,,,,,,,,,,"DTS score ≤17","0.6667",,"Community",,,"1","0.7308",,"0.2692","Mixed","combat-related, rape/sexual assault, accidents, community/school violence, other (unexpected death of or threat of harm to a loved one; unwanted therapeutic abortion)","High","Connor KM, Davidson JRT, Weisler RH, et al. Tiagabine for posttraumatic stress disorder: effects of open-label and double-blind discontinuation treatment. Psychopharmacology (Berl). 2006 Jan;184(1):21-5. doi: 10.1007/s00213-005-0265-3. PMID: 16341846.","29324","2019"
"connor2006_SI-PTSD_A_Baseline_ITT","Pharmacotherapy","PTSD","18","A","PTSD",,"10",,"Tiagabine","Tiagabine","No","Not Applicable","Yes","Mood Stabilizer","No","Not Applicable","No","No","No","No","No","Individual","In Person","10","Structured Clinical Interview","SI-PTSD","SI-PTSD","ITT","LOCF","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Baseline",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"DTS score ≤17",,,"Community",,,"1","0.7308",,"0.2692","Mixed","combat-related, rape/sexual assault, accidents, community/school violence, other (unexpected death of or threat of harm to a loved one; unwanted therapeutic abortion)","High","Connor KM, Davidson JRT, Weisler RH, et al. Tiagabine for posttraumatic stress disorder: effects of open-label and double-blind discontinuation treatment. Psychopharmacology (Berl). 2006 Jan;184(1):21-5. doi: 10.1007/s00213-005-0265-3. PMID: 16341846.","29324","2019"
"connor2006_SI-PTSD_B_0_ITT","Pharmacotherapy","PTSD","18","B","Control",,"7",,"Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","8","Structured Clinical Interview","SI-PTSD","SI-PTSD","ITT","LOCF","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","End of Treatment","0",,"12.8","15.4",,,,,,,,,,,,,,,,,,,,,,,,,,"DTS score ≤17","0",,"Community",,,"1","0.7308",,"0.2692","Mixed","combat-related, rape/sexual assault, accidents, community/school violence, other (unexpected death of or threat of harm to a loved one; unwanted therapeutic abortion)","High","Connor KM, Davidson JRT, Weisler RH, et al. Tiagabine for posttraumatic stress disorder: effects of open-label and double-blind discontinuation treatment. Psychopharmacology (Berl). 2006 Jan;184(1):21-5. doi: 10.1007/s00213-005-0265-3. PMID: 16341846.","29324","2019"
"connor2006_SI-PTSD_B_Baseline_ITT","Pharmacotherapy","PTSD","18","B","Control",,"8",,"Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","8","Structured Clinical Interview","SI-PTSD","SI-PTSD","ITT","LOCF","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Baseline",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"DTS score ≤17",,,"Community",,,"1","0.7308",,"0.2692","Mixed","combat-related, rape/sexual assault, accidents, community/school violence, other (unexpected death of or threat of harm to a loved one; unwanted therapeutic abortion)","High","Connor KM, Davidson JRT, Weisler RH, et al. Tiagabine for posttraumatic stress disorder: effects of open-label and double-blind discontinuation treatment. Psychopharmacology (Berl). 2006 Jan;184(1):21-5. doi: 10.1007/s00213-005-0265-3. PMID: 16341846.","29324","2019"
"connor2006_SPRINT_A_0_NA","Pharmacotherapy","PTSD","18","A","PTSD",,,,"Tiagabine","Tiagabine","No","Not Applicable","Yes","Mood Stabilizer","No","Not Applicable","No","No","No","No","No","Individual","In Person","10","Self report","SPRINT","SPRINT",,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","End of Treatment","0","combined groups","6.6","6.9",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.7308",,"0.2692","Mixed","combat-related, rape/sexual assault, accidents, community/school violence, other (unexpected death of or threat of harm to a loved one; unwanted therapeutic abortion)","High","Connor KM, Davidson JRT, Weisler RH, et al. Tiagabine for posttraumatic stress disorder: effects of open-label and double-blind discontinuation treatment. Psychopharmacology (Berl). 2006 Jan;184(1):21-5. doi: 10.1007/s00213-005-0265-3. PMID: 16341846.","29324","2019"
"connor2006_SPRINT_A_Baseline_NA","Pharmacotherapy","PTSD","18","A","PTSD",,,,"Tiagabine","Tiagabine","No","Not Applicable","Yes","Mood Stabilizer","No","Not Applicable","No","No","No","No","No","Individual","In Person","10","Self report","SPRINT","SPRINT",,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Baseline",,,"9.2","7.0",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.7308",,"0.2692","Mixed","combat-related, rape/sexual assault, accidents, community/school violence, other (unexpected death of or threat of harm to a loved one; unwanted therapeutic abortion)","High","Connor KM, Davidson JRT, Weisler RH, et al. Tiagabine for posttraumatic stress disorder: effects of open-label and double-blind discontinuation treatment. Psychopharmacology (Berl). 2006 Jan;184(1):21-5. doi: 10.1007/s00213-005-0265-3. PMID: 16341846.","29324","2019"
"connor2006_SPRINT_B_0_NA","Pharmacotherapy","PTSD","18","B","Control",,,,"Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","8","Self report","SPRINT","SPRINT",,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","End of Treatment","0","combined groups","5.8","7.4",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.7308",,"0.2692","Mixed","combat-related, rape/sexual assault, accidents, community/school violence, other (unexpected death of or threat of harm to a loved one; unwanted therapeutic abortion)","High","Connor KM, Davidson JRT, Weisler RH, et al. Tiagabine for posttraumatic stress disorder: effects of open-label and double-blind discontinuation treatment. Psychopharmacology (Berl). 2006 Jan;184(1):21-5. doi: 10.1007/s00213-005-0265-3. PMID: 16341846.","29324","2019"
"connor2006_SPRINT_B_Baseline_NA","Pharmacotherapy","PTSD","18","B","Control",,,,"Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","8","Self report","SPRINT","SPRINT",,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Baseline",,,"9.2","7.0",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.7308",,"0.2692","Mixed","combat-related, rape/sexual assault, accidents, community/school violence, other (unexpected death of or threat of harm to a loved one; unwanted therapeutic abortion)","High","Connor KM, Davidson JRT, Weisler RH, et al. Tiagabine for posttraumatic stress disorder: effects of open-label and double-blind discontinuation treatment. Psychopharmacology (Berl). 2006 Jan;184(1):21-5. doi: 10.1007/s00213-005-0265-3. PMID: 16341846.","29324","2019"
"cook2010_CAPS_A_0_Comp","Psychotherapy","PTSD","124","A","PTSD",,"39",,"Imagery Rehearsal","Imagery Rehearsal Training (IRT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","61","Structured Clinical Interview","CAPS","CAPS","Completer","Mixed effects model","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","End of Treatment","0",,"72.9","20.46",,,,,"-7.36",,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Cook JM, Harb GC, Gehrman PR, et al. Imagery rehearsal for posttraumatic nightmares: a randomized controlled trial. J Trauma Stress. 2010 Oct;23(5):553-63. doi: 10.1002/jts.20569. PMID: 20839311.","84153","2019"
"cook2010_CAPS_A_0_ITT","Psychotherapy","PTSD","124","A","PTSD",,"45",,"Imagery Rehearsal","Imagery Rehearsal Training (IRT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","61","Structured Clinical Interview","CAPS","CAPS","ITT","Mixed effects model","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","End of Treatment","0",,"74.04","20.36",,,,,"-7.3",,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Cook JM, Harb GC, Gehrman PR, et al. Imagery rehearsal for posttraumatic nightmares: a randomized controlled trial. J Trauma Stress. 2010 Oct;23(5):553-63. doi: 10.1002/jts.20569. PMID: 20839311.","84153","2019"
"cook2010_CAPS_A_Baseline_Comp","Psychotherapy","PTSD","124","A","PTSD",,"39",,"Imagery Rehearsal","Imagery Rehearsal Training (IRT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","61","Structured Clinical Interview","CAPS","CAPS","Completer","Mixed effects model","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Baseline",,,"81.38","14.96",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Cook JM, Harb GC, Gehrman PR, et al. Imagery rehearsal for posttraumatic nightmares: a randomized controlled trial. J Trauma Stress. 2010 Oct;23(5):553-63. doi: 10.1002/jts.20569. PMID: 20839311.","84153","2019"
"cook2010_CAPS_A_Baseline_ITT","Psychotherapy","PTSD","124","A","PTSD",,"61",,"Imagery Rehearsal","Imagery Rehearsal Training (IRT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","61","Structured Clinical Interview","CAPS","CAPS","ITT","Mixed effects model","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Baseline",,,"81.34","14",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Cook JM, Harb GC, Gehrman PR, et al. Imagery rehearsal for posttraumatic nightmares: a randomized controlled trial. J Trauma Stress. 2010 Oct;23(5):553-63. doi: 10.1002/jts.20569. PMID: 20839311.","84153","2019"
"cook2010_CAPS_B_0_Comp","Psychotherapy","PTSD","124","B","PTSD",,"51",,"Sleep and nightmare management","Sleep and nightmare management","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","63","Structured Clinical Interview","CAPS","CAPS","Completer","Mixed effects model","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","End of Treatment","0",,"74.16","18.97",,,,,"-6.1",,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Cook JM, Harb GC, Gehrman PR, et al. Imagery rehearsal for posttraumatic nightmares: a randomized controlled trial. J Trauma Stress. 2010 Oct;23(5):553-63. doi: 10.1002/jts.20569. PMID: 20839311.","84153","2019"
"cook2010_CAPS_B_0_ITT","Psychotherapy","PTSD","124","B","PTSD",,"56",,"Sleep and nightmare management","Sleep and nightmare management","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","63","Structured Clinical Interview","CAPS","CAPS","ITT","Mixed effects model","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","End of Treatment","0",,"74.85","19.52",,,,,"-4.63",,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Cook JM, Harb GC, Gehrman PR, et al. Imagery rehearsal for posttraumatic nightmares: a randomized controlled trial. J Trauma Stress. 2010 Oct;23(5):553-63. doi: 10.1002/jts.20569. PMID: 20839311.","84153","2019"
"cook2010_CAPS_B_Baseline_Comp","Psychotherapy","PTSD","124","B","PTSD",,"51",,"Sleep and nightmare management","Sleep and nightmare management","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","63","Structured Clinical Interview","CAPS","CAPS","Completer","Mixed effects model","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Baseline",,,"80.26","1527",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Cook JM, Harb GC, Gehrman PR, et al. Imagery rehearsal for posttraumatic nightmares: a randomized controlled trial. J Trauma Stress. 2010 Oct;23(5):553-63. doi: 10.1002/jts.20569. PMID: 20839311.","84153","2019"
"cook2010_CAPS_B_Baseline_ITT","Psychotherapy","PTSD","124","B","PTSD",,"63",,"Sleep and nightmare management","Sleep and nightmare management","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","63","Structured Clinical Interview","CAPS","CAPS","ITT","Mixed effects model","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Baseline",,,"79.48","15.27",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Cook JM, Harb GC, Gehrman PR, et al. Imagery rehearsal for posttraumatic nightmares: a randomized controlled trial. J Trauma Stress. 2010 Oct;23(5):553-63. doi: 10.1002/jts.20569. PMID: 20839311.","84153","2019"
"cook2010_PCL_A_0_ITT","Psychotherapy","PTSD","124","A","PTSD",,,,"Imagery Rehearsal","Imagery Rehearsal Training (IRT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","61","Self report","PCL","PCL-M","ITT",,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","End of Treatment","0",,"58.83","13.56",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Cook JM, Harb GC, Gehrman PR, et al. Imagery rehearsal for posttraumatic nightmares: a randomized controlled trial. J Trauma Stress. 2010 Oct;23(5):553-63. doi: 10.1002/jts.20569. PMID: 20839311.","84153","2019"
"cook2010_PCL_A_12_ITT","Psychotherapy","PTSD","124","A","PTSD",,,,"Imagery Rehearsal","Imagery Rehearsal Training (IRT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","61","Self report","PCL","PCL-M","ITT",,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Assessment at 3 to <6 Months","12",,"60.13","12.16",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Cook JM, Harb GC, Gehrman PR, et al. Imagery rehearsal for posttraumatic nightmares: a randomized controlled trial. J Trauma Stress. 2010 Oct;23(5):553-63. doi: 10.1002/jts.20569. PMID: 20839311.","84153","2019"
"cook2010_PCL_A_26_ITT","Psychotherapy","PTSD","124","A","PTSD",,,,"Imagery Rehearsal","Imagery Rehearsal Training (IRT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","61","Self report","PCL","PCL-M","ITT",,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Assessment at 6 to <12 Months","26",,"59.05","11.87",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Cook JM, Harb GC, Gehrman PR, et al. Imagery rehearsal for posttraumatic nightmares: a randomized controlled trial. J Trauma Stress. 2010 Oct;23(5):553-63. doi: 10.1002/jts.20569. PMID: 20839311.","84153","2019"
"cook2010_PCL_A_Baseline_ITT","Psychotherapy","PTSD","124","A","PTSD",,,,"Imagery Rehearsal","Imagery Rehearsal Training (IRT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","61","Self report","PCL","PCL-M","ITT",,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Baseline",,,"62.73","10.18",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Cook JM, Harb GC, Gehrman PR, et al. Imagery rehearsal for posttraumatic nightmares: a randomized controlled trial. J Trauma Stress. 2010 Oct;23(5):553-63. doi: 10.1002/jts.20569. PMID: 20839311.","84153","2019"
"cook2010_PCL_B_0_ITT","Psychotherapy","PTSD","124","B","PTSD",,,,"Sleep and nightmare management","Sleep and nightmare management","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","63","Self report","PCL","PCL-M","ITT",,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","End of Treatment","0",,"60.96","11.43",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Cook JM, Harb GC, Gehrman PR, et al. Imagery rehearsal for posttraumatic nightmares: a randomized controlled trial. J Trauma Stress. 2010 Oct;23(5):553-63. doi: 10.1002/jts.20569. PMID: 20839311.","84153","2019"
"cook2010_PCL_B_12_ITT","Psychotherapy","PTSD","124","B","PTSD",,,,"Sleep and nightmare management","Sleep and nightmare management","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","63","Self report","PCL","PCL-M","ITT",,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Assessment at 3 to <6 Months","12",,"61.13","12.00",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Cook JM, Harb GC, Gehrman PR, et al. Imagery rehearsal for posttraumatic nightmares: a randomized controlled trial. J Trauma Stress. 2010 Oct;23(5):553-63. doi: 10.1002/jts.20569. PMID: 20839311.","84153","2019"
"cook2010_PCL_B_26_ITT","Psychotherapy","PTSD","124","B","PTSD",,,,"Sleep and nightmare management","Sleep and nightmare management","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","63","Self report","PCL","PCL-M","ITT",,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Assessment at 6 to <12 Months","26",,"59.64","12.30",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Cook JM, Harb GC, Gehrman PR, et al. Imagery rehearsal for posttraumatic nightmares: a randomized controlled trial. J Trauma Stress. 2010 Oct;23(5):553-63. doi: 10.1002/jts.20569. PMID: 20839311.","84153","2019"
"cook2010_PCL_B_Baseline_ITT","Psychotherapy","PTSD","124","B","PTSD",,,,"Sleep and nightmare management","Sleep and nightmare management","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","63","Self report","PCL","PCL-M","ITT",,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Baseline",,,"65.06","9.48",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Cook JM, Harb GC, Gehrman PR, et al. Imagery rehearsal for posttraumatic nightmares: a randomized controlled trial. J Trauma Stress. 2010 Oct;23(5):553-63. doi: 10.1002/jts.20569. PMID: 20839311.","84153","2019"
"cottraux2008_PCL_A_0_Comp","Psychotherapy","PTSD","60","A","PTSD",,"27",,"CBT","Trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","31","Self report","PCL","PCL","Completer",,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","End of Treatment","0",,"46.22","14.11",,,,,"-15.18","12.9",,,,,,,,,,,,,,,,,,,,"PCL <44","0.3704","Additional definitions of Clinically Meaningful Response reported in the study","Community",,,"1","0.7619",,"0.2381","Mixed","rape/sexual assault, accidents, illness/medical procedure, community/school violence, other (not specified)","Medium","Cottraux J, Note I, Yao S-N, et al. Randomized controlled comparison of cognitive behavior therapy with Rogerian supportive therapy in chronic post-traumatic stress disorder: a 2-year follow-up. Psychother Psychosom. 2008 Jan;77(2):101-10. doi: 10.1159/000112887. PMID: 18230943.","30573","2019"
"cottraux2008_PCL_A_0_ITT","Psychotherapy","PTSD","60","A","PTSD",,"30",,"CBT","Trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","31","Self report","PCL","PCL","ITT","LOCF","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","End of Treatment","0",,,,,,,,"-13.5","13.2",,,,,,,,,,,,,,,,,,,,"PCL <44","0.3333","Additional definitions of Clinically Meaningful Response reported in the study","Community",,,"1","0.7619",,"0.2381","Mixed","rape/sexual assault, accidents, illness/medical procedure, community/school violence, other (not specified)","Medium","Cottraux J, Note I, Yao S-N, et al. Randomized controlled comparison of cognitive behavior therapy with Rogerian supportive therapy in chronic post-traumatic stress disorder: a 2-year follow-up. Psychother Psychosom. 2008 Jan;77(2):101-10. doi: 10.1159/000112887. PMID: 18230943.","30573","2019"
"cottraux2008_PCL_A_104_Comp","Psychotherapy","PTSD","60","A","PTSD",,"16",,"CBT","Trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","31","Self report","PCL","PCL","Completer",,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Assessment at ≥12 Months","104",,"42.56","16.58",,,,,"-18.56","14.91",,,,,,,,,,,,,,,,,,,,"PCL <44","0.5","Additional definitions of Clinically Meaningful Response reported in the study","Community",,,"1","0.7619",,"0.2381","Mixed","rape/sexual assault, accidents, illness/medical procedure, community/school violence, other (not specified)","Medium","Cottraux J, Note I, Yao S-N, et al. Randomized controlled comparison of cognitive behavior therapy with Rogerian supportive therapy in chronic post-traumatic stress disorder: a 2-year follow-up. Psychother Psychosom. 2008 Jan;77(2):101-10. doi: 10.1159/000112887. PMID: 18230943.","30573","2019"
"cottraux2008_PCL_A_52_Comp","Psychotherapy","PTSD","60","A","PTSD",,"24",,"CBT","Trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","31","Self report","PCL","PCL","Completer",,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Assessment at ≥12 Months","52",,"44.62","15.2",,,,,"-16.75","14.94",,,,,,,,,,,,,,,,,,,,"PCL <44","0.5","Additional definitions of Clinically Meaningful Response reported in the study","Community",,,"1","0.7619",,"0.2381","Mixed","rape/sexual assault, accidents, illness/medical procedure, community/school violence, other (not specified)","Medium","Cottraux J, Note I, Yao S-N, et al. Randomized controlled comparison of cognitive behavior therapy with Rogerian supportive therapy in chronic post-traumatic stress disorder: a 2-year follow-up. Psychother Psychosom. 2008 Jan;77(2):101-10. doi: 10.1159/000112887. PMID: 18230943.","30573","2019"
"cottraux2008_PCL_A_Baseline_Comp","Psychotherapy","PTSD","60","A","PTSD",,"27",,"CBT","Trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","31","Self report","PCL","PCL","Completer",,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Baseline",,,"61.37","9.48",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.7619",,"0.2381","Mixed","rape/sexual assault, accidents, illness/medical procedure, community/school violence, other (not specified)","Medium","Cottraux J, Note I, Yao S-N, et al. Randomized controlled comparison of cognitive behavior therapy with Rogerian supportive therapy in chronic post-traumatic stress disorder: a 2-year follow-up. Psychother Psychosom. 2008 Jan;77(2):101-10. doi: 10.1159/000112887. PMID: 18230943.","30573","2019"
"cottraux2008_PCL_A_Baseline_ITT","Psychotherapy","PTSD","60","A","PTSD",,"31",,"CBT","Trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","31","Self report","PCL","PCL","ITT","LOCF","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Baseline",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.7619",,"0.2381","Mixed","rape/sexual assault, accidents, illness/medical procedure, community/school violence, other (not specified)","Medium","Cottraux J, Note I, Yao S-N, et al. Randomized controlled comparison of cognitive behavior therapy with Rogerian supportive therapy in chronic post-traumatic stress disorder: a 2-year follow-up. Psychother Psychosom. 2008 Jan;77(2):101-10. doi: 10.1159/000112887. PMID: 18230943.","30573","2019"
"cottraux2008_PCL_B_0_Comp","Psychotherapy","PTSD","60","B","Control",,"15",,"Rogerian supportive therapy","Supportive counseling","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","29","Self report","PCL","PCL","Completer",,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","End of Treatment","0",,"46.93","13.44",,,,,"-12.06","13.86",,,,,,,,,,,,,,,,,,,,"PCL <44","0.2667","Additional definitions of Clinically Meaningful Response reported in the study","Community",,,"1","0.7619",,"0.2381","Mixed","rape/sexual assault, accidents, illness/medical procedure, community/school violence, other (not specified)","Medium","Cottraux J, Note I, Yao S-N, et al. Randomized controlled comparison of cognitive behavior therapy with Rogerian supportive therapy in chronic post-traumatic stress disorder: a 2-year follow-up. Psychother Psychosom. 2008 Jan;77(2):101-10. doi: 10.1159/000112887. PMID: 18230943.","30573","2019"
"cottraux2008_PCL_B_0_ITT","Psychotherapy","PTSD","60","B","Control",,"28",,"Rogerian supportive therapy","Supportive counseling","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","29","Self report","PCL","PCL","ITT","LOCF","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","End of Treatment","0",,,,,,,,"-6.3","12.9",,,,,,,,,,,,,,,,,,,,"PCL <44","0.1429","Additional definitions of Clinically Meaningful Response reported in the study","Community",,,"1","0.7619",,"0.2381","Mixed","rape/sexual assault, accidents, illness/medical procedure, community/school violence, other (not specified)","Medium","Cottraux J, Note I, Yao S-N, et al. Randomized controlled comparison of cognitive behavior therapy with Rogerian supportive therapy in chronic post-traumatic stress disorder: a 2-year follow-up. Psychother Psychosom. 2008 Jan;77(2):101-10. doi: 10.1159/000112887. PMID: 18230943.","30573","2019"
"cottraux2008_PCL_B_104_Comp","Psychotherapy","PTSD","60","B","Control",,"9",,"Rogerian supportive therapy","Supportive counseling","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","29","Self report","PCL","PCL","Completer",,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Assessment at ≥12 Months","104",,"42.77","12.82",,,,,"-18.11","14.18",,,,,,,,,,,,,,,,,,,,"PCL <44","0.4444","Additional definitions of Clinically Meaningful Response reported in the study","Community",,,"1","0.7619",,"0.2381","Mixed","rape/sexual assault, accidents, illness/medical procedure, community/school violence, other (not specified)","Medium","Cottraux J, Note I, Yao S-N, et al. Randomized controlled comparison of cognitive behavior therapy with Rogerian supportive therapy in chronic post-traumatic stress disorder: a 2-year follow-up. Psychother Psychosom. 2008 Jan;77(2):101-10. doi: 10.1159/000112887. PMID: 18230943.","30573","2019"
"cottraux2008_PCL_B_52_Comp","Psychotherapy","PTSD","60","B","Control",,"14",,"Rogerian supportive therapy","Supportive counseling","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","29","Self report","PCL","PCL","Completer",,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Assessment at ≥12 Months","52",,"46.85","12.96",,,,,"-12","10.5",,,,,,,,,,,,,,,,,,,,"PCL <44","0.5","Additional definitions of Clinically Meaningful Response reported in the study","Community",,,"1","0.7619",,"0.2381","Mixed","rape/sexual assault, accidents, illness/medical procedure, community/school violence, other (not specified)","Medium","Cottraux J, Note I, Yao S-N, et al. Randomized controlled comparison of cognitive behavior therapy with Rogerian supportive therapy in chronic post-traumatic stress disorder: a 2-year follow-up. Psychother Psychosom. 2008 Jan;77(2):101-10. doi: 10.1159/000112887. PMID: 18230943.","30573","2019"
"cottraux2008_PCL_B_Baseline_Comp","Psychotherapy","PTSD","60","B","Control",,"15",,"Rogerian supportive therapy","Supportive counseling","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","29","Self report","PCL","PCL","Completer",,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Baseline",,,"59","7.79",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.7619",,"0.2381","Mixed","rape/sexual assault, accidents, illness/medical procedure, community/school violence, other (not specified)","Medium","Cottraux J, Note I, Yao S-N, et al. Randomized controlled comparison of cognitive behavior therapy with Rogerian supportive therapy in chronic post-traumatic stress disorder: a 2-year follow-up. Psychother Psychosom. 2008 Jan;77(2):101-10. doi: 10.1159/000112887. PMID: 18230943.","30573","2019"
"cottraux2008_PCL_B_Baseline_ITT","Psychotherapy","PTSD","60","B","Control",,"29",,"Rogerian supportive therapy","Supportive counseling","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","29","Self report","PCL","PCL","ITT","LOCF","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Baseline",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.7619",,"0.2381","Mixed","rape/sexual assault, accidents, illness/medical procedure, community/school violence, other (not specified)","Medium","Cottraux J, Note I, Yao S-N, et al. Randomized controlled comparison of cognitive behavior therapy with Rogerian supportive therapy in chronic post-traumatic stress disorder: a 2-year follow-up. Psychother Psychosom. 2008 Jan;77(2):101-10. doi: 10.1159/000112887. PMID: 18230943.","30573","2019"
"davidson1990_IES_A_0_Comp","Pharmacotherapy","PTSD","46","A","PTSD",,,,"Amitriptyline","Amitriptyline","No","Not Applicable","Yes","Antidepressant: TCA","No","Not Applicable","No","No","No","No","No","Individual","In Person","25","Self report","IES","IES","Completer",,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","End of Treatment","0",,"25.0","11.5",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0",,,,"Combat-related",,"High","Davidson J, Kudler H, Smith R, et al. Treatment of posttraumatic stress disorder with amitriptyline and placebo. Arch Gen Psychiatry. 1990 Mar;47(3):259-66. PMID: 2407208.","00912","2019"
"davidson1990_IES_A_0_I","Pharmacotherapy","PTSD","46","A","PTSD",,,,"Amitriptyline","Amitriptyline","No","Not Applicable","Yes","Antidepressant: TCA","No","Not Applicable","No","No","No","No","No","Individual","In Person","25","Self report","IES","IES","Efficacy/ITT",,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","End of Treatment","0",,"27.4","11.7",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0",,,,"Combat-related",,"High","Davidson J, Kudler H, Smith R, et al. Treatment of posttraumatic stress disorder with amitriptyline and placebo. Arch Gen Psychiatry. 1990 Mar;47(3):259-66. PMID: 2407208.","00912","2019"
"davidson1990_IES_A_Baseline_Comp","Pharmacotherapy","PTSD","46","A","PTSD",,,,"Amitriptyline","Amitriptyline","No","Not Applicable","Yes","Antidepressant: TCA","No","Not Applicable","No","No","No","No","No","Individual","In Person","25","Self report","IES","IES","Completer",,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Baseline",,,"31.8","8.5",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0",,,,"Combat-related",,"High","Davidson J, Kudler H, Smith R, et al. Treatment of posttraumatic stress disorder with amitriptyline and placebo. Arch Gen Psychiatry. 1990 Mar;47(3):259-66. PMID: 2407208.","00912","2019"
"davidson1990_IES_A_Baseline_I","Pharmacotherapy","PTSD","46","A","PTSD",,,,"Amitriptyline","Amitriptyline","No","Not Applicable","Yes","Antidepressant: TCA","No","Not Applicable","No","No","No","No","No","Individual","In Person","25","Self report","IES","IES","Efficacy/ITT",,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Baseline",,,"33.1","8.5",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0",,,,"Combat-related",,"High","Davidson J, Kudler H, Smith R, et al. Treatment of posttraumatic stress disorder with amitriptyline and placebo. Arch Gen Psychiatry. 1990 Mar;47(3):259-66. PMID: 2407208.","00912","2019"
"davidson1990_IES_B_0_Comp","Pharmacotherapy","PTSD","46","B","Control",,,,"Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","21","Self report","IES","IES","Completer",,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","End of Treatment","0",,"33.7","6.6",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0",,,,"Combat-related",,"High","Davidson J, Kudler H, Smith R, et al. Treatment of posttraumatic stress disorder with amitriptyline and placebo. Arch Gen Psychiatry. 1990 Mar;47(3):259-66. PMID: 2407208.","00912","2019"
"davidson1990_IES_B_0_I","Pharmacotherapy","PTSD","46","B","Control",,,,"Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","21","Self report","IES","IES","Efficacy/ITT",,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","End of Treatment","0",,"34.1","6.4",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0",,,,"Combat-related",,"High","Davidson J, Kudler H, Smith R, et al. Treatment of posttraumatic stress disorder with amitriptyline and placebo. Arch Gen Psychiatry. 1990 Mar;47(3):259-66. PMID: 2407208.","00912","2019"
"davidson1990_IES_B_Baseline_Comp","Pharmacotherapy","PTSD","46","B","Control",,,,"Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","21","Self report","IES","IES","Completer",,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Baseline",,,"36.6","5.4",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0",,,,"Combat-related",,"High","Davidson J, Kudler H, Smith R, et al. Treatment of posttraumatic stress disorder with amitriptyline and placebo. Arch Gen Psychiatry. 1990 Mar;47(3):259-66. PMID: 2407208.","00912","2019"
"davidson1990_IES_B_Baseline_I","Pharmacotherapy","PTSD","46","B","Control",,,,"Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","21","Self report","IES","IES","Efficacy/ITT",,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Baseline",,,"36.8","5.3",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0",,,,"Combat-related",,"High","Davidson J, Kudler H, Smith R, et al. Treatment of posttraumatic stress disorder with amitriptyline and placebo. Arch Gen Psychiatry. 1990 Mar;47(3):259-66. PMID: 2407208.","00912","2019"
"davidson1990_SI-PTSD_A_0_Comp","Pharmacotherapy","PTSD","46","A","PTSD",,"17",,"Amitriptyline","Amitriptyline","No","Not Applicable","Yes","Antidepressant: TCA","No","Not Applicable","No","No","No","No","No","Individual","In Person","25","Structured Clinical Interview","SI-PTSD","SI-PTSD","Completer",,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","End of Treatment","0",,"15.2","8.3",,,,,"-7.2",,,,,,,,,,,,,,,,,,"Not meeting criteria for PTSD according to SI-PTSD",,,"≥50% decrease on SI-PTSD",,"Additional definitions of Clinically Meaningful Response reported in the study","Veteran","0","1","0",,,,"Combat-related",,"High","Davidson J, Kudler H, Smith R, et al. Treatment of posttraumatic stress disorder with amitriptyline and placebo. Arch Gen Psychiatry. 1990 Mar;47(3):259-66. PMID: 2407208.","00912","2019"
"davidson1990_SI-PTSD_A_0_I","Pharmacotherapy","PTSD","46","A","PTSD",,"22",,"Amitriptyline","Amitriptyline","No","Not Applicable","Yes","Antidepressant: TCA","No","Not Applicable","No","No","No","No","No","Individual","In Person","25","Structured Clinical Interview","SI-PTSD","SI-PTSD","Efficacy/ITT","LOCF","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","End of Treatment","0",,"17.9","9.1",,,,,"-6.2",,,,,,,,,,,,,,,,,,"Not meeting criteria for PTSD according to SI-PTSD","0.3636",,"≥50% decrease on SI-PTSD","0.2727","Additional definitions of Clinically Meaningful Response reported in the study","Veteran","0","1","0",,,,"Combat-related",,"High","Davidson J, Kudler H, Smith R, et al. Treatment of posttraumatic stress disorder with amitriptyline and placebo. Arch Gen Psychiatry. 1990 Mar;47(3):259-66. PMID: 2407208.","00912","2019"
"davidson1990_SI-PTSD_A_Baseline_Comp","Pharmacotherapy","PTSD","46","A","PTSD",,"17",,"Amitriptyline","Amitriptyline","No","Not Applicable","Yes","Antidepressant: TCA","No","Not Applicable","No","No","No","No","No","Individual","In Person","25","Structured Clinical Interview","SI-PTSD","SI-PTSD","Completer",,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Baseline",,,"22.4","7.8",,,,,,,,,,,,,,,,,,,,,,,"Not meeting criteria for PTSD according to SI-PTSD",,,"≥50% decrease on SI-PTSD",,"Additional definitions of Clinically Meaningful Response reported in the study","Veteran","0","1","0",,,,"Combat-related",,"High","Davidson J, Kudler H, Smith R, et al. Treatment of posttraumatic stress disorder with amitriptyline and placebo. Arch Gen Psychiatry. 1990 Mar;47(3):259-66. PMID: 2407208.","00912","2019"
"davidson1990_SI-PTSD_A_Baseline_I","Pharmacotherapy","PTSD","46","A","PTSD",,"22",,"Amitriptyline","Amitriptyline","No","Not Applicable","Yes","Antidepressant: TCA","No","Not Applicable","No","No","No","No","No","Individual","In Person","25","Structured Clinical Interview","SI-PTSD","SI-PTSD","Efficacy/ITT","LOCF","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Baseline",,,"24.1","8.4",,,,,,,,,,,,,,,,,,,,,,,"Not meeting criteria for PTSD according to SI-PTSD",,,"≥50% decrease on SI-PTSD",,"Additional definitions of Clinically Meaningful Response reported in the study","Veteran","0","1","0",,,,"Combat-related",,"High","Davidson J, Kudler H, Smith R, et al. Treatment of posttraumatic stress disorder with amitriptyline and placebo. Arch Gen Psychiatry. 1990 Mar;47(3):259-66. PMID: 2407208.","00912","2019"
"davidson1990_SI-PTSD_B_0_Comp","Pharmacotherapy","PTSD","46","B","Control",,"16",,"Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","21","Structured Clinical Interview","SI-PTSD","SI-PTSD","Completer",,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","End of Treatment","0",,"20.3","7.5",,,,,"-5.2",,,,,,,,,,,,,,,,,,"Not meeting criteria for PTSD according to SI-PTSD",,,"≥50% decrease on SI-PTSD",,"Additional definitions of Clinically Meaningful Response reported in the study","Veteran","0","1","0",,,,"Combat-related",,"High","Davidson J, Kudler H, Smith R, et al. Treatment of posttraumatic stress disorder with amitriptyline and placebo. Arch Gen Psychiatry. 1990 Mar;47(3):259-66. PMID: 2407208.","00912","2019"
"davidson1990_SI-PTSD_B_0_I","Pharmacotherapy","PTSD","46","B","Control",,"18",,"Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","21","Structured Clinical Interview","SI-PTSD","SI-PTSD","Efficacy/ITT","LOCF","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","End of Treatment","0",,"20.8","7.2",,,,,"-5.6",,,,,,,,,,,,,,,,,,"Not meeting criteria for PTSD according to SI-PTSD","0.2778",,"≥50% decrease on SI-PTSD","0.1667","Additional definitions of Clinically Meaningful Response reported in the study","Veteran","0","1","0",,,,"Combat-related",,"High","Davidson J, Kudler H, Smith R, et al. Treatment of posttraumatic stress disorder with amitriptyline and placebo. Arch Gen Psychiatry. 1990 Mar;47(3):259-66. PMID: 2407208.","00912","2019"
"davidson1990_SI-PTSD_B_Baseline_Comp","Pharmacotherapy","PTSD","46","B","Control",,"16",,"Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","21","Structured Clinical Interview","SI-PTSD","SI-PTSD","Completer",,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Baseline",,,"25.5","7.4",,,,,,,,,,,,,,,,,,,,,,,"Not meeting criteria for PTSD according to SI-PTSD",,,"≥50% decrease on SI-PTSD",,"Additional definitions of Clinically Meaningful Response reported in the study","Veteran","0","1","0",,,,"Combat-related",,"High","Davidson J, Kudler H, Smith R, et al. Treatment of posttraumatic stress disorder with amitriptyline and placebo. Arch Gen Psychiatry. 1990 Mar;47(3):259-66. PMID: 2407208.","00912","2019"
"davidson1990_SI-PTSD_B_Baseline_I","Pharmacotherapy","PTSD","46","B","Control",,"18",,"Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","21","Structured Clinical Interview","SI-PTSD","SI-PTSD","Efficacy/ITT","LOCF","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Baseline",,,"26.4","7.5",,,,,,,,,,,,,,,,,,,,,,,"Not meeting criteria for PTSD according to SI-PTSD",,,"≥50% decrease on SI-PTSD",,"Additional definitions of Clinically Meaningful Response reported in the study","Veteran","0","1","0",,,,"Combat-related",,"High","Davidson J, Kudler H, Smith R, et al. Treatment of posttraumatic stress disorder with amitriptyline and placebo. Arch Gen Psychiatry. 1990 Mar;47(3):259-66. PMID: 2407208.","00912","2019"
"davidson2001_CAPS_A_0_ITT","Pharmacotherapy","PTSD","208","A","PTSD",,"98",,"Sertraline","Sertraline","No","Not Applicable","Yes","Antidepressant: SSRI","No","Not Applicable","No","No","No","No","No","Individual","In Person","100","Structured Clinical Interview","CAPS","CAPS-2","ITT",,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","End of Treatment","0",,"40.9",,,,,,"-33.0",,,,,,,,,,,,,,,,,,,,,"≥30% decrease in CAPS-2 score and CGI-I score of 1 or 2 (very much improved or much improved)","0.6",,"Community",,,"1","0.7788",,"0.2212","Mixed","accidents, rape/sexual assault, combat-related, natural or manmade disasters, community/school violence, other (""seeing someone hurt or die"", ""other event"")","Medium","Davidson JR, Rothbaum BO, van der Kolk BA, et al. Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder. Arch Gen Psychiatry. 2001 May;58(5):485-92. PMID: 11343529.","23358","2019"
"davidson2001_CAPS_A_Baseline_ITT","Pharmacotherapy","PTSD","208","A","PTSD",,"100",,"Sertraline","Sertraline","No","Not Applicable","Yes","Antidepressant: SSRI","No","Not Applicable","No","No","No","No","No","Individual","In Person","100","Structured Clinical Interview","CAPS","CAPS-2","ITT",,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Baseline",,,"73.9","16.2",,,,,,,,,,,,,,,,,,,,,,,,,,"≥30% decrease in CAPS-2 score and CGI-I score of 1 or 2 (very much improved or much improved)",,,"Community",,,"1","0.7788",,"0.2212","Mixed","accidents, rape/sexual assault, combat-related, natural or manmade disasters, community/school violence, other (""seeing someone hurt or die"", ""other event"")","Medium","Davidson JR, Rothbaum BO, van der Kolk BA, et al. Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder. Arch Gen Psychiatry. 2001 May;58(5):485-92. PMID: 11343529.","23358","2019"
"davidson2001_CAPS_B_0_ITT","Pharmacotherapy","PTSD","208","B","Control",,"104",,"Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","108","Structured Clinical Interview","CAPS","CAPS-2","ITT",,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","End of Treatment","0",,"47.3",,,,,,"-26.2","2.3",,,,,,,,,,,,,,,,,,,,"≥30% decrease in CAPS-2 score and CGI-I score of 1 or 2 (very much improved or much improved)","0.38",,"Community",,,"1","0.7788",,"0.2212","Mixed","accidents, rape/sexual assault, combat-related, natural or manmade disasters, community/school violence, other (""seeing someone hurt or die"", ""other event"")","Medium","Davidson JR, Rothbaum BO, van der Kolk BA, et al. Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder. Arch Gen Psychiatry. 2001 May;58(5):485-92. PMID: 11343529.","23358","2019"
"davidson2001_CAPS_B_Baseline_ITT","Pharmacotherapy","PTSD","208","B","Control",,"108",,"Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","108","Structured Clinical Interview","CAPS","CAPS-2","ITT",,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Baseline",,,"73.5","16.1",,,,,,,,,,,,,,,,,,,,,,,,,,"≥30% decrease in CAPS-2 score and CGI-I score of 1 or 2 (very much improved or much improved)",,,"Community",,,"1","0.7788",,"0.2212","Mixed","accidents, rape/sexual assault, combat-related, natural or manmade disasters, community/school violence, other (""seeing someone hurt or die"", ""other event"")","Medium","Davidson JR, Rothbaum BO, van der Kolk BA, et al. Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder. Arch Gen Psychiatry. 2001 May;58(5):485-92. PMID: 11343529.","23358","2019"
"davidson2001_DTS_A_0_NA","Pharmacotherapy","PTSD","208","A","PTSD",,,,"Sertraline","Sertraline","No","Not Applicable","Yes","Antidepressant: SSRI","No","Not Applicable","No","No","No","No","No","Individual","In Person","100","Self report","DTS","DTS",,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","End of Treatment","0",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.7788",,"0.2212","Mixed","accidents, rape/sexual assault, combat-related, natural or manmade disasters, community/school violence, other (""seeing someone hurt or die"", ""other event"")","Medium","Davidson JR, Rothbaum BO, van der Kolk BA, et al. Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder. Arch Gen Psychiatry. 2001 May;58(5):485-92. PMID: 11343529.","23358","2019"
"davidson2001_DTS_A_Baseline_NA","Pharmacotherapy","PTSD","208","A","PTSD",,,,"Sertraline","Sertraline","No","Not Applicable","Yes","Antidepressant: SSRI","No","Not Applicable","No","No","No","No","No","Individual","In Person","100","Self report","DTS","DTS",,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Baseline",,,"74.5","26.9",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.7788",,"0.2212","Mixed","accidents, rape/sexual assault, combat-related, natural or manmade disasters, community/school violence, other (""seeing someone hurt or die"", ""other event"")","Medium","Davidson JR, Rothbaum BO, van der Kolk BA, et al. Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder. Arch Gen Psychiatry. 2001 May;58(5):485-92. PMID: 11343529.","23358","2019"
"davidson2001_DTS_B_0_NA","Pharmacotherapy","PTSD","208","B","Control",,,,"Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","108","Self report","DTS","DTS",,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","End of Treatment","0",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.7788",,"0.2212","Mixed","accidents, rape/sexual assault, combat-related, natural or manmade disasters, community/school violence, other (""seeing someone hurt or die"", ""other event"")","Medium","Davidson JR, Rothbaum BO, van der Kolk BA, et al. Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder. Arch Gen Psychiatry. 2001 May;58(5):485-92. PMID: 11343529.","23358","2019"
"davidson2001_DTS_B_Baseline_NA","Pharmacotherapy","PTSD","208","B","Control",,,,"Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","108","Self report","DTS","DTS",,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Baseline",,,"73.8","26.2",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.7788",,"0.2212","Mixed","accidents, rape/sexual assault, combat-related, natural or manmade disasters, community/school violence, other (""seeing someone hurt or die"", ""other event"")","Medium","Davidson JR, Rothbaum BO, van der Kolk BA, et al. Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder. Arch Gen Psychiatry. 2001 May;58(5):485-92. PMID: 11343529.","23358","2019"
"davidson2001_IES_A_0_NA","Pharmacotherapy","PTSD","208","A","PTSD",,,,"Sertraline","Sertraline","No","Not Applicable","Yes","Antidepressant: SSRI","No","Not Applicable","No","No","No","No","No","Individual","In Person","100","Self report","IES","IES",,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","End of Treatment","0",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.7788",,"0.2212","Mixed","accidents, rape/sexual assault, combat-related, natural or manmade disasters, community/school violence, other (""seeing someone hurt or die"", ""other event"")","Medium","Davidson JR, Rothbaum BO, van der Kolk BA, et al. Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder. Arch Gen Psychiatry. 2001 May;58(5):485-92. PMID: 11343529.","23358","2019"
"davidson2001_IES_A_Baseline_NA","Pharmacotherapy","PTSD","208","A","PTSD",,,,"Sertraline","Sertraline","No","Not Applicable","Yes","Antidepressant: SSRI","No","Not Applicable","No","No","No","No","No","Individual","In Person","100","Self report","IES","IES",,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Baseline",,,"38.5","15.6",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.7788",,"0.2212","Mixed","accidents, rape/sexual assault, combat-related, natural or manmade disasters, community/school violence, other (""seeing someone hurt or die"", ""other event"")","Medium","Davidson JR, Rothbaum BO, van der Kolk BA, et al. Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder. Arch Gen Psychiatry. 2001 May;58(5):485-92. PMID: 11343529.","23358","2019"
"davidson2001_IES_B_0_NA","Pharmacotherapy","PTSD","208","B","Control",,,,"Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","108","Self report","IES","IES",,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","End of Treatment","0",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.7788",,"0.2212","Mixed","accidents, rape/sexual assault, combat-related, natural or manmade disasters, community/school violence, other (""seeing someone hurt or die"", ""other event"")","Medium","Davidson JR, Rothbaum BO, van der Kolk BA, et al. Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder. Arch Gen Psychiatry. 2001 May;58(5):485-92. PMID: 11343529.","23358","2019"
"davidson2001_IES_B_Baseline_NA","Pharmacotherapy","PTSD","208","B","Control",,,,"Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","108","Self report","IES","IES",,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Baseline",,,"40.0","14.5",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.7788",,"0.2212","Mixed","accidents, rape/sexual assault, combat-related, natural or manmade disasters, community/school violence, other (""seeing someone hurt or die"", ""other event"")","Medium","Davidson JR, Rothbaum BO, van der Kolk BA, et al. Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder. Arch Gen Psychiatry. 2001 May;58(5):485-92. PMID: 11343529.","23358","2019"
"davidson2003_DTS_A_0_ITT","Pharmacotherapy","PTSD","29","A","PTSD",,,,"Mirtazapine","Mirtazapine","No","Not Applicable","Yes","Antidepressant: Other","No","Not Applicable","No","No","No","No","No","Individual","In Person","17","Self report","DTS","DTS","ITT",,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","End of Treatment","0",,"54.1","40.0",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1",,"65.00% of 8-week completers",,"Mixed","child sexual abuse, community/school violence, combat-related, accidents, other (non-specified)","Medium","Davidson JR, Weisler RH, Butterfield MI, et al. Mirtazapine vs. placebo in posttraumatic stress disorder: a pilot trial. Biol Psychiatry. 2003 Jan 15;53(2):188-91. PMID: 12547477.","25290","2019"
"davidson2003_DTS_A_Baseline_ITT","Pharmacotherapy","PTSD","29","A","PTSD",,,,"Mirtazapine","Mirtazapine","No","Not Applicable","Yes","Antidepressant: Other","No","Not Applicable","No","No","No","No","No","Individual","In Person","17","Self report","DTS","DTS","ITT",,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Baseline",,,"74.8","36.5",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1",,"65.00% of 8-week completers",,"Mixed","child sexual abuse, community/school violence, combat-related, accidents, other (non-specified)","Medium","Davidson JR, Weisler RH, Butterfield MI, et al. Mirtazapine vs. placebo in posttraumatic stress disorder: a pilot trial. Biol Psychiatry. 2003 Jan 15;53(2):188-91. PMID: 12547477.","25290","2019"
"davidson2003_DTS_B_0_ITT","Pharmacotherapy","PTSD","29","B","Control",,,,"Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","9","Self report","DTS","DTS","ITT",,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","End of Treatment","0",,"82.6","27.7",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1",,"65.00% of 8-week completers",,"Mixed","child sexual abuse, community/school violence, combat-related, accidents, other (non-specified)","Medium","Davidson JR, Weisler RH, Butterfield MI, et al. Mirtazapine vs. placebo in posttraumatic stress disorder: a pilot trial. Biol Psychiatry. 2003 Jan 15;53(2):188-91. PMID: 12547477.","25290","2019"
"davidson2003_DTS_B_Baseline_ITT","Pharmacotherapy","PTSD","29","B","Control",,,,"Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","9","Self report","DTS","DTS","ITT",,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Baseline",,,"93.8","29.4",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1",,"65.00% of 8-week completers",,"Mixed","child sexual abuse, community/school violence, combat-related, accidents, other (non-specified)","Medium","Davidson JR, Weisler RH, Butterfield MI, et al. Mirtazapine vs. placebo in posttraumatic stress disorder: a pilot trial. Biol Psychiatry. 2003 Jan 15;53(2):188-91. PMID: 12547477.","25290","2019"
"davidson2003_SI-PTSD_A_0_Comp","Pharmacotherapy","PTSD","29","A","PTSD",,"14",,"Mirtazapine","Mirtazapine","No","Not Applicable","Yes","Antidepressant: Other","No","Not Applicable","No","No","No","No","No","Individual","In Person","17","Structured Clinical Interview","SI-PTSD","SI-PTSD","Completer",,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","End of Treatment","0",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"SPRINT Global item rated 1 or 2 (""very much improved"" or ""much improved"")","0.7857",,"Community",,,"1",,"65.00% of 8-week completers",,"Mixed","child sexual abuse, community/school violence, combat-related, accidents, other (non-specified)","Medium","Davidson JR, Weisler RH, Butterfield MI, et al. Mirtazapine vs. placebo in posttraumatic stress disorder: a pilot trial. Biol Psychiatry. 2003 Jan 15;53(2):188-91. PMID: 12547477.","25290","2019"
"davidson2003_SI-PTSD_A_0_ITT","Pharmacotherapy","PTSD","29","A","PTSD",,"17",,"Mirtazapine","Mirtazapine","No","Not Applicable","Yes","Antidepressant: Other","No","Not Applicable","No","No","No","No","No","Individual","In Person","17","Structured Clinical Interview","SI-PTSD","SI-PTSD","ITT","LOCF","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","End of Treatment","0",,"17.4","4.0",,,,,"-17.3",,,,,,,,,,,,,,,,,,,,,"SPRINT Global item rated 1 or 2 (""very much improved"" or ""much improved"")","0.6471",,"Community",,,"1",,"65.00% of 8-week completers",,"Mixed","child sexual abuse, community/school violence, combat-related, accidents, other (non-specified)","Medium","Davidson JR, Weisler RH, Butterfield MI, et al. Mirtazapine vs. placebo in posttraumatic stress disorder: a pilot trial. Biol Psychiatry. 2003 Jan 15;53(2):188-91. PMID: 12547477.","25290","2019"
"davidson2003_SI-PTSD_A_Baseline_Comp","Pharmacotherapy","PTSD","29","A","PTSD",,"14",,"Mirtazapine","Mirtazapine","No","Not Applicable","Yes","Antidepressant: Other","No","Not Applicable","No","No","No","No","No","Individual","In Person","17","Structured Clinical Interview","SI-PTSD","SI-PTSD","Completer",,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Baseline",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"SPRINT Global item rated 1 or 2 (""very much improved"" or ""much improved"")",,,"Community",,,"1",,"65.00% of 8-week completers",,"Mixed","child sexual abuse, community/school violence, combat-related, accidents, other (non-specified)","Medium","Davidson JR, Weisler RH, Butterfield MI, et al. Mirtazapine vs. placebo in posttraumatic stress disorder: a pilot trial. Biol Psychiatry. 2003 Jan 15;53(2):188-91. PMID: 12547477.","25290","2019"
"davidson2003_SI-PTSD_A_Baseline_ITT","Pharmacotherapy","PTSD","29","A","PTSD",,"17",,"Mirtazapine","Mirtazapine","No","Not Applicable","Yes","Antidepressant: Other","No","Not Applicable","No","No","No","No","No","Individual","In Person","17","Structured Clinical Interview","SI-PTSD","SI-PTSD","ITT","LOCF","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Baseline",,,"34.7","7.0",,,,,,,,,,,,,,,,,,,,,,,,,,"SPRINT Global item rated 1 or 2 (""very much improved"" or ""much improved"")",,,"Community",,,"1",,"65.00% of 8-week completers",,"Mixed","child sexual abuse, community/school violence, combat-related, accidents, other (non-specified)","Medium","Davidson JR, Weisler RH, Butterfield MI, et al. Mirtazapine vs. placebo in posttraumatic stress disorder: a pilot trial. Biol Psychiatry. 2003 Jan 15;53(2):188-91. PMID: 12547477.","25290","2019"
"davidson2003_SI-PTSD_B_0_Comp","Pharmacotherapy","PTSD","29","B","Control",,"6",,"Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","9","Structured Clinical Interview","SI-PTSD","SI-PTSD","Completer",,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","End of Treatment","0",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"SPRINT Global item rated 1 or 2 (""very much improved"" or ""much improved"")","0.1667",,"Community",,,"1",,"65.00% of 8-week completers",,"Mixed","child sexual abuse, community/school violence, combat-related, accidents, other (non-specified)","Medium","Davidson JR, Weisler RH, Butterfield MI, et al. Mirtazapine vs. placebo in posttraumatic stress disorder: a pilot trial. Biol Psychiatry. 2003 Jan 15;53(2):188-91. PMID: 12547477.","25290","2019"
"davidson2003_SI-PTSD_B_0_ITT","Pharmacotherapy","PTSD","29","B","Control",,"9",,"Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","9","Structured Clinical Interview","SI-PTSD","SI-PTSD","ITT","LOCF","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","End of Treatment","0",,"32.9","12.7",,,,,"-5.5",,,,,,,,,,,,,,,,,,,,,"SPRINT Global item rated 1 or 2 (""very much improved"" or ""much improved"")","0.2222",,"Community",,,"1",,"65.00% of 8-week completers",,"Mixed","child sexual abuse, community/school violence, combat-related, accidents, other (non-specified)","Medium","Davidson JR, Weisler RH, Butterfield MI, et al. Mirtazapine vs. placebo in posttraumatic stress disorder: a pilot trial. Biol Psychiatry. 2003 Jan 15;53(2):188-91. PMID: 12547477.","25290","2019"
"davidson2003_SI-PTSD_B_Baseline_Comp","Pharmacotherapy","PTSD","29","B","Control",,"6",,"Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","9","Structured Clinical Interview","SI-PTSD","SI-PTSD","Completer",,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Baseline",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"SPRINT Global item rated 1 or 2 (""very much improved"" or ""much improved"")",,,"Community",,,"1",,"65.00% of 8-week completers",,"Mixed","child sexual abuse, community/school violence, combat-related, accidents, other (non-specified)","Medium","Davidson JR, Weisler RH, Butterfield MI, et al. Mirtazapine vs. placebo in posttraumatic stress disorder: a pilot trial. Biol Psychiatry. 2003 Jan 15;53(2):188-91. PMID: 12547477.","25290","2019"
"davidson2003_SI-PTSD_B_Baseline_ITT","Pharmacotherapy","PTSD","29","B","Control",,"9",,"Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","9","Structured Clinical Interview","SI-PTSD","SI-PTSD","ITT",,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Baseline",,,"38.4","6.7",,,,,,,,,,,,,,,,,,,,,,,,,,"SPRINT Global item rated 1 or 2 (""very much improved"" or ""much improved"")",,,"Community",,,"1",,"65.00% of 8-week completers",,"Mixed","child sexual abuse, community/school violence, combat-related, accidents, other (non-specified)","Medium","Davidson JR, Weisler RH, Butterfield MI, et al. Mirtazapine vs. placebo in posttraumatic stress disorder: a pilot trial. Biol Psychiatry. 2003 Jan 15;53(2):188-91. PMID: 12547477.","25290","2019"
"davidson2003_SPRINT_A_0_ITT","Pharmacotherapy","PTSD","29","A","PTSD",,,,"Mirtazapine","Mirtazapine","No","Not Applicable","Yes","Antidepressant: Other","No","Not Applicable","No","No","No","No","No","Individual","In Person","17","Self report","SPRINT","SPRINT","ITT",,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","End of Treatment","0",,"12.4","8.8",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1",,"65.00% of 8-week completers",,"Mixed","child sexual abuse, community/school violence, combat-related, accidents, other (non-specified)","Medium","Davidson JR, Weisler RH, Butterfield MI, et al. Mirtazapine vs. placebo in posttraumatic stress disorder: a pilot trial. Biol Psychiatry. 2003 Jan 15;53(2):188-91. PMID: 12547477.","25290","2019"
"davidson2003_SPRINT_A_Baseline_ITT","Pharmacotherapy","PTSD","29","A","PTSD",,,,"Mirtazapine","Mirtazapine","No","Not Applicable","Yes","Antidepressant: Other","No","Not Applicable","No","No","No","No","No","Individual","In Person","17","Self report","SPRINT","SPRINT","ITT",,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Baseline",,,"21.7","6.0",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1",,"65.00% of 8-week completers",,"Mixed","child sexual abuse, community/school violence, combat-related, accidents, other (non-specified)","Medium","Davidson JR, Weisler RH, Butterfield MI, et al. Mirtazapine vs. placebo in posttraumatic stress disorder: a pilot trial. Biol Psychiatry. 2003 Jan 15;53(2):188-91. PMID: 12547477.","25290","2019"
"davidson2003_SPRINT_B_0_ITT","Pharmacotherapy","PTSD","29","B","Control",,,,"Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","9","Self report","SPRINT","SPRINT","ITT",,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","End of Treatment","0",,"19.4","8.2",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1",,"65.00% of 8-week completers",,"Mixed","child sexual abuse, community/school violence, combat-related, accidents, other (non-specified)","Medium","Davidson JR, Weisler RH, Butterfield MI, et al. Mirtazapine vs. placebo in posttraumatic stress disorder: a pilot trial. Biol Psychiatry. 2003 Jan 15;53(2):188-91. PMID: 12547477.","25290","2019"
"davidson2003_SPRINT_B_Baseline_ITT","Pharmacotherapy","PTSD","29","B","Control",,,,"Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","9","Self report","SPRINT","SPRINT","ITT",,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Baseline",,,"25.0","4.2",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1",,"65.00% of 8-week completers",,"Mixed","child sexual abuse, community/school violence, combat-related, accidents, other (non-specified)","Medium","Davidson JR, Weisler RH, Butterfield MI, et al. Mirtazapine vs. placebo in posttraumatic stress disorder: a pilot trial. Biol Psychiatry. 2003 Jan 15;53(2):188-91. PMID: 12547477.","25290","2019"
"davidson2006a_CAPS_A_0_Comp","Pharmacotherapy","PTSD","329","A","PTSD",,"112",,"Venlafaxine extended release","Venlafaxine","No","Not Applicable","Yes","Antidepressant: SNRI","No","Not Applicable","No","No","No","No","No","Individual","In Person","161","Structured Clinical Interview","CAPS","CAPS-SX17","Completer",,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","End of Treatment","0",,,,,,,,"-59.2","23.76",,,,,,,,,,,,,,,,,,,,"CAPS-SX17 score ≤20","0.447",,"Community",,,"1","0.541",,"0.459","Mixed","combat-related, child sexual abuse, rape/sexual assault, accidents, natural or manmade disasters, other (nonsexual abuse, witnessing unexpected death)","Medium","Davidson JRT, Baldwin DV, Stein DJ, et al. Treatment of posttraumatic stress disorder with venlafaxine extended release: a 6-month randomized controlled trial. Arch Gen Psychiatry. 2006 Oct;63(10):1158-65. doi: 10.1001/archpsyc.63.10.1158. PMID: 17015818.","28838","2019"
"davidson2006a_CAPS_A_0_ITT","Pharmacotherapy","PTSD","329","A","PTSD",,"161",,"Venlafaxine extended release","Venlafaxine","No","Not Applicable","Yes","Antidepressant: SNRI","No","Not Applicable","No","No","No","No","No","Individual","In Person","161","Structured Clinical Interview","CAPS","CAPS-SX17","ITT","LOCF","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","End of Treatment","0",,"29.2","26.09",,,,,"-51.7","27.16",,,,,,,,,,,,,,,,,,,,"CAPS-SX17 score ≤20","0.509",,"Community",,,"1","0.541",,"0.459","Mixed","combat-related, child sexual abuse, rape/sexual assault, accidents, natural or manmade disasters, other (nonsexual abuse, witnessing unexpected death)","Medium","Davidson JRT, Baldwin DV, Stein DJ, et al. Treatment of posttraumatic stress disorder with venlafaxine extended release: a 6-month randomized controlled trial. Arch Gen Psychiatry. 2006 Oct;63(10):1158-65. doi: 10.1001/archpsyc.63.10.1158. PMID: 17015818.","28838","2019"
"davidson2006a_CAPS_A_Baseline_Comp","Pharmacotherapy","PTSD","329","A","PTSD",,"112",,"Venlafaxine extended release","Venlafaxine","No","Not Applicable","Yes","Antidepressant: SNRI","No","Not Applicable","No","No","No","No","No","Individual","In Person","161","Structured Clinical Interview","CAPS","CAPS-SX17","Completer",,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Baseline",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"CAPS-SX17 score ≤20",,,"Community",,,"1","0.541",,"0.459","Mixed","combat-related, child sexual abuse, rape/sexual assault, accidents, natural or manmade disasters, other (nonsexual abuse, witnessing unexpected death)","Medium","Davidson JRT, Baldwin DV, Stein DJ, et al. Treatment of posttraumatic stress disorder with venlafaxine extended release: a 6-month randomized controlled trial. Arch Gen Psychiatry. 2006 Oct;63(10):1158-65. doi: 10.1001/archpsyc.63.10.1158. PMID: 17015818.","28838","2019"
"davidson2006a_CAPS_A_Baseline_ITT","Pharmacotherapy","PTSD","329","A","PTSD",,"161",,"Venlafaxine extended release","Venlafaxine","No","Not Applicable","Yes","Antidepressant: SNRI","No","Not Applicable","No","No","No","No","No","Individual","In Person","161","Structured Clinical Interview","CAPS","CAPS-SX17","ITT","LOCF","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Baseline",,,"81.0","14.62",,,,,,,,,,,,,,,,,,,,,,,,,,"CAPS-SX17 score ≤20",,,"Community",,,"1","0.541",,"0.459","Mixed","combat-related, child sexual abuse, rape/sexual assault, accidents, natural or manmade disasters, other (nonsexual abuse, witnessing unexpected death)","Medium","Davidson JRT, Baldwin DV, Stein DJ, et al. Treatment of posttraumatic stress disorder with venlafaxine extended release: a 6-month randomized controlled trial. Arch Gen Psychiatry. 2006 Oct;63(10):1158-65. doi: 10.1001/archpsyc.63.10.1158. PMID: 17015818.","28838","2019"
"davidson2006a_CAPS_B_0_Comp","Pharmacotherapy","PTSD","329","B","Control",,"112",,"Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","168","Structured Clinical Interview","CAPS","CAPS-SX17","Completer",,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","End of Treatment","0",,,,,,,,"-54.0","23.63",,,,,,,,,,,,,,,,,,,,"CAPS-SX17 score ≤20","0.333",,"Community",,,"1","0.541",,"0.459","Mixed","combat-related, child sexual abuse, rape/sexual assault, accidents, natural or manmade disasters, other (nonsexual abuse, witnessing unexpected death)","Medium","Davidson JRT, Baldwin DV, Stein DJ, et al. Treatment of posttraumatic stress disorder with venlafaxine extended release: a 6-month randomized controlled trial. Arch Gen Psychiatry. 2006 Oct;63(10):1158-65. doi: 10.1001/archpsyc.63.10.1158. PMID: 17015818.","28838","2019"
"davidson2006a_CAPS_B_0_ITT","Pharmacotherapy","PTSD","329","B","Control",,"168",,"Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","168","Structured Clinical Interview","CAPS","CAPS-SX17","ITT","LOCF","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","End of Treatment","0",,"38.1","29.11",,,,,"-43.9","28.93",,,,,,,,,,,,,,,,,,,,"CAPS-SX17 score ≤20","0.375",,"Community",,,"1","0.541",,"0.459","Mixed","combat-related, child sexual abuse, rape/sexual assault, accidents, natural or manmade disasters, other (nonsexual abuse, witnessing unexpected death)","Medium","Davidson JRT, Baldwin DV, Stein DJ, et al. Treatment of posttraumatic stress disorder with venlafaxine extended release: a 6-month randomized controlled trial. Arch Gen Psychiatry. 2006 Oct;63(10):1158-65. doi: 10.1001/archpsyc.63.10.1158. PMID: 17015818.","28838","2019"
"davidson2006a_CAPS_B_Baseline_Comp","Pharmacotherapy","PTSD","329","B","Control",,"112",,"Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","168","Structured Clinical Interview","CAPS","CAPS-SX17","Completer",,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Baseline",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"CAPS-SX17 score ≤20",,,"Community",,,"1","0.541",,"0.459","Mixed","combat-related, child sexual abuse, rape/sexual assault, accidents, natural or manmade disasters, other (nonsexual abuse, witnessing unexpected death)","Medium","Davidson JRT, Baldwin DV, Stein DJ, et al. Treatment of posttraumatic stress disorder with venlafaxine extended release: a 6-month randomized controlled trial. Arch Gen Psychiatry. 2006 Oct;63(10):1158-65. doi: 10.1001/archpsyc.63.10.1158. PMID: 17015818.","28838","2019"
"davidson2006a_CAPS_B_Baseline_ITT","Pharmacotherapy","PTSD","329","B","Control",,"168",,"Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","168","Structured Clinical Interview","CAPS","CAPS-SX17","ITT","LOCF","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Baseline",,,"82.9","15.50",,,,,,,,,,,,,,,,,,,,,,,,,,"CAPS-SX17 score ≤20",,,"Community",,,"1","0.541",,"0.459","Mixed","combat-related, child sexual abuse, rape/sexual assault, accidents, natural or manmade disasters, other (nonsexual abuse, witnessing unexpected death)","Medium","Davidson JRT, Baldwin DV, Stein DJ, et al. Treatment of posttraumatic stress disorder with venlafaxine extended release: a 6-month randomized controlled trial. Arch Gen Psychiatry. 2006 Oct;63(10):1158-65. doi: 10.1001/archpsyc.63.10.1158. PMID: 17015818.","28838","2019"
"davidson2006b_CAPS_A_0_ITT","Pharmacotherapy","PTSD","538","A","PTSD",,"179",,"Venlafaxine extended release","Venlafaxine","No","Not Applicable","Yes","Antidepressant: SNRI","No","Not Applicable","No","No","No","No","No","Individual","In Person","179","Structured Clinical Interview","CAPS","CAPS-SX17","ITT","LOCF","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","End of Treatment","0",,"42.49",,,,,,"-41.51",,"-45.66","-37.36",,,,,,,,,,,,,,,,,,"CAPS-SX17 score ≤20",,,"Community",,,"1",,,,"Mixed","combat-related, child sexual abuse, rape/sexual assault, accidents, community/school violence, other (""unexpected death"")","Medium","Davidson JRT, Rothbaum BO, Tucker PM, et al. Venlafaxine extended release in posttraumatic stress disorder: a sertraline- and placebo-controlled study. J Clin Psychopharmacol. 2006 Jun 1;26(3):259-67. doi: 10.1097/01.jcp.0000222514.71390.c1. PMID: 16702890.","28788","2019"
"davidson2006b_CAPS_A_Baseline_ITT","Pharmacotherapy","PTSD","538","A","PTSD",,"179",,"Venlafaxine extended release","Venlafaxine","No","Not Applicable","Yes","Antidepressant: SNRI","No","Not Applicable","No","No","No","No","No","Individual","In Person","179","Structured Clinical Interview","CAPS","CAPS-SX17","ITT","LOCF","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Baseline",,,"84.0","14.97",,,,,,,,,,,,,,,,,,,,,,,,,,"CAPS-SX17 score ≤20",,,"Community",,,"1",,,,"Mixed","combat-related, child sexual abuse, rape/sexual assault, accidents, community/school violence, other (""unexpected death"")","Medium","Davidson JRT, Rothbaum BO, Tucker PM, et al. Venlafaxine extended release in posttraumatic stress disorder: a sertraline- and placebo-controlled study. J Clin Psychopharmacol. 2006 Jun 1;26(3):259-67. doi: 10.1097/01.jcp.0000222514.71390.c1. PMID: 16702890.","28788","2019"
"davidson2006b_CAPS_B_0_ITT","Pharmacotherapy","PTSD","538","B","PTSD",,"173",,"Sertraline","Sertraline","No","Not Applicable","Yes","Antidepressant: SSRI","No","Not Applicable","No","No","No","No","No","Individual","In Person","173","Structured Clinical Interview","CAPS","CAPS-SX17","ITT","LOCF","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","End of Treatment","0",,"42.56",,,,,,"-39.44",,"-43.67","-35.21",,,,,,,,,,,,,,,,,,"CAPS-SX17 score ≤20",,,"Community",,,"1",,,,"Mixed","combat-related, child sexual abuse, rape/sexual assault, accidents, community/school violence, other (""unexpected death"")","Medium","Davidson JRT, Rothbaum BO, Tucker PM, et al. Venlafaxine extended release in posttraumatic stress disorder: a sertraline- and placebo-controlled study. J Clin Psychopharmacol. 2006 Jun 1;26(3):259-67. doi: 10.1097/01.jcp.0000222514.71390.c1. PMID: 16702890.","28788","2019"
"davidson2006b_CAPS_B_Baseline_ITT","Pharmacotherapy","PTSD","538","B","PTSD",,"173",,"Sertraline","Sertraline","No","Not Applicable","Yes","Antidepressant: SSRI","No","Not Applicable","No","No","No","No","No","Individual","In Person","173","Structured Clinical Interview","CAPS","CAPS-SX17","ITT","LOCF","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Baseline",,,"82.0","15.49",,,,,,,,,,,,,,,,,,,,,,,,,,"CAPS-SX17 score ≤20",,,"Community",,,"1",,,,"Mixed","combat-related, child sexual abuse, rape/sexual assault, accidents, community/school violence, other (""unexpected death"")","Medium","Davidson JRT, Rothbaum BO, Tucker PM, et al. Venlafaxine extended release in posttraumatic stress disorder: a sertraline- and placebo-controlled study. J Clin Psychopharmacol. 2006 Jun 1;26(3):259-67. doi: 10.1097/01.jcp.0000222514.71390.c1. PMID: 16702890.","28788","2019"
"davidson2006b_CAPS_C_0_ITT","Pharmacotherapy","PTSD","538","C","Control",,"179",,"Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","179","Structured Clinical Interview","CAPS","CAPS-SX17","ITT","LOCF","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","End of Treatment","0",,"47.43",,,,,,"-34.17",,"-38.33","-30.01",,,,,,,,,,,,,,,,,,"CAPS-SX17 score ≤20",,,"Community",,,"1",,,,"Mixed","combat-related, child sexual abuse, rape/sexual assault, accidents, community/school violence, other (""unexpected death"")","Medium","Davidson JRT, Rothbaum BO, Tucker PM, et al. Venlafaxine extended release in posttraumatic stress disorder: a sertraline- and placebo-controlled study. J Clin Psychopharmacol. 2006 Jun 1;26(3):259-67. doi: 10.1097/01.jcp.0000222514.71390.c1. PMID: 16702890.","28788","2019"
"davidson2006b_CAPS_C_Baseline_ITT","Pharmacotherapy","PTSD","538","C","Control",,"179",,"Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","179","Structured Clinical Interview","CAPS","CAPS-SX17","ITT","LOCF","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Baseline",,,"81.6","14.66",,,,,,,,,,,,,,,,,,,,,,,,,,"CAPS-SX17 score ≤20",,,"Community",,,"1",,,,"Mixed","combat-related, child sexual abuse, rape/sexual assault, accidents, community/school violence, other (""unexpected death"")","Medium","Davidson JRT, Rothbaum BO, Tucker PM, et al. Venlafaxine extended release in posttraumatic stress disorder: a sertraline- and placebo-controlled study. J Clin Psychopharmacol. 2006 Jun 1;26(3):259-67. doi: 10.1097/01.jcp.0000222514.71390.c1. PMID: 16702890.","28788","2019"
"davidson2007_CAPS_A_0_Comp","Pharmacotherapy","PTSD","232","A","PTSD",,"105",,"Tiagabine","Tiagabine","No","Not Applicable","Yes","Mood Stabilizer","No","Not Applicable","No","No","No","No","No","Individual","In Person","116","Structured Clinical Interview","CAPS","CAPS","Completer",,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","End of Treatment","0",,"51.7",,,,,,"-30.7","25.1",,,,,,,,,,,,,,,,,,,,"CAPS total score <20","0.16","Additional definitions of Clinically Meaningful Response reported in the study","Community",,,"1","0.66",,"0.34","Mixed","rape/sexual assault, community/school violence, accidents, combat-related, natural or manmade disasters, other (non-specified)","Medium","Davidson JR, Brady K, Mellman TA, et al. The efficacy and tolerability of tiagabine in adult patients with post-traumatic stress disorder. J Clin Psychopharmacol. 2007 Feb;27(1):85-8. doi: 10.1097/JCP.0b013e31802e5115. PMID: 17224720.","29658","2019"
"davidson2007_CAPS_A_Baseline_Comp","Pharmacotherapy","PTSD","232","A","PTSD",,"116",,"Tiagabine","Tiagabine","No","Not Applicable","Yes","Mood Stabilizer","No","Not Applicable","No","No","No","No","No","Individual","In Person","116","Structured Clinical Interview","CAPS","CAPS","Completer",,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Baseline",,,"82.4","15.8",,,,,,,,,,,,,,,,,,,,,,,,,,"CAPS total score <20",,"Additional definitions of Clinically Meaningful Response reported in the study","Community",,,"1","0.66",,"0.34","Mixed","rape/sexual assault, community/school violence, accidents, combat-related, natural or manmade disasters, other (non-specified)","Medium","Davidson JR, Brady K, Mellman TA, et al. The efficacy and tolerability of tiagabine in adult patients with post-traumatic stress disorder. J Clin Psychopharmacol. 2007 Feb;27(1):85-8. doi: 10.1097/JCP.0b013e31802e5115. PMID: 17224720.","29658","2019"
"davidson2007_CAPS_B_0_Comp","Pharmacotherapy","PTSD","232","B","Control",,"97",,"Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","116","Structured Clinical Interview","CAPS","CAPS","Completer",,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","End of Treatment","0",,"52.5",,,,,,"-30.2","26.3",,,,,,,,,,,,,,,,,,,,"CAPS total score <20","0.14","Additional definitions of Clinically Meaningful Response reported in the study","Community",,,"1","0.66",,"0.34","Mixed","rape/sexual assault, community/school violence, accidents, combat-related, natural or manmade disasters, other (non-specified)","Medium","Davidson JR, Brady K, Mellman TA, et al. The efficacy and tolerability of tiagabine in adult patients with post-traumatic stress disorder. J Clin Psychopharmacol. 2007 Feb;27(1):85-8. doi: 10.1097/JCP.0b013e31802e5115. PMID: 17224720.","29658","2019"
"davidson2007_CAPS_B_Baseline_Comp","Pharmacotherapy","PTSD","232","B","Control",,"116",,"Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","116","Structured Clinical Interview","CAPS","CAPS","Completer",,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Baseline",,,"82.7","14.4",,,,,,,,,,,,,,,,,,,,,,,,,,"CAPS total score <20",,"Additional definitions of Clinically Meaningful Response reported in the study","Community",,,"1","0.66",,"0.34","Mixed","rape/sexual assault, community/school violence, accidents, combat-related, natural or manmade disasters, other (non-specified)","Medium","Davidson JR, Brady K, Mellman TA, et al. The efficacy and tolerability of tiagabine in adult patients with post-traumatic stress disorder. J Clin Psychopharmacol. 2007 Feb;27(1):85-8. doi: 10.1097/JCP.0b013e31802e5115. PMID: 17224720.","29658","2019"
"davis2004_CAPS_A_0_ITT","Pharmacotherapy","PTSD","42","A","PTSD",,"26",,"Nefazodone","Nefazodone","No","Not Applicable","Yes","Antidepressant: Other","No","Not Applicable","No","No","No","No","No","Individual","In Person","27","Structured Clinical Interview","CAPS","CAPS","ITT","LOCF","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","End of Treatment","0",,"61.9",,,,,,"-19.1","24",,,,,,,,,,,,,,,,,,,,"≥30% improvement in CAPS Total Score for patients who completed at least 4 weeks of treatment","0.4737",,"Mixed","0","0.9762","0.0238","0.0238",,"0.9762","Mixed","combat-related, rape/sexual assault","High","Davis LL, Jewell ME, Ambrose S, et al. A placebo-controlled study of nefazodone for the treatment of chronic posttraumatic stress disorder: a preliminary study. J Clin Psychopharmacol. 2004;24(3):291-7.  PMID: 15118483.","26401","2019"
"davis2004_CAPS_A_Baseline_ITT","Pharmacotherapy","PTSD","42","A","PTSD",,"26",,"Nefazodone","Nefazodone","No","Not Applicable","Yes","Antidepressant: Other","No","Not Applicable","No","No","No","No","No","Individual","In Person","27","Structured Clinical Interview","CAPS","CAPS","ITT","LOCF","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Baseline",,,"81.0","20",,,,,,,,,,,,,,,,,,,,,,,,,,"≥30% improvement in CAPS Total Score for patients who completed at least 4 weeks of treatment",,,"Mixed","0","0.9762","0.0238","0.0238",,"0.9762","Mixed","combat-related, rape/sexual assault","High","Davis LL, Jewell ME, Ambrose S, et al. A placebo-controlled study of nefazodone for the treatment of chronic posttraumatic stress disorder: a preliminary study. J Clin Psychopharmacol. 2004;24(3):291-7.  PMID: 15118483.","26401","2019"
"davis2004_CAPS_B_0_ITT","Pharmacotherapy","PTSD","42","B","Control",,"15",,"Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","15","Structured Clinical Interview","CAPS","CAPS","ITT","LOCF","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","End of Treatment","0",,"69.7",,,,,,"-13.5","25",,,,,,,,,,,,,,,,,,,,"≥30% improvement in CAPS Total Score for patients who completed at least 4 weeks of treatment","0.4166",,"Mixed","0","0.9762","0.0238","0.0238",,"0.9762","Mixed","combat-related, rape/sexual assault","High","Davis LL, Jewell ME, Ambrose S, et al. A placebo-controlled study of nefazodone for the treatment of chronic posttraumatic stress disorder: a preliminary study. J Clin Psychopharmacol. 2004;24(3):291-7.  PMID: 15118483.","26401","2019"
"davis2004_CAPS_B_Baseline_ITT","Pharmacotherapy","PTSD","42","B","Control",,"15",,"Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","15","Structured Clinical Interview","CAPS","CAPS","ITT","LOCF","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Baseline",,,"83.2","17",,,,,,,,,,,,,,,,,,,,,,,,,,"≥30% improvement in CAPS Total Score for patients who completed at least 4 weeks of treatment",,,"Mixed","0","0.9762","0.0238","0.0238",,"0.9762","Mixed","combat-related, rape/sexual assault","High","Davis LL, Jewell ME, Ambrose S, et al. A placebo-controlled study of nefazodone for the treatment of chronic posttraumatic stress disorder: a preliminary study. J Clin Psychopharmacol. 2004;24(3):291-7.  PMID: 15118483.","26401","2019"
"davis2004_PCL_A_0_NA","Pharmacotherapy","PTSD","42","A","PTSD",,,,"Nefazodone","Nefazodone","No","Not Applicable","Yes","Antidepressant: Other","No","Not Applicable","No","No","No","No","No","Individual","In Person","27","Self report","PCL","PCL",,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","End of Treatment","0",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Mixed","0","0.9762","0.0238","0.0238",,"0.9762","Mixed","combat-related, rape/sexual assault","High","Davis LL, Jewell ME, Ambrose S, et al. A placebo-controlled study of nefazodone for the treatment of chronic posttraumatic stress disorder: a preliminary study. J Clin Psychopharmacol. 2004;24(3):291-7.  PMID: 15118483.","26401","2019"
"davis2004_PCL_A_Baseline_NA","Pharmacotherapy","PTSD","42","A","PTSD",,,,"Nefazodone","Nefazodone","No","Not Applicable","Yes","Antidepressant: Other","No","Not Applicable","No","No","No","No","No","Individual","In Person","27","Self report","PCL","PCL",,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Baseline",,,"64.1","11",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Mixed","0","0.9762","0.0238","0.0238",,"0.9762","Mixed","combat-related, rape/sexual assault","High","Davis LL, Jewell ME, Ambrose S, et al. A placebo-controlled study of nefazodone for the treatment of chronic posttraumatic stress disorder: a preliminary study. J Clin Psychopharmacol. 2004;24(3):291-7.  PMID: 15118483.","26401","2019"
"davis2004_PCL_B_0_NA","Pharmacotherapy","PTSD","42","B","Control",,,,"Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","15","Self report","PCL","PCL",,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","End of Treatment","0",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Mixed","0","0.9762","0.0238","0.0238",,"0.9762","Mixed","combat-related, rape/sexual assault","High","Davis LL, Jewell ME, Ambrose S, et al. A placebo-controlled study of nefazodone for the treatment of chronic posttraumatic stress disorder: a preliminary study. J Clin Psychopharmacol. 2004;24(3):291-7.  PMID: 15118483.","26401","2019"
"davis2004_PCL_B_Baseline_NA","Pharmacotherapy","PTSD","42","B","Control",,,,"Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","15","Self report","PCL","PCL",,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Baseline",,,"61.5","10",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Mixed","0","0.9762","0.0238","0.0238",,"0.9762","Mixed","combat-related, rape/sexual assault","High","Davis LL, Jewell ME, Ambrose S, et al. A placebo-controlled study of nefazodone for the treatment of chronic posttraumatic stress disorder: a preliminary study. J Clin Psychopharmacol. 2004;24(3):291-7.  PMID: 15118483.","26401","2019"
"davis2008a_CAPS_A_0_ITT","Pharmacotherapy","PTSD","36","A","PTSD",,"18",,"Guanfacine","Guanfacine","No","Not Applicable","Yes","Antiadrenergic","No","Not Applicable","No","No","No","No","No","Individual","In Person","18","Structured Clinical Interview","CAPS","CAPS","ITT","LOCF","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","End of Treatment","0",,"66.94","29.87",,,,,"-15.12",,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0.0571",,"0.9429","Combat-related",,"Medium","Davis LL, Ward C, Rasmusson A, et al. A placebo-controlled trial of guanfacine for the treatment of posttraumatic stress disorder in veterans. Psychopharmacol Bull. 2008;41(1):8-18.  PMID: 18362867.","34102","2019"
"davis2008a_CAPS_A_Baseline_ITT","Pharmacotherapy","PTSD","36","A","PTSD",,"18",,"Guanfacine","Guanfacine","No","Not Applicable","Yes","Antiadrenergic","No","Not Applicable","No","No","No","No","No","Individual","In Person","18","Structured Clinical Interview","CAPS","CAPS","ITT","LOCF","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Baseline",,,"82.06","16.81",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0.0571",,"0.9429","Combat-related",,"Medium","Davis LL, Ward C, Rasmusson A, et al. A placebo-controlled trial of guanfacine for the treatment of posttraumatic stress disorder in veterans. Psychopharmacol Bull. 2008;41(1):8-18.  PMID: 18362867.","34102","2019"
"davis2008a_CAPS_B_0_ITT","Pharmacotherapy","PTSD","36","B","Control",,"17",,"Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","18","Structured Clinical Interview","CAPS","CAPS","ITT","LOCF","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","End of Treatment","0",,"74.82","29.26",,,,,"-13.59",,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0.0571",,"0.9429","Combat-related",,"Medium","Davis LL, Ward C, Rasmusson A, et al. A placebo-controlled trial of guanfacine for the treatment of posttraumatic stress disorder in veterans. Psychopharmacol Bull. 2008;41(1):8-18.  PMID: 18362867.","34102","2019"
"davis2008a_CAPS_B_Baseline_ITT","Pharmacotherapy","PTSD","36","B","Control",,"17",,"Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","18","Structured Clinical Interview","CAPS","CAPS","ITT","LOCF","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Baseline",,,"88.41","17.87",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0.0571",,"0.9429","Combat-related",,"Medium","Davis LL, Ward C, Rasmusson A, et al. A placebo-controlled trial of guanfacine for the treatment of posttraumatic stress disorder in veterans. Psychopharmacol Bull. 2008;41(1):8-18.  PMID: 18362867.","34102","2019"
"davis2008a_DTS_A_0_NA","Pharmacotherapy","PTSD","36","A","PTSD",,,,"Guanfacine","Guanfacine","No","Not Applicable","Yes","Antiadrenergic","No","Not Applicable","No","No","No","No","No","Individual","In Person","18","Self report","DTS","DTS",,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","End of Treatment","0",,"75.11","32.51",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0.0571",,"0.9429","Combat-related",,"Medium","Davis LL, Ward C, Rasmusson A, et al. A placebo-controlled trial of guanfacine for the treatment of posttraumatic stress disorder in veterans. Psychopharmacol Bull. 2008;41(1):8-18.  PMID: 18362867.","34102","2019"
"davis2008a_DTS_A_Baseline_NA","Pharmacotherapy","PTSD","36","A","PTSD",,,,"Guanfacine","Guanfacine","No","Not Applicable","Yes","Antiadrenergic","No","Not Applicable","No","No","No","No","No","Individual","In Person","18","Self report","DTS","DTS",,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Baseline",,,"92.33","22.50",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0.0571",,"0.9429","Combat-related",,"Medium","Davis LL, Ward C, Rasmusson A, et al. A placebo-controlled trial of guanfacine for the treatment of posttraumatic stress disorder in veterans. Psychopharmacol Bull. 2008;41(1):8-18.  PMID: 18362867.","34102","2019"
"davis2008a_DTS_B_0_NA","Pharmacotherapy","PTSD","36","B","Control",,,,"Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","18","Self report","DTS","DTS",,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","End of Treatment","0",,"82.59","31.04",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0.0571",,"0.9429","Combat-related",,"Medium","Davis LL, Ward C, Rasmusson A, et al. A placebo-controlled trial of guanfacine for the treatment of posttraumatic stress disorder in veterans. Psychopharmacol Bull. 2008;41(1):8-18.  PMID: 18362867.","34102","2019"
"davis2008a_DTS_B_Baseline_NA","Pharmacotherapy","PTSD","36","B","Control",,,,"Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","18","Self report","DTS","DTS",,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Baseline",,,"100.77","24.74",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0.0571",,"0.9429","Combat-related",,"Medium","Davis LL, Ward C, Rasmusson A, et al. A placebo-controlled trial of guanfacine for the treatment of posttraumatic stress disorder in veterans. Psychopharmacol Bull. 2008;41(1):8-18.  PMID: 18362867.","34102","2019"
"davis2008b_CAPS_A_0_Comp","Pharmacotherapy","PTSD","85","A","PTSD",,"34",,"Divalproex","Divalproex","No","Not Applicable","Yes","Mood Stabilizer","No","Not Applicable","No","No","No","No","No","Individual","In Person","44","Structured Clinical Interview","CAPS","CAPS","Completer",,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","End of Treatment","0",,,,,,,,,,,,,,,,,,,,,,,,,,,,,">30% PTSD scores",,"Additional definitions of Clinically Meaningful Response reported in the study","Veteran","0","1","0","0.0244",,"0.9756","Mixed","combat-related, other (non-specified)","Low","Davis LL, Davidson JR, Ward LC, et al. Divalproex in the treatment of posttraumatic stress disorder: a randomized, double-blind, placebo-controlled trial in a veteran population. J Clin Psychopharmacol. 2008 Feb;28(1):84-8. doi: 10.1097/JCP.0b013e318160f83b. PMID: 18204347","30463","2019"
"davis2008b_CAPS_A_0_ITT","Pharmacotherapy","PTSD","85","A","PTSD",,"41",,"Divalproex","Divalproex","No","Not Applicable","Yes","Mood Stabilizer","No","Not Applicable","No","No","No","No","No","Individual","In Person","44","Structured Clinical Interview","CAPS","CAPS","ITT","LOCF","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","End of Treatment","0",,"60.1","24.1",,,,,"-15.1",,,,,,,,,,,,,,,,,,,,,">30% PTSD scores",,"Additional definitions of Clinically Meaningful Response reported in the study","Veteran","0","1","0","0.0244",,"0.9756","Mixed","combat-related, other (non-specified)","Low","Davis LL, Davidson JR, Ward LC, et al. Divalproex in the treatment of posttraumatic stress disorder: a randomized, double-blind, placebo-controlled trial in a veteran population. J Clin Psychopharmacol. 2008 Feb;28(1):84-8. doi: 10.1097/JCP.0b013e318160f83b. PMID: 18204347","30463","2019"
"davis2008b_CAPS_A_Baseline_Comp","Pharmacotherapy","PTSD","85","A","PTSD",,"34",,"Divalproex","Divalproex","No","Not Applicable","Yes","Mood Stabilizer","No","Not Applicable","No","No","No","No","No","Individual","In Person","44","Structured Clinical Interview","CAPS","CAPS","Completer",,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Baseline",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,">30% PTSD scores",,"Additional definitions of Clinically Meaningful Response reported in the study","Veteran","0","1","0","0.0244",,"0.9756","Mixed","combat-related, other (non-specified)","Low","Davis LL, Davidson JR, Ward LC, et al. Divalproex in the treatment of posttraumatic stress disorder: a randomized, double-blind, placebo-controlled trial in a veteran population. J Clin Psychopharmacol. 2008 Feb;28(1):84-8. doi: 10.1097/JCP.0b013e318160f83b. PMID: 18204347","30463","2019"
"davis2008b_CAPS_A_Baseline_ITT","Pharmacotherapy","PTSD","85","A","PTSD",,"41",,"Divalproex","Divalproex","No","Not Applicable","Yes","Mood Stabilizer","No","Not Applicable","No","No","No","No","No","Individual","In Person","44","Structured Clinical Interview","CAPS","CAPS","ITT","LOCF","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Baseline",,,"75.2","19.1",,,,,,,,,,,,,,,,,,,,,,,,,,">30% PTSD scores",,"Additional definitions of Clinically Meaningful Response reported in the study","Veteran","0","1","0","0.0244",,"0.9756","Mixed","combat-related, other (non-specified)","Low","Davis LL, Davidson JR, Ward LC, et al. Divalproex in the treatment of posttraumatic stress disorder: a randomized, double-blind, placebo-controlled trial in a veteran population. J Clin Psychopharmacol. 2008 Feb;28(1):84-8. doi: 10.1097/JCP.0b013e318160f83b. PMID: 18204347","30463","2019"
"davis2008b_CAPS_B_0_Comp","Pharmacotherapy","PTSD","85","B","Control",,"34",,"Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","44","Structured Clinical Interview","CAPS","CAPS","Completer",,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","End of Treatment","0",,,,,,,,,,,,,,,,,,,,,,,,,,,,,">30% PTSD scores",,"Additional definitions of Clinically Meaningful Response reported in the study","Veteran","0","1","0","0.0244",,"0.9756","Mixed","combat-related, other (non-specified)","Low","Davis LL, Davidson JR, Ward LC, et al. Divalproex in the treatment of posttraumatic stress disorder: a randomized, double-blind, placebo-controlled trial in a veteran population. J Clin Psychopharmacol. 2008 Feb;28(1):84-8. doi: 10.1097/JCP.0b013e318160f83b. PMID: 18204347","30463","2019"
"davis2008b_CAPS_B_0_ITT","Pharmacotherapy","PTSD","85","B","Control",,"41",,"Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","44","Structured Clinical Interview","CAPS","CAPS","ITT","LOCF","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","End of Treatment","0",,"60.8","26.6",,,,,"-16.5",,,,,,,,,,,,,,,,,,,,,">30% PTSD scores",,"Additional definitions of Clinically Meaningful Response reported in the study","Veteran","0","1","0","0.0244",,"0.9756","Mixed","combat-related, other (non-specified)","Low","Davis LL, Davidson JR, Ward LC, et al. Divalproex in the treatment of posttraumatic stress disorder: a randomized, double-blind, placebo-controlled trial in a veteran population. J Clin Psychopharmacol. 2008 Feb;28(1):84-8. doi: 10.1097/JCP.0b013e318160f83b. PMID: 18204347","30463","2019"
"davis2008b_CAPS_B_Baseline_Comp","Pharmacotherapy","PTSD","85","B","Control",,"34",,"Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","44","Structured Clinical Interview","CAPS","CAPS","Completer",,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Baseline",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,">30% PTSD scores",,"Additional definitions of Clinically Meaningful Response reported in the study","Veteran","0","1","0","0.0244",,"0.9756","Mixed","combat-related, other (non-specified)","Low","Davis LL, Davidson JR, Ward LC, et al. Divalproex in the treatment of posttraumatic stress disorder: a randomized, double-blind, placebo-controlled trial in a veteran population. J Clin Psychopharmacol. 2008 Feb;28(1):84-8. doi: 10.1097/JCP.0b013e318160f83b. PMID: 18204347","30463","2019"
"davis2008b_CAPS_B_Baseline_ITT","Pharmacotherapy","PTSD","85","B","Control",,"41",,"Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","44","Structured Clinical Interview","CAPS","CAPS","ITT","LOCF","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Baseline",,,"77.3","15.3",,,,,,,,,,,,,,,,,,,,,,,,,,">30% PTSD scores",,"Additional definitions of Clinically Meaningful Response reported in the study","Veteran","0","1","0","0.0244",,"0.9756","Mixed","combat-related, other (non-specified)","Low","Davis LL, Davidson JR, Ward LC, et al. Divalproex in the treatment of posttraumatic stress disorder: a randomized, double-blind, placebo-controlled trial in a veteran population. J Clin Psychopharmacol. 2008 Feb;28(1):84-8. doi: 10.1097/JCP.0b013e318160f83b. PMID: 18204347","30463","2019"
"davis2008b_TOP-8_A_0_ITT","Pharmacotherapy","PTSD","85","A","PTSD",,,,"Divalproex","Divalproex","No","Not Applicable","Yes","Mood Stabilizer","No","Not Applicable","No","No","No","No","No","Individual","In Person","44","Self report","TOP-8","TOP-8","ITT",,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","End of Treatment","0",,"15.4","6.6",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0.0244",,"0.9756","Mixed","combat-related, other (non-specified)","Low","Davis LL, Davidson JR, Ward LC, et al. Divalproex in the treatment of posttraumatic stress disorder: a randomized, double-blind, placebo-controlled trial in a veteran population. J Clin Psychopharmacol. 2008 Feb;28(1):84-8. doi: 10.1097/JCP.0b013e318160f83b. PMID: 18204347","30463","2019"
"davis2008b_TOP-8_A_Baseline_ITT","Pharmacotherapy","PTSD","85","A","PTSD",,,,"Divalproex","Divalproex","No","Not Applicable","Yes","Mood Stabilizer","No","Not Applicable","No","No","No","No","No","Individual","In Person","44","Self report","TOP-8","TOP-8","ITT",,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Baseline",,,"19.4","5.3",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0.0244",,"0.9756","Mixed","combat-related, other (non-specified)","Low","Davis LL, Davidson JR, Ward LC, et al. Divalproex in the treatment of posttraumatic stress disorder: a randomized, double-blind, placebo-controlled trial in a veteran population. J Clin Psychopharmacol. 2008 Feb;28(1):84-8. doi: 10.1097/JCP.0b013e318160f83b. PMID: 18204347","30463","2019"
"davis2008b_TOP-8_B_0_ITT","Pharmacotherapy","PTSD","85","B","Control",,,,"Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","44","Self report","TOP-8","TOP-8","ITT",,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","End of Treatment","0",,"15.8","6.5",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0.0244",,"0.9756","Mixed","combat-related, other (non-specified)","Low","Davis LL, Davidson JR, Ward LC, et al. Divalproex in the treatment of posttraumatic stress disorder: a randomized, double-blind, placebo-controlled trial in a veteran population. J Clin Psychopharmacol. 2008 Feb;28(1):84-8. doi: 10.1097/JCP.0b013e318160f83b. PMID: 18204347","30463","2019"
"davis2008b_TOP-8_B_Baseline_ITT","Pharmacotherapy","PTSD","85","B","Control",,,,"Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","44","Self report","TOP-8","TOP-8","ITT",,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests","Baseline",,,"19.7","4.3",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0.0244",,"0.9756","Mixed","combat-related, other (non-specified)","Low","Davis LL, Davidson JR, Ward LC, et al. Divalproex in the treatment of posttraumatic stress disorder: a randomized, double-blind, placebo-controlled trial in a veteran population. J Clin Psychopharmacol. 2008 Feb;28(1):84-8. doi: 10.1097/JCP.0b013e318160f83b. PMID: 18204347","30463","2019"
"davis2018b_CAPS_A_0_mI","Pharmacotherapy","PTSD","214","A","PTSD",,"65",,"MBSR","Mindfulness-based stress reduction (MBSR)","No","Not Applicable","No","Not Applicable","Yes","Meditation","No","No","No","No","No","Group","In person","107","Structured Clinical Interview","CAPS","CAPS-IV","Modified ITT (patients attending ≥1 therapy sessions)",,"Mixed-effects linear regression analysis used. Each model included up to four repeated assessments of CAPS-IV as the dependent variable (baseline and weeks 3, 6, and 9). Likelihood ratio tests examined treatment by time interaction.","End of Treatment","0",,"59.1","27.1",,,,,"-25.2",,,,,,,,,,,,,,,,,,"CAPS-IV ≤45 (""remission"")","0.307",,"≥30% reduction in CAPS-IV score","0.452",,"Veteran","0","1","0","0.162",,"0.838","Mixed","Combat-related; Rape/sexual assault; Other (noncombat military, civilian)","Low","Davis LL, Whetsell C, Hamner MB, et al. A multisite randomized controlled trial of mindfulness-based stress reduction in the treatment of posttraumatic stress disorder. Psychiatric Research and Clinical Practice. 2018b Nov 5;1(2):39-48. doi: 10.1176/appi.prcp.20180002..","51046","2020"
"davis2018b_CAPS_A_8_mI","Pharmacotherapy","PTSD","214","A","PTSD",,"61",,"MBSR","Mindfulness-based stress reduction (MBSR)","No","Not Applicable","No","Not Applicable","Yes","Meditation","No","No","No","No","No","Group","In person","107","Structured Clinical Interview","CAPS","CAPS-IV","Modified ITT (patients attending ≥1 therapy sessions)",,"Mixed-effects linear regression analysis used. Each model included up to four repeated assessments of CAPS-IV as the dependent variable (baseline and weeks 3, 6, and 9). Likelihood ratio tests examined treatment by time interaction.","Assessment at <3 Months","8",,"64.8","30.8",,,,,"-19.5",,,,,,,,,,,,,,,,,,"CAPS-IV ≤45 (""remission"")",,,"≥30% reduction in CAPS-IV score",,,"Veteran","0","1","0","0.162",,"0.838","Mixed","Combat-related; Rape/sexual assault; Other (noncombat military, civilian)","Low","Davis LL, Whetsell C, Hamner MB, et al. A multisite randomized controlled trial of mindfulness-based stress reduction in the treatment of posttraumatic stress disorder. Psychiatric Research and Clinical Practice. 2018b Nov 5;1(2):39-48. doi: 10.1176/appi.prcp.20180002..","51046","2020"
"davis2018b_CAPS_A_Baseline_mI","Pharmacotherapy","PTSD","214","A","PTSD",,"96",,"MBSR","Mindfulness-based stress reduction (MBSR)","No","Not Applicable","No","Not Applicable","Yes","Meditation","No","No","No","No","No","Group","In person","107","Structured Clinical Interview","CAPS","CAPS-IV","Modified ITT (patients attending ≥1 therapy sessions)",,"Mixed-effects linear regression analysis used. Each model included up to four repeated assessments of CAPS-IV as the dependent variable (baseline and weeks 3, 6, and 9). Likelihood ratio tests examined treatment by time interaction.","Baseline",,,"84.3","19.5",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0.162",,"0.838","Mixed","Combat-related; Rape/sexual assault; Other (noncombat military, civilian)","Low","Davis LL, Whetsell C, Hamner MB, et al. A multisite randomized controlled trial of mindfulness-based stress reduction in the treatment of posttraumatic stress disorder. Psychiatric Research and Clinical Practice. 2018b Nov 5;1(2):39-48. doi: 10.1176/appi.prcp.20180002..","51046","2020"
"davis2018b_CAPS_B_0_mI","Pharmacotherapy","PTSD","214","B","Control",,"77",,"Present-centered group therapy","Present Centered Therapy (PCT)","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Group","In person","107","Structured Clinical Interview","CAPS","CAPS-IV","Modified ITT (patients attending ≥1 therapy sessions)",,"Mixed-effects linear regression analysis used. Each model included up to four repeated assessments of CAPS-IV as the dependent variable (baseline and weeks 3, 6, and 9). Likelihood ratio tests examined treatment by time interaction.","End of Treatment","0",,"64.5","28.2",,,,,"-16.2",,,,,,,,,,,,,,,,,,"CAPS-IV ≤45 (""remission"")","0.273",,"≥30% reduction in CAPS-IV score","0.377",,"Veteran","0","1","0","0.162",,"0.838","Mixed","Combat-related; Rape/sexual assault; Other (noncombat military, civilian)","Low","Davis LL, Whetsell C, Hamner MB, et al. A multisite randomized controlled trial of mindfulness-based stress reduction in the treatment of posttraumatic stress disorder. Psychiatric Research and Clinical Practice. 2018b Nov 5;1(2):39-48. doi: 10.1176/appi.prcp.20180002..","51046","2020"
"davis2018b_CAPS_B_8_mI","Pharmacotherapy","PTSD","214","B","Control",,"69",,"Present-centered group therapy","Present Centered Therapy (PCT)","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Group","In person","107","Structured Clinical Interview","CAPS","CAPS-IV","Modified ITT (patients attending ≥1 therapy sessions)",,"Mixed-effects linear regression analysis used. Each model included up to four repeated assessments of CAPS-IV as the dependent variable (baseline and weeks 3, 6, and 9). Likelihood ratio tests examined treatment by time interaction.","Assessment at <3 Months","8",,"62.9","28.3",,,,,"-17.8",,,,,,,,,,,,,,,,,,"CAPS-IV ≤45 (""remission"")",,,"≥30% reduction in CAPS-IV score",,,"Veteran","0","1","0","0.162",,"0.838","Mixed","Combat-related; Rape/sexual assault; Other (noncombat military, civilian)","Low","Davis LL, Whetsell C, Hamner MB, et al. A multisite randomized controlled trial of mindfulness-based stress reduction in the treatment of posttraumatic stress disorder. Psychiatric Research and Clinical Practice. 2018b Nov 5;1(2):39-48. doi: 10.1176/appi.prcp.20180002..","51046","2020"
"davis2018b_CAPS_B_Baseline_mI","Pharmacotherapy","PTSD","214","B","Control",,"95",,"Present-centered group therapy","Present Centered Therapy (PCT)","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Group","In person","107","Structured Clinical Interview","CAPS","CAPS-IV","Modified ITT (patients attending ≥1 therapy sessions)",,"Mixed-effects linear regression analysis used. Each model included up to four repeated assessments of CAPS-IV as the dependent variable (baseline and weeks 3, 6, and 9). Likelihood ratio tests examined treatment by time interaction.","Baseline",,,"80.7","16.7",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0.162",,"0.838","Mixed","Combat-related; Rape/sexual assault; Other (noncombat military, civilian)","Low","Davis LL, Whetsell C, Hamner MB, et al. A multisite randomized controlled trial of mindfulness-based stress reduction in the treatment of posttraumatic stress disorder. Psychiatric Research and Clinical Practice. 2018b Nov 5;1(2):39-48. doi: 10.1176/appi.prcp.20180002..","51046","2020"
"davis2018b_PCL_A_0_mI","Pharmacotherapy","PTSD","214","A","PTSD",,,,"MBSR","Mindfulness-based stress reduction (MBSR)","No","Not Applicable","No","Not Applicable","Yes","Meditation","No","No","No","No","No","Group","In person","107","Self report","PCL","PCL","Modified ITT (patients attending ≥1 therapy sessions)",,"Mixed-effects linear regression analysis used. Each model included up to four repeated assessments of CAPS-IV as the dependent variable (baseline and weeks 3, 6, and 9). Likelihood ratio tests examined treatment by time interaction.","End of Treatment","0",,"53.8","17.4",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0.162",,"0.838","Mixed","Combat-related; Rape/sexual assault; Other (noncombat military, civilian)","Low","Davis LL, Whetsell C, Hamner MB, et al. A multisite randomized controlled trial of mindfulness-based stress reduction in the treatment of posttraumatic stress disorder. Psychiatric Research and Clinical Practice. 2018b Nov 5;1(2):39-48. doi: 10.1176/appi.prcp.20180002..","51046","2020"
"davis2018b_PCL_A_8_mI","Pharmacotherapy","PTSD","214","A","PTSD",,,,"MBSR","Mindfulness-based stress reduction (MBSR)","No","Not Applicable","No","Not Applicable","Yes","Meditation","No","No","No","No","No","Group","In person","107","Self report","PCL","PCL","Modified ITT (patients attending ≥1 therapy sessions)",,"Mixed-effects linear regression analysis used. Each model included up to four repeated assessments of CAPS-IV as the dependent variable (baseline and weeks 3, 6, and 9). Likelihood ratio tests examined treatment by time interaction.","Assessment at <3 Months","8",,"56.2","16.5",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0.162",,"0.838","Mixed","Combat-related; Rape/sexual assault; Other (noncombat military, civilian)","Low","Davis LL, Whetsell C, Hamner MB, et al. A multisite randomized controlled trial of mindfulness-based stress reduction in the treatment of posttraumatic stress disorder. Psychiatric Research and Clinical Practice. 2018b Nov 5;1(2):39-48. doi: 10.1176/appi.prcp.20180002..","51046","2020"
"davis2018b_PCL_A_Baseline_mI","Pharmacotherapy","PTSD","214","A","PTSD",,,,"MBSR","Mindfulness-based stress reduction (MBSR)","No","Not Applicable","No","Not Applicable","Yes","Meditation","No","No","No","No","No","Group","In person","107","Self report","PCL","PCL","Modified ITT (patients attending ≥1 therapy sessions)",,"Mixed-effects linear regression analysis used. Each model included up to four repeated assessments of CAPS-IV as the dependent variable (baseline and weeks 3, 6, and 9). Likelihood ratio tests examined treatment by time interaction.","Baseline",,,"63.1","12.2",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0.162",,"0.838","Mixed","Combat-related; Rape/sexual assault; Other (noncombat military, civilian)","Low","Davis LL, Whetsell C, Hamner MB, et al. A multisite randomized controlled trial of mindfulness-based stress reduction in the treatment of posttraumatic stress disorder. Psychiatric Research and Clinical Practice. 2018b Nov 5;1(2):39-48. doi: 10.1176/appi.prcp.20180002..","51046","2020"
"davis2018b_PCL_B_0_mI","Pharmacotherapy","PTSD","214","B","Control",,,,"Present-centered group therapy","Present Centered Therapy (PCT)","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Group","In person","107","Self report","PCL","PCL","Modified ITT (patients attending ≥1 therapy sessions)",,"Mixed-effects linear regression analysis used. Each model included up to four repeated assessments of CAPS-IV as the dependent variable (baseline and weeks 3, 6, and 9). Likelihood ratio tests examined treatment by time interaction.","End of Treatment","0",,"52.6","14.4",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0.162",,"0.838","Mixed","Combat-related; Rape/sexual assault; Other (noncombat military, civilian)","Low","Davis LL, Whetsell C, Hamner MB, et al. A multisite randomized controlled trial of mindfulness-based stress reduction in the treatment of posttraumatic stress disorder. Psychiatric Research and Clinical Practice. 2018b Nov 5;1(2):39-48. doi: 10.1176/appi.prcp.20180002..","51046","2020"
"davis2018b_PCL_B_8_mI","Pharmacotherapy","PTSD","214","B","Control",,,,"Present-centered group therapy","Present Centered Therapy (PCT)","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Group","In person","107","Self report","PCL","PCL","Modified ITT (patients attending ≥1 therapy sessions)",,"Mixed-effects linear regression analysis used. Each model included up to four repeated assessments of CAPS-IV as the dependent variable (baseline and weeks 3, 6, and 9). Likelihood ratio tests examined treatment by time interaction.","Assessment at <3 Months","8",,"53.8","15.9",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0.162",,"0.838","Mixed","Combat-related; Rape/sexual assault; Other (noncombat military, civilian)","Low","Davis LL, Whetsell C, Hamner MB, et al. A multisite randomized controlled trial of mindfulness-based stress reduction in the treatment of posttraumatic stress disorder. Psychiatric Research and Clinical Practice. 2018b Nov 5;1(2):39-48. doi: 10.1176/appi.prcp.20180002..","51046","2020"
"davis2018b_PCL_B_Baseline_mI","Pharmacotherapy","PTSD","214","B","Control",,,,"Present-centered group therapy","Present Centered Therapy (PCT)","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Group","In person","107","Self report","PCL","PCL","Modified ITT (patients attending ≥1 therapy sessions)",,"Mixed-effects linear regression analysis used. Each model included up to four repeated assessments of CAPS-IV as the dependent variable (baseline and weeks 3, 6, and 9). Likelihood ratio tests examined treatment by time interaction.","Baseline",,,"58.7","12.2",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0.162",,"0.838","Mixed","Combat-related; Rape/sexual assault; Other (noncombat military, civilian)","Low","Davis LL, Whetsell C, Hamner MB, et al. A multisite randomized controlled trial of mindfulness-based stress reduction in the treatment of posttraumatic stress disorder. Psychiatric Research and Clinical Practice. 2018b Nov 5;1(2):39-48. doi: 10.1176/appi.prcp.20180002..","51046","2020"
"davis2020_CAPS_A_0_Comp","Pharmacotherapy","PTSD","212","A","PTSD",,"70",,"Holistic yoga program","Yoga","No","Not Applicable","No","Not Applicable","Yes","Yoga","No","No","No","No","No","Mixed","In person","108","Structured Clinical Interview","CAPS","CAPS-5","Completer",,"Constrained longitudinal data analysis model incorporating the baseline outcome as a dependent variable and assuming a common baseline mean across groups","End of Treatment","0",,"25.8","12.1",,,,,"-11.3",,,,,,,,,,,,,,,,,,"PTSD diagnosis based on CAPS","0.4",,,,,"Mixed",,,"0.086","0.34",,"0.66","Mixed","MST; Combat-related; Rape/sexual assault; Other (childhood, not specified; other adult, not specified)","Medium","Davis LW, Schmid AA, Daggy JK, et al. Symptoms improve after a yoga program designed for PTSD in a randomized controlled trial with veterans and civilians. Psychol Trauma. 2020 Apr 20 doi: https://dx.doi.org/10.1037/tra0000564. PMID: 32309986.",,"2020"
"davis2020_CAPS_A_30.3_Comp","Pharmacotherapy","PTSD","212","A","PTSD",,"67",,"Holistic yoga program","Yoga","No","Not Applicable","No","Not Applicable","Yes","Yoga","No","No","No","No","No","Mixed","In person","108","Structured Clinical Interview","CAPS","CAPS-5","Completer",,"Constrained longitudinal data analysis model incorporating the baseline outcome as a dependent variable and assuming a common baseline mean across groups","Assessment at 6 to <12 Months","30.3",,"27.5","13.2",,,,,"-9.6",,,,,,,,,,,,,,,,,,"PTSD diagnosis based on CAPS","0.403",,,,,"Mixed",,,"0.086","0.34",,"0.66","Mixed","MST; Combat-related; Rape/sexual assault; Other (childhood, not specified; other adult, not specified)","Medium","Davis LW, Schmid AA, Daggy JK, et al. Symptoms improve after a yoga program designed for PTSD in a randomized controlled trial with veterans and civilians. Psychol Trauma. 2020 Apr 20 doi: https://dx.doi.org/10.1037/tra0000564. PMID: 32309986.",,"2020"
"davis2020_CAPS_A_Baseline_Comp","Pharmacotherapy","PTSD","212","A","PTSD",,"108",,"Holistic yoga program","Yoga","No","Not Applicable","No","Not Applicable","Yes","Yoga","No","No","No","No","No","Mixed","In person","108","Structured Clinical Interview","CAPS","CAPS-5","Completer",,"Constrained longitudinal data analysis model incorporating the baseline outcome as a dependent variable and assuming a common baseline mean across groups","Baseline",,,"37.1","8.7",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Mixed",,,"0.086","0.34",,"0.66","Mixed","MST; Combat-related; Rape/sexual assault; Other (childhood, not specified; other adult, not specified)","Medium","Davis LW, Schmid AA, Daggy JK, et al. Symptoms improve after a yoga program designed for PTSD in a randomized controlled trial with veterans and civilians. Psychol Trauma. 2020 Apr 20 doi: https://dx.doi.org/10.1037/tra0000564. PMID: 32309986.",,"2020"
"davis2020_CAPS_B_0_Comp","Pharmacotherapy","PTSD","212","B","Control",,"70",,"Wellness lifestyle program","Wellness lifestyle program","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Mixed","In person","101","Structured Clinical Interview","CAPS","CAPS-5","Completer",,"Constrained longitudinal data analysis model incorporating the baseline outcome as a dependent variable and assuming a common baseline mean across groups","End of Treatment","0",,"31.0","13.0",,,,,"-5.0",,,,,,,,,,,,,,,,,,"PTSD diagnosis based on CAPS","0.314",,,,,"Mixed",,,"0.086","0.34",,"0.66","Mixed","MST; Combat-related; Rape/sexual assault; Other (childhood, not specified; other adult, not specified)","Medium","Davis LW, Schmid AA, Daggy JK, et al. Symptoms improve after a yoga program designed for PTSD in a randomized controlled trial with veterans and civilians. Psychol Trauma. 2020 Apr 20 doi: https://dx.doi.org/10.1037/tra0000564. PMID: 32309986.",,"2020"
"davis2020_CAPS_B_30.3_Comp","Pharmacotherapy","PTSD","212","B","Control",,"65",,"Wellness lifestyle program","Wellness lifestyle program","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Mixed","In person","101","Structured Clinical Interview","CAPS","CAPS-5","Completer",,"Constrained longitudinal data analysis model incorporating the baseline outcome as a dependent variable and assuming a common baseline mean across groups","Assessment at 6 to <12 Months","30.3",,"27.9","12.8",,,,,"-8.1",,,,,,,,,,,,,,,,,,"PTSD diagnosis based on CAPS","0.415",,,,,"Mixed",,,"0.086","0.34",,"0.66","Mixed","MST; Combat-related; Rape/sexual assault; Other (childhood, not specified; other adult, not specified)","Medium","Davis LW, Schmid AA, Daggy JK, et al. Symptoms improve after a yoga program designed for PTSD in a randomized controlled trial with veterans and civilians. Psychol Trauma. 2020 Apr 20 doi: https://dx.doi.org/10.1037/tra0000564. PMID: 32309986.",,"2020"
"davis2020_CAPS_B_Baseline_Comp","Pharmacotherapy","PTSD","212","B","Control",,"101",,"Wellness lifestyle program","Wellness lifestyle program","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Mixed","In person","101","Structured Clinical Interview","CAPS","CAPS-5","Completer",,"Constrained longitudinal data analysis model incorporating the baseline outcome as a dependent variable and assuming a common baseline mean across groups","Baseline",,,"36.0","8.7",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Mixed",,,"0.086","0.34",,"0.66","Mixed","MST; Combat-related; Rape/sexual assault; Other (childhood, not specified; other adult, not specified)","Medium","Davis LW, Schmid AA, Daggy JK, et al. Symptoms improve after a yoga program designed for PTSD in a randomized controlled trial with veterans and civilians. Psychol Trauma. 2020 Apr 20 doi: https://dx.doi.org/10.1037/tra0000564. PMID: 32309986.",,"2020"
"davis2020_PCL_A_0_Comp","Pharmacotherapy","PTSD","212","A","PTSD",,,,"Holistic yoga program","Yoga","No","Not Applicable","No","Not Applicable","Yes","Yoga","No","No","No","No","No","Mixed","In person","108","Self report","PCL","PCL-5","Completer",,"Constrained longitudinal data analysis model incorporating the baseline outcome as a dependent variable and assuming a common baseline mean across groups","End of Treatment","0",,"33.0","17.5",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Mixed",,,"0.086","0.34",,"0.66","Mixed","MST; Combat-related; Rape/sexual assault; Other (childhood, not specified; other adult, not specified)","Medium","Davis LW, Schmid AA, Daggy JK, et al. Symptoms improve after a yoga program designed for PTSD in a randomized controlled trial with veterans and civilians. Psychol Trauma. 2020 Apr 20 doi: https://dx.doi.org/10.1037/tra0000564. PMID: 32309986.",,"2020"
"davis2020_PCL_A_30.3_Comp","Pharmacotherapy","PTSD","212","A","PTSD",,,,"Holistic yoga program","Yoga","No","Not Applicable","No","Not Applicable","Yes","Yoga","No","No","No","No","No","Mixed","In person","108","Self report","PCL","PCL-5","Completer",,"Constrained longitudinal data analysis model incorporating the baseline outcome as a dependent variable and assuming a common baseline mean across groups","Assessment at 6 to <12 Months","30.3",,"37.0","17.7",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Mixed",,,"0.086","0.34",,"0.66","Mixed","MST; Combat-related; Rape/sexual assault; Other (childhood, not specified; other adult, not specified)","Medium","Davis LW, Schmid AA, Daggy JK, et al. Symptoms improve after a yoga program designed for PTSD in a randomized controlled trial with veterans and civilians. Psychol Trauma. 2020 Apr 20 doi: https://dx.doi.org/10.1037/tra0000564. PMID: 32309986.",,"2020"
"davis2020_PCL_A_Baseline_Comp","Pharmacotherapy","PTSD","212","A","PTSD",,,,"Holistic yoga program","Yoga","No","Not Applicable","No","Not Applicable","Yes","Yoga","No","No","No","No","No","Mixed","In person","108","Self report","PCL","PCL-5","Completer",,"Constrained longitudinal data analysis model incorporating the baseline outcome as a dependent variable and assuming a common baseline mean across groups","Baseline",,,"45.2","12.1",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Mixed",,,"0.086","0.34",,"0.66","Mixed","MST; Combat-related; Rape/sexual assault; Other (childhood, not specified; other adult, not specified)","Medium","Davis LW, Schmid AA, Daggy JK, et al. Symptoms improve after a yoga program designed for PTSD in a randomized controlled trial with veterans and civilians. Psychol Trauma. 2020 Apr 20 doi: https://dx.doi.org/10.1037/tra0000564. PMID: 32309986.",,"2020"
"davis2020_PCL_B_0_Comp","Pharmacotherapy","PTSD","212","B","Control",,,,"Wellness lifestyle program","Wellness lifestyle program","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Mixed","In person","101","Self report","PCL","PCL-5","Completer",,"Constrained longitudinal data analysis model incorporating the baseline outcome as a dependent variable and assuming a common baseline mean across groups","End of Treatment","0",,"40.2","15.2",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Mixed",,,"0.086","0.34",,"0.66","Mixed","MST; Combat-related; Rape/sexual assault; Other (childhood, not specified; other adult, not specified)","Medium","Davis LW, Schmid AA, Daggy JK, et al. Symptoms improve after a yoga program designed for PTSD in a randomized controlled trial with veterans and civilians. Psychol Trauma. 2020 Apr 20 doi: https://dx.doi.org/10.1037/tra0000564. PMID: 32309986.",,"2020"
"davis2020_PCL_B_30.3_Comp","Pharmacotherapy","PTSD","212","B","Control",,,,"Wellness lifestyle program","Wellness lifestyle program","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Mixed","In person","101","Self report","PCL","PCL-5","Completer",,"Constrained longitudinal data analysis model incorporating the baseline outcome as a dependent variable and assuming a common baseline mean across groups","Assessment at 6 to <12 Months","30.3",,"37.9","17.4",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Mixed",,,"0.086","0.34",,"0.66","Mixed","MST; Combat-related; Rape/sexual assault; Other (childhood, not specified; other adult, not specified)","Medium","Davis LW, Schmid AA, Daggy JK, et al. Symptoms improve after a yoga program designed for PTSD in a randomized controlled trial with veterans and civilians. Psychol Trauma. 2020 Apr 20 doi: https://dx.doi.org/10.1037/tra0000564. PMID: 32309986.",,"2020"
"davis2020_PCL_B_Baseline_Comp","Pharmacotherapy","PTSD","212","B","Control",,,,"Wellness lifestyle program","Wellness lifestyle program","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Mixed","In person","101","Self report","PCL","PCL-5","Completer",,"Constrained longitudinal data analysis model incorporating the baseline outcome as a dependent variable and assuming a common baseline mean across groups","Baseline",,,"45.1","13.0",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Mixed",,,"0.086","0.34",,"0.66","Mixed","MST; Combat-related; Rape/sexual assault; Other (childhood, not specified; other adult, not specified)","Medium","Davis LW, Schmid AA, Daggy JK, et al. Symptoms improve after a yoga program designed for PTSD in a randomized controlled trial with veterans and civilians. Psychol Trauma. 2020 Apr 20 doi: https://dx.doi.org/10.1037/tra0000564. PMID: 32309986.",,"2020"
"decker2018_PCL_A_0_Comp","Mixed: Psychotherapy & CIH","PTSD","38","A","PTSD",,,,"Art therapy + CPT","Art therapy + Cognitive Processing Therapy (CPT)","Yes","TF","No","Not Applicable","Yes","Creative therapies","No","No","No","No","No","Individual","In person","19","Self report","PCL","PCL-M","Completer",,"ANOVA with repeated measures","End of Treatment","0",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0.0323",,"0.9677","Combat-related",,"High","Decker KP, Deaver SP, Abbey V, et al. Quantitatively improved treatment outcomes for combat-associated PTSD with adjunctive art therapy: randomized controlled trial. Art Therapy. 2018;35(4):184-94. doi: 10.1080/07421656.2018.1540822.",,"2020"
"decker2018_PCL_A_Baseline_Comp","Mixed: Psychotherapy & CIH","PTSD","38","A","PTSD",,"16",,"Art therapy + CPT","Art therapy + Cognitive Processing Therapy (CPT)","Yes","TF","No","Not Applicable","Yes","Creative therapies","No","No","No","No","No","Individual","In person","19","Self report","PCL","PCL-M","Completer",,"ANOVA with repeated measures","Baseline",,,"71.2","7.4",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0.0323",,"0.9677","Combat-related",,"High","Decker KP, Deaver SP, Abbey V, et al. Quantitatively improved treatment outcomes for combat-associated PTSD with adjunctive art therapy: randomized controlled trial. Art Therapy. 2018;35(4):184-94. doi: 10.1080/07421656.2018.1540822.",,"2020"
"decker2018_PCL_B_0_Comp","Mixed: Psychotherapy & CIH","PTSD","38","B","PTSD",,,,"Supportive psychotherapy + CPT","Supportive psychotherapy + Cognitive Processing Therapy (CPT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","19","Self report","PCL","PCL-M","Completer",,"ANOVA with repeated measures","End of Treatment","0",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0.0323",,"0.9677","Combat-related",,"High","Decker KP, Deaver SP, Abbey V, et al. Quantitatively improved treatment outcomes for combat-associated PTSD with adjunctive art therapy: randomized controlled trial. Art Therapy. 2018;35(4):184-94. doi: 10.1080/07421656.2018.1540822.",,"2020"
"decker2018_PCL_B_Baseline_Comp","Mixed: Psychotherapy & CIH","PTSD","38","B","PTSD",,"15",,"Supportive psychotherapy + CPT","Supportive psychotherapy + Cognitive Processing Therapy (CPT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","19","Self report","PCL","PCL-M","Completer",,"ANOVA with repeated measures","Baseline",,,"65.1","8.6",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0.0323",,"0.9677","Combat-related",,"High","Decker KP, Deaver SP, Abbey V, et al. Quantitatively improved treatment outcomes for combat-associated PTSD with adjunctive art therapy: randomized controlled trial. Art Therapy. 2018;35(4):184-94. doi: 10.1080/07421656.2018.1540822.",,"2020"
"dedert2019_CAPS_A_0_ITT","Psychotherapy","PTSD+SUD","40","A","PTSD+SUD","Integrated","11",,"CPT + smoking cessation","Cognitive Processing Therapy (CPT) + smoking cessation","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","15","Structured Clinical Interview","CAPS","CAPS-5","ITT","Imputed and maximum likelihood methods","Mixed random and fixed effect regression models.","End of Treatment","0",,"34.1","13.3",,,,,"-9.82","14.30",,,,"Cohen's d","0.687",,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0.825",,"0.175",,,"High","Dedert EA, Resick PA, Dennis PA, et al. Pilot trial of a combined cognitive processing therapy and smoking cessation treatment. J Addict Med. 2019 Jul/Aug;13(4):322-30. doi: 10.1097/ADM.0000000000000502. PMID: 30664539.",,"2020"
"dedert2019_CAPS_A_26_ITT","Psychotherapy","PTSD+SUD","40","A","PTSD+SUD","Integrated","12",,"CPT + smoking cessation","Cognitive Processing Therapy (CPT) + smoking cessation","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","15","Structured Clinical Interview","CAPS","CAPS-5","ITT","Imputed and maximum likelihood methods","Mixed random and fixed effect regression models.","Assessment at 6 to <12 Months","26",,"36.6","15.3",,,,,"-6.3","11.9",,,,"Cohen's d","0.529",,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0.825",,"0.175",,,"High","Dedert EA, Resick PA, Dennis PA, et al. Pilot trial of a combined cognitive processing therapy and smoking cessation treatment. J Addict Med. 2019 Jul/Aug;13(4):322-30. doi: 10.1097/ADM.0000000000000502. PMID: 30664539.",,"2020"
"dedert2019_CAPS_A_Baseline_ITT","Psychotherapy","PTSD+SUD","40","A","PTSD+SUD","Integrated","15",,"CPT + smoking cessation","Cognitive Processing Therapy (CPT) + smoking cessation","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","15","Structured Clinical Interview","CAPS","CAPS-5","ITT","Imputed and maximum likelihood methods","Mixed random and fixed effect regression models.","Baseline",,,"43.9","8.1",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0.825",,"0.175",,,"High","Dedert EA, Resick PA, Dennis PA, et al. Pilot trial of a combined cognitive processing therapy and smoking cessation treatment. J Addict Med. 2019 Jul/Aug;13(4):322-30. doi: 10.1097/ADM.0000000000000502. PMID: 30664539.",,"2020"
"dedert2019_CAPS_B_0_ITT","Psychotherapy","PTSD+SUD","40","B","SUD","Not integrated","17",,"Present-focused smoking cessation","Smoking cessation","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","25","Structured Clinical Interview","CAPS","CAPS-5","ITT","Imputed and maximum likelihood methods","Mixed random and fixed effect regression models.","End of Treatment","0",,"32.4","20.4",,,,,"-3.82","13.34",,,,"Cohen's d","0.687",,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0.825",,"0.175",,,"High","Dedert EA, Resick PA, Dennis PA, et al. Pilot trial of a combined cognitive processing therapy and smoking cessation treatment. J Addict Med. 2019 Jul/Aug;13(4):322-30. doi: 10.1097/ADM.0000000000000502. PMID: 30664539.",,"2020"
"dedert2019_CAPS_B_26_ITT","Psychotherapy","PTSD+SUD","40","B","SUD","Not integrated","19",,"Present-focused smoking cessation","Smoking cessation","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","25","Structured Clinical Interview","CAPS","CAPS-5","ITT","Imputed and maximum likelihood methods","Mixed random and fixed effect regression models.","Assessment at 6 to <12 Months","26",,"35.1","17.9",,,,,"-1.17","13.98",,,,"Cohen's d","0.084",,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0.825",,"0.175",,,"High","Dedert EA, Resick PA, Dennis PA, et al. Pilot trial of a combined cognitive processing therapy and smoking cessation treatment. J Addict Med. 2019 Jul/Aug;13(4):322-30. doi: 10.1097/ADM.0000000000000502. PMID: 30664539.",,"2020"
"dedert2019_CAPS_B_Baseline_ITT","Psychotherapy","PTSD+SUD","40","B","SUD","Not integrated","25",,"Present-focused smoking cessation","Smoking cessation","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","25","Structured Clinical Interview","CAPS","CAPS-5","ITT","Imputed and maximum likelihood methods","Mixed random and fixed effect regression models.","Baseline",,,"36.2","10.4",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0.825",,"0.175",,,"High","Dedert EA, Resick PA, Dennis PA, et al. Pilot trial of a combined cognitive processing therapy and smoking cessation treatment. J Addict Med. 2019 Jul/Aug;13(4):322-30. doi: 10.1097/ADM.0000000000000502. PMID: 30664539.",,"2020"
"dedert2019_PCL_A_0_ITT","Psychotherapy","PTSD+SUD","40","A","PTSD+SUD","Integrated",,,"CPT + smoking cessation","Cognitive Processing Therapy (CPT) + smoking cessation","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","15","Self report","PCL","PCL-5","ITT","Imputed and maximum likelihood methods","Mixed random and fixed effect regression models.","End of Treatment","0",,"33.0","17.7",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0.825",,"0.175",,,"High","Dedert EA, Resick PA, Dennis PA, et al. Pilot trial of a combined cognitive processing therapy and smoking cessation treatment. J Addict Med. 2019 Jul/Aug;13(4):322-30. doi: 10.1097/ADM.0000000000000502. PMID: 30664539.",,"2020"
"dedert2019_PCL_A_26_ITT","Psychotherapy","PTSD+SUD","40","A","PTSD+SUD","Integrated",,,"CPT + smoking cessation","Cognitive Processing Therapy (CPT) + smoking cessation","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","15","Self report","PCL","PCL-5","ITT","Imputed and maximum likelihood methods","Mixed random and fixed effect regression models.","Assessment at 6 to <12 Months","26",,"42.6","18.3",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0.825",,"0.175",,,"High","Dedert EA, Resick PA, Dennis PA, et al. Pilot trial of a combined cognitive processing therapy and smoking cessation treatment. J Addict Med. 2019 Jul/Aug;13(4):322-30. doi: 10.1097/ADM.0000000000000502. PMID: 30664539.",,"2020"
"dedert2019_PCL_A_Baseline_ITT","Psychotherapy","PTSD+SUD","40","A","PTSD+SUD","Integrated",,,"CPT + smoking cessation","Cognitive Processing Therapy (CPT) + smoking cessation","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","15","Self report","PCL","PCL-5","ITT","Imputed and maximum likelihood methods","Mixed random and fixed effect regression models.","Baseline",,,"55.1","11.8",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0.825",,"0.175",,,"High","Dedert EA, Resick PA, Dennis PA, et al. Pilot trial of a combined cognitive processing therapy and smoking cessation treatment. J Addict Med. 2019 Jul/Aug;13(4):322-30. doi: 10.1097/ADM.0000000000000502. PMID: 30664539.",,"2020"
"dedert2019_PCL_B_0_ITT","Psychotherapy","PTSD+SUD","40","B","SUD","Not integrated",,,"Present-focused smoking cessation","Smoking cessation","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","25","Self report","PCL","PCL-5","ITT","Imputed and maximum likelihood methods","Mixed random and fixed effect regression models.","End of Treatment","0",,"38.5","21.6",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0.825",,"0.175",,,"High","Dedert EA, Resick PA, Dennis PA, et al. Pilot trial of a combined cognitive processing therapy and smoking cessation treatment. J Addict Med. 2019 Jul/Aug;13(4):322-30. doi: 10.1097/ADM.0000000000000502. PMID: 30664539.",,"2020"
"dedert2019_PCL_B_26_ITT","Psychotherapy","PTSD+SUD","40","B","SUD","Not integrated",,,"Present-focused smoking cessation","Smoking cessation","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","25","Self report","PCL","PCL-5","ITT","Imputed and maximum likelihood methods","Mixed random and fixed effect regression models.","Assessment at 6 to <12 Months","26",,"43.5","23.3",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0.825",,"0.175",,,"High","Dedert EA, Resick PA, Dennis PA, et al. Pilot trial of a combined cognitive processing therapy and smoking cessation treatment. J Addict Med. 2019 Jul/Aug;13(4):322-30. doi: 10.1097/ADM.0000000000000502. PMID: 30664539.",,"2020"
"dedert2019_PCL_B_Baseline_ITT","Psychotherapy","PTSD+SUD","40","B","SUD","Not integrated",,,"Present-focused smoking cessation","Smoking cessation","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","25","Self report","PCL","PCL-5","ITT","Imputed and maximum likelihood methods","Mixed random and fixed effect regression models.","Baseline",,,"46.0","16.6",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0.825",,"0.175",,,"High","Dedert EA, Resick PA, Dennis PA, et al. Pilot trial of a combined cognitive processing therapy and smoking cessation treatment. J Addict Med. 2019 Jul/Aug;13(4):322-30. doi: 10.1097/ADM.0000000000000502. PMID: 30664539.",,"2020"
"dekleine2012_CAPS_A_0_Comp","Mixed: Psychotherapy & pharmacotherapy","PTSD","75","A","PTSD",,"24",,"PE + D-cycloserine","Prolonged Exposure (PE) + D-cycloserine","Yes","TF","Yes","Other pharmacotherapy","No","Not Applicable","No","No","No","No","No","Individual","In Person","33","Structured Clinical Interview","CAPS","CAPS-1 (Dutch version)","Completer",,"Mixed random and fixed effect regression models.","End of Treatment","0",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"≥10 points decrease in CAPS-1 score","0.875","Additional definitions of Clinically Meaningful Response reported in the study","Community",,,"1","0.806",,"0.194","Mixed","combat-related, rape/sexual assault, accidents, other (violent nonsexual assault; ""miscellaneous"")","Medium","de Kleine RA, Hendriks GJ, Kusters WJ, et al. A randomized placebo-controlled trial of D-cycloserine to enhance exposure therapy for posttraumatic stress disorder. Biol Psychiatry. 2012 Jun 1;71(11):962-8. doi: 10.1016/j.biopsych.2012.02.033. PMID: 22480663.","38434","2019"
"dekleine2012_CAPS_A_0_ITT","Mixed: Psychotherapy & pharmacotherapy","PTSD","75","A","PTSD",,"24",,"PE + D-cycloserine","Prolonged Exposure (PE) + D-cycloserine","Yes","TF","Yes","Other pharmacotherapy","No","Not Applicable","No","No","No","No","No","Individual","In Person","33","Structured Clinical Interview","CAPS","CAPS-1 (Dutch version)","ITT","LOCF for dichotomous outcomes, mixed models for continuous outcomes","Mixed random and fixed effect regression models.","End of Treatment","0",,"34.33",,"SE","6.46",,,"-27.42",,,,,,,,,,,,,,,,,,,,,"≥10 points decrease in CAPS-1 score","0.6364","Additional definitions of Clinically Meaningful Response reported in the study","Community",,,"1","0.806",,"0.194","Mixed","combat-related, rape/sexual assault, accidents, other (violent nonsexual assault; ""miscellaneous"")","Medium","de Kleine RA, Hendriks GJ, Kusters WJ, et al. A randomized placebo-controlled trial of D-cycloserine to enhance exposure therapy for posttraumatic stress disorder. Biol Psychiatry. 2012 Jun 1;71(11):962-8. doi: 10.1016/j.biopsych.2012.02.033. PMID: 22480663.","38434","2019"
"dekleine2012_CAPS_A_12_Comp","Mixed: Psychotherapy & pharmacotherapy","PTSD","75","A","PTSD",,,,"PE + D-cycloserine","Prolonged Exposure (PE) + D-cycloserine","Yes","TF","Yes","Other pharmacotherapy","No","Not Applicable","No","No","No","No","No","Individual","In Person","33","Structured Clinical Interview","CAPS","CAPS-1 (Dutch version)","Completer",,"Mixed random and fixed effect regression models.","Assessment at 3 to <6 Months","12",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"≥10 points decrease in CAPS-1 score","0.9583","Additional definitions of Clinically Meaningful Response reported in the study","Community",,,"1","0.806",,"0.194","Mixed","combat-related, rape/sexual assault, accidents, other (violent nonsexual assault; ""miscellaneous"")","Medium","de Kleine RA, Hendriks GJ, Kusters WJ, et al. A randomized placebo-controlled trial of D-cycloserine to enhance exposure therapy for posttraumatic stress disorder. Biol Psychiatry. 2012 Jun 1;71(11):962-8. doi: 10.1016/j.biopsych.2012.02.033. PMID: 22480663.","38434","2019"
"dekleine2012_CAPS_A_12_ITT","Mixed: Psychotherapy & pharmacotherapy","PTSD","75","A","PTSD",,,,"PE + D-cycloserine","Prolonged Exposure (PE) + D-cycloserine","Yes","TF","Yes","Other pharmacotherapy","No","Not Applicable","No","No","No","No","No","Individual","In Person","33","Structured Clinical Interview","CAPS","CAPS-1 (Dutch version)","ITT","LOCF for dichotomous outcomes, mixed models for continuous outcomes","Mixed random and fixed effect regression models.","Assessment at 3 to <6 Months","12",,"30.28",,"SE","6.26",,,"-31.47",,,,,,,,,,,,,,,,,,,,,"≥10 points decrease in CAPS-1 score","0.697","Additional definitions of Clinically Meaningful Response reported in the study","Community",,,"1","0.806",,"0.194","Mixed","combat-related, rape/sexual assault, accidents, other (violent nonsexual assault; ""miscellaneous"")","Medium","de Kleine RA, Hendriks GJ, Kusters WJ, et al. A randomized placebo-controlled trial of D-cycloserine to enhance exposure therapy for posttraumatic stress disorder. Biol Psychiatry. 2012 Jun 1;71(11):962-8. doi: 10.1016/j.biopsych.2012.02.033. PMID: 22480663.","38434","2019"
"dekleine2012_CAPS_A_Baseline_Comp","Mixed: Psychotherapy & pharmacotherapy","PTSD","75","A","PTSD",,"24",,"PE + D-cycloserine","Prolonged Exposure (PE) + D-cycloserine","Yes","TF","Yes","Other pharmacotherapy","No","Not Applicable","No","No","No","No","No","Individual","In Person","33","Structured Clinical Interview","CAPS","CAPS-1 (Dutch version)","Completer",,"Mixed random and fixed effect regression models.","Baseline",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"≥10 points decrease in CAPS-1 score",,"Additional definitions of Clinically Meaningful Response reported in the study","Community",,,"1","0.806",,"0.194","Mixed","combat-related, rape/sexual assault, accidents, other (violent nonsexual assault; ""miscellaneous"")","Medium","de Kleine RA, Hendriks GJ, Kusters WJ, et al. A randomized placebo-controlled trial of D-cycloserine to enhance exposure therapy for posttraumatic stress disorder. Biol Psychiatry. 2012 Jun 1;71(11):962-8. doi: 10.1016/j.biopsych.2012.02.033. PMID: 22480663.","38434","2019"
"dekleine2012_CAPS_A_Baseline_ITT","Mixed: Psychotherapy & pharmacotherapy","PTSD","75","A","PTSD",,"33",,"PE + D-cycloserine","Prolonged Exposure (PE) + D-cycloserine","Yes","TF","Yes","Other pharmacotherapy","No","Not Applicable","No","No","No","No","No","Individual","In Person","33","Structured Clinical Interview","CAPS","CAPS-1 (Dutch version)","ITT","LOCF for dichotomous outcomes, mixed models for continuous outcomes","Mixed random and fixed effect regression models.","Baseline",,,"61.75",,"SE","2.92",,,,,,,,,,,,,,,,,,,,,,,,"≥10 points decrease in CAPS-1 score",,"Additional definitions of Clinically Meaningful Response reported in the study","Community",,,"1","0.806",,"0.194","Mixed","combat-related, rape/sexual assault, accidents, other (violent nonsexual assault; ""miscellaneous"")","Medium","de Kleine RA, Hendriks GJ, Kusters WJ, et al. A randomized placebo-controlled trial of D-cycloserine to enhance exposure therapy for posttraumatic stress disorder. Biol Psychiatry. 2012 Jun 1;71(11):962-8. doi: 10.1016/j.biopsych.2012.02.033. PMID: 22480663.","38434","2019"
"dekleine2012_CAPS_B_0_Comp","Mixed: Psychotherapy & pharmacotherapy","PTSD","75","B","PTSD",,"21",,"PE + placebo","Prolonged Exposure (PE) + placebo","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","34","Structured Clinical Interview","CAPS","CAPS-1 (Dutch version)","Completer",,"Mixed random and fixed effect regression models.","End of Treatment","0",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"≥10 points decrease in CAPS-1 score","0.619","Additional definitions of Clinically Meaningful Response reported in the study","Community",,,"1","0.806",,"0.194","Mixed","combat-related, rape/sexual assault, accidents, other (violent nonsexual assault; ""miscellaneous"")","Medium","de Kleine RA, Hendriks GJ, Kusters WJ, et al. A randomized placebo-controlled trial of D-cycloserine to enhance exposure therapy for posttraumatic stress disorder. Biol Psychiatry. 2012 Jun 1;71(11):962-8. doi: 10.1016/j.biopsych.2012.02.033. PMID: 22480663.","38434","2019"
"dekleine2012_CAPS_B_0_ITT","Mixed: Psychotherapy & pharmacotherapy","PTSD","75","B","PTSD",,"21",,"PE + placebo","Prolonged Exposure (PE) + placebo","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","34","Structured Clinical Interview","CAPS","CAPS-1 (Dutch version)","ITT","LOCF for dichotomous outcomes, mixed models for continuous outcomes","Mixed random and fixed effect regression models.","End of Treatment","0",,"53.65","6.55","SE","6.55",,,"-20.17",,,,,,,,,,,,,,,,,,,,,"≥10 points decrease in CAPS-1 score","0.3824","Additional definitions of Clinically Meaningful Response reported in the study","Community",,,"1","0.806",,"0.194","Mixed","combat-related, rape/sexual assault, accidents, other (violent nonsexual assault; ""miscellaneous"")","Medium","de Kleine RA, Hendriks GJ, Kusters WJ, et al. A randomized placebo-controlled trial of D-cycloserine to enhance exposure therapy for posttraumatic stress disorder. Biol Psychiatry. 2012 Jun 1;71(11):962-8. doi: 10.1016/j.biopsych.2012.02.033. PMID: 22480663.","38434","2019"
"dekleine2012_CAPS_B_12_Comp","Mixed: Psychotherapy & pharmacotherapy","PTSD","75","B","PTSD",,,,"PE + placebo","Prolonged Exposure (PE) + placebo","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","34","Structured Clinical Interview","CAPS","CAPS-1 (Dutch version)","Completer",,"Mixed random and fixed effect regression models.","Assessment at 3 to <6 Months","12",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"≥10 points decrease in CAPS-1 score","0.7143","Additional definitions of Clinically Meaningful Response reported in the study","Community",,,"1","0.806",,"0.194","Mixed","combat-related, rape/sexual assault, accidents, other (violent nonsexual assault; ""miscellaneous"")","Medium","de Kleine RA, Hendriks GJ, Kusters WJ, et al. A randomized placebo-controlled trial of D-cycloserine to enhance exposure therapy for posttraumatic stress disorder. Biol Psychiatry. 2012 Jun 1;71(11):962-8. doi: 10.1016/j.biopsych.2012.02.033. PMID: 22480663.","38434","2019"
"dekleine2012_CAPS_B_12_ITT","Mixed: Psychotherapy & pharmacotherapy","PTSD","75","B","PTSD",,,,"PE + placebo","Prolonged Exposure (PE) + placebo","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","34","Structured Clinical Interview","CAPS","CAPS-1 (Dutch version)","ITT","LOCF for dichotomous outcomes, mixed models for continuous outcomes","Mixed random and fixed effect regression models.","Assessment at 3 to <6 Months","12",,"43.52",,"SE","6.22",,,"-30.30",,,,,,,,,,,,,,,,,,,,,"≥10 points decrease in CAPS-1 score","0.50","Additional definitions of Clinically Meaningful Response reported in the study","Community",,,"1","0.806",,"0.194","Mixed","combat-related, rape/sexual assault, accidents, other (violent nonsexual assault; ""miscellaneous"")","Medium","de Kleine RA, Hendriks GJ, Kusters WJ, et al. A randomized placebo-controlled trial of D-cycloserine to enhance exposure therapy for posttraumatic stress disorder. Biol Psychiatry. 2012 Jun 1;71(11):962-8. doi: 10.1016/j.biopsych.2012.02.033. PMID: 22480663.","38434","2019"
"dekleine2012_CAPS_B_Baseline_Comp","Mixed: Psychotherapy & pharmacotherapy","PTSD","75","B","PTSD",,"21",,"PE + placebo","Prolonged Exposure (PE) + placebo","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","34","Structured Clinical Interview","CAPS","CAPS-1 (Dutch version)","Completer",,"Mixed random and fixed effect regression models.","Baseline",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"≥10 points decrease in CAPS-1 score",,"Additional definitions of Clinically Meaningful Response reported in the study","Community",,,"1","0.806",,"0.194","Mixed","combat-related, rape/sexual assault, accidents, other (violent nonsexual assault; ""miscellaneous"")","Medium","de Kleine RA, Hendriks GJ, Kusters WJ, et al. A randomized placebo-controlled trial of D-cycloserine to enhance exposure therapy for posttraumatic stress disorder. Biol Psychiatry. 2012 Jun 1;71(11):962-8. doi: 10.1016/j.biopsych.2012.02.033. PMID: 22480663.","38434","2019"
"dekleine2012_CAPS_B_Baseline_ITT","Mixed: Psychotherapy & pharmacotherapy","PTSD","75","B","PTSD",,"34",,"PE + placebo","Prolonged Exposure (PE) + placebo","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","34","Structured Clinical Interview","CAPS","CAPS-1 (Dutch version)","ITT","LOCF for dichotomous outcomes, mixed models for continuous outcomes","Mixed random and fixed effect regression models.","Baseline",,,"73.82",,"SE","2.88",,,,,,,,,,,,,,,,,,,,,,,,"≥10 points decrease in CAPS-1 score",,"Additional definitions of Clinically Meaningful Response reported in the study","Community",,,"1","0.806",,"0.194","Mixed","combat-related, rape/sexual assault, accidents, other (violent nonsexual assault; ""miscellaneous"")","Medium","de Kleine RA, Hendriks GJ, Kusters WJ, et al. A randomized placebo-controlled trial of D-cycloserine to enhance exposure therapy for posttraumatic stress disorder. Biol Psychiatry. 2012 Jun 1;71(11):962-8. doi: 10.1016/j.biopsych.2012.02.033. PMID: 22480663.","38434","2019"
"dekleine2012_PSS-SR_A_0_ITT","Mixed: Psychotherapy & pharmacotherapy","PTSD","75","A","PTSD",,,,"PE + D-cycloserine","Prolonged Exposure (PE) + D-cycloserine","Yes","TF","Yes","Other pharmacotherapy","No","Not Applicable","No","No","No","No","No","Individual","In Person","33","Self report","PSS-SR","PSS-SR (Dutch version)","ITT",,"Mixed random and fixed effect regression models.","End of Treatment","0",,"11.80",,"SE","2.59",,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.806",,"0.194","Mixed","combat-related, rape/sexual assault, accidents, other (violent nonsexual assault; ""miscellaneous"")","Medium","de Kleine RA, Hendriks GJ, Kusters WJ, et al. A randomized placebo-controlled trial of D-cycloserine to enhance exposure therapy for posttraumatic stress disorder. Biol Psychiatry. 2012 Jun 1;71(11):962-8. doi: 10.1016/j.biopsych.2012.02.033. PMID: 22480663.","38434","2019"
"dekleine2012_PSS-SR_A_12_ITT","Mixed: Psychotherapy & pharmacotherapy","PTSD","75","A","PTSD",,,,"PE + D-cycloserine","Prolonged Exposure (PE) + D-cycloserine","Yes","TF","Yes","Other pharmacotherapy","No","Not Applicable","No","No","No","No","No","Individual","In Person","33","Self report","PSS-SR","PSS-SR (Dutch version)","ITT",,"Mixed random and fixed effect regression models.","Assessment at 3 to <6 Months","12",,"12.40",,"SE","2.68",,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.806",,"0.194","Mixed","combat-related, rape/sexual assault, accidents, other (violent nonsexual assault; ""miscellaneous"")","Medium","de Kleine RA, Hendriks GJ, Kusters WJ, et al. A randomized placebo-controlled trial of D-cycloserine to enhance exposure therapy for posttraumatic stress disorder. Biol Psychiatry. 2012 Jun 1;71(11):962-8. doi: 10.1016/j.biopsych.2012.02.033. PMID: 22480663.","38434","2019"
"dekleine2012_PSS-SR_A_Baseline_ITT","Mixed: Psychotherapy & pharmacotherapy","PTSD","75","A","PTSD",,,,"PE + D-cycloserine","Prolonged Exposure (PE) + D-cycloserine","Yes","TF","Yes","Other pharmacotherapy","No","Not Applicable","No","No","No","No","No","Individual","In Person","33","Self report","PSS-SR","PSS-SR (Dutch version)","ITT",,"Mixed random and fixed effect regression models.","Baseline",,,"26.05",,"SE","1.43",,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.806",,"0.194","Mixed","combat-related, rape/sexual assault, accidents, other (violent nonsexual assault; ""miscellaneous"")","Medium","de Kleine RA, Hendriks GJ, Kusters WJ, et al. A randomized placebo-controlled trial of D-cycloserine to enhance exposure therapy for posttraumatic stress disorder. Biol Psychiatry. 2012 Jun 1;71(11):962-8. doi: 10.1016/j.biopsych.2012.02.033. PMID: 22480663.","38434","2019"
"dekleine2012_PSS-SR_B_0_ITT","Mixed: Psychotherapy & pharmacotherapy","PTSD","75","B","PTSD",,,,"PE + placebo","Prolonged Exposure (PE) + placebo","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","34","Self report","PSS-SR","PSS-SR (Dutch version)","ITT",,"Mixed random and fixed effect regression models.","End of Treatment","0",,"18.41",,"SE","2.59",,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.806",,"0.194","Mixed","combat-related, rape/sexual assault, accidents, other (violent nonsexual assault; ""miscellaneous"")","Medium","de Kleine RA, Hendriks GJ, Kusters WJ, et al. A randomized placebo-controlled trial of D-cycloserine to enhance exposure therapy for posttraumatic stress disorder. Biol Psychiatry. 2012 Jun 1;71(11):962-8. doi: 10.1016/j.biopsych.2012.02.033. PMID: 22480663.","38434","2019"
"dekleine2012_PSS-SR_B_12_ITT","Mixed: Psychotherapy & pharmacotherapy","PTSD","75","B","PTSD",,,,"PE + placebo","Prolonged Exposure (PE) + placebo","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","34","Self report","PSS-SR","PSS-SR (Dutch version)","ITT",,"Mixed random and fixed effect regression models.","Assessment at 3 to <6 Months","12",,"15.28",,"SE","2.63",,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.806",,"0.194","Mixed","combat-related, rape/sexual assault, accidents, other (violent nonsexual assault; ""miscellaneous"")","Medium","de Kleine RA, Hendriks GJ, Kusters WJ, et al. A randomized placebo-controlled trial of D-cycloserine to enhance exposure therapy for posttraumatic stress disorder. Biol Psychiatry. 2012 Jun 1;71(11):962-8. doi: 10.1016/j.biopsych.2012.02.033. PMID: 22480663.","38434","2019"
"dekleine2012_PSS-SR_B_Baseline_ITT","Mixed: Psychotherapy & pharmacotherapy","PTSD","75","B","PTSD",,,,"PE + placebo","Prolonged Exposure (PE) + placebo","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","34","Self report","PSS-SR","PSS-SR (Dutch version)","ITT",,"Mixed random and fixed effect regression models.","Baseline",,,"28.34",,"SE","1.43",,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.806",,"0.194","Mixed","combat-related, rape/sexual assault, accidents, other (violent nonsexual assault; ""miscellaneous"")","Medium","de Kleine RA, Hendriks GJ, Kusters WJ, et al. A randomized placebo-controlled trial of D-cycloserine to enhance exposure therapy for posttraumatic stress disorder. Biol Psychiatry. 2012 Jun 1;71(11):962-8. doi: 10.1016/j.biopsych.2012.02.033. PMID: 22480663.","38434","2019"
"devilly1998_M-PTSD_A_0_Comp","Psychotherapy","PTSD","51","A","PTSD",,"12",,"EMDR","Eye Movement Desensitization and Reprocessing (EMDR)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","19","Self report","M-PTSD","M-PTSD","Completer",,"Mixed random and fixed effect regression models.","End of Treatment","0",,"110.42","27.72",,,,,"-10",,,,,,,,,,,,,,,,,,,,,"RCI for M-PTSD","0.6667",,"Veteran","0","1","0","0",,"1","Combat-related",,"High","Devilly GJ, Spence SH, Rapee RM. Statistical and reliable change with eye movement desensitization and reprocessing: treating trauma within a veteran population. Behav. Ther. 1998 Summer;29(3):435-55. doi: 10.1016/S0005-7894(98)80042-7.","20740","2019"
"devilly1998_M-PTSD_A_26_Comp","Psychotherapy","PTSD","51","A","PTSD",,"9",,"EMDR","Eye Movement Desensitization and Reprocessing (EMDR)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","19","Self report","M-PTSD","M-PTSD","Completer",,"Mixed random and fixed effect regression models.","Assessment at 6 to <12 Months","26",,"115","33.26",,,,,"-5.42",,,,,,,,,,,,,,,,,,,,,"RCI for M-PTSD","0.3333",,"Veteran","0","1","0","0",,"1","Combat-related",,"High","Devilly GJ, Spence SH, Rapee RM. Statistical and reliable change with eye movement desensitization and reprocessing: treating trauma within a veteran population. Behav. Ther. 1998 Summer;29(3):435-55. doi: 10.1016/S0005-7894(98)80042-7.","20740","2019"
"devilly1998_M-PTSD_A_Baseline_Comp","Psychotherapy","PTSD","51","A","PTSD",,"12",,"EMDR","Eye Movement Desensitization and Reprocessing (EMDR)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","19","Self report","M-PTSD","M-PTSD","Completer",,"Mixed random and fixed effect regression models.","Baseline",,,"102.42","26.48",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"High","Devilly GJ, Spence SH, Rapee RM. Statistical and reliable change with eye movement desensitization and reprocessing: treating trauma within a veteran population. Behav. Ther. 1998 Summer;29(3):435-55. doi: 10.1016/S0005-7894(98)80042-7.","20740","2019"
"devilly1998_M-PTSD_B_0_Comp","Psychotherapy","PTSD","51","B","PTSD",,"12",,"Reactive Eye Dilation Desensitization and Reprocessing","Eye Movement Desensitization and Reprocessing (EMDR)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","16","Self report","M-PTSD","M-PTSD","Completer",,"Mixed random and fixed effect regression models.","End of Treatment","0",,"118.58","22.64",,,,,"-4.59",,,,,,,,,,,,,,,,,,,,,"RCI for M-PTSD","0.4167",,"Veteran","0","1","0","0",,"1","Combat-related",,"High","Devilly GJ, Spence SH, Rapee RM. Statistical and reliable change with eye movement desensitization and reprocessing: treating trauma within a veteran population. Behav. Ther. 1998 Summer;29(3):435-55. doi: 10.1016/S0005-7894(98)80042-7.","20740","2019"
"devilly1998_M-PTSD_B_26_Comp","Psychotherapy","PTSD","51","B","PTSD",,"9",,"Reactive Eye Dilation Desensitization and Reprocessing","Eye Movement Desensitization and Reprocessing (EMDR)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","16","Self report","M-PTSD","M-PTSD","Completer",,"Mixed random and fixed effect regression models.","Assessment at 6 to <12 Months","26",,"122.44","21.05",,,,,"-0.73",,,,,,,,,,,,,,,,,,,,,"RCI for M-PTSD","0.3333",,"Veteran","0","1","0","0",,"1","Combat-related",,"High","Devilly GJ, Spence SH, Rapee RM. Statistical and reliable change with eye movement desensitization and reprocessing: treating trauma within a veteran population. Behav. Ther. 1998 Summer;29(3):435-55. doi: 10.1016/S0005-7894(98)80042-7.","20740","2019"
"devilly1998_M-PTSD_B_Baseline_Comp","Psychotherapy","PTSD","51","B","PTSD",,"12",,"Reactive Eye Dilation Desensitization and Reprocessing","Eye Movement Desensitization and Reprocessing (EMDR)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","16","Self report","M-PTSD","M-PTSD","Completer",,"Mixed random and fixed effect regression models.","Baseline",,,"123.17","18.93",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"High","Devilly GJ, Spence SH, Rapee RM. Statistical and reliable change with eye movement desensitization and reprocessing: treating trauma within a veteran population. Behav. Ther. 1998 Summer;29(3):435-55. doi: 10.1016/S0005-7894(98)80042-7.","20740","2019"
"devilly1998_M-PTSD_C_Baseline_Comp","Psychotherapy","PTSD","51","C","Control",,,,"Standard Psychiatric Support","Treatment as usual (TAU)","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,"16","Self report","M-PTSD","M-PTSD","Completer",,"Mixed random and fixed effect regression models.","Baseline",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"High","Devilly GJ, Spence SH, Rapee RM. Statistical and reliable change with eye movement desensitization and reprocessing: treating trauma within a veteran population. Behav. Ther. 1998 Summer;29(3):435-55. doi: 10.1016/S0005-7894(98)80042-7.","20740","2019"
"difede2014_CAPS_A_0_ITT","Mixed: Psychotherapy & pharmacotherapy","PTSD","25","A","PTSD",,"13",,"Exposure therapy with virtual reality plus D-cycloserine","Virtual reality exposure therapy (VRET) + D-cycloserine","Yes","TF","Yes","Other pharmacotherapy","No","Not Applicable","No","No","No","No","No","Individual","In Person","13","Structured Clinical Interview","CAPS","CAPS","ITT","LOCF","Mixed random and fixed effect regression models.","End of Treatment","0",,"32.38","28.55",,,,,"-49.24",,,,,,,,,,,,,,,,,,,,,"CAPS total score of ≤20 and minimal or no impairment in social, occupational and other important areas of functioning (CAPS items F21 and F22 ≤1)","0.4615",,"Community",,,"1","0.24",,"0.76","Terrorism/political violence/forced displacement",,"Medium","Difede J, Cukor J, Wyka KE, et al. D-cycloserine augmentation of exposure therapy for post-traumatic stress disorder: a pilot randomized clinical trial. Neuropsychopharmacology. 2014 Apr;39(5):1052-108. doi: 10.1038/npp.2013.317. PMID: 24217129.","41641","2019"
"difede2014_CAPS_A_26_ITT","Mixed: Psychotherapy & pharmacotherapy","PTSD","25","A","PTSD",,"13",,"Exposure therapy with virtual reality plus D-cycloserine","Virtual reality exposure therapy (VRET) + D-cycloserine","Yes","TF","Yes","Other pharmacotherapy","No","Not Applicable","No","No","No","No","No","Individual","In Person","13","Structured Clinical Interview","CAPS","CAPS","ITT","LOCF","Mixed random and fixed effect regression models.","Assessment at 6 to <12 Months","26",,"24.15","26.48",,,,,"-57.47",,,,,,,,,,,,,,,,,,,,,"CAPS total score of ≤20 and minimal or no impairment in social, occupational and other important areas of functioning (CAPS items F21 and F22 ≤1)","0.6923",,"Community",,,"1","0.24",,"0.76","Terrorism/political violence/forced displacement",,"Medium","Difede J, Cukor J, Wyka KE, et al. D-cycloserine augmentation of exposure therapy for post-traumatic stress disorder: a pilot randomized clinical trial. Neuropsychopharmacology. 2014 Apr;39(5):1052-108. doi: 10.1038/npp.2013.317. PMID: 24217129.","41641","2019"
"difede2014_CAPS_A_Baseline_ITT","Mixed: Psychotherapy & pharmacotherapy","PTSD","25","A","PTSD",,"13",,"Exposure therapy with virtual reality plus D-cycloserine","Virtual reality exposure therapy (VRET) + D-cycloserine","Yes","TF","Yes","Other pharmacotherapy","No","Not Applicable","No","No","No","No","No","Individual","In Person","13","Structured Clinical Interview","CAPS","CAPS","ITT","LOCF","Mixed random and fixed effect regression models.","Baseline",,,"81.62","22.13",,,,,,,,,,,,,,,,,,,,,,,,,,"CAPS total score of ≤20 and minimal or no impairment in social, occupational and other important areas of functioning (CAPS items F21 and F22 ≤1)",,,"Community",,,"1","0.24",,"0.76","Terrorism/political violence/forced displacement",,"Medium","Difede J, Cukor J, Wyka KE, et al. D-cycloserine augmentation of exposure therapy for post-traumatic stress disorder: a pilot randomized clinical trial. Neuropsychopharmacology. 2014 Apr;39(5):1052-108. doi: 10.1038/npp.2013.317. PMID: 24217129.","41641","2019"
"difede2014_CAPS_B_0_ITT","Mixed: Psychotherapy & pharmacotherapy","PTSD","25","B","PTSD",,"12",,"Exposure therapy with virtual reality plus placebo","Virtual reality exposure therapy (VRET) + placebo","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","12","Structured Clinical Interview","CAPS","CAPS","ITT","LOCF","Mixed random and fixed effect regression models.","End of Treatment","0",,"42.17","20.75",,,,,"-32.91",,,,,,,,,,,,,,,,,,,,,"CAPS total score of ≤20 and minimal or no impairment in social, occupational and other important areas of functioning (CAPS items F21 and F22 ≤1)","0.0833",,"Community",,,"1","0.24",,"0.76","Terrorism/political violence/forced displacement",,"Medium","Difede J, Cukor J, Wyka KE, et al. D-cycloserine augmentation of exposure therapy for post-traumatic stress disorder: a pilot randomized clinical trial. Neuropsychopharmacology. 2014 Apr;39(5):1052-108. doi: 10.1038/npp.2013.317. PMID: 24217129.","41641","2019"
"difede2014_CAPS_B_26_ITT","Mixed: Psychotherapy & pharmacotherapy","PTSD","25","B","PTSD",,"12",,"Exposure therapy with virtual reality plus placebo","Virtual reality exposure therapy (VRET) + placebo","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","12","Structured Clinical Interview","CAPS","CAPS","ITT","LOCF","Mixed random and fixed effect regression models.","Assessment at 6 to <12 Months","26",,"45.92","25.66",,,,,"-29.16",,,,,,,,,,,,,,,,,,,,,"CAPS total score of ≤20 and minimal or no impairment in social, occupational and other important areas of functioning (CAPS items F21 and F22 ≤1)","0.1667",,"Community",,,"1","0.24",,"0.76","Terrorism/political violence/forced displacement",,"Medium","Difede J, Cukor J, Wyka KE, et al. D-cycloserine augmentation of exposure therapy for post-traumatic stress disorder: a pilot randomized clinical trial. Neuropsychopharmacology. 2014 Apr;39(5):1052-108. doi: 10.1038/npp.2013.317. PMID: 24217129.","41641","2019"
"difede2014_CAPS_B_Baseline_ITT","Mixed: Psychotherapy & pharmacotherapy","PTSD","25","B","PTSD",,"12",,"Exposure therapy with virtual reality plus placebo","Virtual reality exposure therapy (VRET) + placebo","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","12","Structured Clinical Interview","CAPS","CAPS","ITT","LOCF","Mixed random and fixed effect regression models.","Baseline",,,"75.08","23.80",,,,,,,,,,,,,,,,,,,,,,,,,,"CAPS total score of ≤20 and minimal or no impairment in social, occupational and other important areas of functioning (CAPS items F21 and F22 ≤1)",,,"Community",,,"1","0.24",,"0.76","Terrorism/political violence/forced displacement",,"Medium","Difede J, Cukor J, Wyka KE, et al. D-cycloserine augmentation of exposure therapy for post-traumatic stress disorder: a pilot randomized clinical trial. Neuropsychopharmacology. 2014 Apr;39(5):1052-108. doi: 10.1038/npp.2013.317. PMID: 24217129.","41641","2019"
"dorrepaal2012_DTS_A_0_Comp","Psychotherapy","PTSD","71","A","PTSD",,"31",,"Group CBT","Cognitive behavioral therapy (CBT) without a trauma focus","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Group","In Person","38","Self report","DTS","DTS","Completer",,"Mixed random and fixed effect regression models.","End of Treatment","0",,"66.7","29.4",,,,,"-24.7","27.3",,,,"Cohen's d","1.09",,,,"p=0.000",,,,,,,,,,,"≥1 standard deviation decrease from baseline on DTS (equivalent to 22.5 points)","0.5484",,"Community",,,"1","1",,"0","Mixed","child sexual abuse, child physical abuse","High","Dorrepaal E, Thomaes K, Smit JH, et al. Stabilizing group treatment for complex posttraumatic stress disorder related to child abuse based on psychoeducation and cognitive behavioural therapy: a multisite randomized controlled trial. Psychother Psychosom. 2012;81(4):217-25. doi: 10.1159/000335044. PMID: 22585094.","39141","2019"
"dorrepaal2012_DTS_A_0_ITT","Psychotherapy","PTSD","71","A","PTSD",,"38",,"Group CBT","Cognitive behavioral therapy (CBT) without a trauma focus","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Group","In Person","38","Self report","DTS","DTS","ITT","LOCF","Mixed random and fixed effect regression models.","End of Treatment","0",,"69.6","27.4",,,,,"-20.2","26.4",,,,"Cohen's d","1",,,,"p=0.000",,,,,,,,,,,"≥1 standard deviation decrease from baseline on DTS (equivalent to 22.5 points)","0.4474",,"Community",,,"1","1",,"0","Mixed","child sexual abuse, child physical abuse","High","Dorrepaal E, Thomaes K, Smit JH, et al. Stabilizing group treatment for complex posttraumatic stress disorder related to child abuse based on psychoeducation and cognitive behavioural therapy: a multisite randomized controlled trial. Psychother Psychosom. 2012;81(4):217-25. doi: 10.1159/000335044. PMID: 22585094.","39141","2019"
"dorrepaal2012_DTS_A_Baseline_Comp","Psychotherapy","PTSD","71","A","PTSD",,"31",,"Group CBT","Cognitive behavioral therapy (CBT) without a trauma focus","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Group","In Person","38","Self report","DTS","DTS","Completer",,"Mixed random and fixed effect regression models.","Baseline",,,"91.4","21.8",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","1",,"0","Mixed","child sexual abuse, child physical abuse","High","Dorrepaal E, Thomaes K, Smit JH, et al. Stabilizing group treatment for complex posttraumatic stress disorder related to child abuse based on psychoeducation and cognitive behavioural therapy: a multisite randomized controlled trial. Psychother Psychosom. 2012;81(4):217-25. doi: 10.1159/000335044. PMID: 22585094.","39141","2019"
"dorrepaal2012_DTS_A_Baseline_ITT","Psychotherapy","PTSD","71","A","PTSD",,"38",,"Group CBT","Cognitive behavioral therapy (CBT) without a trauma focus","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Group","In Person","38","Self report","DTS","DTS","ITT","LOCF","Mixed random and fixed effect regression models.","Baseline",,,"89.8","20.3",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","1",,"0","Mixed","child sexual abuse, child physical abuse","High","Dorrepaal E, Thomaes K, Smit JH, et al. Stabilizing group treatment for complex posttraumatic stress disorder related to child abuse based on psychoeducation and cognitive behavioural therapy: a multisite randomized controlled trial. Psychother Psychosom. 2012;81(4):217-25. doi: 10.1159/000335044. PMID: 22585094.","39141","2019"
"dorrepaal2012_DTS_B_0_Comp","Psychotherapy","PTSD","71","B","Control",,"29",,"TAU","Treatment as usual (TAU)","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,"33","Self report","DTS","DTS","Completer",,"Mixed random and fixed effect regression models.","End of Treatment","0",,"65.5","30.3",,,,,"-14.9","22.2",,,,"Cohen's d","0.65",,,,"p=0.001",,,,,,,,,,,"≥1 standard deviation decrease from baseline on DTS (equivalent to 22.5 points)","0.2414",,"Community",,,"1","1",,"0","Mixed","child sexual abuse, child physical abuse","High","Dorrepaal E, Thomaes K, Smit JH, et al. Stabilizing group treatment for complex posttraumatic stress disorder related to child abuse based on psychoeducation and cognitive behavioural therapy: a multisite randomized controlled trial. Psychother Psychosom. 2012;81(4):217-25. doi: 10.1159/000335044. PMID: 22585094.","39141","2019"
"dorrepaal2012_DTS_B_0_ITT","Psychotherapy","PTSD","71","B","Control",,"33",,"TAU","Treatment as usual (TAU)","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,"33","Self report","DTS","DTS","ITT","LOCF","Mixed random and fixed effect regression models.","End of Treatment","0",,"66.5","29.8",,,,,"-13.1","21.3",,,,"Cohen's d","0.61",,,,"p=0.001",,,,,,,,,,,"≥1 standard deviation decrease from baseline on DTS (equivalent to 22.5 points)","0.2121",,"Community",,,"1","1",,"0","Mixed","child sexual abuse, child physical abuse","High","Dorrepaal E, Thomaes K, Smit JH, et al. Stabilizing group treatment for complex posttraumatic stress disorder related to child abuse based on psychoeducation and cognitive behavioural therapy: a multisite randomized controlled trial. Psychother Psychosom. 2012;81(4):217-25. doi: 10.1159/000335044. PMID: 22585094.","39141","2019"
"dorrepaal2012_DTS_B_Baseline_Comp","Psychotherapy","PTSD","71","B","Control",,"29",,"TAU","Treatment as usual (TAU)","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,"33","Self report","DTS","DTS","Completer",,"Mixed random and fixed effect regression models.","Baseline",,,"80.5","23.1",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","1",,"0","Mixed","child sexual abuse, child physical abuse","High","Dorrepaal E, Thomaes K, Smit JH, et al. Stabilizing group treatment for complex posttraumatic stress disorder related to child abuse based on psychoeducation and cognitive behavioural therapy: a multisite randomized controlled trial. Psychother Psychosom. 2012;81(4):217-25. doi: 10.1159/000335044. PMID: 22585094.","39141","2019"
"dorrepaal2012_DTS_B_Baseline_ITT","Psychotherapy","PTSD","71","B","Control",,"33",,"TAU","Treatment as usual (TAU)","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,"33","Self report","DTS","DTS","ITT","LOCF","Mixed random and fixed effect regression models.","Baseline",,,"79.6","23.5",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","1",,"0","Mixed","child sexual abuse, child physical abuse","High","Dorrepaal E, Thomaes K, Smit JH, et al. Stabilizing group treatment for complex posttraumatic stress disorder related to child abuse based on psychoeducation and cognitive behavioural therapy: a multisite randomized controlled trial. Psychother Psychosom. 2012;81(4):217-25. doi: 10.1159/000335044. PMID: 22585094.","39141","2019"
"dowd2020_CAPS_A_0_ITT","Pharmacotherapy","PTSD","25","A","PTSD",,"7",,"Eszopiclone","Eszopiclone","No","Not Applicable","Yes","Antianxiety: nonbenzodiazepine","No","Not Applicable","No","No","No","No","No","Individual","In person","13","Structured Clinical Interview","CAPS","CAPS","ITT","LOCF (Modified ITT included only participants who had completed at least one dose)","0","End of Treatment","0",,"40","20.13",,,,,"-25",,,,,,,,,,"p=0.005",,,,,,,,"CAPS score >45",,,,,,"Mixed",,"0.04","0.96","0.40",,"0.60","Mixed","Rape/sexual assault; Accidents; Illness/medical procedure; Community/school violence; Natural or manmade disasters; Other (observed violence to or death of a loved one)","High","Dowd SM, Zalta AK, Burgess HJ, et al. Double-blind randomized controlled study of the efficacy, safety and tolerability of eszopiclone vs placebo for the treatment of patients with post-traumatic stress disorder and insomnia. World j. 2020 Mar 19;10(3):21-8. doi: https://dx.doi.org/10.5498/wjp.v10.i3.21. PMID: 32257848.",,"2020"
"dowd2020_CAPS_A_Baseline_ITT","Pharmacotherapy","PTSD","25","A","PTSD",,"13",,"Eszopiclone","Eszopiclone","No","Not Applicable","Yes","Antianxiety: nonbenzodiazepine","No","Not Applicable","No","No","No","No","No","Individual","In person","13","Structured Clinical Interview","CAPS","CAPS","ITT","LOCF (Modified ITT included only participants who had completed at least one dose)","0","Baseline",,,"65","22.04",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Mixed",,"0.04","0.96","0.40",,"0.60","Mixed","Rape/sexual assault; Accidents; Illness/medical procedure; Community/school violence; Natural or manmade disasters; Other (observed violence to or death of a loved one)","High","Dowd SM, Zalta AK, Burgess HJ, et al. Double-blind randomized controlled study of the efficacy, safety and tolerability of eszopiclone vs placebo for the treatment of patients with post-traumatic stress disorder and insomnia. World j. 2020 Mar 19;10(3):21-8. doi: https://dx.doi.org/10.5498/wjp.v10.i3.21. PMID: 32257848.",,"2020"
"dowd2020_CAPS_B_0_ITT","Pharmacotherapy","PTSD","25","B","Control",,"9",,"Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In person","12","Structured Clinical Interview","CAPS","CAPS","ITT","LOCF (Modified ITT included only participants who had completed at least one dose)","0","End of Treatment","0","41 ± 16.94",,,,,,,"-23",,,,,,,,,,"p=0.002",,,,,,,,"CAPS score >45",,,,,,"Mixed",,"0.04","0.96","0.40",,"0.60","Mixed","Rape/sexual assault; Accidents; Illness/medical procedure; Community/school violence; Natural or manmade disasters; Other (observed violence to or death of a loved one)","High","Dowd SM, Zalta AK, Burgess HJ, et al. Double-blind randomized controlled study of the efficacy, safety and tolerability of eszopiclone vs placebo for the treatment of patients with post-traumatic stress disorder and insomnia. World j. 2020 Mar 19;10(3):21-8. doi: https://dx.doi.org/10.5498/wjp.v10.i3.21. PMID: 32257848.",,"2020"
"dowd2020_CAPS_B_Baseline_ITT","Pharmacotherapy","PTSD","25","B","Control",,"12",,"Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In person","12","Structured Clinical Interview","CAPS","CAPS","ITT","LOCF (Modified ITT included only participants who had completed at least one dose)","0","Baseline",,,"64","10.93",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Mixed",,"0.04","0.96","0.40",,"0.60","Mixed","Rape/sexual assault; Accidents; Illness/medical procedure; Community/school violence; Natural or manmade disasters; Other (observed violence to or death of a loved one)","High","Dowd SM, Zalta AK, Burgess HJ, et al. Double-blind randomized controlled study of the efficacy, safety and tolerability of eszopiclone vs placebo for the treatment of patients with post-traumatic stress disorder and insomnia. World j. 2020 Mar 19;10(3):21-8. doi: https://dx.doi.org/10.5498/wjp.v10.i3.21. PMID: 32257848.",,"2020"
"dowd2020_SPRINT_A_0_ITT","Pharmacotherapy","PTSD","25","A","PTSD",,,,"Eszopiclone","Eszopiclone","No","Not Applicable","Yes","Antianxiety: nonbenzodiazepine","No","Not Applicable","No","No","No","No","No","Individual","In person","13","Structured Clinical Interview","SPRINT","SPRINT","ITT","LOCF (Modified ITT included only participants who had completed at least one dose)","0","End of Treatment","0",,"13","6.58",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Mixed",,"0.04","0.96","0.40",,"0.60","Mixed","Rape/sexual assault; Accidents; Illness/medical procedure; Community/school violence; Natural or manmade disasters; Other (observed violence to or death of a loved one)","High","Dowd SM, Zalta AK, Burgess HJ, et al. Double-blind randomized controlled study of the efficacy, safety and tolerability of eszopiclone vs placebo for the treatment of patients with post-traumatic stress disorder and insomnia. World j. 2020 Mar 19;10(3):21-8. doi: https://dx.doi.org/10.5498/wjp.v10.i3.21. PMID: 32257848.",,"2020"
"dowd2020_SPRINT_A_Baseline_ITT","Pharmacotherapy","PTSD","25","A","PTSD",,,,"Eszopiclone","Eszopiclone","No","Not Applicable","Yes","Antianxiety: nonbenzodiazepine","No","Not Applicable","No","No","No","No","No","Individual","In person","13","Structured Clinical Interview","SPRINT","SPRINT","ITT","LOCF (Modified ITT included only participants who had completed at least one dose)","0","Baseline",,,"22","5.55",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Mixed",,"0.04","0.96","0.40",,"0.60","Mixed","Rape/sexual assault; Accidents; Illness/medical procedure; Community/school violence; Natural or manmade disasters; Other (observed violence to or death of a loved one)","High","Dowd SM, Zalta AK, Burgess HJ, et al. Double-blind randomized controlled study of the efficacy, safety and tolerability of eszopiclone vs placebo for the treatment of patients with post-traumatic stress disorder and insomnia. World j. 2020 Mar 19;10(3):21-8. doi: https://dx.doi.org/10.5498/wjp.v10.i3.21. PMID: 32257848.",,"2020"
"dowd2020_SPRINT_B_0_ITT","Pharmacotherapy","PTSD","25","B","Control",,,,"Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In person","12","Structured Clinical Interview","SPRINT","SPRINT","ITT","LOCF (Modified ITT included only participants who had completed at least one dose)","0","End of Treatment","0",,"14","4.79",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Mixed",,"0.04","0.96","0.40",,"0.60","Mixed","Rape/sexual assault; Accidents; Illness/medical procedure; Community/school violence; Natural or manmade disasters; Other (observed violence to or death of a loved one)","High","Dowd SM, Zalta AK, Burgess HJ, et al. Double-blind randomized controlled study of the efficacy, safety and tolerability of eszopiclone vs placebo for the treatment of patients with post-traumatic stress disorder and insomnia. World j. 2020 Mar 19;10(3):21-8. doi: https://dx.doi.org/10.5498/wjp.v10.i3.21. PMID: 32257848.",,"2020"
"dowd2020_SPRINT_B_Baseline_ITT","Pharmacotherapy","PTSD","25","B","Control",,,,"Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In person","12","Structured Clinical Interview","SPRINT","SPRINT","ITT","LOCF (Modified ITT included only participants who had completed at least one dose)","0","Baseline",,,"24","3.61",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Mixed",,"0.04","0.96","0.40",,"0.60","Mixed","Rape/sexual assault; Accidents; Illness/medical procedure; Community/school violence; Natural or manmade disasters; Other (observed violence to or death of a loved one)","High","Dowd SM, Zalta AK, Burgess HJ, et al. Double-blind randomized controlled study of the efficacy, safety and tolerability of eszopiclone vs placebo for the treatment of patients with post-traumatic stress disorder and insomnia. World j. 2020 Mar 19;10(3):21-8. doi: https://dx.doi.org/10.5498/wjp.v10.i3.21. PMID: 32257848.",,"2020"
"duberstein2018_MPSS_A_0_ITT","Psychotherapy","PTSD","161","A","PTSD",,"66",,"IPT-T","Interpersonal Psychotherapy (IPT)","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","83","Self report","MPSS","MPSS","ITT","Weighted generalized estimating equations assuming data missing at random","Multivariable weighted generalized estimating equations; weights computed using logistic regression models","End of Treatment","0",,"47.6","33.1",,,,,"-20.3",,,,,,,,,,,,,,,,,,,,,,,,"Community","0","0","1","1",,"0","Child sexual abuse",,"Medium","Duberstein PR, Ward EA, Chaudron LH, et al. Effectiveness of interpersonal psychotherapy-trauma for depressed women with childhood abuse histories. J Consult Clin Psychol. 2018 Oct;86(10):868-78. doi: 10.1037/ccp0000335. PMID: 30265045.","51365","2020"
"duberstein2018_MPSS_A_52_ITT","Psychotherapy","PTSD","161","A","PTSD",,"41",,"IPT-T","Interpersonal Psychotherapy (IPT)","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","83","Self report","MPSS","MPSS","ITT","Weighted generalized estimating equations assuming data missing at random","Multivariable weighted generalized estimating equations; weights computed using logistic regression models","Assessment at ≥12 Months","52",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community","0","0","1","1",,"0","Child sexual abuse",,"Medium","Duberstein PR, Ward EA, Chaudron LH, et al. Effectiveness of interpersonal psychotherapy-trauma for depressed women with childhood abuse histories. J Consult Clin Psychol. 2018 Oct;86(10):868-78. doi: 10.1037/ccp0000335. PMID: 30265045.","51365","2020"
"duberstein2018_MPSS_A_Baseline_ITT","Psychotherapy","PTSD","161","A","PTSD",,"83",,"IPT-T","Interpersonal Psychotherapy (IPT)","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","83","Self report","MPSS","MPSS","ITT","Weighted generalized estimating equations assuming data missing at random","Multivariable weighted generalized estimating equations; weights computed using logistic regression models","Baseline",,,"67.9","31.7",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community","0","0","1","1",,"0","Child sexual abuse",,"Medium","Duberstein PR, Ward EA, Chaudron LH, et al. Effectiveness of interpersonal psychotherapy-trauma for depressed women with childhood abuse histories. J Consult Clin Psychol. 2018 Oct;86(10):868-78. doi: 10.1037/ccp0000335. PMID: 30265045.","51365","2020"
"duberstein2018_MPSS_B_0_ITT","Psychotherapy","PTSD","161","B","PTSD",,"56",,"Clinic Psychotherapy","Psychotherapy as usual","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","78","Self report","MPSS","MPSS","ITT","Weighted generalized estimating equations assuming data missing at random","Multivariable weighted generalized estimating equations; weights computed using logistic regression models","End of Treatment","0",,"58.9","37.4",,,,,"-14.6",,,,,,,,,,,,,,,,,,,,,,,,"Community","0","0","1","1",,"0","Child sexual abuse",,"Medium","Duberstein PR, Ward EA, Chaudron LH, et al. Effectiveness of interpersonal psychotherapy-trauma for depressed women with childhood abuse histories. J Consult Clin Psychol. 2018 Oct;86(10):868-78. doi: 10.1037/ccp0000335. PMID: 30265045.","51365","2020"
"duberstein2018_MPSS_B_52_ITT","Psychotherapy","PTSD","161","B","PTSD",,"30",,"Clinic Psychotherapy","Psychotherapy as usual","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","78","Self report","MPSS","MPSS","ITT","Weighted generalized estimating equations assuming data missing at random","Multivariable weighted generalized estimating equations; weights computed using logistic regression models","Assessment at ≥12 Months","52",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community","0","0","1","1",,"0","Child sexual abuse",,"Medium","Duberstein PR, Ward EA, Chaudron LH, et al. Effectiveness of interpersonal psychotherapy-trauma for depressed women with childhood abuse histories. J Consult Clin Psychol. 2018 Oct;86(10):868-78. doi: 10.1037/ccp0000335. PMID: 30265045.","51365","2020"
"duberstein2018_MPSS_B_Baseline_ITT","Psychotherapy","PTSD","161","B","PTSD",,"78",,"Clinic Psychotherapy","Psychotherapy as usual","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In person","78","Self report","MPSS","MPSS","ITT","Weighted generalized estimating equations assuming data missing at random","Multivariable weighted generalized estimating equations; weights computed using logistic regression models","Baseline",,,"73.5","32.8",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community","0","0","1","1",,"0","Child sexual abuse",,"Medium","Duberstein PR, Ward EA, Chaudron LH, et al. Effectiveness of interpersonal psychotherapy-trauma for depressed women with childhood abuse histories. J Consult Clin Psychol. 2018 Oct;86(10):868-78. doi: 10.1037/ccp0000335. PMID: 30265045.","51365","2020"
"duffy2007_PDS_A_0_Comp","Psychotherapy","PTSD","58","A","PTSD",,"20",,"Cognitive Therapy","Cognitive Therapy for PTSD (CT-PTSD)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","29","Self report","PDS","PDS","Completer",,"Multivariable weighted generalized estimating equations; weights computed using logistic regression models","End of Treatment","0",,"15.1","9.9",,,,,"-19.6",,,,,,,,,,"p<0.001",,,,,,,,,,,,,,"Community",,,"1","0.3966",,"0.6034","Mixed","terrorism/political violence/forced displacement, community/school violence, accidents","Medium","Duffy M, Gillespie K, Clark DM. Post-traumatic stress disorder in the context of terrorism and other civil conflict in Northern Ireland: randomised controlled trial. BMJ. 2007 Jun 2;334(7604):1147-50. doi: 10.1136/bmj.39021.846852.BE. PMID: 17495988.","29736","2019"
"duffy2007_PDS_A_0_ITT","Psychotherapy","PTSD","58","A","PTSD",,"29",,"Cognitive Therapy","Cognitive Therapy for PTSD (CT-PTSD)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","29","Self report","PDS","PDS","ITT",,"Multivariable weighted generalized estimating equations; weights computed using logistic regression models","End of Treatment","0",,"21.8","14.4",,,,,"-12.9",,,,,,,,,,"p<0.001",,,,,,,,,,,,,,"Community",,,"1","0.3966",,"0.6034","Mixed","terrorism/political violence/forced displacement, community/school violence, accidents","Medium","Duffy M, Gillespie K, Clark DM. Post-traumatic stress disorder in the context of terrorism and other civil conflict in Northern Ireland: randomised controlled trial. BMJ. 2007 Jun 2;334(7604):1147-50. doi: 10.1136/bmj.39021.846852.BE. PMID: 17495988.","29736","2019"
"duffy2007_PDS_A_Baseline_ITT","Psychotherapy","PTSD","58","A","PTSD",,"29",,"Cognitive Therapy","Cognitive Therapy for PTSD (CT-PTSD)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","29","Self report","PDS","PDS","ITT",,"Multivariable weighted generalized estimating equations; weights computed using logistic regression models","Baseline",,,"34.7","7.8",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.3966",,"0.6034","Mixed","terrorism/political violence/forced displacement, community/school violence, accidents","Medium","Duffy M, Gillespie K, Clark DM. Post-traumatic stress disorder in the context of terrorism and other civil conflict in Northern Ireland: randomised controlled trial. BMJ. 2007 Jun 2;334(7604):1147-50. doi: 10.1136/bmj.39021.846852.BE. PMID: 17495988.","29736","2019"
"duffy2007_PDS_B_0_Comp","Psychotherapy","PTSD","58","B","Control",,"25",,"Waitlist","Waitlist","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,"29","Self report","PDS","PDS","Completer",,"Multivariable weighted generalized estimating equations; weights computed using logistic regression models","End of Treatment","0",,"33.1","9.9",,,,,"-3.7",,,,,,,,,,"p=NS",,,,,,,,,,,,,,"Community",,,"1","0.3966",,"0.6034","Mixed","terrorism/political violence/forced displacement, community/school violence, accidents","Medium","Duffy M, Gillespie K, Clark DM. Post-traumatic stress disorder in the context of terrorism and other civil conflict in Northern Ireland: randomised controlled trial. BMJ. 2007 Jun 2;334(7604):1147-50. doi: 10.1136/bmj.39021.846852.BE. PMID: 17495988.","29736","2019"
"duffy2007_PDS_B_0_ITT","Psychotherapy","PTSD","58","B","Control",,"29",,"Waitlist","Waitlist","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,"29","Self report","PDS","PDS","ITT",,"Multivariable weighted generalized estimating equations; weights computed using logistic regression models","End of Treatment","0",,"33.4","11.6",,,,,"-3.4",,,,,,,,,,"p=NS",,,,,,,,,,,,,,"Community",,,"1","0.3966",,"0.6034","Mixed","terrorism/political violence/forced displacement, community/school violence, accidents","Medium","Duffy M, Gillespie K, Clark DM. Post-traumatic stress disorder in the context of terrorism and other civil conflict in Northern Ireland: randomised controlled trial. BMJ. 2007 Jun 2;334(7604):1147-50. doi: 10.1136/bmj.39021.846852.BE. PMID: 17495988.","29736","2019"
"duffy2007_PDS_B_Baseline_ITT","Psychotherapy","PTSD","58","B","Control",,"29",,"Waitlist","Waitlist","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,"29","Self report","PDS","PDS","ITT",,"Multivariable weighted generalized estimating equations; weights computed using logistic regression models","Baseline",,,"36.8","6.8",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.3966",,"0.6034","Mixed","terrorism/political violence/forced displacement, community/school violence, accidents","Medium","Duffy M, Gillespie K, Clark DM. Post-traumatic stress disorder in the context of terrorism and other civil conflict in Northern Ireland: randomised controlled trial. BMJ. 2007 Jun 2;334(7604):1147-50. doi: 10.1136/bmj.39021.846852.BE. PMID: 17495988.","29736","2019"
"dunlop2017_CAPS_A_0_Comp","Pharmacotherapy","PTSD","128","A","PTSD",,"47",,"GSK561679 investigational drug","GSK561679 investigational drug","No","Not Applicable","Yes","Other pharmacotherapy","No","Not Applicable","No","No","No","No","No","Individual","In Person","63","Structured Clinical Interview","CAPS","CAPS (past week total score)","Completer",,"Multivariable weighted generalized estimating equations; weights computed using logistic regression models","End of Treatment","0",,"46.4",,,,,,"-30.0","25.3",,,,"Cohen's d","1.80",,,,"p=0.001",,,,,,,,,,,">50% decrease in total CAPS score from baseline",,"Additional definitions of Clinically Meaningful Response reported in the study",,,,,"1",,"0","Mixed","combat-related, other (unspecified child abuse, unspecified)","Medium","Dunlop BW, Binder EB, Iosifescu D, et al. Corticotropin-releasing factor receptor 1 antagonism is ineffective for women with posttraumatic stress disorder. Biol Psychiatry. 2017 Dec;82(12):866-74. doi: 10.1016/j.biopsych.2017.06.024. PMID: 28793974","49315","2019"
"dunlop2017_CAPS_A_0_ITT","Pharmacotherapy","PTSD","128","A","PTSD",,,,"GSK561679 investigational drug","GSK561679 investigational drug","No","Not Applicable","Yes","Other pharmacotherapy","No","Not Applicable","No","No","No","No","No","Individual","In Person","63","Structured Clinical Interview","CAPS","CAPS (past week total score)","ITT","Restricted maximum likelihood estimation with dichotomous outcomes imputed as negative/ nonresponsive to treatment.","Multivariable weighted generalized estimating equations; weights computed using logistic regression models","End of Treatment","0",,,,,,,,,,,,,,,,,,,,,,,,,,,,,">50% decrease in total CAPS score from baseline","0.2222","Additional definitions of Clinically Meaningful Response reported in the study",,,,,"1",,"0","Mixed","combat-related, other (unspecified child abuse, unspecified)","Medium","Dunlop BW, Binder EB, Iosifescu D, et al. Corticotropin-releasing factor receptor 1 antagonism is ineffective for women with posttraumatic stress disorder. Biol Psychiatry. 2017 Dec;82(12):866-74. doi: 10.1016/j.biopsych.2017.06.024. PMID: 28793974","49315","2019"
"dunlop2017_CAPS_A_Baseline_Comp","Pharmacotherapy","PTSD","128","A","PTSD",,"47",,"GSK561679 investigational drug","GSK561679 investigational drug","No","Not Applicable","Yes","Other pharmacotherapy","No","Not Applicable","No","No","No","No","No","Individual","In Person","63","Structured Clinical Interview","CAPS","CAPS (past week total score)","Completer",,"Multivariable weighted generalized estimating equations; weights computed using logistic regression models","Baseline",,,"76.4","14.1",,,,,,,,,,,,,,,,,,,,,,,,,,">50% decrease in total CAPS score from baseline",,"Additional definitions of Clinically Meaningful Response reported in the study",,,,,"1",,"0","Mixed","combat-related, other (unspecified child abuse, unspecified)","Medium","Dunlop BW, Binder EB, Iosifescu D, et al. Corticotropin-releasing factor receptor 1 antagonism is ineffective for women with posttraumatic stress disorder. Biol Psychiatry. 2017 Dec;82(12):866-74. doi: 10.1016/j.biopsych.2017.06.024. PMID: 28793974","49315","2019"
"dunlop2017_CAPS_A_Baseline_ITT","Pharmacotherapy","PTSD","128","A","PTSD",,"63",,"GSK561679 investigational drug","GSK561679 investigational drug","No","Not Applicable","Yes","Other pharmacotherapy","No","Not Applicable","No","No","No","No","No","Individual","In Person","63","Structured Clinical Interview","CAPS","CAPS (past week total score)","ITT","Restricted maximum likelihood estimation with dichotomous outcomes imputed as negative/ nonresponsive to treatment.","Multivariable weighted generalized estimating equations; weights computed using logistic regression models","Baseline",,,"77.5","14.3",,,,,,,,,,,,,,,,,,,,,,,,,,">50% decrease in total CAPS score from baseline",,"Additional definitions of Clinically Meaningful Response reported in the study",,,,,"1",,"0","Mixed","combat-related, other (unspecified child abuse, unspecified)","Medium","Dunlop BW, Binder EB, Iosifescu D, et al. Corticotropin-releasing factor receptor 1 antagonism is ineffective for women with posttraumatic stress disorder. Biol Psychiatry. 2017 Dec;82(12):866-74. doi: 10.1016/j.biopsych.2017.06.024. PMID: 28793974","49315","2019"
"dunlop2017_CAPS_B_0_Comp","Pharmacotherapy","PTSD","128","B","Control",,"49",,"Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","65","Structured Clinical Interview","CAPS","CAPS (past week total score)","Completer",,"Multivariable weighted generalized estimating equations; weights computed using logistic regression models","End of Treatment","0",,"42.0",,,,,,"-30.4","23.1",,,,"Cohen's d","1.70",,,,"p=0.001",,,,,,,,,,,">50% decrease in total CAPS score from baseline",,"Additional definitions of Clinically Meaningful Response reported in the study",,,,,"1",,"0","Mixed","combat-related, other (unspecified child abuse, unspecified)","Medium","Dunlop BW, Binder EB, Iosifescu D, et al. Corticotropin-releasing factor receptor 1 antagonism is ineffective for women with posttraumatic stress disorder. Biol Psychiatry. 2017 Dec;82(12):866-74. doi: 10.1016/j.biopsych.2017.06.024. PMID: 28793974","49315","2019"
"dunlop2017_CAPS_B_0_ITT","Pharmacotherapy","PTSD","128","B","Control",,,,"Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","65","Structured Clinical Interview","CAPS","CAPS (past week total score)","ITT","Restricted maximum likelihood estimation with dichotomous outcomes imputed as negative/ nonresponsive to treatment.","Multivariable weighted generalized estimating equations; weights computed using logistic regression models","End of Treatment","0",,,,,,,,,,,,,,,,,,,,,,,,,,,,,">50% decrease in total CAPS score from baseline","0.2769","Additional definitions of Clinically Meaningful Response reported in the study",,,,,"1",,"0","Mixed","combat-related, other (unspecified child abuse, unspecified)","Medium","Dunlop BW, Binder EB, Iosifescu D, et al. Corticotropin-releasing factor receptor 1 antagonism is ineffective for women with posttraumatic stress disorder. Biol Psychiatry. 2017 Dec;82(12):866-74. doi: 10.1016/j.biopsych.2017.06.024. PMID: 28793974","49315","2019"
"dunlop2017_CAPS_B_Baseline_Comp","Pharmacotherapy","PTSD","128","B","Control",,"49",,"Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","65","Structured Clinical Interview","CAPS","CAPS (past week total score)","Completer",,"Multivariable weighted generalized estimating equations; weights computed using logistic regression models","Baseline",,,"72.4","17.9",,,,,,,,,,,,,,,,,,,,,,,,,,">50% decrease in total CAPS score from baseline",,"Additional definitions of Clinically Meaningful Response reported in the study",,,,,"1",,"0","Mixed","combat-related, other (unspecified child abuse, unspecified)","Medium","Dunlop BW, Binder EB, Iosifescu D, et al. Corticotropin-releasing factor receptor 1 antagonism is ineffective for women with posttraumatic stress disorder. Biol Psychiatry. 2017 Dec;82(12):866-74. doi: 10.1016/j.biopsych.2017.06.024. PMID: 28793974","49315","2019"
"dunlop2017_CAPS_B_Baseline_ITT","Pharmacotherapy","PTSD","128","B","Control",,"65",,"Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","65","Structured Clinical Interview","CAPS","CAPS (past week total score)","ITT","Restricted maximum likelihood estimation with dichotomous outcomes imputed as negative/ nonresponsive to treatment.","Multivariable weighted generalized estimating equations; weights computed using logistic regression models","Baseline",,,"74.8","17.6",,,,,,,,,,,,,,,,,,,,,,,,,,">50% decrease in total CAPS score from baseline",,"Additional definitions of Clinically Meaningful Response reported in the study",,,,,"1",,"0","Mixed","combat-related, other (unspecified child abuse, unspecified)","Medium","Dunlop BW, Binder EB, Iosifescu D, et al. Corticotropin-releasing factor receptor 1 antagonism is ineffective for women with posttraumatic stress disorder. Biol Psychiatry. 2017 Dec;82(12):866-74. doi: 10.1016/j.biopsych.2017.06.024. PMID: 28793974","49315","2019"
"dunlop2017_PSS-SR_A_0_Comp","Pharmacotherapy","PTSD","128","A","PTSD",,,,"GSK561679 investigational drug","GSK561679 investigational drug","No","Not Applicable","Yes","Other pharmacotherapy","No","Not Applicable","No","No","No","No","No","Individual","In Person","63","Self report","PSS-SR","PSS-SR","Completer",,"Multivariable weighted generalized estimating equations; weights computed using logistic regression models","End of Treatment","0",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"1",,"0","Mixed","combat-related, other (unspecified child abuse, unspecified)","Medium","Dunlop BW, Binder EB, Iosifescu D, et al. Corticotropin-releasing factor receptor 1 antagonism is ineffective for women with posttraumatic stress disorder. Biol Psychiatry. 2017 Dec;82(12):866-74. doi: 10.1016/j.biopsych.2017.06.024. PMID: 28793974","49315","2019"
"dunlop2017_PSS-SR_A_0_ITT","Pharmacotherapy","PTSD","128","A","PTSD",,,,"GSK561679 investigational drug","GSK561679 investigational drug","No","Not Applicable","Yes","Other pharmacotherapy","No","Not Applicable","No","No","No","No","No","Individual","In Person","63","Self report","PSS-SR","PSS-SR","ITT",,"Multivariable weighted generalized estimating equations; weights computed using logistic regression models","End of Treatment","0",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"1",,"0","Mixed","combat-related, other (unspecified child abuse, unspecified)","Medium","Dunlop BW, Binder EB, Iosifescu D, et al. Corticotropin-releasing factor receptor 1 antagonism is ineffective for women with posttraumatic stress disorder. Biol Psychiatry. 2017 Dec;82(12):866-74. doi: 10.1016/j.biopsych.2017.06.024. PMID: 28793974","49315","2019"
"dunlop2017_PSS-SR_A_Baseline_Comp","Pharmacotherapy","PTSD","128","A","PTSD",,,,"GSK561679 investigational drug","GSK561679 investigational drug","No","Not Applicable","Yes","Other pharmacotherapy","No","Not Applicable","No","No","No","No","No","Individual","In Person","63","Self report","PSS-SR","PSS-SR","Completer",,"Multivariable weighted generalized estimating equations; weights computed using logistic regression models","Baseline",,,"32.3","5.6",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"1",,"0","Mixed","combat-related, other (unspecified child abuse, unspecified)","Medium","Dunlop BW, Binder EB, Iosifescu D, et al. Corticotropin-releasing factor receptor 1 antagonism is ineffective for women with posttraumatic stress disorder. Biol Psychiatry. 2017 Dec;82(12):866-74. doi: 10.1016/j.biopsych.2017.06.024. PMID: 28793974","49315","2019"
"dunlop2017_PSS-SR_A_Baseline_ITT","Pharmacotherapy","PTSD","128","A","PTSD",,,,"GSK561679 investigational drug","GSK561679 investigational drug","No","Not Applicable","Yes","Other pharmacotherapy","No","Not Applicable","No","No","No","No","No","Individual","In Person","63","Self report","PSS-SR","PSS-SR","ITT",,"Multivariable weighted generalized estimating equations; weights computed using logistic regression models","Baseline",,,"31.1","7.1",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"1",,"0","Mixed","combat-related, other (unspecified child abuse, unspecified)","Medium","Dunlop BW, Binder EB, Iosifescu D, et al. Corticotropin-releasing factor receptor 1 antagonism is ineffective for women with posttraumatic stress disorder. Biol Psychiatry. 2017 Dec;82(12):866-74. doi: 10.1016/j.biopsych.2017.06.024. PMID: 28793974","49315","2019"
"dunlop2017_PSS-SR_B_0_Comp","Pharmacotherapy","PTSD","128","B","Control",,,,"Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","65","Self report","PSS-SR","PSS-SR","Completer",,"Multivariable weighted generalized estimating equations; weights computed using logistic regression models","End of Treatment","0",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"1",,"0","Mixed","combat-related, other (unspecified child abuse, unspecified)","Medium","Dunlop BW, Binder EB, Iosifescu D, et al. Corticotropin-releasing factor receptor 1 antagonism is ineffective for women with posttraumatic stress disorder. Biol Psychiatry. 2017 Dec;82(12):866-74. doi: 10.1016/j.biopsych.2017.06.024. PMID: 28793974","49315","2019"
"dunlop2017_PSS-SR_B_0_ITT","Pharmacotherapy","PTSD","128","B","Control",,,,"Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","65","Self report","PSS-SR","PSS-SR","ITT",,"Multivariable weighted generalized estimating equations; weights computed using logistic regression models","End of Treatment","0",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"1",,"0","Mixed","combat-related, other (unspecified child abuse, unspecified)","Medium","Dunlop BW, Binder EB, Iosifescu D, et al. Corticotropin-releasing factor receptor 1 antagonism is ineffective for women with posttraumatic stress disorder. Biol Psychiatry. 2017 Dec;82(12):866-74. doi: 10.1016/j.biopsych.2017.06.024. PMID: 28793974","49315","2019"
"dunlop2017_PSS-SR_B_Baseline_Comp","Pharmacotherapy","PTSD","128","B","Control",,,,"Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","65","Self report","PSS-SR","PSS-SR","Completer",,"Multivariable weighted generalized estimating equations; weights computed using logistic regression models","Baseline",,,"29.9","9.8",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"1",,"0","Mixed","combat-related, other (unspecified child abuse, unspecified)","Medium","Dunlop BW, Binder EB, Iosifescu D, et al. Corticotropin-releasing factor receptor 1 antagonism is ineffective for women with posttraumatic stress disorder. Biol Psychiatry. 2017 Dec;82(12):866-74. doi: 10.1016/j.biopsych.2017.06.024. PMID: 28793974","49315","2019"
"dunlop2017_PSS-SR_B_Baseline_ITT","Pharmacotherapy","PTSD","128","B","Control",,,,"Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","65","Self report","PSS-SR","PSS-SR","ITT",,"Multivariable weighted generalized estimating equations; weights computed using logistic regression models","Baseline",,,"30.0","9.3",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"1",,"0","Mixed","combat-related, other (unspecified child abuse, unspecified)","Medium","Dunlop BW, Binder EB, Iosifescu D, et al. Corticotropin-releasing factor receptor 1 antagonism is ineffective for women with posttraumatic stress disorder. Biol Psychiatry. 2017 Dec;82(12):866-74. doi: 10.1016/j.biopsych.2017.06.024. PMID: 28793974","49315","2019"
"dunne2012_IES_A_0_NA","Psychotherapy","PTSD","26","A","PTSD",,,,"Trauma-focused CBT","Trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","13","Self report","IES","IES-R",,,"Multivariable weighted generalized estimating equations; weights computed using logistic regression models","End of Treatment","0",,"19.92","10.43",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.5",,"0.5","Accidents",,"High","Dunne RL, Kenardy JA, Sterling M. A randomized controlled trial of cognitive-behavioral therapy for the treatment of PTSD in the context of chronic whiplash. Clin J Pain. 2012 Nov-Dec;28(9):755-65. doi: 10.1097/AJP.0b013e318243e16b. PMID: 22209798.","39572","2019"
"dunne2012_IES_A_Baseline_NA","Psychotherapy","PTSD","26","A","PTSD",,,,"Trauma-focused CBT","Trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","13","Self report","IES","IES-R",,,"Multivariable weighted generalized estimating equations; weights computed using logistic regression models","Baseline",,,"34.77","12.93",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.5",,"0.5","Accidents",,"High","Dunne RL, Kenardy JA, Sterling M. A randomized controlled trial of cognitive-behavioral therapy for the treatment of PTSD in the context of chronic whiplash. Clin J Pain. 2012 Nov-Dec;28(9):755-65. doi: 10.1097/AJP.0b013e318243e16b. PMID: 22209798.","39572","2019"
"dunne2012_IES_B_0_NA","Psychotherapy","PTSD","26","B","Control",,,,"Waitlist","Waitlist","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,"13","Self report","IES","IES-R",,,"Multivariable weighted generalized estimating equations; weights computed using logistic regression models","End of Treatment","0",,"22.23","11.93",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.5",,"0.5","Accidents",,"High","Dunne RL, Kenardy JA, Sterling M. A randomized controlled trial of cognitive-behavioral therapy for the treatment of PTSD in the context of chronic whiplash. Clin J Pain. 2012 Nov-Dec;28(9):755-65. doi: 10.1097/AJP.0b013e318243e16b. PMID: 22209798.","39572","2019"
"dunne2012_IES_B_Baseline_NA","Psychotherapy","PTSD","26","B","Control",,,,"Waitlist","Waitlist","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,"13","Self report","IES","IES-R",,,"Multivariable weighted generalized estimating equations; weights computed using logistic regression models","Baseline",,,"32.62","11.92",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.5",,"0.5","Accidents",,"High","Dunne RL, Kenardy JA, Sterling M. A randomized controlled trial of cognitive-behavioral therapy for the treatment of PTSD in the context of chronic whiplash. Clin J Pain. 2012 Nov-Dec;28(9):755-65. doi: 10.1097/AJP.0b013e318243e16b. PMID: 22209798.","39572","2019"
"dunne2012_PDS_A_0_ITT","Psychotherapy","PTSD","26","A","PTSD",,"12",,"Trauma-focused CBT","Trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","13","Self report","PDS","PDS","ITT","LOCF","Multivariable weighted generalized estimating equations; weights computed using logistic regression models","End of Treatment","0",,"15.62","8.16",,,,,"-5.77",,,,,,,,,,,,,,,,,,"Not meeting criteria for PTSD according to SCID","0.6154",,"RCI of 7.8 on PDS","0.3077",,"Community",,,"1","0.5",,"0.5","Accidents",,"High","Dunne RL, Kenardy JA, Sterling M. A randomized controlled trial of cognitive-behavioral therapy for the treatment of PTSD in the context of chronic whiplash. Clin J Pain. 2012 Nov-Dec;28(9):755-65. doi: 10.1097/AJP.0b013e318243e16b. PMID: 22209798.","39572","2019"
"dunne2012_PDS_A_26_ITT","Psychotherapy","PTSD","26","A","PTSD",,"11",,"Trauma-focused CBT","Trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","13","Self report","PDS","PDS","ITT","LOCF","Multivariable weighted generalized estimating equations; weights computed using logistic regression models","Assessment at 6 to <12 Months","26",,"14.85","7.63",,,,,"-6.54",,,,,,,,,,"p<0.001",,,,,,,,"Not meeting criteria for PTSD according to SCID","0.6923",,"RCI of 7.8 on PDS","0.3846",,"Community",,,"1","0.5",,"0.5","Accidents",,"High","Dunne RL, Kenardy JA, Sterling M. A randomized controlled trial of cognitive-behavioral therapy for the treatment of PTSD in the context of chronic whiplash. Clin J Pain. 2012 Nov-Dec;28(9):755-65. doi: 10.1097/AJP.0b013e318243e16b. PMID: 22209798.","39572","2019"
"dunne2012_PDS_A_Baseline_ITT","Psychotherapy","PTSD","26","A","PTSD",,"13",,"Trauma-focused CBT","Trauma-focused cognitive behavioral therapy (TF-CBT)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","13","Self report","PDS","PDS","ITT","LOCF","Multivariable weighted generalized estimating equations; weights computed using logistic regression models","Baseline",,,"21.39","8.93",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.5",,"0.5","Accidents",,"High","Dunne RL, Kenardy JA, Sterling M. A randomized controlled trial of cognitive-behavioral therapy for the treatment of PTSD in the context of chronic whiplash. Clin J Pain. 2012 Nov-Dec;28(9):755-65. doi: 10.1097/AJP.0b013e318243e16b. PMID: 22209798.","39572","2019"
"dunne2012_PDS_B_0_ITT","Psychotherapy","PTSD","26","B","Control",,"12",,"Waitlist","Waitlist","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,"13","Self report","PDS","PDS","ITT","LOCF","Multivariable weighted generalized estimating equations; weights computed using logistic regression models","End of Treatment","0",,"23.31","7.97",,,,,"0",,,,,,,,,,,,,,,,,,"Not meeting criteria for PTSD according to SCID","0.0769",,"RCI of 7.8 on PDS","0",,"Community",,,"1","0.5",,"0.5","Accidents",,"High","Dunne RL, Kenardy JA, Sterling M. A randomized controlled trial of cognitive-behavioral therapy for the treatment of PTSD in the context of chronic whiplash. Clin J Pain. 2012 Nov-Dec;28(9):755-65. doi: 10.1097/AJP.0b013e318243e16b. PMID: 22209798.","39572","2019"
"dunne2012_PDS_B_Baseline_ITT","Psychotherapy","PTSD","26","B","Control",,"13",,"Waitlist","Waitlist","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,"13","Self report","PDS","PDS","ITT","LOCF","Multivariable weighted generalized estimating equations; weights computed using logistic regression models","Baseline",,,"23.31","7.75",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.5",,"0.5","Accidents",,"High","Dunne RL, Kenardy JA, Sterling M. A randomized controlled trial of cognitive-behavioral therapy for the treatment of PTSD in the context of chronic whiplash. Clin J Pain. 2012 Nov-Dec;28(9):755-65. doi: 10.1097/AJP.0b013e318243e16b. PMID: 22209798.","39572","2019"
"echeburua1996_SS-PTSD_A_0_ITT","Mixed: Psychotherapy & CIH","PTSD","20","A","PTSD",,"10",,"Cognitive Restructuring and coping-skills training","Cognitive restructuring and coping-skills training","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","10","Self report","SS-PTSD","Scale of Severity of Posttraumatic Stress Disorder Symptoms","ITT",,"Multivariable weighted generalized estimating equations; weights computed using logistic regression models","End of Treatment","0",,"12","6.94",,,,,"-24.7",,,,,,,,,,"p<0.001",,,,,,,,"Not meeting criteria for PTSD according to DSM-III-R","0.8",,,,,"Community",,,"1","1",,"0","Rape/sexual assault",,"High","Echeburua E, de Corral P, Sarasua B, et al. Treatment of acute posttraumatic stress disorder in rape victims: an experimental study. J Anxiety Disord. 1996 May-Jun;10(3):185-99. doi: 10.1016/0887-6185(96)89842-2.","07521","2019"
"echeburua1996_SS-PTSD_A_26_ITT","Mixed: Psychotherapy & CIH","PTSD","20","A","PTSD",,"10",,"Cognitive Restructuring and coping-skills training","Cognitive restructuring and coping-skills training","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","10","Self report","SS-PTSD","Scale of Severity of Posttraumatic Stress Disorder Symptoms","ITT",,"Multivariable weighted generalized estimating equations; weights computed using logistic regression models","Assessment at 6 to <12 Months","26",,"6","3.62",,,,,"-30.7",,,,,,,,,,"p<0.05",,,,,,,,"Not meeting criteria for PTSD according to DSM-III-R","1",,,,,"Community",,,"1","1",,"0","Rape/sexual assault",,"High","Echeburua E, de Corral P, Sarasua B, et al. Treatment of acute posttraumatic stress disorder in rape victims: an experimental study. J Anxiety Disord. 1996 May-Jun;10(3):185-99. doi: 10.1016/0887-6185(96)89842-2.","07521","2019"
"echeburua1996_SS-PTSD_A_4_ITT","Mixed: Psychotherapy & CIH","PTSD","20","A","PTSD",,"10",,"Cognitive Restructuring and coping-skills training","Cognitive restructuring and coping-skills training","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","10","Self report","SS-PTSD","Scale of Severity of Posttraumatic Stress Disorder Symptoms","ITT",,"Multivariable weighted generalized estimating equations; weights computed using logistic regression models","Assessment at <3 Months","4",,"8","4.42",,,,,"-28.7",,,,,,,,,,"p<0.001",,,,,,,,"Not meeting criteria for PTSD according to DSM-III-R","1",,,,,"Community",,,"1","1",,"0","Rape/sexual assault",,"High","Echeburua E, de Corral P, Sarasua B, et al. Treatment of acute posttraumatic stress disorder in rape victims: an experimental study. J Anxiety Disord. 1996 May-Jun;10(3):185-99. doi: 10.1016/0887-6185(96)89842-2.","07521","2019"
"echeburua1996_SS-PTSD_A_52_ITT","Mixed: Psychotherapy & CIH","PTSD","20","A","PTSD",,"10",,"Cognitive Restructuring and coping-skills training","Cognitive restructuring and coping-skills training","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","10","Self report","SS-PTSD","Scale of Severity of Posttraumatic Stress Disorder Symptoms","ITT",,"Multivariable weighted generalized estimating equations; weights computed using logistic regression models","Assessment at ≥12 Months","52",,"5","2.49",,,,,"-31.7",,,,,,,,,,"p<0.01",,,,,,,,"Not meeting criteria for PTSD according to DSM-III-R","1",,,,,"Community",,,"1","1",,"0","Rape/sexual assault",,"High","Echeburua E, de Corral P, Sarasua B, et al. Treatment of acute posttraumatic stress disorder in rape victims: an experimental study. J Anxiety Disord. 1996 May-Jun;10(3):185-99. doi: 10.1016/0887-6185(96)89842-2.","07521","2019"
"echeburua1996_SS-PTSD_A_Baseline_ITT","Mixed: Psychotherapy & CIH","PTSD","20","A","PTSD",,"10",,"Cognitive Restructuring and coping-skills training","Cognitive restructuring and coping-skills training","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","10","Self report","SS-PTSD","Scale of Severity of Posttraumatic Stress Disorder Symptoms","ITT",,"Multivariable weighted generalized estimating equations; weights computed using logistic regression models","Baseline",,,"36.7","8.59",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","1",,"0","Rape/sexual assault",,"High","Echeburua E, de Corral P, Sarasua B, et al. Treatment of acute posttraumatic stress disorder in rape victims: an experimental study. J Anxiety Disord. 1996 May-Jun;10(3):185-99. doi: 10.1016/0887-6185(96)89842-2.","07521","2019"
"echeburua1996_SS-PTSD_B_0_ITT","Mixed: Psychotherapy & CIH","PTSD","20","B","PTSD",,"10",,"Progressive muscular relaxation","Progressive muscle relaxation (PMR)","No","Not Applicable","No","Not Applicable","Yes","Relaxation","No","No","No","No","No","Individual","In Person","10","Self report","SS-PTSD","Scale of Severity of Posttraumatic Stress Disorder Symptoms","ITT",,"Multivariable weighted generalized estimating equations; weights computed using logistic regression models","End of Treatment","0",,"18.7","9.2",,,,,"-15.6",,,,,,,,,,"p<0.001",,,,,,,,"Not meeting criteria for PTSD according to DSM-III-R","0.5",,,,,"Community",,,"1","1",,"0","Rape/sexual assault",,"High","Echeburua E, de Corral P, Sarasua B, et al. Treatment of acute posttraumatic stress disorder in rape victims: an experimental study. J Anxiety Disord. 1996 May-Jun;10(3):185-99. doi: 10.1016/0887-6185(96)89842-2.","07521","2019"
"echeburua1996_SS-PTSD_B_26_ITT","Mixed: Psychotherapy & CIH","PTSD","20","B","PTSD",,"10",,"Progressive muscular relaxation","Progressive muscle relaxation (PMR)","No","Not Applicable","No","Not Applicable","Yes","Relaxation","No","No","No","No","No","Individual","In Person","10","Self report","SS-PTSD","Scale of Severity of Posttraumatic Stress Disorder Symptoms","ITT",,"Multivariable weighted generalized estimating equations; weights computed using logistic regression models","Assessment at 6 to <12 Months","26",,"10.3","6.7",,,,,"-24",,,,,,,,,,"p<0.001",,,,,,,,"Not meeting criteria for PTSD according to DSM-III-R","0.9",,,,,"Community",,,"1","1",,"0","Rape/sexual assault",,"High","Echeburua E, de Corral P, Sarasua B, et al. Treatment of acute posttraumatic stress disorder in rape victims: an experimental study. J Anxiety Disord. 1996 May-Jun;10(3):185-99. doi: 10.1016/0887-6185(96)89842-2.","07521","2019"
"echeburua1996_SS-PTSD_B_4_ITT","Mixed: Psychotherapy & CIH","PTSD","20","B","PTSD",,"10",,"Progressive muscular relaxation","Progressive muscle relaxation (PMR)","No","Not Applicable","No","Not Applicable","Yes","Relaxation","No","No","No","No","No","Individual","In Person","10","Self report","SS-PTSD","Scale of Severity of Posttraumatic Stress Disorder Symptoms","ITT",,"Multivariable weighted generalized estimating equations; weights computed using logistic regression models","Assessment at <3 Months","4",,"14","8.34",,,,,"-20.3",,,,,,,,,,"p<0.001",,,,,,,,"Not meeting criteria for PTSD according to DSM-III-R","0.8",,,,,"Community",,,"1","1",,"0","Rape/sexual assault",,"High","Echeburua E, de Corral P, Sarasua B, et al. Treatment of acute posttraumatic stress disorder in rape victims: an experimental study. J Anxiety Disord. 1996 May-Jun;10(3):185-99. doi: 10.1016/0887-6185(96)89842-2.","07521","2019"
"echeburua1996_SS-PTSD_B_52_ITT","Mixed: Psychotherapy & CIH","PTSD","20","B","PTSD",,"10",,"Progressive muscular relaxation","Progressive muscle relaxation (PMR)","No","Not Applicable","No","Not Applicable","Yes","Relaxation","No","No","No","No","No","Individual","In Person","10","Self report","SS-PTSD","Scale of Severity of Posttraumatic Stress Disorder Symptoms","ITT",,"Multivariable weighted generalized estimating equations; weights computed using logistic regression models","Assessment at ≥12 Months","52",,"10.5","7.16",,,,,"-23.8",,,,,,,,,,"p<0.001",,,,,,,,"Not meeting criteria for PTSD according to DSM-III-R","0.8",,,,,"Community",,,"1","1",,"0","Rape/sexual assault",,"High","Echeburua E, de Corral P, Sarasua B, et al. Treatment of acute posttraumatic stress disorder in rape victims: an experimental study. J Anxiety Disord. 1996 May-Jun;10(3):185-99. doi: 10.1016/0887-6185(96)89842-2.","07521","2019"
"echeburua1996_SS-PTSD_B_Baseline_ITT","Mixed: Psychotherapy & CIH","PTSD","20","B","PTSD",,"10",,"Progressive muscular relaxation","Progressive muscle relaxation (PMR)","No","Not Applicable","No","Not Applicable","Yes","Relaxation","No","No","No","No","No","Individual","In Person","10","Self report","SS-PTSD","Scale of Severity of Posttraumatic Stress Disorder Symptoms","ITT",,"Multivariable weighted generalized estimating equations; weights computed using logistic regression models","Baseline",,,"34.3","7.54",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1","1",,"0","Rape/sexual assault",,"High","Echeburua E, de Corral P, Sarasua B, et al. Treatment of acute posttraumatic stress disorder in rape victims: an experimental study. J Anxiety Disord. 1996 May-Jun;10(3):185-99. doi: 10.1016/0887-6185(96)89842-2.","07521","2019"
"ehlers2003_CAPS_A_0_Comp","Psychotherapy","PTSD","85","A","PTSD",,"28",,"Cognitive Therapy","Cognitive Therapy for PTSD (CT-PTSD)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","28","Structured Clinical Interview","CAPS","CAPS intensity","Completer",,"Multivariable weighted generalized estimating equations; weights computed using logistic regression models","End of Treatment","0",,"10.2","9.4",,,,,"-16.5",,,,,"Cohen's d","2.28",,,,,,,,,,,,"Not meeting criteria for PTSD according to CAPS.","0.8571","Additional definitions of Diagnostic Change reported in the study","≥50% decrease on PDS","0.8214","Additional definitions of Clinically Meaningful Response reported in the study","Community",,,"1",,,,"Accidents",,"Medium","Ehlers A, Clark DM, Hackmann A, et al. A randomized controlled trial of cognitive therapy, a self-help booklet, and repeated assessments as early interventions for posttraumatic stress disorder. Arch Gen Psychiatry. 2003;60(10):1024-32. doi: 10.1001/archpsyc.60.10.1024. PMID: 14557148.","25861","2019"
"ehlers2003_CAPS_A_0_ITT","Psychotherapy","PTSD","85","A","PTSD",,,,"Cognitive Therapy","Cognitive Therapy for PTSD (CT-PTSD)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","28","Structured Clinical Interview","CAPS","CAPS intensity","ITT",,"Multivariable weighted generalized estimating equations; weights computed using logistic regression models","End of Treatment","0",,,,,,,,,,,,,,,,,,,,,,,,,,"Not meeting criteria for PTSD according to CAPS.","0.8571","Additional definitions of Diagnostic Change reported in the study","≥50% decrease on PDS","0.8214","Additional definitions of Clinically Meaningful Response reported in the study","Community",,,"1",,,,"Accidents",,"Medium","Ehlers A, Clark DM, Hackmann A, et al. A randomized controlled trial of cognitive therapy, a self-help booklet, and repeated assessments as early interventions for posttraumatic stress disorder. Arch Gen Psychiatry. 2003;60(10):1024-32. doi: 10.1001/archpsyc.60.10.1024. PMID: 14557148.","25861","2019"
"ehlers2003_CAPS_A_39_Comp","Psychotherapy","PTSD","85","A","PTSD",,"28",,"Cognitive Therapy","Cognitive Therapy for PTSD (CT-PTSD)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","28","Structured Clinical Interview","CAPS","CAPS intensity","Completer",,"Multivariable weighted generalized estimating equations; weights computed using logistic regression models","Assessment at 6 to <12 Months","39",,"9.7","9.5",,,,,"-17",,,,,"Cohen's d","2.37",,,,,,,,,,,,"Not meeting criteria for PTSD according to CAPS.","0.8571","Additional definitions of Diagnostic Change reported in the study","≥50% decrease on PDS","0.8929","Additional definitions of Clinically Meaningful Response reported in the study","Community",,,"1",,,,"Accidents",,"Medium","Ehlers A, Clark DM, Hackmann A, et al. A randomized controlled trial of cognitive therapy, a self-help booklet, and repeated assessments as early interventions for posttraumatic stress disorder. Arch Gen Psychiatry. 2003;60(10):1024-32. doi: 10.1001/archpsyc.60.10.1024. PMID: 14557148.","25861","2019"
"ehlers2003_CAPS_A_39_ITT","Psychotherapy","PTSD","85","A","PTSD",,,,"Cognitive Therapy","Cognitive Therapy for PTSD (CT-PTSD)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","28","Structured Clinical Interview","CAPS","CAPS intensity","ITT",,"Multivariable weighted generalized estimating equations; weights computed using logistic regression models","Assessment at 6 to <12 Months","39",,,,,,,,,,,,,,,,,,,,,,,,,,"Not meeting criteria for PTSD according to CAPS.","0.8571","Additional definitions of Diagnostic Change reported in the study","≥50% decrease on PDS","0.8929","Additional definitions of Clinically Meaningful Response reported in the study","Community",,,"1",,,,"Accidents",,"Medium","Ehlers A, Clark DM, Hackmann A, et al. A randomized controlled trial of cognitive therapy, a self-help booklet, and repeated assessments as early interventions for posttraumatic stress disorder. Arch Gen Psychiatry. 2003;60(10):1024-32. doi: 10.1001/archpsyc.60.10.1024. PMID: 14557148.","25861","2019"
"ehlers2003_CAPS_A_Baseline_Comp","Psychotherapy","PTSD","85","A","PTSD",,"28",,"Cognitive Therapy","Cognitive Therapy for PTSD (CT-PTSD)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","28","Structured Clinical Interview","CAPS","CAPS intensity","Completer",,"Multivariable weighted generalized estimating equations; weights computed using logistic regression models","Baseline",,,"26.7","7.4",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1",,,,"Accidents",,"Medium","Ehlers A, Clark DM, Hackmann A, et al. A randomized controlled trial of cognitive therapy, a self-help booklet, and repeated assessments as early interventions for posttraumatic stress disorder. Arch Gen Psychiatry. 2003;60(10):1024-32. doi: 10.1001/archpsyc.60.10.1024. PMID: 14557148.","25861","2019"
"ehlers2003_CAPS_B_0_Comp","Psychotherapy","PTSD","85","B","Control",,"25",,"Self-help booklet","Self-help booklet","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,"28","Structured Clinical Interview","CAPS","CAPS intensity","Completer",,"Multivariable weighted generalized estimating equations; weights computed using logistic regression models","End of Treatment","0",,"19.6","9",,,,,"-7.1",,,,,"Cohen's d","1.11",,,,,,,,,,,,"Not meeting criteria for PTSD according to CAPS.","0.24","Additional definitions of Diagnostic Change reported in the study","≥50% decrease on PDS","0.28","Additional definitions of Clinically Meaningful Response reported in the study","Community",,,"1",,,,"Accidents",,"Medium","Ehlers A, Clark DM, Hackmann A, et al. A randomized controlled trial of cognitive therapy, a self-help booklet, and repeated assessments as early interventions for posttraumatic stress disorder. Arch Gen Psychiatry. 2003;60(10):1024-32. doi: 10.1001/archpsyc.60.10.1024. PMID: 14557148.","25861","2019"
"ehlers2003_CAPS_B_0_ITT","Psychotherapy","PTSD","85","B","Control",,,,"Self-help booklet","Self-help booklet","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,"28","Structured Clinical Interview","CAPS","CAPS intensity","ITT",,"Multivariable weighted generalized estimating equations; weights computed using logistic regression models","End of Treatment","0",,,,,,,,,,,,,,,,,,,,,,,,,,"Not meeting criteria for PTSD according to CAPS.","0.2143","Additional definitions of Diagnostic Change reported in the study","≥50% decrease on PDS","0.25","Additional definitions of Clinically Meaningful Response reported in the study","Community",,,"1",,,,"Accidents",,"Medium","Ehlers A, Clark DM, Hackmann A, et al. A randomized controlled trial of cognitive therapy, a self-help booklet, and repeated assessments as early interventions for posttraumatic stress disorder. Arch Gen Psychiatry. 2003;60(10):1024-32. doi: 10.1001/archpsyc.60.10.1024. PMID: 14557148.","25861","2019"
"ehlers2003_CAPS_B_39_Comp","Psychotherapy","PTSD","85","B","Control",,"25",,"Self-help booklet","Self-help booklet","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,"28","Structured Clinical Interview","CAPS","CAPS intensity","Completer",,"Multivariable weighted generalized estimating equations; weights computed using logistic regression models","Assessment at 6 to <12 Months","39",,"18.6","10.1",,,,,"-8.1",,,,,"Cohen's d","1.28",,,,,,,,,,,,"Not meeting criteria for PTSD according to CAPS.","0.28","Additional definitions of Diagnostic Change reported in the study","≥50% decrease on PDS","0.28","Additional definitions of Clinically Meaningful Response reported in the study","Community",,,"1",,,,"Accidents",,"Medium","Ehlers A, Clark DM, Hackmann A, et al. A randomized controlled trial of cognitive therapy, a self-help booklet, and repeated assessments as early interventions for posttraumatic stress disorder. Arch Gen Psychiatry. 2003;60(10):1024-32. doi: 10.1001/archpsyc.60.10.1024. PMID: 14557148.","25861","2019"
"ehlers2003_CAPS_B_39_ITT","Psychotherapy","PTSD","85","B","Control",,,,"Self-help booklet","Self-help booklet","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,"28","Structured Clinical Interview","CAPS","CAPS intensity","ITT",,"Multivariable weighted generalized estimating equations; weights computed using logistic regression models","Assessment at 6 to <12 Months","39",,,,,,,,,,,,,,,,,,,,,,,,,,"Not meeting criteria for PTSD according to CAPS.","0.25","Additional definitions of Diagnostic Change reported in the study","≥50% decrease on PDS","0.25","Additional definitions of Clinically Meaningful Response reported in the study","Community",,,"1",,,,"Accidents",,"Medium","Ehlers A, Clark DM, Hackmann A, et al. A randomized controlled trial of cognitive therapy, a self-help booklet, and repeated assessments as early interventions for posttraumatic stress disorder. Arch Gen Psychiatry. 2003;60(10):1024-32. doi: 10.1001/archpsyc.60.10.1024. PMID: 14557148.","25861","2019"
"ehlers2003_CAPS_B_Baseline_Comp","Psychotherapy","PTSD","85","B","Control",,"25",,"Self-help booklet","Self-help booklet","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,"28","Structured Clinical Interview","CAPS","CAPS intensity","Completer",,"Multivariable weighted generalized estimating equations; weights computed using logistic regression models","Baseline",,,"26.7","7.4",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1",,,,"Accidents",,"Medium","Ehlers A, Clark DM, Hackmann A, et al. A randomized controlled trial of cognitive therapy, a self-help booklet, and repeated assessments as early interventions for posttraumatic stress disorder. Arch Gen Psychiatry. 2003;60(10):1024-32. doi: 10.1001/archpsyc.60.10.1024. PMID: 14557148.","25861","2019"
"ehlers2003_CAPS_C_0_Comp","Psychotherapy","PTSD","85","C","Control",,"27",,"Repeated assessments","Assessment","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","29","Structured Clinical Interview","CAPS","CAPS intensity","Completer",,"Multivariable weighted generalized estimating equations; weights computed using logistic regression models","End of Treatment","0",,"22.4","11.9",,,,,"-3.5",,,,,"Cohen's d","0.52",,,,,,,,,,,,"Not meeting criteria for PTSD according to CAPS.","0.2963","Additional definitions of Diagnostic Change reported in the study","≥50% decrease on PDS","0.2222","Additional definitions of Clinically Meaningful Response reported in the study","Community",,,"1",,,,"Accidents",,"Medium","Ehlers A, Clark DM, Hackmann A, et al. A randomized controlled trial of cognitive therapy, a self-help booklet, and repeated assessments as early interventions for posttraumatic stress disorder. Arch Gen Psychiatry. 2003;60(10):1024-32. doi: 10.1001/archpsyc.60.10.1024. PMID: 14557148.","25861","2019"
"ehlers2003_CAPS_C_0_ITT","Psychotherapy","PTSD","85","C","Control",,,,"Repeated assessments","Assessment","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","29","Structured Clinical Interview","CAPS","CAPS intensity","ITT",,"Multivariable weighted generalized estimating equations; weights computed using logistic regression models","End of Treatment","0",,,,,,,,,,,,,,,,,,,,,,,,,,"Not meeting criteria for PTSD according to CAPS.","0.2759","Additional definitions of Diagnostic Change reported in the study","≥50% decrease on PDS","0.2069","Additional definitions of Clinically Meaningful Response reported in the study","Community",,,"1",,,,"Accidents",,"Medium","Ehlers A, Clark DM, Hackmann A, et al. A randomized controlled trial of cognitive therapy, a self-help booklet, and repeated assessments as early interventions for posttraumatic stress disorder. Arch Gen Psychiatry. 2003;60(10):1024-32. doi: 10.1001/archpsyc.60.10.1024. PMID: 14557148.","25861","2019"
"ehlers2003_CAPS_C_39_Comp","Psychotherapy","PTSD","85","C","Control",,"27",,"Repeated assessments","Assessment","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","29","Structured Clinical Interview","CAPS","CAPS intensity","Completer",,"Multivariable weighted generalized estimating equations; weights computed using logistic regression models","Assessment at 6 to <12 Months","39",,"17","13.8",,,,,"-8.9",,,,,"Cohen's d","1.00",,,,,,,,,,,,"Not meeting criteria for PTSD according to CAPS.","0.4615","Additional definitions of Diagnostic Change reported in the study","≥50% decrease on PDS","0.4231","Additional definitions of Clinically Meaningful Response reported in the study","Community",,,"1",,,,"Accidents",,"Medium","Ehlers A, Clark DM, Hackmann A, et al. A randomized controlled trial of cognitive therapy, a self-help booklet, and repeated assessments as early interventions for posttraumatic stress disorder. Arch Gen Psychiatry. 2003;60(10):1024-32. doi: 10.1001/archpsyc.60.10.1024. PMID: 14557148.","25861","2019"
"ehlers2003_CAPS_C_39_ITT","Psychotherapy","PTSD","85","C","Control",,,,"Repeated assessments","Assessment","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","29","Structured Clinical Interview","CAPS","CAPS intensity","ITT",,"Multivariable weighted generalized estimating equations; weights computed using logistic regression models","Assessment at 6 to <12 Months","39",,,,,,,,,,,,,,,,,,,,,,,,,,"Not meeting criteria for PTSD according to CAPS.","0.4483","Additional definitions of Diagnostic Change reported in the study","≥50% decrease on PDS","0.4138","Additional definitions of Clinically Meaningful Response reported in the study","Community",,,"1",,,,"Accidents",,"Medium","Ehlers A, Clark DM, Hackmann A, et al. A randomized controlled trial of cognitive therapy, a self-help booklet, and repeated assessments as early interventions for posttraumatic stress disorder. Arch Gen Psychiatry. 2003;60(10):1024-32. doi: 10.1001/archpsyc.60.10.1024. PMID: 14557148.","25861","2019"
"ehlers2003_CAPS_C_Baseline_Comp","Psychotherapy","PTSD","85","C","Control",,"27",,"Repeated assessments","Assessment","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","29","Structured Clinical Interview","CAPS","CAPS intensity","Completer",,"Multivariable weighted generalized estimating equations; weights computed using logistic regression models","Baseline",,,"25.9","10.4",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1",,,,"Accidents",,"Medium","Ehlers A, Clark DM, Hackmann A, et al. A randomized controlled trial of cognitive therapy, a self-help booklet, and repeated assessments as early interventions for posttraumatic stress disorder. Arch Gen Psychiatry. 2003;60(10):1024-32. doi: 10.1001/archpsyc.60.10.1024. PMID: 14557148.","25861","2019"
"ehlers2003_PDS_A_0_NA","Psychotherapy","PTSD","85","A","PTSD",,,,"Cognitive Therapy","Cognitive Therapy for PTSD (CT-PTSD)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","28","Self report","PDS","PDS frequency",,,"Multivariable weighted generalized estimating equations; weights computed using logistic regression models","End of Treatment","0",,"8.3","9.8",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1",,,,"Accidents",,"Medium","Ehlers A, Clark DM, Hackmann A, et al. A randomized controlled trial of cognitive therapy, a self-help booklet, and repeated assessments as early interventions for posttraumatic stress disorder. Arch Gen Psychiatry. 2003;60(10):1024-32. doi: 10.1001/archpsyc.60.10.1024. PMID: 14557148.","25861","2019"
"ehlers2003_PDS_A_39_NA","Psychotherapy","PTSD","85","A","PTSD",,,,"Cognitive Therapy","Cognitive Therapy for PTSD (CT-PTSD)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","28","Self report","PDS","PDS frequency",,,"Multivariable weighted generalized estimating equations; weights computed using logistic regression models","Assessment at 6 to <12 Months","39",,"8.7","8.1",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1",,,,"Accidents",,"Medium","Ehlers A, Clark DM, Hackmann A, et al. A randomized controlled trial of cognitive therapy, a self-help booklet, and repeated assessments as early interventions for posttraumatic stress disorder. Arch Gen Psychiatry. 2003;60(10):1024-32. doi: 10.1001/archpsyc.60.10.1024. PMID: 14557148.","25861","2019"
"ehlers2003_PDS_A_Baseline_NA","Psychotherapy","PTSD","85","A","PTSD",,,,"Cognitive Therapy","Cognitive Therapy for PTSD (CT-PTSD)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","28","Self report","PDS","PDS frequency",,,"Multivariable weighted generalized estimating equations; weights computed using logistic regression models","Baseline",,,"26.2","7.4",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1",,,,"Accidents",,"Medium","Ehlers A, Clark DM, Hackmann A, et al. A randomized controlled trial of cognitive therapy, a self-help booklet, and repeated assessments as early interventions for posttraumatic stress disorder. Arch Gen Psychiatry. 2003;60(10):1024-32. doi: 10.1001/archpsyc.60.10.1024. PMID: 14557148.","25861","2019"
"ehlers2003_PDS_B_0_NA","Psychotherapy","PTSD","85","B","Control",,,,"Self-help booklet","Self-help booklet","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,"28","Self report","PDS","PDS frequency",,,"Multivariable weighted generalized estimating equations; weights computed using logistic regression models","End of Treatment","0",,"19.9","7.8",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1",,,,"Accidents",,"Medium","Ehlers A, Clark DM, Hackmann A, et al. A randomized controlled trial of cognitive therapy, a self-help booklet, and repeated assessments as early interventions for posttraumatic stress disorder. Arch Gen Psychiatry. 2003;60(10):1024-32. doi: 10.1001/archpsyc.60.10.1024. PMID: 14557148.","25861","2019"
"ehlers2003_PDS_B_39_NA","Psychotherapy","PTSD","85","B","Control",,,,"Self-help booklet","Self-help booklet","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,"28","Self report","PDS","PDS frequency",,,"Multivariable weighted generalized estimating equations; weights computed using logistic regression models","Assessment at 6 to <12 Months","39",,"20.0","7.8",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1",,,,"Accidents",,"Medium","Ehlers A, Clark DM, Hackmann A, et al. A randomized controlled trial of cognitive therapy, a self-help booklet, and repeated assessments as early interventions for posttraumatic stress disorder. Arch Gen Psychiatry. 2003;60(10):1024-32. doi: 10.1001/archpsyc.60.10.1024. PMID: 14557148.","25861","2019"
"ehlers2003_PDS_B_Baseline_NA","Psychotherapy","PTSD","85","B","Control",,,,"Self-help booklet","Self-help booklet","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,"28","Self report","PDS","PDS frequency",,,"Multivariable weighted generalized estimating equations; weights computed using logistic regression models","Baseline",,,"27.9","7.1",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1",,,,"Accidents",,"Medium","Ehlers A, Clark DM, Hackmann A, et al. A randomized controlled trial of cognitive therapy, a self-help booklet, and repeated assessments as early interventions for posttraumatic stress disorder. Arch Gen Psychiatry. 2003;60(10):1024-32. doi: 10.1001/archpsyc.60.10.1024. PMID: 14557148.","25861","2019"
"ehlers2003_PDS_C_0_NA","Psychotherapy","PTSD","85","C","Control",,,,"Repeated assessments","Assessment","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","29","Self report","PDS","PDS frequency",,,"Multivariable weighted generalized estimating equations; weights computed using logistic regression models","End of Treatment","0",,"22.6","11.6",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Community",,,"1",,,,"Accidents",,"Medium","Ehlers A, Clark DM, Hackmann A, et al. A randomized controlled trial of cognitive therapy, a self-help booklet, and repeated assessments as early interventions for posttraumatic stress disorder. Arch Gen Psychiatry. 2003;60(10):1024-32. doi: 10.1001/archpsyc.60.10.1024. PMID: 14557148.","25861","2019"
